@@96272859595 SETTING/VBG :/: University/NNP hospital-based/JJ ,/, tertiary/JJ care/NN infertility/NN center/NN ./.
@@86474344011 Large/NEWGENE T/NEWGENE antigen/NEWGENE was/VBD coimmunoprecipitated/VBN by/IN antibodies/NNS to/IN epitope-tagged/NN TBP/NEWGENE ,/, endogenous/JJ TBP/NEWGENE ,/, hTAF/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE 100/NEWGENE ,/, hTAF/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE 130/NEWGENE ,/, and/CC hTAF/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE 250/NEWGENE ,/, under/IN conditions/NNS where/CC holo-TFIID/NEWGENE would/MD be/VB precipitated/VBN ./.
@@107672516335 CONCLUSIONS/IN :/: This/DT randomized/JJ study/NN shows/VBZ that/IN Vivostat/NN fibrin/NEWGENE sealant/NN is/VBZ effective/JJ in/IN preventing/JJ air/NN leakage/NN after/IN small/JJ lung/NN resections/NNS in/IN pigs/NNS ,/, even/VB at/IN high/JJ inspiratory/JJ pressures/NNS ./.
@@96910312235 We/PRP propose/VBP a/DT model/NN in/IN which/WDT Sro7/NEWGENE function/NN is/VBZ involved/VBN in/IN the/DT targeting/NN of/IN the/DT myosin/NEWGENE proteins/NEWGENE to/IN their/PRP intrinsic/JJ pathways/NNS ./.
@@64685655 The/DT response/NN properties/NNS of/IN cat/NN horizontal/JJ canal/NN afferents/NNS (/( N/JJ =/SYM 81/CD )/SYM were/VBD characterized/VBN by/IN three/CD parameters/NNS :/: their/PRP long/JJ time/NN constants/NNS (/( tau/NN )/SYM ,/, low/JJ frequency/NN gain/NN constants/NNS (/( G1/NN )/SYM ,/, and/CC middle/JJ frequency/NN gain/NN constants/NNS (/( Gm/NN )/SYM ./.
@@97818718424 Glycogen/NNS synthesis/NN and/CC catabolism/NN ,/, gluconeogenesis/NN ,/, glycolysis/NN ,/, motility/NN ,/, cell/NN surface/NN properties/NNS and/CC adherence/NN are/VBP modulated/VBN by/IN csrA/NEWGENE in/NEWGENE Escherichia/NEWGENE coli/NEWGENE ,/, while/CC the/DT production/NN of/IN several/DT secreted/VBN virulence/NN factors/NNS ,/, the/DT plant/NN hypersensitive/JJ response/NN elicitor/NN HrpN/NN (/NN Ecc/NN )/NN and/CC ,/, potentially/RB ,/, other/DT secondary/JJ metabolites/NNS are/VBP regulated/VBN by/IN rsmA/NEWGENE in/NEWGENE Erwinia/NEWGENE carotovora/NEWGENE ./.
@@96258078427 We/PRP have/VBP applied/VBN the/DT mRNA/NN differential/JJ display/NN method/NN to/IN compare/NN and/CC analyze/VB mRNAs/NNS prepared/VBN from/IN five/CD normal/JJ nasopharyngeal/JJ epithelial/JJ cell/NN cultures/NNS and/CC five/CD nasopharyngeal/JJ carcinoma/NN cell/NN lines/NNS ./.
@@92056779158 Lung/NNP and/CC multi-system/NN damage/NN were/VBD early/NN indicators/NN of/IN poor/JJ outcome/NN in/IN severe/JJ non-fatal/NN disease/NN ./.
@@93543491565 Histological/JJ slides/NNS of/IN one/PRP biopsy/NN of/IN each/DT patient/NN (/( formalin-fixed/JJ and/CC paraffin-embedded/JJ )/SYM were/VBD stained/VBN with/IN a/DT Modified/JJ Giemsa/JJ (/( MG/NNP )/SYM ,/, the/DT Warthin-Starry/NNP (/( WS/NN )/SYM ,/, and/CC an/DT immunohistochemical/JJ method/NN (/( IMM/IN )/SYM using/VBG purified/VBN polyclonal/JJ H/NNP ./NNP pylori/NNS antiserum/NN (/( DAKO/NN B471/NN )/SYM ./.
@@94719849428 BACKGROUND/IN :/: Chemicals/NNPS vary/VBP considerably/RB in/IN their/PRP intrinsic/JJ ability/NN to/IN cause/NN allergic/JJ contact/NN dermatitis/NN ./.
@@88492087930 Demispan/NN is/VBZ a/DT reliable/JJ and/CC reproducible/JJ measure/NN of/IN stature/NN in/IN the/DT elderly/NN ./.
@@28097223507 In/NN one/PRP acromegalic/JJ patient/NN visual/JJ improvement/NN was/VBD obtained/VBN while/CC the/DT abnormal/JJ GH/NEWGENE secretion/NN remained/VBD unaltered/JJ ./.
@@97141098702 When/WRB the/DT blood/NN pressure/NN increase/NN in/IN response/NN to/IN smoking/NN was/VBD blunted/VBN by/IN nitroprusside/NN infusion/NN ,/, there/RB was/VBD a/DT striking/JJ increase/NN in/IN muscle/NN SNA/NN ./.
@@86493739552 Multiple/NNP single-stranded/JJ cis/NN elements/NN are/VBP associated/VBN with/IN activated/VBN chromatin/NN of/IN the/DT human/NEWGENE c-myc/NEWGENE gene/NEWGENE in/IN vivo/NN ./.
@@483735200 Removal/NNP of/IN thick/JJ ,/, permanently/RB altered/VBN mucoas/NNS is/VBZ recommended/VBN even/VB in/IN the/DT absence/NN of/IN squamous/JJ epithelium/NN ./.
@@92686319718 The/DT position/NN ,/, transcription/NN orientation/NN ,/, and/CC imprinted/JJ status/NN of/IN the/DT genes/NNS immediately/RB flanking/JJ Igf2r/NEWGENE have/VB been/VBN assessed/VBN ./.
@@1004346641 High-pressure/NNP effects/NNS on/IN ultrafast-relaxation/JJ kinetics/NN of/IN excitons/NNS in/IN polydiacetylene/NN 4BCMU/CD ./.
@@9832504194 Interestingly/RB ,/, we/PRP find/VBP that/IN the/DT interaction/NN between/IN Tat/NEWGENE and/CC hCycT1/NEWGENE requires/VBZ zinc/NN as/RB well/VB as/IN essential/JJ cysteine/NN residues/NNS in/IN both/DT proteins/NNS ./.
@@2221021104 Treatment/NNP of/IN 2/CD patients/NNS with/IN pseudohypoparathyroidism/NN type/NN I/NN with/IN vitamin-D-3/NN and/CC 1/CD alpha-Hydroxycholecalciferol/JJ consecutively/RB resulted/VBN in/IN a/DT nonuniform/JJ response/NN with/IN regard/NN to/IN the/DT normalisation/NN of/IN serum-calcium/NN ./.
@@2572777192 Tumour/NEWGENE necrosis/NEWGENE factor/NEWGENE and/CC adult/JJ respiratory/JJ distress/NN syndrome/NN ./.
@@4173014835 Immunologic/NNP mechanisms/NNS in/IN chronic/JJ brucellosis/NN in/IN humans/NNS ./.
@@9210329166 Biological/JJ evaluation/NN of/IN mibolerone/NN in/IN the/DT female/JJ Beagle/NN ./.
@@89470289528 These/DT results/NNS suggest/VBP that/IN Rho1p/NEWGENE regulates/VBZ cytoskeletal/JJ reorganization/NN at/IN least/RB through/RB Bni1p/NEWGENE and/CC Pkc1p/NEWGENE ./.
@@85303847381 This/DT protein-protein/JJ interaction/NN does/VBP not/RB require/VB the/DT simultaneous/JJ binding/NN of/IN Oct/NEWGENE proteins/NEWGENE to/IN DNA/NN ,/, and/CC high/JJ resolution/NN footprinting/VBG of/IN the/DT Oct-DNA/NEWGENE interaction/NN reveals/VBZ that/DT binding/NN of/IN BOB/NEWGENE ./NEWGENE 1/NEWGENE //NEWGENE OBF/NEWGENE ./NEWGENE 1/NEWGENE to/IN Oct1/NEWGENE or/CC Oct2/NEWGENE does/VBP not/RB alter/VB the/DT interaction/NN with/IN DNA/NN ./.
@@99718068393 The/DT lytic/JJ cycle/NN of/IN KSHV/NN ,/, probably/RB under/IN the/DT initial/JJ control/NN of/IN the/DT KSHV/NEWGENE //NEWGENE Rta/NEWGENE gene/NEWGENE ,/, may/MD directly/RB contribute/VB to/IN tumor/NN pathogenesis/NN ./.
@@104232922444 In/NN about/RB 770/CD bp/NN upstream/JJ region/NN of/IN Spam1/NEWGENE that/WDT has/VBZ been/VBN cloned/VBN and/CC sequenced/VBN ,/, multiple/JJ transcription/NN factor/NN binding/JJ sites/NNS including/JJ a/DT CRE/NEWGENE (/( cAMP-responsive/NEWGENE element/NEWGENE )/SYM were/VBD found/VBN ./.
@@27242275773 Perfusion/NNS washout/NN :/: increasing/JJ a/DT microvascular/JJ free/JJ flap/NN tolerance/NN to/IN ischemia/NN ./.
@@51387385394 A/DT case/NN of/IN M/NN hemoglobinosis/NN ./.
@@80559392833 The/DT location/NN and/CC approximate/JJ length/NN of/IN the/DT intron/NN are/VBP conserved/VBN in/IN both/PDT the/DT tomato/NN and/CC Arabidopsis/NN genes/NNS ,/, with/IN the/DT intron/NN separating/VBG the/DT 'nose'/NN region/NN (/( encoded/VBN by/IN exon/NN 1/CD )/SYM from/IN the/DT central/JJ globular/JJ domain/NN (/( exon/NN 2/CD )/SYM ./SYM
@@96899199766 Thus/RB ,/, the/DT bovine/NEWGENE PEDF/NEWGENE cDNA/NEWGENE isolated/VBN here/RB codes/NNS for/IN a/DT functional/JJ soluble/RB secreted/NEWGENE PEDF/NEWGENE glycoprotein/NEWGENE ./.
@@10471587312 Using/VBG 16/CD strains/NNS of/IN C/NNP ./NNP trachomatis/JJ in/IN triplicate/JJ assays/NNS ,/, we/PRP found/VBP the/DT RT-PCR/NN method/NN consistently/RB more/RB sensitive/JJ than/IN the/DT conventional/JJ technique/NN for/IN all/DT eight/CD antimicrobials/NNS tested/VBN ,/, with/IN resultant/JJ MICs/NNS determined/VBN by/IN RT-PCR/NN ranging/VBG from/IN 1/CD ./CD 6-fold/CD higher/JJ (/( erythromycin/NN )/SYM to/IN >/SYM //CD =/CD 195-fold/CD higher/JJ (/( amoxicillin/NN )/SYM ./.
@@10787437720 However/RB ,/, the/DT element/NN proximal/JJ to/IN the/DT transcription/NN start/NN site/NN is/VBZ dependent/JJ on/IN the/DT SRE-1/NEWGENE ./.
@@105721314753 Klebsiella/NN oxytoca/NN can/MD assimilate/VB nitrate/VB and/CC nitrite/NN by/IN using/VBG enzymes/NNS encoded/VBN by/IN the/DT nasFEDCBA/NEWGENE operon/NEWGENE ./.
@@62041206021 Use/VB of/IN the/DT immunofluorescence/NN method/NN for/IN identification/NN of/IN enteroviruses/NNS in/IN cell/NN cultures/NNS ./.
@@78160495141 Atcys1/NEWGENE ,/, Athyp1/NEWGENE ,/, AKin10/NEWGENE and/CC the/DT ORF/NN are/VBP very/RB close/JJ to/IN each/DT other/DT and/CC organized/VBN in/IN the/DT same/JJ polarity/NN ;/: hence/RB ,/, the/DT intergenic/JJ regions/NNS probably/RB contain/VBP ,/, within/IN less/PRP than/IN 0/CD ./CD 5/CD kb/NN ,/, all/PDT the/DT regulatory/JJ elements/NNS necessary/JJ to/IN govern/VB initiation/NN and/CC termination/NN of/IN transcription/NN ./.
@@32469993941 The/DT increase/NN in/IN amplitudes/NNS of/IN the/DT b-wave/NN during/IN the/DT adaptation/NN period/NN was/VBD more/RB prominent/JJ in/IN lead-exposed/JJ subjects/NNS than/IN in/IN controls/NNS ./.
@@935201658 (/( ii/NN )/SYM An/DT AF/NN G-CSF/NEWGENE level/NN >/SYM 2000/CD pg/NN //NN ml/NN is/VBZ a/DT strong/JJ positive/JJ predictor/NN of/IN CAM/NN ./.
@@85242415677 I/PRP report/VBP here/RB that/DT induction/NN of/IN HSP82/NEWGENE is/VBZ regulated/VBN by/IN the/DT early/JJ meiotic/JJ IME1-IME2/NEWGENE transcriptional/JJ cascade/NN ./.
@@85242845606 We/PRP now/RB report/VBP the/DT isolation/NN and/CC expression/NN of/IN cDNAs/NNS encoding/VBG PTF/NEWGENE gamma/NEWGENE and/CC PTF/NEWGENE delta/NEWGENE ,/, as/RB well/VB as/IN functional/JJ studies/NNS with/IN cognate/JJ antibodies/NNS that/WDT recognize/VBP the/DT native/JJ PTF/NEWGENE complex/NEWGENE in/IN HeLa/DT extracts/NNS ./.
@@95069832348 Primers/NNS for/IN subsequent/JJ rounds/NNS of/IN RACE/NN were/VBD designed/VBN from/IN the/DT 5'-ends/NNS of/IN amplified/VBN RACE/NEWGENE products/NEWGENE ./.
@@1092248744 Current/JJ status/NN of/IN zinc/NN deficiency/NN in/IN the/DT pathogenesis/NN of/IN neurological/JJ ,/, dermatological/JJ and/CC musculoskeletal/JJ disorders/NNS ./.
@@7226527057 Several/JJ free/JJ 2nd-generation/JJ schizonts/NNS ,/, which/WDT varied/VBD in/IN diameter/NN from/IN 11/CD to/IN 21/CD ./CD 6/CD micrometer/NN ,/, were/VBD found/VBN on/IN the/DT epithelial/JJ surface/NN of/IN the/DT cecum/NN ./.
@@30350568878 Active/JJ lambda/NEWGENE and/NEWGENE kappa/NEWGENE antibody/NEWGENE gene/NEWGENE rearrangement/NN in/IN Abelson/NN murine/JJ leukemia/NN virus-transformed/JJ pre-B/NN cell/NN lines/NNS ./.
@@65689398340 Brainstem/NN auditory/RB evoked/VBD responses/NNS (/( BAERs/NN )/SYM and/CC quantitative/JJ saccadic/JJ eye/NN movement/NN studies/NNS provide/VBP information/NN on/IN the/DT integrity/NN of/IN pathways/NNS traversing/VBG the/DT brainstem/NN ./.
@@53536675484 Spinal/JJ cord/NN representation/NN of/IN the/DT micturition/NN reflex/NN ./.
@@85088618471 The/DT patients/NNS were/VBD divided/VBN into/IN ischaemia/NN and/CC non-ischaemia/JJ groups/NNS on/IN the/DT basis/NN of/IN the/DT change/NN in/IN lactate/NN extraction/NN ratio/NN during/IN balloon/NN inflation/NN ./.
@@91357729077 Glycemic/NNP response/NN to/IN malted/JJ ,/, popped/JJ and/CC roller/NN dried/JJ wheat-legume/NN based/VBD foods/NNS in/IN normal/JJ subjects/NNS ./.
@@86266106026 Sterol-mediated/JJ suppression/NN of/IN cleavage/NN of/IN SREBP-1/NEWGENE was/VBD found/VBN to/IN be/VB dependent/JJ on/IN the/DT extreme/JJ COOH-terminal/NN region/NN (/( residue/NN 1034/CD to/IN the/DT COOH/NNP terminus/NN )/SYM ,/, which/WDT exists/VBZ in/IN two/JJ forms/NNS as/IN a/DT result/NN of/IN alternative/JJ splicing/JJ ./.
@@116778391526 The/DT difference/NN between/IN the/DT patients/NNS and/CC the/DT controls/NNS was/VBD statistically/RB significant/JJ (/( p/NN =/SYM 0/CD ./CD 03/CD )/SYM ./.
@@103425117109 The/DT coefficient/NN of/IN determination/NN ,/, r2/NN ,/, of/IN the/PDT other/DT scores/NNS ranged/VBN from/IN 0/CD ./CD 56/CD to/IN 0/CD ./CD 61/CD ./.
@@111815257803 The/DT androgen/NEWGENE receptor/NEWGENE (/( AR/NEWGENE )/SYM amino-terminus/NN imposes/VBZ androgen-specific/JJ regulation/NN of/IN AR/NEWGENE gene/NEWGENE expression/NN via/NN an/DT exonic/JJ enhancer/NN ./.
@@38812605019 A/DT yeast/NN DNA/NN fragment/NN carrying/JJ the/DT gene/NEWGENE CP/NEWGENE A1/NEWGENE encoding/VBG the/DT small/JJ subunit/NN of/IN the/DT arginine/NN pathway/NN carbamoyl-phosphate/NEWGENE synthetase/NEWGENE has/VBZ been/VBN sequenced/VBN ./.
@@94454888550 In/NN an/DT effort/NN to/IN identify/VB the/DT USH1C/NEWGENE disease/NEWGENE gene/NEWGENE we/PRP have/VBP isolated/VBN the/DT region/NN between/IN these/DT markers/NNS in/IN yeast/NN artificial/JJ chromosomes/NNS (/( YACs/NNS )/SYM using/VBG a/DT combination/NN of/IN STS/NN content/NN mapping/NN and/CC Alu-PCR/NNS hybridization/NN ./.
@@21151223034 Critical/NNP residues/NNS required/VBN for/IN repression/NN are/VBP located/VBN within/IN the/DT C-terminal/NN 27/NN amino/JJ acids/NNS of/IN c-Fos/NEWGENE ,/, since/IN v-Fos/NEWGENE and/CC C-terminal/NN truncations/NNS of/IN c-Fos/NEWGENE did/VBD not/RB down/VB regulate/VB ./.
@@16459027349 Altogether/RB these/DT results/NNS indicate/VBP that/IN the/DT Syn/NEWGENE 5/NEWGENE locus/NEWGENE segregates/NNS from/IN the/DT gene/NN specifying/VBG gH/NEWGENE ,/, to/IN a/DT region/NN encompassing/VBG portions/NNS of/IN the/DT TK/NEWGENE and/CC UL/NEWGENE 24/NEWGENE genes/NEWGENE ,/, and/CC that/IN the/DT syn/NEWGENE mutation/NEWGENE does/VBP not/RB affect/VB the/DT expression/NN or/CC activity/NN of/IN TK/NNP ./NNP
@@84181831476 To/TO identify/VB factors/NNS that/WDT may/MD modify/VB the/DT heterosexual/JJ transmission/NN of/IN human/JJ T/NN cell/NN leukemia/NN //NN lymphoma/NN virus/NN type/NN I/NN (/( HTLV-I/NN )/SYM ,/, 534/CD married/JJ couples/NNS enrolled/VBN in/IN the/DT Miyazaki/NNP Cohort/NNP Study/NNP between/IN November/NN 1984/CD and/CC April/NN 1989/CD were/VBD studied/VBN :/: 95/CD husband/NN HTLV-I-seropositive/NNP (/( H+/NN )/NN //NN wife/NN seropositive/JJ (/( W+/NNP )/SYM ,/, 33/CD H+/NNP //NNP W-/NNP ,/, 64/CD H-/NNP //NNP W+/NNP ,/, and/CC 342/CD H-/NNP //NNP W-/NNP ./.
@@4114654803 2/CD ./CD
@@94524447903 Upon/IN analysis/NN of/IN various/JJ deletion/NN and/CC point-mutated/NN variants/NN of/IN the/DT human/NEWGENE IL-6/NEWGENE gene/NEWGENE promoter/NEWGENE coupled/VBN to/IN a/DT reporter/NN gene/NN ,/, we/PRP screened/VBD for/IN possible/JJ cooperating/JJ transcription/NN factors/NNS ./.
@@19820612533 Characterization/NNS of/IN the/DT 5'/CD end/NN of/IN the/DT growth-regulated/JJ Syrian/NEWGENE hamster/NEWGENE CAD/NEWGENE gene/NEWGENE ./.
@@75322781939 Horvath/NNP ,/, I/NNP ./NNP
@@15352423457 Switching/NNP FDC-P1/NNP //NNP MAC/NNP cells/NNS from/IN growth/NN in/IN M-CSF/NEWGENE to/IN GM-CSF/NEWGENE caused/VBD the/DT selective/JJ degradation/NN of/IN c-fms/NEWGENE mRNA/NEWGENE within/IN 6/CD h/NN after/IN factor/NN switching/NN ./.
@@82125711631 Analysis/NNP of/IN the/DT gag/NEWGENE and/CC rev/NEWGENE proteins/NEWGENE in/IN the/DT transfected/VBN cells/NNS demonstrated/VBN that/IN these/DT proteins/NNS were/VBD not/RB detectable/JJ in/IN cells/NNS transfected/VBN with/IN the/DT tat/NEWGENE mutants/NEWGENE but/CC could/MD be/VB readily/RB detected/VBN when/CC the/DT mutations/NNS were/VBD complemented/VBN in/IN trans/JJ with/IN a/DT tat/NEWGENE expression/NN vector/NN ./.
@@98368819826 However/RB ,/, the/DT BCH/NN group/NN showed/VBD inferior/JJ gross/JJ motor/JJ performance/NN on/IN the/DT Bruininks-Oseretsky/NNP Test/NNP of/IN Motor/NNP Proficiency/NNS (/( Bruininks/NNP 1978/CD )/SYM ./.
@@82893418574 Repression/NN is/VBZ alleviated/VBN when/CC the/DT two/JJ (/( for/IN E2/NEWGENE )/SYM or/CC three/CD (/( for/IN E2-C/NEWGENE )/SYM promoter-proximal/NN copies/NNS of/IN E2-RS/NEWGENE are/VBP mutated/JJ ./.
@@94485746243 Our/PRP findings/NNS suggest/VBP that/IN striatal/JJ FDG/NN and/CC particularly/RB RACLO/NN are/VBP sensitive/JJ and/CC effective/JJ measures/NNS of/IN striatal/JJ function/NN and/CC may/MD help/VB characterizing/VBG patients/NNS with/IN multiple/JJ system/NN atrophy/NN ./.
@@4503674997 A/DT prospective/JJ trail/NN comparing/VBG hysterectomy/NN ,/, hysterectomy/NN plus/IN vaginal/JJ radium/NN ,/, and/CC uterine/JJ radium/NN plus/IN hysterectomy/NN in/IN stage/NN I/PRP endometrial/JJ carcinoma/NN ./.
@@22784748380 Serum/NEWGENE Fibrin/NEWGENE Degradation/NNS Products/NNPS (/( FDP/NN )/SYM were/VBD determined/VBN in/IN 50/CD oral/JJ cancer/NN patients/NNS and/CC 50/CD normal/JJ individuals/NNS prior/NN to/IN any/DT kind/NN of/IN treatment/NN ./.
@@99253729405 Among/IN these/DT 360/CD ZFPs/NEWGENE ,/, a/DT novel/JJ ZFP/NEWGENE cDNA/NEWGENE named/VBN HFHZ/NEWGENE (/( human/NEWGENE fetal/NEWGENE heart/NEWGENE ZFP/NEWGENE )/SYM with/IN sequence/NN homology/NN to/IN a/DT Kruppel-associated/NEWGENE box/NEWGENE (/( KRAB/NEWGENE )/SYM was/VBD identified/VBN ./.
@@77044567651 Such/JJ a/DT mechanism/NN may/MD allow/VB acceleration/NN of/IN degenerative/JJ joint/JJ conditions/NNS ,/, and/CC may/MD account/VB for/IN the/DT increased/VBN prevalence/NN of/IN such/JJ conditions/NNS seen/VBP with/IN HMS/NNP subjects/NNS ./.
@@112072823044 Furthermore/RB ,/, stable/JJ expression/NN of/IN a/DT constitutively/RB active/JJ form/NN of/IN chicken/NN Notch1/NEWGENE or/CC Notch2/NEWGENE in/IN a/DT B/NNP cell/NN line/NN results/NNS in/IN a/DT down-regulation/NN of/IN surface/NN IgM/NEWGENE expression/NN ,/, which/WDT is/VBZ accompanied/VBN by/IN the/DT reduction/NN of/IN IgH/NEWGENE gene/NEWGENE transcripts/NEWGENE ./.
@@96933069661 Cochlear/JJ microphonic/JJ potentials/NNS in/IN patients/NNS with/IN vestibular/JJ schwannomas/NNS ./.
@@14607725851 A/DT case/NN of/IN chronic/JJ hepatitis/NN C/NN with/IN primary/JJ hypothyroidism/NN manifested/VBN during/IN interferon/NEWGENE treatment/NN ./.
@@110079685152 For/IN this/DT purpose/NN ,/, a/DT segment/NN of/IN dxr/NEWGENE was/VBD amplified/VBN from/IN Synechococcus/NNP leopoliensis/NNP SAUG/NN 1402-1/NN DNA/NN via/NN PCR/NN using/VBG oligonucleotides/NNS for/IN conserved/VBN regions/NNS ./.
@@21536831828 This/DT result/NN indicates/VBZ that/IN separate/JJ complexes/NNS exist/VBP containing/NN ankyrin/NEWGENE and/CC fodrin/NEWGENE with/IN either/DT uvomorulin/NEWGENE or/CC Na+/NEWGENE ,/NEWGENE K+-ATPase/NEWGENE ./.
@@111582363713 Nerve/NEWGENE growth/NEWGENE factor/NEWGENE (/( NGF/NEWGENE )/SYM and/CC retinoic/JJ acid/NN (/( RA/NN )/SYM exert/VB important/JJ actions/NNS on/IN PC12/NNP cells/NNS ./.
@@10683072500 Sustained/JJ ventricular/JJ tachycardia/NN and/CC its/PRP successful/JJ prophylaxis/NN during/IN high-dose/JJ bolus/NN interleukin-2/NEWGENE therapy/NN for/IN metastatic/JJ renal/JJ cell/NN carcinoma/NN ./.
@@4034220216 Because/IN of/IN its/PRP wide/JJ spectrum/NN of/IN activity/NN particularly/RB against/IN ampicillin/NN resistant/JJ strains/NNS of/IN H/NNP ./NNP influenzae/NNS and/CC because/IN of/IN its/PRP good/JJ tolerance/NN Cefaclor/NN is/VBZ very/RB useful/JJ in/IN treatment/NN of/IN respiratory/JJ tract/NN infections/NNS in/IN children/NNS ./.
@@110440976105 Using/VBG purified/VBN recombinant/NEWGENE HMG/NEWGENE I/NEWGENE ,/, we/PRP have/VBP identified/VBN several/DT high-affinity/JJ binding/JJ sites/NNS which/WDT overlap/VBP important/JJ transcription/NN factor/NN binding/JJ sites/NNS ./.
@@104908436507 BCL6/NEWGENE encodes/VBZ a/DT POZ/NEWGENE //NEWGENE Zn/NEWGENE finger/NEWGENE protein/NEWGENE ,/, a/DT structure/NN similar/JJ to/IN that/DT of/IN many/JJ Drosophila/NN developmental/JJ regulators/NNS and/CC to/IN another/DT protein/NN involved/VBN in/IN a/DT human/JJ hematopoietic/JJ malignancy/NN ,/, PLZF/NEWGENE ./.
@@68283966617 The/DT level/NN of/IN contamination/NN in/IN the/DT wound/NN can/MD be/VB determined/VBN with/IN the/DT rapid/JJ biopsy/NN fixation/NN technique/NN ./.
@@82702577877 A/DT sequence/NN homology/NN analysis/NN between/IN human/NEWGENE nm23-H1/NEWGENE and/CC the/DT homolog/NN gene/NN of/IN the/DT rat/NN (/( NDP-K/NEWGENE beta/NEWGENE )/SYM shows/VBZ that/IN exon-intron/JJ boundaries/NNS are/VBP well/VB conserved/VBN between/IN these/DT two/JJ species/NN ./.
@@97570122773 The/DT presence/NN of/IN PDZ/NEWGENE and/CC SAM/NEWGENE domains/NEWGENE in/IN the/DT KS5/NEWGENE protein/NEWGENE suggests/VBZ that/IN it/PRP may/MD act/VB as/IN a/DT molecular/JJ adaptor/NN ,/, promoting/JJ and/CC relaying/JJ information/NN in/IN a/DT signal/JJ transduction/NN pathway/NN ./.
@@506289706 An/DT IgG/NEWGENE monoclonal/JJ gammopathy/NN was/VBD present/VB in/IN the/DT serum/NN of/IN 4/CD patients/NNS and/CC Bence-Joanes/NN proteinuria/NN was/VBD found/VBN in/IN 1/CD patient/NN ./.
@@11588381482 The/DT eluting/JJ solvent/NN was/VBD methanol-chloroform/JJ (/( 10+90/CD )/SYM at/IN a/DT flow/NN rate/NN of/IN 2/CD ./CD 0/CD ml/NN //NN min/NN ./.
@@6775834181 HLA-A/NEWGENE and/NEWGENE B/NEWGENE phenotypes/NNS of/IN 105/CD patients/NNS suffering/VBG from/IN malignant/JJ melanomas/NNS were/VBD determined/VBN ,/, with/IN special/JJ regard/NN for/IN metastatic/JJ form/NN or/CC relapse/NN ./.
@@108029092279 PATIENTS/DT OR/NN OTHER/NN PARTICIPANTS/NNP :/: Twenty/CD children/NNS met/VBP the/DT criteria/NNS for/IN being/VBP learning/JJ disabled/NN ./.
@@45620385030 Further/JJ investigation/NN on/IN the/DT chemotactic/JJ influence/NN of/IN thymic/NEWGENE hormone/NEWGENE on/IN lymphocytes/NNS ./.
@@78200576835 Tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE alpha/NEWGENE ,/, the/DT cytokine/NN that/WDT participates/VBZ in/IN the/DT autocrine/JJ growth/NN control/NN of/IN hairy/JJ cell/NN leukemia/NN has/VBZ strong/JJ bone/NN resorptive/JJ properties/NNS ./.
@@34187274120 This/DT rapid/JJ and/CC extensive/JJ penetration/NN of/IN intrathecally/RB administered/VBN chemotherapy/NN may/MD offer/VB insight/NN into/IN the/DT myelopathy/NN observed/VBN with/IN these/DT treatments/NNS ./.
@@2424273093 The/DT 'field/NN of/IN stress'/NN of/IN the/DT supervisory/JJ nurse/NN ./.
@@104877599950 Using/VBG transgenic/JJ Xenopus/JJ embryos/NNS ,/, we/PRP demonstrate/VBP that/IN the/DT integrity/NN of/IN these/DT two/JJ sequences/NNS is/VBZ necessary/JJ for/IN correct/JJ spatial/JJ expression/NN of/IN a/DT Xbra2/NEWGENE promoter-driven/NEWGENE reporter/NEWGENE gene/NEWGENE ./.
@@75090538834 Its/PRP role/NN in/IN these/DT processes/NNS suggests/VBZ that/IN the/DT function/NN of/IN c-Myb/NEWGENE may/MD be/VB important/JJ early/RB in/IN the/DT establishment/NN of/IN the/DT hematopoietic/JJ lineage/NN ./.
@@33876654081 The/DT development/NN and/CC distribution/NN of/IN Trypanosoma/JJ congolense/NN ,/, T/NN vivax/NN and/CC T/NN brucei/NN in/IN the/DT skin/NN of/IN goats/NNS was/VBD examined/VBN after/IN the/DT animals/NNS were/VBD bitten/VBP by/IN infected/JJ Glossina/NN morsitans/NNS centralis/JJ ./.
@@36640388541 The/DT purpose/NN of/IN this/DT study/NN is/VBZ twofold/RB :/: (/( 1/CD )/SYM to/IN present/NN a/DT parallel/JJ form/NN of/IN the/DT Gudjonsson/NNP Suggestibility/NNP Scale/NNP (/( GSS/NN ,/, Form/NN 1/CD )/SYM ;/: (/( 2/CD )/SYM to/IN study/NN test-retest/NN reliabilities/NNS of/IN interrogative/JJ suggestibility/NN ./.
@@111051297979 Antimicrobial/JJ Susceptibility/NNS of/IN Klebsiella/NN pneumoniae/NNS Producing/NNP Extended-Spectrum/NEWGENE beta-lactamase/NEWGENE (/( ESBL/NEWGENE )/SYM Isolated/JJ in/IN Hospitals/NNS in/IN Brazil/NN ./.
@@77490883182 Coronary/NNP T1/NN and/CC T2/NN weighted/JJ images/NNS were/VBD obtained/VBN ./.
@@105188229919 CONCLUSION/IN :/: These/DT findings/NNS imply/VBP that/DT eotaxin/NN either/DT is/VBZ mechanistically/RB involved/VBN in/IN acute/JJ asthma/NN or/CC serves/VBP as/IN a/DT biomarker/NN for/IN activity/NN of/IN the/DT CCR3/NEWGENE receptor/NEWGENE ligand/NEWGENE system/NN ,/, which/WDT is/VBZ functionally/RB linked/JJ to/IN asthma/NN ./.
@@98130418728 GH/NEWGENE failed/VBN to/IN stimulate/VB phosphorylation/NN or/CC activation/NN of/IN Jun/NEWGENE N-terminal/NEWGENE kinase/NEWGENE under/IN the/DT conditions/NNS used/VBN ./.
@@63203806115 Surgical/NNP treatment/NN of/IN pulmonary/JJ metastases/NNS ./.
@@102061522708 We/PRP found/VBP that/IN the/DT expression/NN of/IN the/DT protein/NN was/VBD maximum/JJ in/IN mitosis/NN and/CC minimum/JJ in/IN G1/NNP ,/, which/WDT correlated/VBD with/IN the/DT expression/NN of/IN its/PRP messenger/NN RNA/NN ./.
@@86621933902 Three/CD separate/JJ activation/NN subdomains/NN ,/, and/CC one/PRP negative-acting/JJ region/NN ,/, which/WDT function/VBP in/IN yeast/NN were/VBD located/VBN in/IN the/DT carboxyl-terminal/NN region/NN of/IN NIT4/NEWGENE ./.
@@17824242392 The/DT existence/NN of/IN threshold/NN concentrations/NNS ,/, above/RB which/WDT certain/JJ phenomena/NNS may/MD occur/VB ,/, strengthens/VBZ the/DT role/NN of/IN sentinels/NNS ./.
@@114037195479 Our/PRP results/NNS indicate/VBP that/IN Gab1/NEWGENE is/VBZ involved/VBN in/IN the/DT control/NN of/IN egr-1/NEWGENE expression/NN regulated/VBN by/IN insulin/NEWGENE ./.
@@90299568993 Object/NN relations/NNS ,/, affect/VB management/NN ,/, and/CC psychic/JJ structure/NN formation/NN ./.
@@3023679355 The/DT molecular/JJ weight/NN of/IN in/IN vivo-labeled/NN proteins/NN was/VBD increased/VBN relative/JJ to/IN that/DT of/IN in/IN vitro-translated/NN proteins/NN ,/, indicating/VBG that/IN a/DT posttranslational/JJ modification/NN had/VBP occurred/VBN ./.
@@104775834860 Cross-linking/VBG the/DT B/NEWGENE cell/NEWGENE Ag/NEWGENE receptor/NEWGENE (/( BCR/NEWGENE )/SYM to/IN surface/NEWGENE Fc/NEWGENE receptors/NEWGENE for/IN IgG/NEWGENE (/( Fc/NEWGENE gamma/NEWGENE R/NEWGENE )/SYM inhibits/VBZ G1-to-S/NN progression/NN ;/: the/DT mechanism/NN by/IN which/WDT this/DT occurs/VBZ is/VBZ not/RB completely/RB known/VBP ./.
@@19862254377 We/PRP report/VBP here/RB the/DT identification/NN of/IN HSF/NEWGENE in/IN the/DT fission/NN yeast/NN Schizosaccharomyces/NN pombe/NN ./.
@@104097496462 Role/NN of/IN secondary/JJ structure/NN in/IN discrimination/NN between/IN constitutive/JJ and/CC inducible/NN activators/NN ./.
@@5103415374 A/DT study/NN of/IN the/DT E/NNP ./NNP O/NNP ./NNP R/NNP ./NNP T/NNP ./NNP C/NNP ./.
@@107582891924 METHODS/IN :/: The/DT most/RB distal/JJ muscle/NN fibres/NNS from/IN the/DT deep/JJ and/CC superficial/JJ finger/NN flexors/NN were/VBD measured/VBN relative/JJ to/IN the/DT pisiform/JJ bone/NN in/IN 18/CD cadaveric/JJ specimens/NNS ./.
@@846983183 The/DT microcirculatory/JJ dynamics/NNS of/IN prostaglandin/NEWGENE E1/NEWGENE and/DT //DT or/DT nicardipine/NN and/CC their/PRP different/JJ reactions/NNS in/IN the/DT hyper-/JJ and/CC hypodynamic/JJ state/NN of/IN septic/JJ shock/NN in/IN a/DT rat/NN model/NN ./.
@@16942802291 A/DT new/JJ ,/, flexible/JJ fiberoptic/JJ ventriculoscope/NN for/IN observation/NN of/IN the/DT ventricles/NNS and/CC major/JJ cisterns/NNS is/VBZ reported/VBN ./.
@@80653106267 The/DT highly/RB conserved/VBN ninth/JJ heptad/NN ,/, which/WDT is/VBZ involved/VBN in/IN heterodimerization/NN ,/, appears/VBZ to/IN participate/VB in/IN the/DT receptor-inhibitor/NN interaction/NN ,/, suggesting/VBG that/IN the/DT inhibitor/NN is/VBZ a/DT related/NN member/NN of/IN the/DT receptor/NN gene/NN family/NN ./.
@@8183552100 The/DT human/NEWGENE eps15/NEWGENE gene/NEWGENE ,/, encoding/VBG a/DT tyrosine/NEWGENE kinase/NEWGENE substrate/NN ,/, is/VBZ conserved/VBN in/IN evolution/NN and/CC maps/NNS to/IN 1p31-p32/CD ./.
@@82767328258 The/DT rate/NN of/IN decrement/NN in/IN DPOAE/NN amplitude/NN over/RB a/DT prescribed/VBN time/NN period/NN was/VBD utilized/VBN as/IN a/DT measure/NN of/IN susceptibility/NN to/IN the/DT acoustic/JJ trauma/NN ./.
@@105291988326 Its/PRP C-terminal/NN catalytic/JJ domain/NN was/VBD found/VBN to/IN be/VB highly/RB conserved/VBN in/IN the/DT homologues/NEWGENE p140/NEWGENE (/NEWGENE ras-GRF/NEWGENE )/NEWGENE and/CC Sos/NEWGENE ./.
@@16888416984 Expression/NNS of/IN six/CD genes/NNS ,/, ipaB/NEWGENE ,/, ipaC/NEWGENE ,/, invE/NEWGENE ,/, invG/NEWGENE ,/, invJ/NEWGENE ,/, and/CC invK/NEWGENE ,/, was/VBD apparently/RB regulated/VBN by/IN the/DT positive/JJ regulator/NN virF/NEWGENE ./.
@@82482537966 These/DT combined/JJ observations/NNS define/VBP a/DT promoter/NN and/CC an/DT enhancer/NN for/IN the/DT chicken/NEWGENE L-CAM/NEWGENE gene/NEWGENE ./.
@@84144103254 METHODS/IN :/: Fifty-one/VBZ healthy/JJ eyes/NNS ,/, 169/CD ocular/JJ hypertensive/JJ eyes/NNS with/IN normal/JJ visual/JJ fields/NNS ,/, and/CC 132/CD glaucomatous/JJ eyes/NNS with/IN early/NN visual/NN field/NN defects/NNS were/VBD evaluated/VBN with/IN qualitative/JJ and/CC quantitative/JJ measures/NNS of/IN structural/JJ damage/NN to/IN the/DT optic/JJ nerve/NN and/CC nerve/NN fiber/NN layer/NN ./.
@@13981045847 From/IN these/DT results/NNS ,/, CBF-A/NEWGENE is/VBZ a/DT novel/JJ CArG/NN box-/JJ ,/, ssDNA-/NEWGENE and/NEWGENE RNA-binding/NEWGENE protein/NEWGENE ,/, as/RB well/VB as/IN a/DT repressive/JJ transcriptional/JJ factor/NN ./.
@@104691405205 We/PRP have/VBP tested/VBN the/DT function/NN of/IN two/JJ potential/JJ NF-kappaB-like/NEWGENE sites/NEWGENE present/VBP in/IN the/DT PAI-2/NEWGENE proximal/NEWGENE promoter/NEWGENE for/IN responsiveness/NN to/IN TNFalpha/NEWGENE using/VBG chloramphenicol/NEWGENE acetyl/NEWGENE transferase/NEWGENE reporter/NEWGENE gene/NEWGENE deletion/NN and/CC mutation/NN analyses/NNS ./.
@@75886281162 Overexpression/NNS of/IN wild-type/NEWGENE p53/NEWGENE also/RB induces/VBZ apoptosis/NN in/IN an/DT LCL/NN ./.
@@9053494466 RESULTS/NNS :/: The/DT medians/NNS of/IN average/JJ daily/JJ CD34+/NEWGENE cell/NN yields/NNS for/IN patients/NNS who/WP received/VBD paclitaxel/NN plus/IN CY/NN ,/, CE/NN ,/, and/CC CEP/NNS with/IN G-CSF/NEWGENE were/VBD 12/CD ./CD 9/CD ,/, 11/CD ./CD 03/CD ,/, and/CC 5/CD ./CD 37/CD x/NN 10/NN (/NN 6/NN )/NN //NN kg/NN ,/, respectively/RB ,/, compared/VBN with/IN 2/CD ./CD 02/CD x/NN 10/NN (/NN 6/NN )/NN //NN kg/NN in/IN the/DT reference/NN group/NN that/WDT received/VBD CY/NN with/IN G-CSF/NEWGENE (/( P/NN =/SYM </SYM ./CD 0001/CD ,/, ./CD 002/CD ,/, and/CC ./CD 09/CD ,/, respectively/RB )/SYM ./.
@@7252579791 The/DT calculated/VBN pD2/NN values/NNS were/VBD 8/CD ./CD 8/CD for/IN E/NN ,/, 8/CD ./CD 6/CD for/IN DHE/NN and/CC 6/CD ./CD 6/CD for/IN M/NNP ./NNP
@@27296663419 Significant/JJ intergroup/JJ differences/NNS are/VBP highlighted/VBN for/IN both/DT selected/VBN dentoskeletal/JJ and/CC soft/JJ tissue/NN profile/NN variables/NNS ./.
@@77063962157 Mutations/NNS in/IN the/DT VPS45/NEWGENE gene/NEWGENE ,/, a/DT SEC1/NEWGENE homologue/NN ,/, result/NN in/IN vacuolar/JJ protein/NN sorting/JJ defects/NNS and/CC accumulation/NN of/IN membrane/NN vesicles/NNS ./.
@@84737318115 B/NN cell-specific/NN mb-1/NEWGENE and/CC B29/NEWGENE genes/NEWGENE encode/VBP the/DT alpha/NN //NN beta/NN components/NN of/IN the/DT BCR-associated/NEWGENE complex/NEWGENE in/IN mature/NNP sIgM+/NEWGENE B/NNP cells/NNS ./.
@@76565883321 Comparative/JJ DNA/NN sequence/NN analysis/NN showed/VBD the/DT Genethon/NNP microsatellite/NEWGENE D19S596/NEWGENE lies/NNS 2/CD ./CD 2/CD kb/NN downstream/RB of/IN the/DT coding/JJ region/NN of/IN FUT1/NEWGENE ,/, indicating/VBG that/IN the/DT cluster/NN comprising/VBG the/DT closely/RB linked/NN FUT1/NEWGENE and/CC FUT2/NEWGENE genes/NEWGENE is/VBZ located/VBN 4/CD cM/NN distal/JJ to/IN D19S412/NEWGENE (/( lod/NN score/NN 13/CD ./CD 7/CD )/SYM and/CC 9/CD cM/NN proximal/JJ to/IN D19S571/NEWGENE (/( lod/NN score/NN 11/CD ./CD 7/CD )/SYM ./.
@@926899227 Only/JJ 17%/NN of/IN all/DT patients/NNS admitted/VBN it/PRP at/IN all/DT times/NNS ./.
@@77798125315 The/DT c-myc/NEWGENE gene/NEWGENE is/VBZ overexpressed/VBN in/IN a/DT variety/NN of/IN tumor/NN types/NNS and/CC appears/VBZ to/IN play/NN an/DT important/JJ role/NN in/IN the/DT abnormal/JJ growth/NN of/IN a/DT number/NN of/IN cell/NN types/NNS ./.
@@97924394706 Inhibition/NNS of/IN the/DT apolipoprotein/NEWGENE B/NEWGENE mRNA/NEWGENE editing/VBG enzyme-complex/NN by/IN hnRNP/NEWGENE C1/NEWGENE protein/NEWGENE and/CC 40S/NEWGENE hnRNP/NEWGENE complexes/NEWGENE ./.
@@111668638596 Twenty-six/JJ (/( 55%/JJ )/SYM (/( 95%/CD CI/NN ,/, 41-69%/NN )/SYM patients/NNS experienced/VBN >/SYM or/CC =/NN grade/NN 3/CD acute/JJ toxicity/NN (/( RTOG/NN )/SYM ./.
@@104790256258 To/TO estimate/VB the/DT locations/NNS of/IN sources/NNS with/IN the/DT TF-MUSIC/NN algorithm/NN ,/, we/PRP first/JJ set/VBP the/DT target/NN region/NN on/IN the/DT spectrogram/NN of/IN the/DT somatosensory/JJ responses/NNS ./.
@@111983851039 A/DT microsporidian/NN ,/, Nosema/NN algerae/NNP Vavra/NNP and/CC undeen/NN ,/, was/VBD found/VBN parasitizing/VBG larvae/NNS and/CC adults/NNS of/IN a/DT laboratory/NN colony/NN of/IN Culex/NN pipiens/VBZ L/NNP ./NNP originated/VBN from/IN Gharbia/NNP Governorate/NNS ./.
@@7792727767 Serological/JJ studies/NNS of/IN antibodies/NNS to/IN Epstein-Barr/NNP virus/NN in/IN infectious/JJ mononucleosis/NN ./.
@@40327164699 The/DT mean/JJ transfer/NN ratios/NNS of/IN the/DT drug/NN into/IN the/DT genital/JJ tissues/NNS to/IN the/DT concentration/NN in/IN the/DT uterine/JJ arterial/JJ blood/NN were/VBD such/JJ that/IN the/DT transfer/NN ratio/NN into/IN the/DT portio/NN vaginalis/NN was/VBD the/DT highest/JJS ,/, followed/VBN by/IN the/DT uterine/JJ cervix/NN and/CC the/DT myometrium/NN ,/, and/CC that/IN into/IN the/DT oviduct/NN was/VBD the/DT lowest/JJS with/IN about/RB 1/CD //CD 2/CD that/IN into/IN the/DT portio/NN vaginalis/NN ./.
@@11223256980 We/PRP have/VBP also/RB isolated/VBN and/CC analyzed/VBD the/DT 5'/CD flanking/JJ region/NN of/IN the/DT pea/NN 33RNP/NEWGENE gene/NEWGENE ./.
@@36493405336 We/PRP conclude/VBP that/IN for/IN mono-intronic/JJ precursors/NNS in/IN which/WDT there/RB is/VBZ only/RB one/PRP choice/NN of/IN splice/NN sites/NNS ,/, most/RB of/IN the/DT exon/NN sequences/NNS are/VBP not/RB mechanistically/RB involved/VBN in/IN the/DT splicing/JJ process/NN ./.
@@95456386803 Identification/NNP and/CC characterization/NN of/IN two/JJ putative/JJ human/NEWGENE arginine/NEWGENE methyltransferases/NEWGENE (/( HRMT1L1/NEWGENE and/CC HRMT1L2/NEWGENE )/SYM ./.
@@1067493492 The/DT contraceptive/JJ pattern/NN of/IN 157/CD women/NNS was/VBD analysed/VBN and/CC 13/CD ./CD 8/CD percent/NN were/VBD using/VBG inefficient/JJ methods/NNS ./.
@@95668712150 In/NN fus3/NEWGENE mutants/NEWGENE ,/, the/DT levels/NNS of/IN Ty1/NEWGENE RNA/NEWGENE ,/, protein/NN synthesis/NN ,/, and/CC proteolytic/JJ processing/NN were/VBD not/RB altered/VBN relative/JJ to/IN those/DT in/NN FUS3/NEWGENE strains/NNS but/CC steady-state/JJ levels/NNS of/IN TyA/NEWGENE ,/, integrase/NEWGENE ,/, and/CC reverse/NEWGENE transcriptase/NEWGENE proteins/NN and/CC Ty1/NEWGENE cDNA/NEWGENE were/VBD all/DT increased/VBN ./.
@@747587372 Patients/NNS at/IN risk/NN of/IN hypothyroidism/NN ./.
@@96288219221 Thus/RB ,/, included/VBN in/IN the/DT KG1a/NNP EST/NN dataset/NN are/VBP candidates/NNS for/IN new/JJ human/JJ genes/NNS that/WDT may/MD play/VB roles/NNS in/IN hematopoietic/JJ differentiative/JJ progression/NN and/CC lineage/NN commitment/NN ./.
@@81431989402 Restoration/NNP of/IN opponens/JJ function/NN with/IN transplantation/NN of/IN free/JJ composites/NNS dorsal/JJ pedal/JJ skin/NN flap/NN containing/JJ m/CD ./CD extensor/NN hallucis/NN brevis/JJ ./.
@@92553497526 They/PRP also/RB interact/VBP with/IN GTPase/NEWGENE activating/NEWGENE proteins/NEWGENE encoded/VBN by/IN IRA1/NEWGENE and/CC IRA2/NEWGENE ./.
@@105702625445 Activation/NNS of/IN T/NN cells/NNS via/NN the/DT TCR/NEWGENE and/CC other/DT costimulatory/JJ receptors/NNS triggers/VBP a/DT number/NN of/IN signaling/JJ cascades/NNS ./.
@@96033456994 GLRaV-2/NN is/VBZ the/DT only/JJ closterovirus/NN ,/, so/RB far/RB ,/, that/WDT matches/VBZ the/DT genome/NN organization/NN of/IN the/DT type/NN member/NN of/IN the/DT group/NN ,/, BYV/NNP ,/, and/CC thus/RB can/MD be/VB unambiguously/RB classified/VBN as/IN a/DT definitive/JJ member/NN of/IN the/DT genus/NN Closterovirus/NNP ./.
@@89551115094 Our/PRP results/NNS demonstrate/VBP that/IN the/DT promoter/NN and/CC enhancer/NN regions/NNS identified/VBN here/RB are/VBP essential/JJ for/IN maintaining/VBG the/DT efficient/JJ promoter/NN activity/NN of/IN the/DT human/NEWGENE activin/NEWGENE betaA/NEWGENE subunit/NEWGENE gene/NEWGENE ./.
@@96945999669 CONCLUSIONS/IN :/: Significant/JJ elevations/NNS of/IN IL-1alpha/NEWGENE and/CC IL-1beta/NEWGENE occur/VB in/IN patients/NNS with/IN bacterial/JJ cystitis/NN and/CC microscopic/JJ hematuria/NN ./.
@@100947015397 Recent/JJ work/NN in/IN this/DT laboratory/NN has/VBZ shown/VBP that/IN the/DT gene/NN coding/JJ for/IN acetate/NEWGENE kinase/NEWGENE (/( ackA/NEWGENE )/SYM in/IN Sinorhizobium/NNP meliloti/NN is/VBZ up-regulated/IN in/IN response/NN to/IN phosphate/NN limitation/NN ./.
@@965648550 Five/CD additional/JJ copies/NNS of/IN Lian/NEWGENE elements/NEWGENE were/VBD isolated/VBN ,/, mapped/VBN by/IN restriction/NN digestion/NN ,/, and/CC partially/RB sequenced/VBN ./.
@@92309869189 Autoimmune/NNP neutropenia/NN (/( AIN/NN )/SYM is/VBZ a/DT frequent/JJ cause/NN of/IN chronic/JJ neutropenia/NN especially/RB in/IN youngest/JJS children/NNS ./.
@@88281527829 Comparison/NNS of/IN the/DT amino/JJ acid/NN sequences/NNS of/IN the/DT RPO1/NEWGENE polypeptides/NEWGENE of/NEWGENE IIV6/NEWGENE ,/NEWGENE LCDV/NEWGENE ,/NEWGENE and/NEWGENE MCV-1/NEWGENE with/IN the/DT corresponding/JJ prokaryotic/JJ ,/, eukaryotic/JJ ,/, and/CC viral/JJ proteins/NNS revealed/VBD differences/NNS in/IN amino/JJ acid/NN similarity/NN and/CC phylogenetic/JJ relationships/NNS ./.
@@82090518179 Intravenous/JJ antibiotic/JJ therapy/NN in/IN cystic/JJ fibrosis/NN :/: in/IN hospital/NN or/CC at/IN home/NN ?/.
@@81399141828 Concordantly/RB ,/, it/PRP was/VBD shown/VBP that/IN the/DT dnHLH/NEWGENE protein/NEWGENE Id1/NEWGENE1 inhibits/VBZ differentiation/NN of/IN muscle/NN and/CC myeloid/JJ cells/NNS in/IN vitro/FW ./.
@@36157631207 Data/NNP from/IN 119/CD men/NNS and/CC 40/CD women/NNS undergoing/VBG coronary/JJ angiography/NN provide/VB an/DT opportunity/NN to/IN compare/NN these/DT associations/NNS in/IN relation/NN to/IN a/DT direct/JJ and/CC continuous/JJ measure/NN of/IN atherosclerosis/NN while/CC controlling/JJ for/IN age/NN ,/, sex/NN ,/, income/NN ,/, hypertension/NN ,/, serum/JJ cholesterol/NN ,/, smoking/NN ,/, angina/NN ,/, diabetes/NN ,/, family/NN history/NN of/IN heart/NN disease/NN ,/, Type/NN A/NN behavior/NN pattern/NN ,/, and/CC hostility/NN ./.
@@110272895361 The/DT Drosophila/NEWGENE melanogaster/NEWGENE suppressor/NEWGENE of/NEWGENE sable/NEWGENE gene/NEWGENE ,/, su/NEWGENE (/NEWGENE s/NEWGENE )/NEWGENE ,/, encodes/VBZ a/DT novel/NN ,/, 150-kDa/NN nuclear/NN RNA/NN binding/NN protein/NN ,/, SU/NEWGENE (/NEWGENE S/NEWGENE )/NEWGENE ,/, that/WDT negatively/RB regulates/VBZ RNA/NN accumulation/NN from/IN mutant/NN alleles/NN of/IN other/DT genes/NNS that/WDT have/VBP transposon/NN insertions/NNS in/IN the/DT 5'/CD transcribed/VBN region/NN ./.
@@78856787865 0/CD ./CD 61/CD +/NN //NN -/NN 0/NN ./NN 04/NN )/NN ./.
@@79195403414 In/NN addition/NN ,/, both/PDT the/DT exon/NN 1-/CD and/CC exon/NN 2-initiated/JJ forms/NNS of/IN the/DT c-Myc/NEWGENE protein/NEWGENE stimulated/VBD transcription/NN of/IN a/DT Myc/NEWGENE //NEWGENE Max-responsive/NEWGENE reporter/NEWGENE construct/NEWGENE to/IN a/DT similar/JJ level/NN ./.
@@106695962787 Productive/JJ growth/NN of/IN phage/NN P22/NN in/IN wild-type/NN Salmonella/NN typhimurium/NN correlates/VBP with/IN the/DT presence/NN of/IN Abc2/NEWGENE ,/, but/CC is/VBZ independent/NN of/IN the/DT absolute/JJ level/NN of/IN ATP-dependent/NEWGENE nuclease/NEWGENE activity/NN ,/, suggesting/VBG a/DT qualitative/JJ change/NN in/IN the/DT nature/NN of/IN Abc2-modified/NN RecBCD/NEWGENE1 nuclease/NEWGENE1 activity/NN relative/JJ to/IN the/DT native/JJ enzyme/NN ./.
@@98068264964 These/DT data/NN may/MD also/RB aid/VB in/IN the/DT localization/NN of/IN other/DT disease/NN loci/NNS mapped/VBN to/IN this/DT region/NN ,/, including/JJ the/DT gene/NN for/IN tricho-dento-osseous/JJ syndrome/NN and/CC a/DT murine/NN locus/NN for/IN susceptibility/NN to/IN ozone-induced/JJ acute/JJ lung/NN injury/NN ./.
@@76680098476 Thus/RB ,/, endemic/JJ cumlations/NNS of/IN hepatitis/NN A/NN diseases/NNS are/VBP possible/JJ ./.
@@112204871054 Systematic/JJ review/NN of/IN diagnostic/JJ tests/NNS for/IN vaginal/JJ trichomoniasis/NN ./.
@@223606063 Modification/NNS by/IN this/DT latter/JJ compound/NN was/VBD so/RB extensive/JJ that/IN the/DT amount/NN of/IN membrane-associated/JJ N-myristoylated/JJ protein/NN was/VBD decreased/VBN ./.
@@82085404143 Rearrangements/NNS of/IN the/DT NFKB2/NEWGENE gene/NEWGENE are/VBP associated/VBN with/IN lymphoid/JJ malignancies/NNS ,/, but/CC the/DT functional/JJ significance/NN of/IN these/DT alterations/NNS is/VBZ not/RB known/VBP ./.
@@87894413413 Using/VBG fluorescence/NN in/IN situ/NN hybridization/NN ,/, we/PRP mapped/VBD the/DT chromosome-17/JJ breakpoint/NN in/IN a/DT patient/NN with/IN acampomelic/JJ CMPD/NN and/CC sex/NN reversal/NN ,/, who/WP carries/VBZ a/DT de/FW novo/FW constitutional/JJ t/NN (/NN 12/NN ;/: 17/NN )/NN translocation/NN ,/, between/IN two/JJ known/VBP cosmid/NN markers/NNS in/IN the/DT 17q24-q25/NN region/NN ./.
@@97246548604 Thus/RB ,/, in/IN the/DT presence/NN of/IN active/NEWGENE S-CDKs/NEWGENE and/CC Dbf4/NEWGENE //NEWGENE Cdc7/NEWGENE ,/, Mcms/NEWGENE may/MD open/VB origins/NNS and/CC thereby/RB facilitate/VB the/DT loading/NN of/IN RPA/NEWGENE ./.
@@96734369650 In/NN canrenoate-treated/JJ rats/NNS ,/, ANP/NEWGENE infusion/NN caused/VBN greater/JJR increases/NNS in/IN sodium/NN excretion/NN (/( FENA/NNP from/IN 3/CD ./CD 05/CD +/NN //NN -/NN 0/CD ./CD 71/CD to/IN 7/CD ./CD 21/CD +/NN //NN -/NN 0/CD ./CD 45%/CD ;/: P/NN </SYM 0/CD ./CD 05/CD ;/: n/NN =/SYM 8/CD )/SYM than/IN saline/JJ infusion/NN (/( FENA/NNP from/IN 4/NN ./NN 16/NN +/NN //NN -/NN 1/CD ./CD 11/CD to/IN 5/CD ./CD 47/CD +/NN //NN -/NN 0/CD ./CD 66%/CD ;/: n/NN =/SYM 6/CD )/SYM ,/, despite/IN the/DT hypocapnia/NN ./.
@@98324361336 RT-PCR/NN analysis/NN showed/VBD that/RB PLP-H/NEWGENE as/NNP well/VB as/IN PLP-C/NEWGENE and/CC PLP-D/NEWGENE are/VBP expressed/VBN in/IN all/DT rat/NN strains/NNS examined/VBN ,/, confirming/VBG that/DT PLP/NEWGENE diversity/NN is/VBZ not/RB due/NN to/IN strain/NN differences/NNS ./.
@@28141824871 In/NN rats/NNS bearing/JJ Walker-256-carcinosarcoma/NN 4-EPI/NN was/VBD effective/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@98379787531 Resultant/NNP activation/NN of/IN c-Jun/NEWGENE N-terminal/NEWGENE kinase/NEWGENE //NEWGENE stress-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( JNK/NEWGENE //NEWGENE SAPK/NEWGENE )/SYM ./.
@@30526413767 This/DT makes/NN these/DT compounds/NNS attractive/JJ as/IN vehicles/NNS for/IN these/DT and/CC other/DT gases/NNS in-vivo/JJ and/CC in-vitro/JJ ./.
@@76866191599 Chem/NNP ./.
@@76014453386 We/PRP now/RB show/VBP that/IN the/DT BAT1/NEWGENE translation/NEWGENE product/NEWGENE is/VBZ the/DT homolog/NN of/IN the/DT rat/NEWGENE p47/NEWGENE nuclear/NEWGENE protein/NEWGENE ,/, the/DT WM6/NEWGENE Drosophila/NEWGENE gene/NEWGENE product/NEWGENE ,/, and/CC probably/RB also/RB Ce08102/NEWGENE of/IN Caenorhabditis/ORG elegans/NNS ,/, all/DT members/NNS of/IN the/DT DEAD/NEWGENE protein/NEWGENE family/NEWGENE of/IN ATP-dependent/NEWGENE RNA/NEWGENE helicases/NEWGENE ./.
@@86282552126 In/NN synchronized/JJ HeLa/IN cells/NNS ,/, expression/NN of/IN luciferase/NEWGENE activity/NN was/VBD induced/VBN at/IN the/DT beginning/NN of/IN DNA/NN synthesis/NN and/CC was/VBD dependent/JJ on/IN the/DT presence/NN of/IN an/DT E2F-binding/NEWGENE site/NEWGENE in/IN the/DT H2A/NEWGENE ./NEWGENE 1/NEWGENE promoter/NEWGENE ./.
@@75657201086 The/DT DNA/NN binding/JJ domain/NN of/IN NirA/NEWGENE was/VBD expressed/VBN as/IN a/DT fusion/NN protein/NN with/IN the/DT glutathione/NEWGENE S-transferase/NEWGENE of/IN Schistosoma/ORG japonicum/NN ./.
@@28947416054 Seventy-one/VBZ supplementary/JJ doses/NNS of/IN vecuronium/NN were/VBD used/VBN for/IN muscle/NN relaxation/NN during/IN a/DT 22-h-long/NN NLA/NN II/NN anaesthesia/NN ./.
@@9572491455 Strikingly/RB ,/, these/DT cells/NNS contain/VBP a/DT missense/JJ mutation/NN of/IN the/DT p53/NEWGENE gene/NEWGENE at/IN codon/NN 242/CD (/( p53/NN (/NN 242/NN )/NN )/NN ,/, which/WDT substitutes/VBZ alanine/NN for/IN glycine/NN ./.
@@98201633564 The/DT mapping/NN was/VBD completed/VBN with/IN Southern/NNP blotting/NN and/CC restriction/NN analysis/NN ./.
@@90297135784 Together/RB ,/, the/DT data/NN suggest/VB that/IN cAMP-dependent/JJ control/NN of/IN the/DT amounts/NNS of/IN the/DT activator/NN SF-1/NEWGENE vs/IN ./IN the/DT repressor/NN COUP-TF/NEWGENE could/MD influence/VB CRS2-dependent/NNP transcription/NN ./.
@@110238324777 Altogether/RB these/DT results/NNS suggest/VBP that/IN ,/, in/IN KG1a/NNP cells/NNS ,/, TNFalpha/NEWGENE can/MD stimulate/VB in/IN parallel/JJ PC-PLC/NEWGENE and/CC PLD/NEWGENE ,/, whose/WP lipid/NN products/NN activate/VBP in/IN turn/NN mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( MAP/NEWGENE kinase/NEWGENE )/SYM and/CC NF-kappaB/NEWGENE signalling/JJ respectively/RB ./.
@@34302214133 The/DT findings/NNS are/VBP discussed/VBN in/IN the/DT context/NN of/IN known/VBP properties/NNS of/IN cortical-bar/JJ detectors/NNS ./.
@@30145152753 Human/NEWGENE alpha-galactosidase/NEWGENE A/NEWGENE :/: nucleotide/NN sequence/NN of/IN a/DT cDNA/NN clone/NN encoding/VBG the/DT mature/JJ enzyme/NN ./.
@@93070651640 In/NN the/DT absence/NN of/IN MHC/NEWGENE class/NEWGENE II/NEWGENE ,/, purified/NEWGENE soluble/NEWGENE D10/NEWGENE TCR/NEWGENE bound/JJ to/IN Staphylococcus/NEWGENE aureus/NEWGENE enterotoxin/NEWGENE C2/NEWGENE with/IN an/DT association/NN rate/NN of/IN 1/CD ./CD 69+/CD //CD -0/CD ./CD 12/CD x/NN 10/NN (/NN 4/NN )/NN M/NN (/NN -1/NN )/NN sec/NN (/NN -1/NN )/NN and/CC a/DT dissociation/NN rate/NN of/IN 1/CD ./CD 9+/CD //CD -0/CD ./CD 47/CD x/NN 10/NN (/NN -2/NN )/NN sec/NN (/NN -1/NN )/NN ,/, giving/JJ a/DT dissociation/NN constant/NN of/IN 1/CD ./CD 1/CD microM/NN ./.
@@10646820462 The/DT case/NN for/IN completing/VBG the/DT lymphadenectomy/NN when/CC positive/JJ lymph/NN nodes/NNS are/VBP found/VB during/IN radical/JJ hysterectomy/NN for/IN cervical/JJ carcinoma/NN ./.
@@10474898977 To/TO further/RB characterize/VB the/DT structure/NN and/CC evolutionary/JJ synthesis/NN of/IN the/DT CMT1A-REP/NEWGENE repeat/NEWGENE ,/, fluorescent/JJ in/IN situ/NN hybridization/NN (/( FISH/ORG )/SYM analysis/NN and/CC heterologous/JJ PCR-based/JJ assays/NNS were/VBD carried/VBN out/RB for/IN a/DT series/NN of/IN primates/NNS ./.
@@78699371340 When/WRB expressed/VBN per/IN kilogram/NN body/NN weight/NN ,/, mean/JJ GIT/NNS increased/VBN in/IN the/DT dF/NN group/NN from/IN 0/CD ./CD 14%/CD to/IN 0/NN ./NN 16%/NN above/RB RMR/VBZ ,/, with/IN a/DT significant/JJ decrease/NN from/IN 0/CD ./CD 15%/CD to/IN 0/CD ./CD 13%/CD in/IN the/DT P/NN group/NN ./.
@@87331238982 The/DT mature/JJ chromosome/NN 4/NN FRG1/NEWGENE transcript/NEWGENE is/VBZ 1042/CD bp/NN in/IN length/NN and/CC contains/VBZ nine/JJ exons/NNS which/WDT encode/VBP a/DT putative/JJ protein/NN of/IN 258/CD amino/JJ acid/NN residues/NNS ./.
@@75574466132 Various/JJ transcripts/NNS are/VBP generated/VBN from/IN the/DT VCSA1/NEWGENE gene/NEWGENE by/IN alternative/JJ splicing/JJ and/CC poly/NN (/NN A/NN )/NN processing/VBG in/IN the/DT rat/NN submandibular/JJ gland/NN ./.
@@34873484179 A/DT stochastic/JJ version/NN of/IN Kernell's/NNP (/( 1968/CD ,/, 1972/CD )/SYM model/NN with/IN cumulative/JJ afterhyperpolarization/NN (/( AHP/NNS )/SYM was/VBD simulated/JJ ./.
@@10556089490 The/DT data/NN indicate/VB that/IN etr-1/NEWGENE is/VBZ essential/JJ for/IN muscle/NN development/NN in/IN C/NNP ./NNP elegans/NNS ,/, perhaps/RB by/IN playing/JJ a/DT role/NN in/IN post-transcriptional/JJ processing/NN of/IN some/DT muscle/NN component/NN ,/, and/CC thus/RB suggesting/VBG a/DT possible/JJ conservation/NN of/IN gene/NN function/NN with/IN human/NEWGENE CUG-bp/NEWGENE ./.
@@97196362911 This/DT hypothesis/NN was/VBD tested/VBN by/IN introducing/JJ mutations/NNS at/IN each/DT of/IN the/DT three/CD histidine/NN pairs/NNS ,/, the/DT H382-X2-H385/NEWGENE pair/NEWGENE ,/, the/DT H411-X2-H414/NEWGENE pair/NEWGENE and/CC the/DT H430-X5-H436/NEWGENE pair/NEWGENE ,/, which/WDT constitute/VBP the/DT histidine-rich/JJ region/NN near/IN the/DT C/NN terminus/NN of/IN gp17/NEWGENE ./.
@@86318227296 The/DT isolated/VBN plasmin/NN fragments/NN of/IN VEGF/NEWGENE were/VBD compared/VBN with/IN respect/NN to/IN heparin/NN binding/JJ ,/, interaction/NN with/IN soluble/NN VEGF/NEWGENE receptors/NEWGENE ,/, and/CC ability/NN to/IN promote/VB endothelial/JJ cell/NN mitogenesis/NN ./.
@@117098909348 Hepatitis/NN A/NN infected/VBN food/NN handler/NN at/IN an/DT Edmonton/NNP ,/, Alberta/NN retail/NN food/NN facility/NN :/: public/JJ health/NN protection/NN strategies/NNS ./.
@@112915521130 METHODS/IN :/: 126/CD patients/NNS with/IN histologically/RB confirmed/VBN MFH/NN were/VBD analyzed/VBN ./.
@@11094073826 A/DT recently/RB reported/VBN new/JJ member/NN of/IN the/DT Vav/NEWGENE family/NEWGENE proteins/NEWGENE ,/, Vav3/NEWGENE has/VBZ been/VBN identified/VBN as/IN a/DT Ros/NEWGENE receptor/NEWGENE1 protein/NEWGENE1 tyrosine/NEWGENE1 kinase/NEWGENE1 (/( RPTK/NEWGENE )/SYM interacting/VBG protein/NN by/IN yeast/NN two-hybrid/JJ screening/NN ./.
@@94536896860 Our/PRP purpose/NN was/VBD to/IN determine/VB if/IN intact/JJ perianal/JJ (/( S4-5/NN )/SYM pin/NN sensation/NN (/( PPS/IN )/SYM and/CC bulbocavernosus/NN (/( S2-4/NN )/SYM reflex/NN (/( BCR/NN )/SYM shortly/RB after/IN spinal/JJ cord/NN injury/NN (/( SCI/NN )/SYM are/VBP predictive/JJ of/IN bladder/NN function/NN recovery/NN ./.
@@95565733716 Further/RB studies/VBZ demonstrated/VBN that/IN the/DT PPARalpha/NEWGENE ligand/NN 8/NN (/NN S/NN )/NN -hydroxyeicosatetraenoic/NN acid/NN strongly/RB promotes/VBZ the/DT interaction/NN of/IN PPARalpha/NEWGENE with/IN the/DT co-activator/NN RIP-140/NEWGENE but/CC decreases/VBZ the/DT interaction/NN of/IN PPARalpha/NEWGENE with/IN the/DT co-repressor/NN SMRT/NEWGENE ./.
@@68956636686 When/WRB O2/NN therapy/NN was/VBD controlled/VBN for/IN ,/, the/DT association/NN between/IN RBT/NN and/CC RLF/NN did/VBD not/RB achieve/VB statistical/JJ significance/NN (/( P/NN =/SYM ./CD 07/CD )/SYM ./.
@@100374601412 In/NN the/DT brain/NN ,/, muscarinic/NEWGENE receptors/NEWGENE mediate/VBP motor/NN and/CC memory/NN function/NN by/IN interaction/NN with/IN their/PRP ligand/NN acetylcholine/NN ./.
@@9563644746 Batch/NN cultures/NNS of/IN S/NNP ./NNP mutans/NNS serotype/NN a/DT demonstrated/VBN no/DT growth/NN on/IN MSB/NN agar/NN ./.
@@17399565834 Management/NNP often/RB involves/VBZ beta-/DT and/CC calcium/NN channel/NN blocking/JJ drugs/NNS or/CC type/NN IC/NN antiarrhythmic/JJ drugs/NNS ./.
@@15814097762 Sensitivity/NNS and/CC specificity/NN was/VBD established/VBN for/IN the/DT Pharmacia/NNP CAP/NN System/NNP and/CC the/DT DPC/NN AlaSTAT/NN System/NNP by/IN comparison/NN with/IN results/NNS of/IN the/DT skin/NN prick/NN test/NN ./.
@@75927104866 The/DT interferon-inducible/NN protein/NEWGENE kinase/NEWGENE PKR/NEWGENE modulates/VBZ the/DT transcriptional/JJ activation/NN of/IN immunoglobulin/NEWGENE kappa/NEWGENE gene/NEWGENE ./.
@@89590628917 We/PRP report/VBP a/DT case/NN of/IN vasculitis/NN (/( cutaneous/JJ and/CC neurologic/JJ )/SYM which/WDT led/VBD to/IN the/DT discovery/NN of/IN a/DT selective/JJ immunodeficit/NN towards/IN EBV/NN ,/, similar/JJ to/IN Purtilo's/NNP syndrome/NN ./.
@@79811435213 A/DT stretch/NN of/IN 16/CD nucleotides/NNS just/RB upstream/RB of/IN the/DT IL-4RE/NEWGENE contributed/VBD to/IN IL-4/NEWGENE inducibility/NN and/CC formed/VBN nucleoprotein/NN complexes/NNS with/IN constitutive/JJ factors/NNS ./.
@@93882006316 Inhibition/NNS appears/VBZ to/IN result/NN from/IN titration/NN of/IN general/NN transcription/NN factors/NN because/IN MDM2/NEWGENE overexpression/NN inhibits/VBZ c-fos/NEWGENE as/RB well/VB as/IN other/DT promoters/NNS in/IN vivo/NN and/CC basal/JJ transcription/NN in/IN vitro/FW ./.
@@104061226141 A/DT 13-bp/JJ cis-regulatory/NN element/NN in/IN the/DT LTR/NN promoter/NN of/IN the/DT tobacco/NEWGENE retrotransposon/NEWGENE Tto1/NEWGENE is/VBZ involved/VBN in/IN responsiveness/NN to/IN tissue/NN culture/NN ,/, wounding/VBG ,/, methyl/NN jasmonate/NN and/CC fungal/JJ elicitors/NNS ./.
@@107107421338 Serum/NN leptin/NEWGENE concentrations/NNS in/IN women/NNS during/IN gonadotropin/NEWGENE stimulation/NN cycles/NNS ./.
@@1644796232 In/NN this/DT study/NN ,/, we/PRP purified/VBN and/CC characterized/VBD the/DT recombinant/NEWGENE furin/NEWGENE from/IN the/DT conditioned/JJ medium/NN of/IN these/DT cells/NNS ./.
@@80161024824 The/DT presence/NN of/IN regulatory/JJ sequences/NNS for/IN the/DT binding/NN of/IN transcription/NN factors/NNS such/JJ as/IN NF-kappa/NEWGENE B/NEWGENE and/CC AP-2/NEWGENE ,/, whose/WP activation/NN is/VBZ associated/VBN with/IN the/DT immediate/JJ response/NN of/IN the/DT cell/NN to/IN an/DT injury/NN ,/, may/MD be/VB an/DT indication/NN of/IN the/DT important/JJ role/NN which/WDT HO-1/NEWGENE may/MD play/VB in/IN defense/NN mechanisms/NNS against/IN tissue/NN injury/NN ./.
@@90208569446 Moreover/RB ,/, the/DT effect/NN exerted/VBN by/IN TIS1/NEWGENE appeared/VBN to/IN be/VB selective/JJ for/IN the/DT MCK/NEWGENE promoter/NEWGENE ./.
@@7535593625 CD7+/NEWGENE //NEWGENE CD3-/NEWGENE T-cell/NN precursors/NNS exhibit/VBP V/NEWGENE delta/NEWGENE 2D/NEWGENE delta/NEWGENE 3/NEWGENE rearrangements/NEWGENE ./.
@@15889651051 GCR1/NEWGENE gene/NEWGENE function/NN is/VBZ required/VBN for/IN high-level/JJ glycolytic/JJ gene/NN expression/NN in/IN Saccharomyces/NN cerevisiae/NN ./.
@@81408478114 Crohn's/NNP disease/NN in/IN prolonged/JJ remission/NN :/: should/MD one/PRP augment/VB protein-calorie/NN intake/NN as/IN compared/VBN to/IN healthy/JJ subjects/NNS ?/. The/DT aim/NN of/IN our/PRP two/JJ year/NN prospective/JJ study/NN was/VBD to/IN evaluate/VB whether/IN adult/JJ Crohn's/NNP disease/NN patients/NNS in/IN prolonged/JJ remission/NN (/( CDAI/NNP </SYM 150/CD )/SYM ,/, in/IN order/NN to/IN maintain/VB their/PRP body/NN weight/NN as/RB close/JJ as/IN possible/JJ to/IN the/DT ideal/JJ one/PRP ,/, need/NN a/DT protein-calorie/NN intake/NN higher/JJ than/IN the/DT predicted/VBN one/PRP and/CC that/IN of/IN healthy/JJ controls/NNS ./.
@@10391075259 We/PRP are/VBP reporting/JJ an/DT autopsy/NN case/NN of/IN so-called/JJ "acute/NN multiple/JJ sclerosis"/NN that/WDT was/VBD difficult/JJ to/IN differentiate/VB from/IN a/DT brain/NN tumor/NN on/IN MRI/NN findings/NNS ./.
@@15322298624 Thus/RB ,/, this/DT study/NN provides/VBZ evidence/NN that/IN a/DT novel/NN ,/, ubiquitous/JJ factor/NN (/( HF-1a/NEWGENE )/SYM and/CC a/DT muscle/NN factor/NN (/( HF-1b/NEWGENE //NEWGENE MEF-2/NEWGENE )/SYM can/MD form/VB a/DT novel/NN ,/, E-box-independent/NNP pathway/NN for/IN muscle-specific/JJ expression/NN in/IN ventricular/JJ cardiac/JJ muscle/NN cells/NNS ./.
@@34044954103 Thyroid/NN function/NN tests/NNS were/VBD performed/VBN on/IN 300/CD admissions/NNS ,/, leaving/VBG 707/CD untested/JJ ./.
@@83404006177 Molecular/NNP cloning/NN and/CC expression/NN of/IN RPE65/NEWGENE ,/, a/DT novel/JJ retinal/JJ pigment/NN epithelium-specific/NN microsomal/NN protein/NN that/WDT is/VBZ post-transcriptionally/RB regulated/VBN in/IN vitro/FW ./.
@@39217272688 The/DT concentrations/NNS of/IN apo/NEWGENE A-I/NEWGENE and/CC apo/NEWGENE A-II/NEWGENE of/IN abstainers/NNS decreased/VBN significantly/RB compared/VBN with/IN the/DT corresponding/JJ changes/NNS in/IN controls/NNS ./.
@@86226753815 Inclusion/NNS of/IN the/DT extended/VBN N/JJ terminus/NN into/IN the/DT originally/RB reported/VBN protein/NN resulted/VBN in/IN a/DT striking/JJ similarity/NN to/IN the/DT lymphoid/NEWGENE factor/NEWGENE Lef-1/NEWGENE ./.
@@96790662821 These/DT results/NNS provide/VBP the/DT first/JJ demonstration/NN that/IN an/DT SR/NEWGENE protein/NEWGENE can/MD influence/VB splicing/JJ of/IN specific/JJ pre-mRNAs/NNS in/IN vivo/NN ./.
@@21151212495 Yeast/NN mutants/NNS assigned/VBN to/IN the/DT pet/NN complementation/NN group/NN G104/NN were/VBD found/VBN to/IN lack/NN alpha-ketoglutarate/NEWGENE dehydrogenase/NEWGENE activity/NN as/IN a/DT result/NN of/IN mutations/NNS in/IN the/DT dihydrolipoyl/NEWGENE transsuccinylase/NEWGENE (/( KE2/NEWGENE )/SYM component/NN of/IN the/DT complex/NN ./.
@@107204344939 We/PRP show/VBP ,/, by/IN injection/NN of/IN synthetic/JJ mRNAs/NNS ,/, that/IN the/DT cis-acting/JJ sequences/NNS responsible/JJ for/IN repression/NN of/IN cyclin/NEWGENE B1/NEWGENE mRNA/NEWGENE reside/VB within/IN its/PRP 3'UTR/CD ./.
@@109041913703 The/DT present/NN study/NN was/VBD designed/VBN to/IN evaluate/VB the/DT sensitivity/NN and/CC specificity/NN of/IN AMP/NN CT/NN (/( Gen-Probe/NNP Incorporated/NNP ,/, San/NNP Diego/NN ,/, CA/NN ,/, USA/NN )/SYM on/IN urogenital/JJ specimens/NNS taken/VBP from/IN symptomatic/JJ patients/NNS and/CC on/IN first/JJ void/JJ urine/NN (/( FVU/NNP )/SYM specimens/NNS from/IN asymptomatic/JJ patients/NNS ./.
@@75627753991 The/DT range/NN of/IN eosinophils/NNS was/VBD 22-56%/NN of/IN the/DT number/NN of/IN peripheral/NN white/NN blood/NN cells/NNS (/( mean/JJ nadir/NN 33%/JJ )/SYM ./.
@@29194833626 There/EX were/VBD 35/CD boys/NNS and/CC 15/CD girls/NNS ,/, with/IN a/DT mean/JJ age/NN of/IN five/CD and/CC a/DT half/NN years/NNS ./.
@@82898311646 Analysis/NNP of/IN mig/NEWGENE //NEWGENE CAT/NEWGENE chimeric/JJ constructs/NNS transiently/RB transfected/VBN into/IN the/DT RAW/NNP 264/CD ./CD 7/CD mouse/NN monocytic/JJ cell/NN line/NN revealed/VBD a/DT unique/JJ IFN-gamma-responsive/NEWGENE element/NEWGENE (/( gamma/NEWGENE RE-1/NEWGENE )/SYM ./.
@@20264617625 In/NN most/RB cases/VBZ ,/, DR4-homozygous/JJ ,/, DRB1-heterozygous/JJ individuals/NNS could/MD be/VB genotyped/VBN with/IN the/DT panel/NN of/IN probes/NNS ./.
@@19161684873 In/NN study/NN 2/CD ,/, the/DT correlation/NN coefficients/NNS between/IN the/DT ISO2/NN measurements/NNS obtained/VBN at/IN the/DT ulcer/NN margin/NN and/CC at/IN the/DT adjacent/JJ normal/JJ mucosa/NN ,/, and/CC delta/NN ISO2/NN obtained/VBN by/IN the/DT experienced/JJ observer/NN and/CC one/PRP of/IN the/DT three/CD learners/NNS were/VBD 0/CD ./CD 94/CD ,/, 0/CD ./CD 97/CD ,/, and/CC 0/CD ./CD 94/CD ,/, respectively/RB ./.
@@86520811382 More/RBR specific/JJ adverse/JJ events/NNS ,/, also/RB frequently/RB considered/VBN as/IN dose-limiting/JJ toxicities/NNS ,/, include/VB hypotension/NN with/IN IL-1/NEWGENE ,/, severe/JJ headache/NN or/CC skin/NN rash/NN with/IN IL-3/NEWGENE ,/, and/CC nasal/JJ congestion/NN and/CC gastroduodenal/JJ lesions/NNS with/IN IL-4/NEWGENE ./.
@@108057389957 Much/JJ evidence/NN indicates/VBZ that/IN p38/NEWGENE is/VBZ an/DT activator/NN of/IN MyoD/NEWGENE :/: (/( i/NN )/SYM p38/NEWGENE kinase/NEWGENE activity/NN is/VBZ required/VBN for/IN the/DT expression/NN of/IN MyoD-responsive/NEWGENE genes/NEWGENE ,/, (/( ii/NN )/SYM enforced/VBN induction/NN of/IN p38/NEWGENE stimulates/VBZ the/DT transcriptional/JJ activity/NN of/IN a/DT Gal4-MyoD/NEWGENE fusion/NEWGENE protein/NEWGENE and/CC allows/VBZ efficient/JJ activation/NN of/IN chromatin-integrated/JJ reporters/NNS by/IN MyoD/NEWGENE ,/, and/CC (/( iii/NN )/SYM MyoD-dependent/NNP myogenic/JJ conversion/NN is/VBZ reduced/VBN in/IN mouse/NN embryonic/JJ fibroblasts/NNS derived/VBN from/IN p38alpha/NEWGENE (/NEWGENE -/NEWGENE //NEWGENE -/NEWGENE )/NEWGENE embryos/NNS ./.
@@85552898538 Magnetic/JJ storm/NN indicators/NNS could/MD be/VB used/VBN in/IN medicine/NN ,/, in/IN geophysics/NN and/CC for/IN special/JJ purposes/NNS ./.
@@75761799543 However/RB ,/, a/DT strongly/RB increased/VBN frequency/NN of/IN CpG/NN dinucleotides/NN was/VBD found/VBN ./.
@@74933276332 Thus/RB ,/, as/IN expected/VBN ,/, trans-splicing/NN depends/VBZ on/IN the/DT integrity/NN of/IN U2/NEWGENE ,/, U4/NEWGENE ,/, and/CC U6/NEWGENE snRNAs/NEWGENE ./.
@@37890528352 An/DT exaggerated/JJ tissue/NN response/NN adjacent/JJ to/IN the/DT cyanoacrylate/NN site/NN suggested/VBD a/DT potential/JJ toxic/JJ chemical/JJ or/CC thermal/JJ reaction/NN ,/, or/CC both/DT ,/, to/IN the/DT tissue/NN adhesive/JJ ,/, but/CC there/RB was/VBD no/DT evidence/NN of/IN any/DT distant/JJ ocular/JJ effects/NNS ./.
@@86217142835 The/DT protein/NN folds/NNS correctly/RB with/IN two/JJ disulfide/NN bonds/NNS and/CC a/DT free/JJ thiol/NN group/NN at/IN Cys25/NN ./.
@@21545995482 In/NN this/DT study/NN ,/, we/PRP used/VBD footprinting/VBG and/CC gel/NN mobility/NN retardation/NN assays/NNS to/IN reveal/VB that/IN bacterially/RB synthesized/VBN Zta/NEWGENE fusion/NEWGENE proteins/NEWGENE bound/JJ directly/RB to/IN six/CD TGTGCAA-like/NEWGENE motifs/NEWGENE within/IN DSL/NEWGENE ./.
@@110369393280 Dsh/NEWGENE is/VBZ required/VBN for/IN two/JJ different/JJ pathways/NNS ,/, the/DT Wnt/NEWGENE pathway/NN and/CC planar/JJ polarity/NN pathway/NN in/IN Drosophila/NN ./.
@@104872171319 The/DT C2C-Prx/NEWGENE is/VBZ encoded/VBN as/IN a/DT preprotein/NN of/IN 273/CD amino/JJ acids/NNS containing/JJ a/DT putative/JJ chloroplast-targeting/JJ signal/NN of/IN 65/CD amino/JJ acids/NNS at/IN its/PRP N-terminus/NN ./.
@@10099576102 In/NN throttling/JJ valves/NNS ,/, the/DT aim/NN is/VBZ to/IN correlate/NN the/DT effect/NN of/IN shear/NN to/IN a/DT parameter/NN related/VBN to/IN the/DT inner/JJ geometry/NN of/IN the/DT valve/NN and/CC to/IN operating/JJ conditions/NNS ./.
@@111147185360 Here/RB we/PRP show/VBP in/IN mouse/NN fibroblasts/NNS stably/RB transformed/VBN by/IN v-Src/NEWGENE that/DT mRNA/NN and/CC protein/NN levels/NNS of/IN p21/NEWGENE (/( WAF1/NEWGENE //NEWGENE CIP1/NEWGENE )/SYM ,/, cyclin/NEWGENE D1/NEWGENE ,/, and/CC cyclin/NEWGENE E/NEWGENE are/VBP elevated/VBN ./.
@@83967132128 These/DT experiments/NNS confirm/VBP that/IN the/DT 6-S/NN liganded/JJ form/NN of/IN the/DT receptor/NN identified/VBN in/IN nuclear/JJ extracts/NNS of/IN cells/NNS treated/VBN with/IN 2/JJ ,/JJ 3/JJ ,/JJ 7/JJ ,/JJ 8-tetrachlorodibenzo-p-dioxin/JJ (/( TCDD/NN )/SYM contains/VBZ the/DT Ah/NEWGENE receptor/NEWGENE protein/NEWGENE and/CC ARNT/NEWGENE but/CC not/RB the/DT 90-kDa/NEWGENE heat/NEWGENE shock/NEWGENE protein/NEWGENE ./.
@@64345727359 These/DT children/NNS were/VBD grouped/VBN into/IN four/CD diagnostic/JJ categories/NNS :/: 1/NN )/NN idiopathic/JJ GH/NEWGENE deficiency/NN (/( n/NN =/SYM 10/CD )/SYM ;/: 2/NN )/NN organic/JJ hypopituitarism/NN (/( n/NN =/SYM 7/CD )/SYM ;/: 3/NN )/NN intrauterine/JJ growth/NN retardation/NN (/( n/NN =/SYM 5/CD )/SYM ;/: and/CC 4/NN )/NN constitutional/JJ delay/NN of/IN growth/NN and/IN //IN or/IN familial/JJ short/JJ stature/NN (/( n/NN =/SYM 18/CD )/SYM ,/, by/IN standard/JJ clinical/JJ criteria/NNS and/CC physiological/JJ and/CC pharmacological/JJ tests/NNS of/IN GH/NEWGENE reserve/NN ./.
@@79491379320 A/DT total/NN of/IN 125/CD acute/JJ leukemia/NN adult/JJ patients/NNS were/VBD autografted/VBN with/IN bone/NN marrow/NN (/( BM/NN )/SYM purged/VBN by/IN mafosfamide/NN (/( ASTA/NN Z/NN )/SYM during/IN the/DT period/NN of/IN January/NN 1983/CD to/IN January/NN 1993/CD ./.
@@95258913089 Members/NNS of/IN the/DT meis1/NEWGENE and/CC pbx/NEWGENE homeodomain/NEWGENE protein/NEWGENE families/NEWGENE cooperatively/RB bind/VBP a/DT cAMP-responsive/NEWGENE sequence/NEWGENE (/( CRS1/NEWGENE )/SYM from/IN bovine/NEWGENE CYP17/NEWGENE ./.
@@106486195795 We/PRP have/VBP investigated/VBN the/DT contribution/NN of/IN specific/NN TATA-binding/NEWGENE protein/NEWGENE (/( TBP/NEWGENE )/NN -TATA/NN interactions/NNS to/IN the/DT promoter/NN activity/NN of/IN a/DT constitutively/RB expressed/VBN silkworm/NEWGENE tRNA/NEWGENE (/NEWGENE C/NEWGENE )/NEWGENE (/NEWGENE Ala/NEWGENE )/NEWGENE gene/NEWGENE and/CC have/VB also/RB asked/VBN whether/IN the/DT lack/NN of/IN similar/JJ interactions/NNS accounts/NNS for/IN the/DT low/JJ promoter/NN activity/NN of/IN a/DT silk/NEWGENE gland-specific/NEWGENE tRNA/NEWGENE (/NEWGENE SG/NEWGENE )/NEWGENE (/NEWGENE Ala/NEWGENE )/NEWGENE gene/NEWGENE ./.
@@20246252637 Differences/NNS in/IN the/DT clinical/JJ presentation/NN and/CC the/DT gross/JJ appearance/NN of/IN the/DT two/JJ cases/NNS are/VBP described/VBN ,/, and/CC similarities/NNS in/IN the/DT microscopic/JJ features/NNS are/VBP discussed/VBN ./.
@@78416637815 Superoxide/NEWGENE dismutase/NEWGENE (/( SOD/NEWGENE )/SYM activity/NN decreased/VBN significantly/RB in/IN sperm/NN subjected/VBN to/IN direct/JJ electric/JJ current/NN in/IN comparison/NN to/IN the/DT control/NN or/CC the/DT sample/NN incubated/VBN with/IN electrolyzed/VBN medium/NN ./.
@@99502136771 Thus/RB ,/, in/IN normal/JJ intestinal/JJ epithelial/JJ goblet/NN cells/NNS ,/, TbetaRI/NEWGENE and/CC TbetaRII/NEWGENE can/MD respond/VB to/IN autocrine/JJ but/CC not/RB exogenous/JJ TGF-beta/NEWGENE without/IN the/DT participation/NN of/IN TbetaRIII/NEWGENE ./.
@@2107548163 Reverse/VB transcription-PCR/NN was/VBD then/RB used/VBN to/IN clone/NN from/IN human/JJ poly/NN (/NN A/NN )/NN +/NN RNA/NN the/DT cDNA/NN corresponding/JJ to/IN the/DT expressed/VBN homolog/NN of/IN psi/NEWGENE ARF/NEWGENE 4/NEWGENE ,/, referred/VBN to/RB as/IN human/NEWGENE ARF/NEWGENE 4/NEWGENE ./.
@@75168663813 A/DT full-length/NEWGENE PRL/NEWGENE receptor/NEWGENE (/( PRLR/NEWGENE )/SYM complementary/JJ DNA/NN from/IN pigeons/NNS was/VBD obtained/VBN by/IN screening/JJ pigeon/NN crop/NN sac/NN libraries/NNS and/CC by/IN reverse/JJ transcription/NN coupled/VBN with/IN polymerase/NEWGENE chain/NN reaction/NN ./.
@@75657756680 Individual/JJ mutations/NNS in/IN motifs/NEWGENE III/NEWGENE ,/NEWGENE IV/NEWGENE ,/NEWGENE and/NEWGENE V/NEWGENE had/VBP distinctive/JJ effects/NNS on/IN the/DT affinity/NN of/IN enzyme/NN for/IN GTP/NN ,/, the/DT rate/NN of/IN covalent/JJ catalysis/NN (/( EpG/NN formation/NN )/SYM ,/, or/CC the/DT transfer/NN of/IN GMP/NN from/IN enzyme/NN to/IN RNA/NN ./.
@@80934509577 Mutagenesis/NNS of/IN each/DT NRF-1/NEWGENE motif/NEWGENE in/IN the/DT ALAS/NEWGENE promoter/NEWGENE gave/VBD substantially/RB lowered/VBN levels/NNS of/IN chloramphenicol/NEWGENE acetyltransferase/NEWGENE expression/NN ,/, whereas/IN mutagenesis/NN of/IN both/DT NRF-1/NEWGENE motifs/NEWGENE resulted/VBN in/IN the/DT almost/RB complete/JJ loss/NN of/IN expression/NN ./.
@@104308868801 The/DT C-terminal/NN mutants/NN were/VBD strongly/RB dominant/JJ over/RB TraR/NEWGENE ,/, suggesting/VBG that/IN they/PRP can/MD form/VB heteromultimers/NNS with/IN the/DT wild-type/NN activator/NN ./.
@@93831568505 The/DT major/JJ RNase/NEWGENE E/NEWGENE cleavage/NN product/NN (/( denoted/VBN pSok-6/NEWGENE )/SYM is/VBZ rapidly/RB degraded/VBN by/IN polynucleotide/NEWGENE phosphorylase/NEWGENE (/( PNPase/NEWGENE )/SYM ./.
@@1986254773 Gel/NNP mobility/NN shift/NN assays/NNS using/VBG a/DT synthetic/JJ E6/NEWGENE motif/NEWGENE detected/VBD a/DT B-cell-specific/NN complex/NN in/IN addition/NN to/IN a/DT ubiquitous/JJ band/NN found/VB also/RB in/IN T/NN cells/NNS and/CC HeLa/DT cells/NNS ./.
@@1532796218 Mutations/NNS in/IN either/DT gene/NN block/NN some/DT crucial/JJ late/JJ step/NN in/IN assembly/NN of/IN F1/NEWGENE ,/, causing/JJ the/DT alpha/NN and/CC beta/NN subunits/NN to/IN accumulate/VB in/RB mitochondria/NNS as/IN inactive/JJ aggregates/NNS (/( Ackerman/NNP ,/, S/NNP ./NNP
@@96390746327 Sp1/NEWGENE and/CC two/JJ Sp3/NEWGENE isoforms/NEWGENE were/VBD detected/VBN as/IN the/DT primary/JJ cellular/JJ constituents/NNS of/IN DNA-protein/NN complexes/NNS formed/VBN with/IN the/DT NF-kappaB-proximal/NEWGENE site/NEWGENE ./.
@@82470058208 Strains/NNS bearing/JJ the/DT drs2/NEWGENE mutation/NEWGENE process/NN the/DT 20S/NEWGENE precursor/NEWGENE of/IN the/DT mature/NEWGENE 18S/NEWGENE rRNA/NEWGENE slowly/RB and/CC are/VBP deficient/JJ in/IN 40S/NEWGENE ribosomal/NEWGENE subunits/NEWGENE ./.
@@86144039695 We/PRP observed/VBD abundant/JJ levels/NNS of/IN Rev-erbA/NEWGENE alpha/NEWGENE mRNA/NEWGENE in/IN dividing/JJ C2C12/CELL myoblasts/NNS ,/, which/WDT were/VBD suppressed/VBN when/CC the/DT cells/NNS differentiated/VBN into/IN postmitotic/JJ multinucleated/JJ myotubes/NNS ./.
@@24518723111 The/DT recovery/NN of/IN labelled/JJ methoxydextrane/NN is/VBZ 98/CD +/NN //NN -/NN 7%/CD ./CD
@@93901255432 RESULTS/NNS :/: The/DT overall/JJ FNF/NN for/IN 1992/CD was/VBD 12/CD ./CD 3%/CD and/CC was/VBD 19/CD ./CD 1%/CD ,/, 22/CD ./CD 2%/CD ,/, 3/CD ./CD 8%/CD and/CC 6/CD ./CD 1%/CD per/IN successive/JJ quarters/NNS in/IN 1992/CD ./.
@@27209666223 In/NN cerebrospinal/JJ fluid/NN ,/, an/DT ADA/NEWGENE catalytic/JJ concentration/NN above/RB 0/CD ./CD 15/CD mu/NN kat/NN //NN L/NN strongly/RB suggests/VBZ tuberculous/JJ meningitis/NN in/IN patients/NNS older/JJR than/IN 7/CD years/NNS (/( sensitivity/NN 1/CD ./CD 00/CD ,/, specificity/NN 0/CD ./CD 99/CD and/CC efficiency/NN 0/CD ./CD 99/CD )/SYM ./.
@@19708015396 Along/IN with/IN previously/RB mapped/VBN genes/NNS including/JJ Ly-1/NEWGENE and/CC CD20/NEWGENE ,/, OSBP/NEWGENE defines/VBZ a/DT new/RB conserved/VBN syntenic/JJ group/NN on/IN the/DT long/JJ arm/NN of/IN chromosome/NN 11/CD in/IN the/DT human/JJ and/CC the/DT proximal/JJ end/NN of/IN chromosome/NN 19/CD in/IN the/DT mouse/NN ./.
@@77595252922 The/DT proteins/NNS are/VBP more/RB than/IN 90%/NN identical/JJ to/IN each/DT other/DT within/IN the/DT protein/NEWGENE kinase/NEWGENE domain/NEWGENE but/CC only/RB 51-59%/NN identical/JJ to/IN other/DT casein/NEWGENE kinase/NEWGENE I/NEWGENE isoforms/NEWGENE within/IN this/DT region/NN ./.
@@8395010539 The/DT conserved/VBN ninth/JJ C-terminal/NN heptad/NN in/IN thyroid/JJ hormone/NN and/CC retinoic/NEWGENE acid/NEWGENE receptors/NEWGENE mediates/VBZ diverse/JJ responses/NNS by/IN affecting/VBG heterodimer/NN but/CC not/RB homodimer/NN formation/NN ./.
@@105102953741 Secondly/RB ,/, an/DT ethanol/NEWGENE repression/NEWGENE autoregulation/NEWGENE (/NEWGENE ERA/NEWGENE )/NEWGENE //NEWGENE twelve-fold/NEWGENE TA/NEWGENE repeat/NEWGENE (/NEWGENE TAB/NEWGENE )/NEWGENE repressor/NEWGENE element/NEWGENE was/VBD identified/VBN within/IN the/DT promoter/NN region/NN of/IN the/DT GLK1/NEWGENE gene/NEWGENE ./.
@@27989532164 With/IN a/DT sample/NN of/IN mothers/NNS of/IN healthy/JJ infants/NNS ,/, all/DT three/CD subscales/NNS of/IN the/DT revised/VBN instrument/NN ,/, WPL-R/NN ,/, had/VBP acceptable/JJ levels/NNS of/IN internal/JJ consistency/NN at/IN 7/CD ,/, 30/CD ,/, and/CC 90/CD days/NNS postpartum/JJ ,/, and/CC stability/NN across/IN administrations/NNS ./.
@@93729507217 These/DT results/NNS implicate/VBP a/DT precursor-specific/JJ base-paired/JJ structure/NN involving/VBG sequences/NNS on/IN both/DT sides/NNS of/IN the/DT mature/JJ cleavage/NN site/NN in/IN the/DT 3'/CD processing/NN of/IN human/NEWGENE U2/NEWGENE RNA/NEWGENE ./.
@@96866034958 To/TO further/RB understand/VB the/DT role/NN of/IN cis-acting/JJ elements/NNS in/IN these/DT regulatory/JJ mechanisms/NNS ,/, we/PRP have/VBP characterized/VBN a/DT transcriptional/JJ promoter/NN that/IN drives/NNS germline/NN expression/NN of/IN TCR/NEWGENE beta/NEWGENE gene/NEWGENE segments/NEWGENE in/IN vivo/NN ./.
@@14297401986 It/PRP corresponds/VBZ to/IN the/DT complete/JJ mitochondrial/JJ presequence/NN and/CC the/DT lipoyl-bearing/JJ domain/NN that/WDT are/VBP encoded/VBN by/IN exons/NNS I/PRP through/JJ IV/NN of/IN the/DT functional/JJ E2/NEWGENE gene/NEWGENE ./.
@@104601715330 Viscosity/NNS experiments/NNS on/IN the/DT catalytic/JJ fragment/NN kinase/NEWGENE reaction/NN demonstrated/VBN that/IN the/DT chemical/JJ (/( phosphoryl/NN transfer/NN )/SYM step/NN had/VBP a/DT reduced/VBN rate/NN ./.
@@23073719139 To/TO define/VB the/DT mechanism/NN responsible/JJ for/IN the/DT loss/NN of/IN transcription/NN elongation/NN blockage/NN and/CC resulting/JJ c-myc/NEWGENE deregulation/NN in/IN Burkitt's/NNP lymphoma/NN ,/, we/PRP analyzed/VBD transcription/NN patterns/NNS after/IN transfer/NN of/IN normal/JJ and/CC Burkitt's/NNP lymphoma/NN c-myc/NEWGENE alleles/NN into/IN murine/JJ cells/NNS and/CC Xenopus/NN oocyte/NN germinal/JJ vesicles/NNS ./.
@@11356853175 Mutation/NN analyses/NNS identified/VBD the/DT cobalt-responsive/JJ sequences/NNS as/IN the/DT stress-response/NEWGENE elements/NEWGENE (/( StREs/NEWGENE )/SYM ./.
@@18638872460 Space/NNP limitations/NNS prevent/VBP an/DT exhaustive/JJ review/NN of/IN all/DT biologic/JJ pharmaceuticals/NNS ,/, such/JJ as/IN tissue/NEWGENE plasminogen/NEWGENE activating/NEWGENE substance/NEWGENE ,/, hormones/NNS (/( e/FW ./FW g/FW ./FW ,/, thyroid/JJ ,/, insulin/NEWGENE ,/, growth/NEWGENE hormone/NEWGENE ,/, erythropoietin/NEWGENE )/SYM ,/, clotting/JJ factors/NNS ,/, and/CC blood/NN products/NNS ./.
@@104641859546 Molecular/NNP characterization/NN of/IN type-specific/NEWGENE capsular/NEWGENE polysaccharide/NEWGENE biosynthesis/NEWGENE genes/NEWGENE of/NEWGENE Streptococcus/NEWGENE agalactiae/NEWGENE type/NEWGENE Ia/NNP ./NNP
@@88726713235 The/DT model/NN also/RB predicts/VBZ that/DT blood/NN flow/NN shunt/NN fraction/NN (/( Qs/NN //NN QT/NN )/SYM is/VBZ directly/RB related/VBN to/IN the/DT oxygen/NN sine-wave/NN amplitude/NN perturbations/NNS transmitted/VBN to/IN end-expired/JJ air/NN and/CC arterial/JJ and/CC mixed-venous/JJ blood/NN through/RB two/JJ simple/JJ equations/NNS ./.
@@89641728918 Filter/NNP and/CC cytocentrifuge/NN preparations/NNS of/IN the/DT urine/NN were/VBD studied/VBN and/CC all/DT cases/NNS displayed/VBD numerous/JJ scattered/JJ aggregates/NNS or/CC single/JJ tumor/NN cells/NNS in/IN an/DT inflammatory/JJ background/NN ./.
@@76669667591 Mean/VB longitudinal/JJ extension/NN of/IN the/DT epidural/JJ lesion/NN was/VBD 2/CD ./CD 6/CD vertebral/JJ segments/NNS ./.
@@32758736679 The/DT effects/NNS of/IN these/DT mutations/NNS on/IN RNA/NEWGENE polymerase/NEWGENE II/NEWGENE activity/NN were/VBD assayed/VBN by/IN measuring/JJ the/DT ability/NN of/IN mutant/JJ genes/NNS to/IN confer/VB alpha-amanitin/NEWGENE resistance/NN after/IN transfection/NN of/IN susceptible/JJ rodent/NN cells/NNS ./.
@@112437779959 Cis-acting/VBG CCAAT/NEWGENE elements/NEWGENE are/VBP frequently/RB found/VB in/IN eukaryotic/NN promoter/NN regions/NN ./.
@@95397461259 Expression/NNS of/IN Bcl-XL/NEWGENE inhibited/VBN the/DT association/NN of/IN Apaf-1/NEWGENE with/IN caspase-9/NEWGENE in/IN mammalian/JJ cells/NNS ./.
@@104788485048 SF-1/NEWGENE does/VBP not/RB have/VB an/DT N-terminal/NEWGENE AF1/NEWGENE domain/NEWGENE ./.
@@23512973011 Basing/VBG on/IN experimental/JJ toxicity/NN research/NN it/PRP was/VBD established/VBN that/IN ,/, out/RB of/IN 50/CD atmosphere/NN metal/NN corrosion/NN inhibitors/NNS ,/, some/DT 14/CD per/IN cent/NN were/VBD found/VBN extremely/RB hazardous/JJ ,/, 42/CD per/IN cent--of/CD high/JJ level/NN hazardous/JJ ,/, 33/CD percent--of/JJ moderate/JJ and/CC 11/CD per/IN cent--of/CD low/JJ hazardous/JJ ./.
@@98130987261 Paralemmin/NEWGENE is/VBZ also/RB phosphorylated/VBN ,/, and/CC its/PRP mRNA/NN is/VBZ differentially/RB spliced/VBN in/IN a/DT tissue-specific/JJ and/CC developmentally/RB regulated/VBN manner/NN ./.
@@66005331339 Azygos/NNP vein/NN abutting/VBG the/DT posterior/JJ wall/NN of/IN the/DT right/JJ main/JJ and/CC upper/JJ lobe/NN bronchi/NNS :/: a/DT normal/JJ CT/NN variant/NN ./.
@@106203351423 We/PRP also/RB report/VBP that/DT AHR/NEWGENE interacts/VBZ with/IN COUP-TF/NEWGENE in/IN transfected/VBN CV-1/NNP cells/NNS ./.
@@10211422146 Acute/JJ pancreatitis/NN as/IN a/DT complication/NN of/IN polyarteritis/NN nodosa/NN ./.
@@86708536486 Cluster/NN formation/NN of/IN E-cadherin/NEWGENE on/IN the/DT cell/NN surface/NN is/VBZ believed/VBN to/IN be/VB of/IN major/JJ importance/NN for/IN cell-cell/JJ adhesion/NN ./.
@@28955663599 DPA/NN attenuated/VBN the/DT increase/NN of/IN the/DT intensity/NN of/IN the/DT ischemic/JJ and/CC pressure/NN pain/NN components/NNS with/IN increasing/JJ ischemia/NN duration/NN ,/, but/CC only/RB the/DT effect/NN on/IN the/DT pressure/NN pain/NN component/NN was/VBD significant/JJ ./.
@@40822674768 Following/VBG seven/JJ days'/NN incubation/NN both/DT at/IN 20/CD degrees/NNS C/NN and/CC 28/CD degrees/NNS C/NN ,/, Ae/NNP ./NNP vexans/NNS nip/NN ./. was/VBD capable/JJ of/IN transmitting/JJ the/DT virus/NN ./.
@@99809446997 Interplane/NNP coupling/NN in/IN the/DT superconductor/NN Y2Ba4Cu7O15/NN as/IN revealed/VBN by/IN NQR/NN spin-echo/NN double/JJ resonance/NN ./.
@@890284740 The/DT evidence/NN in/IN support/NN of/IN this/DT was/VBD derived/VBN from/IN the/DT fact/NN that/IN the/DT affinity/NN or/CC interaction/NN between/IN the/DT two/JJ subunits/NNS was/VBD impaired/VBN as/IN indicated/VBN by/IN the/DT first/JJ order/NN rate/NN constant/NN of/IN hCG/NEWGENE alpha/NEWGENE 1/NEWGENE beta/NEWGENE (/( km/NN =/SYM 4/CD ./CD 1/CD x/NN 10/NN (/NN -2/NN )/SYM min-1/NN )/NN at/IN pH/NN 3/CD ./CD 0/CD at/IN 23/CD degrees/NNS C/NN which/WDT is/VBZ one/PRP order/NN of/IN magnitude/NN greater/RBR relative/JJ to/IN rehCG/NEWGENE (/( kw/NN =/SYM 4/CD ./CD 6/CD x/NN 10/NN (/NN -3/NN )/SYM min-1/NN )/NN ./.
@@74838573365 Correlation/NNS coefficients/NNS between/IN the/DT reference/NN methods/NNS and/CC NIT/NN were/VBD >/SYM or/CC =/SYM 0/CD ./CD 95/CD for/IN water/NN ,/, fat/JJ ,/, crude/JJ protein/NN and/CC connective-tissue-protein/JJ frei/NN meat/NN protein/NN ,/, and/CC >/SYM or/CC =/SYM 0/CD ./CD 86/CD for/IN connective-tissue-protein/NN ./.
@@100514883078 Further/JJ analysis/NN of/IN AP-1/NEWGENE DNA/NN binding/JJ activities/NNS in/IN 7-/CD to/IN 14-day/NN culture/NN activated/VBN HSCs/NNS led/VBN to/IN the/DT discovery/NN of/IN high/NEWGENE mobility/NEWGENE AP-1/NEWGENE complexes/NEWGENE (/( HMAP-1/NEWGENE )/SYM ./.
@@21442904605 Sci/NNS ./.
@@90648689014 A/DT miracle/NN cure/NN and/CC its/PRP solution/NN ./.
@@98520686182 The/DT human/NEWGENE SHBG/NEWGENE proximal/NEWGENE promoter/NEWGENE was/VBD analyzed/VBN by/IN DNase/NEWGENE I/NEWGENE footprinting/VBG ,/, and/CC the/DT functional/JJ significance/NN of/IN 6/CD footprinted/VBN regions/NNS (/( FP1-FP6/NNP )/SYM within/IN the/DT proximal/JJ promoter/NN was/VBD studied/VBN in/IN human/JJ HepG2/NNP hepatoblastoma/NN cells/NNS ./.
@@30276619519 Two/CD activities/NNS of/IN the/DT D/NEWGENE protein/NEWGENE of/IN the/DT miniF/NN plasmid/NN have/NN been/VBN found/VB ./.
@@91680835196 No/DT patient/NN in/IN group/NN 2/CD developed/VBN HAT/NN (/( P/NN =/SYM 0/CD ./CD 006/CD versus/IN group/NN 1/CD )/SYM ./SYM
@@106839891923 After/IN nitric/JJ oxide/NN inhalation/NN ,/, the/DT results/NNS showed/VBD moderate/JJ increases/NNS in/IN PaO2/NN and/CC SaO2/NN (/( P/NN >/SYM 0/CD ./CD 05/CD )/SYM and/CC a/DT significant/JJ decrease/NN in/IN Qs/NN //NN Q/NN tau/NN ratio/NN (/( P/NN </SYM 0/CD ./CD 01/CD )/SYM ./.
@@7046759948 The/DT mass/NN of/IN UO2/NN in/IN the/DT extrapulmonary/JJ bronchi/NNS and/CC first/JJ bifurcation/NN decreased/VBN more/RB slowly/RB over/RB 0--8/JJ d/NN after/IN inhalation/NN than/IN the/DT corresponding/JJ mass/NN on/IN the/DT trachea/NN ./.
@@83006019953 This/DT region/NN is/VBZ required/VBN for/IN activation/NN of/IN DNA/NN binding/NN of/IN MyoD/NEWGENE and/CC E12/NEWGENE homodimers/NEWGENE and/CC E12/NEWGENE //NEWGENE MyoD/NEWGENE heterodimers/NEWGENE ./.
@@20109127250 In/NN this/DT paper/NN ,/, we/PRP report/VBP a/DT detailed/JJ study/NN of/IN the/DT structure/NN and/CC the/DT functional/JJ role/NN of/IN the/DT MalT/NEWGENE binding/NEWGENE sites/NEWGENE located/VBN in/IN the/DT adjacent/JJ and/CC divergent/JJ pulAp/NEWGENE and/CC pulCp/NEWGENE promoters/NEWGENE ./.
@@7969135416 Thus/RB ,/, the/DT presence/NN of/IN the/DT Cln2/NEWGENE PEST/NEWGENE domain/NEWGENE was/VBD sufficient/JJ to/IN destabilize/VB a/DT heterologous/JJ protein/NN ./.
@@93482267820 Interestingly/RB ,/, EGF/NEWGENE ,/, but/CC not/RB insulin/NEWGENE ,/, stimulated/VBN tyrosine/NN phosphorylation/NN of/IN c-cbl/NEWGENE and/CC its/PRP association/NN with/IN Crk-II/NEWGENE ./.
@@10323463187 Interferon-alpha/NEWGENE may/MD exacerbate/VB cryoblobulinemia-related/JJ ischemic/JJ manifestations/NNS :/: an/DT adverse/JJ effect/NN potentially/RB related/VBD to/IN its/PRP anti-angiogenic/JJ activity/NN ./.
@@75459203165 Two/CD such/JJ genes/NNS ,/, designated/VBN hsiggll150/NEWGENE and/CC hsiggll295/NEWGENE ,/, were/VBD cloned/VBN and/CC sequenced/VBN from/IN genomic/JJ DNA/NN ./.
@@91113141031 Cyclin/NEWGENE D1/NEWGENE could/MD not/RB be/VB displaced/VBN from/IN cdk4/NEWGENE in/IN the/DT resistant/JJ 184A1L5R/CD cell/NN lysates/NNS ./.
@@4950975265 These/DT characteristics/NNS indicated/VBD the/DT pronounced/VBN activity/NN of/IN collagenous/JJ fiber/NN synthesis/NN and/CC the/DT matrix/NN of/IN the/DT osteoid/JJ tissue/NN ./.
@@95026279585 RESULTS/NNS :/: Patients/NNS in/IN Group/NNP A/DT had/VBP a/DT higher/JJ incidence/NN of/IN posterolateral/JJ wall/NN motion/NN abnormalities/NNS (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM on/IN radionuclide/NN ventriculography/NN ,/, a/DT larger/JJR infarct/NN area/NN (/( as/IN evidenced/VBN by/IN higher/JJ peak/NN creatine/NEWGENE kinase/NEWGENE levels/NNS )/SYM (/( p/NN </SYM 0/CD ./CD 02/CD )/SYM and/CC a/DT lower/JJR left/NN ventricular/JJ ejection/NN fraction/NN (/( LVEF/NN )/SYM at/IN hospital/NN discharge/NN (/( p/NN </SYM 0/CD ./CD 008/CD )/SYM than/IN those/DT in/NNP Group/NNP B/NNP ./NNP
@@18321524538 The/DT incompatibility/NN group/NN W/NN plasmid/NN pSa/NN suppresses/VBZ Agrobacterium/NN tumefaciens/NN oncogenicity/NN (/( J/NNP ./NNP
@@9268387693 In/NN this/DT report/NN ,/, we/PRP identify/VBP and/CC characterize/VB two/JJ overlapping/NN ELL/NEWGENE functional/NEWGENE domains/NEWGENE that/WDT govern/VBP its/PRP interaction/NN with/IN RNA/NEWGENE polymerase/NEWGENE II/NEWGENE and/CC the/DT ternary/JJ elongation/NN complex/NN ./.
@@109979049894 The/DT Spo0F/NEWGENE residues/NEWGENE making/VBG up/VB the/DT hydrophobic/JJ patch/NN are/VBP very/RB similar/JJ in/IN all/DT response/NN regulators/NN suggesting/VBG that/IN the/DT binding/NN is/VBZ initiated/VBN through/RB the/DT same/JJ residues/NNS in/IN all/DT interacting/VBG response/NN regulator-kinase/NN pairs/NNS ./.
@@88293935190 We/PRP performed/VBD dipole/NN estimation/NN of/IN spikes/NNS and/CC SEP/NN components/NN in/IN identical/JJ patients/NNS ./.
@@108354851720 The/DT so-called/JJ "SH3"/NEWGENE segment/NEWGENE of/IN the/DT linker/NN domain/NN ,/, in/IN contrast/NN ,/, shows/VBZ species-specific/NN sequence/NN identity/NN in/IN all/DT but/CC one/PRP amino/JJ acid/NN residues/NNS in/IN both/DT factors/NNS ,/, in/IN cattle/NNS ,/, human/JJ ,/, and/CC mouse/NN ./.
@@113413493135 Early/NN indicators/NN of/IN the/DT effect/NN of/IN a/DT breast/NN cancer/NN screening/JJ program/NN for/IN low-income/JJ women/NNS ./.
@@115333406068 There/EX was/VBD no/DT significant/JJ difference/NN in/IN developmental/JJ scores/NNS at/IN 9/CD or/CC 18/CD months/NNS ,/, although/IN PDF/NN infants/NNS had/VBP a/DT 2/CD ./CD 8/CD (/( -1/CD ./CD 3-6/CD ./CD 8/CD )/SYM point/NN advantage/NN in/IN Bayley/NNP motor/JJ score/NN scales/NNS ./.
@@10575231120 Analysis/NNP of/IN its/PRP genomic/JJ region/NN revealed/VBN that/IN the/DT 13-kb/JJ Cdc6/NEWGENE gene/NEWGENE is/VBZ divided/VBN into/IN 12/CD exons/NNS by/IN 11/CD introns/NNS ./.
@@75019926693 These/DT incisors/NNS were/VBD studied/VBN by/IN scanning/JJ electron/NN microscopy-energy/JJ dispersive/JJ spectroscopy/NN analysis/NN (/( SEM-EDS/NN )/SYM and/CC light/NN microscopy/NN to/IN examine/VB the/DT calciotraumatic/JJ lines/NNS of/IN strontium/NN in/IN the/DT rat/NEWGENE incisor/NEWGENE labial/NEWGENE dentin/NEWGENE ./.
@@67004696459 Private/JJ hospital/NN accreditation/NN ./.
@@19766383878 One/CD of/IN these/DT is/VBZ located/VBN in/IN the/DT 5'-untranslated/JJ region/NN ,/, and/CC may/MD encode/VB regulatory/JJ sequences/NNS ./.
@@8284227932 Glomerular/JJ mesangial/JJ cells/NNS expressed/VBD an/DT abundant/JJ 1/CD ./CD 1/CD kb/NN mRNA/NN transcript/NN for/IN Id1/NEWGENE ,/, but/CC in/IN contrast/NN to/IN other/DT cell/NN types/NNS Id1/NEWGENE mRNA/NEWGENE was/VBD expressed/VBN in/IN both/DT randomly/RB cycling/JJ cells/NNS and/CC in/IN serum-deprived/JJ ,/, quiescent/JJ cultures/NNS ./.
@@53689785506 CNS/NN effects/NNS of/IN local/JJ anesthetics/NNS only/RB partially/RB dependent/JJ on/IN biogenic/JJ amine/NN mechanisms/NNS ./.
@@33319334008 By/IN Felix/NNP Lagrange/NNP ,/, 1918/CD ./.
@@90841765806 Transcriptional/JJ activity/NN was/VBD measured/VBN by/IN slot-blot/NN hybridization/NN with/IN steady-state/JJ RNA/NN isolated/VBN from/IN lacZ+/NEWGENE M/NEWGENE ./NEWGENE smegmatis/NEWGENE clones/NNS ./.
@@77868214489 CONCLUSION/IN :/: The/DT MTD/NN for/IN CPT-11/NN administered/VBN in/IN a/DT 3/CD consecutive-days-every-3/NN weeks/NNS schedule/NN in/IN this/DT patient/NN population/NN is/VBZ 115/CD mg/CD //CD m2/CD //CD day/CD ./.
@@14261092048 4/CD ./CD
@@77917692138 ICP4/NEWGENE has/VBZ been/VBN shown/VBP to/IN form/NN tripartite/JJ complexes/NNS cooperatively/RB with/IN the/DT TATA/NEWGENE box-binding/NEWGENE protein/NEWGENE and/CC TFIIB/NEWGENE on/IN DNA/NN containing/JJ an/DT ICP4/NEWGENE binding/NEWGENE site/NEWGENE and/CC a/DT TATA/NN box/NN (/( C/NNP ./NNP
@@105266705880 However/RB ,/, a/DT specific/NN ICE/NEWGENE //NEWGENE caspase-1/NEWGENE inhibitor/NN called/VBN N1445/NN completely/RB abolished/VBN the/DT CK-induced/JJ apoptosis/NN by/IN reactivating/JJ PKB/NEWGENE ,/, but/CC without/IN affecting/VBG the/DT CK-induced/JJ suppression/NN of/IN Ras/NEWGENE transformation/NN ./.
@@84568798419 OBJECTIVE/IN :/: Our/PRP purpose/NN was/VBD to/IN determine/VB the/DT simultaneous/JJ concentrations/NNS of/IN serum/JJ cotinine/NN in/IN both/DT fetal/JJ and/CC maternal/JJ blood/NN ./.
@@32610051757 Records/NNS of/IN 31/CD children/NNS with/IN AIDS/NN or/CC AIDS-related/NN complex/NN admitted/VBN to/IN the/DT pediatric/JJ intensive/JJ care/NN unit/NN for/IN acute/JJ respiratory/JJ failure/NN throughout/IN a/DT 46-month/JJ period/NN were/VBD reviewed/VBN ./.
@@33828554072 The/DT artery/NN cuff/NN was/VBD slightly/RB superior/JJ to/IN the/DT fat/JJ wrap/NN ,/, particularly/RB in/IN having/VBG fewer/DT adhesions/NNS and/CC a/DT better/RBR histological/JJ picture/NN ./.
@@92005305579 Liquid/NNP chromatographic/JJ separation/NN was/VBD achieved/VBN on/IN a/DT Zorbax/NNP RX/NN C8/NN analytical/JJ column/NN using/VBG gradient/NN elution/NN ./.
@@83886008346 Estrogen/NN treatment/NN in/IN high/JJ doses/NNS is/VBZ effective/JJ in/IN reducing/JJ adult/JJ stature/NN in/IN constitutionally/RB tall/JJ girls/NNS ./.
@@76040477399 A/DT cDNA/NN clone/NN corresponding/JJ to/IN the/DT putative/JJ GA/NEWGENE 20-oxidase/NEWGENE genomic/NEWGENE sequence/NEWGENE was/VBD constructed/VBN with/IN the/DT reverse/JJ transcription-PCR/NN method/NN ,/, and/CC the/DT identity/NN of/IN the/DT cDNA/NN clone/NN was/VBD confirmed/VBN by/IN analyzing/VBG the/DT capability/NN of/IN the/DT fusion/NN protein/NN expressed/VBN in/IN Escherichia/NN coli/JJ to/IN convert/NN GA53/NEWGENE to/IN GA44/NEWGENE and/CC GA19/NEWGENE to/IN GA20/NEWGENE ./.
@@1830632430 The/DT incidence/NN of/IN DNCB/NN reactions/NNS was/VBD 78/CD per/IN cent/NN for/IN Stage/NNP I/PRP and/CC II/NNP cancers/NNS (/( 37/CD patinets/NNS )/SYM ,/, 73/CD per/IN cent/NN for/IN resectable/JJ Stage/NNP III/NNP cancer/NN (/( 22/CD patients/NNS )/SYM ,/, and/CC 66/CD per/IN cent/NN in/IN patients/NNS with/IN unresectable/JJ or/CC inoperable/JJ Stage/NNP III/NNP cancer/NN ./.
@@117362541579 An/DT analysis/NN of/IN the/DT dynamics/NNS is/VBZ performed/VBN of/IN exactly/RB solvable/JJ models/NNS for/IN fragile/JJ and/CC strong/JJ glasses/NNS ,/, exploiting/VBG the/DT partitioning/NN of/IN the/DT free-energy/NN landscape/NN in/IN inherent/JJ structures/NNS ./.
@@115027781381 Moreover/RB ,/, elderly/JJ men/NNS with/IN bioavailable/JJ estradiol/NN levels/NNS below/RB the/DT median/JJ [/NN 40/NN pmol/NN //NN liter/NN (/( 11/CD pg/NN //NN ml/NN )/NN ]/NN had/VBP significantly/RB higher/JJ rates/NNS of/IN bone/NN loss/NN and/CC levels/NNS of/IN bone/NN resorption/NN markers/NNS than/IN men/NNS with/IN bioavailable/JJ estradiol/NN levels/NNS above/RB 40/CD pmol/NN //NN liter/NN ./.
@@13729002543 We/PRP also/RB report/VBP here/RB the/DT complete/JJ structural/JJ organization/NN of/IN the/DT goat/NEWGENE alpha/NEWGENE s1-casein/NEWGENE transcription/NEWGENE unit/NEWGENE ,/, deduced/VBN from/IN polymerase/NN chain/NN reaction/NN experiments/NNS ./.
@@89402985787 Replacing/VBG residues/NNS 405-419/CD on/IN delta419/CD with/IN the/DT conserved/VBN AF-2/NEWGENE domain/NEWGENE from/IN the/DT vitamin/NEWGENE D3/NEWGENE receptor/NEWGENE or/CC the/DT estrogen/NEWGENE receptor/NEWGENE results/NNS in/IN a/DT receptor/NN with/IN wild-type/NN or/CC low/JJ transcriptional/JJ activity/NN ,/, respectively/RB ./.
@@33778916222 Psychological/JJ disturbance/NN was/VBD greater/JJR in/IN the/DT high/JJ life/NN stress/NN group/NN as/IN indicated/VBN by/IN significant/JJ elevations/NNS on/IN the/DT global/JJ severity/NN index/NN of/IN the/DT Symptom/NN Checklist-90/NN and/CC elevations/NNS on/IN somatization/NN ,/, obsessive/JJ compulsive/NN ,/, interpersonal/JJ sensitivity/NN ,/, depression/NN ,/, anxiety/NN and/CC psychoticism/NN subscales/NNS ./.
@@76441275777 Since/IN electrical/JJ stimulation/NN of/IN neurones/NNS may/MD activate/VB not/RB only/JJ cell/NN bodies/NNS but/CC also/RB neuronal/JJ fibres/NNS ,/, this/DT study/NN aimed/VBN to/IN test/NN a/DT selectively/RB cholinergic/JJ neurochemical/JJ stimulation/NN of/IN the/DT rat/NN substantia/NN innominata/NN (/( SI/NN )/SYM by/IN the/DT local/JJ microinjection/NN of/IN carbachol/NN ;/: the/DT effects/NNS of/IN this/DT acetylcholine/NN agonist/NN were/VBD compared/VBN with/IN glutamate/NN ./.
@@23988971085 Eucaryotic/JJ transcription/NN factors/NNS that/WDT stimulate/VBP RNA/NEWGENE polymerase/NEWGENE II/NEWGENE by/IN increasing/JJ the/DT efficiency/NN of/IN elongation/NN of/IN specifically/RB or/CC randomly/RB initiated/VBN RNA/NN chains/NNS have/VBP been/VBN isolated/VBN and/CC characterized/VBN ./.
@@94698209822 The/DT mRNAs/NNS of/IN these/DT genes/NNS contain/VBP respectively/RB one/PRP (/( YAP1/NEWGENE uORF/NEWGENE )/SYM and/CC two/JJ (/( YAP2/NEWGENE uORF1/NEWGENE and/CC uORF2/NEWGENE )/SYM upstream/RB open/JJ reading/JJ frames/NNS ./. uORF-mediated/JJ modulation/NN of/IN post-termination/NN events/NNS on/IN the/DT 5'-untranslated/JJ region/NN (/( 5'-UTR/NN )/SYM directs/VBZ differential/JJ control/NN not/RB only/RB of/IN translation/NN but/CC also/RB of/IN mRNA/NN decay/NN ./.
@@113123268386 We/PRP used/VBD a/DT rev-/JJ and/CC RRE-defective/NNP HIV/NN type/NN 1/NN (/( HIV-1/NN )/SYM molecular/JJ clone/NN in/IN complementation/NN experiments/NNS to/IN establish/VB a/DT method/NN for/IN the/DT rapid/JJ isolation/NN of/IN posttranscriptional/NN regulatory/NN elements/NN from/IN the/DT mammalian/JJ genome/NN by/IN selecting/VBG for/IN rescue/NN of/IN virus/NN replication/NN ./.
@@25738293219 Evolutionary/NNP conservation/NN of/IN homeodomain-binding/NEWGENE sites/NEWGENE and/CC other/DT sequences/NNS upstream/RB and/CC within/IN the/DT major/JJ transcription/NN unit/NN of/IN the/DT Drosophila/NEWGENE segmentation/NEWGENE gene/NEWGENE engrailed/NEWGENE ./.
@@91927323949 Furthermore/RB ,/, the/DT NH2-terminal/NN portion/NN of/IN the/DT homologue/NN was/VBD not/RB translocated/VBN into/IN the/DT outer/JJ membrane/NN without/IN its/PRP COOH-terminal/NN part/NN ./.
@@85225114131 The/DT 5'/CD flanking/JJ regions/NNS of/IN both/DT pelA/NEWGENE and/CC pelB/NEWGENE were/VBD translationally/RB fused/VBN to/IN the/DT beta-glucuronidase/NEWGENE gene/NEWGENE and/CC introduced/VBN into/IN F/NN ./NN solani/JJ f/CD ./CD sp/NN ./NN pisi/NN ,/, and/CC beta-glucuronidase/NEWGENE activities/NNS of/IN the/DT transformants/NNS were/VBD measured/VBN ./.
@@105019691874 The/DT results/NNS suggest/VBP that/IN GATA-5/NEWGENE may/MD have/VB specific/JJ downstream/RB targets/VBZ and/CC that/IN GATA-4/NEWGENE ,/NEWGENE -5/NEWGENE ,/NEWGENE and/NEWGENE -6/NEWGENE can/MD only/RB partially/RB substitute/VB for/IN each/DT other/DT in/NN cardiogenesis/NN ./.
@@85380523779 A/DT human/JJ recombinant/JJ cDNA/NN clone/NN that/IN encoded/VBN 253/CD amino/JJ acids/NNS residues/NNS of/IN a/DT zinc-finger/NEWGENE protein/NEWGENE (/( THZif-1/NEWGENE )/SYM was/VBD cloned/VBN by/IN screening/JJ a/DT cDNA/NN library/NN prepared/VBN from/IN human/JJ promyelocytic/JJ leukemia/NN HL60/JJ cells/NNS with/IN synthetic/JJ oligodeoxynucleotide/NN probes/NNS that/WDT corresponded/VBD to/IN the/DT amino/JJ acid/NN sequences/NNS of/IN tryptic/JJ peptides/NNS derived/VBN from/IN the/DT DNA-binding/NN protein/NN specific/JJ for/IN the/DT nuclease-hypersensitive/NEWGENE element/NEWGENE (/( NHE/NEWGENE )/SYM of/IN the/DT human/NEWGENE c-myc/NEWGENE gene/NEWGENE ./.
@@77456844737 Human/NEWGENE papillomavirus/NEWGENE type/NEWGENE 31b/NEWGENE late/NEWGENE gene/NEWGENE expression/NN is/VBZ regulated/VBN through/JJ protein/NEWGENE kinase/NEWGENE C-mediated/JJ changes/NNS in/IN RNA/NN processing/VBG ./.
@@9354757759 Amino/NN acid/NN residues/NNS of/IN beta/NN 1'/CD ,/, alpha/JJ A'/NNS ,/, alpha/NN B'/NN ,/, and/CC the/DT loop/NN containing/JJ His539/CD of/IN the/DT RNase/NEWGENE H/NEWGENE domain/NEWGENE interact/VB with/IN the/DT primer/NN strand/NN of/IN the/DT dsDNA/NN ./.
@@83971232969 Regulated/JJ activity/NN of/IN the/DT distal/JJ promoter-like/NN element/NN of/IN the/DT human/NEWGENE corticotropin-releasing/NEWGENE hormone/NEWGENE gene/NEWGENE and/CC secondary/JJ structural/JJ features/NNS of/IN its/PRP corresponding/JJ transcripts/NNS ./.
@@86494281183 In/NN this/DT study/NN ,/, we/PRP further/RB investigated/VBD the/DT regulation/NN of/IN the/DT synthesis/NN of/IN the/DT c-mos/NEWGENE oncogene/NEWGENE product/NEWGENE ,/, which/WDT is/VBZ necessary/JJ for/IN the/DT activation/NN of/IN Cdc2/NEWGENE ./.
@@16011811182 The/DT 60A/NEWGENE transcripts/NEWGENE and/CC protein/NN are/VBP first/RB detected/VBN at/IN the/DT onset/NN of/IN gastrulation/NN ,/, primarily/RB in/IN the/DT mesoderm/NN of/IN the/DT extending/VBG germ/NN band/NN ./.
@@32187145675 An/DT 11-month-old/NN girl/NN suffering/JJ from/IN Dandy-Walker/NNP malformation/NN (/( DWM/NNP )/SYM associated/VBN with/IN tetralogy/NN of/IN Fallot/NNS (/( TOF/NN )/SYM is/VBZ presented/VBN ./.
@@56936055653 Determination/NNS of/IN transaminases/NEWGENE with/IN an/DT autoanalyzer/NN ./.
@@80256697499 The/DT proteins/NNS encoded/VBN downstream/RB of/IN rpoN/NEWGENE are/VBP known/VBP to/IN negatively/RB regulate/VB sigma/NEWGENE 54/NEWGENE activity/NN ./.
@@644146239 Sings/NNS which/WDT are/VBP indicative/NN of/IN metaplastic/JJ erythropoiesis/NN are/VBP absent/VB ./.
@@23078489419 The/DT genomic/JJ and/CC transcriptional/JJ complexity/NN of/IN the/DT Crry/NEWGENE and/CC Crry-ps/NEWGENE genes/NEWGENE ./.
@@66894133512 The/DT apparatus/NN consists/VBZ of/IN an/DT Am-241/NN exciting/JJ source/NN (/NN 300/NN mCi/NN )/NN and/CC pure/JJ Ge/NN detector/NN (/NN 50/NN mm2/NN X/NN 5/CD mm/NN )/NN for/IN measuring/JJ K/NN alpha/NN fluorescent/JJ x-rays/NN (/NN 28/NN ./NN 3/NN and/CC 28/CD ./CD 6/CD KeV/NN )/NN emitted/VBD from/IN exited/VBN iodine/NN ./.
@@74567747340 The/DT potentially/RB SLE-inducing/JJ drugs/NNS are/VBP reviewed/VBN ./.
@@92185999671 In/NN this/DT study/NN ,/, we/PRP sought/VBP to/IN identify/VB mechanisms/NNS that/WDT could/MD account/VB for/IN the/DT antimitogenic/JJ effects/NNS of/IN IL-4/NEWGENE ./.
@@106112357892 12/CD :/: 2684-2697/CD ,/, 1998/NN )/NN :/: a/DT key/NN step/NN of/IN this/DT model/NN is/VBZ the/DT activation/NN of/IN the/DT MAPK/NEWGENE Fus3p/NEWGENE through/RB the/DT G/NN (/NN betagamma/NN )/NN -dependent/NN relocalization/NN of/IN the/DT Ste5p-MAPK/NEWGENE cascade/NEWGENE to/IN the/DT plasma/NN membrane/NN ./.
@@84961852020 Subsequent/JJ cloning/NN and/CC nucleotide/NN sequence/NN analysis/NN of/IN the/DT S/NEWGENE ./NEWGENE pombe/NEWGENE adenylate/NEWGENE kinase/NEWGENE gene/NEWGENE ,/, adk1/NEWGENE ,/, revealed/VBD a/DT coding/JJ region/NN of/IN 660/CD nucleotides/NNS ./.
@@10364314161 Three/CD subgenomes/NNS also/RB comprised/VBN 15/CD to/IN 75/CD nucleotides/NNS derived/VBN from/IN the/DT 5'/CD part/NN of/IN the/DT NS2/NEWGENE gene/NEWGENE ./.
@@35591933997 The/DT present/NN investigation/NN sought/VBP to/IN identify/VB the/DT principal/JJ dimensions/NNS of/IN the/DT Framingham/NN Type/NN A/NN scale/NN (/( FTAS/NNP )/SYM and/CC then/RB to/IN examine/VB their/PRP physiological/JJ and/CC psychological/JJ correlates/VBP ./.
@@35490453776 SCL/NN prolonged/JJ promptly/RB after/IN verapamil/NN ,/, and/CC sinus/NN arrest/NN developed/VBN in/IN two/NN of/IN 10/NN group/NN 2/NN and/CC two/NN of/IN five/CD group/NN 3/CD animals/NNS ./.
@@107691447839 The/DT CRE/NEWGENE ,/, 5'-TGACGTCA-3'/NEWGENE ,/, has/VBZ been/VBN described/VBN as/IN the/DT consensus/NN sequence/NN for/IN the/DT cis-element/NN that/WDT directs/VBZ cAMP-regulated/NN gene/NN expression/NN ./.
@@79497705077 Enhanced/NNP hepatic/JJ portal/JJ blood/NN flow/NN induced/VBN by/IN prostaglandin/NN E1/NN following/IN liver/NN transplantation/NN in/IN pigs/NNS ./.
@@86632197948 The/DT promoter/NN of/IN the/DT rat/NEWGENE PGS-2/NEWGENE gene/NEWGENE contains/VBZ a/DT CAAT/NEWGENE enhancer-binding/NEWGENE protein/NEWGENE consensus/NEWGENE site/NEWGENE (/NEWGENE CAAT/NEWGENE box/NEWGENE )/NEWGENE which/WDT can/MD confer/VB hormone/NN inducibility/NN to/IN a/DT PGS-2/NEWGENE ./NEWGENE CAT/NEWGENE reporter/NEWGENE gene/NEWGENE ,/, as/RB well/VB as/IN a/DT putative/JJ E-box/NN region/NN ./.
@@85893584954 A/DT 3-week/JJ regimen/NN of/IN erythropoietin/NEWGENE may/MD help/VB prevent/VB the/DT donor's/NNS need/NN to/IN receive/VB allogeneic/JJ blood/NN transfusion/NN ,/, when/CC the/DT initial/JJ Hb/NEWGENE levels/NNS were/VBD below/RB 130/CD milligrams/NNS ./.
@@73280007187 Nutritional/NNP cataracts/NNS in/IN timber/NN wolves/NNS ./.
@@113090771144 Nine/CD strains/NNS were/VBD subtyped/VBN as/IN Camp/NNP ./. jejuni/JJ subsp/NN ./. jejuni/JJ biotype/NN II/NN and/CC the/DT remaining/JJ ones/NNS as/IN biotype/NN I/NNP ./NNP
@@24053932322 Molecular/NNP and/CC functional/JJ characterization/NN of/IN the/DT promoter/NN of/IN ETS2/NEWGENE ,/, the/DT human/NN c-ets-2/NEWGENE gene/NN ./.
@@84964758461 Calcification/NNS of/IN a/DT cariogenic/JJ Streptococcus/NN and/CC of/IN Corynebacterium/NN (/( Bacterionema/NN )/SYM matruchotii/NN ./.
@@98570382726 E/NNP ./NNP ,/, Scott/NN ,/, J/NNP ./NNP
@@78166174324 These/DT results/NNS suggest/VBP that/IN HAC1/NEWGENE may/MD also/RB be/VB one/PRP of/IN the/DT meiotic/JJ genes/NNS ./.
@@92784545565 Examination/NN of/IN the/DT MMP-2/NEWGENE RE1/NEWGENE sequence/NEWGENE revealed/VBD an/DT incomplete/JJ Y-box/NEWGENE sequence/NEWGENE (/( CTGCTGGGCAAG/NEWGENE )/SYM ,/, which/WDT specifically/RB interacted/VBN with/IN recombinant/NEWGENE YB-1/NEWGENE on/IN DMS/NN protection/NN footprinting/VBG analysis/NN ./.
@@78094107355 In/NN some/DT of/IN the/DT cases/NNS of/IN solitary/JJ lesion/NN ,/, serum/NEWGENE TSH/NEWGENE levels/NNS ,/, serum/NEWGENE thyroglobulin/NEWGENE values/NNS ,/, and/CC 131I/NN protein/NN bounded/VBD iodine/NN (/( 131I-PBI/JJ )/SYM were/VBD measured/VBN ,/, but/CC there/RB were/VBD no/DT significant/JJ differences/NNS between/IN successful/JJ and/CC unsuccessful/JJ therapy/NN ./.
@@10331730192 RESULTS/NNS :/: Each/DT year/NN ,/, on/IN average/JJ 39%/CD of/IN cases/NNS seen/VBP in/IN Sardinia/NN are/VBP notified/VBN ;/: 646/CD (/( 40%/CD )/SYM of/IN the/DT 1591/CD patients/NNS notified/VBN during/IN the/DT study/NN period/NN were/VBD never/RB seen/VBP by/IN regional/JJ medical/JJ centres/NNS ./.
@@100361813094 Northern/NNP blot/NN and/CC in/IN situ/NN hybridization/NN analyses/NNS revealed/VBN GPR34/NEWGENE mRNA/NEWGENE transcripts/NEWGENE in/IN several/DT human/NN and/CC rat/NN brain/NN regions/NNS ./.
@@100992474615 A/DT high/JJ reactor/NN pH/NN (/( +/JJ //JJ -8/JJ )/SYM ,/, a/DT short/JJ solid/JJ retention/NN time/NN (/( </SYM 150/CD days/NNS )/SYM ,/, and/CC the/DT presence/NN of/IN a/DT substantial/JJ SRB/NN population/NN in/IN the/DT inoculum/NN may/MD considerably/RB reduce/VB the/DT time/NN required/VBN for/IN acetate-utilising/JJ SRB/NN to/IN outcompete/VB MB/NNP ./NNP
@@24376253101 The/DT study/NN included/VBN 139/CD eyes/NNS with/IN presumed/VBN ocular/JJ histoplasmosis/NN syndrome/NN (/( POHS/NNP )/SYM and/CC age-related/JJ macular/JJ degeneration/NN (/( AMD/NNS )/SYM ./.
@@6218005169 Five/CD of/IN the/DT patients/NNS with/IN increased/VBN L-L/NNP size/NN had/VBP a/DT normal/JJ A-P/NN diameter/NN ./.
@@79589206213 Antibodies/NNS directed/VBN against/IN the/DT SNM1/NEWGENE protein/NEWGENE immunoprecipitated/VBN RNase/NEWGENE MRP/NEWGENE RNA/NEWGENE from/IN whole-cell/JJ extracts/NNS without/IN precipitating/JJ the/DT structurally/RB and/CC functionally/RB related/VBN RNase/NEWGENE P/NEWGENE RNA/NEWGENE ./.
@@96764193537 METHOD/IN :/: 50/CD consecutive/JJ children/NNS aged/VBN from/IN 6/CD months/NNS to/IN 17/CD years/NNS were/VBD included/VBN into/IN the/DT study/NN which/WDT comprised/VBD questionnaires/NNS of/IN patient/NN and/CC family/NN histories/NNS ,/, serological/JJ screening/JJ tests/NNS for/IN common/JJ inhalational/JJ allergens/NNS (/( CAP/NN SX1/NN )/SYM ,/, and/CC determination/NN of/IN total/JJ serum/NEWGENE immunoglobulin/NEWGENE E/NEWGENE (/( IgE/NEWGENE )/SYM and/CC of/IN latex-specific/NN serum/NEWGENE IgE/NEWGENE by/IN solid-phase/JJ immunoassays/NNS ./.
@@13310571884 We/PRP have/VBP cloned/VBN and/CC sequenced/VBN COX12/NEWGENE ,/, the/DT nuclear/JJ gene/NN for/IN subunit/NEWGENE VIb/NEWGENE of/IN Saccharomyces/NEWGENE cerevisiae/NEWGENE cytochrome/NEWGENE c/NEWGENE oxidase/NEWGENE ./.
@@83956548265 Steroidogenic/NEWGENE factor/NEWGENE 1/NEWGENE ,/, an/DT orphan/NEWGENE nuclear/NEWGENE receptor/NEWGENE ,/, regulates/VBZ the/DT expression/NN of/IN the/DT rat/NEWGENE aromatase/NEWGENE gene/NEWGENE in/IN gonadal/JJ tissues/NNS ./.
@@30645243775 The/DT efficacy/NN of/IN these/DT immunosuppressive/JJ drugs/NNS is/VBZ clinical/JJ proven/VBP ./.
@@84088255477 Neonatal/JJ lupus/NN erythematosus/NN is/VBZ most/RB often/RB associated/VBN with/IN autoantibodies/NNS against/IN Ro/NEWGENE and/CC La/NEWGENE antigens/NNS ./.
@@8504707887 The/DT etiology/NN ,/, pathology/NN ,/, brain/NN CT/NN scan/NN features/NNS ,/, clinical/JJ manifestations/NNS and/CC treatment/NN of/IN these/DT accidents/NNS were/VBD discussed/VBN ./.
@@27409553430 Among/IN booked/VBN patients/NNS the/DT maternal/JJ mortality/NN rate/NN was/VBD 0/CD ./CD 32/CD and/CC among/IN unbooked/JJ patients/NNS 11/CD ./CD 13/CD per/IN 1000/CD deliveries/NNS ./.
@@98782565252 The/DT peroxisome/NN biogenesis/NN disorders/NNS (/( PBDs/NNP )/SYM are/VBP a/DT set/NN of/IN lethal/JJ genetic/JJ diseases/NNS characterized/VBN by/IN peroxisomal/JJ metabolic/JJ deficiencies/NNS ,/, multisystem/JJ abnormalities/NNS ,/, mental/JJ retardation/NN ,/, and/CC premature/JJ death/NN ./.
@@88447128202 Effect/NN of/IN nitrous/JJ oxide/NN (/( N2O/NN )/SYM on/IN the/DT somatosympathetic/JJ A-/DT and/CC C-reflexes/NN was/VBD investigated/VBN using/VBG artificially/RB ventilated/VBN rats/NNS anesthetized/JJ with/IN alpha-chloralose/NN and/CC urethane/NN ./.
@@28759673571 The/DT sensitivity/NN of/IN the/DT vas/NN deferens/NN to/IN adrenaline/NN was/VBD also/RB reduced/VBN in/IN scorbutic/JJ guinea/NN pigs/NNS ,/, thus/RB decreasing/JJ their/PRP fertility/NN rate/NN ./.
@@107126184176 An/DT amino-acid/NN sequence/NN comparison/NN revealed/VBD that/DT Bacillus/NEWGENE YM55-1/NEWGENE aspartase/NEWGENE shared/VBD 71%/JJ homology/NN with/IN Bacillus/NEWGENE subtilis/NEWGENE aspartase/NEWGENE and/CC 49%/CD with/IN Escherichia/NN coli/JJ and/CC Pseudomonas/NEWGENE fluorescens/NEWGENE aspartases/NEWGENE ./.
@@25666803220 In/NN contrast/NN ,/, the/DT full/JJ mu-opioid/JJ agonists/NNS fentanyl/NN ,/, morphine/NN ,/, I-methadone/NNP and/CC levorphanol/NN produced/VBN 50%/CD fentanyl-appropriate/JJ responding/VBG at/IN doses/NNS only/RB 1/CD ./CD 3/CD to/IN 10/CD ./CD 9/CD times/NNS smaller/JJR than/IN those/DT required/VBN to/IN decrease/NN response/NN rates/NNS by/IN 50%/CD ./.
@@108057391902 This/DT activity/NN is/VBZ stimulated/VBN by/IN complex/NN formation/NN with/IN the/PDT other/DT eIF2B/NEWGENE subunits/NEWGENE ./.
@@104777483761 A/DT portion/NN of/IN p193/NEWGENE is/VBZ nuclear/JJ and/CC localizes/VBZ to/IN the/DT mitotic/JJ spindle/NN ./.
@@89458107485 Evolutive/NNP morphology/NN of/IN the/DT olfactory/NN bulb/NN in/IN man/NN and/CC certain/JJ non-human/JJ mammals/NNS ./.
@@113753925547 The/DT core/NN promoter/NN of/IN human/NEWGENE thioredoxin/NEWGENE reductase/NEWGENE 1/NEWGENE ./NEWGENE cloning/NN ,/, transcriptional/JJ activity/NN ,/, and/CC oct-1/NEWGENE ,/, sp1/NEWGENE ,/, and/CC sp3/NEWGENE binding/JJ reveal/VB a/DT housekeeping-type/NN promoter/NN for/IN the/DT au-rich/JJ element-regulated/NN gene/NN ./.
@@7214665632 The/DT five-drug/JJ combination/NN of/IN fluorouracil/NN imidazole/NN carboxamide/NN dimethyl/JJ triazeno/NN ,/, vincristine/NN ,/, bis-chloroethyl/JJ nitrosourea/NN ,/, and/CC prednisone/NN (/( FIVB/NN +/SYM P/NN )/SYM was/VBD given/VBP to/IN 120/CD women/NNS with/IN metastatic/JJ breast/NN cancer/NN ./.
@@105854636530 Recombinant/NEWGENE prenylcysteine/NEWGENE lyase/NEWGENE was/VBD produced/VBN in/IN a/DT baculovirus-Sf9/NN expression/NN system/NN ./.
@@92155251370 Here/RB ,/, we/PRP correlate/VBP Dox/NN effects/NNS on/IN cell/NN cycle/NN with/IN changes/NNS of/IN E2F/NEWGENE //NEWGENE DP/NEWGENE complexes/NEWGENE and/CC activity/NN in/IN differentiating/JJ C2C12/NEWGENE myocytes/NNS ./.
@@109444663567 We/PRP have/VBP determined/VBN the/DT structure/NN of/IN the/DT WNT-2B/NEWGENE gene/NEWGENE ./.
@@98298366440 Positive/JJ genetic/JJ selections/NNS for/IN inhibition/NN of/IN cyclin/NEWGENE //NEWGENE CDK/NEWGENE function/NN were/VBD characterized/VBN using/VBG the/DT E/NEWGENE ./NEWGENE coli/NEWGENE neo/NEWGENE and/CC yeast/NEWGENE LEU2/NEWGENE genes/NEWGENE ./.
@@84640562235 Finger/NEWGENE associated/NEWGENE box-zinc/NEWGENE finger/NEWGENE proteins/NEWGENE (/( FAX-ZFPs/NEWGENE )/SYM constitute/VB a/DT subfamily/NN of/IN the/DT many/JJ C2H2/NEWGENE type/NEWGENE ZFPs/NEWGENE in/IN Xenopus/NN laevis/NNS ./.
@@85616077685 Neither/CC class/NN II/NN nor/CC IV/NN infections/NNS precluded/VBD transplantation/NN ./.
@@2677643352 This/DT report/NN has/VBZ reviewed/VBN some/DT of/IN the/DT reasons/NNS for/IN treatment/NN failures/NNS and/CC has/VBZ presented/VBN a/DT philosophy/NN for/IN their/PRP management/NN ./.
@@64391147900 Ceftazidime/NN shows/VBZ promise/VB as/IN single-agent/NN therapy/NN for/IN serious/JJ gram-negative/JJ bacillary/JJ infections/NNS ./.
@@392714576 Anti-anxiety/NNP action/NN of/IN diazepam/NN after/IN intra-amygdaloid/JJ application/NN in/IN the/DT rat/NN ./.
@@92412324442 The/DT Ogg1/NEWGENE protein/NEWGENE efficiently/RB cleaves/VBZ a/DT DNA/NN duplex/JJ where/CC a/DT preformed/JJ AP/NEWGENE site/NEWGENE is/VBZ placed/VBN opposite/NN a/DT cytosine/NN (/( AP/NNP //NNP C/NNP )/SYM ./.
@@84751049019 We/PRP report/VBP here/RB that/IN a/DT 25-bp/JJ promoter/NN element/NN previously/RB shown/VBP to/IN be/VB important/JJ for/IN the/DT G1-S/NNP activation/NN of/IN the/DT human/NEWGENE thymidine/NEWGENE kinase/NEWGENE (/( htk/NEWGENE )/SYM promoter/NN in/IN growth-stimulated/JJ cells/NNS is/VBZ a/DT cellular/JJ target/NN of/IN cyclin/NEWGENE A/NEWGENE and/CC the/DT p33cdk2/NEWGENE complexes/NEWGENE ./.
@@63105536350 Molecular/NNP structure/NN and/CC evolutionary/JJ origin/NN of/IN human/NEWGENE cardiac/NEWGENE muscle/NEWGENE actin/NEWGENE gene/NEWGENE ./.
@@103472038903 Serine/NN phosphorylation/NN of/IN STAT3/NEWGENE was/VBD only/RB apparent/JJ after/IN somatostatin/NEWGENE treatment/NN and/CC was/VBD abolished/VBN by/IN pertussis/NEWGENE toxin/NEWGENE or/CC PD/NN 98059/CD ,/, together/RB with/IN the/DT associated/VBN increases/NNS in/IN proliferation/NN ./.
@@62793091230 The/DT genome/NN of/IN avian/JJ erythroblastosis/NN virus/NN contains/VBZ two/JJ independently/RB expressed/VBN genetic/JJ loci/NNS (/( v-erbA/NEWGENE and/CC v-erbB/NEWGENE )/SYM whose/WP activities/NNS are/VBP probably/RB responsible/JJ for/IN oncogenesis/NN by/IN the/DT virus/NN ./.
@@86629805153 This/DT phenomenon/NN did/VBD not/RB require/VB DNA/NN binding/JJ by/IN the/DT "interfering"/NN receptor/NN but/CC required/VBN it/PRP to/IN be/VB hormone-bound/JJ ,/, indicating/VBG that/IN a/DT transcriptionally/RB active/JJ form/NN of/IN the/DT interfering/JJ receptor/NN is/VBZ essential/JJ for/IN the/DT interfering/JJ effect/NN ./.
@@94439783242 Here/RB we/PRP report/VBP that/IN in/IN cultured/JJ cells/NNS from/IN Drosophila/NN melanogaster/NN human/NEWGENE Sp1/NEWGENE efficiently/RB activates/VBZ transcription/NN from/IN synthetic/JJ promoters/NNS containing/JJ TATA/NN boxes/NNS ,/, but/CC not/RB from/IN promoters/NNS that/WDT contain/VBP an/DT initiator/NN instead/RB of/IN a/DT TATA/NN box/NN ./.
@@105486225288 We/PRP recommend/VBP that/IN paracervical/JJ block/NN with/IN lignocaine/NN should/MD be/VB used/VBN in/IN conjunction/NN with/IN i/CD ./CD v/CD ./. sedation/NN //NN analgesia/NN during/IN egg/NN collection/NN performed/VBN through/RB the/DT transvaginal/JJ route/NN under/IN ultrasound/JJ guidance/NN (/( TUGOR/NN )/SYM to/IN reduce/VB the/DT pain/NN of/IN the/DT procedure/NN ./.
@@7287187145 Thyroid/NN disease/NN and/CC pregnancy/NN ./.
@@95511828863 To/TO study/VB retinoid/JJ signalling/JJ in/IN zebrafish/NN embryos/NNS ,/, we/PRP developed/VBD a/DT novel/JJ method/NN to/IN detect/VB endogenous/JJ retinoids/NNS in/IN situ/NN in/IN embryos/NNS ,/, using/VBG a/DT fusion/NN protein/NN of/IN the/DT ligand/NN inducible/JJ transactivation/NN domain/NN of/IN a/DT retinoic/NEWGENE acid/NEWGENE receptor/NEWGENE and/CC a/DT heterologous/JJ DNA/NN binding/JJ domain/NN ./.
@@112218457571 Northern/NNP blot/NN analysis/NN revealed/VBD that/DT mlt/NEWGENE 1/NEWGENE is/VBZ normally/RB expressed/VBN in/IN brain/NN ,/, spleen/NN ,/, stom/NN ach/NN ,/, and/CC liver/NN ./.
@@30651415804 The/DT results/NNS indicated/VBN that/IN two/JJ genes/NNS (/( citA/NEWGENE and/CC citB/NEWGENE )/SYM have/VB separate/JJ promoters/NNS ,/, and/CC the/DT location/NN of/IN the/DT promoter/NN for/IN the/DT citB/NEWGENE gene/NEWGENE in/IN the/DT Tn3411/NEWGENE nucleotide/NN sequence/NN was/VBD different/JJ from/IN that/DT in/NN pMS185/NNP ./.
@@10576177398 This/DT distinction/NN was/VBD based/VBN upon/IN whether/IN the/DT diagnosis/NN provided/VBD a/DT straightforward/JJ range/NN of/IN prognoses/NNS or/CC an/DT ambiguous/JJ clinical/JJ implication/NN ./.
@@2868848860 However/RB ,/, vancomycin/NN and/CC fosfomycin/NN ,/, which/WDT revealed/VBD suboptimal/JJ in/IN vitro/FW bactericidal/JJ activity/NN ,/, proved/VBD as/RB efficacious/JJ as/IN penicillin/NN G/NN and/CC imipenem/NN in/IN an/DT experimental/JJ mode/NN of/IN murine/JJ gas/NN gangrene/NN ./.
@@79514103681 For/IN HeLa/DT ,/, 293/CD ,/, U937/CD ,/, and/CC A549/CD cells/NNS ,/, participation/NN of/IN E2F-1/NEWGENE ,/, DP-1/NEWGENE ,/, cyclin/NEWGENE A/NEWGENE ,/, and/CC RB/NEWGENE was/VBD involved/VBN in/IN formation/NN of/IN some/DT complexes/NNS only/RB ,/, assuming/VBG participation/NN of/IN factors/NNS different/JJ from/IN E2F-1/NEWGENE or/CC DP-1/NEWGENE in/IN others/NNS ./.
@@117236754437 The/DT severity/NN of/IN clinical/JJ course/NN was/VBD expressed/VBN by/IN means/NN of/IN SOFA/NNP score/NN (/( group/NN A/DT 0/CD ./CD 3-1-1/CD ./CD 3/CD point/NN ,/, group/NN B/NNP 2/CD ./CD 2-2/CD ./CD 9-2/CD ./CD 6/CD point/NN ,/, group/NN C/NN 7/CD ./CD 4-8/CD ./CD 3-7/CD ./CD 7/CD point/NN )/SYM and/CC APACHE/NN II/NN score/NN (/( group/NN A/DT 3/CD ./CD 7-7/CD ./CD 6-8/CD ./CD 1/CD point/NN ,/, group/NN B/NNP 8/CD ./CD 6-11/CD ./CD 1-10/CD ./CD 5/CD point/NN ,/, group/NN C/NN 16/CD ./CD 3-15/CD ./CD 2-14/CD ./CD 3/CD point/NN )/SYM ./.
@@68754786104 5/NN microU/NN //NN l/NN thyrotropin/NN :/: 75%/JJ (/( 1974/CD )/SYM ,/, 45%/JJ (/( 1977/CD )/SYM and/CC 20%/CD (/( 1980/CD )/SYM ./.
@@29392607342 Partial/JJ N-terminal/NN amino/JJ acid/NN sequence/NN analysis/NN showed/VBN that/IN the/DT 43K/NEWGENE and/NEWGENE 42K/NEWGENE T/NEWGENE antigens/NEWGENE contain/VBP methionine/NN at/IN residues/NNS 1/CD and/CC 5/CD ,/, as/IN predicted/VBN from/IN the/DT DNA/NN sequence/NN ,/, whereas/IN no/DT methionine/NN was/VBD released/VBN from/IN the/DT 39K/NEWGENE T/NEWGENE antigen/NEWGENE during/IN the/DT first/JJ six/CD cycles/NNS of/IN Edman/NN degradation/NN ./.
@@71685316989 A/DT new/JJ Onchocerca/NN species/NN ,/, a/DT parasite/NN of/IN domestic/JJ cattle/NNS ,/, in/IN Senegal/NN ./.
@@114167379985 Ga-67/NN and/CC Tl-201/NN scintigraphy/NN in/IN extramedullary/JJ plasmacytoma/NN :/: a/DT case/NN report/NN ./.
@@14508153454 The/DT addition/NN of/IN diatrizoate/NN to/IN the/DT IPRK/NN led/VBN to/IN a/DT dose-dependent/JJ biphasic/JJ change/NN in/IN RPF/NN and/CC GFR/NN characterized/VBN by/IN an/DT initial/JJ transient/JJ increase/NN followed/VBN by/IN a/DT marked/JJ and/CC sustained/JJ decrease/NN ./.
@@10619353589 Role/NN of/IN estrogen/NEWGENE receptor/NEWGENE ligand/NN and/CC estrogen/NEWGENE response/NEWGENE element/NEWGENE sequence/NN on/IN interaction/NN with/IN chicken/NEWGENE ovalbumin/NEWGENE upstream/NEWGENE promoter/NEWGENE transcription/NEWGENE factor/NEWGENE (/( COUP-TF/NEWGENE )/SYM ./.
@@104069548752 Chemical/NNP stability/NN tests/NNS and/CC site-specific/JJ mutagenesis/NN identified/VBD amino/JJ acids/NNS H219/NN and/CC D63/NN of/IN RegS/NEWGENE and/CC RegR/NEWGENE ,/, respectively/RB ,/, as/IN the/DT phosphorylated/VBN residues/NNS ./.
@@30613013771 Prostacyclin/DT formation/NN ,/, reflected/VBN by/IN the/DT excretion/NN rate/NN of/IN its/PRP stable/JJ metabolite/NN 6-keto-prostaglandin/NN F1/NN alpha/NN ,/, was/VBD measured/VBN by/IN means/NN of/IN radioimmunoassay/NN in/IN 4-hour/JJ urine/NN specimens/NNS obtained/VBN during/IN a/DT smoking-free/JJ period/NN and/CC after/IN participants/NNS had/VBP inhaled/JJ smoke/NN from/IN four/CD high-nicotine/JJ cigarettes/NNS ./.
@@31994366578 There/EX were/VBD gene/NN clusters/NNS encoding/VBG photosynthesis/NN components/NNS such/JJ as/IN the/DT psbB-psbH-petB-petD/NEWGENE and/CC the/DT psbE-psbF/NEWGENE clusters/NEWGENE ./.
@@92699008774 Together/RB ,/, these/DT results/NNS suggest/VBP that/IN EGF/NEWGENE //NEWGENE Ras/NEWGENE //NEWGENE Raf/NEWGENE induces/VBZ transcription/NN via/NN combined/JJ activation/NN of/IN ATF3/NEWGENE //NEWGENE c-Jun/NEWGENE and/CC a/DT 52-kDa/NN nuclear/NN factor/NN ,/, whereas/IN JunD/NEWGENE acts/NNS as/IN a/DT repressor/NN of/IN this/DT response/NN ./.
@@13098949646 Both/DT Rep78/NEWGENE and/CC Rep68/NEWGENE cut/VBD the/DT terminal/NN AAV/NN sequence/NN at/IN the/DT same/JJ site/NN (/( nucleotide/NN 124/CD )/SYM ./.
@@94215071122 The/DT SR/NEWGENE protein/NEWGENE family/NEWGENE is/VBZ involved/VBN in/IN constitutive/JJ and/CC regulated/VBN pre-mRNA/NN splicing/JJ and/CC has/VBZ been/VBN found/VB to/IN be/VB evolutionarily/RB conserved/VBN in/IN metazoan/JJ organisms/NNS ./.
@@12793741520 Here/RB we/PRP describe/VBP and/CC map/NN two/JJ more/RB new/JJ genes/NNS identified/VBN as/IN allele-specific/NN suppressors/NN that/WDT compensate/VBP for/IN carboxy-terminal/JJ truncation/NN of/IN PET122/NEWGENE ./.
@@70595676825 2/CD ./CD
@@97803363622 Analysis/NNP of/IN Msy2/NEWGENE mRNA/NEWGENE expression/NN in/IN prepubertal/JJ and/CC adult/JJ mouse/NN testes/NNS ,/, and/CC in/IN isolated/VBN populations/NNS of/IN germ/NN cells/NNS ,/, reveals/VBZ maximal/JJ expression/NN in/IN postmeiotic/JJ round/JJ spermatids/NNS ,/, a/DT cell/NN type/NN with/IN abundant/JJ amounts/NNS of/IN stored/VBN messenger/NN ribonucleoproteins/NNS ./.
@@82469841580 Northern/NNP (/( RNA/NN )/SYM analysis/NN demonstrated/VBD expression/NN of/IN human/NN PI/NEWGENE 3-kinase/NEWGENE in/IN all/DT tissues/NNS and/CC cell/NN lines/NNS tested/VBN ./.
@@61437345964 In/NN vitro/FW metabolism/NN of/IN progesterone/NN by/IN the/DT human/JJ undescended/JJ testis/NN ./.
@@68181136304 Asthmatic/JJ patients/NNS showed/VBD greater/JJR responses/NNS of/IN both/DT parameters/NNS to/IN adrenaline/NN than/IN controls/NNS indicating/VBG that/IN long-term/JJ corticosteroid/NN treatment/NN enhances/VBZ the/DT acute/JJ responses/NNS of/IN plasminogen/NEWGENE activator/NEWGENE and/CC clotting/NEWGENE factor/NEWGENE VIII/NEWGENE to/IN adrenaline/NN infusion/NN ./.
@@31270345095 The/DT heart/NN rate/NN ,/, respiratory/JJ rate/NN ,/, arterial/JJ O2/NN and/CC systemic/JJ vascular/JJ resistance/NN were/VBD not/RB significantly/RB altered/VBN ./.
@@106873667631 National/NNP abortion/NN laws/NNS usually/RB do/VBP not/RB allow/VB abortion/NN when/CC a/DT foetus/NN is/VBZ independently/NN viable/NN ,/, i/NN ./NN e/NN ./. from/IN a/DT gestational/JJ age/NN of/IN about/RB 24/CD weeks/NNS ./.
@@88242013550 Chernoff/NNP ,/, submitted/VBN for/IN publication/NN )/NN ./.
@@97800027907 Although/IN E2FBP1/NEWGENE lacks/VBZ the/DT transactivation/NN domain/NN ,/, it/PRP stimulates/VBZ E2F/NEWGENE site-dependent/JJ transcription/NN in/IN cooperation/NN with/IN E2F-1/NEWGENE ./.
@@84848919224 Although/IN olfactory/JJ associative/JJ conditioning/NN in/IN newborn/JJ rats/NNS produces/VBZ marked/JJ structural/JJ and/CC functional/JJ changes/NNS in/IN the/DT olfactory/NN bulb/NN ,/, recent/JJ evidence/NN suggests/VBZ that/IN extrabulbar/JJ circuits/NNS must/MD be/VB involved/VBN in/IN storing/JJ these/DT early/JJ memories/NNS ./.
@@22048105154 The/DT 3'/CD region/NN ,/, GA2/NEWGENE ,/, is/VBZ necessary/JJ for/IN maximal/JJ expression/NN ./.
@@8322823290 There/EX was/VBD no/DT clear/JJ correlation/NN between/IN the/DT MFA/NNP and/CC the/DT severity/NN of/IN the/DT UTS/NN phenotype/NN ./.
@@40314884698 A/DT high/JJ degree/NN of/IN correlation/NN in/IN the/DT sense/NN of/IN the/DT classic/JJ conception/NN of/IN brain/NN localization/NN of/IN neuropsychological/JJ syndromes/NNS was/VBD found/VBN ./.
@@1173026215 Encouraged/VBN by/IN a/DT Dutch/JJ study/NN using/VBG etidronate/NN //NN fluoride/NN in/IN corticoid-induced/JJ osteoporosis/NN ,/, we/PRP performed/VBD a/DT pilot/JJ study/NN in/IN 33/CD men/NNS with/IN severe/RB established/VBN primary/JJ osteoporosis/NN giving/JJ cyclically/RB etidronate/NN for/IN 14/CD days/NNS followed/VBN by/IN fluoride/NN plus/IN calcium/NN //NN vitamin/NN D/NN for/IN 76/CD days/NNS ./.
@@107601093816 The/DT prevalence/NN of/IN malnutrition/NN was/VBD 30%/CD in/IN the/DT 47/CD patients/NNS without/IN CVD/NN and/CC was/VBD significantly/RB higher/JJ (/( 70%/NN ,/, P/NN </SYM 0/CD ./CD 001/CD )/SYM in/IN the/DT 70/CD patients/NNS with/IN CVD/NN ,/, who/WP also/RB had/VBP lower/JJR tHcy/NN ,/, SAlb/NNP ,/, plasma/NEWGENE IGF-1/NEWGENE ,/, serum/JJ creatinine/NN (/( SCr/NN )/SYM ,/, and/CC blood/NEWGENE hemoglobin/NEWGENE ./.
@@94639641074 The/DT assay/NN exhibits/VBP a/DT dynamic/JJ range/NN of/IN 0/CD ./CD 1-100/CD micrograms/NNS l-1/NN using/VBG a/DT monoclonal/JJ antibody/NN or/CC alternatively/RB 10/CD micrograms/NNS l-1/NN to/IN 10/CD mg/NN l-1/NN using/VBG commercially/RB available/JJ antiserum/NN ./.
@@26776664359 Mapping/NN results/NNS suggested/VBN that/IN the/DT complementation/NN group/NN identified/VBN by/IN these/DT mutants/NNS is/VBZ allelic/JJ to/IN the/DT ag/NEWGENE alpha/NEWGENE 1/NEWGENE mutation/NN identified/VBN previously/RB ./.
@@2175908953 Some/DT of/IN the/DT mutations/NNS obtained/VBD do/NN not/RB contain/VB a/DT copy/NN of/IN the/DT Ulysses/NEWGENE element/NEWGENE at/IN the/DT mutant/JJ locus/NN ,/, suggesting/VBG that/IN a/DT different/JJ transposable/JJ element/NN may/MD be/VB responsible/JJ for/IN the/DT mutation/NN ./.
@@111348225813 3/CD ./CD 04+/CD //CD -1/CD ./CD 2/CD ,/, P/NN </NN 0/NN ./NN 0001/NN )/NN ,/, large/JJ accelerations/NN //NN 30/NN min/NN (/( 1/CD ./CD 46+/CD //CD -1/CD ./CD 96/CD vs/IN ./IN
@@112305347105 We/PRP describe/VBP a/DT total/NN of/IN 39/NN DEAH/NEWGENE helicases/NEWGENE in/IN these/DT four/CD species/NN ./.
@@55292834415 Quantitation/NNS of/IN exocrine/NEWGENE IgA/NEWGENE in/IN human/JJ serum/NN in/IN health/NN and/CC disease/NN ./.
@@64869326284 For/IN 228/CD of/IN 425/CD deaths/NNS (/( 54%/JJ )/SYM occurring/VBG among/IN 26/CD 100/CD people/NN of/IN known/VBP age/NN in/IN the/DT Malumfashi/NNP area/NN of/IN northern/JJ Nigeria/NN ,/, data/NN were/VBD collected/VBN on/IN symptoms/NNS present/VBP prior/NN to/IN death/NN ./.
@@104097303573 The/DT transcription/NN of/IN most/JJ RP/NEWGENE genes/NEWGENE is/VBZ activated/VBN by/IN two/JJ Rap1p/NEWGENE binding/NEWGENE sites/NEWGENE ,/, 250/CD to/IN 400/CD bp/NN upstream/RB from/IN the/DT initiation/NN of/IN transcription/NN ./.
@@82375781684 As/IN regards/VBZ lipid/NN metabolism/NN ,/, the/DT mean/JJ values/NNS for/IN total/JJ triglycerides/NNS ,/, cholesterol/NN ,/, LDL-cholesterol/NN and/CC HDL-cholesterol/NN seen/VBP at/IN the/DT end/NN of/IN five/CD years/NNS of/IN Norplant-2/NN rod/NN use/NN and/CC six/CD months/NNS postremoval/NN were/VBD similar/JJ to/IN the/DT preinsertion/JJ mean/JJ ./.
@@87694099494 We/PRP have/VBP recently/RB shown/VBP that/IN the/DT tissue-specific/JJ expression/NN of/IN the/DT RAR/NEWGENE beta/NEWGENE 2/NEWGENE gene/NEWGENE in/NEWGENE mouse/NEWGENE embryos/NEWGENE is/VBZ regulated/VBN at/IN the/DT translational/JJ level/NN by/IN short/JJ upstream/RB open/JJ reading/JJ frames/NNS (/( uORFs/NNS )/SYM In/NN the/DT 5'-untranslated/JJ region/NN (/( Zimmer/NNP ,/, A/NNP ./NNP ,/, A/RB ./RB M/RB ./.
@@81870889540 Frequent/JJ loss/NN of/IN heterozygosity/NN (/( LOH/NN )/SYM of/IN >/SYM 30%/CD of/IN the/DT informative/JJ cases/NNS was/VBD observed/VBN on/IN chromosomes/NNS 3p/CD (/( 41/CD ./CD 1%/CD )/SYM ,/, 5q/JJ (/( 52/CD ./CD 6%/CD )/SYM ,/, 6p/CD (/( 30/CD ./CD 4%/CD )/SYM ,/, 8p/CD (/( 33/CD ./CD 3%/CD )/SYM ,/, 9p/CD (/( 35/CD ./CD 7%/CD )/SYM ,/, 9q/CD (/( 30/CD ./CD 8%/CD )/SYM ,/, 11p/CD (/( 32/CD ./CD 4%/CD )/SYM ,/, 13q/CD (/( 52/CD ./CD 7%/CD )/SYM ,/, 17p/CD (/( 55/CD ./CD 2%/CD )/SYM ,/, 17q/CD (/( 33/CD ./CD 3%/CD )/SYM ,/, 18q/CD (/( 45/CD ./CD 7%/CD )/SYM ,/, and/CC 19q/CD (/( 30/CD ./CD 4%/CD )/SYM ./.
@@94454883640 PowerBLAST/JJ analysis/NN identified/VBN six/CD clusters/NNS of/IN expressed/VBN sequence/NN tags/NNS (/( ESTs/NNS )/SYM ,/, two/JJ known/VBP genes/NNS (/( BIR/NEWGENE ,/, SUR1/NEWGENE )/SYM mapped/VBN previously/RB to/IN this/DT region/NN ,/, and/CC a/DT previously/RB characterized/VBN but/CC unmapped/JJ gene/NEWGENE NEFA/NEWGENE (/( DNA/NEWGENE binding/NEWGENE //NEWGENE EF/NEWGENE hand/NEWGENE //NEWGENE acidic/NEWGENE amino-acid-rich/NEWGENE )/SYM ./.
@@80004273107 A/DT cDNA/NN clone/NN pCZ1/NN ,/, with/IN a/DT 1/CD ./CD 1/CD kb/NN insert/NN ,/, was/VBD isolated/VBN from/IN a/DT NaCl-adapted/JJ tobacco/NN cell/NN cDNA/NN library/NN that/IN encodes/VBZ an/DT apparently/RB full-length/JJ 29/NN kDa/NN protein/NN (/( 251/CD amino/JJ acids/NNS )/SYM with/IN a/DT calculated/VBN pI/NN of/IN 5/CD ./CD 7/CD ./.
@@20247913966 MEASUREMENTS/NNP AND/CC MAIN/NNP RESULTS/NNS :/: The/DT two/JJ groups/NNS were/VBD similar/JJ on/IN entry/NN into/IN the/DT study/NN ,/, including/JJ mean/JJ FEV1/NN measurements/NNS (/( 0/CD ./CD 70/CD L/JJ atropine/NN //NN 0/NN ./NN 60/NN L/NN metaproterenol/NN ,/, P/NN greater/JJR than/IN ./CD 05/CD )/SYM ./.
@@95649176497 Decreased/JJ levels/NNS of/IN alpha2-antiplasmin/NEWGENE were/VBD also/RB observed/VBN in/IN the/DT mediastinum/NN (/( 0/CD ./CD 50/CD versus/IN 0/CD ./CD 61/CD U/NNS //NNS mL/NNS ;/: p/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@40866574775 Postnatal/JJ volumetric/JJ development/NN of/IN the/DT prefrontal/JJ cortex/NN in/IN the/DT rat/NN ./.
@@26486463516 There/EX was/VBD no/DT significant/JJ correlation/NN between/IN baseline/NN PC40/NN methacholine/NN and/CC the/DT maximal/JJ fall/NN in/IN Vp30/NNP after/IN either/DT the/DT first/JJ (/( 12/CD micrograms/NNS )/SYM or/CC the/DT second/JJ dose/NN (/( 24/CD micrograms/NNS )/SYM of/IN platelet/NEWGENE activating/NEWGENE factor/NEWGENE ./.
@@25293786901 S1/NEWGENE nuclease/NEWGENE analysis/NN of/IN RNA/NN prepared/VBN after/IN transfection/NN of/IN these/DT HIV/NN constructs/NN into/IN HeLa/DT cells/NNS infected/VBN with/IN wild-type/NN adenovirus/NN indicated/VBN that/IN the/DT enhancer/NN ,/, SP1/NEWGENE ,/, TATA/NN ,/, and/CC a/DT portion/NN of/IN the/DT transactivation-responsive/NEWGENE element/NEWGENE were/VBD each/DT required/VBN for/IN complete/JJ E1A/JJ //JJ E1B-mediated/JJ activation/NN of/IN the/DT HIV/NEWGENE LTR/NEWGENE ./.
@@75096241363 Long-range/JJ mapping/NN of/IN the/DT 11q23/NN region/NN involved/VBN in/IN chromosome/NN aberrations/NNS in/IN human/JJ tumors/NNS by/IN pulsed-field/JJ gel/NN electrophoresis/NN with/IN a/DT yeast/NN artificial/JJ chromosome/NN ./.
@@26514481755 An/DT implant/NN may/MD release/NN a/DT drug/NN either/DT by/IN diffusion/NN concurrent/JJ with/IN dissolution/NN of/IN the/DT polymeric/JJ implant/NN material/NN without/IN depolymerization/NN (/( Type/NN A/NN )/SYM or/CC by/IN bioerosion/NN involving/VBG depolymerization/NN (/( Type/NN B/NN )/SYM ./SYM
@@61526706974 Plasma/NEWGENE secretin/NEWGENE ,/, pancreozymin/NEWGENE ,/, and/CC somatostatin-like/NEWGENE hormone/NEWGENE in/IN chronic/JJ renal/JJ failure/NN patients/NNS ./.
@@30236828371 Insertion/NNS of/IN 4/CD bp/NN reduced/VBD SV40/NN early/NN promoter-dependent/NN chloramphenicol/NEWGENE acetyltransferase/NEWGENE (/( CAT/NEWGENE )/SYM expression/NN by/IN six-/DT to/IN eightfold/RB ./.
@@118320195200 CONCLUSIONS/IN :/: AMVT/NN is/VBZ rare/JJ but/CC a/DT potentially/RB lethal/JJ emergency/NN disease/NN ./.
@@16390928733 Lewis/NN ,/, N/NNP ./NNP
@@72022247025 The/DT preferences/NNS were/VBD for/IN intact/JJ vis-a-vis/FW castrated/JJ males/NNS ,/, though/CC injections/NNS of/IN TP/NN restored/VBD the/DT castrates'/NN attractiveness/NN to/IN the/DT females/NNS ./.
@@111640781009 This/DT animal/NN model/NN of/IN dystonia/NN appears/VBZ to/IN be/VB a/DT model/NN of/IN NAD/NN in/IN man/NN from/IN the/DT viewpoint/NN of/IN treatment-response/NN ./.
@@95203981731 These/DT changes/NNS correlate/NN directly/RB with/IN an/DT increase/NN in/IN the/DT acetylation/NN levels/NNS of/IN all/DT four/CD core/NEWGENE histones/NEWGENE in/IN vivo/NN ./.
@@11016724851 In/NN group/NN B/NN 37/NN MBq/NN in/IN 150/CD microL/NN of/IN 99mTc-HSA/NN nanocolloid/NN was/VBD additionally/RB injected/VBN intradermally/RB 18/CD h/NN before/IN surgery/NN (/( 3-6/CD aliquots/NNS injected/VBN perilesionally/RB )/SYM ./.
@@16005312188 Coronary/NNP flow/NN was/VBD reduced/VBN by/IN 10%/CD in/IN the/DT phosphocreatine/NN and/CC by/IN 18%/JJ in/IN the/DT control/NN group/NN ./.
@@104717465317 In/NN vivo/NN ,/, MyoD/NEWGENE requires/VBZ this/DT tryptophan/NN motif/NN to/IN evoke/VB chromatin/NN remodeling/NN in/IN the/DT Myogenin/NEWGENE promoter/NEWGENE and/CC to/IN activate/VB Myogenin/NEWGENE transcription/NN ./.
@@86265295112 Using/VBG autoantibodies/NNS from/IN a/DT Sjogren's/NNP syndrome/NN patient/NN ,/, we/PRP have/VBP previously/RB identified/VBN a/DT 230-kDa/NN peripheral/NN membrane/NN protein/NN associated/VBN with/IN the/DT cytosolic/JJ face/NN of/IN the/DT trans-Golgi/NN (/( Kooy/NNS ,/, J/NNP ./NNP ,/, Toh/NNP ,/, B/NNP ./NNP
@@106290352033 The/DT single/JJ strandedness/NN is/VBZ manifested/VBN as/IN a/DT terminal/JJ extension/NN of/IN the/DT G-rich/NNP strand/NN (/( G/NN tails/NNS )/SYM that/WDT can/MD occur/VB independently/RB of/IN telomerase/NEWGENE ,/, suggesting/VBG that/IN cdc17/NEWGENE //NEWGENE pol1/NEWGENE mutants/NEWGENE exhibit/VBP defects/NNS in/IN telomeric/JJ lagging-strand/JJ synthesis/NN ./.
@@83241078302 The/DT plasmatic/NEWGENE albumin/NEWGENE concentration/NN (/( 3/CD ./CD 5-4/CD ./CD 5/CD g/NN //NN dl/NN )/SYM represents/VBZ about/RB 60%/CD of/IN the/DT total/JJ plasma/NN protein/NN ./.
@@79078467887 Group/NNP 6/CD was/VBD given/VBP physostigmine/NN ,/, 0/CD ./CD 1/CD mg/CD //CD kg/CD i/CD ./CD v/CD ./CD ,/, known/VBP to/IN inhibit/VB cholinesterase/NEWGENE degradation/NN ,/, 5/CD min/NN before/IN bupivacaine/NN administration/NN ,/, and/CC Group/NNP 7/CD received/VBN a/DT combination/NN of/IN physostigmine/NN pretreatment/JJ and/CC electrical/JJ vagal/JJ stimulation/NN ./.
@@63190406110 We/PRP conclude/VBP that/IN ,/, with/IN autonomic/JJ nervous/JJ system/NN activity/NN intact/JJ ,/, carotid/JJ chemoreceptor/NN reflex/NN activation/NN can/MD elicit/VB an/DT absolute/JJ reflexly/NN mediated/JJ reduction/NN in/IN coronary/JJ blood/NN flow/NN in/IN the/DT normal/NN ,/, conscious/JJ dog/NN ,/, despite/IN an/DT increase/NN in/IN arterial/JJ pressure/NN ./.
@@95417214810 Furthermore/RB ,/, in/IN the/DT ischemia/NN //NN angiotension/NN II-induced/NN AHF/NN model/NN ,/, NIC/IN decreased/VBN left/NN ventricular/JJ end-diastolic/JJ pressure/NN (/( LVEDP/NN )/SYM ./.
@@14335025440 These/DT results/NNS suggest/VBP that/WDT decreased/VBD class/NEWGENE I/NEWGENE enhancer/NEWGENE activity/NN in/IN Ad12-transformed/JJ cells/NNS may/MD ,/, at/IN least/RB in/IN part/NN ,/, be/VB due/NN to/IN the/DT higher/JJ levels/NNS of/IN an/DT enhancer-specific/NN factor/NN ,/, possibly/RB acting/JJ as/IN a/DT repressor/NN ./.
@@41236624809 Evaluation/NN of/IN thyroid/JJ function/NN ./.
@@9605137105 Combined/VBN expression/NN of/IN c-Jun/NEWGENE and/CC p65/NEWGENE induced/NN vigorous/NN transcription/NN of/IN IL-2/NEWGENE promoter-/NN and/CC CD28RE-driven/NEWGENE reporter/NEWGENE constructs/NEWGENE in/IN both/DT LFA-3-/NN and/CC B7-1-costimulated/JJ Jurkat/NN cells/NNS ./.
@@117307121576 Treadmill/NN training/NN at/IN least/RB for/IN 2/CD weeks/NNS can/MD reduce/VB the/DT infarction/NN size/NN and/CC edema/NN caused/VBN by/IN MCA/NN occlusion/NN (/( P/CD </CD 0/CD ./CD 01/CD )/SYM ./.
@@100229213657 However/RB ,/, unlike/IN the/DT SIN3/NEWGENE gene/NEWGENE of/IN Saccharomyces/NN cerevisiae/NN ,/, pst1/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE is/VBZ essential/JJ for/IN cell/NN viability/NN ./.
@@90473441227 Calmodulin-binding/NEWGENE peptide/NEWGENE (/( CBP/NEWGENE )/SYM ,/, a/DT peptide/NN of/IN 26/CD amino/JJ acids/NNS derived/VBN from/IN muscle/NEWGENE myosin/NEWGENE light/NEWGENE chain/NEWGENE kinase/NEWGENE (/( MLCK/NEWGENE )/SYM ,/, binds/VBZ to/IN calmodulin/NEWGENE with/IN nanomolar/JJ affinity/NN ./.
@@33551224045 After/IN the/DT meal/NN containing/JJ potato/NN ,/, plasma/NN glucose/NN levels/NNS rose/VBD sharply/RB ,/, peaked/VBN at/IN 30-45/JJ min/NN and/CC fell/NN below/RB initial/JJ levels/NNS 2/CD to/IN 3/CD h/NN later/JJR ./.
@@2449431764 ATP/NN gamma/NN S/NN inhibition/NN can/MD be/VB overcome/VB by/IN high/JJ concentrations/NNS of/IN ATP/NN ,/, dATP/NN ,/, araATP/NN ,/, or/CC ddATP/NN ./.
@@85975969430 The/DT gene/NN encodes/VBZ an/DT ATP-binding/NEWGENE cassette/NEWGENE ,/NEWGENE ABC/NEWGENE transporter/NEWGENE ./.
@@77795586272 Muscle/NEWGENE GSH-Px/NEWGENE activity/NN after/IN prolonged/JJ exercise/NN ,/, training/NN ,/, and/CC selenium/NN supplementation/NN ./.
@@94401663741 RESULTS/NNS :/: The/DT bovine/NN cDNA/NN insert/NN sequence/NN was/VBD 273/CD nucleotides/NNS in/IN length/NN for/IN the/DT entire/JJ mRNA/NN coding/JJ region/NN ,/, 212/CD nucleotides/NNS in/IN the/DT 5'/CD untranslated/JJ region/NN ,/, 83/CD nucleotides/NNS in/IN the/DT 3'/CD untranslated/JJ region/NN and/CC a/DT poly/NN (/NN A/NN )/NN tail/NN ./.
@@95045539467 Therapeutic/JJ use/NN of/IN cannabis/NN ./.
@@17406822321 Toxicity/NNS was/VBD mild/JJ ,/, mainly/RB consisting/VBG of/IN emesis/NN (/( 81%/NN of/IN the/DT patients/NNS ;/: 66%/NN of/IN the/DT courses/NNS )/SYM ,/, leukopenia/NN of/IN World/NNP Health/NNP Organization/NNP (/( WHO/WP )/SYM grade/NN 1/CD to/IN 2/CD (/( 47%/NN of/IN the/DT patients/NNS ;/: 18%/NN of/IN the/DT courses/NNS )/SYM ,/, and/CC thrombocytopenia/NN (/( 12%/NN of/IN the/DT patients/NNS ;/: 3%/NN of/IN the/DT courses/NNS )/SYM ./.
@@66103476074 Refractory/JJ periods/NNS of/IN the/DT AV/NN junction/NN were/VBD altered/VBN in/IN a/DT comparable/JJ fashion/NN to/IN conduction/NN through/RB the/DT AV/JJ node/NN ./.
@@3550444369 Development/NNP of/IN a/DT yeast/NN system/NN to/IN assay/NN mutational/JJ specificity/NN ./.
@@86084489971 Although/IN some/DT residues/NNS are/VBP found/VB reactive/NN toward/IN dimethylsulphate/NN and/CC kethoxal/NN in/IN regions/NNS predicted/VBN to/IN be/VB unpaired/JJ by/IN the/DT phylogenetic/JJ secondary/JJ structure/NN model/NN of/IN 4/NEWGENE ./NEWGENE 5S/NEWGENE RNA/NEWGENE ,/, generally/RB the/DT reactivity/NN is/VBZ low/JJ ,/, and/CC some/DT residues/NNS in/IN internal/JJ loops/NNS are/VBP not/RB reactive/VB at/IN all/DT ./.
@@3192724577 Interpersonal/JJ style/NN differences/NNS among/IN drug/NN abusers/NNS were/VBD explored/VBN using/VBG Ryan's/NNP (/( 1977/CD )/SYM typological/JJ system/NN of/IN FIRO-B/NN interpretation/NN ./.
@@74261016025 Fasting/NN plasma/NN and/CC lipoprotein/NN lipid/NN concentrations/NNS ,/, adipose/NEWGENE tissue/NEWGENE lipoprotein/NEWGENE lipase/NEWGENE activity/NN ,/, anthropometric/JJ data/NN ,/, alcohol/NN consumption/NN ,/, smoking/NN habits/NNS ,/, weekly/JJ mileage/NN run/NN and/CC performance/NN on/IN a/DT bicycle/NN ergometer/NN were/VBD recorded/VBN before/IN and/CC after/IN the/DT training/NN period/NN ./.
@@30418022856 The/DT presence/NN of/IN circulating/JJ platelet/NN aggregates/NNS and/CC elevated/VBN levels/NNS of/IN fibrinopeptide/NEWGENE A/NEWGENE (/( a/DT cleavage/NN product/NN of/IN fibrin/NEWGENE )/SYM suggests/VBZ that/DT platelet/NN activation/NN and/CC fibrin/NEWGENE deposition/NN may/MD play/VB a/DT role/NN in/IN the/DT pathogenesis/NN of/IN this/DT disorder/NN ./.
@@97897959765 Additionally/RB in/IN seven/JJ subjects/NNS adrenaline/NN (/( A/DT )/SYM and/CC noradrenaline/NN (/( NA/NN )/SYM concentrations/NNS were/VBD determined/VBN ./.
@@116003141936 Direct/JJ current/JJ polarography/NN and/CC differential/JJ pulse/NN polarographic/JJ methods/NNS have/VBP been/VBN developed/VBN for/IN the/DT qualitative/JJ as/RB well/NN as/IN quantitative/JJ analysis/NN of/IN vitamin/NN B1/NN ,/, B2/NN and/CC B6/NNP ./NNP
@@112661941099 Body/NNP fat/JJ distribution/NN was/VBD determined/VBN by/IN abdominal/JJ computed/JJ tomography/NN ./.
@@16953784962 Induction/NNS of/IN Jurkat/NN leukemic/JJ T/NN cells/NNS with/IN phorbol/NN 12-myristate/JJ 13-acetate/NN and/CC ionomycin/NN did/VBD not/RB affect/VB the/DT level/NN of/IN FKBP/NEWGENE mRNA/NEWGENE ./.
@@118005865588 Because/IN the/DT DPPD/NEWGENE gene/NEWGENE is/VBZ not/RB present/VB in/IN non-tuberculous/JJ bacilli/NNS ,/, these/DT results/NNS suggest/VBP that/IN this/DT molecule/NN can/MD be/VB an/DT additional/JJ tool/NN for/IN a/DT more/RB specific/JJ diagnosis/NN of/IN tuberculosis/NN ./.
@@28366231065 Mo/NN +/SYM SV/NN M-MuLV-inoculated/JJ animals/NNS became/VBD moribund/JJ at/IN 3/CD to/IN 13/CD months/NNS postinoculation/JJ ,/, whereas/IN delta/NN Mo/NN +/SYM SV/NN M-MuLV-inoculated/JJ animals/NNS became/VBD moribund/JJ at/IN 6/CD to/IN 24/CD months/NNS postinoculation/JJ ./.
@@80916655593 Cowpox/ORG virus/NN contains/VBZ two/JJ copies/NNS of/IN an/DT early/JJ gene/NN encoding/VBG a/DT soluble/RB secreted/VBN form/NN of/IN the/DT type/NEWGENE II/NEWGENE TNF/NEWGENE receptor/NEWGENE ./.
@@95700309520 Fetal/JJ growth/NN retardation/NN as/IN a/DT cause/NN of/IN impaired/VBN ovarian/JJ development/NN ./.
@@86216598187 Gas6/NEWGENE contains/VBZ an/DT NH2-terminal/NN Gla/NN domain/NN followed/VBN by/IN four/CD epidermal/NEWGENE growth/NEWGENE factor-like/NEWGENE repeats/NEWGENE and/CC tandem/NN globular/JJ (/( G/NN )/SYM domains/NNS ./.
@@10984122366 As/IN control/NN ,/, the/DT cells/NNS were/VBD transfected/VBN with/IN DNA/NN mixtures/NNS containing/JJ vector/NN mU6-C1/NN or/CC mU6-C2/NN ./.
@@18468035927 This/DT result/NN suggests/VBZ that/DT phosphorylation/NN of/IN Thr/NN 14/CD and/DT //DT or/DT Tyr/NN 15/CD inhibits/VBZ p34cdc2/NEWGENE kinase/NEWGENE activity/NN ,/, in/IN line/NN with/IN the/DT location/NN of/IN these/DT residues/NNS within/IN the/DT putative/JJ ATP/NN binding/JJ site/NN of/IN the/DT kinase/NEWGENE ./.
@@94416643115 We/PRP have/VBP previously/RB identified/VBN a/DT liver-enriched/JJ transcription/NN factor/NN ,/, HNF-6/NEWGENE ,/, which/WDT is/VBZ required/VBN for/IN HNF-3/NEWGENE beta/NEWGENE promoter/NEWGENE activity/NN and/CC also/RB recognizes/VBZ the/DT regulatory/JJ region/NN of/IN numerous/JJ hepatocyte-specific/NN genes/NN ./.
@@103301688311 Two/CD evolutionarily/RB conserved/VBN kinases/NEWGENE ,/, the/DT cyclin/NEWGENE B/NEWGENE (/NEWGENE Clb/NEWGENE )/NEWGENE //NEWGENE cyclin-dependent/NEWGENE kinase/NEWGENE (/( Cdk/NEWGENE //NEWGENE Cdc28p/NEWGENE )/SYM and/CC Cdc7p/NEWGENE along/IN with/IN its/PRP interacting/NN factor/NN Dbf4p/NEWGENE ,/, are/VBP required/VBN late/RB in/IN G1/NNP to/IN initiate/NN DNA/NN replication/NN ./.
@@38268714504 An/DT ion/NN chromatographic/JJ method/NN was/VBD used/VBN to/IN determine/VB Br/NN ion/NN in/IN the/DT urine/NN of/IN Greyhounds/NNS ./.
@@26947316420 On/IN the/PDT other/DT hand/NN ,/, knowledge/NN of/IN the/DT epidemiology/NN of/IN Parkinson's/NN disease/NN is/VBZ necessary/JJ in/IN creating/VBG etiological/JJ hypotheses/NNS ,/, since/IN only/JJ hypotheses/NNS consistent/JJ with/IN the/DT epidemiological/JJ profile/NN deserve/VB careful/JJ testing/NN ./.
@@14066776144 To/TO define/VB transcriptional/JJ control/NN elements/NNS responsible/JJ for/IN muscle-specific/JJ expression/NN of/IN the/DT human/NEWGENE myoglobin/NEWGENE gene/NEWGENE ,/, we/PRP performed/VBD mutational/JJ analysis/NN of/IN upstream/JJ sequences/NNS (/( nucleotide/NN positions/NNS -373/CD to/IN +7/NN relative/JJ to/IN the/DT transcriptional/JJ start/NN site/NN )/SYM linked/JJ to/IN a/DT firefly/NEWGENE luciferase/NEWGENE gene/NEWGENE ./.
@@86320188934 A/DT DNA/NN fragment/NN carrying/JJ 1/CD ,/CD 100/CD nucleotides/NNS derived/VBN from/IN the/DT 5'-flanking/JJ region/NN of/IN the/DT UGT1A1/NEWGENE gene/NEWGENE was/VBD enough/RB for/IN MC/NN induction/NN ./.
@@114516821328 The/DT present/NN chemotherapy/NN of/IN AE/NN is/VBZ based/VBN on/IN the/DT administration/NN of/IN benzimidazole/NN carbamate/NN derivatives/NNS ,/, such/JJ as/IN mebendazole/NN and/CC albendazole/NN ./.
@@18953582514 Limits/NNPS of/IN energy/NN turnover/NN in/IN relation/NN to/IN physical/JJ performance/NN were/VBD addressed/VBN in/IN terms/NNS of/IN upper/JJ and/CC lower/JJR limit/NN ,/, changes/VBZ during/IN a/DT training/NN programme/NN and/CC how/RB to/IN regulate/VB energy/NN balance/NN at/IN a/DT changing/JJ energy/NN turnover/NN ./.
@@10962593110 Non-poliomyelitis/NN AFP/NN rate/NN had/VBP increased/VBN from/IN 0/CD ./CD 9/CD in/IN 1997/CD to/IN 2/CD ./CD 8/CD in/IN 1998/CD ./.
@@113613385727 Most/JJS yeast/NEWGENE peroxisomal/NEWGENE matrix/NEWGENE proteins/NEWGENE contain/VBP a/DT type/NEWGENE 1C-terminal/NEWGENE peroxisomal/NEWGENE targeting/NEWGENE signal/NEWGENE (/( PTS1/NEWGENE )/SYM consisting/VBG of/IN the/DT tripeptide/NEWGENE SKL/NEWGENE or/CC a/DT conservative/JJ variant/NN thereof/RB ./.
@@75864038904 On/IN the/DT basis/NN of/IN these/DT relations/NNS ,/, a/DT risk/NN factor-selection/JJ scale/NN (/( RFSS/NN )/SYM (/( range/NN ,/, 0/CD to/IN 10/CD )/SYM was/VBD developed/VBN by/IN computing/JJ appropriate/JJ weights/NNS for/IN each/DT risk/NN factor/NN ./.
@@109478407451 Mis3/NEWGENE is/VBZ needed/VBN for/IN the/DT formation/NN of/IN 18S/NEWGENE ribosome/NEWGENE RNA/NEWGENE ,/, and/CC may/MD hence/RB direct/VB the/DT level/NN of/IN proteins/NNS required/VBN for/IN the/DT coupling/NN ./.
@@32758678829 GRFI/NEWGENE bound/JJ to/IN sequences/NNS at/IN the/DT negative/JJ regulatory/JJ elements/NNS (/( silencers/NNS )/SYM of/IN the/DT silent/NEWGENE mating/NEWGENE type/NEWGENE loci/NEWGENE HML/NEWGENE1 E/NEWGENE1 and/CC HMR/NEWGENE E/NEWGENE and/CC to/IN the/DT upstream/NEWGENE activating/NEWGENE sequence/NEWGENE (/( UAS/NEWGENE )/SYM required/VBN for/IN transcription/NN of/IN the/DT MAT/NEWGENE alpha/NEWGENE genes/NEWGENE ./.
@@97997934634 Large-scale/NNP sequencing/VBG of/IN two/JJ regions/NNS in/IN human/JJ chromosome/NN 7q22/NN :/: analysis/NN of/IN 650/CD kb/NN of/IN genomic/JJ sequence/NN around/IN the/DT EPO/NEWGENE and/CC CUTL1/NEWGENE loci/NEWGENE reveals/VBZ 17/CD genes/NNS ./.
@@98643357160 Taken/VBN together/RB ,/, our/PRP results/NNS indicate/VBP that/IN the/DT FCR1/NEWGENE gene/NEWGENE behaves/VBZ as/IN a/DT negative/JJ regulator/NN of/IN drug/NN resistance/NN in/IN C/NNP ./NNP albicans/JJ and/CC constitute/VB the/DT first/JJ evidence/NN that/DT FCZ/NN resistance/NN can/MD result/VB from/IN the/DT inactivation/NN of/IN a/DT regulatory/JJ factor/NN such/JJ as/IN Fcr1p/NEWGENE ./.
@@21901222810 This/DT emancipation/NN of/IN the/DT ability/NN to/IN copulate/VB from/IN hormonal/JJ influence/NN makes/VBP female/JJ sexual/JJ motivation/NN the/DT primary/NN regulator/NN of/IN mating/JJ in/IN primates/NNS ./.
@@78168083948 These/DT data/NN demonstrate/VB that/IN the/DT STR/NEWGENE family/NEWGENE of/IN genes/NNS is/VBZ represented/VBN in/IN a/DT nematode/JJ whose/WP ancestor/NN appeared/VBN well/VB before/IN the/DT branching/JJ that/WDT gave/VBD rise/NN to/IN the/DT Arthropoda/NN and/CC Chordata/NNP ./.
@@81570093970 The/DT Saccharomyces/NEWGENE cerevisiae/NEWGENE APS1/NEWGENE gene/NEWGENE encodes/VBZ a/DT homolog/NN of/IN the/DT small/JJ subunit/NN of/IN the/DT mammalian/NEWGENE clathrin/NEWGENE AP-1/NEWGENE1 complex/NEWGENE1 :/: evidence/NN for/IN functional/JJ interaction/NN with/IN clathrin/NEWGENE at/IN the/DT Golgi/JJ complex/NN ./.
@@5980123008 In/NN girls/NNS prolactin/NEWGENE levels/NNS rise/NN at/IN stage/NN 2/CD ,/, and/CC are/VBP higher/JJ after/IN menarche/NN ;/: in/IN boys/NNS there/RB is/VBZ no/DT change/NN in/IN prolactin/NEWGENE levels/NNS ./.
@@51017621654 Spasmus/NN nutans/VBZ :/: a/DT syndrome/NN of/IN auto-arousal/NN ./.
@@14188602038 The/DT effects/NNS of/IN diltiazem/NN were/VBD stereoselective/JJ ,/, thus/RB the/DT potentiation/NN induced/VBN by/IN d-cis/NN diltiazem/NN was/VBD significantly/RB greater/JJR in/IN all/DT cases/NNS than/IN that/DT induced/VBD by/IN l-cis/NN diltiazem/NN ,/, which/WDT suggests/VBZ that/DT calcium/NN channel/NN blockade/NN plays/VBP a/DT role/NN in/IN these/DT interactions/NNS ./.
@@99209039498 These/DT results/NNS suggest/VBP that/IN the/DT c-met/NEWGENE gene/NEWGENE is/VBZ also/RB a/DT target/NN of/IN p53/NEWGENE gene/NEWGENE regulation/NN ./.
@@3592297228 Dorsal/JJ foot/JJ TcpO2/NN was/VBD measured/VBN by/IN using/VBG oxygen-sensing/JJ electrodes/NNS with/IN surface/NN temperatures/NNS of/IN 42/CD degrees/NNS C/NN and/CC 45/CD degrees/NNS C/NN ;/: in/IN theory/NN ,/, changes/VBZ in/IN sympathetic/JJ activity/NN should/MD affect/VB vasomotor/JJ tone/NN and/CC TcpO2/NN in/IN skin/NN beneath/IN an/DT electrode/NN at/IN 42/CD degrees/NNS C/NN (/( submaximal/JJ vasodilation/NN )/SYM ,/, but/CC not/RB at/IN 45/CD degrees/NNS C/NN (/( maximal/JJ vasodilation/NN )/SYM ./.
@@24739072335 The/DT 84/NEWGENE ./NEWGENE 1C/NEWGENE mAb/NEWGENE recognizes/VBZ a/DT site/NN on/IN IgE/NEWGENE which/WDT is/VBZ identical/JJ or/CC very/RB close/JJ to/IN the/DT Fc/NEWGENE epsilon/NEWGENE R/NEWGENE binding/NEWGENE site/NEWGENE ,/, and/CC 95/CD ./CD 3/CD recognizes/VBZ a/DT site/NN on/IN IgE/NEWGENE which/WDT is/VBZ related/VBN ,/, but/CC not/RB identical/JJ to/IN the/DT Fc/NEWGENE epsilon/NEWGENE R/NEWGENE binding/NEWGENE site/NEWGENE ./.
@@111142944583 Previous/JJ studies/NNS have/VBP shown/VBP that/IN the/DT pro-inflammatory/JJ cytokines/NNS tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE alpha/NEWGENE and/CC interferon/NEWGENE gamma/NEWGENE reduce/VB the/DT expression/NN of/IN the/DT cystic/NEWGENE fibrosis/NEWGENE transmembrane/NEWGENE conductance/NEWGENE regulator/NEWGENE (/( CFTR/NEWGENE )/SYM gene/NN (/( CFTR/NEWGENE )/SYM in/IN HT-29/JJ and/CC T84/NNP cells/NNS by/IN acting/JJ post-transcriptionally/RB ./.
@@105972221810 Therefore/RB ,/, we/PRP propose/VBP that/IN p27/NEWGENE represents/VBZ a/DT crucial/JJ molecule/NN in/IN HMBA/NN signaling/JJ that/WDT cannot/MD be/VB replaced/VBN by/IN p21/NEWGENE ./.
@@18126909936 No/DT case/NN of/IN SMF/NN demonstrated/VBN expansive/JJ tumorous/JJ growth/NN ./.
@@104877531726 The/DT injection/NN of/IN XDRP1/NEWGENE protein/NEWGENE into/IN fertilized/JJ Xenopus/JJ eggs/NNS blocked/VBD embryonic/JJ cell/NN division/NN ./.
@@8798782121 Lck/NEWGENE has/VBZ been/VBN postulated/VBN to/IN dimerize/VB through/RB the/DT SH2/NEWGENE and/CC SH3/NEWGENE domains/NEWGENE ./.
@@107274263266 The/DT kinase/NN activity/NN of/IN PfPK6/NEWGENE is/VBZ sensitive/JJ to/IN CDK/NEWGENE inhibitors/NN such/JJ as/IN olomoucine/NN and/CC roscovitine/NN ./.
@@105160265028 Both/DT HERV-K/NN type/NN 1/CD and/CC 2/CD clones/NNS were/VBD isolated/VBN ./.
@@117260221568 These/DT results/NNS were/VBD compared/VBN with/IN the/DT estimates/NNS of/IN penetration/NN from/IN steady-state/JJ calculations/NNS ,/, square/NN root/NN of/IN time/NN calculations/NNS ,/, and/CC a/DT biologically/RB based/VBN mathematical/JJ model/NN ./.
@@74943038241 Human/NEWGENE immunodeficiency/NEWGENE virus/NEWGENE type/NEWGENE 1/NEWGENE Vpr/NEWGENE is/VBZ a/DT virion-associated/NN ,/, regulatory/JJ protein/NN that/WDT is/VBZ required/VBN for/IN efficient/JJ viral/JJ replication/NN in/IN monocytes/NNS //NNS macrophages/NNS ./.
@@41022804797 Treatment/NNP of/IN Paget's/NNP disease/NN ./.
@@107816111306 Furthermore/RB ,/, bone/NN marrow-derived/JJ macrophages/NNS from/IN LAT-deficient/NNP mice/NNS displayed/VBN reduced/VBN phagocytic/JJ efficiency/NN in/IN comparison/NN to/IN the/DT macrophages/NNS from/IN wild-type/NN mice/NNS ./.
@@108564917358 SETTING/VBG :/: University/NNP of/IN Paris/NN VII/NN hospital/NN ./NN Patient/NN (/NN s/NN )/NN :/: Nine/CD women/NNS had/VBP embolization/NN for/IN symptomatic/JJ myoma/NN ,/, with/IN 12/CD pregnancies/NNS observed/VBN ./.
@@106447607647 Analysis/NNP of/IN functional/JJ domains/NNS of/IN Arix/NEWGENE reveals/VBZ an/DT N-terminal/NN activation/NN domain/NN and/CC a/DT C-terminal/NN repression/NN domain/NN ./.
@@102051766399 Nuclear/NEWGENE receptors/NEWGENE (/( NRs/NEWGENE )/SYM can/MD function/VB as/IN ligandinducible/NN transregulators/NN in/IN both/DT mammalian/JJ and/CC yeast/NN cells/NNS ,/, indicating/VBG that/IN important/JJ features/NNS of/IN transcriptional/JJ control/NN have/NN been/VBN conserved/VBN throughout/IN evolution/NN ./.
@@110296568810 Mn2+/NN increased/VBD both/PDT the/DT junction/NN binding/JJ and/CC cleaving/JJ activities/NNS of/IN the/DT mutant/JJ proteins/NNS ./.
@@17036323980 The/DT Drosophila/NEWGENE suppressor/NEWGENE of/NEWGENE sable/NEWGENE gene/NEWGENE encodes/VBZ a/DT polypeptide/NN with/IN regions/NNS similar/JJ to/IN those/DT of/IN RNA-binding/NN proteins/NN ./.
@@10651076467 High/NNP resolution/NN computed/JJ tomography/NN of/IN the/DT lungs/NNS in/IN patients/NNS with/IN rheumatoid/JJ arthritis/NN ./.
@@98458569082 RESULTS/NNS :/: During/IN the/DT 7-year/JJ period/NN ,/, 10/NN ,/NN 331/NN symptomatic/JJ duodenal/JJ ulcer/NN diseases/NNS were/VBD diagnosed/VBN ./.
@@85678471484 In/NN our/PRP opinion/NN ,/, the/DT SM-CMA/NN system/NN is/VBZ ,/, despite/IN some/DT shortcomings/NNS in/IN its/PRP user-interface/JJ ,/, a/DT useful/JJ and/CC versatile/JJ instrument/NN for/IN examination/NN of/IN human/JJ semen/NN samples/NNS ,/, with/IN desirable/JJ features/NNS ./.
@@16164752199 These/DT results/NNS support/NN the/DT diagnostic/JJ validity/NN of/IN NFPD/NNP in/IN CP/NNP //NNP NCA/NNP patients/NNS ,/, because/IN such/JJ patients/NNS had/VBP a/DT family/NN history/NN of/IN panic/NN disorder/NN similar/JJ to/IN patients/NNS with/IN a/DT more/RB classical/JJ panic/NN disorder/NN presentation/NN ./.
@@68586406659 On/IN the/DT basis/NN of/IN histopathological/JJ findings/NNS ,/, the/DT origin/NN of/IN amyloid/RB appeared/VBN to/IN be/VB closely/RB related/VBN to/IN the/DT fibroblasts/NNS ./.
@@75902689429 We/PRP have/VBP isolated/VBN a/DT Drosophila/NN melanogaster/NN (/( Dm/IN )/SYM cDNA/NN encoding/VBG a/DT polypeptide/NN that/WDT has/VBZ extensive/JJ sequence/NN similarity/NN to/IN the/DT mammalian/NEWGENE MAPKAPK-2/NEWGENE ./.
@@9461594784 Here/RB ,/, we/PRP present/VBP evidence/VBP that/DT exposure/NN of/IN DT40/NNP lymphoma/NN B/NNP cells/NNS to/IN low/JJ energy/NN electromagnetic/JJ field/NN (/( EMF/NN )/SYM results/NNS in/IN a/DT tyrosine/NN kinase-dependent/JJ activation/NN of/IN phospholipase/NEWGENE Cgamma2/NEWGENE (/( PLC-gamma2/NEWGENE )/SYM leading/VBG to/IN increased/VBN inositol/NN phospholipid/NN turnover/NN ./.
@@110693072426 Inhibition/NNS of/IN RNA2/NEWGENE translation/NN was/VBD selective/JJ ,/, with/IN no/DT effect/NN on/IN general/JJ cellular/JJ translation/NN or/CC translation/NN of/IN BMV/DT RNA1-encoded/NEWGENE replication/NEWGENE factor/NEWGENE 1a/NEWGENE ,/, and/CC was/VBD independent/NN of/IN p20/NEWGENE ,/, a/DT cellular/JJ antagonist/NN of/IN DED1/NEWGENE function/NN in/IN translation/NN ./.
@@72198217043 Clinical/NNP and/CC anatomical/JJ considerations/NNS ./.
@@80988828077 Salazopyrine/NNP desensitization/NN ./.
@@86293483742 Despite/IN the/DT favourable/JJ natural/JJ history/NN of/IN acute/NN BI/NN ,/, mild/JJ ,/, moderate/JJ ,/, and/CC severe/JJ posttraumatic/JJ changes/NNS were/VBD shown/VBP to/RB appear/VB as/IN cicatricial-adhesive/JJ and/CC atrophic/JJ processes/NNS ,/, intracerebral/JJ cysts/NNS ,/, porencephaly/NN ,/, which/WDT result/VBP in/IN posttraumatic/JJ epilepsy/NN ,/, hydrocephalus/NN ,/, etc/NN ./.
@@27936206043 Third-/DT and/CC later-parity/JJ cows/NNS were/VBD randomly/RB assigned/VBN after/IN each/DT parturition/NN to/IN Charolais/NNP and/CC Red/NN Poll/NN bulls/NNS in/IN multiple-sire/JJ pastures/NNS ./.
@@116954816932 Under/IN our/PRP conditions/NNS ,/, the/DT combination/NN O3/NN //NN UV/NN did/VBD not/RB improve/VB the/DT degradation/NN rate/NN obtained/VBN by/IN ozonation/NN ./.
@@93013504783 For/IN sputum/NEWGENE interleukin-8/NEWGENE there/RB was/VBD an/DT estimated/VBN true/JJ treatment/NN median/JJ difference/NN of/IN 142/CD pg/NN //NN ml/NN (/( 95%/CD confidence/NN interval/NN (/( CI/NN )/SYM 8/CD to/IN 2866/CD pg/NN //NN ml/NN )/NN in/IN favour/NN of/IN placebo/NN ;/: while/CC for/IN maximal/JJ expiratory/JJ flow/NN at/IN 25%/JJ (/( MEF25%/NNP )/SYM remaining/JJ forced/JJ vital/JJ capacity/NN predicted/VBN for/IN sex/NN and/CC height/NN there/RB was/VBD a/DT 15/CD percentage/NN points/NNS (/( pp/NN )/SYM (/( 95%/CD CI/NN 4/NN to/IN 26/CD pp/NN )/SYM mean/JJ treatment/NN difference/NN in/IN favour/NN of/IN placebo/NN ./.
@@79267291688 Genetic/NNP alterations/NNS in/IN elements/NNS of/IN normal/JJ signal/JJ transduction/NN mechanisms/NNS are/VBP known/VBP to/IN be/VB oncogenic/JJ events/NNS often/RB resulting/JJ in/IN aberrant/JJ activation/NN of/IN programs/NNS of/IN gene/NN transcription/NN ./.
@@70263282800 In/NN the/DT diabetics/NNS ,/, Ca2+/NN infusions/NNS induced/VBD a/DT rise/NN of/IN plasma/NN Ca2+/NN up/JJ to/IN 3/CD ./CD 2/CD +/NN //NN -/NN 0/CD ./CD 1/CD mmol/NN //NN 1/NN and/CC a/DT fall/NN of/IN circulating/JJ glucagon/NEWGENE (/( -26/CD ./CD 4/CD +/NN //NN -/NN 5/CD ./CD 7%/CD ;/: p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM and/CC glucose/NN (/( -23/CD ./CD 3/CD +/NN //NN -/NN 3/CD ./CD 6%/CD ;/: p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@85163013875 This/DT gene/NN spans/NNS 23/CD kb/NN and/CC is/VBZ composed/VBN of/IN five/CD exons/NNS and/CC four/CD introns/NNS ./.
@@91511525896 They/PRP observed/VBD depressed/VBN protein/NEWGENE C/NEWGENE activity/NN that/IN significantly/RB (/( p/NN </SYM 0/CD ./CD 005/CD )/SYM increased/VBN and/CC became/VBD normal/JJ immediately/RB after/IN hemodialysis/NN while/CC factor/NEWGENE X/NEWGENE and/CC factor/NEWGENE VII/NEWGENE increased/VBD (/( p/NN </SYM 0/CD ./CD 01/CD ;/: p/NN </SYM 0/CD ./CD 05/CD )/SYM despite/IN heparinization/NN together/RB with/IN amount/NN of/IN serum/NEWGENE lipoprotein/NEWGENE (/NEWGENE a/NEWGENE )/NEWGENE ./.
@@87902916498 The/DT data/NN presented/VBN in/IN this/DT work/NN indicate/VB that/IN thi1/NEWGENE may/MD also/RB be/VB involved/VBN in/IN DNA/NN damage/NN tolerance/NN in/IN plant/NN cells/NNS ./.
@@94940784893 For/IN the/DT 5HT5A/NEWGENE receptor/NEWGENE the/DT addition/NN of/IN yohimbine/NN resulted/VBN in/IN a/DT similar/JJ but/CC smaller/JJR effect/NN ./.
@@81570091965 Sequence/NN comparisons/NNS have/VBP shown/VBP that/IN Aps1p/NEWGENE is/VBZ more/RB similar/JJ to/IN the/DT sigma/NN subunit/NN of/IN the/DT Golgi-localized/JJ mammalian/JJ AP-1/NEWGENE complex/NEWGENE than/IN Aps2p/NEWGENE ,/, which/WDT is/VBZ more/RB related/VBN to/IN the/DT plasma/NN membrane/NN AP-2/NEWGENE sigma/NEWGENE subunit/NN ./.
@@87315118933 The/DT levels/NNS of/RB fibrinogen/NEWGENE as/RB well/VB as/IN antithrombin/NEWGENE III/NEWGENE (/( ATIII/NEWGENE )/SYM and/CC heparin/NEWGENE cofactor/NEWGENE II/NEWGENE (/( HCII/NEWGENE )/SYM activities/NNS were/VBD steadily/RB increased/VBN in/IN loop-bearing/JJ animals/NNS ./.
@@99524259947 Another/DT group/NN of/IN HIPP-/NNP and/CC HCX-lesioned/NN animals/NNS trained/VBN on/IN the/DT tasks/NNS after/IN the/DT lesion/NN showed/VBD reduced/VBN impairments/NNS of/IN the/DT type/NN described/VBN above/RB ,/, suggesting/VBG that/IN extrahippocampal/JJ structures/NNS trained/VBN after/IN the/DT lesion/NN can/MD assume/VB the/DT role/NN of/IN the/DT hippocampus/NN to/IN some/DT degree/NN ./.
@@75953747234 Two/CD domains/NNS of/IN EBNA2/NEWGENE defined/VBN by/IN deletion/NN of/IN amino/JJ acids/NNS 247-337/NN and/CC 437-476/NN were/VBD found/VBN to/IN be/VB important/JJ for/IN the/DT activation/NN of/IN both/DT promoters/NNS ,/, while/CC two/JJ different/JJ domains/NNS corresponding/JJ to/IN residues/NNS 4-18/JJ and/CC 118-198/CD were/VBD required/VBN solely/RB for/IN the/DT LMP1/NEWGENE promoter/NEWGENE ./.
@@97926824020 These/DT results/NNS indicate/VBP that/IN the/DT total/JJ number/NN of/IN subunit/NN c/NN in/IN F0/NEWGENE should/MD be/VB a/DT multiple/NN of/IN 2/CD and/CC 3/CD ./CD
@@114895979767 At/NN termination/NN (/( gd/NN 20/NN )/SYM ,/, confirmed-pregnant/JJ females/NNS (/( 21/CD to/IN 25/CD per/IN group/NN )/SYM were/VBD evaluated/VBN for/IN clinical/JJ status/NN and/CC gestational/JJ outcome/NN ;/: live/VB fetuses/NNS were/VBD examined/VBN for/IN external/NN ,/, visceral/JJ ,/, and/CC skeletal/JJ malformations/NNS ./.
@@110717897608 Is/VBZ more/RB better/JJR ?/. About/IN dose/NN levels/NNS of/IN ACE/NEWGENE inhibitors/NN in/IN chronic/JJ heart/NN failure/NN ./.
@@91806879341 To/TO determine/VB which/WDT region/NN of/IN SulA/NEWGENE is/VBZ essential/JJ for/IN the/DT inhibition/NN of/IN cell/NN division/NN ,/, we/PRP constructed/VBD a/DT series/NN of/IN N-terminal/NN and/CC C-terminal/NN deletions/NNS of/IN SulA/NEWGENE and/CC a/DT series/NN of/IN alanine/NN substitution/NN mutants/NNS ./.
@@40368384702 Shape/NNP factor/NN correlated/VBN well/VB with/IN hemodynamic/JJ data/NN for/IN RV/NNP //NNP LV/NNP systolic/JJ pressure/NN ratios/NNS (/( r/JJ =/SYM 0/CD ./CD 93/CD ,/, p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM for/IN normalized/VBN interventricular/JJ pressure/NN differences/NNS (/( r/JJ =/SYM -0/CD ./CD 95/CD ,/, p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@115547276810 The/DT mutation/NN experiments/NNS showed/VBN that/IN the/DT most/RB critical/JJ sequence/NN for/IN the/DT repression/NN of/IN PTH/NEWGENE was/VBD 5'-GGGGGAGGGGAG-3'/NEWGENE (/NEWGENE +1/NEWGENE to/NEWGENE +12/NEWGENE )/NEWGENE of/IN PTHSR/NEWGENE ./.
@@79571587943 In/NN general/JJ ,/, the/DT filtration/NN rate/NN in/IN relevant/JJ areas/NNS appears/VBZ to/IN be/VB an/DT integrative/JJ and/CC easily/RB determined/VBN parameter/NN ,/, reflecting/JJ hormonal/JJ and/CC neurogenic/JJ vascular/JJ as/RB well/VB as/IN local/JJ interstitial/JJ control/NN of/IN the/DT Starling/NNP forces/NNS ./.
@@16532386073 Two/CD putative/JJ 12-O-tetradecanoyl-phorbol-13-acetate/NEWGENE (/NEWGENE TPA/NEWGENE )/NEWGENE response/NEWGENE elements/NEWGENE ,/, that/WDT might/MD serve/VB as/IN binding/JJ sites/NNS for/IN the/DT transcription/NEWGENE factor/NEWGENE AP-1/NEWGENE and/CC a/DT consensus/NN sequence/NN of/IN a/DT transforming/NEWGENE growth/NEWGENE factor/NEWGENE beta/NEWGENE 1/NEWGENE (/( TGF-beta/NEWGENE 1/NEWGENE )/SYM inhibitory/JJ element/NN were/VBD found/VBN in/IN the/DT promoter/NN region/NN ./.
@@92586069567 Crosstalk/NNP among/IN the/DT pathways/NNS may/MD explain/VB how/RB some/DT forms/NNS of/IN stress/NN can/MD contribute/VB to/IN the/DT development/NN of/IN a/DT malignancy/NN ./.
@@20758766307 Analysis/NNP of/IN electrically/RB evoked/VBN response/NN (/( EER/NN )/SYM in/IN relation/NN to/IN the/DT central/NN visual/NN pathway/NN of/IN the/DT cat/NN (/( 1/CD )/SYM ./.
@@18823868783 The/DT effectiveness/NN of/IN alpha-mercapto-beta-/NN (/NN 2-furyl/NN )/NN acrylic/NN acid/NN (/( MFA/NNP )/SYM and/CC N-benzyl-N-dithiocarboxy-D-glucamine/CHEM (/( NaB/NN )/SYM ,/, used/VBN in/IN combination/NN ,/, in/IN the/DT mobilization/NN and/CC excretion/NN of/IN lead/NN was/VBD investigated/VBN in/IN rats/NNS ./.
@@13263298542 The/DT 319/CD base/NN pair/NN region/NN immediately/RB upstream/RB of/IN the/DT CAP/NN site/NN is/VBZ characterized/VBN by/IN the/DT lack/NN of/IN a/DT proximal/JJ TATA/NN box/NN and/CC the/DT presence/NN of/IN sequences/NNS similar/JJ to/IN GC/NN boxes/NNS ,/, CACCC/NNP boxes/NNS ,/, CCAAT/NNP boxes/NNS ,/, activator/NEWGENE protein/NEWGENE 2/NEWGENE (/( Ap-2/NEWGENE )/SYM sites/NNS ,/, partial/JJ glucocorticoid/NEWGENE response/NEWGENE elements/NEWGENE (/( GREs/NEWGENE )/SYM ,/, and/CC partial/JJ cyclic/NEWGENE AMP/NEWGENE response/NEWGENE elements/NEWGENE (/( CREs/NEWGENE )/SYM ./.
@@6897114866 This/DT two-helix/JJ motif/NN is/NNS thought/VBP to/IN be/VB involved/VBN in/IN specific/JJ DNA/NN sequence/NN recognition/NN by/IN CAP/NEWGENE ./.
@@42844355921 Vitamin/NN D3/NN and/CC calcium/NN absorption/NN in/IN the/DT chick/NN ./.
@@92673062147 Far/NNP from/IN this/DT being/NN the/DT case/NN ,/, however/RB ,/, the/DT measurement/NN of/IN apo/NEWGENE B/NEWGENE has/VBZ met/VBP every/DT reasonable/JJ standard/NN of/IN laboratory/NN precision/NN and/CC reliability/NN to/IN allow/VB its/PRP widespread/JJ introduction/NN in/IN clinical/JJ laboratories/NNS ./.
@@5699892673 Under/IN halothane/NN anesthesia/NN ,/, the/DT flow/NN pneumocardiogram/NN (/( PnCG/NN )/SYM and/CC its/PRP time/NN derivative/NN (/( acceleration/NN pneumocardiogram/NN or/CC dPn/NN //NN dt/NN )/SYM were/VBD transduced/VBN during/IN apnea/NN by/IN a/DT small/NN high-gain/NN pneumotachograph/NN ./.
@@105797222839 Phosphorylation/NNS of/IN myosin-binding/NEWGENE subunit/NEWGENE (/( MBS/NEWGENE )/SYM of/IN myosin/NEWGENE phosphatase/NEWGENE by/IN Rho-kinase/NEWGENE in/IN vivo/NN ./.
@@75098117172 GTRE/NEWGENE ,/, TRE/NEWGENE ,/, and/CC CRE/NEWGENE oligonucleotides/NN all/DT compete/VB more/RB efficiently/RB for/IN protein/NN binding/JJ to/IN their/PRP labeled/JJ congeners/NNS than/IN for/IN protein/NN binding/JJ to/IN either/DT of/IN the/PDT other/DT labeled/JJ oligonucleotides/NNS ,/, suggesting/VBG that/IN the/DT GTRE/NEWGENE ,/, TRE/NEWGENE ,/, and/CC CRE/NEWGENE oligonucleotides/NN ,/, suggesting/VBG that/IN the/DT GTRE/NEWGENE ,/, TRE/NEWGENE ,/, and/CC CRE/NEWGENE oligonucleotides/NN each/DT bind/NN unique/JJ as/RB well/VB as/IN common/JJ proteins/NNS ,/, likely/RB to/IN be/VB members/NNS of/IN the/DT Jun/NEWGENE //NEWGENE Fos/NEWGENE and/CC cAMP-responsive/NEWGENE element-binding/NEWGENE protein/NEWGENE //NEWGENE activating/NEWGENE transcription/NEWGENE factors/NEWGENE (/( CREB/NEWGENE //NEWGENE ATF/NEWGENE )/SYM families/NNS of/IN transcription/NN factors/NNS ,/, in/IN chromaffin/JJ cells/NNS ./.
@@7797583545 We/PRP have/VBP generated/VBN various/JJ base/NN substitutions/NNS and/CC internal/JJ deletions/NNS in/IN and/CC around/IN DRE/NEWGENE (/( nucleotide/NN positions/NNS -93/CD to/IN -100/CD with/IN respect/NN to/IN the/DT transcription/NN initiation/NN site/NN )/SYM of/IN the/DT PCNA/NEWGENE gene/NEWGENE in/IN vitro/FW and/CC subsequently/RB examined/VBN their/PRP effects/NNS on/IN the/DT binding/NN to/IN DREF/NEWGENE (/( DRE-binding/NEWGENE factor/NEWGENE )/SYM and/CC PCNA/NEWGENE gene/NEWGENE promote/VB activity/NN in/IN cultured/JJ Drosophila/NN Kc/NN cells/NNS as/RB well/VBP as/IN in/IN living/VBG flies/NNS ./.
@@111607219536 Transient/JJ transfections/NNS showed/VBN that/IN a/DT single/JJ mutation/NN (/( 556M/CD )/SYM decreased/VBN TBLV/NEWGENE enhancer/NEWGENE activity/NN at/IN least/RB 20-fold/JJ in/IN two/JJ different/JJ T-cell/NN lines/NNS ./.
@@89721821640 Fas/NEWGENE has/VBZ been/VBN shown/VBP to/IN require/VB ICE/NEWGENE (/( interleukin-1/NEWGENE beta-converting/NEWGENE enzyme/NEWGENE )/SYM family/NN proteases/NNS to/IN induce/VB apoptosis/NN from/IN studies/NNS utilizing/VBG the/DT cowpox/NN ICE/NEWGENE inhibitor/NEWGENE protein/NEWGENE CrmA/NEWGENE1 ,/, the/DT synthetic/JJ tetrapeptide/NN ICE/NEWGENE inhibitor/NN YVAD-CMK/NEWGENE ,/, and/CC the/DT tripeptide/NN pan-ICE/JJ inhibitor/NN Z-VAD-FMK/NEWGENE ./.
@@77902719238 However/RB ,/, the/DT lens/NN dose/NN (/( 3/CD ./CD 6/CD Gy/NN //NN 25/NN fractions/NNS )/SYM was/VBD higher/RB compared/VBN to/IN the/PDT other/DT techniques/NNS ./.
@@8825639545 An/DT inverted/JJ Alu/NEWGENE repeat/NEWGENE element/NEWGENE ,/, flanked/VBN by/IN nonamer/NN direct/JJ repeats/NNS ,/, was/VBD identified/VBN within/IN the/DT region/NN -913/CD //CD -620/CD ,/, relative/JJ to/IN the/DT cap/NN site/NN ./.
@@10894816952 Studies/NNS using/VBG a/DT reporter/NN plasmid/NN with/IN a/DT functionally/RB disrupted/VBN sterol-responsive/NEWGENE element/NEWGENE (/( SRE/NEWGENE )/NN -1/NN revealed/VBN a/DT reduced/VBN stimulatory/JJ response/NN to/IN IL-6/NEWGENE ./.
@@11055786895 The/DT proposed/VBN algorithm/NN consists/VBZ of/IN several/DT steps/NNS ./.
@@95156652123 Ganciclovir/NNP and/CC foscarnet/NN efficacy/NN in/IN AIDS-related/NN CMV/NN polyradiculopathy/NN ./.
@@87640159925 A/NNP ./NNP
@@75280280 Although/IN both/DT transfected/VBN cell/NN lines/NNS contain/VBP FGF-1/NEWGENE cell/NEWGENE surface/NEWGENE receptors/NEWGENE as/IN judged/VBN by/IN crosslinking/JJ studies/NNS ,/, the/DT wild-type/NN transfectants/NNS are/VBP refractory/JJ to/IN exogenous/JJ FGF-1/NEWGENE ,/, whereas/IN the/DT mutant/JJ transfectants/NNS respond/VBP normally/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@90034632859 This/DT report/NN presents/VBP the/DT isolation/NN and/CC characterization/NN of/IN the/DT 5'-flanking/JJ region/NN (/( 1/CD ./CD 2/CD kb/NN )/SYM and/CC exon/NN 1/CD of/IN the/DT human/NEWGENE RII/NEWGENE alpha/NEWGENE gene/NEWGENE ./.
@@9090050561 It/PRP is/VBZ also/RB homologous/JJ to/IN other/DT sugar/NN carriers/NNS from/IN human/JJ ,/, mouse/NN and/CC Escherichia/NN coli/JJ ./.
@@86839833218 Our/PRP results/NNS confirm/VBP the/DT participation/NN of/IN intron/NN 1/CD in/IN transcriptional/JJ regulation/NN of/IN the/DT c-myb/NEWGENE gene/NEWGENE (/( in/IN mouse/NN and/CC human/JJ )/SYM and/CC implicate/VB multiple/NN and/CC complex/NN regulatory/JJ mechanisms/NNS of/IN activation/NN during/IN myelomonocytic/JJ differentiation/NN and/CC leukemic/JJ cell/NN growth/NN control/NN ./.
@@87039592887 There/EX was/VBD a/DT general/JJ broadening/NN of/IN proton/NN resonances/NNS for/IN a/DT three-nucleotide/NN segment/NN centered/VBN about/RB the/DT lesion/NN site/NN which/WDT resulted/VBD in/IN a/DT tentative/JJ assignment/NN for/IN the/DT sugar/NN protons/NNS of/IN the/DT C7/NN residue/NN in/IN the/DT spectrum/NN of/IN the/DT adduct/NN duplex/JJ ./.
@@79163272149 We/PRP report/VBP here/RB the/DT cloning/NN of/IN the/DT human/NEWGENE goosecoid/NEWGENE gene/NEWGENE (/( GSC/NEWGENE )/SYM from/IN a/DT genomic/JJ library/NN and/CC the/DT sequence/NN of/IN its/PRP encoded/VBN protein/NN ./.
@@106138433329 The/DT accumulated/VBN products/NNS of/IN ancient/JJ duplication/NN events/NNS can/MD be/VB readily/RB observed/VBN among/IN the/DT genes/NNS encoding/VBG voltage-dependent/JJ Ca/NN (/NN 2+/NN )/NN ion/NN channels/NNS ./.
@@27932166555 On/IN the/PDT other/DT hand/NN ,/, lack/NN of/IN conservation/NN of/IN the/DT membrane/NEWGENE attachment/NEWGENE sequence/NEWGENE arginine-glycine-aspartic/NEWGENE acid/NEWGENE argues/VBZ against/IN its/PRP functional/JJ importance/NN in/IN CgA/NEWGENE ./.
@@116915852205 The/DT hcKrox/NEWGENE gene/NN family/NN regulates/VBZ multiple/JJ extracellular/JJ matrix/NN genes/NNS ./.
@@30256557129 A/DT noncatalytic/JJ domain/NN conserved/VBN among/IN cytoplasmic/NEWGENE protein-tyrosine/NEWGENE kinases/NEWGENE modifies/VBZ the/DT kinase/NN function/NN and/CC transforming/JJ activity/NN of/IN Fujinami/NEWGENE sarcoma/NEWGENE virus/NEWGENE P130gag-fps/NEWGENE ./.
@@21431864016 Northern/NNP blot/NN analysis/NN indicates/VBZ that/IN AHA2/NEWGENE mRNA/NEWGENE relative/JJ to/IN total/JJ cellular/JJ RNA/NN is/VBZ expressed/VBN at/IN significantly/RB higher/JJ levels/NNS in/IN root/JJ tissue/NN as/IN compared/VBN with/IN shoot/NN tissue/NN ./.
@@72192977041 A/DT unified/JJ approach/NN to/IN the/DT standardization/NN of/IN allergens/NNS ./.
@@112104017699 Sevelamer/NNP hydrochloride/NN (/( Renagel/NN )/SYM is/VBZ a/DT nonabsorbed/JJ phosphate-binding/JJ polymer/NN marketed/VBN for/IN the/DT treatment/NN of/IN hyperphosphatemia/NN in/IN adult/JJ patients/NNS receiving/JJ hemodialysis/NN ./.
@@76377186099 Here/RB we/PRP show/VBP that/IN messenger/NN RNAs/NNS encoding/VBG trans-sialidases/NEWGENE containing/JJ the/DT repeats/NNS are/VBP not/RB present/VB in/IN epimastigotes/NNS but/CC are/VBP abundant/JJ in/IN trypomastigotes/NNS ./.
@@39822889329 Doctor/NNP Berglund/NN warns/VBZ members/NNS of/IN union/NN pitfalls/NNS ./.
@@24961003709 Enzyme-linked/JJ immunosorbent/JJ assay/NN for/IN screening/JJ aflatoxin/NEWGENE B1/NEWGENE in/IN cottonseed/NN products/NNS and/CC mixed/JJ feed/JJ :/: collaborative/JJ study/NN ./.
@@9150595537 Molecular/NNP characterization/NN and/CC expression/NN of/IN the/DT Erwinia/NEWGENE carotovora/NEWGENE hrpNEcc/NEWGENE gene/NEWGENE ,/, which/WDT encodes/VBZ an/DT elicitor/NN of/IN the/DT hypersensitive/JJ reaction/NN ./.
@@112433066030 CONCLUSIONS/IN :/: Although/IN the/DT levels/NNS of/IN oxLDL/NEWGENE antibodies/NEWGENE might/MD be/VB modified/JJ in/IN early/JJ hypertension/NN ,/, once/CC advanced/JJ coronary/JJ artery/NN disease/NN has/VBZ developed/VBN the/DT presence/NN of/IN hypertension/NN does/VBP not/RB affect/VB anti-oxLDL/NEWGENE levels/NNS ./.
@@16587415151 The/DT strategy/NN has/VBZ been/VBN used/VBN to/IN determine/VB 2/CD ./CD 6/CD kilobases/NNS of/IN nucleotide/NN sequence/NN in/IN the/DT Saccharomyces/NEWGENE cerevisiae/NEWGENE ADE/NEWGENE 1/NEWGENE locus/NEWGENE ./.
@@105236342569 A/DT subset/NN of/IN mutations/NNS in/IN the/DT Psi/NEWGENE synthase/NEWGENE domain/NEWGENE impairs/VBZ association/NN of/IN the/DT altered/VBN Cbf5p/NEWGENE proteins/NEWGENE with/IN selected/VBN box/NN H/NEWGENE //NEWGENE ACA/NEWGENE snoRNAs/NEWGENE ,/, suggesting/VBG that/IN the/DT functional/JJ catalytic/JJ domain/NN is/VBZ essential/JJ for/IN that/DT interaction/NN ./.
@@66271236367 Female/JJ Wistar/NN rats/NNS were/VBD fed/VBN a/DT liquid/JJ diet/NN ,/, Sustacal/NN ,/, which/WDT contained/VBD ethanol/NN (/( 40%/CD of/IN calories/NNS )/SYM or/CC isocaloric/JJ sucrose/NN ./.
@@107335913347 They/PRP share/VBP many/JJ downstream/RB targets/VBZ ,/, including/JJ remodeling/NN of/IN the/DT actin/NEWGENE cytoskeleton/NN ,/, activation/NN of/IN p70/NEWGENE (/NEWGENE S6/NEWGENE )/NEWGENE kinase/NEWGENE and/CC c-jun/NEWGENE N-terminal/NEWGENE kinase/NEWGENE (/( JNK/NEWGENE )/SYM ,/, and/CC regulation/NN of/IN transcription/NN and/CC cell/NN proliferation/NN ./.
@@96513947939 272/CD ,/, 19107-19110/NN )/NN ./.
@@114908621857 In/NN the/DT further/JJ development/NN of/IN bladder/NN neck/NN suspension/NN according/VBG to/IN Stamey-Pereyra/NNP ,/, the/DT use/NN of/IN miniature/NN bone/NN anchors/NN received/VBD considerable/JJ support/NN ./.
@@10598316111 GHB/NN ,/, 2/CD CB/NN ,/, HMB/NN ,/, are/VBP some/DT of/IN these/DT recent/JJ substances/NNS ./.
@@15494659538 Previous/JJ transactivation/NN experiments/NNS indicated/VBN that/IN three/CD amino/JJ acids/NNS residing/VBG in/IN this/DT region/NN ,/, Gly/NN ,/, Ser/NN and/CC Val/NN ,/, appear/VB to/IN be/VB critical/JJ for/IN target-site/NN discrimination/NN ./.
@@9481826714 Control/NNP of/IN fatty/JJ liver/NN syndrome/NN in/IN a/DT Jersey/NNP herd/NN by/IN a/DT change/NN of/IN diet/NN and/CC the/DT use/NN of/IN recombinant/JJ bovine/NN somatotrophin/NEWGENE ./.
@@1087288692 A/DT comparison/NN of/IN physical/JJ and/CC cytogenetic/JJ estimates/NNS of/IN radiation/NN dose/NN in/IN patients/NNS treated/VBN with/IN iodine-131/NN for/IN thyroid/JJ carcinoma/NN ./.
@@98425179459 Initial/JJ experience/NN with/IN the/DT new/JJ technology/NN indicates/VBZ that/IN SieScape/NN is/VBZ an/DT alternative/NN to/IN other/DT methods/NNS such/JJ as/IN CT/NN and/CC MRI/NN ./.
@@88988661593 To/TO map/VB this/DT regulatory/JJ serine/NN phosphorylation/NN site/NN we/PRP developed/VBD a/DT baculovirus-mediated/JJ expression/NN system/NN for/IN wild-type/NEWGENE annexin/NEWGENE II/NEWGENE and/CC for/IN a/DT series/NN of/IN annexin/NEWGENE II/NEWGENE mutants/NEWGENE which/WDT contained/VBD substitutions/NNS in/IN one/PRP or/CC more/JJ serine/NN residues/NNS present/VBP in/IN the/DT N-terminal/NN domain/NN ./.
@@86305998285 No/DT difference/NN in/IN elastin/NEWGENE peptide/NEWGENE concentration/NN was/VBD observed/VBN between/IN emphysematous/JJ patients/NNS and/CC control/NN subjects/NNS (/( mean/JJ +/NN //NN -/NN SD/NN =/SYM 2/CD ./CD 39/CD +/NN //NN -/NN 1/CD ./CD 18/CD micrograms/NN //NN ml/NN in/IN patients/NNS versus/IN 2/CD ./CD 55/CD +/NN //NN -/NN 1/CD ./CD 34/CD micrograms/NN //NN ml/NN in/IN policemen/NNS and/CC 2/CD ./CD 59/CD +/NN //NN -/NN 1/CD ./CD 20/CD micrograms/NN //NN ml/NN in/IN coal/NN miners/NNS )/SYM ./.
@@104550875738 CONCLUSIONS/IN :/: In/NN healthy/JJ individuals/NNS ,/, whole/JJ body/NN insulin/NEWGENE sensitivity/NN is/VBZ related/VBN ,/, or/CC "coupled/VBD ,/, "/" to/IN the/DT anaerobic/JJ threshold/NN ./.
@@82776324905 The/DT survival/NN rate/NN at/IN forty/CD months/NNS in/IN 15/CD patients/NNS with/IN N2/NN disease/NN who/WP underwent/VBD R2b/NN operation/NN was/VBD 51%/JJ ./.
@@86662416460 Furthermore/RB ,/, we/PRP have/VBP identified/VBN a/DT 43-bp/JJ region/NN of/IN the/DT 24p3/NEWGENE promoter/NEWGENE required/VBN for/IN the/DT Dex/NN responsiveness/NN ./.
@@40562564739 Histamine/NNS reactivity/NN was/VBD significantly/RB reduced/VBN after/IN the/DT nifedipine/NN aerosol/NN ,/, the/DT geometric/JJ mean/JJ provocative/JJ concentration/NN causing/JJ a/DT 35%/JJ fall/NN in/IN specific/JJ airway/NN conductance/NN ,/, rising/JJ from/IN 5/CD ./CD 0/CD to/IN 10/CD ./CD 9/CD mg/NN //NN ml/NN of/IN histamine/NN (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@27186835724 Handgrip/NN dynamometry/NN was/VBD also/RB carried/VBN out/RB in/IN 249/CD of/IN the/DT patients/NNS ./.
@@84922902154 By/IN applying/VBG the/DT potentiometric/JJ method/NN ,/, in/IN aqueous/JJ medium/NN of/IN ionic/JJ strength/NN mu/NN =/SYM 0/CD ./CD 2/CD ,/, the/DT stability/NN constants/NNS ,/, log/NN beta/NN 1/NN =/SYM 4/CD ./CD 42/CD and/CC log/NN beta/NN 2/NN =/SYM 8/CD ./CD 57/CD were/VBD obtained/VBN ./.
@@92630102711 Induction/NNS of/IN B/NNP cell/NN apoptosis/NN by/IN co-cross-linking/NN CD23/NEWGENE and/CC sIg/NEWGENE involves/VBZ aberrant/JJ regulation/NN of/IN c-myc/NEWGENE and/CC is/VBZ inhibited/VBN by/IN bcl-2/NEWGENE ./.
@@84202309555 SAECG/NN ,/, echocardiography/NN and/CC thallium-201/NN imaging/VBG were/VBD performed/VBN before/IN and/CC 1/CD month/NN after/IN attempted/VBN angioplasty/NN ./.
@@75462939746 Our/PRP results/NNS suggest/VBP that/DT protein/NN binding/JJ to/IN the/DT E2F-like/NEWGENE sequences/NEWGENE may/MD act/VB to/IN reduce/VB expression/NN ./.
@@85540694790 The/DT patient/NN was/VBD homozygous/JJ for/IN the/DT underlying/JJ mutation/NN ,/, which/WDT was/VBD found/VBN to/IN be/VB a/DT G--/NNP >/NNP T/NNP transversion/NN within/IN the/DT acceptor/NN splice/NN site/NN between/IN intron/NN e/NN and/CC exon/NN 6/CD ,/, abolishing/VBG normal/JJ RNA/NN splicing/JJ ./.
@@76831319858 The/DT genomic/JJ structure/NN of/IN four/CD members/NNS of/IN the/DT SRC-family/NEWGENE revealed/VBN nearly/RB identical/JJ exon/NN //NN intron/NN boundaries/NNS within/IN the/DT catalytic/JJ domain/NN of/IN this/DT family/NN ./.
@@114318571309 The/DT students/NNS who/WP had/VBP abnormal/JJ urine/NN screening/JJ results/NNS at/IN the/DT first/JJ time/NN received/VBD a/DT second/JJ urine/NN analysis/NN 10/CD to/IN 15/CD days/NNS later/JJR to/IN confirm/VB the/DT abnormal/JJ urine/NN analysis/NN ./.
@@78906804178 However/RB ,/, addition/NN of/IN core/NEWGENE DNA/NEWGENE polymerase/NEWGENE III/NEWGENE to/IN preinitiation/JJ complex/NN ,/, fully/RB reconstituting/JJ holoenzyme/NN resulted/VBN in/IN replacement/NN of/IN gamma/JJ by/IN alpha/NN at/IN the/DT primer/NN terminus/NN ./.
@@103959112290 Characterisation/NNS of/IN the/DT chicken/NEWGENE apolipoprotein/NEWGENE A-I/NEWGENE gene/NEWGENE 5'-flanking/JJ region/NN ./.
@@82832927028 Plasma/NN ,/, LDL/NEWGENE and/CC liver/NN cholesterol/NN concentrations/NNS were/VBD higher/JJ in/IN the/DT hyperlipidemic/JJ control/NN than/IN the/DT nonhyperlipidemic/JJ control/NN and/CC lower/JJR in/IN the/DT groups/NNS fed/VBD diets/NNS containing/NN pectin/NEWGENE or/CC prune/NN fiber/NN than/IN in/IN the/DT hyperlipidemic/JJ control/NN group/NN ./.
@@84173496189 All/DT of/IN these/DT data/NN suggest/VB that/DT replication/NN of/IN UV-damaged/JJ templates/NNS occurs/VBZ in/RB vitro/FW as/IN it/PRP does/VBP in/IN vivo/NN and/CC that/IN this/DT replication/NN results/NNS in/IN mutation/NN fixation/NN ./.
@@40251794691 In/NN group/NN I/PRP adults/NNS both/DT of/IN these/DT variables/NNS increased/VBN ./.
@@54718665554 The/DT plasma/NEWGENE growth/NEWGENE hormone/NEWGENE concentration/NN of/IN the/DT foetal/JJ lamb/NN ./.
@@106816792574 Despite/IN resolution/NN of/IN the/DT solid/JJ portion/NN of/IN the/DT tumor/NN ,/, serial/JJ MRI/NN showed/VBD enlargement/NN of/IN a/DT bilobar/JJ tumor/NN cyst/NN 3/NN years/NNS after/IN the/DT original/JJ diagnosis/NN ./.
@@104111406970 This/DT approximately/RB 125-nt/JJ RNA/NN proved/VBN to/IN arise/VB via/NN RNase/NEWGENE E/NEWGENE cleavage/NN from/IN the/DT 3'-terminal/NN region/NN of/IN the/DT mRNAs/NNS bearing/JJ the/DT terminator/NN ./.
@@86276496277 Electrophoretic/JJ mobility/NN shift/NN assays/NNS using/VBG crude/JJ extracts/NNS from/IN FREJ4/NNP cells/NNS revealed/VBD the/DT binding/NN of/IN a/DT member/NN (/NN s/NN )/NN of/IN the/DT Ets/NEWGENE family/NEWGENE of/NEWGENE transcription/NEWGENE factors/NEWGENE to/IN the/DT P4/NEWGENE EBS/NEWGENE ,/, as/RB well/VB as/IN the/DT interaction/NN of/IN two/JJ members/NNS of/IN the/DT Sp1/NEWGENE family/NEWGENE ,/, Sp1/NEWGENE and/CC Sp3/NEWGENE ,/, with/IN the/DT adjacent/JJ GC/NN box/NN ./.
@@115349009332 The/DT binary/JJ and/CC tertiary/JJ combinations/NNS of/IN plant-derived/JJ molluscicides/NNS Azadirachta/NNP indica/NN and/CC Cedrus/NNP deodara/JJ oil/NN with/IN synergists/NNS MGK-264/NN ,/, piperonyl/NN butoxide/NN (/( PB/NN )/SYM and/CC fruit/NN powder/NN of/IN Embelia/NNP ribes/NNS were/VBD used/VBN against/IN the/DT Lymnaea/NN acuminata/NN ./.
@@72831105096 The/DT known/VBP B1/NN -/: deficiency/NN reaches/VBP excessive/JJ high/JJ values/NNS with/IN light/NN exercise/NN ./.
@@82486888397 The/DT rate/NN of/IN enzymic/JJ stimulation/NN induced/VBN by/IN a/DT given/NN nitrate/NN correlates/VBP closely/RB with/IN the/DT rate/NN of/IN measured/VBN NO/DT production/NN from/IN the/DT nitrate/NN molecule/NN ./.
@@62785446074 Physiology/NNP and/CC Physiopathology/NNS ./.
@@23416692993 Experiments/NNS were/VBD performed/VBN in/IN which/WDT brain-stem/NN auditory-evoked/JJ responses/NNS (/( BAERs/NN )/SYM were/VBD elicited/VBN by/IN two/JJ types/NNS of/IN pseudorandom/JJ pulse/NN trains/NNS :/: maximum/JJ length/NN sequences/NNS (/( MLS/NN )/SYM and/CC Legendre/NNP sequences/NNS (/( LGS/NN )/SYM ./.
@@9994949991 Six/CD patients/NNS with/IN the/DT diagnosis/NN of/IN acute/JJ mania/NN were/VBD treated/VBN with/IN high/JJ doses/NNS of/IN the/DT beta-adrenergic/JJ blocking/JJ agent/NN propranolol/NN ./.
@@93665172724 PKA/NEWGENE phosphorylated/VBN WT1/NEWGENE at/IN Ser-365/NN and/CC Ser-393/NN in/IN vitro/FW ,/, as/RB well/VB as/IN at/IN additional/JJ sites/NNS ,/, and/CC this/DT phosphorylation/NN abolished/VBD the/DT DNA-binding/NN activity/NN of/IN WT1/NEWGENE in/IN vitro/FW ./.
@@10129043213 The/DT color-word/NN interference/NN effect/NN previously/RB reported/VBD with/IN normal/JJ populations/NNS when/CC given/VBP the/DT Stroop/NN test/NN was/VBD demonstrated/VBN for/IN this/DT retarded/VBN sample/NN using/VBG a/DT special/JJ format/NN ./.
@@42474724879 Estral/JJ cycle/NN in/IN white/JJ rats/NNS in/IN the/DT low/JJ and/CC high/JJ mountains/NNS of/IN Kirghizia/NN ./.
@@23065392956 Use/VB of/IN Selenastrum/NNP capricornutum/NN and/CC Microfeast/NNP as/IN food/NN for/IN Daphnia/NN pulex/NN ./.
@@100279047667 The/DT other/DT is/VBZ located/VBN at/IN -1335/JJ ,/, outside/RB this/DT highly/RB conserved/VBN region/NN ./.
@@39763237277 No/DT consistent/JJ correlation/NN between/IN blood/NN pressure/NN change/NN and/CC SCR-change/NN was/VBD seen/VBP ./.
@@97675935362 Although/IN YopH/NEWGENE is/VBZ a/DT highly/RB active/JJ PTP/NEWGENE ,/, it/PRP preferentially/RB targets/VBZ a/DT subset/NN of/IN tyrosine-phosphorylated/JJ proteins/NNS in/IN host/NN cells/NNS ,/, including/JJ p130Cas/NEWGENE ./.
@@16030888008 These/DT results/NNS indicate/VBP that/IN baculovirus-expressed/NN TR/NEWGENE mediates/VBZ transcriptional/JJ activation/NN and/CC repression/NN in/IN a/DT promoter-specific/JJ manner/NN in/IN vitro/FW ./.
@@109132765702 The/DT carboxyl-terminal/JJ proline-rich/JJ domain/NN of/IN SOS1/NEWGENE is/VBZ involved/VBN in/IN the/DT interaction/NN with/IN the/DT PLC-gamma1/NEWGENE SH3/NEWGENE1 domain/NEWGENE1 ./.
@@78541307897 The/DT pilE/NEWGENE gene/NEWGENE product/NEWGENE of/NEWGENE Pseudomonas/NEWGENE aeruginosa/NEWGENE ,/, required/VBN for/IN pilus/NN biogenesis/NN ,/, shares/VBP amino/JJ acid/NN sequence/NN identity/NN with/IN the/DT N-termini/NNS of/IN type/NEWGENE 4/NEWGENE prepilin/NEWGENE proteins/NEWGENE ./.
@@85984496153 In/NN contrast/NN to/IN the/DT signaling/JJ triggered/VBN by/IN surface/NN Ig/NN engagement/NN in/IN B/NNP lymphocytes/NNS ,/, CD38/NEWGENE ligation/NN did/VBD not/RB appear/VB to/IN induce/VB tyrosine/NN phosphorylation/NN of/IN the/DT src-like/NEWGENE protein/NEWGENE tyrosine/NEWGENE kinases/NEWGENE lyn/NEWGENE1 ,/, fyn/NEWGENE ,/, and/CC btk/NEWGENE ,/, or/CC of/IN vav-/JJ and/CC ras-GTPase-activating/NEWGENE protein/NEWGENE ,/, nor/CC did/VBD it/PRP induce/VBP detectable/JJ changes/NNS in/IN cytosolic/JJ CA2+/NNP concentrations/NNS ./.
@@4277154897 A/DT total/NN of/IN 57/CD patients/NNS with/IN Hodgkin's/NNP disease/NN limited/VBN to/IN above/RB the/DT diaphragm/NN (/( Stages/NNS I/PRP and/CC II/NNP ,/, A/DT and/CC B/NNP )/SYM were/VBD treated/VBN with/IN radiation/NN therapy/NN alone/RB at/IN the/DT University/NNP of/IN Florida/NN between/IN 1964/CD and/CC 1974/CD ./.
@@105972328717 The/DT RET/NEWGENE //NEWGENE PTC3/NEWGENE rearrangement/NEWGENE is/VBZ formed/VBN by/IN fusion/NN of/IN the/DT ELE1/NEWGENE and/CC RET/NEWGENE genes/NEWGENE ,/, and/CC is/VBZ highly/RB prevalent/JJ in/IN radiation-induced/JJ post-Chernobyl/JJ papillary/JJ thyroid/JJ carcinomas/NNS ./.
@@82097721710 The/DT ns2/NEWGENE gene/NEWGENE comprises/VBZ an/DT open/JJ reading/JJ frame/NN (/( ORF/NN )/SYM encoding/VBG a/DT putative/JJ nonstructural/JJ (/( ns/NNS )/SYM protein/NN of/IN 279/CD amino/JJ acids/NNS with/IN a/DT predicted/VBN molecular/JJ mass/NN of/IN 32-kDa/NN ./.
@@98219787596 These/DT cognitive/JJ deficits/NNS were/VBD prevented/VBN in/IN animals/NNS treated/VBN with/IN MK-801/NN during/IN SE/NN ./NN
@@79330955310 We/PRP previously/RB showed/VBD that/DT v-Rel/NEWGENE ,/, the/DT oncoprotein/NN of/IN the/DT avian/JJ retrovirus/NN Rev-T/NN ,/, can/MD increase/VB expression/NN from/IN promoters/NN containing/NN binding/NN sites/NN for/IN the/DT cellular/JJ transcription/NN factor/NN Sp1/NEWGENE in/IN chicken/NN embryo/NN fibroblasts/NNS (/( S/NNP ./NNP
@@5928873138 Allergic/NNP reaction/NN to/IN Patent/NNP Blue/NN Violet/NN during/IN lymphography/NN ./.
@@98805128283 The/DT data/NN indicate/VB that/IN Bmp2/NEWGENE is/VBZ directly/RB regulated/VBN by/IN retinoic/NEWGENE acid-bound/NEWGENE receptors/NEWGENE and/CC Sp1/NEWGENE ./.
@@104877627916 NuA4/NEWGENE has/VBZ an/DT apparent/JJ molecular/JJ mass/NN of/IN 1/CD ./CD 3/CD MDa/NNS ./.
@@97909865444 We/PRP also/RB raised/VBD a/DT polyclonal/JJ antibody/NN against/IN the/DT glutathione/NEWGENE S-transferase/NEWGENE fusion/NEWGENE protein/NEWGENE containing/JJ the/DT NH2-terminal/NN 86/NN amino/JJ acids/NNS of/IN human/NEWGENE NRAMP2/NEWGENE ./.
@@77582466851 The/DT protein/NN coding/JJ region/NN ,/, 1/NN ,/NN 696/NN bps/NNS long/JJ ,/, is/VBZ divided/VBN by/IN an/DT intron/NN into/IN two/JJ exons/NNS ./.
@@79840886079 Transcription/NNS of/IN the/DT gene/NN for/IN ivanolysin/NEWGENE O/NEWGENE and/CC expression/NN of/IN other/DT genes/NNS of/IN the/DT virulence/NEWGENE gene/NEWGENE cluster/NEWGENE in/NEWGENE L/NEWGENE ./NEWGENE ivanovii/NEWGENE were/VBD dependent/JJ on/IN PrfA/NEWGENE ./.
@@75381735106 MBP-Rep68/NEWGENE delta-mediated/NEWGENE DNA-RNA/NEWGENE helicase/NEWGENE activity/NN required/VBD ATP/NN hydrolysis/NN and/CC the/DT presence/NN of/IN Mg2+/NN ions/NNS and/CC was/VBD inhibited/VBN by/IN high/JJ ionic/JJ strength/NN ./.
@@89345404352 The/DT nm23-H1/NEWGENE //NEWGENE nm23-H2/NEWGENE gene/NEWGENE transcriptional/JJ activity/NN ratio/NN varied/VBN depending/VBG on/IN the/DT cell/NN line/NN ./.
@@18931956808 Experimentally/RB in/IN green/JJ monkeys/NNS ,/, Syrian/JJ hamsters/NNS and/CC white/NN mice/NNS the/DT authors/NNS studied/VBD the/DT pathogenic/JJ properties/NNS of/IN a/DT new/JJ virus/NN Issyk-Kul/NNP ./.
@@96850213124 METHODS/IN :/: Millipore/NNP ultrafiltration/NN membranes/NNS of/IN three/CD different/JJ pore/NN sizes/NNS were/VBD used/VBN as/IN model/NN lenticule/NN materials/CD ./CD The/CD nominal/JJ membrane/NN pore/NN sizes/NNS were/VBD 0/CD ./CD 1/CD microm/NN ,/, 0/CD ./CD 45/CD microm/NN ,/, and/CC 3/CD microm/NN ;/: the/DT surface/NN roughness/NN increased/VBN in/IN the/DT same/JJ order/NN The/DT membranes/NNS were/VBD coated/JJ with/IN a/DT thin/JJ layer/NN of/IN collagen/NEWGENE I/NEWGENE and/CC implanted/VBN in/IN a/DT circular/JJ pocket/NN of/IN the/DT anterior/JJ cornea/NN of/IN adult/JJ cats/NNS ,/, and/CC were/VBD clinically/RB evaluated/VBN for/IN the/DT extent/NN of/IN epithelialization/NN and/CC the/DT persistence/NN of/IN epithelial/JJ attachment/NN ./.
@@53227475471 Comparative/JJ study/NN on/IN acute/JJ oral/JJ overload/NN using/VBG tolbutamide/NN and/CC tolazamide/NN in/IN normal/JJ and/CC diabetic/JJ subjects/NNS ./.
@@83821398343 3/CD ./CD
@@1565882457 According/VBG to/IN the/DT changes/NNS of/IN perfusion/NN defects/NNS between/IN Ex/NN ,/, RD/NN and/CC ReI/NN images/NNS ,/, they/PRP were/VBD classified/VBN into/IN 3/CD types/NNS :/: Type/NN I/NN ;/: perfusion/NN defect/NN on/IN the/DT RD/NN image/NN was/VBD identical/JJ to/IN ReI/NN image/NN (/( 75%/JJ )/SYM Type/NN I/NN was/VBD divided/VBN into/IN 2/CD subgroups/NNS whether/IN perfusion/NN defect/NN at/IN Ex/NN was/VBD unchanged/JJ (/( Ia/NN ,/, 42%/JJ )/SYM or/CC improved/VBN (/( Ib/NN ,/, 33%/JJ )/SYM on/IN the/DT RD/NN image/NN ./.
@@66850044240 The/DT associations/NNS between/IN sex-hormone-binding/NEWGENE globulin/NEWGENE capacity/NN (/( SHBG/NEWGENE )/SYM ,/, age/NN ,/, body/NN mass/JJ index/NN (/( BMI/NN )/SYM ,/, and/CC physical/JJ fitness/NN have/NN been/VBN studied/VBN in/IN 34/CD men/NNS and/CC 36/CD women/NNS ./.
@@71365691926 In/NN Malmo/NN ,/, Sweden/NN ,/, 17/NN ,/NN 181/NN school/NN children/NNS born/JJ in/IN the/DT years/NNS 1961-1965/CD were/VBD screened/VBN for/IN scoliosis/NN once/CC a/DT year/NN between/IN the/DT ages/NNS of/IN 7/CD and/CC 16/CD years/NNS ,/, during/IN 1971-1980/CD ./.
@@75041711436 A/DT platelet-derived/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE (/( PDGF-R/NEWGENE )/SYM phosphopeptide/NN containing/NN Tyr-857/NN does/VBP not/RB bind/VB appreciably/RB to/IN the/DT Src/NEWGENE SH2/NEWGENE domain/NEWGENE ,/, suggesting/VBG it/PRP is/VBZ not/RB the/DT PDGF-R/NEWGENE binding/NN site/NN for/RB Src/NEWGENE as/IN previously/RB reported/VBN ./.
@@87326653928 Amplification/NNS and/CC overexpression/NN of/IN the/DT c-erbB-2/NEWGENE gene/NEWGENE in/IN 21MT-2/CD and/CC 21MT-1/CD human/JJ breast/NN carcinoma/NN cells/NNS results/NNS in/IN progressively/RB elevated/VBN levels/NNS of/IN constitutively/RB tyrosine-phosphorylated/NEWGENE p185erbB-2/NEWGENE and/CC is/VBZ associated/VBN with/IN progressive/JJ insulin-like/NEWGENE growth/NEWGENE factor/NEWGENE (/( IGF/NEWGENE )/SYM and/CC combined/JJ IGF/NEWGENE //NEWGENE epidermal/NEWGENE growth/NEWGENE factor/NEWGENE (/( EGF/NEWGENE )/SYM independence/NN in/IN culture/NN ./.
@@92346773064 Here/RB we/PRP have/VBP tested/VBN the/DT hypothesis/NN that/IN the/DT short/JJ transcripts/NNS ,/, or/CC proteins/NNS translated/VBN from/IN the/DT short/JJ transcripts/NNS ,/, are/VBP also/RB required/VBN for/IN respiration/NN ./.
@@13371422486 Also/RB ,/, the/DT human/NEWGENE glycoprotein/NEWGENE alpha-subunit/NEWGENE promoter/NEWGENE was/VBD induced/VBN 10-fold/JJ by/IN FSK/NEWGENE in/IN GH4/NNP rat/NN pituitary/JJ cells/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@39346675189 Three/CD chromosomal/NEWGENE crsA/NEWGENE mutations/NEWGENE ,/, crsA1/NEWGENE ,/, crsA4/NEWGENE ,/, and/CC crsA47/NEWGENE ,/, were/VBD transferred/VBN by/IN the/DT "gene/NN conversion"/NN process/NN to/IN B/NNP ./NNP subtilis/JJ plasmid/NN pRPD11/NN ,/, which/WDT consists/VBZ of/IN the/DT entire/JJ wild-type/NEWGENE rpoD/NEWGENE coding/NEWGENE sequence/NEWGENE ,/, encoding/VBG the/DT major/NEWGENE sigma/NEWGENE 43/NEWGENE factor/NEWGENE of/NEWGENE B/NEWGENE ./NEWGENE subtilis/NEWGENE RNA/NEWGENE polymerase/NEWGENE ,/, and/CC pUB110/NN ./.
@@65247276312 Lymphocytes/NNS from/IN all/DT 3/CD species/NN yielded/VBD maximum/JJ responses/NNS with/IN a/DT 48-hour/JJ prelabel/VB and/CC 12-/CD to-/JJ 16/CD hour/NN postlabel/NN incubation/NN period/NN at/IN 41/CD C/NN and/CC 1/CD :/: 20/CD blood/NN dilution/NN ./.
@@23070672889 The/DT persistence/NN of/IN members/NNS of/IN the/DT prostigmatid/NN families/NNS Tydeidae/NNP ,/, Nanorchestidae/NNP and/CC Tarsonemidae/NNP in/IN the/DT moisture-deficient/JJ 90%-concentration/NN treatments/NNS supports/VBP previous/JJ evidence/NN of/IN adaptations/NNS to/IN low-water-content/JJ habitats/NNS ./.
@@90508476428 Unlike/IN class/NEWGENE II-/NEWGENE and/NEWGENE III-specific/NEWGENE TBP-TAF/NEWGENE complexes/NEWGENE ,/, the/DT corresponding/JJ murine/JJ and/CC human/NEWGENE class/NEWGENE I-specific/NEWGENE transcription/NEWGENE initiation/NEWGENE factor/NEWGENE TIF-IB/NEWGENE //NEWGENE SL1/NEWGENE exhibits/VBP a/DT pronounced/VBN selectivity/NN for/IN its/PRP homologous/JJ promoter/NN ./.
@@19326952509 The/DT suppression/NN was/VBD also/RB demonstrated/VBN in/IN a/DT transient/JJ expression/NN assay/NN in/IN vivo/NN using/VBG isolated/VBN barley/NN endosperms/NNS ./.
@@10934751752 CREST/NNP syndrome/NN ;/: a/DT changing/JJ clinical/JJ significance/NN ./.
@@114540048244 Hormonal/JJ regulation/NN of/IN multiple/JJ promoters/NNS of/IN the/DT rat/NEWGENE mitochondrial/NEWGENE glycerol-3-phosphate/NEWGENE dehydrogenase/NEWGENE gene/NEWGENE :/: identification/NN of/IN a/DT complex/JJ hormone-response/NEWGENE element/NEWGENE in/IN the/DT ubiquitous/JJ promoter/NN B/NNP ./NNP
@@104906628458 Mutants/NNS with/IN mild/JJ lace/NEWGENE alleles/NEWGENE grow/VBP to/IN become/VB adults/NNS with/IN multiple/JJ aberrant/JJ morphologies/NNS in/IN the/DT appendages/NNS ,/, compound/NN eye/NN ,/, and/CC bristles/NNS ./.
@@31170467647 Isolation/NNS and/CC characterization/NN of/IN a/DT vinculin/NEWGENE cDNA/NEWGENE from/NEWGENE chick-embryo/NEWGENE fibroblasts/NEWGENE ./.
@@57873185723 Long-term/JJ effects/NNS of/IN clofibrate/NN (/( Atromid-S/NNP )/SYM on/IN serum/JJ lipids/NNS in/IN man/NN ./.
@@85049282421 Drosophila/NN 230-kD/NN TFIID/NEWGENE subunit/NN ,/, a/DT functional/JJ homolog/NN of/IN the/DT human/JJ cell/NN cycle/NN gene/NN product/NN ,/, negatively/RB regulates/VBZ DNA/NN binding/NN of/IN the/DT TATA/NEWGENE box-binding/NEWGENE subunit/NEWGENE of/NEWGENE TFIID/NEWGENE ./.
@@25910785629 Recent/JJ investigations/NNS have/VBP shown/VBP that/IN Grenz/NN rays/NNS can/MD suppress/VB the/DT allergic/JJ contact/NN dermatitis/NN reaction/NN completely/RB and/CC that/IN Langerhans/NN cells/NNS ,/, identified/VBN by/IN OKT6/NEWGENE antibodies/NEWGENE and/CC electron/NN microscopy/NN ,/, disappear/VB from/IN the/DT epidermis/NN at/IN the/DT same/JJ time/NN ./.
@@85667474767 SBF/NEWGENE binds/VBZ to/IN the/DT promoter/NN prior/NN to/IN the/DT activation/NN of/IN transcription/NN in/IN late/JJ G1/NN ,/, suggesting/VBG that/IN Cln/NEWGENE //NEWGENE Cdc28/NEWGENE kinase/NEWGENE regulates/VBZ the/DT ability/NN of/IN previously/RB bound/JJ SBF/NEWGENE to/IN activate/VB transcription/NN ./.
@@82440344730 Recombinant/NEWGENE Leishmania/NEWGENE surface/NEWGENE glycoprotein/NEWGENE GP63/NEWGENE is/VBZ secreted/VBN in/IN the/DT baculovirus/NN expression/NN system/NN as/IN a/DT latent/JJ metalloproteinase/NEWGENE ./.
@@78596657847 The/DT mean/JJ jitter/NN and/CC the/DT fiber/NN density/NN did/VBD not/RB change/VB significantly/RB from/IN day/NN 0/CD (/( 30/CD ./CD 1/CD +/NN //NN -/NN 3/CD ./CD 6/CD microseconds/NNS ;/: 1/CD ./CD 4/CD +/NN //NN -/NN 0/CD ./CD 07/CD )/SYM to/IN day/NN 30/CD (/( 34/CD ./CD 5/CD +/NN //NN -/NN 2/CD ./CD 7/CD microseconds/NNS ;/: 1/CD ./CD 6/CD +/NN //NN -/NN 0/CD ./CD 13/CD )/SYM ./.
@@47781292292 9/NN ,/NN 11-Seco/NN steroids/NNS derived/VBN from/IN estradiol/NN 3-methyl/JJ ether/NN ./.
@@1317391951 Several/JJ demographic/JJ indices/NNS of/IN isolated/VBN populations/NNS in/IN Uzbekistan/NN ./.
@@103234637163 Interferon-alpha/NEWGENE may/MD exacerbate/VB cryoblobulinemia-related/JJ ischemic/JJ manifestations/NNS :/: an/DT adverse/JJ effect/NN potentially/RB related/VBD to/IN its/PRP anti-angiogenic/JJ activity/NN ./.
@@75212856009 Our/PRP findings/NNS confirm/VBP the/DT high/JJ frequency/NN of/IN proximal/JJ nerve/NN lesions/NNS in/IN early/NN GBS/NN and/CC CIDP/NN ,/, not/RB all/DT of/IN which/WDT are/VBP associated/VBN with/IN distal/JJ motor/JJ conduction/NN abnormalities/NNS ,/, and/CC suggest/VB that/DT assessment/NN of/IN multiple/JJ F/NN wave/NN parameters/NNS ,/, in/IN particular/JJ chronodispersion/NN ,/, mean/JJ latency/NN and/CC mean/JJ amplitude/NN (/( in/IN addition/NN to/IN absence/NN and/CC minimum/JJ latency/NN )/SYM ,/, increases/VBZ the/DT yield/NN of/IN F/NN wave/NN studies/NNS ./.
@@64441196018 Each/DT causative/JJ organism/NN has/VBZ a/DT species-specific/JJ preference/NN and/CC requirement/NN for/IN temperature/NN ,/, salinity/NN ,/, pH/NN ,/, the/DT basic/JJ nutrients/NNS ,/, and/CC growth/NEWGENE factors/NEWGENE ,/, and/CC the/DT toxin/NN formation/NN is/VBZ affected/VBN by/IN these/DT environmental/JJ factors/NNS ./.
@@90157576695 Structural/NNP analysis/NN and/CC characterization/NN of/IN tissue/NN and/CC hormonal/JJ responsive/JJ expression/NN of/IN the/DT avian/NEWGENE bone/NEWGENE sialoprotein/NEWGENE (/( BSP/NEWGENE )/SYM gene/NN ./.
@@43024784914 I/NNP ./NNP
@@93967962985 This/DT emphasizes/VBZ the/DT conclusion/NN that/IN CDF-1/NEWGENE is/VBZ not/RB an/DT E2F/NEWGENE family/NEWGENE member/NEWGENE and/CC points/NNS to/IN profound/JJ differences/NNS in/IN the/DT cell/NN cycle/NN regulation/NN of/IN CDF-1/NEWGENE and/CC E2F/NEWGENE ./.
@@96059302450 Identical/JJ results/NNS were/VBD obtained/VBN when/CC transfections/NNS and/CC mobility/NN shift/NN assays/NNS were/VBD performed/VBN in/IN primary/JJ rat/NN hepatocytes/NNS in/IN which/WDT the/DT endogenous/JJ ALS/NEWGENE gene/NEWGENE is/VBZ expressed/VBN ./.
@@54604665549 Elimination/NN of/IN gamma-irradiation/NN induced/VBD oxidation/NN in/IN aqueous/JJ drug/NN preparations/NNS ./.
@@77688245178 The/DT timing/NN of/IN fla/NEWGENE gene/NEWGENE expression/NN in/IN the/DT cell/NN cycle/NN is/VBZ determined/VBN by/IN specialized/JJ forms/NNS of/IN RNA/NEWGENE polymerase/NEWGENE and/CC the/DT appearance/NN and/DT //DT or/DT activation/NN of/IN regulatory/JJ proteins/NNS ./.
@@28267295202 Growth/NN ,/, 4-PA/JJ and/CC 14C/CD turnover/NN data/NN indicated/VBN that/IN WB/NNP contributed/VBD to/IN B-6/NN intake/NN of/IN these/DT rats/NNS ./.
@@72470598258 Catheter/NNP transit/NN slows/VBZ the/DT response/NN to/IN a/DT step/NN increase/NN in/IN concentration/NN by/IN about/RB 0/CD ./CD 13/CD s/NN (/( from/IN 10/CD per/IN cent-90/NN per/IN cent/NN )/SYM and/CC prolongs/VBZ the/DT transit/NN time/NN through/RB the/DT catheter/NN for/IN a/DT volatile/JJ anesthetic/NN by/IN about/RB 0/CD ./CD 04/CD s/NN more/RB than/IN N2/NNP ./NNP
@@8082668063 Advances/NNS in/IN the/DT management/NN of/IN gynecologic/JJ cancer--radiation/JJ therapy/NN ./.
@@89122328869 To/TO test/VB the/DT role/NN of/IN ML/NN in/IN human/JJ reproductive/JJ axis/NN ,/, 128/CD healthy/JJ children/NNS ,/, 68/CD boys/NNS and/CC 60/CD girls/NNS ,/, were/VBD studied/VBN ./.
@@113501759645 It/PRP has/VBZ been/VBN suggested/VBN that/IN members/NNS of/IN this/DT protein/NN family/NN exhibit/NN both/DT prolyl/NEWGENE isomerase/NEWGENE and/CC chaperone/NN activity/NN ./.
@@107560075346 Recently/RB ,/, identical/JJ RBE/NEWGENE sequences/NEWGENE have/VBP been/VBN identified/VBN at/IN other/DT locations/NNS in/IN the/DT human/JJ genome/NN ./.
@@14716023985 The/DT appropriate/JJ use/NN and/CC benefits/NNS of/IN bile/NN acid/JJ sequestrants/NNS ,/, nicotinic/JJ acid/NN ,/, fibric/JJ acids/NNS ,/, 3-hydroxy-3-methylglutaryl/NEWGENE coenzyme/NEWGENE A/NEWGENE (/NEWGENE HMG-CoA/NEWGENE )/NEWGENE reductase/NEWGENE inhibitors/NN ,/, and/CC probucol/NN are/VBP individually/RB discussed/VBN ,/, whereas/IN nonpharmacologic/JJ approaches/NNS used/VBN in/IN conjunction/NN with/IN the/DT drugs/NNS are/VBP recommended/VBN emphatically/RB ./.
@@75242652710 Increased/VBN granulocyte-colony/NEWGENE stimulating/NEWGENE factor/NEWGENE (/( G-CSF/NEWGENE )/SYM levels/NNS in/IN neonates/NNS with/IN perinatal/JJ complications/NNS ./.
@@90493134374 In/NN some/DT instances/NNS ,/, this/DT is/VBZ partly/RB mediated/JJ by/IN the/DT expression/NN of/IN virally/RB encoded/VBN proteases/NEWGENE which/WDT lead/VBP to/IN the/DT cleavage/NN of/IN initiation/NEWGENE factor/NEWGENE eIF4G/NEWGENE ./.
@@13779625748 In/NN contrast/NN ,/, tobacco/NEWGENE GS-2/NEWGENE is/VBZ composed/VBN of/IN subunits/NNS of/IN identical/JJ size/NN in/IN all/DT organs/NNS examined/VBN ./.
@@81949706111 Women's/NNP opportunities/NNS for/IN paid/VBP work/NN outside/RB the/DT home/JJ are/VBP constrained/VBN by/IN their/PRP role/NN as/IN primary/JJ carer/NN within/IN the/DT family/NN ,/, writes/VBZ Trudy/NN Wynne/NNP ./.
@@72343087060 Multi/NN drug/NN regimens/NNS like/JJ C-MOPP/NN ,/, CHOP/NN and/CC BACOP/NN led/VBN to/IN high/JJ remission/NN rates/NNS and/CC in/IN some/DT cases/NNS probably/RB also/RB to/IN a/DT cure/NN of/IN the/DT disease/NN ./.
@@31107463770 The/DT mean/JJ percentage/NN of/IN linoleic/JJ acid/NN in/IN the/DT triglycerides/NNS of/IN the/DT subcutaneous/JJ adipose/JJ tissue/NN (/( PLASAT/NN )/SYM of/IN these/DT subjects/NNS was/VBD substantially/RB higher/JJ than/IN that/DT in/NN a/DT similar/JJ group/NN examined/VBN in/IN 1975-1976/CD ./.
@@89290895478 However/RB ,/, the/DT ratio/NN M/NN //NN Pc/NN provides/VBZ a/DT useful/JJ index/NN that/WDT seems/VBZ to/IN be/VB independent/NN of/IN the/DT metabolic/JJ demand/NN ./.
@@087986485087 Cys-757/NNP within/IN the/DT (/NEWGENE Fe4S4/NEWGENE )/NEWGENE -siroheme-binding/NEWGENE domain/NEWGENE was/VBD essential/JJ for/IN native/JJ enzyme/NN activity/NN ./.
@@93439829299 The/DT amplitude/NN of/IN detrusor/NN contractions/NNS at/IN 6/CD ,/, 12/CD ,/, and/CC 24/CD hours/NNS showed/VBD no/DT significant/JJ difference/NN from/IN that/DT in/NN the/DT controls/NNS ./.
@@16743695483 A/DT third/RB is/VBZ a/DT partial/JJ element/NN terminating/JJ at/IN a/DT probable/JJ internal/JJ restriction/NN site/NN used/VBN for/IN cloning/NN ./.
@@106606762034 Zebrafish/NNP cyclops/NEWGENE (/( cyc/NEWGENE )/SYM encodes/VBZ a/DT Transforming/NEWGENE Growth/NEWGENE Factor/NEWGENE beta/NEWGENE (/( TGFbeta/NEWGENE )/SYM signaling/NN factor/NN closely/RB related/VBD to/IN mouse/NN Nodal/NEWGENE ./.
@@84556297628 Breitbart/NNP ,/, L/NNP ./NNP
@@1082833633 A/DT newly/RB synthesized/VBN anti-inflammatory/JJ agent/NN ,/, Y-8004/NN demonstrated/VBN a/DT greater/JJR inhibition/NN than/IN did/VBD indomethacin/NN (/( IM/RB )/SYM ./. on/IN inflammatory/JJ response/NN such/JJ as/IN ultraviolet/JJ erythema/NN in/IN guinea/NN pigs/NNS ,/, carrageenin/NN edema/NN ,/, evans/NNS blue/JJ and/CC carrageenin-induced/JJ pleuritis/NN and/CC acetic/JJ acid-induced/JJ peritonitis/NN in/IN rats/NNS ./.
@@58102595749 Polyvinyl/NN alcohol/NN as/IN a/DT solution/NN mediator/NN ./.
@@112876112966 Herein/DT PPARgamma/NEWGENE ,/, liganded/JJ by/IN either/DT natural/JJ (/( 15d-PGJ/NN (/NN 2/NN )/SYM and/CC PGD/NN (/NN 2/NN )/NN )/NN or/CC synthetic/JJ ligands/NNS (/( BRL49653/CD and/CC troglitazone/NN )/SYM ,/, selectively/RB inhibited/VBN expression/NN of/IN the/DT cyclin/NEWGENE D1/NEWGENE gene/NEWGENE ./.
@@93250229691 Ovaries/NNS of/IN 10/CD animals/NNS per/IN group/NN from/IN 16/CD studies/NNS in/IN CD-1/NN mice/NNS and/CC 1/CD study/NN each/DT in/NN C3H/NN and/CC C57BL/IN //IN 6/IN mice/NNS were/VBD sectioned/VBN serially/RB at/IN 6/CD &mgr/NN ;/: m/NN ./.
@@110456073212 5'-RACE/JJ analysis/NN suggested/VBD a/DT single/NN transcription/NN initiation/NN site/NN 187/NN bp/NN upstream/RB from/IN the/DT translational/JJ start/NN site/NN ./.
@@106484896549 Treatment/NNP also/RB led/VBD to/IN a/DT significant/JJ dose/NN dependent/JJ reduction/NN in/IN the/DT sum/NN of/IN ST/NN segment/NN depression/NN at/IN both/DT trough/NN and/CC peak/NN concentrations/NNS ./.
@@86681582128 Our/PRP data/NN demonstrate/VB directly/RB that/IN Rpm1r/NEWGENE is/VBZ transcribed/VBN with/IN its/PRP substrates/NNS ,/, tRNA/NEWGENE met/NEWGENE f/NEWGENE and/CC tRNAPro/NEWGENE ,/, from/IN a/DT promoter/NN located/VBN upstream/RB of/IN the/DT tRNA/NEWGENE met/NEWGENE f/NEWGENE gene/NEWGENE and/CC suggest/VB that/IN a/DT portion/NN also/RB originates/VBZ from/IN a/DT second/JJ promoter/NN ,/, located/VBN between/IN the/DT tRNA/NEWGENE met/NEWGENE f/NEWGENE gene/NEWGENE and/CC RPM1/NEWGENE ./.
@@21234671434 Furthermore/RB ,/, expression/NN of/IN the/DT promoter/NN in/IN embryonic/JJ Drosophila/NN melanogaster/NN cells/NNS that/WDT lack/VBP MyoD1/NEWGENE and/CC Sp1/NEWGENE is/VBZ strictly/RB dependent/JJ on/IN all/DT three/CD sites/NNS remaining/JJ intact/JJ and/CC on/IN the/DT presence/NN of/IN exogenously/RB supplied/VBN Sp1/NEWGENE and/CC MyoD1/NEWGENE ./.
@@86267853546 Retinoid-dependent/NNP activation/NN of/IN the/DT tissue/NEWGENE transglutaminase/NEWGENE promoter/NEWGENE depends/VBZ on/IN both/PDT a/DT proximal/JJ regulatory/NN region/NN containing/NN sequences/NN highly/RB conserved/VBN between/IN the/DT human/JJ and/CC the/DT mouse/NEWGENE tissue/NEWGENE transglutaminase/NEWGENE promoters/NEWGENE and/CC a/DT distal/JJ region/NN that/WDT includes/VBZ a/DT 30-base/NEWGENE pair/NEWGENE retinoid/NEWGENE response/NEWGENE element/NEWGENE (/NEWGENE mTGRRE1/NEWGENE )/NEWGENE ./. mTGRRE1/NEWGENE contains/VBZ three/CD hexanucleotide/NN half-sites/NNS (/( two/JJ canonical/JJ and/CC one/PRP non-canonical/JJ )/SYM in/IN a/DT DR7/NEWGENE //NEWGENE DR5/NEWGENE motif/NEWGENE that/WDT bind/VBP both/DT RAR*RXR/NEWGENE heterodimers/NEWGENE and/CC RXR/NEWGENE homodimers/NEWGENE ./.
@@92962519257 However/RB ,/, the/DT published/VBN reports/NNS consist/VBP of/IN a/DT small/JJ number/NN of/IN patients/NNS and/CC limited/VBN data/NN ./.
@@19001943568 Relationship/NNP between/IN mitochondrial/NEWGENE NADH-ubiquinone/NEWGENE reductase/NEWGENE and/CC a/DT bacterial/NEWGENE NAD-reducing/NEWGENE hydrogenase/NEWGENE ./.
@@92807476351 The/DT combination/NN of/IN hydralazine/NN hydrochloride/NN and/CC isosorbide/NN dinitrate/NN also/RB improves/VBZ survival/NN ,/, but/CC direct/JJ comparison/NN of/IN both/DT regimens/NNS provided/VBD evidence/NN for/IN a/DT less/PRP favourable/NN effect/NN than/IN that/DT of/IN the/DT ACE/NEWGENE inhibitors/NN ./.
@@98226618161 Quinone-binding/VBG domain/NN and/CC amino/JJ acid/NN residues/NNS involved/VBN in/IN quinone/NN binding/JJ ./.
@@6287212135 In/NN fact/NN ,/, families/NNS of/IN polypeptides/NNS were/VBD produced/VBN by/IN initiation/NN of/IN translation/NN at/IN AUG/NNS codons/NNS within/IN sequences/NNS coding/JJ for/IN VP1/NEWGENE and/CC T/NEWGENE ,/, presumably/RB as/IN a/DT result/NN of/IN transcription/NN initiation/NN events/NNS that/WDT generated/VBD 5'/NN ends/NNS immediately/RB upstream/RB from/IN these/DT AUGs/NNS ./.
@@95044239872 Although/IN the/DT expression/NN of/IN the/DT 4E-BP1/NEWGENE gene/NEWGENE alone/RB has/VBZ not/RB yet/RB been/VBN accomplished/VBN ,/, the/DT gene/NN was/VBD expressed/VBN in/IN Escherichia/NN coli/JJ [/NN BL21/NN (/NN DE3/NN )/NN ]/NN as/IN a/DT fusion/NN gene/NN with/IN the/DT glutathione-S-transferase/NEWGENE (/( GST/NEWGENE )/SYM gene/NN using/VBG a/DT prokaryotic/JJ gene/NN fusion/NN vector/NN (/( pGEX-4T-2/NN )/SYM ,/, which/WDT contains/VBZ a/DT gene/NN sequence/NN coding/JJ the/DT cleavage/NN site/NN for/IN a/DT specific/JJ protease/NEWGENE ,/, alpha-thrombin/NEWGENE ./.
@@110182643772 Reporter/NNP gene/NN expression/NN analyses/NNS indicate/VBP that/IN both/DT WASP/NEWGENE promoters/NEWGENE show/VBP high/JJ levels/NNS of/IN expression/NN in/IN different/JJ hematopoietic/JJ cell/NN lines/NNS ./.
@@73376097191 The/DT geometric/JJ mean/JJ hemagglutination-inhibition/JJ antibody/NN titers/NNS (/( GMT/NN )/SYM of/IN non-immunized/JJ ,/, once-immunized/JJ ,/, and/CC twice-immunized/JJ chickens/NNS were/VBD compared/VBN at/IN 2-week/JJ intervals/NNS following/IN primary/JJ immunization/NN ,/, secondary/JJ immunization/NN ,/, and/CC challenge/NN ./.
@@76798367177 These/DT results/NNS suggest/VBP that/DT FK/NN 506/NN is/VBZ a/DT useful/JJ immunosuppressive/JJ agent/NN in/IN kidney/NN transplantation/NN ./.
@@9722766474 The/DT micturition/NN pressure/NN was/VBD significantly/RB decreased/VBN only/RB after/IN injection/NN with/IN BUP-4/NN in/IN both/DT normal/JJ and/CC obstructed/JJ rats/NNS ./.
@@87695661248 We/PRP have/VBP previously/RB isolated/VBN a/DT cDNA/NN for/IN a/DT transcription/NN factor/NN referred/VBN to/RB as/IN Zfhep/NEWGENE (/( zinc/NEWGENE finger/NEWGENE homeodomain/NEWGENE enhancer-binding/NEWGENE protein/NEWGENE )/SYM containing/JJ two/JJ separate/JJ zinc/NN finger/NN domains/NNS ,/, ZD1/NEWGENE and/CC ZD2/NEWGENE ,/, each/DT of/IN which/WDT binds/VBZ DNA/NN ,/, and/CC a/DT homeodomain/NN ./.
@@97653886720 Inactivation/NNS of/IN p53/NEWGENE but/CC not/RB p73/NEWGENE by/IN adenovirus/NEWGENE type/NEWGENE 5/NEWGENE E1B/NEWGENE 55-kilodalton/NEWGENE and/NEWGENE E4/NEWGENE 34-kilodalton/NEWGENE oncoproteins/NEWGENE ./.
@@108954173614 Following/VBG EPI-C0401/NN ,/, but/CC not/RB saline/JJ or/CC DepoFoam/NNP vehicle/NN ,/, there/RB were/VBD transient/JJ (/( </SYM 72/CD hr/NN )/SYM decreases/NNS in/IN food/NN consumption/NN ,/, arousal/NN ,/, hindlimb/NN muscle/NN tone/NN ,/, and/CC body/NN temperature/NN ./.
@@92346906089 Upstream/NEWGENE activating/NEWGENE sequences/NEWGENE (/( UASs/NEWGENE )/SYM derived/VBN from/IN known/VBP Ste12p-dependent/NN genes/NN have/VBP previously/RB been/VBN characterized/VBN to/IN require/VB either/DT multiple/JJ PREs/NEWGENE or/CC a/DT single/NN PRE/NEWGENE coupled/VBN to/IN a/DT binding/JJ site/NN for/IN a/DT second/JJ protein/NN ./.
@@80079542742 Deletion/NNS studies/NNS identified/VBD a/DT distal/JJ response/NN element/NN that/WDT is/VBZ responsible/JJ for/IN the/DT cytokine/NN response/NN and/CC has/VBZ properties/NNS of/IN an/DT inducible/NN transcriptional/NN enhancer/NN ./.
@@64060607980 195mPt-labeled/NN cisplatin/NN was/VBD administered/VBN iv/NN and/CC ip/NN to/IN control/NN mice/NNS and/CC to/IN mice/NNS bearing/JJ Sarcoma/NN 180/NN ./.
@@71825237004 Both/DT groups/NNS rejected/VBD pops/NNS with/IN added/VBN SOA/NNS ,/, decreasing/JJ mouthing/NN times/NNS as/IN SOA/NNS concentration/NN increased/VBN ./.
@@33483821921 One/CD millimolar/JJ ouabain/NN completely/RB inhibited/VBD net/NN HCO3-/NN secretion/NN ./.
@@89234699775 These/DT results/NNS are/VBP consistent/JJ with/IN the/DT well/NN established/VBD polarity/NN of/IN RXR/NEWGENE heterodimer/NN binding/JJ to/IN bipartite/NEWGENE hormone/NEWGENE response/NEWGENE elements/NEWGENE ,/, with/IN the/DT VDR/NEWGENE recognizing/VBG the/DT 3'-half-element/NN ./.
@@70750246845 The/DT uncomplicated/JJ cases/NNS of/IN typhoid/JJ fever/NN were/VBD found/VBN to/IN have/NN an/DT intact/JJ CMIR/NN as/IN compared/VBN to/IN the/DT complicated/VBN cases/NNS ./.
@@98068309294 Copyright/NNP 1998/CD Academic/NNP Press/NNP ./.
@@87392098725 Zatebradine/NNP weakly/RB depressed/VBD the/DT ectopic/JJ ventricular/JJ rate/NN but/CC not/RB the/DT arrhythmic/JJ ratio/NN of/IN the/DT ventricular/JJ arrhythmias/NNS induced/VBN by/IN two-stage/JJ coronary/JJ ligation/NN 24/CD h/NN after/IN the/DT ligation/NN in/IN conscious/JJ dogs/NNS ./.
@@8436708399 The/DT sense/NN of/IN self/NN ./.
@@58969965805 On/IN catabolism/NN of/IN aminoketones/NNS in/IN climacteric/JJ age/NN ./.
@@94053802669 The/DT existence/NN of/IN these/DT two/JJ categories/NNS of/IN strains/NNS offers/VBP a/DT new/JJ genetic/JJ system/NN in/IN which/WDT the/DT properties/NNS of/IN a/DT potential/JJ invertebrate/JJ retrovirus/NN can/MD be/VB tested/VBN ./.
@@89956812817 (/( ii/NN )/SYM ICP27/NEWGENE binds/VBZ preferentially/RB to/IN less/PRP modified/JJ forms/NNS of/IN ICP4/NEWGENE ,/, a/DT protein/NN that/WDT is/VBZ extensively/RB modified/JJ posttranslationally/RB ./.
@@14517712065 To/TO prepare/VB for/IN analyses/NNS with/IN the/DT family/NN variables/NNS ,/, we/PRP next/JJ present/VBP descriptive/JJ data/NN based/VBN on/IN separate/JJ principal/JJ components/NNS analysis/NN (/( PCA/NN )/SYM and/CC multidimensional/JJ scaling/JJ analysis/NN (/( MDS/NN )/SYM of/IN 14/CD self-reported/DT health/NN scores/NNS for/IN husbands/NNS and/CC for/IN wives/NNS ./.
@@110928505238 Based/VBN on/IN 16S/NEWGENE rRNA/NEWGENE gene/NEWGENE sequence/NEWGENE analysis/NN ,/, the/DT 11/CD species/NN having/VBG two/JJ tuf/NEWGENE genes/NEWGENE all/DT have/NN a/DT common/JJ ancestor/NN ,/, while/CC the/DT six/CD species/NN having/VBG only/RB one/PRP copy/NN diverged/VBN from/IN the/DT enterococcal/JJ lineage/NN before/IN that/DT common/JJ ancestor/NN ./.
@@105675387745 In/NN addition/NN ,/, the/DT acetyltransferase/NEWGENE activity/NN of/IN p300/NEWGENE was/VBD observed/VBN to/IN be/VB distinct/JJ from/IN the/DT broadly/RB essential/JJ activation/NN function/NN of/IN the/DT CH3/NEWGENE domain/NEWGENE //NEWGENE E1A-binding/NEWGENE region/NEWGENE ./.
@@78358889171 The/DT locus/NN encoding/VBG the/DT XD/NEWGENE gene/NEWGENE (/( designated/VBN Xd/NEWGENE )/SYM was/VBD mapped/VBN to/IN the/DT distal/JJ part/NN of/IN mouse/NN chromosome/NN 17/CD by/IN haplotype/NN analysis/NN of/IN 114/CD interspecific/JJ backcross/NN mice/NNS ./.
@@91851833794 Merosin/NEWGENE positive/JJ congenital/JJ muscular/JJ dystrophy/NN with/IN mental/JJ deficiency/NN ,/, epilepsy/NN and/CC MRI/NN changes/NNS in/IN the/DT cerebral/JJ white/JJ matter/NN ./.
@@71845987008 Lacrimal/JJ secretion/NN in/IN hyperthyroidism/NN ./.
@@115520581428 Once/RB ICP/NN reaches/VBP critical/JJ values/NNS (/( >/SYM 30/CD mm/NN Hg/NN )/SYM herniation/NN occurs/VBZ ,/, usually/RB within/IN 2/CD to/IN 5/CD days/NNS ./.
@@93968235287 The/DT proofreading/JJ domain/NN of/IN Escherichia/NEWGENE coli/NEWGENE DNA/NEWGENE polymerase/NEWGENE I/NEWGENE and/CC other/DT DNA/NEWGENE and/NEWGENE //NEWGENE or/NEWGENE RNA/NEWGENE exonuclease/NEWGENE domains/NEWGENE ./.
@@45332085014 Changes/NNS following/IN periodontal/JJ surgery/NN ./.
@@116694767199 Pro-inflammatory/JJ cytokine/NN ,/, tumor/NEWGENE necrosis/NEWGENE factor-alpha/NEWGENE (/( TNF-alpha/NEWGENE )/SYM ,/, produced/VBN from/IN adipose/JJ tissues/NNS in/IN obese/JJ subjects/NNS ,/, is/NNS known/VBP to/IN play/NN a/DT predominant/JJ role/NN in/IN inducing/NN insulin/NEWGENE resistance/NN ./.
@@39644892098 Below/IN 50%/CD decrease/NN of/IN PaO2/NN ,/, NADH/NN was/VBD reduced/VBN largely/RB ./.
@@20785701890 In/NN all/DT cases/NNS ,/, high-level/JJ expression/NN of/IN the/DT truncated/NEWGENE avian/NEWGENE integrins/NEWGENE was/VBD obtained/VBN ./.
@@12491988218 Her/PRP serum/JJ FT3/NN concentration/NN was/VBD ,/, however/RB ,/, much/JJ higher/JJ than/IN the/DT ranges/NNS in/IN normal/JJ pregnancy/NN or/CC in/IN GTD/DT patients/NNS without/IN clinical/JJ hyperthyroidism/NN ./.
@@88498348823 A/DT system/NN is/VBZ described/VBN in/IN which/WDT the/DT volume/NN flow/NN rate/NN of/IN blood/NN in/IN a/DT vessel/NN is/VBZ determined/VBN using/VBG transverse/JJ colour/NN Doppler/NN ultrasound/JJ imaging/NN ./.
@@59996075868 Studies/NNS of/IN lipogenesis/NN by/IN labelled/JJ precursors/NNS in/IN the/DT pregnant/JJ rat/NN ./.
@@17480672332 A/DT prospective/JJ trial/NN was/VBD carried/VBN out/RB in/IN 156/CD unselected/JJ patients/NNS (/( 41/CD men/NNS ,/, mean/JJ age/NN 67/CD ./CD 5/CD years/NNS ,/, 115/CD women/NNS ,/, mean/JJ age/NN 71/CD ./CD 4/CD years/NNS )/SYM who/WP had/VBP undergone/VBP total/JJ hip/NN joint/JJ replacement/NN because/IN of/IN degenerative/JJ or/CC inflammatory/JJ arthritis/NN or/CC fracture/NN of/IN the/DT neck/NN of/IN the/DT femur/NN ./.
@@78317997266 Nucleotide/NN sequence/NN and/CC transcriptional/JJ analysis/NN of/IN the/DT DNA/NEWGENE polymerase/NEWGENE gene/NEWGENE of/NEWGENE Bombyx/NEWGENE mori/NEWGENE nuclear/NEWGENE polyhedrosis/NEWGENE virus/NEWGENE ./.
@@30523279542 In/NN view/NN of/IN these/DT results/NNS ,/, simultaneous/JJ pancreas-kidney/JJ transplantation/NN appears/VBZ to/IN be/VB the/DT treatment/NN of/IN choice/JJ for/IN Type/NN I/NN diabetic/JJ patients/NNS ./.
@@8021225771 Sequence/NN analysis/NN of/IN a/DT 6/CD ./CD 3-kbp/CD genomic/JJ EcoRI-fragment/NNS of/IN Alcaligenes/NN eutrophus/NN ,/, which/WDT was/VBD recently/RB identified/VBN by/IN using/VBG a/DT dihydrolipoamide/NN dehydrogenase-specific/NN DNA/NN probe/NN (/( A/NNP ./NNP
@@85938132013 Polysome/NN analysis/NN further/RB indicated/VBD that/IN these/DT germ/NEWGENE cell-specific/NEWGENE Sp1/NEWGENE mRNAs/NEWGENE are/VBP translated/VBN ,/, albeit/IN with/IN a/DT lower/JJR efficiency/NN than/IN the/DT somatic/JJ transcript/NN ./.
@@85554463765 Transgenic/NNP tobacco/NN plants/NNS (/( ppa-1/NN )/SYM constitutively/RB expressing/JJ Escherichia/NEWGENE coli/NEWGENE pyrophosphatase/NEWGENE behind/RB the/DT 35S/NEWGENE CaMV/NEWGENE promoter/NEWGENE accumulate/VB high/JJ levels/NNS of/IN soluble/JJ sugars/NNS in/IN their/PRP leaves/NNS [/NN 27/NN ]/NN ./.
@@75657123126 Deletions/NNS were/VBD examined/VBN in/IN the/DT LYS2/NEWGENE gene/NEWGENE ,/, using/VBG a/DT set/NN of/IN 31-/CD to/IN 156-bp/CD inserts/NNS that/WDT included/VBD inserts/NNS with/IN no/DT apparent/JJ potential/NN for/IN secondary/JJ structure/NN as/RB well/VB as/IN two/JJ quasipalindromes/NNS ./.
@@27998926355 Since/IN 1948/CD ,/, the/DT use/NN of/IN saline-washed/JJ red/JJ cells/NNS (/( WRBCs/NN )/SYM has/VBZ been/VBN advocated/VBN to/IN minimize/VB hemolysis/NN after/IN transfusion/NN to/IN patients/NNS with/IN PNH/NN ./.
@@6365266160 Diagnosis/NNP and/CC differential/JJ diagnosis/NN ./.
@@14491834492 In/NN addition/NN ,/, the/DT utility/NN of/IN beta/NEWGENE 2/NEWGENE transferrin/NEWGENE assay/NN in/IN the/DT diagnosis/NN of/IN cerebrospinal/JJ fluid/NN otorrhea/NN is/VBZ presented/VBN ./.
@@102091199126 We/PRP show/VBP here/RB that/IN ,/, despite/IN their/PRP structural/JJ and/CC functional/JJ similarities/NNS ,/, the/DT pop1/NEWGENE and/CC pop2/NEWGENE genes/NEWGENE fail/NN to/IN complement/NN each/DT other's/NNS deletion/NN phenotypes/NNS ,/, indicating/VBG that/IN they/PRP perform/VBP non-redundant/JJ ,/, but/CC potentially/RB interdependent/JJ ,/, functions/VBZ in/IN proteolysis/NN ./.
@@82077957367 To/TO identify/VB the/DT precise/JJ location/NN of/IN the/DT phosphorylation/NN site/NN on/IN the/DT 64-kDa/NN protein/NN ,/, a/DT step-by-step/JJ mutagenesis/NN procedures/NNS was/VBD followed/VBN ./.
@@78534482108 A/DT major/JJ task/NN for/IN sports/NNS scientists/NNS may/MD be/VB to/IN verify/VB empirically/RB the/DT nature/NN of/IN an/DT integrated/JJ model/NN of/IN the/DT sport/NN performer/NN ./.
@@96680633931 To/TO better/JJR understand/VB the/DT role/NN of/IN Ets/NEWGENE proteins/NEWGENE in/IN Ras/NEWGENE transformation/NN ,/, we/PRP have/VBP now/RB analyzed/VBN the/DT effects/NNS of/IN stably/RB expressing/JJ a/DT variety/NN of/IN Ets2/NEWGENE constructs/NEWGENE in/IN Ras-transformed/JJ NIH3T3/CELL (/( DT/NN )/SYM cells/NNS ./.
@@118360468284 They/PRP were/VBD randomly/RB allocated/VBN to/IN receive/VB either/DT 625/CD mg/NN of/IN calcium/NN carbonate/NN (/( 250/CD mg/NN of/IN elemental/JJ calcium/NN )/SYM at/IN the/DT end/NN of/IN a/DT meal/NN three/CD times/VBZ a/DT day/NN (/( group/NN A/DT ,/, n/CD =/CD 26/CD )/SYM or/CC calcium/NN carbonate/NN in/IN the/DT same/JJ manner/NN plus/IN 0/CD ./CD 625/CD mg/NN //NN day/NN of/IN conjugated/NN equine/NN estrogen/NN and/CC 5/CD mg/NN medrogestone/NN acetate/NN from/IN day/NN 1-12/CD each/DT month/NN (/( group/NN B/NNP ,/, n/CD =/CD 30/CD )/SYM ./.
@@96206065628 In/NN addition/NN to/IN the/DT signals/NNS obtained/VBN by/IN ligation/NN of/IN the/DT TCR/NEWGENE ,/, T/NN cells/NNS need/NN additional/JJ ,/, co-stimulatory/JJ signals/NNS to/IN be/VB activated/VBN ./.
@@116004671494 However/RB ,/, most/RB produced/VBN significant/JJ alteration/NN of/IN small/JJ intestinal/JJ permeability/NN ./.
@@75595241007 Cyclin/NEWGENE D1/NEWGENE promoter/NEWGENE activity/NN was/VBD stimulated/VBN by/IN overexpression/NN of/IN mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( p41MAPK/NEWGENE )/SYM or/CC c-Ets-2/NEWGENE through/RB the/DT proximal/JJ 22/CD base/NN pairs/NNS ./.
@@85927138568 Synthetic/JJ enantiomers/NNS of/IN drugs/NNS ./.
@@81200293297 Furthermore/RB ,/, in/IN vitro/FW decay/NN reaction/NN mixtures/NNS supplemented/VBN with/IN the/DT 20-nt/JJ sense/NN RNA/NN transcript/NN resulted/VBN in/IN stabilization/NN of/IN R2/NEWGENE message/NEWGENE ./.
@@30052318110 The/DT 5'/CD and/CC 3'/CD untranslated/JJ sequences/NNS contain/VBP characteristic/JJ sequences/NNS that/WDT are/VBP involved/VBN in/IN the/DT initiation/NN and/CC termination/NN of/IN transcription/NN ,/, including/JJ two/JJ possible/JJ promoters/NNS ,/, one/PRP of/IN which/WDT may/MD contain/VB two/JJ overlapping/JJ -10/CD sequences/NNS ./.
@@106696336795 In/NN this/DT study/NN ,/, we/PRP investigated/VBD the/DT molecular/JJ mechanisms/NNS underlying/JJ the/DT inducible/JJ expression/NN of/IN the/DT flt-1/NEWGENE gene/NEWGENE during/IN the/DT activation/NN of/IN THP-1/NNP cells/NNS ./.
@@75803302227 Estimated/VBN daily/JJ intakes/NNS (/( EDIs/NNS )/SYM per/IN person/NN were/VBD 0/CD ./CD 56/CD microgram/NN for/IN total/JJ HCH/NN ,/, 0/CD ./CD 20/CD microgram/NN for/IN gamma-HCH/NN ,/, 0/CD ./CD 09/CD microgram/NN for/IN dieldrin/NN ,/, 1/CD ./CD 42/CD micrograms/NNS for/IN total/JJ DDT/NN ,/, and/CC 0/CD ./CD 15/CD microgram/NN for/IN HCB/NN ./.
@@26077663273 A/DT protocol/NN is/VBZ elaborated/VBN for/IN the/DT preparation/NN and/CC characterization/NN of/IN a/DT quality/NN control/NN material/NN (/( QCM/NNP )/SYM containing/JJ intrinsic/JJ concentration/NN of/IN cadmium/NN (/( Cd/NN )/SYM (/( 0/CD ./CD 8/CD microgram/NN //NN L/NN )/SYM and/CC lead/VB (/( Pb/NN )/SYM (/( 13/CD ./CD 4/CD micrograms/NN //NN dL/NN )/SYM from/IN bovine/JJ blood/NN and/CC an/DT elevated/VBN QCM/NN containing/NN Cd/NN (/( 5/CD ./CD 0/CD micrograms/NN //NN L/NN )/SYM ,/, mercury/NN (/( Hg/NN )/SYM (/( 11/CD ./CD 2/CD micrograms/NN //NN L/NN )/SYM ,/, and/CC Pb/NN (/( 34/CD ./CD 5/CD micrograms/NN //NN dL/NN )/SYM from/IN bovine/JJ blood/NN spiked/VBN with/IN aqueous/JJ spiking-solutions/NNS prepared/VBN with/IN salts/NNS of/IN Cd/NN ,/, Hg/NN ,/, and/CC Pb/NNP ./NNP
@@103919031198 Gab2/NEWGENE ,/, a/DT new/JJ pleckstrin/NEWGENE homology/NN domain-containing/JJ adapter/NN protein/NN ,/, acts/VBZ to/IN uncouple/VB signaling/JJ from/IN ERK/NEWGENE kinase/NEWGENE to/IN Elk-1/NEWGENE ./.
@@2536096372 In/NN HeLa/IN cells/NNS ,/, it/PRP activated/VBN transcription/NN from/IN the/DT herpes/NEWGENE simplex/NEWGENE virus/NEWGENE type/NEWGENE 1/NEWGENE thymidine/NEWGENE kinase/NEWGENE promoter/NEWGENE linked/JJ to/IN the/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE gene/NEWGENE when/CC located/VBN in/IN inverted/JJ orientation/NN upstream/RB of/IN the/DT thymidine/NEWGENE kinase/NEWGENE promoter/NEWGENE or/CC downstream/RB of/IN the/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE gene/NEWGENE coding/NEWGENE sequence/NEWGENE ./.
@@22001502818 Guiding/VBG patients/NNS in/IN the/DT decision/NN should/MD involve/VB a/DT multidisciplinary/JJ team/NN composed/VBN of/IN a/DT surgical/JJ oncologist/NN ,/, geneticist/NN ,/, pathologist/NN ,/, psychotherapist/NN and/CC plastic/JJ surgeon/NN ./.
@@19398992568 Neither/CC model/NN ,/, as/IN applied/VBN ,/, provided/VBD a/DT satisfactory/JJ account/NN of/IN the/DT effects/NNS of/IN the/DT main/JJ variables/NNS of/IN number/NN of/IN tones/NNS and/CC amount/NN of/IN perturbation/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@51195465376 Treatment/NNP of/IN ovarian/JJ neoplasms/NNS ./.
@@246007940 The/DT variable/NN HMG/NEWGENE dosage/NN regimen/NN was/VBD found/VBN to/IN offer/NN no/DT advantages/NNS when/CC compared/VBN with/IN our/PRP standard/JJ daily/JJ dosage/NN regimen/NN ./.
@@113544061204 The/DT improved/VBN CSF/NN outflow/NN conductance/NN may/MD increase/VB the/DT intracranial/JJ compliance/NN and/CC thereby/RB dampen/VB a/DT pathological/JJ ICP/NN waveform/NN ./.
@@14081372272 The/DT sequence/NN of/IN this/DT region/NN shows/VBZ high/JJ G+C/NN content/NN (/( 62%/JJ )/SYM ,/, which/WDT is/VBZ particularly/RB emphasized/VBN in/IN the/DT 200/CD bp/NN upstream/RB from/IN the/DT mRNA/NN start/NN (/( 80%/CD G+C/NN )/SYM ./.
@@93831883623 This/DT difference/NN may/MD result/NN from/IN the/DT lower/JJR match/NN to/IN the/DT ARG/NEWGENE box/NEWGENE consensus/NEWGENE of/IN the/DT O/NEWGENE (/NEWGENE rocD/NEWGENE )/NEWGENE site/NEWGENE ./.
@@21151114727 Expression/NNS ,/, nucleotide/NN sequence/NN and/CC mutational/JJ analysis/NN of/IN two/JJ open/JJ reading/JJ frames/NNS in/IN the/DT nif/NEWGENE gene/NEWGENE region/NEWGENE of/NEWGENE Anabaena/NEWGENE sp/NEWGENE ./NEWGENE strain/NEWGENE PCC7120/NEWGENE ./.
@@82267988773 We/PRP postulate/VBP that/DT CaM/NEWGENE binding/JJ by/IN HIV/NEWGENE envelope/NEWGENE proteins/NEWGENE is/VBZ likely/RB to/IN exert/VB diverse/JJ modulatory/JJ effects/NNS ,/, and/CC the/DT mechanism/NN for/IN HIV-induced/JJ cytotoxicity/NN may/MD involve/VB ,/, in/IN part/NN ,/, inhibition/NN of/IN CaM-regulated/JJ cellular/JJ functions/NNS ./.
@@86611142424 Both/DT of/IN these/DT domains/NNS have/NN striking/JJ sequence/NN homology/NN with/IN human/JJ SIM/NEWGENE and/CC Drosophila/NN SIM/NEWGENE proteins/NN ./.
@@21852509827 Truncations/NNS composed/VBN of/IN 78/CD and/CC 64/CD amino/JJ acids/NNS were/VBD translocated/VBN across/IN the/DT endoplasmic/JJ reticulum/NN membrane/NN ,/, and/CC translocation/NN was/VBD found/VBN to/IN be/VB strictly/RB co-translational/JJ and/CC SRP-dependent/NNP ./.
@@18926803246 Toxicity/NNS was/VBD very/RB mild/JJ with/IN both/DT regimens/NNS ,/, although/IN sedation/NN was/VBD significantly/RB higher/JJ in/IN arm/NN B/NN (/( p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@51019975373 6/CD ./CD
@@3212614132 The/DT uterine/JJ response/NN to/IN prostaglandin/NN E2/NN (/( PGE2/NN )/SYM and/CC prostaglandin/NN F2alpha/IN (/( administered/VBN by/IN intravenous/JJ and/CC intrauterine/JJ routes/NNS )/SYM was/VBD evaluated/VBN during/IN different/JJ phases/NNS of/IN the/DT menstrual/JJ cycle/NN in/IN five/CD functionally/RB infertile/JJ women/NNS ./.
@@74942742229 Shift-down/NNP experiments/NNS indicated/VBN that/IN the/PDT 10/NN (/NN 4/NN )/NN -/NN to/IN 10/NN (/NN 5/NN )/NN -fold/NN reduction/NN in/IN virus/NN yield/NN at/IN the/DT nonpermissive/JJ temperature/NN was/VBD due/NN to/IN the/DT disfunction/NN of/IN alpha/NEWGENE TIF/NEWGENE late/RB in/IN infection/NN ,/, presumably/RB in/IN virion/NN maturation/NN ./.
@@86629363841 Specifically/RB ,/, the/DT deduced/VBN FR-19/NEWGENE amino/NEWGENE acid/NEWGENE sequence/NEWGENE has/VBZ approximately89/NN ,/, 77/CD ,/, and/CC 68%/JJ overall/JJ identity/NN to/IN chicken/NEWGENE TEF-1A/NEWGENE ,/, mouse/NEWGENE TEF-1/NEWGENE ,/, and/CC mouse/NEWGENE embryonic/NEWGENE TEA/NEWGENE domain-containing/NEWGENE factor/NEWGENE ,/, respectively/RB ./.
@@20360662648 We/PRP examined/VBD the/DT effects/NNS of/IN long-term/JJ perfusion/NN with/IN pyridoxalated/VBN hemoglobin/NEWGENE polyoxyethylene/NN conjugate/NN (/( PHP/NN )/SYM solution/NN on/IN cardiac/JJ function/NN of/IN isolated/VBN rat/NN hearts/NNS ./.
@@89554022057 Two/CD classes/NNS of/IN mutations/NNS were/VBD obtained/VBN :/: (/( i/NN )/SYM those/DT that/WDT altered/VBD the/DT coding/JJ region/NN of/IN HOL1/NEWGENE ,/, conferring/JJ the/DT ability/NN to/IN take/NN up/RP histidinol/NN ;/: and/CC (/( ii/NN )/SYM cis-acting/JJ mutations/NNS (/( selected/VBN in/IN a/DT mutant/JJ HOL1-1/NEWGENE background/NN )/SYM that/WDT increased/VBD expression/NN of/IN the/DT Hol1/NEWGENE protein/NEWGENE ./.
@@89866928936 INTERVENTION/NN (/NN S/NN )/NN :/: Twenty-six/JJ hemostasis/NN parameters/NNS evaluated/VBN repeatedly/RB in/IN patients/NNS undergoing/VBG IVF-ET/NNS ./.
@@111316342079 NF/NEWGENE kappa/NEWGENE B/NEWGENE was/VBD activated/VBN to/IN a/DT much/RB greater/JJR extent/NN by/IN roscovitine/NN in/IN the/DT WT/NN cells/NNS than/IN in/IN Y8/NNP cells/NNS ./.
@@98206219798 Although/IN pathological/JJ thyroid/JJ function/NN is/VBZ related/VBN to/IN changes/NNS in/IN energy/NN expenditure/NN and/CC body/NN composition/NN ,/, its/PRP possible/JJ influence/NN on/IN leptin/NEWGENE levels/NNS remains/VBP to/IN be/VB determined/VBN ./.
@@16976833728 Identification/NNP and/CC characterization/NN of/IN the/DT promoter/NN for/IN the/DT cytotactin/NEWGENE gene/NEWGENE ./.
@@103664464306 A/DT coiled-coil/NN domain/NN ,/, conserved/VBN within/IN each/DT encoded/VBN protein/NN ,/, serves/VBP as/IN a/DT potential/JJ interaction/NN motif/NN for/IN FLI/NEWGENE LRR/NEWGENE ./.
@@80916555961 We/PRP have/VBP identified/VBN two/JJ Marek's/NNP Disease/NNP Virus/NN (/( MDV/IN )/SYM genes/NNS within/IN the/DT EcoRI-B/NEWGENE fragment/NEWGENE of/IN MDV-GA/NNP genomic/JJ DNA/NN ./.
@@67514554174 Twenty-eight/CD were/VBD excluded/VBN as/IN gallstones/NNS were/VBD not/RB proved/VBN :/: of/IN the/DT remainder/NN ,/, 21/CD patients/NNS received/VBD glucagon/NEWGENE and/CC 22/CD placebo/NN ./.
@@72933275883 Fibrinogen/NEWGENE determination/NN using/VBG the/DT KZM-1/NN meter/NN ./.
@@11084022788 Unexpectedly/RB ,/, ALK7/NEWGENE signaling/JJ produced/VBN a/DT remarkable/JJ change/NN in/IN cell/NN morphology/NN characterized/VBN by/IN cell/NN flattening/NN and/CC elaboration/NN of/IN blunt/JJ ,/, short/JJ cell/NN processes/NNS ./.
@@61730325997 The/DT effect/NN of/IN echothiophate/NN on/IN the/DT biphasic/JJ response/NN of/IN rabbit/NN ocular/JJ pressure/NN to/IN dipivefrin/NN ./.
@@113038901133 At/NN the/DT time/NN of/IN the/DT blind/JJ therapeutic/JJ doses/NNS ,/, Tg-off/NNP values/NNS ranged/VBN from/IN 8/CD to/IN 608/CD microg/NN //NN l/NN ./.
@@75929466612 We/PRP report/VBP here/RB the/DT cloning/NN of/IN the/DT murine/NEWGENE p44/NEWGENE MAP/NEWGENE kinase/NEWGENE (/( extracellular/NEWGENE signal-regulated/NEWGENE kinase/NEWGENE 1/NEWGENE )/SYM gene/NN ,/, the/DT determination/NN of/IN its/PRP intron/JJ //JJ exon/JJ boundaries/NNS ,/, and/CC the/DT characterization/NN of/IN its/PRP promoter/NN ./.
@@12241164554 Besides/IN ,/, we/PRP found/VBP in/IN 3/CD patients/NNS increased/VBD serum/JJ immunoglobulins/NNS ,/, chiefly/RB IgG/NEWGENE ,/, as/IN first/JJ Russe/NN ,/, Busey/NNP and/CC Barbeau/NN demonstrated/VBD in/IN a/DT large/JJ French-Canadian/NNP family/NN ./.
@@18816712498 Uptake/NNS of/IN ofloxacin/NN by/IN Escherichia/NN coli/JJ ./.
@@24814293135 A/DT rapid/JJ staining/NN technique/NN for/IN Leishmania/NN parasites/NNS in/IN splenic/JJ aspirate/NN smears/NNS ./.
@@2417023282 Role/NN of/IN superoxide/NEWGENE dismutase/NEWGENE in/IN cellular/JJ oxidative/JJ processes/NNS and/CC method/NN of/IN its/PRP determination/NN in/IN biological/JJ materials/NNS ./.
@@74913054190 This/DT study/NN analyzed/VBN whether/IN the/DT localization/NN of/IN an/DT accessory/JJ pathway/NN could/MD be/VB predicted/VBN by/IN using/VBG the/DT polarity/NN of/IN the/DT QRS/NN complex/NN during/IN sinus/NN rhythm/NN on/IN the/DT surface/NN ECG/NN ,/, instead/RB of/IN the/DT delta/JJ wave/NN polarity/NN as/IN used/VBN in/IN many/JJ reports/NNS ./.
@@113760079268 Here/RB we/PRP show/VBP that/IN phosphorylation-induced/JJ loss/NN of/IN the/DT protein/NEWGENE kinase/NEWGENE activity/NN of/IN DNA-PK/NEWGENE is/VBZ restored/VBN by/IN the/DT addition/NN of/IN the/DT purified/VBN catalytic/JJ subunit/NN of/IN either/DT protein/NEWGENE phosphatase/NEWGENE 1/NEWGENE or/CC protein/NEWGENE phosphatase/NEWGENE 2A/NEWGENE (/( PP2A/NEWGENE )/SYM and/CC that/IN this/DT reactivation/NN is/VBZ blocked/VBN by/IN the/DT potent/JJ protein/NEWGENE phosphatase/NEWGENE inhibitor/NN ,/, microcystin/NN ./.
@@88064911202 Transcripts/NNS for/IN both/DT ODV-E18/NEWGENE and/CC ODV-EC27/NEWGENE initiate/VB from/IN conserved/VBN TAAG/NN motifs/NN ,/, and/CC transcripts/NNS are/VBP detected/VBN from/IN 16/CD through/RB 72/CD hr/NN p/CD ./CD i/CD ./.
@@86178008579 Control/NNP of/IN transcription/NN of/IN the/DT erbB-2/NEWGENE gene/NEWGENE is/VBZ an/DT important/JJ determinant/NN of/IN receptor/NN expression/NN ./.
@@35345816236 The/DT incidence/NN of/IN second/JJ malignant/JJ neoplasms/NNS was/VBD lower/JJR (/( 1/CD ./CD 3%/CD )/SYM in/IN the/DT group/NN treated/VBN with/IN 5-fluorouracil/NN ,/, doxorubicin/NN ,/, and/CC cyclophosphamide/NN than/IN in/IN the/DT historical/JJ control/NN group/NN (/( 4/CD ./CD 8%/CD )/SYM ./.
@@99209829916 The/DT aim/NN of/IN the/DT present/NN study/NN was/VBD to/IN examine/VB the/DT antimicrobial/JJ susceptibility/NN to/IN 10/CD currently/RB used/VBN antimicrobial/JJ agents/NNS of/IN 50/CD strains/NNS of/IN P/NNP ./NNP acnes/NNS isolated/VBN from/IN acne/NN lesions/NNS and/CC identified/VBN using/VBG a/DT Rap/NN ID/NN ANA/NN II/NN panel/NN ./.
@@9372908608 Polyhomeotic/NEWGENE and/NEWGENE Posterior/NEWGENE Sex/NEWGENE Combs/NEWGENE may/MD participate/VB in/IN a/DT more/RB general/JJ transcriptional/JJ mechanism/NN that/IN causes/NNS modulated/VBN gene/NN repression/NN ,/, whereas/IN the/DT inclusion/NN of/IN Polycomb/NEWGENE protein/NEWGENE in/IN the/DT complex/NN at/IN PREs/NEWGENE leads/VBP to/IN stable/JJ silencing/VBG ./.
@@105437287114 The/DT tumorigenic/JJ E1A/NEWGENE +/SYM cHa-ras/NEWGENE cells/NNS are/VBP characterized/VBN by/IN high/JJ and/CC constitutive/JJ DNA/NN binding/JJ activities/NNS of/IN AP-1/NEWGENE ,/, in/IN contrast/NN to/IN nontransformed/JJ cells/NNS and/CC the/DT E1A/NEWGENE cells/NNS ./.
@@99041393128 Unitary-group/NN approach/NN to/IN spin-dependent/JJ operators/NNS ./.
@@106924331577 The/DT transcription/NN factor/NN E2F/NEWGENE plays/VBP an/DT important/JJ role/NN in/IN G/NN (/NN 1/NN )/NN to/IN S/NNP phase/NN transition/NN in/IN the/DT higher/JJ eukaryotic/JJ cell/NN cycle/NN ./.
@@10535715364 The/DT RMR/NNS was/VBD measured/VBN twice/RB in/IN each/DT phase/NN and/CC found/VB to/IN be/VB similar/JJ (/( F/NN (/NN 1/NN ,/NN 18/NN )/SYM =/SYM 0/NN ./NN 863/NN )/NN across/IN the/DT follicular/JJ (/( 5018/NN kJ/NN //NN 24/NN h/NN )/SYM and/CC the/DT luteal/JJ (/( 5098/NN kJ/NN //NN 24/NN h/NN )/SYM phases/NNS ./.
@@91053639050 Inductively/RB coupled/VBN plasma/NN atomic/JJ emission/NN spectroscopy/NN was/VBD employed/VBN to/IN obtain/VB the/DT tissue/NN silicon/NN measurements/NNS ./.
@@112511042259 The/DT expression/NN of/IN alpha-amylase/NEWGENE can/MD be/VB transactivated/VBN by/IN the/DT transcription/NN factor/NN GAMyb/NEWGENE ,/, which/WDT is/VBZ itself/PRP induced/VBN by/IN GA/NNP ./NNP
@@17319332784 Zn/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE coordination/NEWGENE domain/NEWGENE mutants/NNS of/IN T4/NN gene/NEWGENE 32/NEWGENE protein/NN ./.
@@75945921220 Deletion/NNS of/IN the/DT NF-IL6/NEWGENE beta/NEWGENE leucine/NEWGENE zipper/NEWGENE domain/NEWGENE also/RB greatly/RB diminished/VBN the/DT interaction/NN between/IN these/DT two/JJ proteins/NNS ./.
@@86305428896 These/DT findings/NNS suggest/VBP that/IN the/DT increase/NN in/IN V/NN O2/NN may/MD have/VB been/VBN a/DT consequence/NN of/IN the/DT increase/NN in/IN Q/JJ O2/NN rather/RB than/IN a/DT response/NN to/IN the/DT procedure/NN itself/PRP ./.
@@80676073243 Significant/JJ alterations/NNS in/IN CBC/NN results/NNS and/CC serum/NEWGENE CRP/NEWGENE concentration/NN ,/, compared/VBN with/IN baseline/JJ values/NNS ,/, were/VBD lacking/VBG in/IN dogs/NNS of/IN the/DT control/NN group/NN ./.
@@76273177544 For/IN Al/NN ,/, the/DT exposure/NN to/IN 1/CD ./CD 36/CD mg/CD //CD m3/CD during/IN the/DT shift/NN corresponded/VBN to/IN a/DT urinary/JJ concentration/NN at/IN the/DT end/NN of/IN the/DT shift/NN of/IN 200/CD microgram/NN //NN g/NN creatinine/NN ./.
@@71493036958 The/DT tetraphasic/JJ action/NN of/IN lidocaine/NN on/IN CNS/NN electrical/JJ activity/NN and/CC behavior/NN in/IN cats/NNS ./.
@@33356514017 An/DT analytic/JJ method/NN for/IN comparative/JJ parameter/NN weighting/JJ in/IN magnetic/JJ resonance/NN (/( MR/NN )/SYM imaging/JJ has/VBZ been/VBN developed/VBN using/VBG the/DT concept/NN of/IN "fractional/JJ sensitivity/CD ./CD "/CD This/DT new/JJ approach/NN results/NNS in/IN easily/RB calculated/VBN indexes/NNS for/IN T1/NN ,/, T2/NN ,/, and/CC hydrogen/NN weighting/JJ ./.
@@90997437769 Here/RB we/PRP report/VBP the/DT purification/NN of/IN this/DT larger/JJR form/NN as/IN an/DT approximately/RB 320-kDa/JJ particle/NN that/WDT contains/VBZ mRNP3+4/NEWGENE and/CC nine/JJ additional/JJ polypeptides/NNS ,/, including/JJ mRNA-binding/NEWGENE polypeptides/NEWGENE of/NEWGENE 34/NEWGENE and/NEWGENE 36/NEWGENE kDa/NEWGENE and/CC a/DT doublet/NN of/IN 110/CD //CD 105/CD kDa/NN that/WDT proved/VBD to/IN be/VB nucleolin/NEWGENE ./.
@@112636643761 SIP1/NEWGENE (/( Smad/NEWGENE interacting/NEWGENE protein/NEWGENE 1/NEWGENE )/SYM and/CC deltaEF1/NEWGENE (/( delta-crystallin/NEWGENE enhancer/NEWGENE binding/NEWGENE factor/NEWGENE )/SYM are/VBP structurally/RB similar/JJ transcriptional/JJ repressors/NNS ./.
@@76595157338 A/DT new/JJ non-LTR/JJ retrotransposon/NN provides/VBZ evidence/NN for/IN multiple/JJ distinct/JJ site-specific/NN elements/NN in/IN Crithidia/NN fasciculata/NN miniexon/NN arrays/NNS ./.
@@8576042374 Overproduction/NNS of/IN HrcA/NEWGENE protein/NEWGENE from/IN a/DT second/JJ copy/NN of/IN hrcA/NEWGENE derived/VBN from/IN a/DT plasmid/NN (/( phrcA+/NN )/SYM in/IN B/NNP ./NNP subtilis/JJ wild-type/NN and/CC delta/JJ hrcA/NEWGENE strains/NNS prevented/VBD heat/NN shock/NN induction/NN of/IN the/DT dnaK/NEWGENE and/CC groE/NEWGENE operons/NEWGENE at/IN the/DT level/NN of/IN transcription/NN almost/RB completely/RB and/CC strongly/RB reduced/VBN the/DT amounts/NNS of/IN mRNA/NN at/IN a/DT low/JJ temperature/NN as/IN well/NN ./.
@@19391316473 The/DT construct/NN was/VBD introduced/VBN into/IN BW2001/NN (/( xth-11/NN ,/, nfo-2/NN )/SYM strain/NN cells/NNS of/IN Escherichia/NN coli/JJ ./.
@@81041893699 These/DT data/NN suggest/VB that/IN :/: (/( a/DT )/SYM proSRIF/NEWGENE cleavage/NN is/VBZ initiated/VBN in/IN the/DT TGN/NN ,/, and/CC (/( b/NN )/SYM this/DT reaction/NN requires/VBZ an/DT acidic/NN pH/NN which/WDT is/VBZ facilitated/VBN by/IN a/DT Golgi-associated/NEWGENE vacuolar-type/NEWGENE ATPase/NEWGENE ./.
@@88231636971 High-resolution/NNP structure/NN of/IN the/DT diphtheria/NEWGENE toxin/NEWGENE repressor/NEWGENE complexed/VBN with/IN cobalt/NN and/CC manganese/NN reveals/VBZ an/DT SH3-like/NEWGENE third/JJ domain/NN and/CC suggests/VBZ a/DT possible/JJ role/NN of/RB phosphate/NN as/IN co-corepressor/NN ./.
@@8501030182 Second/JJ ,/, nitrate/NN induction/NN of/IN aeg-46/NEWGENE ./NEWGENE 5/NEWGENE operon/NEWGENE expression/NN is/VBZ substantially/RB enhanced/VBN in/IN narL/NEWGENE null/JJ strains/NNS (/( M/NN ./NN H/NN ./.
@@74184985983 In/NN spite/NN of/IN this/DT and/CC other/DT complications/NNS of/IN corticosteroids/NNS ,/, she/PRP made/VBP a/DT full/JJ recovery/NN from/IN the/DT fungal/JJ infection/NN following/IN treatment/NN with/IN amphotericin/NN B/NN and/CC surgical/JJ excision/NN of/IN the/DT lung/NN abscess/NN ./.
@@25908691192 The/DT GALT-primed/JJ calves/NNS had/VBP increased/VBN serum/JJ IgG/NEWGENE ,/, lavage/NN IgG/NEWGENE and/CC IgA/NEWGENE and/CC increased/VBN LNA/NEWGENE titers/NNS in/IN both/DT lavage/NN fluids/NNS and/CC serum/JJ following/IN the/DT SC/NN dose/NN of/IN killed/VBN bacteria/NNS ./.
@@22479243475 We/PRP describe/VBP a/DT case/NN of/IN a/DT perinephric/JJ abscess/NN treated/VBN with/IN amphotericin/NN B/NN and/CC nephrectomy/NN ./.
@@96459614626 Our/PRP results/NNS indicate/VBP that/IN the/DT binding/NN of/IN CBF/NEWGENE //NEWGENE NF-Y/NEWGENE to/IN the/DT inverted/JJ CCAAT/NN box/NN is/VBZ responsible/JJ for/IN transcriptional/JJ activation/NN of/IN the/DT nTPH/NEWGENE gene/NEWGENE ./.
@@83862801519 Mutation/NN of/IN the/DT C/NEWGENE //NEWGENE EBP/NEWGENE binding/NEWGENE sites/NEWGENE in/IN the/DT Rous/NN sarcoma/NN virus/NN long/JJ terminal/JJ repeat/NN and/CC gag/NEWGENE enhancers/NEWGENE ./.
@@10430980285 There/EX were/VBD 27/CD men/NNS and/CC 156/CD women/NNS ./.
@@17024263491 A/DT new/JJ set/NN of/IN cDNA/NN clones/NNS spanning/VBG approximately/RB 3/CD ./CD 2/CD kb/NN was/VBD isolated/VBN from/IN a/DT lambda-ZAP/NN goose/NN liver/NN cDNA/NN library/NN using/VBG the/DT 5'-most/JJ exon-containing/NN fragment/NN of/IN the/DT 5'-most/JJ genomic/JJ DNA/NN clone/NN ./.
@@96177654073 The/DT sequence/NN contains/VBZ an/DT open/JJ reading/JJ frame/NN of/IN 1744/CD nt/NN in/IN the/DT virus-sense/JJ strand/NN ,/, a/DT 3'/CD untranslated/JJ region/NN of/IN 1360/CD nt/NN and/CC a/DT 3'/CD poly/NN (/NN A/NN )/NN tail/NN ./.
@@101021362519 We/PRP found/VBP that/IN total/JJ PSA/NEWGENE can/MD be/VB detected/VBN in/IN all/DT cyst/NN fluids/NNS and/CC in/IN about/JJ 75%/NN of/IN female/JJ sera/NNS ./.
@@33842724079 Depending/VBG on/IN the/DT location/NN and/CC size/NN of/IN the/DT mass/NN ,/, a/DT wide/JJ range/NN of/IN clinical/JJ presentations/NNS is/VBZ associated/VBN with/IN the/DT lesion/NN ./.
@@7975882134 Human/NNP adenovirus/NN type/NN 41/CD contains/VBZ two/JJ fibers/NNS ./.
@@91118633711 The/DT likelihood/NN that/IN a/DT common/JJ region/NN of/IN deletions/NNS would/MD contain/VB a/DT tumor/NN suppressor/NN is/VBZ strongly/RB enhanced/VBN by/IN coincidence/NN of/IN that/DT region/NN with/IN a/DT chromosome/NN fragment/NN suppressing/JJ tumorigenicity/NN upon/IN introduction/NN in/IN tumor/NN cells/NNS ./.
@@91993222936 Denaturation/NNS of/IN the/DT simian/JJ virus/NN 40/CD origin/NN of/IN replication/NN mediated/JJ by/IN human/NEWGENE replication/NEWGENE protein/NEWGENE A/NNP ./NNP
@@2276101553 In/NN both/PDT these/DT respects/NNS ,/, however/RB ,/, the/DT DBP/NEWGENE mRNA/NEWGENE resembles/VBZ the/DT late/JJ messengers/NNS of/IN SV40/NN and/CC polyoma/NN viruses/NNS ./.
@@20309105617 Genomic/NN clones/NNS encompassing/VBG the/DT human/NEWGENE ETS1/NEWGENE gene/NEWGENE were/VBD isolated/VBN and/CC utilized/VBN to/IN define/VB its/PRP molecular/JJ organization/NN ./.
@@79837042103 Type/NN 2/NN genomes/NNS containing/JJ this/DT sequence/NN presumably/RB more/RB closely/RB reflect/VB the/DT structure/NN of/IN the/DT infectious/JJ ,/, replication-competent/JJ retrovirus/NN ancestors/NNS of/IN the/DT HERV-K/NN family/NN than/IN do/NN type/NN 1/CD genomes/NNS that/WDT lack/VBP the/DT sequence/NN ./.
@@111912085737 Multidrug/NNP resistance/NN in/IN Saccharomyces/NN cerevisiae/NN mainly/RB results/VBZ from/IN the/DT overexpression/NN of/IN genes/NNS coding/JJ for/IN the/DT membrane/NN efflux/NN pumps/NNS ,/, the/DT major/JJ facilitators/NNS and/CC the/DT ABC/NEWGENE binding/NEWGENE cassette/NEWGENE transporters/NEWGENE ,/, under/IN the/DT control/NN of/IN key/NN transcription/NN regulators/NN encoded/VBN by/IN the/DT PDR1/NEWGENE and/CC PDR3/NEWGENE genes/NEWGENE ./.
@@100267847360 In/NN the/DT Oct-1/NEWGENE crystal/NN ,/, the/DT POU-specific/NEWGENE domain/NEWGENE recognizes/VBZ a/DT GCAT/NEWGENE half-site/NEWGENE ,/, while/CC the/DT corresponding/JJ sequence/NN recognized/VBN by/IN the/DT Pit-1/NEWGENE POU-specific/NEWGENE domain/NEWGENE ,/, GTAT/NEWGENE ,/, is/VBZ on/IN the/DT opposing/JJ strand/NN ./.
@@103283513017 Blood/NNP samples/NNS were/VBD obtained/VBN daily/JJ during/IN this/DT supplementation/NN period/NN and/CC 5/CD d/NN thereafter/RB (/( d/NN 11/NN to/IN 15/CD )/SYM ./.
@@104060473093 We/PRP were/VBD able/JJ to/IN detect/VB significant/JJ differences/NNS in/IN functional/JJ residual/JJ capacity/NN adjusted/VBN for/IN weight/NN or/CC height/NN ,/, and/CC compliance/NN of/IN the/DT respiratory/JJ system/NN adjusted/VBN for/IN weight/NN or/CC lung/NN volume/NN in/IN the/DT ILD/NN infants/NNS compared/VBN to/IN the/DT healthy/JJ controls/NNS or/CC infants/NNS who/WP had/VBP PPHN/NN ,/, indicating/VBG that/IN these/DT PFTs/NNS were/VBD sensitive/JJ enough/RB to/IN determine/VB abnormal/JJ lung/NN function/NN in/IN this/DT age/NN group/NN ./.
@@38202224157 The/DT in/NN vitro/FW antibacterial/JJ potency/NN is/VBZ greatest/JJS when/CC the/DT 1-substituent/NN is/VBZ 2/JJ ,/JJ 4-difluorophenyl/JJ and/CC the/DT 7-substituent/NN is/VBZ a/DT 3-amino-1-pyrrolidinyl/JJ group/NN ./.
@@18458293578 Previous/JJ analysis/NN of/IN the/DT 98-bp/NN sequence/NN has/VBZ delineated/VBN several/DT protein-binding/NN domains/NN that/WDT are/VBP recognized/VBN by/IN nuclear/JJ factors/NNS present/VBP in/IN human/JJ brain/NN cells/NNS ./.
@@106960078570 There/EX is/VBZ no/DT correlation/NN between/IN C2-C3/NN disk/NN morphology/NN and/CC the/DT diskographically/RB provoked/VBN response/NN ./.
@@106996537463 In/NN experiment/NN 2/CD the/DT rats/NNS had/VBP free/JJ access/NN to/IN two/JJ bottles/NNS ,/, one/PRP of/IN which/WDT contained/VBD tap/NN water/NN ,/, and/CC the/PDT other/DT contained/VBN either/DT an/DT ethanol/NN (/( 6%/JJ )/SYM or/CC a/DT sucrose/NN (/( 5%/JJ )/SYM solution/NN ./.
@@13139096198 The/DT phenotypes/NNS of/IN the/DT ICP0/NEWGENE nonsense/NN mutants/NNS were/VBD intermediate/JJ between/IN those/DT of/IN the/DT wild-type/NN virus/NN and/CC 7134/CD in/IN that/DT the/DT more/RB ICP0-coding/NEWGENE sequence/NEWGENE expressed/VBN by/IN a/DT given/NN nonsense/NN mutant/JJ ,/, the/DT more/RB wild/JJ type-like/NN was/VBD its/PRP phenotype/NN ./.
@@98926624850 Here/RB we/PRP describe/VBP a/DT mutant/NN alpha/NN subunit/NN designed/VBN to/IN inhibit/VB receptor-mediated/NN hormonal/JJ activation/NN of/IN Gs/NEWGENE ,/, the/DT stimulatory/JJ regulator/NN of/IN adenylyl/NEWGENE cyclase/NEWGENE ./.
@@86544355005 An/DT inactive/JJ analog/NN of/IN wortmannin/NN ,/, WM12/NN ,/, did/VBD not/RB affect/VB TCR/NN //NN CD3-induced/NN Erk2/NEWGENE activation/NN ,/, and/CC wortmannin/NN had/VBP no/DT effect/NN on/IN the/DT activity/NN of/IN Erk2/NEWGENE when/CC added/VBN directly/RB to/IN the/DT in/NN vitro/FW assays/NNS ./.
@@82998965185 Concordance/NN of/IN IBDQ/NN scores/NNS was/VBD tested/VBN in/IN 280/CD stable/JJ subjects/NNS ./.
@@13095931345 The/DT UCR/NEWGENE core/NEWGENE sequence/NEWGENE ,/, CGCCATTTT/NEWGENE ,/, binds/VBZ a/DT ubiquitous/JJ nuclear/JJ factor/NN and/CC mediates/VBZ negative/JJ regulation/NN of/IN MuLV/NN promoter/NN activity/NN ./.
@@1008550586 The/DT systolic/JJ peak/NN of/IN pulmonary/JJ vein/NN was/VBD higher/JJ than/IN the/DT diastolic/JJ peak/NN in/IN 45/CD out/RB of/IN 56/CD cases/NNS ./.
@@75800583730 The/DT effects/NNS of/IN Codonopsis/NNP pilosula/NN oral/JJ liquor/NN (/( CPOL/NNP )/SYM on/IN tissue-type/NEWGENE plasminogen/NEWGENE activator/NEWGENE (/( t-PA/NEWGENE )/SYM and/CC plasminogen/NEWGENE activator/NEWGENE inhibitor/NEWGENE (/( PAI/NEWGENE )/SYM in/IN the/DT plasma/NN of/IN 25/CD patients/NNS of/IN coronary/JJ heart/NN disease/NN with/IN blood/NN stasis/NN were/VBD studied/VBN ./.
@@11361338225 Here/RB ,/, the/DT PEX5-TPR/NEWGENE domains/NEWGENE from/IN human/JJ ,/, tobacco/NN ,/, and/CC nematode/NN were/VBD inserted/VBN into/IN a/DT TPR-less/NNP yeast/NN Pex5p/NEWGENE construct/NN to/IN generate/VB Pex5p/NEWGENE chimaeras/NNS ./.
@@67002316455 Despite/IN total/JJ tumor/NN resection/NN ,/, multiple/JJ intraperitoneal/JJ tumor/NN nodules/NNS of/IN varying/JJ sizes/NNS were/VBD found/VBN and/CC resected/VBN six/CD months/NNS and/CC one/PRP year/NN later/JJR ./.
@@11012568842 Primary/JJ adrenal/JJ hypersensitivity/NN to/IN ACTH/NEWGENE drive/NN in/IN obesity/NN has/VBZ also/RB been/VBN suggested/VBN ./.
@@13137157399 The/DT goal/NN of/IN the/DT present/NN study/NN was/VBD to/IN determine/VB the/DT feasibility/NN of/IN retrovirus/NN mediated/JJ expression/NN of/IN rp47phox/NEWGENE in/IN the/DT HL60/JJ and/CC U937/CD human/JJ hematopoietic/JJ cell/NN lines/NNS ,/, and/CC in/IN an/DT Epstein-Barr/NNP virus/NN transformed/VBD B-lymphocyte/NN cell/NN line/NN (/( EBV-BCL/NNP )/SYM derived/VBN from/IN a/DT p47phox-deficient/NN CGD/NN patient/NN ./.
@@77027522151 To/TO determine/VB which/WDT sequences/NNS in/IN the/DT rat/NEWGENE P450c17/NEWGENE promoter/NEWGENE may/MD be/VB responsible/JJ for/IN basal/JJ and/CC cAMP-stimulated/NN gene/NN transcription/NN ,/, deletion/NN constructs/NNS containing/JJ between/IN -1/JJ ,/JJ 560/JJ and/CC -53/CD base/NN pairs/NNS of/IN 5'-flanking/JJ DNA/NN from/IN the/DT rat/NEWGENE P450c17/NEWGENE gene/NEWGENE were/VBD ligated/VBN to/IN plasmids/NNS expressing/JJ the/DT reporter/NN gene/NN luciferase/NEWGENE and/CC transfected/VBN into/IN two/JJ mouse/NN cell/NN lines/NNS ,/, adrenal/JJ Y-1/NNP cells/NNS ,/, and/CC testicular/JJ Leydig/NN MA-10/NNP cells/NNS ./.
@@117106851555 Eliminating/VBG any/DT subset/NN of/IN ASCUS/NN reduces/VBZ the/DT ASCUS/NNP //NNP SIL/NNP ratio/NN but/CC also/RB significantly/RB diminishes/VBZ the/DT sensitivity/NN of/IN the/DT Papanicolaou/NN test/NN ./.
@@93533283896 However/RB ,/, besides/IN the/DT kinase/NN catalytic/JJ domain/NN and/CC double/JJ leucine/NN //NN isoleucine/NN zippers/NN ,/, there/RB was/VBD no/DT significant/JJ homology/NN with/IN known/VBP proteins/NNS ./.
@@96209553697 We/PRP characterized/VBD the/DT structure/NN of/IN this/DT leader/NN mRNA/NN by/IN using/VBG the/DT program/NN Mfold/NNP and/CC a/DT combination/NN of/IN nested/JJ and/CC internal/JJ deletions/NNS transcriptionally/RB fused/VBN to/IN a/DT promoterless/NN lac/NEWGENE operon/NEWGENE ./.
@@96338792350 Despite/IN continuous/JJ compliance/NN ,/, unexplained/JJ resurgence/NN of/IN serum/JJ ferritin/NEWGENE levels/NNS occurred/VBN in/IN 4/CD //CD 7/CD patients/NNS of/IN the/DT 'veteran'/NN group/NN after/IN 4-5/CD years/NNS on/IN L1/NNP ./NNP
@@110631277821 Signal/NNP transduction/NN via/NN modulation/NN of/IN phosphorylation/NN after/IN selective/JJ inhibition/NN of/IN protein/NEWGENE phosphatase/NEWGENE (/NEWGENE PP/NEWGENE )/NEWGENE 1/NEWGENE and/IN //IN or/IN PP2A/NEWGENE appears/VBZ to/IN play/NN a/DT role/NN in/IN okadaic/JJ acid/NN (/( OA/NN )/NN -mediated/NN effects/NNS ./.
@@115609925676 The/DT dual/JJ specificity/NN kinases/NN mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/NEWGENE MAPK/NEWGENE )/NEWGENE kinase/NEWGENE (/( MKK/NEWGENE )/NN 7/NN and/CC MKK4/NEWGENE are/VBP the/DT only/JJ molecules/NNS known/VBP to/IN directly/RB activate/VB the/DT stress/NEWGENE kinases/NEWGENE stress-activated/NEWGENE1 protein/NEWGENE1 kinases/NEWGENE1 (/( SAPKs/NEWGENE )/NN //NEWGENE c-Jun/NEWGENE N-terminal/NEWGENE kinases/NEWGENE (/( JNKs/NEWGENE )/SYM in/IN response/NN to/IN environmental/JJ or/CC mitogenic/JJ stimuli/NNS ./.
@@16810752277 After/IN 2/CD min/NN of/IN dobutamine/NN injection/NN ,/, or/CC after/IN 20/CD min/NN of/IN pimobendan/NN injection/NN ,/, the/DT myocardium/NN was/VBD removed/VBN ,/, and/CC used/VBD for/IN determination/NN of/IN the/DT tissue/NN levels/NNS of/IN metabolites/NNS of/IN energy/NN and/CC carbohydrate/NN metabolism/NN ./.
@@96608366063 Quantitative/JJ evaluation/NN of/IN the/DT steady/JJ state/NN kinetics/NN of/IN MEK/NEWGENE inhibition/NN by/IN these/DT compounds/NNS reveals/VBZ that/IN U0126/NN has/VBZ approximately/RB 100-fold/JJ higher/JJ affinity/NN for/IN deltaN3-S218E/NEWGENE //NEWGENE S222D/NEWGENE MEK/NEWGENE than/IN does/VBP PD098059/CD ./.
@@102036111896 Technetium-99m/NN methylene/NN diphosphonate/NN scintimammography/NN for/IN evaluation/NN of/IN palpable/JJ breast/NN masses/NNS ./.
@@113400481188 Although/IN there/RB was/VBD a/DT high/JJ correlation/NN between/IN sap/NN flux/NN densities/NNS registered/VBN by/IN the/DT old/JJ and/CC new/JJ sensors/NNS ,/, significant/JJ differences/NNS in/IN sap/NN flux/NN densities/NNS between/IN the/DT duplicated/VBN sensors/NNS were/VBD detected/VBN ./.
@@64672416270 Modern/NNP cancer/NN therapy/NN has/VBZ included/VBN surgery/NN ,/, radiotherapy/NN ,/, chemotherapy/NN ,/, and/CC most/RB recently/RB ,/, immunotherapy/NN and/CC hyperthermia/NN ./.
@@93332319298 One/CD skull/NN does/VBP not/RB a/DT species/NN make/NN ./.
@@86259246422 Clones/NNS 33F/NN and/CC 34B/NN encoded/VBN identical/JJ aromatase/NEWGENE proteins/NEWGENE of/IN 503/CD amino/JJ acids/NNS ,/, but/CC differed/VBD in/IN size/NN due/NN to/IN alternative/JJ polyadenylation/NN signal/JJ usage/NN for/IN the/DT corresponding/JJ mRNAs/NNS ./.
@@112413563839 Constitutive/JJ phosphorylation/NN and/CC nuclear/JJ localization/NN of/IN Smad3/NEWGENE are/VBP correlated/VBN with/IN increased/VBN collagen/NEWGENE gene/NEWGENE transcription/NN in/IN activated/VBN hepatic/JJ stellate/JJ cells/NNS ./.
@@111136923591 The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN determine/VB the/DT risk/NN factors/NNS for/IN background/NN diabetic/JJ retinopathy/NN (/( BDR/NN )/SYM and/CC PDR/NN by/IN following/IN 394/CD Japanese/JJ patients/NNS with/IN early-onset/NN type/NN 2/CD diabetes/NN diagnosed/VBN before/IN 30/CD years/NNS of/IN age/NN (/( mean/JJ age/NN 27/CD ,/, mean/JJ blood/NN pressure/NN at/IN entry/NN 116/CD //CD 73/CD mm/NN Hg/NN )/SYM ./.
@@21550178711 The/DT possible/JJ benefits/NNS of/IN LMW/NN heparin/NN (/( reduced/VBN frequency/NN of/IN bleeding/NN ,/, alleviation/NN of/IN hypertriglyceridemia/NN )/SYM were/VBD not/RB ,/, however/RB ,/, apparent/JJ ,/, possibly/RB because/IN of/IN the/DT short/JJ observation/NN period/NN and/CC the/DT low/JJ incidence/NN of/IN hemorrhagic/JJ complications/NNS in/IN routine/JJ dialyses/NNS ./.
@@113445301192 Percentages/NNS of/IN recovery/NN for/IN overload/NN and/CC dilution/NN tests/NNS were/VBD between/IN 87/CD and/CC 120%/CD ./.
@@83063568284 Different/JJ cortical/JJ malformations/NNS were/VBD produced/VBN in/IN rats/NNS by/IN a/DT single/JJ dose/NN of/IN X-rays/NNS (/( 200/CD cGy/NN )/SYM given/VBP on/IN different/JJ days/NNS during/IN gestation/NN ./.
@@107500207790 Thus/RB ,/, growth/NEWGENE factor/NEWGENE activation/NN of/IN ER/NEWGENE can/MD mediate/VB transactivation/NN vs/NNP ER/NEWGENE //NEWGENE Sp1/NEWGENE binding/JJ to/IN GC-rich/NNP sites/NNS and/CC represents/VBZ a/DT novel/JJ pathway/NN for/IN ligand-independent/NN ER/NEWGENE action/NN ./.
@@84867059451 The/DT yeast/NN gene/NN that/IN encodes/VBZ eIF-5/NEWGENE ,/, designated/VBN TIF5/NEWGENE ,/, has/VBZ been/VBN isolated/VBN and/CC expressed/VBN in/IN Escherichia/NN coli/JJ to/IN yield/NN a/DT catalytically/RB active/JJ eIF-5/NEWGENE protein/NEWGENE ./.
@@115306848105 After/IN nerve/NN injury/NN ,/, the/DT nociceptive/JJ responses/NNS through/JJ type/NN I/NN neurons/NNS ,/, which/WDT are/VBP polymodal/JJ C-fibers/NNS and/CC drive/NN NK1-receptor/NEWGENE mechanisms/NNS in/IN spinal/JJ pain/NN transmission/NN ,/, were/VBD completely/RB lost/VBP ,/, but/CC without/IN changes/NNS in/IN type/NN II/NN ones/NNS ,/, which/WDT are/VBP polymodal/JJ C-fibers/NNS and/CC drive/NN NMDA/NN receptor-mechanisms/NNS ,/, while/CC type/NN III/NN ones/NNS ,/, which/WDT are/VBP capsaicin-insensitive/JJ (/( possibly/RB A-fibers/VBZ )/SYM and/CC drive/NN NMDA-receptor/NEWGENE mechanisms/NNS ,/, were/VBD markedly/RB enhanced/VBN ./.
@@97135849700 Respondents/NNS who/WP lived/VBD with/IN a/DT spouse/NN //NN partner/NN only/RB were/VBD less/PRP likely/RB to/IN have/NN an/DT unfavorable/JJ BMI/NN status/NN than/IN people/NN in/IN the/PDT other/DT two/JJ groups/NNS ./.
@@110620689875 Catalytic/JJ activation/NN of/IN mitogen-activated/NEWGENE protein/NEWGENE (/NEWGENE MAP/NEWGENE )/NEWGENE kinase/NEWGENE phosphatase-1/NEWGENE by/IN binding/JJ to/IN p38/NEWGENE MAP/NEWGENE kinase/NEWGENE :/: critical/JJ role/NN of/IN the/DT p38/NEWGENE C-terminal/NEWGENE domain/NEWGENE in/IN its/PRP negative/JJ regulation/NN ./.
@@71657676985 Mastocytosis/NNS ./.
@@18497346787 Whereas/IN a/DT PR55/NEWGENE beta/NEWGENE transcript/NEWGENE of/IN about/RB 2/CD ./CD 3/CD kb/NN was/VBD detected/VBN at/IN high/JJ levels/NNS in/IN the/DT neuroblastoma/NN derived/VBD cell/NN line/NN LA-N-1/CELL ,/, the/DT level/NN of/IN the/DT mRNA/NN was/VBD very/RB low/JJ in/IN the/PDT other/DT human/JJ cell/NN lines/NNS analyzed/VBN ./.
@@78917097509 These/DT observations/NNS indicate/VBP that/IN there/RB are/VBP multiple/JJ mechanisms/NNS by/IN which/WDT an/DT individual/JJ transcript/NN can/MD be/VB degraded/VBN following/IN deadenylation/NN ./.
@@68860317087 Total/JJ PGE/NN levels/NNS in/IN synovial/JJ fluid/NN remained/VBN significantly/RB depressed/VBN in/IN the/DT patient/NN group/NN for/IN 24/CD hours/NNS after/IN the/DT 400-mg/JJ test/NN dose/NN of/IN tolmetin/NN on/IN day/NN 8/CD ./CD
@@79330668574 Mutually/RB exclusive/JJ interaction/NN of/IN the/DT adenovirus/NEWGENE E4-6/NEWGENE //NEWGENE 7/NEWGENE protein/NEWGENE and/CC the/DT retinoblastoma/NEWGENE gene/NEWGENE product/NEWGENE with/IN internal/JJ domains/NNS of/IN E2F-1/NEWGENE and/CC DP-1/NEWGENE ./.
@@103929146805 BACKGROUND/NNP //NNP PURPOSE/NNP :/: Anomalous/JJ arrangement/NN of/IN the/DT pancreaticobiliary/JJ duct/NN (/( AAPBD/NN )/SYM is/VBZ closely/RB related/VBN to/IN congenital/JJ biliary/JJ dilatation/NN and/CC frequently/RB associated/VBN with/IN biliary/JJ tract/NN malignancy/NN ./.
@@77489524371 These/DT results/NNS indicate/VBP that/DT mutL/NEWGENE ,/, miaA/NEWGENE ,/, and/CC hfq/NEWGENE expression/NN could/MD be/VB regulated/VBN by/IN multiple/JJ mechanisms/NNS ,/, including/JJ degree/NN of/IN cotranscription/NN from/IN upstream/JJ genes/NNS ,/, modulation/NN of/IN internal/JJ promoter/NN strength/NN ,/, and/CC by/IN RNase/NEWGENE E/NEWGENE activity/NN ./.
@@97367707132 Transfection/NNS and/CC in/IN vitro/FW binding/JJ studies/NNS identified/VBN within/IN HEFT1/NEWGENE a/NEWGENE promoter/NEWGENE whose/WP basal/JJ activity/NN required/VBD a/DT GC/NN box/NN activated/VBN by/IN Sp1/NEWGENE or/CC Sp3/NEWGENE ./.
@@95287705889 The/DT RAS-cyclic/NEWGENE AMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE cAPK/NEWGENE pathway/NN prevents/VBZ the/DT UAS/NEWGENE activity/NN of/IN IREu/NEWGENE in/IN the/DT presence/NN of/RB glucose/NN as/IN the/DT sole/JJ carbon/NN source/NN ,/, while/CC the/DT transcriptional/NN activators/NN Msn2p/NEWGENE and/CC Msn4p/NEWGENE promote/VB the/DT UAS/NEWGENE activity/NN of/IN this/DT repeat/NN in/IN the/DT presence/NN of/IN acetate/NN ./.
@@109104393777 CONCLUSIONS/IN :/: In/NN essential/JJ hypertension/NN an/DT acute/NN protein/NN load/NN induces/VBZ a/DT decrease/NN in/IN GFR/NN that/WDT may/MD normalize/VB under/IN antihypertensive/JJ treatment/NN ./.
@@78301129108 In/NN contrast/NN ,/, peak/NN filling/JJ rate/NN (/( PFR/NN )/SYM ,/, normalized/VBN to/IN end/NN diastolic/JJ volume/NN (/( EDV/NN )/SYM ,/, or/CC stroke/NN volume/NN (/( SV/NN )/SYM ,/, or/CC expressed/VBD as/IN the/DT ratio/NN of/IN PFR-to-PER/NN was/VBD reduced/VBN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, time/NN to/IN PFR/NN (/( TPFR/NN )/SYM was/VBD prolonged/JJ (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, and/CC echocardiographic/JJ left/NN ventricular/JJ mass/JJ index/NN was/VBD higher/JJ (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM in/IN patients/NNS with/IN acromegaly/NN compared/VBN to/IN normals/NNS ./.
@@126531900 Beta/NNP blocking/JJ agents/NNS ./.
@@70684935147 There/EX was/VBD no/DT further/JJ increase/NN in/IN oxygen/NN consumption/NN when/CC these/DT subjects/NNS breathed/VBN with/IN inspiratory/JJ pressures/NNS above/RB SIP/NN ./.
@@10331875337 This/DT dimer/NN interface/NN is/VBZ likely/RB important/JJ for/IN increasing/JJ the/DT DNA-binding/NN specificity/NN and/CC affinity/NN of/IN the/DT trimeric/JJ form/NN of/IN HSF/NEWGENE ,/, as/RB well/VB as/IN for/IN increasing/JJ cooperativity/NN between/IN adjacent/JJ trimers/NNS ./.
@@25283295174 Three/CD missense/JJ mutants/NNS in/IN subunit/NN a/DT of/IN the/DT Escherichia/NEWGENE coli/NEWGENE F1F0-ATPase/NEWGENE were/VBD isolated/VBN and/CC characterized/VBN after/IN hydroxylamine/NN mutagenesis/NN of/IN a/DT plasmid/NN carrying/JJ the/DT uncB/NEWGENE (/NEWGENE subunit/NEWGENE a/NEWGENE )/NEWGENE gene/NEWGENE ./.
@@110540117849 CONCLUSIONS/IN :/: The/DT surgical/JJ or/CC multimodality/NN treatment/NN of/IN MSGT/NN has/VBZ provided/VBN a/DT good/JJ locoregional/JJ control/NN (/( 78%/JJ )/SYM and/CC 68%/JJ 10-year/JJ survival/NN in/IN a/DT series/NN of/IN patients/NNS treated/VBN at/IN the/DT oncology/NN department/NN of/IN a/DT general/JJ hospital/NN in/IN Quito/NNP ,/, Ecuador/NN ./.
@@79170169861 The/DT predicted/VBN DNA-binding/NN ,/, zinc/NN finger/NN domain/NN protein/NN sequence/NN was/VBD strictly/RB conserved/VBN ./.
@@21580998022 In/NN transient/JJ cotransfection/NN assays/NNS using/VBG Chang/NN liver/NN cells/NNS (/( CCL/NN 13/NN )/SYM ,/, pM1/NN DNA/NN exerts/VBZ a/DT 6-/CD to/IN 10-fold/CD trans-activating/JJ effect/NN on/IN the/DT expression/NN of/IN the/DT pSV2CAT/NN reporter/NN plasmid/NN ./.
@@109425875454 During/IN treatment/NN ,/, the/DT phosphorylation/NN state/NN of/IN Rb/NEWGENE shifted/VBN to/IN a/DT hypophosphorylated/JJ form/NN ./. mRNA/NN for/IN the/DT HPV/NEWGENE E6/NEWGENE //NEWGENE E7/NEWGENE genes/NEWGENE decreased/VBN ;/: however/RB ,/, significant/JJ changes/NNS in/IN the/DT E7/NEWGENE protein/NEWGENE were/VBD not/RB observed/VBN ,/, while/CC increased/VBD levels/NNS of/IN Rb/NEWGENE immunoprecipitated/VBN with/IN anti-E7/NEWGENE antibodies/NEWGENE were/VBD observed/VBN ./.
@@94580219411 51/CD ./CD 9%/CD (/( P/NNP =/NNP 0/NNP ./NNP 0006/NNP )/SYM in/IN the/DT MMF/NN versus/IN the/DT AZA/JJ groups/NNS ,/, respectively/RB ./.
@@118025804343 The/DT General/NNP Practice/NNP Research/NNP Database/NN (/( GPRD/NN )/SYM is/VBZ the/DT world's/NNS largest/JJS computerized/JJ database/NN of/IN anonymized/JJ longitudinal/JJ patient/NN records/NNS from/IN general/JJ practice/NN and/CC is/VBZ a/DT unique/JJ public/JJ health/NN research/NN tool/NN ./.
@@104601723193 Velocity/NNS sedimentation/NN ,/, cross-linking/VBG ,/, and/CC immunoprecipitation/NN analyses/NNS of/IN detergent-solubilized/JJ rat/NN brain/NN revealed/VBN that/IN the/DT 32/CD and/CC 34/NN kDa/NN polypeptides/NN reside/VBP within/IN heterotetramers/NNS ./.
@@75630906416 Characterization/NNS of/IN the/DT 3'/CD ends/NNS of/IN the/DT plus-strand/NN DNA/NN fragments/NNS reveals/VBZ (/( 1/CD )/SYM that/IN the/DT upstream/JJ fragment/NN is/VBZ elongated/JJ beyond/RB PPT2/NEWGENE creating/VBG a/DT plus-strand/NN overlap/NN and/CC (/( 2/CD )/SYM that/IN the/DT majority/NN of/IN plus-strand/NN strong-stop/JJ DNA/NN fragments/NNS bear/VBP a/DT copy/NN of/IN the/DT minus-strand/NN primer/NN binding/JJ site/NN in/IN agreement/NN with/IN the/DT accepted/VBN model/NN of/IN retroviral/JJ genomic/JJ RNA/NN reverse/JJ transcription/NN ./.
@@21151153947 Further/RB ,/, they/PRP are/VBP consistent/JJ with/IN the/DT suggestion/NN that/IN sites/NNS homologous/JJ to/IN the/DT CAR1/NEWGENE URS/NEWGENE may/MD be/VB situated/VBN in/IN the/DT 5'-flanking/JJ regions/NNS of/IN multiple/JJ unrelated/NN yeast/NN genes/NN ./.
@@80976664724 A23187/NN did/VBD not/RB induce/VB any/DT modifications/NNS of/IN the/DT endolymphatic/JJ potential/NN ,/, the/DT ampullar/JJ direct/JJ current/JJ or/CC the/DT frequency/NN of/IN the/DT evoked/VBN afferent/JJ spikes/NNS ./.
@@60734274560 Electrophoretic/JJ characteriaztion/NN of/IN virus-induced/NN interferon/NEWGENE of/IN the/DT blood/NN and/CC urine/NN in/IN rabbits/NNS ./.
@@77917603508 GnRH/NEWGENE treatment/NN was/VBD found/VBN to/IN increase/NN the/DT phosphorylation/NN of/IN tyrosine/NN residues/NNS of/IN MAPK/NEWGENE and/CC to/IN increase/NN MAPK/NEWGENE activity/NN ,/, as/IN determined/VBN by/IN an/DT immune/NN complex/NN kinase/NEWGENE assay/NN ./.
@@57584695708 Hemodynamics/NNS changes/NNS in/IN man/NN during/IN flight/NN ./.
@@92698799231 Nasal/JJ absorption/NN was/VBD rapid/JJ ,/, nasal/JJ bioavailability/NN was/VBD 43%/JJ ,/, and/CC the/DT iv/NN and/CC nasal/JJ elimination/NN profiles/NNS were/VBD similar/JJ ./.
@@10850942655 In/NN experiment/NN 2/CD ,/, no/DT difference/NN in/IN gastric/JJ emptying/NN of/IN 40%/CD peptone/NN or/CC 25%/JJ glucose/NN was/VBD found/VBN between/IN rats/NNS receiving/JJ TPN/NN and/CC those/DT receiving/JJ intragastric/JJ nutrition/NN for/IN 10/CD to/IN 12/CD days/NNS ./.
@@87262478708 To/TO derive/VB quantitative/JJ concentration/NN changes/NNS from/IN measurements/NNS of/IN light/NN attenuation/NN ,/, the/DT optical/JJ path/NN length/NN must/MD be/VB known/VBP ./.
@@97861976795 Analysis/NNP of/IN chromosomal/JJ DNA/NN sequence/NN immediately/RB downstream/RB of/IN the/DT transposon/NN insertion/NN identified/VBD two/JJ open/JJ reading/JJ frames/NNS ,/, designated/VBN csrR/NEWGENE and/CC csrS/NEWGENE ,/, which/WDT exhibited/VBD sequence/NN similarity/NN to/IN bacterial/JJ two-component/JJ regulatory/JJ systems/NNS ./.
@@96112345556 Rev-erbAalpha/NEWGENE //NEWGENE beta/NEWGENE )/NEWGENE ,/, Mxi-1/NEWGENE and/CC Mad/NEWGENE bHLH-zip/NEWGENE proteins/NEWGENE and/CC the/DT oncoproteins/NN PLZF/NEWGENE and/CC LAZ3/NEWGENE //NEWGENE BCL6/NEWGENE is/VBZ mediated/JJ by/IN the/DT corepressors/NN N-CoR/NEWGENE and/CC SMRT/NEWGENE ./.
@@10281637180 Reporting/NNP of/IN adverse/JJ events/NNS occurring/VBG during/IN clinical/JJ trials/NNS of/IN investigational/JJ drugs/NNS is/VBZ a/DT complex/NN and/CC controversial/JJ issue/NN ./.
@@14256532047 The/DT effects/NNS of/IN two/JJ levels/NNS of/IN caffeine/NN ingestion/NN on/IN excess/NN postexercise/JJ oxygen/NN consumption/NN in/IN untrained/JJ women/NNS ./.
@@72647877109 Of/IN the/DT 117/CD patients/NNS (/( out/RB of/IN the/DT 136/CD )/SYM with/IN serologic/JJ evidence/NN of/IN chronic/JJ thyroiditis/NN who/WP could/MD be/VB studied/VBN ,/, eight/CD (/( 7%/JJ )/SYM had/VBP hyperthyroidism/NN and/CC 45/CD (/( 38%/JJ )/SYM were/VBD hypothyroid/JJ ./.
@@22773192926 Unfortunately/RB ,/, these/DT preservatives/NNS may/MD also/RB interfere/VB with/IN microbiological/JJ assays/NNS used/VBN to/IN determine/VB product/NN sterility/NN or/CC bioburden/NN levels/NNS ./.
@@11103601802 Where/WRB UMDNJ/NN is/VBZ headed/VBN ./.
@@7489781953 Serum/NEWGENE relaxin/NEWGENE levels/NNS in/IN prostaglandin/NN E2/NN induced/VBN abortions/NNS ./.
@@18270689400 Human/NEWGENE GATA-3/NEWGENE :/: a/DT lineage-restricted/NN transcription/NN factor/NN that/WDT regulates/VBZ the/DT expression/NN of/IN the/DT T/NEWGENE cell/NEWGENE receptor/NEWGENE alpha/NEWGENE gene/NEWGENE ./.
@@102242892970 Induction/NNS of/IN Fas/NEWGENE ligand/NEWGENE expression/NN by/IN HIV/NN involves/VBZ the/DT interaction/NN of/IN Nef/NEWGENE with/IN the/DT T/NEWGENE cell/NEWGENE receptor/NEWGENE zeta/NEWGENE chain/NEWGENE ./.
@@19754285764 Telomeres/NNS prevent/VBP end-to-end/JJ fusions/NNS and/CC exonucleolytic/JJ degradation/NN ,/, enable/VB the/DT end/NN of/IN the/DT linear/JJ DNA/NN molecule/NN to/IN replicate/VB ,/, and/CC function/NN in/IN cell/NN division/NN ./.
@@71162986923 Specifically/RB ,/, by/IN the/DT type/NN of/IN adjuvant/JJ therapy/NN ,/, the/DT median/JJ disease-free/NN interval/NN and/CC survival/NN from/IN stage/NN IVA/NNS for/IN 23/CD patients/NNS receiving/JJ Corynebacterium/NN parvum/NN were/VBD 6/CD ./CD 9/CD and/CC 19/CD months/NNS ;/: for/IN 39/CD patients/NNS receiving/JJ BCG/NN ,/, eight/CD months/NNS and/CC 26/CD months/NNS ;/: for/IN 24/CD patients/NNS receiving/JJ BCG/NN +/SYM DTIC/NN ,/, eight/CD and/CC 17/CD ./CD 4/CD months/NNS ;/: and/CC for/IN all/DT 51/CD DTIC/NN treated/VBD patients/NNS 6/CD ./CD 3/CD and/CC 17/CD ./CD 8/CD months/NNS ,/, respectively/RB ./.
@@8938418505 Merr/NN ./NN )/NN embryo/NN library/NN ./.
@@114599627540 Altogether/RB ,/, we/PRP confirm/VBP that/IN all/DT genes/NNS of/IN the/DT Rad52/NEWGENE recombinational/NEWGENE repair/NEWGENE pathway/NEWGENE are/VBP required/VBN for/IN the/DT survival/NN of/IN rad27/NEWGENE Delta/NEWGENE strains/NNS at/IN both/DT permissive/JJ (/( 23/CD degrees/NNS C/NN )/SYM and/CC semipermissive/JJ (/( 30/CD degrees/NNS C/NN )/SYM temperatures/NNS for/IN growth/NN ./.
@@103939694629 A/DT single/JJ amino/JJ acid/NN substitution/NN in/IN the/DT cyclin/NEWGENE D/NEWGENE binding/NEWGENE domain/NEWGENE of/IN the/DT infected/NEWGENE cell/NEWGENE protein/NEWGENE no/NN ./NN
@@98767949869 Improving/VBG the/DT evidence/NN base/NN for/IN anaesthesia/NN ./.
@@81223702155 Seven/CD of/IN these/DT had/VBP counterparts/NNS in/IN the/DT US/NN of/IN herpes/NN simplex/JJ type/NN 1/CD (/( HSV-1/NN )/SYM ,/, pseudorabies/NN virus/NN (/( PRV/NN )/SYM ,/, and/CC equine/JJ herpesvirus/NN type/NN 1/CD (/( EHV-1/NN )/SYM ./.
@@33353981826 Since/IN high/JJ levels/NNS of/IN immunoglobulin/NEWGENE G/NEWGENE were/VBD demonstrated/VBN against/IN the/DT surface/NN of/IN the/DT NVS/NNP after/IN immunization/NN ,/, passive/JJ transfer/NN experiments/NNS were/VBD initiated/VBN ./.
@@114571399539 Our/PRP results/NNS show/VBP that/IN CVN/NEWGENE specifically/RB recognizes/VBZ with/IN nanomolar/JJ affinity/NN Man/NEWGENE (/NEWGENE 9/NEWGENE )/NEWGENE GlcNAc/NEWGENE (/NEWGENE 2/NEWGENE )/NEWGENE and/CC the/DT D1D3/NEWGENE isomer/NEWGENE of/IN Man/NEWGENE (/NEWGENE 8/NEWGENE )/NEWGENE GlcNAc/NEWGENE (/NEWGENE 2/NEWGENE )/NEWGENE ./.
@@10669319482 No/DT definite/JJ conclusions/NNS are/VBP possible/JJ because/IN of/IN the/DT small/JJ number/NN of/IN patients/NNS involved/VBN in/IN this/DT phase/NN II/NNP trial/NN ./.
@@66749774994 Out/IN of/IN these/DT families/NNS 74/CD ,/CD 3%/CD planned/VBN next/JJ pregnancy/NN (/( table/NN IX/CD )/SYM ,/, 57/NN ,/NN 6%/NN wanted/VBN to/IN have/NN prenatal/JJ diagnosis/NN (/( table/NN VI/NN )/SYM ./.
@@95081195701 CONCLUSIONS/IN :/: The/DT special/JJ clinical/JJ presentation/NN of/IN our/PRP case/NN of/IN possible/JJ Gardner's/NN syndrome/NN is/VBZ discussed/VBN ./.
@@106886609539 Interestingly/RB ,/, addition/NN of/IN purified/VBN CBP/NEWGENE to/IN the/DT nuclear/JJ extracts/NNS of/IN T47D/DT cells/NNS markedly/RB stimulated/VBN progesterone-/JJ and/CC PR-dependent/NNP transcription/NN from/IN a/DT nucleosome-free/NN ,/, progesterone/NEWGENE response/NEWGENE element/NEWGENE (/( PRE/NEWGENE )/NN -linked/NN reporter/NN DNA/NN template/NN ./.
@@61985327711 Therefore/RB ,/, it/PRP was/VBD concluded/VBN that/IN thrombotic/JJ tendency/NN certainly/RB existed/VBD in/IN patients/NNS with/IN MS/NN compared/VBN to/IN those/DT with/IN non/NN RHD/NN and/CC that/IN it/PRP was/VBD one/PRP of/IN the/DT causes/NNS of/IN the/DT significantly/RB high/JJ incidence/NN of/IN thromboembolism/NN in/IN comparison/NN with/IN non/NN RHD/NN ./.
@@112108391046 Before/IN PO3/NN administration/NN ,/, more/RB than/IN half/NN (/( 57/CD ./CD 4%/CD )/SYM of/IN the/DT patients/NNS received/VBN only/RB 1/CD or/CC 2/CD antituberculous/JJ drugs/NNS (/( ethambutole/NN and/CC ethionamide/NN or/CC ethambutole/NN and/CC oprofloxacin/NN )/SYM ./.
@@82843378267 Routine/JJ psychometric/JJ screening/NN of/IN IHD/NN patients/NNS may/MD provide/VB a/DT cost-effective/JJ means/NN of/IN alerting/JJ cardiologists/NNS and/CC internists/NNS to/IN the/DT relatively/JJ high/JJ levels/NNS of/IN distress/NN among/IN their/PRP patients/NNS ./.
@@80354982317 In/NN addition/NN ,/, computer/NN analysis/NN suggests/VBZ that/IN sequences/NNS similar/JJ to/IN the/PDT A/DT stem/NN element/NN are/VBP present/VB within/IN the/DT three/CD AAV/NEWGENE promoter/NEWGENE regions/NN ./.
@@110441054939 Another/DT cis-acting/JJ element/NN ,/, exonic/NEWGENE splicing/NEWGENE suppressor/NEWGENE 1/NEWGENE (/( ESS1/NEWGENE )/SYM ,/, represses/VBZ use/NN of/IN the/DT nt/NN 3225/CD 3'/CD splice/NN site/NN ./.
@@20727982682 After/IN hemodynamic/JJ stabilization/NN ,/, the/DT goal/NN of/IN therapy/NN is/VBZ to/IN diminish/VB the/DT chance/NN that/IN an/DT ulcer/NN will/MD continue/VB to/IN bleed/VB or/CC will/MD rebleed/VB ./.
@@13213365341 Two/CD splice/NN variants/NNS of/IN ALF1/NEWGENE cDNA/NEWGENE have/NN been/VBN found/VB ,/, differing/JJ by/IN a/DT 72-bp/JJ insertion/NN ,/, coding/JJ for/IN putative/JJ proteins/NNS of/IN 682/CD and/CC 706/CD amino/JJ acids/NNS ./.
@@76731786878 Our/PRP results/NNS suggest/VBP that/IN while/CC many/JJ muscle/NN gene/NN E-boxes/NN are/VBP capable/JJ of/IN binding/JJ the/DT previously/RB characterized/VBN spectrum/NN of/IN MDF/NEWGENE //NEWGENE bH-L-H/NEWGENE heterodimers/NEWGENE in/IN vitro/FW ,/, MCK-L/NEWGENE type/NN E-boxes/NNP probably/RB bind/VB qualitatively/RB different/JJ factors/NNS in/IN vivo/NN ./.
@@109872801394 The/DT amino/JJ acid/NN sequence/NN of/IN matrilysin-2/NEWGENE also/RB contains/VBZ a/DT threonine/NN residue/NN adjacent/JJ to/IN the/DT Zn-binding/NN site/NN that/WDT has/VBZ been/VBN defined/VBN as/IN a/DT specific/JJ feature/NN of/IN matrilysin/NEWGENE ./.
@@7163665349 Value/NNP of/IN determination/NN of/IN alkaline/NEWGENE phosphatase/NEWGENE isoenzymes/NEWGENE for/IN differential/JJ diagnosis/NN of/IN obstructive/JJ jaundice/NN and/CC biliary/JJ liver/NN cirrhosis/NN ./.
@@53167455466 Aedes/NN aegypti/NN (/( L/NNP ./NNP )/SYM and/CC Aedes/NN albopictus/NN (/( Skuse/NNP )/SYM in/IN Singapore/NNP City/NNP ./.
@@80725477737 Ras-/NEWGENE and/NEWGENE ultra-violet-responsive/NEWGENE protein/NEWGENE kinases/NEWGENE that/WDT phosphorylate/VBP c-Jun/NEWGENE on/IN serine/NN residues/NNS at/IN positions/NNS 63/CD and/CC 73/CD and/CC stimulate/VB its/PRP transcriptional/JJ activity/NN have/NN been/VBN identified/VBN ./.
@@118979501806 CONCLUSIONS/IN :/: Lymphoscintigraphy/NNS of/IN the/DT cynomolgus/JJ monkey/NN eyelids/NNS reveals/VBZ discrete/JJ lymphatic/JJ drainage/NN pathways/NNS for/IN the/DT upper/JJ and/CC lower/JJR eyelids/NNS and/CC a/DT dual/JJ pathway/NN for/IN the/DT central/JJ upper/JJ eyelid/NN ./.
@@111458132104 Regional/NNP blood/NN blow/NN was/VBD measured/VBN by/IN means/NN of/IN microspheres/NNS in/IN predefined/JJ regions/NNS of/IN the/DT C6/NN ,/, T11/NN ,/, and/CC L6/NN vertebrae/NNS ./.
@@79271302738 CMV/NN hyperimmunoglobulin/NEWGENE treatment/NN (/( Cytotect/NNP ,/, Biotest/NNP )/SYM was/VBD started/VBN (/( 2/CD ml/NN //NN kg/NN bw/NN on/IN day/NN 1/CD and/CC 3/CD ,/, and/CC 1/CD ml/NN //NN kg/NN on/IN days/NNS 5/CD ,/, 7/CD and/CC 9/CD )/SYM ,/, which/WDT led/VBD to/IN the/DT eradication/NN of/IN the/DT residual/JJ infiltrate/NN and/CC CMV-DNA/NNP in/IN the/DT myocardium/NN ./.
@@88277838813 The/DT ewes/NNS were/VBD returned/VBN to/IN normoxia/NN ,/, and/CC monitoring/VBG was/VBD continued/VBN for/IN 1/CD h/CD ./CD
@@21398918100 The/DT major/JJ promoter/NN responds/VBZ strongly/RB to/IN virus-encoded/JJ trans/JJ activators/NNS EIA/NEWGENE and/CC EIV/NEWGENE and/CC contains/VBZ four/CD elements/NNS :/: a/DT TAGA/NN motif/NN analogous/JJ to/IN the/DT TATA/NN box/NN ,/, two/JJ EIIF/NEWGENE sites/NEWGENE present/VBP in/IN an/DT inverted/JJ orientation/NN ,/, and/CC an/DT ATF/NEWGENE //NEWGENE CREB/NEWGENE site/NEWGENE ./.
@@81007657993 Interestingly/RB ,/, in/IN the/DT adult/NN ,/, transgene/NN expression/NN patterns/NNS within/IN the/DT cerebellum/NN in/IN two/JJ lines/NNS appeared/VBN to/IN mark/NN distinct/JJ anterior-posterior/JJ compartments/NNS ./.
@@92751596202 Heterogeneous/NEWGENE nuclear/NEWGENE ribonucleoprotein/NEWGENE A1/NEWGENE binds/VBZ to/IN the/DT transcription-regulatory/NN region/NN of/IN mouse/NN hepatitis/NN virus/NN RNA/NN ./.
@@84999032750 In/NN 17/CD patients/NNS with/IN deletions/NNS ,/, the/DT parental/JJ origin/NN of/IN deletion/NN was/VBD determined/VBN ./.
@@72353177066 Clinical/NNP accuracy/NN of/IN updated/VBN version/NN of/IN the/DT Phadebas/NNP RAST/NN test/NN ./.
@@24834381722 On/IN the/DT basis/NN of/IN the/DT mechanism/NN of/IN action/NN ,/, two/JJ groups/NNS of/IN inodilators/NNS are/VBP distinguished/VBN ,/, the/DT phosphodiesterase/NEWGENE inhibitors/NN and/CC the/DT dopaminergic/JJ agents/NNS ./.
@@88471388818 The/DT detection/NN ratio/NN peaked/VBN at/IN ages/NNS 30/CD to/IN 34/CD and/CC decreased/VBN heavily/RB during/IN the/DT next/JJ 15/CD years/NNS of/IN age/NN ./.
@@117095616134 Phase/NNP II/NNP trial/NN of/IN the/DT anti-G/NEWGENE (/NEWGENE D2/NEWGENE )/NEWGENE monoclonal/NEWGENE antibody/NEWGENE 3F8/NEWGENE and/CC granulocyte-macrophage/NEWGENE colony-stimulating/NEWGENE factor/NEWGENE for/IN neuroblastoma/NN ./.
@@98587143751 Another/DT ORF/NN ,/, dda/NEWGENE ./NEWGENE 2/NEWGENE located/VBN between/IN modA/NEWGENE and/CC dda/NEWGENE ,/, shares/VBP sequence/NN similarity/NN with/IN sigma70/NEWGENE ,/, and/CC we/PRP call/VBP it/PRP srd/NEWGENE ./.
@@11039780883 The/DT authors/NNS present/NN the/DT only/RB two/JJ studies/NNS that/WDT have/VBP proved/VBN successful/JJ in/IN treating/JJ animal/NN models/NNS of/IN osteoarthritis/NN using/VBG gene/NN therapy/NN ,/, and/CC propose/VB an/DT overview/NN of/IN several/DT strategies/NNS for/IN the/DT development/NN of/IN gene/NN therapy/NN in/IN osteoarthritis/NN treatment/NN in/IN the/DT future/JJ ./.
@@64524612171 There/EX was/VBD significant/JJ correlation/NN of/IN LVM/NN //NN M2/NN and/CC PWVn/VB for/IN pre-AVR/JJ and/CC post/VBD AVR/DT studies/NNS ./.
@@21655892262 A/DT gene/NN in/IN Drosophila/NN melanogaster/NN that/IN maps/NNS cytologically/RB to/IN 2C1-3/NN on/IN the/DT distal/JJ portion/NN of/IN the/DT X-chromosome/NN encodes/VBZ a/DT member/NN of/IN the/DT steroid/NEWGENE //NEWGENE thyroid/NEWGENE hormone/NEWGENE receptor/NEWGENE superfamily/NEWGENE ./.
@@14856486517 We/PRP investigated/VBD the/DT diagnostic/JJ value/NN of/IN a/DT new/JJ in/IN vitro/FW test/NN ,/, Pharmacia/NNP CAP/NN System/NNP (/( Pharmacia/NNP Diagnostics/NNPS AB/NN ,/, Uppsala/NN ,/, Sweden/NN )/SYM ,/, for/IN the/DT quantitative/JJ measurement/NN of/IN allergen-specific/NEWGENE IgE/NEWGENE antibodies/NEWGENE by/IN comparison/NN with/IN RAST/NN in/IN 2/CD groups/NNS of/IN patients/NNS ,/, 71/CD atopic/JJ and/CC 48/CD non-atopic/JJ ./.
@@86839833597 One/CD complex/NN containing/NN a/NN 70/NN D/NN protein/NN was/VBD found/VBN to/IN be/VB associated/VBN specifically/RB with/IN transcriptionally/RB active/JJ leukemia/NN cells/NNS ./.
@@109109088577 This/DT finding/NN suggested/VBN that/IN the/DT PI3K-Akt/NEWGENE activation/NEWGENE pathway/NEWGENE plays/VBP some/DT role/NN in/IN the/DT antiapoptotic/JJ effect/NN of/IN EPO/NEWGENE ./.
@@82784808261 G/NNP ./NNP
@@7936650292 Strikingly/RB ,/, this/DT subdomain/NN is/VBZ also/RB present/VB in/IN the/DT otherwise/RB unrelated/NN N-terminal/NN activating/NN region/NN of/IN p58c-ets-2/NEWGENE and/CC was/VBD thus/RB named/VBN BEC/NEWGENE for/IN Ets-1-beta/NEWGENE //NEWGENE Ets-2-Conserved/NEWGENE sequence/NEWGENE ./.
@@85301079444 Consistent/JJ with/IN the/DT hepatic/JJ and/CC epidermal/JJ expression/NN of/IN histidase/NEWGENE ,/, this/DT finding/NN suggests/VBZ that/DT histidase/NEWGENE transcription/NN may/MD be/VB regulated/VBN by/IN these/DT factors/NNS ./.
@@70684936835 The/DT respiratory/JJ rate/NN was/VBD 13/CD +/NN //NN -/NN 1/CD breaths/NN //NN min/NN with/IN 52/NN +/NN //NN -/NN 4%/NN of/IN the/DT respiratory/JJ cycle/NN spent/VBP in/IN inspiration/NN ;/: end-tidal/JJ CO2/NN pressure/NN increased/VBN by/IN 3/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 0/CD Torr/NNS during/IN runs/VBP at/IN SIP/NN ./.
@@91548276947 Previous/JJ studies/NNS have/VBP indicated/VBN that/IN a/DT hamster/NN cell/NN line/NN (/( ts13/CD )/SYM with/IN a/DT point/NN mutation/NN in/IN the/DT TAF/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE 250/NEWGENE //NEWGENE CCG1/NEWGENE (/( TAF/NEWGENE1 (/NEWGENE1 II/NEWGENE1 )/NEWGENE1 250/NEWGENE1 )/NN gene/NN shows/VBZ temperature-sensitive/JJ expression/NN of/IN a/DT subset/NN of/IN genes/NNS and/CC arrests/NNS in/IN late/JJ G1/NN at/IN 39/CD ./CD 5/CD degrees/NNS C/NNP ./NNP
@@99616829954 Model/NN of/IN spatiotemporal/JJ dynamics/NNS of/IN stick-slip/JJ motion/NN ./.
@@44374064971 A/DT hydrodynamic/JJ description/NN of/IN the/DT osmotic/JJ reflection/NN coefficient/NN with/IN application/NN to/IN the/DT pore/NN theory/NN of/IN transcapillary/JJ exchange/NN ./.
@@31831033871 Sequential/JJ MR/NN examinations/NNS of/IN the/DT nasal/JJ cavity/NN and/CC paranasal/JJ sinuses/NNS were/VBD performed/VBN within/IN a/DT 6-8/CD h/NN period/NN in/IN five/CD normal/JJ volunteers/NNS ./.
@@36257624303 Comparison/NNS of/IN patients/NNS receiving/JJ phenytoin/NN and/CC those/DT who/WP were/VBD not/RB showed/VBN significantly/RB lower/JJR serum/JJ folate/NN in/IN the/DT sub-group/NN receiving/JJ phenytoin/NN ,/, but/CC there/RB was/VBD no/DT significant/JJ difference/NN between/IN the/DT sub-groups/NNS with/IN respect/NN to/IN vitamin/NN B12/NN or/CC behaviour/NN problem/NN rating/JJ ./.
@@89232583338 Jerseys/NN had/VBP higher/JJ hepatic/JJ Cu/NN concentrations/NNS than/IN did/VBD Holsteins/NNP on/IN d/NN 60/NN (/( 346/CD vs/IN ./IN
@@84126209775 A/DT region/NN approximately/RB 100/CD bp/NN upstream/RB from/IN the/DT transcription/NN start/NN point/NN of/IN virB/NEWGENE was/VBD identified/VBN as/IN being/VBP necessary/JJ for/IN full/JJ activation/NN of/IN this/DT promoter/NN by/IN VirF/NEWGENE ./.
@@28133693512 We/PRP also/RB found/VBP that/IN the/DT same/JJ males/NNS ,/, breeding/JJ in/IN different/JJ years/NNS on/IN the/DT same/JJ territories/NNS ,/, had/VBP significantly/RB larger/JJR harems/NNS in/IN the/DT years/NNS they/PRP had/VBP familiar/JJ neighbors/NNS ./.
@@10485585319 Galoyan/NN has/VBZ summarized/VBN the/DT results/NNS of/IN his/PRP discovery/NN of/IN cardioactive/JJ neurohormones/NNS ./.
@@11085600925 The/DT authors/NNS proposed/VBN that/IN the/DT highly/RB convergent/JJ inputs/NNS to/IN the/DT entorhinal/JJ cortex/NN indicate/VB this/DT region/NN may/MD be/VB particularly/RB important/JJ for/IN selecting/VBG or/CC compressing/VBG information/NN ./.
@@20294682643 Serum/NEWGENE TNF/NEWGENE concentrations/NNS were/VBD elevated/VBN at/IN diagnosis/NN and/CC gradually/RB decreased/VBN toward/IN the/DT reference/NN limits/NNS by/IN week/NN 16/CD ./CD
@@19326502551 In/NN group/NN III/NNP ,/, patients/NNS also/RB received/VBN their/PRP own/VB mediastinal/JJ drainage/NN blood/NN ,/, shed/VB for/IN 6/CD hours/NNS after/IN operation/NN ,/, after/IN concentration/NN and/CC washing/JJ in/IN a/DT MBRS/NNS ./.
@@67190576484 The/DT importance/NN of/IN selective/JJ renal/NN vein/NN phlebography/NN in/IN the/DT evaluation/NN of/IN unexplained/JJ hematuria/NN and/CC filing/JJ defects/NNS in/IN the/DT excretory/JJ urogram/NN is/VBZ illustrated/VBN ./.
@@30256614374 Gluzman/NNP ,/, EMBO/NNP J/NNP ./NNP
@@31831273995 Comparison/NNS was/VBD made/VBP with/IN other/DT neuroradiological/JJ imaging/NN modalities/NNS including/JJ CT/NN ,/, myelography/NN ,/, CT/NN ventriculography/NN ,/, and/CC CT/NN myelocisternography/NN ./.
@@115689886000 The/DT best/JJS regression/NN model/NN for/IN predicting/JJ changes/NNS in/IN the/DT WCXR/NN included/VBN time/NN to/IN first/JJ positive/JJ culture/NN and/CC antibody/NN titer/NN for/IN Pa/NEWGENE elastase/NEWGENE ./.
@@20264911573 Two/CD patients/NNS had/VBP immediate/JJ adverse/JJ effects/NNS from/IN NMF/NN ;/: one/PRP had/VBP a/DT grand/JJ mal/NN seizure/NN and/CC the/PDT other/DT developed/VBN severe/JJ abdominal/JJ pain/NN ./.
@@50343739437 A/DT possible/JJ role/NN for/IN the/DT mixed/JJ function/NN oxidase/NEWGENE enzyme/NEWGENE system/NEWGENE in/IN the/DT requirement/NN for/IN selenium/NN in/IN the/DT rat/NN ./.
@@83017028276 Monospecific/NNP antibodies/NNS raised/VBN against/IN rat/NEWGENE cytochrome/NEWGENE P-450/NEWGENE 1A1/NEWGENE recognized/VBN a/DT protein/NN in/IN the/DT hepatic/JJ microsomes/NNS of/IN the/DT double-crested/JJ cormorant/NN ,/, and/CC also/RB in/IN those/DT of/IN the/DT great/JJ blue/JJ heron/NN (/( Ardea/NNP herodias/NNS )/SYM ,/, using/VBG immunoblotting/VBG ./.
@@89204998879 Blood/NNP sampling/JJ procedures/NNS were/VBD videotaped/VBN ./.
@@119122611826 Calcimimetic/JJ agents/NNS directly/RB inhibit/VBP PTH/NEWGENE secretion/NN by/IN activating/JJ the/DT calcium-sensing/JJ receptor/NN in/IN the/DT parathyroid/JJ glands/NNS ,/, but/CC clinical/JJ experience/NN with/IN them/PRP is/VBZ limited/VBN ./.
@@82613985680 The/DT drug-resistant/NN cell/NN lines/NNS P388/CELL //CELL ADR/CELL //CELL 3/CELL and/CC P388/CELL //CELL ADR/CELL //CELL 7/CELL express/VB a/DT shortened/VBN topo/NEWGENE II/NEWGENE alpha/NEWGENE mRNA/NEWGENE transcript/NEWGENE in/IN addition/NN to/IN the/DT native/JJ transcript/NN present/NN in/IN the/DT drug-sensitive/JJ P388/NN //NN 4/NN cell/NN line/NN ./.
@@105854175222 Taken/VBN together/RB ,/, differences/NNS in/IN signaling/NN and/CC tissue/NN expression/NN suggest/VB that/IN the/DT human/NEWGENE intermediate/NEWGENE PRLr/NEWGENE differs/VBZ from/IN the/DT long/NEWGENE PRLr/NEWGENE in/IN physiological/JJ function/NN ./.
@@31984363894 Conservative/NNP treatment/NN of/IN bladder/NN carcinoma/NN by/IN partial/JJ cystectomy/NN and/CC interstitial/JJ iridium/NN 192/CD ./.
@@86398375260 This/DT fragment/NN can/MD bind/NN several/DT trans-acting/JJ factors/NNS in/IN vitro/FW ,/, including/JJ GATA-1/NEWGENE and/CC members/NNS of/IN the/DT Ets/NEWGENE family/NEWGENE ./.
@@85655481027 This/DT study/NN determined/VBD the/DT arthritogenic/JJ potential/NN of/IN silicone/NN gel/NN by/IN either/DT mixing/NN it/PRP with/IN bovine/NEWGENE collagen/NEWGENE II/NEWGENE (/( BII/NEWGENE )/SYM or/CC by/IN injecting/JJ silicone/NN gel/NN alone/RB in/IN DA/NN rats/NNS ./.
@@71303354742 Administration/NNP of/IN the/DT dopamine/NN agonist/NN bromocriptine/NN (/( 2/CD ./CD 5/CD mg/NN three/CD times/VBZ a/DT day/NN for/IN 4/CD days/NNS )/SYM suppressed/VBN (/( P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM mean/JJ 24-h/JJ plasma/NN 18-OHB/NN levels/NNS from/IN 21/CD ./CD 9/CD +/NN //NN -/NN 2/CD ./CD 0/CD to/IN 14/CD ./CD 8/CD +/NN //NN -/NN 1/CD ./CD 4/CD ng/NN //NN dl/NN ./.
@@118228111253 Group/NNP I/PRP comprised/VBD 5/CD adult/JJ Collies/NNPS that/WDT received/VBD at/IN least/RB 400/NN microg/NN //NN kg/NN ivermectin/NN p/CD ./CD o/CD ./. and/CC were/VBD presented/VBN to/IN the/DT VMTH/NN 3/NN hours/NNS after/IN intoxication/NN ./.
@@86608667076 At/NN cuticular/JJ positions/NNS exhibiting/VBG the/DT Brd/NEWGENE bristle/NEWGENE loss/NEWGENE phenotype/NEWGENE ,/, we/PRP have/VBP found/VBN that/IN the/DT progeny/NN of/IN the/DT multiplied/VBN SOPs/NN develop/VB aberrantly/RB ,/, in/IN that/DT neurons/NNS and/CC thecogen/NN (/( sheath/NN )/SYM cells/NNS appear/VBP but/CC not/RB trichogen/VB (/( shaft/NN )/SYM and/CC tormogen/NN (/( socket/NN )/SYM cells/NNS ./.
@@83833239114 Optimal/JJ activation/NN of/IN T/NN cells/NNS requires/VBZ at/IN least/RB two/JJ signals/NNS ./.
@@14411202059 Use/VB of/IN free-access/NN minerals/NNS ./.
@@86705562943 63/CD ./CD 3/CD micromol/NN //NN 1/NN ,/, p/NN </NN 0/NN ./NN 01/NN )/NN and/CC area/NN under/IN the/DT plasma/NN concentration-time/NN curve/NN extrapolated/VBN to/IN infinity/NN AUC/NN 9/NN (/NN 0-infinity/NN )/NN (/NN 518/NN ./NN 7/NN vs/IN ./IN
@@90799025872 Purified/NEWGENE Pra/NEWGENE was/VBD also/RB shown/VBP to/IN physically/RB interact/VB with/IN pyruvate/NEWGENE kinase/NEWGENE (/( Pk/NEWGENE )/SYM ;/: Pk/NEWGENE and/CC Pra/NEWGENE can/MD form/VB a/DT complex/NN ,/, but/CC when/CC the/DT 12-kDa/NEWGENE Ndk/NEWGENE ,/, Pk/NEWGENE ,/, and/CC Pra/NEWGENE are/VBP all/DT present/NN ,/, Pk/NEWGENE has/VBZ a/DT higher/JJ affinity/NN than/IN Pra/NEWGENE for/IN forming/NN a/NN complex/NN with/IN the/DT 12-kDa/NEWGENE Ndk/NEWGENE ./.
@@95829531341 The/DT data/NN suggest/VB that/DT plasminogen/NEWGENE ,/, alpha/NEWGENE 2AP/NEWGENE ,/, and/CC C1-INH/NEWGENE ,/, should/MD be/VB considered/VBN equine/NEWGENE acute-phase/NEWGENE proteins/NEWGENE ./.
@@76875413510 We/PRP here/RB demonstrate/VBP that/IN a/DT temperature-sensitive/JJ fission/NN yeast/NN mutant/JJ which/WDT has/VBZ a/DT mutation/NN in/IN a/DT homologous/JJ gene/NN ,/, and/CC two/NN of/IN three/CD additional/JJ (/( mtr1/NEWGENE //NEWGENE prp20/NEWGENE //NEWGENE srm1/NEWGENE )/SYM mutants/NNS accumulate/VBP nuclear/JJ poly/NN (/NN A/NN )/NN +/NN RNA/NN at/IN 37/CD degrees/NNS C/NNP ./NNP
@@20475972657 Grossly/RB ,/, the/DT experimental/JJ vulvitis/NN was/VBD identical/JJ to/IN the/DT field/NN condition/NN ,/, and/CC bacteria/NNS indistinguishable/JJ from/IN the/DT inoculated/VBN strains/NNS were/VBD reisolated/VBN ./.
@@111214347730 Inhibition/NNS of/IN the/DT Mek/NEWGENE //NEWGENE Erk/NEWGENE pathway/NEWGENE in/IN Rat1/NNP //NNP ras/NNP cells/NNS ,/, using/VBG the/DT Mek/NEWGENE inhibitor/NN ,/, PD98059/NN ,/, resulted/VBN in/IN complete/JJ cytoskeletal/JJ recovery/NN ,/, indistinguishable/JJ from/IN that/DT induced/VBD by/IN HR12/NN ./.
@@104906397385 In/NN Saccharomyces/NN cerevisiae/NN ,/, PHO85/NEWGENE encodes/VBZ a/DT cyclin-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE (/( Cdk/NEWGENE )/SYM catalytic/JJ subunit/NN with/IN multiple/JJ regulatory/JJ roles/NNS thought/VBP to/IN be/VB specified/VBN by/IN association/NN with/IN different/JJ cyclin/NEWGENE partners/NNS (/( Pcls/NEWGENE )/SYM ./.
@@25026023523 Tonometry/NNS of/IN blood/NN samples/NNS from/IN patients/NNS may/MD also/RB be/VB used/VBN in/IN the/DT determination/NN of/IN acid-base/NN quantities/NNS and/CC hemoglobin-oxygen/JJ affinity/NN e/NN ./NN g/NN ./. p50/NN ./.
@@12981731936 The/DT natural/JJ history/NN of/IN these/DT lesions/NNS ,/, locoregional/JJ efficiency/NN of/IN the/DT different/JJ treatments/NNS used/VBN ,/, the/DT part/NN played/VBN by/IN chemotherapy/NN ,/, survival/NN ,/, causes/VBZ of/IN death/NN and/CC therapeutic/JJ modalities/NNS used/VBN as/IN a/DT last/NN measure/NN ,/, have/VB been/VBN analysed/VBN ./.
@@16264302951 The/DT homologies/NNS between/IN RAD16/NEWGENE ,/, RAD54/NEWGENE and/CC SNF2/NEWGENE are/VBP also/RB shared/VBN by/IN several/DT additional/JJ ,/, recently/RB isolated/VBN yeast/NN and/CC Drosophila/NN genes/NN ./.
@@39372947484 Plasma/NEWGENE secretin/NEWGENE levels/NNS also/RB augmented/VBN after/IN the/DT administration/NN of/IN ethanol/NN solutions/NNS ,/, with/IN a/DT delay/NN of/IN about/RB one/PRP hour/NN after/IN the/DT onset/NN of/IN acid/NN secretion/NN ./.
@@114541905241 Background/NNP //NNP Aims/NNP :/: Hepatitis/NN C/NN and/CC nonalcoholic/JJ fatty/JJ liver/NN disease/NN (/( NAFL/NNP )/SYM are/VBP the/DT two/JJ most/RB common/JJ forms/NNS of/IN liver/NN disease/NN in/IN the/DT United/NNP States/NNPS ./.
@@89921159772 The/DT progression/NN of/IN acute/JJ bronchitis/NN is/VBZ associated/VBN with/IN elevated/VBN blood/NN concentrations/NNS of/IN acute-phase/NEWGENE proteins/NEWGENE ,/, KKS/NEWGENE activation/NN in/IN the/DT blood/NN and/CC high/JJ serotonin/NN and/CC lactic/JJ acid/NN content/NN in/IN the/DT humor/NN condensated/VBN from/IN the/DT exhaled/JJ air/NN ./.
@@28957548916 Topical/JJ 1/CD percent/NN isoproterenol/NN in/IN the/DT presence/NN of/IN the/DT phosphodiesterase/NEWGENE inhibitor/NN theophylline/NN was/VBD tested/VBN for/IN its/PRP ability/NN to/IN stimulate/VB the/DT rate/NN of/IN aqueous/JJ humor/NN flow/NN through/RB the/DT anterior/JJ chamber/NN of/IN the/DT normal/JJ and/CC the/DT partially/RB adrenergically/RB denervated/JJ human/JJ eye/NN (/( Horner's/NNP syndrome/NN )/SYM ./.
@@10683244414 Copyright/NNP 2000/CD Academic/NNP Press/NNP ./.
@@22337294825 Some/DT mutations/NNS affected/VBD Dhfr/NEWGENE in/IN a/DT qualitative/JJ manner/NN ,/, such/JJ as/IN by/IN changing/JJ the/DT startpoint/NN of/IN one/PRP of/IN the/DT major/JJ Dhfr/NEWGENE transcripts/NEWGENE or/CC changing/JJ the/DT relative/JJ abundance/NN of/IN the/DT two/JJ major/JJ Dhfr/NEWGENE transcripts/NEWGENE ./.
@@91360154566 The/DT sequencing/VBG of/IN Stellate/NEWGENE copies/NNS located/VBN along/IN the/DT discontinuous/JJ cluster/NN revealed/VBD a/DT complex/NN pattern/NN of/IN diversification/NN ./.
@@103581387611 These/DT results/NNS suggest/VBP that/IN the/DT phenotype/NN of/IN XLP/NN may/MD result/VB from/IN perturbed/VBN signaling/JJ not/RB only/RB through/RB SLAM/NEWGENE ,/, but/CC also/RB other/DT cell/NN surface/NN molecules/NNS that/WDT utilize/VBP SAP/NEWGENE as/IN a/DT signaling/NN adaptor/NN protein/NN ./.
@@27098193380 Only/RB one/PRP ADR/NN was/VBD related/VBN definitely/RB to/IN ciprofloxacin/NN therapy/NN ./.
@@91710389668 Here/RB ,/, a/DT case/NN of/IN Sjogren's/NN syndrome/NN is/VBZ presented/VBN that/WDT was/VBD initially/RB diagnosed/VBN because/IN of/IN dental/JJ complaints/NNS ,/, and/CC long-term/JJ treatment/NN of/IN Sjogren's/NN patients/NNS is/VBZ discussed/VBN ./.
@@18247139805 The/DT 12S/NEWGENE E1A/NEWGENE product/NEWGENE does/VBP not/RB activate/VB a/DT TRE/NEWGENE sequence/NEWGENE ,/, but/CC cotransfection/NN with/IN c-jun/NEWGENE circumvents/VBZ this/DT lack/NN of/IN stimulation/NN ./.
@@97353689056 Second/JJ ,/, the/DT wild-type/NEWGENE m8/NEWGENE 3'/NEWGENE UTR/NEWGENE strongly/RB reduces/VBZ accumulation/NN of/IN heterologous/JJ transcripts/NNS in/IN vivo/NN ,/, an/DT activity/NN that/WDT requires/VBZ its/PRP K/NN box/NN sequences/NN ./.
@@62588068846 Thus/RB it/PRP appears/VBZ that/DT insertion/NN of/IN a/DT transposable/JJ element/NN near/IN the/DT 5'/CD terminus/NN of/IN the/DT structural/JJ gene/NN can/MD produce/VB constitutive/JJ expression/NN of/IN a/DT normally/RB glucose-repressed/JJ enzyme/NN ./.
@@97052587780 The/DT IE13/CD ./CD 1/CD cell/NN line/NN was/VBD able/JJ to/IN complement/NN a/DT recombinant/JJ virus/NN in/IN which/WDT both/DT copies/NNS of/IN the/DT IE/NEWGENE gene/NEWGENE were/VBD replaced/VBN by/IN insertion/NN of/IN the/DT Escherichia/NEWGENE coli/NEWGENE lacZ/NEWGENE gene/NEWGENE ./.
@@118994794441 After/IN taking/VBG smears/NNS from/IN lesions/NNS of/IN the/DT oral/JJ mucosa/NN (/( tongue/NN ,/, cheeks/NNS ,/, palate/NN )/SYM and/CC the/DT contiguous/JJ denture/NN surface/NN by/IN cotton/NN wool/NN swabs/NNS and/CC inoculating/JJ them/PRP onto/IN Sabouraud/NN glucose/NN agar/NN and/CC CHROMagar/JJ Candida/NN ,/, individual/JJ yeast/NN species/NN were/VBD identified/VBN by/IN a/DT germ/NN tube/NN ,/, filamentous/JJ ,/, and/CC assimilation/NN tests/NNS employing/VBG the/DT commercial/JJ kit/NN AuxaColor/NN ./.
@@111386942894 [/NN 18F/NN ]/NN (/NN +/NN )/NN -4-fluorobenzyltrozamicol/NN (/( FBT/NNP )/SYM ,/, which/WDT selectively/RB binds/VBZ to/IN the/DT vesicular/JJ acetylcholine/NEWGENE transporter/NEWGENE in/IN the/DT presynaptic/JJ cholinergic/JJ neuron/NN ,/, has/VBZ previously/RB been/VBN shown/VBP to/IN be/VB a/DT useful/JJ ligand/NN for/IN the/DT study/NN of/IN cholinergic/JJ terminal/JJ density/NN in/IN the/DT basal/JJ ganglia/NNS with/IN PET/NN ./.
@@94287879707 A/DT genomic/JJ clone/NN was/VBD isolated/VBN that/WDT contained/VBD 12/CD ./CD 5/CD kb/NN of/IN the/DT 5'-flanking/JJ region/NN and/CC the/DT first/JJ exon/NN of/IN the/DT p69/NEWGENE //NEWGENE 71/NEWGENE 2-5A/NEWGENE synthetase/NEWGENE gene/NEWGENE ./.
@@103226294383 Here/RB we/PRP report/VBP the/DT cloning/NN and/CC characterization/NN of/IN Xenopus/NEWGENE Pax-5/NEWGENE and/CC Pax-8/NEWGENE ,/, two/JJ orthologues/VBP of/IN the/DT Pax-2/NEWGENE //NEWGENE 5/NEWGENE //NEWGENE 8/NEWGENE gene/NEWGENE family/NEWGENE ./.
@@78381565419 However/RB ,/, cotransfection/NN studies/NNS indicate/VBP that/DT RVR/NEWGENE does/VBP not/RB activate/VB transcription/NN when/CC this/DT hormone/NEWGENE response/NEWGENE element/NEWGENE is/VBZ linked/JJ to/IN a/DT reporter/NN gene/NN but/CC rather/RB acts/VBZ as/IN a/DT potent/JJ competitive/JJ repressor/NN of/IN ROR/NEWGENE alpha/NEWGENE function/NN ./.
@@15488912159 The/DT level/NN of/IN carboxyl-terminal/NEWGENE parathyroid/NEWGENE hormone/NEWGENE in/IN the/DT patients/NNS with/IN thyroid/JJ carcinoma/NN was/VBD higher/JJ than/IN that/DT in/NN the/DT patients/NNS without/IN thyroid/JJ carcinoma/NN (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@97122979698 The/DT prothrombin/NEWGENE gene/NEWGENE G20210A/NEWGENE mutation/NEWGENE is/VBZ not/RB found/VB among/IN Japanese/JJ patients/NNS with/IN deep/JJ vein/NN thrombosis/NN and/CC healthy/JJ individuals/NNS ./.
@@94547191507 The/DT correct/JJ termination/NN of/IN retroviral/NN transcripts/NN at/IN the/DT 3'/CD LTR/NEWGENE R/NEWGENE //NEWGENE U5/NEWGENE junction/NEWGENE is/VBZ primarily/RB dependent/JJ on/IN the/DT canonical/JJ AAUAAA/NEWGENE polyadenylation/NN signal/JJ ,/, so/IN we/PRP have/VBP analyzed/VBN the/DT effect/NN of/IN mutating/JJ the/DT polyadenylation/NN signal/NN sequences/NN on/IN the/DT properties/NNS of/IN a/DT selectable/JJ murine/JJ retroviral/JJ vector/NN ./.
@@37360814405 When/WRB the/DT coronary/JJ sinus/NN pressure/NN reached/VBN 15/CD torr/NN ,/, there/RB was/VBD a/DT significant/JJ decrease/NN in/IN cardiac/JJ index/NN (/( 3/CD ./CD 60/CD +/NN //NN -/NN 0/CD ./CD 5/CD to/IN 2/CD ./CD 70/CD +/NN //NN -/NN 0/CD ./CD 6/CD L/NN //NN min/NN //NN m2/NN ,/, p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ,/, coronary/JJ blood/NN flow/NN (/( 13/CD ./CD 7/CD +/NN //NN -/NN 3/CD ./CD 1/CD to/IN 7/CD ./CD 0/CD +/NN //NN -/NN 2/CD ./CD 1/CD ml/NN //NN min/NN ,/, p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ,/, rate/NN of/IN rise/NN of/IN left/NN ventricular/JJ pressure/NN (/( 1/CD ,/CD 567/CD +/NN //NN -/NN 275/CD to/IN 1/CD ,/CD 331/CD +/NN //NN -/NN 314/CD ,/, p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ,/, and/CC an/DT increase/NN in/IN coronary/JJ arteriovenous/JJ difference/NN (/( 62/CD ./CD 8%/CD +/NN //NN -/NN 9/CD ./CD 3%/CD to/IN 70/CD ./CD 5%/CD +/NN //NN -/NN 5/CD ./CD 4%/CD saturation/NN ,/, p/NN less/PRP than/IN 0/CD ./CD 03/CD )/SYM ./.
@@105570723738 These/DT results/NNS suggest/VBP that/IN ULK2/NEWGENE is/VBZ involved/VBN in/IN a/DT previously/RB uncharacterized/JJ signaling/JJ pathway/NN in/IN mammalian/JJ cells/NNS ./.
@@112218456926 We/PRP compared/VBD previously/RB the/DT methylation/NN status/NN between/IN normal/JJ liver/NN and/CC liver/NN tumors/NNS in/IN SV40/NEWGENE T/NEWGENE //NEWGENE t/NEWGENE antigen/NEWGENE transgenic/JJ mice/NNS (/( MT-D2/NN mice/NNS )/SYM using/VBG Restriction/NNP Landmark/NNP Genomic/NN Scanning/NN for/IN Methylation/NNS (/( RLGS-M/NNP )/SYM and/CC identified/VBD several/DT loci/NNS //NNS spots/NNS that/WDT appeared/VBD to/IN be/VB methylated/JJ frequently/RB in/IN liver/NN tumors/NNS ./.
@@14801835298 The/DT 5'-flanking/JJ region/NN of/IN the/DT human/NEWGENE lactoferrin/NEWGENE gene/NEWGENE was/VBD isolated/VBN from/IN a/DT human/JJ placental/JJ genomic/JJ library/NN ./.
@@67073576468 Additionally/RB ,/, observations/NNS that/WDT patients/NNS with/IN mitral/JJ versus/IN aortic/JJ regurgitation/NN respond/NN differently/RB to/IN valve/NN replacement/NN suggest/VB that/IN differences/NNS exist/VBP preoperatively/RB between/IN these/DT two/JJ types/NNS of/IN volume/NN overload/NN ./.
@@9076336894 GH/NEWGENE deficiency/NN may/MD be/VB absolute/JJ ,/, but/CC often/RB is/VBZ not/RB and/CC the/DT diagnosis/NN may/MD be/VB complicated/VBN by/IN a/DT constellation/NN of/IN physical/JJ and/CC hormonal/JJ findings/NNS that/WDT are/VBP along/IN a/DT spectrum/NN from/IN low/JJ normal/JJ GH/NEWGENE sufficiency/NN to/IN absent/VB GH/NEWGENE secretion/NN ./.
@@112072165803 The/DT bovine/NEWGENE PGHS-2/NEWGENE cDNA/NEWGENE was/VBD cloned/VBN by/IN a/DT combination/NN of/IN reverse/JJ transcription-polymerase/JJ chain/NN reaction/NN and/CC cDNA/NN library/NN screening/JJ ./.
@@96218938556 Previous/JJ studies/NNS have/VBP suggested/VBN that/IN moderate/JJ cooling/NN increases/VBZ the/DT responsiveness/NN of/IN vascular/NEWGENE alpha2-adrenoceptors/NEWGENE ./.
@@119204551836 Copyright/NNP 2002/CD American/NNP Cancer/NNP Society/NNP ./NNP DOI/NNP 10/CD ./CD 1002/CD //CD cncr/CD ./CD 10318/CD
@@18501271262 Stable/NN association/NN of/IN U2/NEWGENE snRNP/NEWGENE with/IN the/DT branchpoint/NN sequence/NN of/IN mammalian/JJ pre-mRNAs/NNS requires/VBZ binding/NN of/IN a/DT non-snRNP/NEWGENE protein/NEWGENE to/IN the/DT polypyrimidine/NN tract/NN ./.
@@89741038920 Patterns/NNS defined/VBN by/IN combinations/NNS of/IN normal/JJ and/CC abnormal/JJ laboratory/NN results/NNS had/VBP decreased/VBN the/DT likelihood/NN of/IN PEM/NN from/IN an/DT all-2/NN to/IN all-0/JJ pattern/NN ./.
@@33790584542 Nucleotide/NN sequencing/VBG indicates/VBZ that/IN this/DT E1/NEWGENE alpha/NEWGENE cDNA/NEWGENE clone/NN is/VBZ 1821/CD base/NN pairs/NNS (/( bp/NN )/SYM in/IN length/NN with/IN an/DT open/JJ reading/JJ frame/NN of/IN 1365/CD bp/NN and/CC a/DT 3'-untranslated/JJ region/NN of/IN 356/CD bp/CD ./CD
@@11748731591 Retinoblastoma/IN :/: a/DT study/NN of/IN natural/JJ history/NN and/CC prognosis/NN of/IN 268/CD cases/NNS ./.
@@9774450685 We/PRP have/VBP recently/RB identified/VBN a/DT mouse/NN enzyme/NN termed/JJ gamma-glutamyl/NEWGENE leukotrienase/NEWGENE (/( GGL/NEWGENE )/SYM that/WDT converts/VBP leukotriene/NN C4/NN (/( LTC4/NN )/SYM to/IN leukotriene/NN D4/NN (/( LTD4/NN )/SYM ./.
@@10864271680 The/DT results/NNS suggest/VBP that/IN the/DT role/NN of/IN S/NNP ./NNP argyrostoma/NN in/IN the/DT dissemination/NN of/IN Trichinella/NN larvae/NNS in/IN nature/NN is/VBZ limited/VBN in/IN comparison/NN to/IN the/DT role/NN played/VBN by/IN mammals/NNS with/IN scavenger/NN and/CC cannibalistic/JJ behavior/NN ./.
@@114087741273 Karger/NNP AG/NN ,/, Basel/NNP
@@45444305024 Proceedings/NNP :/: Reversible/NNP complete/JJ heart/NN block/NN following/IN surgery/NN of/IN congenital/JJ heart/NN defects/NNS ./.
@@113119809738 GABA/NEWGENE (/NEWGENE B/NEWGENE )/NEWGENE R1g/NEWGENE was/VBD expressed/VBN in/IN both/DT brain/NN and/CC peripheral/JJ tissues/NNS ./.
@@58364835771 A/DT malignant/JJ true/JJ teratoma/NN of/IN liver/NN in/IN childhood/NN ./.
@@26867499933 To/TO assess/VB the/DT health/NN significance/NN of/IN the/DT early/JJ renal/JJ changes/NNS after/IN chronic/JJ exposure/NN to/IN cadmium/NN ,/, 23/CD workers/NNS removed/VBN from/IN exposure/NN because/IN of/IN the/DT discovery/NN of/IN an/DT increased/VBN urinary/JJ excretion/NN of/IN beta/NEWGENE 2-microglobulin/NEWGENE or/CC retinol/NEWGENE binding/NEWGENE protein/NEWGENE ,/, or/CC both/DT ,/, have/NN been/VBN examined/VBN once/CC a/DT year/NN for/IN five/CD years/NNS ./.
@@94952837813 We/PRP have/VBP examined/VBN reporter/NN gene/NN (/( beta-gal/NEWGENE )/SYM expression/NN directed/VBN by/IN human/NEWGENE heat/NEWGENE shock/NEWGENE transcription/NEWGENE factors/NEWGENE 1/NEWGENE and/NEWGENE 2/NEWGENE (/( HSF1/NEWGENE and/CC HSF2/NEWGENE )/SYM in/IN HeLa/DT cells/NNS and/CC in/IN yeast/NN (/( Saccharomyces/NN cerevisiae/NN )/SYM ./.
@@92433851137 Therefore/RB ,/, use/NN of/IN presaturation/NN is/VBZ recommended/VBN for/IN myocardial/JJ motion/NN studies/NNS using/VBG cine/NN PC/NN velocity/NN data/NN ./.
@@27677336245 The/DT histological/JJ grading/NN was/VBD certified/VBN in/IN 68/CD cases/NNS :/: 12/CD G1/NN ,/, 39/CD G2/NN ,/, 17/CD G3/NN ;/: extracapsular/JJ spread/NN was/VBD found/VBN in/IN 20/CD //CD 54/CD cases/NNS (/( 37%/JJ )/SYM ./.
@@60700725887 (/( 3/CD )/SYM ./.
@@86263131022 Expression/NNS of/IN Msp/NEWGENE was/VBD toxic/JJ to/IN E/NNP ./NNP coli/JJ when/CC the/DT entire/JJ msp/NEWGENE gene/NEWGENE was/VBD present/VB ./.
@@110440977598 High-mobility-group/NEWGENE protein/NEWGENE I/NEWGENE can/MD modulate/VB binding/NN of/IN transcription/NN factors/NNS to/IN the/PDT U5/NEWGENE region/NEWGENE of/IN the/DT human/NEWGENE immunodeficiency/NEWGENE virus/NEWGENE type/NEWGENE 1/NEWGENE proviral/NEWGENE promoter/NEWGENE ./.
@@70795956860 There/EX was/VBD a/DT significant/JJ correlation/NN between/IN tubular/JJ diameter/NN and/CC spg/NN (/( r/JJ =/SYM 0/CD ./CD 68/CD ,/, P/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM suggesting/VBG that/IN tubular/JJ diameter/NN measurements/NNS in/IN histological/JJ sections/NNS could/MD be/VB used/VBN to/IN predict/VB sperm/NN production/NN ./.
@@35439363125 The/DT rho/NEWGENE genes/NEWGENE comprise/VBP an/DT evolutionarily/RB conserved/VBN family/NN with/IN significant/JJ homology/NN to/IN the/DT ras/NEWGENE oncogene/NEWGENE family/NEWGENE ./.
@@19051992532 The/DT effect/NN of/IN ICRF-187/DT on/IN the/DT antitumor/JJ response/NN induced/VBN by/IN the/DT combination/NN of/IN ADR/NN and/CC WBH/NN was/VBD also/RB investigated/VBN in/IN order/NN to/IN assess/VB alterations/NNS in/IN the/DT therapeutic/JJ index/NN of/IN this/DT combined/JJ therapeutic/JJ modality/NN treatment/NN ./.
@@89901943584 The/DT syndrome/NN of/IN resistance/NN to/IN thyroid/JJ hormone/NN is/VBZ characterized/VBN by/IN elevated/JJ serum/JJ free/JJ thyroid/JJ hormones/NNS ,/, failure/NN to/IN suppress/VB pituitary/NEWGENE thyrotropin/NEWGENE secretion/NN ,/, and/CC variable/JJ peripheral/JJ refractoriness/NN to/IN hormone/NN action/NN ./.
@@26774298870 Survival/NNP rates/NNS for/IN the/DT original/JJ treatment/NN group/NN were/VBD 84/CD ./CD 5%/CD and/CC 57/CD ./CD 6%/CD at/IN 12/CD and/CC 21/CD months/NNS ,/, respectively/RB ;/: for/IN the/DT delayed/JJ treatment/NN group/NN ,/, 78/NN ./NN 8%/NN and/CC 64/CD ./CD 6%/CD at/IN 12/CD and/CC 21/CD months/NNS ,/, respectively/RB ,/, and/CC 78/CD ./CD 8%/CD and/CC 47/CD ./CD 5%/CD at/IN 12/CD and/CC 21/CD months/NNS ,/, respectively/RB ,/, for/IN 77/CD subjects/NNS with/IN AIDS/NN and/CC 93/CD ./CD 0%/CD and/CC 71/CD ./CD 8%/CD ,/, respectively/RB ,/, for/IN 50/CD subjects/NNS with/IN AIDS-related/NN complex/NN in/IN the/DT original/JJ treatment/NN group/NN ./.
@@106033498187 The/DT signalling/NN molecules/NN Wnt1/NEWGENE and/CC Sonic/NEWGENE hedgehog/NEWGENE ,/, implicated/VBN in/IN the/DT activation/NN of/IN Myf5/NEWGENE in/IN myogenic/JJ progenitor/NN cells/NNS in/IN the/DT somite/NN ,/, are/VBP also/RB produced/VBN in/IN the/DT viscinity/NN of/IN the/DT Myf5/NEWGENE expression/NEWGENE domain/NEWGENE in/IN the/DT mesencephalon/NN ./.
@@8626777127 Sequence/NN analysis/NN of/IN this/DT 100-bp/JJ Col2a1/NEWGENE enhancer/NEWGENE revealed/VBD several/DT sequence/NN motifs/NNS similar/JJ to/IN motifs/NNS present/VBP within/IN the/DT regulatory/JJ region/NN of/IN the/DT link/NEWGENE protein/NEWGENE gene/NEWGENE ,/, another/DT cartilage/NN gene/NN ./.
@@16348612237 This/DT is/VBZ in/IN contrast/NN with/IN the/DT classical/JJ 'oxygen/NN debt/NN hypothesis'/NN ,/, which/WDT states/VBZ that/IN the/DT oxygen/NN debt/NN and/CC lactate/NN clearance/NN are/VBP linked/JJ ./.
@@117870411641 Mental/NNP development/NN is/VBZ generally/RB normal/JJ ./.
@@49905565523 Reactivities/NNS to/IN horse/NEWGENE anti-lymphocyte/NEWGENE globulin/NEWGENE ./.
@@106576587330 Further/RB studies/VBZ in/IN T-24/NNP cells/NNS demonstrated/VBD that/IN HA/NN fragments/NN also/RB induced/VBN I/NEWGENE kappa/NEWGENE B/NEWGENE alpha/NEWGENE phosphorylation/NN and/CC degradation/NN ,/, kappa/NEWGENE B-linked/NEWGENE reporter/NEWGENE gene/NEWGENE expression/NN ,/, and/CC ICAM-1/NEWGENE promoter/NEWGENE activity/NN in/IN an/DT NF-kappa/NNP B-dependent/NN manner/NN ./.
@@112741095206 Acetoin/NN can/MD be/VB reused/VBN by/IN the/DT bacteria/NNS during/IN stationary/JJ phase/NN when/CC other/DT carbon/NN sources/NNS have/VBP been/VBN depleted/VBN ./.
@@8549706449 An/DT epidemic/NN of/IN hepatitis/NN B/NN virus/NN infection/NN among/IN intravenous/JJ drug/NN users/NNS in/IN Iceland/NN ./.
@@57428795691 Transformations/NNS in/IN the/DT morphine/NN series/NN ./.
@@46211885054 Morphology/NNS of/IN bacteriophages/NNS of/IN Klebsiella/NN bacilli/NNS ./.
@@30179964311 During/IN the/DT biosynthesis/NN of/IN all/DT three/CD mutant/JJ polypeptides/NNS ,/, the/DT signal/JJ peptide/NN is/VBZ efficiently/RB and/CC accurately/RB cleaved/VBN from/IN the/DT nascent/JJ protein/NN ,/, even/VB though/CC in/IN mutants/NNS X2/NN and/CC X3/NN the/DT cleavage/NN site/NN itself/PRP has/VBZ been/VBN altered/VBN ./.
@@30364151005 Influence/NNS of/IN cyclo-oxygenase/NEWGENE inhibition/NN and/CC of/IN leukotriene/NEWGENE receptor/NEWGENE blockade/NN on/IN pulmonary/JJ vascular/JJ pressure/NN //NN cardiac/NN index/NN relationships/NNS in/IN hyperoxic/JJ and/CC in/IN hypoxic/JJ dogs/NNS ./.
@@23589759508 Of/IN the/DT remaining/JJ seven/NN ,/, five/CD reacted/VBN either/DT with/IN immediate/JJ and/CC strong/JJ symptoms/NNS or/CC had/VBP spontaneously/RB reduced/VBN gluten/NEWGENE intake/NN ,/, or/CC had/VBP an/DT acquired/VBN IgA/NEWGENE deficiency/NN ./.
@@40269032598 Polysorbate/NN 80/NN did/VBD not/RB have/VB a/DT direct/JJ stimulant/JJ or/CC relaxant/JJ effect/NN on/IN either/DT guinea/NN pig/NN ileum/NN or/CC rat/NN uterus/NN ,/, however/RB ,/, it/PRP antagonised/VBN the/DT contractions/NNS induced/VBN by/IN acetylcholine/NN ,/, histamine/NN ,/, barium/NN ,/, 5-hydroxytryptamine/NN and/CC carbachol/NN in/IN a/DT dose-dependent/NN manner/NN ./.
@@102090211711 The/DT molecular/JJ mechanism/NN by/IN which/WDT Gle2p/NEWGENE and/CC the/DT Gle2p-Nup116p/NEWGENE interaction/NN function/NN in/IN mRNA/NN export/NN is/VBZ unknown/JJ ./.
@@20229209 The/DT C4BP/NEWGENE alpha/NEWGENE gene/NEWGENE is/VBZ organized/VBN as/IN follows/VBZ :/: the/DT first/JJ exon/NN codes/NNS for/IN the/DT first/JJ 198/CD nucleotides/NNS of/IN the/DT 5'/CD UTR/NNS ./.
@@93177579283 EXERCISE/NNP IN/IN THE/DT TERRESTRIAL/NNP CHRISTMAS/NNP ISLAND/NNP RED/VBD CRAB/ORG GECARCOIDEA/NNP NATALIS/ORG -/: ENERGETICS/NN OF/IN LOCOMOTION/NN ./.
@@39816408536 We/PRP have/VBP now/RB located/VBN the/DT 5'/CD ends/NNS of/IN the/DT two/JJ remaining/JJ late/JJ mRNAs/NNS ./.
@@7980468836 Acta/NN 572/CD ,/, 113-120/NN ]/NN ./.
@@99173877132 The/DT RNA/NEWGENE polymerase/NEWGENE III-recruiting/NEWGENE factor/NEWGENE TFIIIB/NEWGENE induces/VBZ a/DT DNA/NN bend/NN between/IN the/DT TATA/NN box/NN and/CC the/DT transcriptional/JJ start/NN site/NN ./.
@@81395432771 To/TO search/VB for/IN genes/NNS that/WDT interact/VBP with/IN the/DT SLK1-SLT2/NEWGENE pathway/NN ,/, a/DT synthetic/JJ lethal/JJ suppression/NN screen/NN was/VBD carried/VBN out/RB ./.
@@27009773371 Scotchbond/NNP 2/CD showed/VBD the/DT least/JJ dye/NN penetration/NN but/CC not/RB statistically/RB less/PRP than/IN the/DT XR/NN bond/NNP //NNP Silus/NNP Plus/NNP combination/NN ./.
@@98149059791 The/DT consequences/NNS of/IN intensive/JJ swine/NN production/NN on/IN the/DT environment/NN and/CC possible/JJ solutions/NNS by/IN means/NN of/IN nutrition/NN are/VBP outlined/VBN ./.
@@115172695550 Pitx2/NEWGENE rescues/VBP the/DT GABAergic/JJ differentiation/NN defect/NN and/CC partially/RB rescues/VBP the/DT axon/NN guidance/NN and/CC behavioral/JJ phenotypes/NNS of/IN unc-30/NEWGENE mutants/NEWGENE ,/, indicating/VBG a/DT high/JJ degree/NN of/IN functional/JJ conservation/NN between/IN these/DT evolutionarily/RB related/VBN genes/NNS ./.
@@21532438093 These/DT data/NN strongly/RB implicate/VB the/DT normal/JJ product/NN of/IN the/DT int-2/NEWGENE gene/NEWGENE ,/, which/WDT is/VBZ related/VBN to/IN the/DT fibroblast/NEWGENE growth/NEWGENE factor/NEWGENE family/NEWGENE ,/, as/IN a/DT contributory/JJ factor/NN in/IN virally/RB induced/VBN mammary/JJ tumors/NNS ./.
@@99275895309 Similarity/NN of/IN DNA/NN binding/JJ and/CC transcriptional/JJ regulation/NN by/IN Caenorhabditis/NEWGENE elegans/NEWGENE MAB-3/NEWGENE and/CC Drosophila/NEWGENE melanogaster/NEWGENE DSX/NEWGENE suggests/VBZ conservation/NN of/IN sex/NN determining/JJ mechanisms/NNS ./.
@@1285358141 Serum/NN gastrin/NEWGENE and/CC AFP/NEWGENE levels/NNS had/VBP the/DT same/JJ evolution/NN and/CC appear/VB to/IN have/NN the/DT same/JJ interest/NN to/IN follow/VB the/DT course/NN of/IN the/DT disease/NN ./.
@@8453101501 Pokeweed/NEWGENE mitogen/NEWGENE (/( PWM/NEWGENE )/SYM or/CC anti-CD3/NEWGENE significantly/RB increases/VBZ c-jun/NEWGENE messenger/NEWGENE RNA/NEWGENE (/NEWGENE mRNA/NEWGENE )/NEWGENE levels/NNS in/IN T/NN cells/NNS ./.
@@23843898676 The/DT same/JJ trend/NN was/VBD noted/VBN between/IN YG/NN 4/NN ./NN 5/NN heifers/NNS and/CC YG/NN 5/NN ./NN 5/NN steers/VBZ ,/, indicating/VBG a/DT sex-related/JJ deposition/NN of/IN seam/NN fat/JJ in/IN fed/VBN cattle/NNS ./.
@@16459058724 Nucleoprotein/NN (/( N/JJ )/SYM expressed/VBN by/IN both/DT recombinant/JJ vaccinia/NN virus/NN and/CC TGEV/DT had/VBP a/DT relative/JJ molecular/JJ mass/JJ (/( Mr/NNP )/SYM of/IN 47/CD ,/CD 000/CD and/CC was/VBD susceptible/JJ to/IN degradation/NN at/IN the/DT C-terminus/JJ yielding/JJ discrete/JJ breakdown/NN products/NNS ./.
@@19617475479 A/DT herpesvirus/NEWGENE proteinase/NEWGENE activity/NN has/VBZ been/VBN identified/VBN and/CC partially/RB characterized/VBN by/IN using/VBG the/DT cloned/VBN enzyme/NN and/CC substrate/NN genes/NNS in/IN transient/JJ transfection/NN assays/NNS ./.
@@110993776001 Molecular/NNP cloning/NN and/CC expression/NN of/IN human/NEWGENE UDP-d-Xylose/NEWGENE :/NEWGENE proteoglycan/NEWGENE core/NEWGENE protein/NEWGENE beta-d-xylosyltransferase/NEWGENE1 and/CC its/PRP first/JJ isoform/NEWGENE XT-II/NEWGENE ./.
@@70636065686 Microwave/NNP hyperthermia-induced/NN blood-brain/NN barrier/NN alterations/NNS ./.
@@36637899382 These/DT results/NNS suggest/VBP that/IN less/PRP antidopaminergic/JJ activity/NN of/IN RHAL/NN in/IN this/DT neuroleptic/JJ test/NN might/MD be/VB explained/VBN by/IN the/DT lesser/JJ conversion/NN of/IN RHAL/NN to/IN HAL/NNP ./.
@@34573304900 All/DT patients/NNS had/VBP the/DT CA/NEWGENE 125/NEWGENE assay/NN performed/VBN within/IN one/PRP week/NN before/IN their/PRP second-look/JJ operation/NN ./.
@@54174315537 Early/JJ disagnosis/NN of/IN cancer--50/JJ per/IN cent/NN of/IN all/DT patients/NNS could/MD be/VB cured/VBN ./.
@@107049754752 Thiopentone/NNP sodium/NN administered/VBN at/IN 30/CD and/CC 10/CD min/NN before/IN or/CC 5/CD ,/, 10/CD and/CC 15/CD min/NN after/IN exposure/NN to/IN NOC-5/NN ,/, but/CC not/RB thereafter/RB ,/, significantly/RB attenuated/VBN NO-induced/JJ neurotoxicity/NN compared/VBN with/IN controls/NNS ./.
@@96181644183 Essentially/RB ,/, 2'-/JJ O/NN -methyl/NN oligoribonucleotides/NN (/( 2'OMeRNA/NN )/SYM were/VBD delivered/VBN to/IN the/DT nuclei/NNS of/IN primary/NN mdx/NN myoblasts/NNS in/IN culture/NN ./.
@@74290097290 Microscopic/JJ anatomy/NN and/CC cell/NN population/NN dynamics/NNS ./.
@@1141595275 Angina/NNS (/( Q/JJ )/SYM persistence/NN showed/VBD marked/JJ associations/NNS with/IN previous/JJ myocardial/JJ infarction/NN ,/, diagnosed/VBN angina/NN ,/, electrocardiogram/NN ischemia/NN ,/, and/CC subsequent/JJ major/JJ ischemic/JJ heart/NN disease/NN events/NNS from/IN Q5/NN onward/RB ./.
@@77056277434 We/PRP propose/VBP that/IN Mad/NEWGENE and/CC Medea/NEWGENE encode/VB rate-limiting/JJ components/NNS integral/JJ to/IN dpp/NEWGENE pathways/NEWGENE throughout/IN development/NN ./.
@@104826206550 Furthermore/RB ,/, we/PRP demonstrate/VBP that/DT transcription/NN from/IN the/DT MMTV/NEWGENE 5'/NEWGENE LTR/NEWGENE is/VBZ highly/RB active/JJ in/IN the/DT absence/NN of/IN Stat5a/NEWGENE ,/, a/DT transcription/NN factor/NN that/WDT had/VBP been/VBN shown/VBP previously/RB to/IN be/VB required/VBN for/IN transcription/NN from/IN the/DT MMTV/NEWGENE LTR/NEWGENE ./.
@@10967361795 Functional/JJ magnetic/JJ resonance/NN imaging/JJ (/( fMRI/NN )/SYM has/VBZ been/VBN increasingly/RB used/VBN in/IN studying/VBG human/JJ brain/NN function/NN given/VBP its/PRP non-invasive/JJ feature/NN and/CC good/JJ spatial/JJ resolution/NN ./.
@@40214374689 Viral/JJ infections/NNS have/VBP long/RB been/VBN suspected/VBN to/IN be/VB causative/JJ agents/NNS in/IN a/DT number/NN of/IN inner/JJ ear/NN dysfunctions/NNS ./.
@@47273445119 Microdetermination/NNS of/IN adrenocortical/JJ steroids/NNS by/IN double/JJ isotope/NN method/NN ./.
@@100523716483 STUDY/NN DESIGN/IN :/: Salivary/NEWGENE immunoglobulin/NEWGENE A/NEWGENE levels/NNS of/IN each/DT of/IN 20/CD subjects/NNS were/VBD determined/VBN on/IN 3/CD occasions/NNS :/: first/JJ ,/, while/CC the/DT subject/NN was/VBD still/JJ smoking/NN ;/: second/JJ ,/, 7/CD days/NNS after/IN cessation/NN of/IN smoking/NN ;/: third/RB ,/, on/IN the/DT 14th/CD day/NN after/IN cessation/NN ./.
@@33827724071 Practical/JJ interest/NN of/IN such/JJ studies/NNS is/VBZ limited/VBN since/IN the/DT pharmacokinetic/JJ parameters/NNS are/VBP systematically/RB evaluated/VBN in/IN man/NN during/IN phase/NN I/PRP trials/NNS ./.
@@63622396157 Martin/NNP Luther/NNP and/CC his/PRP physicians/NNS ./.
@@40497994724 40/NN ,/NN 000/NN )/NN ./.
@@111127909720 These/DT results/NNS also/RB suggest/VBP the/DT involvement/NN of/IN additional/JJ elements/NNS in/IN the/DT UPR/NN ./.
@@10811079619 RESULTS/NNS :/: Abnormal/JJ color/NN perception/NN was/VBD found/VBN in/IN 32%/NN of/IN the/DT epilepsy/NN patients/NNS treated/VBN with/IN vigabatrin/NN monotherapy/NN and/CC 28%/NN of/IN the/DT epilepsy/NN patients/NNS treated/VBN with/IN carbamazepine/NN monotherapy/NN ./.
@@71433476956 Cramps/NNP in/IN extrapyramidal/JJ disorders/NNS ./.
@@111618163090 Interestingly/RB ,/, the/DT similarities/NNS with/IN the/DT endophilin/NEWGENE proteins/NEWGENE cover/NN the/DT entire/JJ sequence/NN of/IN the/DT SH3GLB/NEWGENE family/NEWGENE ,/, suggesting/VBG a/DT common/JJ fold/NN and/CC presumably/RB a/DT common/JJ mode/NN of/IN action/NN ./.
@@63216345015 Each/DT of/IN these/DT spliced/VBN mRNAs/NNS has/VBZ an/DT untranslated/JJ leader/NN sequence/NN of/IN 249/CD bases/NNS and/CC a/DT single/JJ intron/NN of/IN approximately/RB 540/CD bases/NNS which/WDT are/VBP contained/VBN entirely/RB within/IN TRs/NN //NN IRs/NN sequences/NN ./.
@@87025568539 We/PRP previously/RB described/VBD the/DT purification/NN of/IN an/DT 83-kDa/NEWGENE phosphatidic/NEWGENE acid/NEWGENE phosphatase/NEWGENE (/( PAP/NEWGENE )/SYM from/IN the/DT porcine/JJ thymus/NN membranes/NNS (/( Kanoh/NNP ,/, H/NNP ./NNP ,/, Imai/NNP ,/, S/NNP ./NNP -i/NNP ./NNP ,/, Yamada/NNP ,/, K/NNP ./NNP and/CC Sakane/NNP ,/, F/NN ./NN (/NN 1992/NN )/SYM J/NNP ./NNP
@@88445774265 Tilmicosin/NN is/VBZ a/DT novel/JJ macrolide/NN antibiotic/RB developed/VBD for/IN exclusive/JJ use/NN in/IN veterinary/JJ medicine/NN ./.
@@105330666224 TSC1/NEWGENE mutations/NEWGENE include/VBP two/JJ nonsense/JJ mutations/NNS ,/, four/CD insertions/NNS ,/, and/CC three/CD splice/NN mutations/NNS ./.
@@112665409547 We/PRP have/VBP now/RB tested/VBN all/DT known/VBP mammalian/NEWGENE Groucho/NEWGENE family/NEWGENE members/NEWGENE for/IN their/PRP ability/NN to/IN interact/VB specifically/RB with/IN individual/JJ Tcf/NEWGENE //NEWGENE Lef/NEWGENE family/NEWGENE members/NEWGENE ./.
@@67956546564 Fenfluramine/NNP (/( in/IN doses/NNS ranging/VBG from/IN 0/CD ./CD 0625-4/CD ./CD 0/CD mg/NN //NN kg/NN //NN infusion/NN )/SYM did/VBD not/RB maintain/VB self-administration/NN behavior/NN at/IN or/CC above/RB the/DT minimum/JJ requirement/NN (/( FR/NN 30/CD )/SYM ./.
@@94871303629 No/DT difference/NN in/IN telomere/NN length/NN was/VBD seen/VBP in/IN mutants/NNS affected/VBN in/IN the/DT regulation/NN of/IN Cdc2/NEWGENE ,/, whereas/IN some/DT of/IN the/DT DNA/NN repair/NN mutants/NN examined/VBN had/VBP slightly/RB longer/JJR telomeres/NNS than/IN did/VBD the/DT wild/JJ type/NN ./.
@@7045156187 Using/VBG an/DT opsonophagocytic/JJ bacterial/JJ assay/NN and/CC a/DT suckling/JJ rat/NN model/NN of/IN GBS/NN sepsis/NN ,/, we/PRP analyzed/VBD a/DT modified/JJ human/NEWGENE immunoglobulin/NEWGENE for/IN opsonic/JJ and/CC protective/JJ antibody/NN ./.
@@9108239058 Near/IN term/NN ,/, under/IN experimental/JJ conditions/NNS ,/, maternal/JJ and/CC fetal/JJ blood/NN gases/NNS ,/, pH/NN ,/, uterine/JJ and/CC umbilical/JJ blood/NN flows/NNS were/VBD measured/VBN or/CC calculated/VBN ./.
@@78886299725 Translation/NNP of/IN the/DT coding/JJ segment/NN ,/, which/WDT was/VBD designated/VBN MsPRP2/NEWGENE ,/, suggested/VBD it/PRP encodes/VBZ a/DT chimeric/JJ 40/CD ,/CD 569/CD Da/NNP cell/NN wall/NN protein/NN with/IN an/DT amino-terminal/NN signal/NN sequence/NN ,/, a/DT repetitive/JJ proline-rich/JJ sequence/NN ,/, and/CC a/DT cysteine-rich/JJ carboxyl-terminal/NN sequence/NN homologous/JJ to/IN nonspecific/NN lipid/NN transfer/NN proteins/NN ./.
@@19859203166 Cloning/VBG ,/, expression/NN ,/, and/CC nucleotide/NN sequence/NN of/IN rat/NEWGENE liver/NEWGENE sterol/NEWGENE carrier/NEWGENE protein/NEWGENE 2/NEWGENE cDNAs/NEWGENE ./.
@@89851098927 Just/RB before/IN inserting/VBG on/IN the/DT anterior/JJ margin/NN and/CC apex/NN of/IN the/DT iliac/JJ crest/NN it/PRP widens/VBZ ,/, assuming/VBG the/DT aspect/NN of/IN a/DT small/JJ cone/NN ./.
@@78290571766 Integrated/NNP mapping/NN analysis/NN of/IN the/DT Werner/NEWGENE syndrome/NEWGENE region/NEWGENE of/IN chromosome/NN 8/CD ./CD
@@8111035132 The/DT cis-acting/JJ regulatory/JJ properties/NNS of/IN an/DT 872/CD bp/NN promoter/NN fragment/NN of/IN a/DT B/NNP ./NNP napus/NN oleosin/NEWGENE gene/NEWGENE were/VBD examined/VBN by/IN analysis/NN of/IN beta-glucuronidase/NEWGENE (/( GUS/NEWGENE )/SYM expression/NN in/IN transgenic/JJ tobacco/NN plants/NNS containing/JJ an/DT oleosin/NEWGENE promoter-GUS/NEWGENE transcriptional/NEWGENE fusion/NEWGENE ./.
@@11201250524 Plasma/NN DHE/NN concentration/NN rose/VBD promptly/RB above/RB 5/CD ng/NN //NN ml/NN after/IN the/DT application/NN of/IN the/DT PSA/NN tape/NN onto/IN the/DT damaged/VBN skin/NN in/IN hairless/JJ rat/NN ./.
@@8001417991 39-47/CD ./.
@@29062491881 In/NN the/DT first/JJ group/NN ,/, 0/NN ./NN 02%/NN Prazosin/NN (/( 0/CD ./CD 5/CD mg/CD //CD kg/CD )/SYM was/VBD administered/VBN intravenously/RB for/IN 1/CD ./CD 5/CD hours/NNS before/IN the/DT application/NN of/IN Oxy-Hb/NNP or/CC PGF2/NEWGENE alpha/NEWGENE ./.
@@76225214894 Based/VBN on/IN previous/JJ mapping/NN of/IN the/DT G/NEWGENE beta/NEWGENE gamma/NEWGENE binding/NEWGENE region/NEWGENE of/IN beta/NEWGENE ARK/NEWGENE ,/, and/CC conserved/VBN residues/NNS within/IN the/DT PH/NEWGENE domain/NEWGENE ,/, we/PRP have/VBP constructed/VBN a/DT series/NN of/IN mutants/NNS in/IN the/DT carboxyl/NN terminus/NN of/IN beta/NEWGENE ARK/NEWGENE in/IN order/NN to/IN determine/VB important/JJ residues/NNS involved/VBN in/IN G/NEWGENE beta/NEWGENE gamma/NEWGENE and/CC PIP2/NN binding/JJ ./.
@@88222083082 Altogether/RB ,/, the/DT results/NNS demonstrate/VBP that/IN the/DT two/JJ isoforms/NNS elicit/VBP similar/JJ responses/NNS in/IN vivo/NN despite/IN differences/NNS in/IN their/PRP regulation/NN ./.
@@88780441493 An/DT InlC/NEWGENE deletion/NEWGENE mutant/NEWGENE shows/NNS reduced/VBD virulence/NN when/CC tested/VBN in/IN an/DT intravenous/JJ mouse/NN model/NN ,/, but/CC intracellular/JJ replication/NN of/IN the/DT mutant/NN in/IN Caco-2/CELL and/CC J774/CELL cells/NNS appears/VBZ to/IN be/VB comparable/JJ with/IN that/DT of/IN the/DT wild-type/NN strain/NN ./.
@@84443448888 Zinc/NN fingers/NNS (/( Zf/NNP )/SYM are/VBP a/DT common/JJ structural/JJ motif/NN found/VB in/IN many/JJ nucleic/JJ acid-binding/NN proteins/NN ./.
@@2315472989 When/WRB normalized/VBN for/IN imaging/VBG time/NN ,/, all/DT parameters/NNS are/VBP significantly/RB higher/JJ with/IN RASE/NN ,/, with/IN a/DT C/NNP //NNP A/NNP per/IN unit/NN time/NN that/WDT was/VBD 338%/NN higher/JJ ./.
@@28387101626 The/DT levels/NNS of/IN NPY-ir/NEWGENE in/IN the/DT rat/NN vas/NN deferens/NN were/VBD not/RB affected/VBN by/IN either/DT surgical/JJ or/CC pharmacological/JJ treatment/NN ./.
@@114514475365 Gimpl/NNP ,/, F/NN ./NN
@@72051207030 A/DT transparent/JJ overlay/NN for/IN assessing/JJ amplitude/NN of/IN ECG/NN wave/NN forms/NNS ./.
@@14548194059 Mono-ADP-ribosylation/NNS is/VBZ a/DT reversible/JJ modification/NN of/IN proteins/NNS ,/, with/IN NAD/NN :/: arginine/NEWGENE ADP-ribosyltransferases/NEWGENE (/( EC/NEWGENE 2/NEWGENE ./NEWGENE 4/NEWGENE ./NEWGENE 2/NEWGENE ./NEWGENE 31/NEWGENE )/SYM and/CC ADP-ribosylarginine/NEWGENE hydrolases/NEWGENE (/( EC/NEWGENE 3/NEWGENE ./NEWGENE 2/NEWGENE ./NEWGENE 2/NEWGENE ./NEWGENE 19/NEWGENE )/SYM catalyzing/VBG the/DT opposing/JJ reactions/NNS in/IN an/DT ADP-ribosylation/NN cycle/NN ./.
@@113766874848 A/DT single/JJ nucleotide/NN polymorphism/NN (/( SNP/NN )/SYM in/IN exon/NN 2/CD ,/, which/WDT is/VBZ tightly/RB liked/VBN to/IN another/DT SNP/NN (/( GTG83/NN //NN ATG83/NN )/SYM ,/, creates/VBZ an/DT additional/JJ alternative/JJ in-frame/NN AUG/NNS in/IN B-type/NEWGENE MTH1/NEWGENE mRNAs/NEWGENE yielding/VBG the/DT fourth/NN MTH1/NEWGENE polypeptide/NEWGENE ,/, p26/NEWGENE that/WDT possesses/VBZ an/DT additional/JJ mitochondrial/JJ targeting/JJ signal/NN ./.
@@35366824207 Ovulation/NNS was/VBD induced/VBN in/IN 8/CD (/( 56/CD ./CD 7%/CD )/SYM patients/NNS who/WP conceived/VBD ./.
@@27364823427 In/NN contrast/NN ,/, despite/IN external/NN radiation/NN therapy/NN ,/, brain/NN metastases/NNS proved/VBD fatal/JJ ./.
@@103297362236 As/IN determined/VBN in/IN a/DT modified/JJ yeast/NN two-hybrid/JJ system/NN ,/, mIRS3/NEWGENE bound/JJ strongly/RB to/IN the/DT p85/NEWGENE subunit/NEWGENE of/IN phosphatidylinositol/NEWGENE 3-kinase/NEWGENE ./.
@@668122818 Analysis/NNP of/IN liver/NN biopsy/NN specimens/NNS from/IN patients/NNS with/IN hepatitis/NN showed/VBD a/DT large/JJ variation/NN in/IN the/DT mean/JJ iron/NN content/NN of/IN the/DT liver/NN ferritin/NEWGENE molecules/NN ./.
@@39701918957 Electrical/NNP activity/NN was/VBD evaluated/VBN by/IN monitoring/VBG the/DT general/JJ electrocorticogram/NN (/( ECoG/NNS )/SYM as/RB well/VB as/IN local/JJ DC/JJ steady/JJ potential/JJ (/( two/JJ sites/NNS )/SYM ./.
@@26271593808 The/DT antigen-specific/NEWGENE IgG4/NEWGENE antibody/NEWGENE seems/VBZ to/IN be/VB an/DT index/NN in/IN evaluating/VBG immunotherapy/NN objectively/RB ./.
@@97974563333 BACKGROUND/IN :/: The/DT c-myc/NEWGENE proto-oncogene/NEWGENE has/VBZ been/VBN suggested/VBN to/IN play/NN key/NN roles/NNS in/IN cell/NN proliferation/NN ,/, differentiation/NN ,/, transformation/NN and/CC apoptosis/NN ./.
@@82044268177 Simultaneous/JJ ,/, bilateral/JJ and/CC permanent/JJ ventilation/NN with/IN a/DT diaphragm/NN pacing/NN in/IN childhood/NN :/: the/DT implantation/NN technique/NN and/CC indications/NNS ./.
@@97537308205 T7/NN transcription/NN could/MD be/VB manipulated/VBN to/IN achieve/VB different/JJ levels/NNS of/IN constitutive/JJ expression/NN ,/, through/RB the/DT use/NN of/IN promoter/NN mutations/NNS ./.
@@9606633412 Interferon/NEWGENE beta/NEWGENE therapy/NN was/VBD discontinued/VBN for/IN 4/CD weeks/NNS ./.
@@77294279855 Deletion/NNS analysis/NN indicates/VBZ that/DT TBP/NEWGENE and/CC hTAFII18/NEWGENE bind/VB to/IN distinct/JJ domains/NNS of/IN hTAFII28/NEWGENE ./. hTAFII18/NEWGENE also/RB interacts/VBZ with/IN TBP/NEWGENE ,/, but/CC it/PRP interacts/VBZ more/RB strongly/RB with/IN hTAFII28/NEWGENE and/CC hTAFII30/NEWGENE ./.
@@91992865807 The/DT coding/JJ region/NN of/IN mkh1/NEWGENE is/VBZ contained/VBN within/IN a/DT single/JJ exon/NN encoding/VBG a/DT 1/JJ ,/JJ 116-amino-acid/JJ protein/NN ./.
@@10886067712 The/DT outer/JJ diameter/NN and/CC the/DT thickness/NN of/IN the/DT rotor/NN are/VBP 60/CD mm/NN and/CC 8/CD mm/NN ,/, respectively/RB ./.
@@31500158372 Clinical/NNP research/NN of/IN non-A/NN ,/, non-B/NN post-transfusion/JJ hepatitis/NN ./.
@@35173889637 The/DT highest/JJS postoperative/JJ CK-MB/NEWGENE level/NN was/VBD less/PRP after/IN BC/NN (/( BC/NN ,/, 31/NN +/NN //NN -/NN 17/CD U/NNS //NNS L/NNS ;/: CC/NN ,/, 56/NN +/NN //NN -/NN 13/CD U/NNS //NNS L/NNS ;/: p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@89223903040 The/DT current/JJ study/NN defines/VBZ the/DT vinculin-/NEWGENE and/CC FAK-interaction/NEWGENE domains/NEWGENE on/IN paxillin/NEWGENE and/CC identifies/VBZ the/DT principal/JJ paxillin/NEWGENE focal/NEWGENE1 adhesion/NEWGENE1 targeting/NEWGENE1 motif/NEWGENE1 ./.
@@28257503525 In/NN 44/CD evaluable/JJ patients/NNS the/DT response/NN rate/NN was/VBD 50%/CD ,/, with/IN one/PRP complete/JJ response/NN ./.
@@62404489113 The/DT effect/NN of/IN treatment/NN may/MD thus/RB be/VB divided/VBN into/IN two/JJ main/JJ phases--an/NN initial/JJ phase/NN with/IN a/DT reduction/NN in/IN LV/JJ mass/JJ and/CC a/DT reduction/NN in/IN cardiac/JJ output/NN and/CC no/DT change/NN in/IN total/JJ peripheral/NN resistance--and/VBD a/DT second/JJ phase/NN with/IN a/DT constant/NN LV/NN mass/JJ but/CC an/DT increase/NN in/IN cardiac/JJ output/NN to/IN the/DT pretreatment/JJ level/NN again/RB and/CC a/DT concomitant/JJ decrease/NN in/IN total/JJ peripheral/JJ resistance/NN ./.
@@97763603401 NF-kappaB/NEWGENE ,/, which/WDT is/VBZ probably/RB important/JJ for/IN basal/JJ activity/NN of/IN the/DT human/NEWGENE NOS/NEWGENE II/NEWGENE promoter/NEWGENE ,/, is/VBZ unlikely/JJ to/RB function/NN as/IN a/DT major/JJ effector/NN of/IN CM/NN in/IN DLD-1/NNP cells/NNS ./.
@@90174438983 A/DT false/JJ positive/JJ marker/NN screen/NN was/VBD associated/VBN with/IN the/DT occurrence/NN of/IN hand-foot/JJ syndrome/NN even/VB when/CC the/DT effect/NN of/IN regimen/NN was/VBD accounted/VBN for/IN by/IN stratification/NN (/( p/NN =/SYM ./CD 01/CD )/SYM ./.
@@295553653 With/IN the/DT exception/NN of/IN virus/NN assay/NN and/CC quantitation/NN ,/, these/DT methods/NNS are/VBP simple/JJ and/CC inexpensive/JJ enough/RB to/IN be/VB done/VBP in/IN typical/JJ shellfish/NN microbiology/NN laboratories/NNS ./.
@@21870912805 Pulmonary/NNP vascular/JJ resistance/NN was/VBD not/RB altered/VBN ,/, ejection/NN fraction/NN remained/VBD unchanged/JJ and/CC isovolumic/JJ relaxation/NN period/NN was/VBD lengthened/VBN (/( 119/CD +/NN //NN -/NN 20/CD ./CD 1/CD to/IN 147/CD ./CD 39/CD +/NN //NN -/NN 21/CD ./CD 15/CD ,/, P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@111211184238 Presently/RB four/CD unique/JJ variants/NNS carrying/JJ distinct/JJ GAF/NEWGENE sequences/NEWGENE in/IN the/DT N-terminal/NN region/NN have/NN been/VBN identified/VBN ./.
@@81033792843 Through/IN a/DT stretch/NN of/IN 56/CD amino/JJ acids/NNS ,/, constituting/VBG the/DT MADS/NEWGENE domain/NEWGENE ,/, the/DT two/JJ proteins/NNS are/VBP identical/JJ except/VB for/IN two/JJ conservative/JJ amino/JJ acid/NN substitutions/NNS ./.
@@109381352854 The/DT ability/NN of/IN SMRT/NEWGENE to/IN associate/NN with/IN these/DT transcription/NN factors/NNS and/CC thereby/RB to/IN mediate/VB repression/NN is/VBZ strongly/RB inhibited/VBN by/IN activation/NN of/IN tyrosine/NEWGENE kinase/NEWGENE signaling/JJ pathways/NNS ,/, such/JJ as/IN that/DT represented/VBD by/IN the/DT epidermal/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE ./.
@@13601803471 Finally/RB ,/, we/PRP determined/VBD that/IN the/DT P68/NEWGENE amino/JJ terminus/NN was/VBD both/DT necessary/JJ and/CC sufficient/JJ for/IN binding/JJ dsRNA/NN as/IN we/PRP were/VBD able/JJ to/IN transfer/NN dsRNA-binding/JJ properties/NNS to/IN a/DT reporter/NN gene/NN product/NN previously/RB unable/JJ to/IN bind/NN RNA/NN ./.
@@9583823603 METHODS/IN :/: A/DT total/NN of/IN 15/CD pigs/NNS were/VBD randomised/JJ to/IN ligation/NN of/IN left/NN marginal/JJ arteries/NNS (/( infarction/NN group/NN ,/, n/NN =/SYM 5/CD )/SYM ,/, to/IN TMLR/NN of/IN the/DT left/JJ lateral/JJ wall/NN using/VBG a/DT holmium/NN :/: yttrium-aluminium/JJ garnet/NN (/( Ho/NN :/: YAG/NN )/SYM laser/NN (/( laser/NN group/NN ,/, n/NN =/SYM 5/CD )/SYM ,/, and/CC to/IN both/DT (/( laser-infarction/JJ group/NN ,/, n/NN =/SYM 5/CD )/SYM ./SYM
@@18953935043 Moreover/RB ,/, promoters/NN containing/NN a/NN TATA/NN box/NN in/IN the/DT absence/NN of/IN Sp1/NEWGENE sites/NEWGENE or/CC Sp1/NEWGENE sites/NEWGENE in/IN the/DT absence/NN of/IN a/DT TATA/NN box/NN were/VBD equally/RB inducible/JJ in/IN vitro/FW ,/, as/IN was/VBD an/DT RNA/NEWGENE polymerase/NEWGENE III/NEWGENE promoter/NEWGENE ./.
@@2284393294 Further/JJ research/NN is/VBZ recommended/VBN to/IN identify/VB the/DT coping/JJ styles/NNS associated/VBN with/IN the/DT high/JJ EE/NN //NN low/NN EE/NN research/NN classification/NN ./.
@@79492057927 Curiously/RB ,/, testololactone/NN was/VBD earlier/JJR and/CC more/RB widely/RB used/VBN than/IN aminoglutethimide/NN in/IN treating/JJ advanced/JJ breast/NN carcinoma/NN ./.
@@82817406955 Responses/NNS to/IN the/DT Plowright/NNP Rinderpest/NNP vaccine/NN by/IN 43/CD calves/NNS and/CC 70/CD adult/JJ cattle/NNS in/IN Uganda/NN in/IN 1990/CD ,/, through/RB the/DT production/NN of/IN IgG/NEWGENE antibodies/NEWGENE ,/, were/VBD monitored/VBN for/IN 4/CD weeks/NNS using/VBG the/DT ELISA/NN assay/NN ./.
@@87456696892 Fifty-one/NNS patients/NNS with/IN primary/JJ refractory/JJ or/CC relapsed/VBN malignant/JJ lymphoma/NN (/( 47/CD non-Hodgkin's/JJ lymphoma/NN and/CC four/CD Hodgkin's/NNP disease/NN )/SYM were/VBD treated/VBN with/IN a/DT new/JJ chemotherapeutic/JJ regimen/NN (/( cisplatinum/NN ,/, methyl/NN GAG/NN ,/, bleomocyin/NN ,/, methyl/NN prednisolon/NN )/SYM ./.
@@38694424726 In/NN addition/NN ,/, marked/JJ hypertension/NN accompanied/VBD this/DT disorder/NN and/CC all/DT abnormalities/NNS ,/, including/JJ the/DT hypertension/NN ,/, responded/VBN to/IN 1-desamino-8-D-arginine/NEWGENE vasopressin/NEWGENE therapy/NN ./.
@@8899719933 These/DT two/JJ contigs/NNS contain/VBP a/DT total/NN of/IN 163/CD open/JJ reading/JJ frames/NNS (/( ORFs/NNS )/SYM in/IN 26-29/CD putative/JJ operons/NNS ;/: 56/CD ORFs/NNS could/MD be/VB identified/VBN with/IN reasonable/JJ certainty/NN ./.
@@61991326019 Toxicity/NNS was/VBD significant/JJ in/IN selected/VBN cases/NNS ;/: three/CD patients/NNS developed/VBD WBC/NN counts/NNS less/PRP than/IN 1/CD ,/CD 000/CD //CD mm3/CD and/CC one/PRP of/IN these/DT patients/NNS died/VBN with/IN sepsis/NN ./.
@@98267788979 Over-expression/NNS of/IN the/DT cofactor/NN p300/NEWGENE ,/, which/WDT functions/VBZ as/IN a/DT coactivator/NN of/IN myoD-mediated/JJ transcription/NN ,/, alleviated/VBN repression/NN by/IN COUP-TF/NEWGENE II/NEWGENE ./.
@@86360319176 Interaction/NNS of/IN the/DT Fur/NEWGENE repressor/NEWGENE with/IN a/DT 150-bp/JJ fragment/NN encompassing/VBG the/DT pvdS/NEWGENE promoter/NEWGENE was/VBD demonstrated/VBN in/IN vivo/NN by/IN the/DT Fur/NEWGENE titration/NN assay/NN and/CC confirmed/VBN in/IN vitro/FW by/IN gel/NN retardation/NN experiments/NNS with/IN a/DT partially/RB purified/VBN Fur/NEWGENE preparation/NN ./.
@@92282021184 The/DT selective/JJ 5-HT3/NEWGENE receptor/NEWGENE antagonists/NNS ramosetron/NN (/( YM060/NNP )/SYM ,/, YM114/NN (/( KAE-393/NN )/SYM ,/, granisetron/NN and/CC ondansetron/NN ,/, and/CC the/DT substituted/JJ benzamides/NNS (/( 5-HT4/NEWGENE receptor/NEWGENE agonist/NN //NN 5-HT3/NN receptor/NN antagonists/NNS )/SYM cisapride/NN mosapride/NN and/CC SC-53116/NN dose-dependently/RB enhanced/VBN gastric/JJ emptying/NN in/IN normal/JJ rats/NNS ./.
@@83069596229 IFN/NEWGENE alpha/NEWGENE and/CC IFN/NEWGENE gamma/NEWGENE inducibility/NN is/VBZ mediated/JJ by/IN a/DT single/JJ element/NN :/: a/DT high/JJ affinity/NN ,/, nearly/RB palindromic/JJ version/NN of/IN the/DT IFN/NEWGENE gamma/NEWGENE activation/NEWGENE site/NEWGENE (/( GAS/NEWGENE )/SYM ./.
@@108052869589 In/NN the/DT present/NN study/NN ,/, we/PRP characterized/VBD cis-elements/NNS of/IN the/DT human/NEWGENE PCI/NEWGENE gene/NEWGENE required/VBN for/IN expression/NN in/IN the/DT hepatoma-derived/JJ cell/NN line/NN ,/, HepG2/NNP cells/NNS ,/, and/CC also/RB evaluated/VBN rat/NEWGENE PCI/NEWGENE mRNA/NEWGENE expression/NN ,/, particularly/RB on/IN the/DT effect/NN of/IN androgen/NN in/IN rat/NN reproductive/JJ tissues/NNS ./.
@@105236476708 The/DT transcription/NEWGENE factor/NEWGENE CHOP/NEWGENE (/( C/NEWGENE //NEWGENE EBP/NEWGENE homologous/NEWGENE protein/NEWGENE 10/NEWGENE )/SYM is/VBZ a/DT bZIP/NEWGENE protein/NEWGENE induced/VBN by/IN a/DT variety/NN of/IN stimuli/NNS that/WDT evoke/VBP cellular/JJ stress/NN responses/NNS and/CC has/VBZ been/VBN shown/VBP to/IN arrest/NN cell/NN growth/NN and/CC to/IN promote/VB programmed/JJ cell/NN death/NN ./.
@@77841994224 All/DT ribosomal/NEWGENE protein/NEWGENE (/( rp/NEWGENE )/SYM gene/NN promoters/NNS from/IN Saccharomyces/NN cerevisiae/NN studied/VBN so/RB far/RB contain/VB either/DT (/( usually/RB two/JJ )/SYM binding/JJ sites/NNS for/IN the/DT global/JJ gene/NN regulator/NN Rap1p/NEWGENE or/CC one/PRP binding/JJ site/NN for/IN another/DT global/JJ factor/NN ,/, Abf1p/NEWGENE ./.
@@118363031702 Therefore/RB ,/, this/DT study/NN has/VBZ demonstrated/VBN that/IN prenatal/JJ disturbance/NN can/MD induce/VB a/DT lasting/JJ change/NN in/IN cytokine/NN biology/NN ,/, which/WDT persists/VBZ well/VB beyond/RB the/DT fetal/JJ and/CC infant/NN stage/NN ./.
@@37767794449 Seventeen/CD of/IN them/PRP were/VBD on/IN treatment/NN with/IN systemic/JJ steroids/NNS ./.
@@10675331587 In/NN contrast/NN ,/, c-Src/NEWGENE activated/VBN by/IN isoproterenol/NN led/VBN to/IN tyrosine/NN phosphorylation/NN of/IN Shc/NEWGENE and/CC subsequent/JJ Erk/NEWGENE activation/NN ,/, but/CC not/RB tyrosine/NN phosphorylation/NN of/IN cortactin/NEWGENE or/CC Stat3/NEWGENE ./.
@@83836227305 Identity/NNS of/IN GABP/NEWGENE with/IN NRF-2/NEWGENE ,/, a/DT multisubunit/JJ activator/NN of/IN cytochrome/NEWGENE oxidase/NEWGENE expression/NN ,/, reveals/VBZ a/DT cellular/JJ role/NN for/IN an/DT ETS/NEWGENE domain/NEWGENE activator/NN of/IN viral/JJ promoters/NNS ./.
@@69483986718 Thus/RB it/PRP appears/VBZ that/IN the/DT management/NN of/IN blood/NN ,/, including/JJ washing/NN is/NNS of/IN great/JJ importance/NN ./.
@@143569830 In/NN order/NN to/IN investigate/VB the/DT blood/NN compatibility/NN of/IN autogenous/JJ vein/NN graft/NN (/( AVG/NN )/SYM ,/, changes/VBZ in/IN prostacyclin/NN (/( PGI2/NN )/SYM production/NN following/IN harvesting/JJ and/CC arterial/JJ implantation/NN were/VBD studied/VBN experimentally/RB ./.
@@9005273517 MAIN/NNP OUTCOME/NNP MEASURES/NNS :/: Associations/NNP of/IN factor/NN analysis-derived/JJ syndromes/NNS with/IN risk/NN factors/NNS for/IN chemical/JJ interactions/NNS that/WDT inhibit/VBP butyrylcholinesterase/NEWGENE and/CC neuropathy/NN target/NN esterase/NEWGENE ./.
@@9876499868 State/NNP of/IN the/DT body/NN in/IN disorders/NNS of/IN diurnal/JJ physiological/JJ rhythms/NNS and/CC long-term/JJ hypokinesia/NN ./.
@@112232572458 OsBBPI/NEWGENE was/VBD found/VBN to/IN be/VB rapidly/RB induced/VBN in/IN rice/NN seedling/NN leaf/NN in/IN response/NN to/IN cut/NEWGENE ,/, exogenous/JJ jasmonic/JJ acid/NN (/( JA/NNP )/SYM ,/, and/CC two/JJ potent/JJ protein/NEWGENE phosphatase/NEWGENE 2A/NEWGENE (/( PP2A/NEWGENE )/SYM inhibitors/NNS ,/, cantharidin/NN (/( CN/NN )/SYM and/CC endothall/NN (/( EN/NN )/SYM ,/, in/IN a/DT light/NN //NN dark-/NN ,/, time-/NN and/CC dose-dependent/NN manner/NN ;/: this/DT induction/NN was/VBD completely/RB inhibited/VBN by/IN cycloheximide/NN (/( CHX/IN )/SYM ,/, indicating/VBG a/DT requirement/NN for/IN de/FW novo/FW protein/NN synthesis/NN in/IN its/PRP induction/NN ./.
@@103963438471 Moreover/RB ,/, a/DT high/JJ proportion/NN of/IN blood/NN samples/NNS from/IN a/DT random/JJ sample/NN of/IN the/DT rest/NN of/IN the/DT suspects/NNS tested/VBD positive/JJ for/IN trypanosome-specific/NN DNA/NN by/IN PCR/NN (/( 79/CD ./CD 9%/CD for/IN T/NNP ./NNP b/CD ./CD gambiense/NN and/CC 13/CD ./CD 9%/CD for/IN T/NNP ./NNP b/CD ./CD rhodesiense/NN )/SYM ./.
@@19117675762 Mutations/NNS in/IN the/DT small/JJ subunit/NN of/IN ribulosebisphosphate/NEWGENE carboxylase/NEWGENE affect/NN subunit/NN binding/NN and/CC catalysis/NN ./.
@@10824958629 Increased/VBN dietary/JJ energy/NN decreased/VBD PAB/NN and/CC the/DT use/NN of/IN added/VBN dietary/JJ CO/NN rather/RB than/IN PF/RB decreased/VBN PSHL/NNP in/IN broiler/NN breeders/NNS between/IN 26/CD and/CC 47/CD wk/NN of/IN age/NN ./.
@@95852534883 Our/PRP data/NN showed/VBD that/DT activation/NN of/IN the/DT raf-ERK/NEWGENE pathway/NN led/VBN to/IN activation/NN of/IN TF/NEWGENE expression/NN in/IN breast/NN carcinoma/NN cells/NNS and/CC suggested/VBN that/IN constitutive/JJ activation/NN of/IN this/DT pathway/NN leads/VBP to/IN high/JJ TF/NEWGENE expression/NN in/IN MDA-MB-231/NNP cells/NNS ./.
@@114181306694 As/IN expected/VBN ,/, homologous/NEWGENE loxP/NEWGENE sequences/NEWGENE efficiently/RB underwent/VBD Cre-mediated/JJ recombination/NN ./.
@@112395291071 IL-1beta/NEWGENE was/VBD significantly/RB higher/JJ in/IN endometrioma/NN than/IN in/IN lesions/NNS of/IN other/DT localizations/NNS ./.
@@19583682579 Evolution/NNP of/IN lesions/NNS did/VBD not/RB necessarily/RB follow/VB a/DT regular/JJ progression/NN through/RB the/DT later/JJR stages/NNS of/IN the/DT vitelliform/NN classification/NN ./.
@@80583269577 To/TO get/VB further/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS that/WDT control/VBP tal-1/NEWGENE expression/NN ,/, we/PRP have/VBP isolated/VBN 5'/CD sequences/NNS of/IN the/DT murine/NN gene/NN and/CC compared/VBN them/PRP to/IN their/PRP human/JJ counterparts/NNS ./.
@@74322887298 Serum/NN antibody/NN titre/NN was/VBD not/RB significantly/RB associated/VBN with/IN the/DT recurrence/NN rate/NN or/CC the/DT duration/NN of/IN infection/NN ./.
@@82323043856 A/DT series/NN of/IN 5'-deletions/NNS revealed/VBN that/IN the/DT fragment/NN -218/CD to/IN +4/CD from/IN the/DT TSS/NN had/VBP the/DT highest/JJS promoter/NN activity/NN ,/, nearly/RB 1000-fold/RB greater/JJR than/IN the/DT promoterless/JJ chloramphenicol/NEWGENE acetyltransferase/NEWGENE construct/NEWGENE ./.
@@90846217447 Areas/NNS with/IN significantly/RB greater/JJR rCBF/NN for/IN targeting/NN were/VBD the/DT left/JJ motor/JJ cortex/NN ,/, left/NN intraparietal/JJ sulcus/NN ,/, and/CC left/NN caudate/JJ ./.
@@29959678961 A/DT v-erbB-related/NEWGENE protooncogene/NEWGENE ,/, c-erbB-2/NEWGENE ,/, is/VBZ distinct/JJ from/IN the/DT c-erbB-1/NEWGENE //NEWGENE epidermal/NEWGENE growth/NEWGENE factor-receptor/NEWGENE gene/NEWGENE and/CC is/VBZ amplified/VBN in/IN a/DT human/JJ salivary/JJ gland/NN adenocarcinoma/NN ./.
@@97869265797 Finally/RB ,/, using/VBG in/IN vitro/FW binding/JJ studies/NNS ,/, we/PRP showed/VBD that/IN SREBP2/NEWGENE was/VBD able/JJ to/IN displace/VB ADD1/NEWGENE //NEWGENE SREBP1/NEWGENE binding/JJ from/IN the/DT sterol/NEWGENE regulatory/NEWGENE element/NEWGENE (/( SRE/NEWGENE )/SYM site/NN ./.
@@115841071473 Chronic/JJ nutritional/JJ diseases/NNS of/IN infectious/JJ origin/NN :/: an/DT assessment/NN of/IN a/DT nascent/JJ field/NN ./.
@@17099334247 Isolation/NNS and/CC characterization/NN of/IN the/DT rat/NN chromosomal/JJ gene/NN for/IN a/DT polypeptide/NN (/( pS1/NEWGENE )/SYM antigenically/RB related/VBN to/IN statin/NEWGENE ./.
@@64515574105 Deformities/NNS of/IN the/DT tip/NN of/IN the/DT olecranon/NN and/CC of/IN the/DT coronoid/JJ process/NN are/VBP also/RB described/VBN (/( De/NNP Palma/NNP 1956/CD ,/, Jordan/NN 1958/CD ,/, Ahlberg/NN 1965/CD ,/, Weseloh/NN 1973/CD )/SYM ./.
@@78143211894 Deletion/NNS of/IN both/DT prfA/NEWGENE and/CC ponA/NEWGENE resulted/VBN in/IN extremely/RB slow/JJ growth/NN and/CC a/DT reduction/NN in/IN sporulation/NN efficiency/NN ./.
@@112875789888 Secretion/NN of/IN interleukin-8/NEWGENE ,/, RANTES/NEWGENE ,/, macrophage/NEWGENE inflammatory/NEWGENE protein/NEWGENE 1alpha/NEWGENE ,/, and/CC 10-kappaDa/NEWGENE IFN-gamma-inducible/NEWGENE protein/NEWGENE were/VBD increased/VBN in/IN differentiating/JJ keratinocytes/NNS by/IN E6/NEWGENE ./.
@@64686946275 Stimulation/NNS of/IN the/DT caudate/JJ nucleus'/NN dophamine-reactive/JJ system/NN in/IN dogs/NNS by/IN means/NN of/IN administration/NN of/IN dophamine/NN (/( 60/CD micrograms/NNS )/SYM and/CC phenamine/NN led/VBN to/IN deterioration/NN of/IN conditioned/JJ and/CC unconditioned/JJ components/NNS of/IN feeding/JJ behaviour/NN ./.
@@105560444821 Binding/NN to/IN sulphatides/NNS and/CC the/DT alpha-dystroglycan/NEWGENE receptor/NEWGENE was/VBD much/RB stronger/RBR and/CC required/VBN at/IN least/RB two/JJ LG/NEWGENE modules/NEWGENE ./.
@@80822157271 The/DT immune/JJ response/NN of/IN past-infection/NN of/IN cytomegalovirus/NN in/IN the/DT patients/NNS of/IN RTID/NN is/VBZ rather/RB remarkable/JJ ./.
@@105401500 The/DT effect/NN of/IN CBZ/NN and/CC DPH/NN can/MD be/VB explained/VBN by/IN interference/NN with/IN thyroid/JJ hormone/NN binding/JJ to/IN TBG/NEWGENE combined/JJ with/IN enzyme-induced/RB increased/VBN metabolic/JJ clearance/NN rate/NN of/IN thyroid/JJ hormones/NNS without/IN homeostatic/JJ maintenance/NN of/IN premedication/NN levels/NNS of/IN FT4/NN and/CC FT3/NN ./.
@@76939752745 Reverse/NEWGENE transcriptase/NEWGENE and/CC protease/NEWGENE activities/NNS of/IN avian/JJ leukosis/NN virus/NN Gag-Pol/NEWGENE fusion/NEWGENE proteins/NEWGENE expressed/VBN in/IN insect/NN cells/NNS ./.
@@25494177584 Erythrocytic/JJ stages/NNS of/IN mammalian/JJ malarial/JJ parasites/NNS contain/VBP acristate/VBG mitochondria/NNS whose/WP functions/NNS are/VBP not/RB well/VB understood/VBP ./.
@@38969914554 New/NNP techniques/NNS for/IN the/DT mass/JJ spectrometry/NN of/IN natural/JJ products/NNS ./.
@@76404227942 Thromboxane/NEWGENE B2/NEWGENE increased/VBN (/( 97/CD +/NN //NN -/NN 105/CD versus/IN 40/CD +/NN //NN -/NN 26/CD pg/NN //NN ml/NN )/SYM and/CC was/VBD significantly/RB higher/JJ during/IN heparin/NN free/JJ hemodialysis/NN than/IN during/IN hemodialysis/NN with/IN heparin/NN (/( p/NN =/SYM 0/CD ./CD 01/CD ,/, Wilcoxon/NN matched/JJ pairs/NNS signed/VBD rank/JJ test/NN )/SYM ./.
@@25374414930 None/NN were/VBD restricted/VBN from/IN clinical/JJ duties/NNS ,/, were/VBD given/VBP varicella-zoster/NEWGENE immune/NEWGENE globulin/NEWGENE ,/, or/CC developed/VBD disease/NN ./.
@@76238383104 D/NN ./NN
@@90316395658 This/DT 0/CD ./CD 74/CD kb/NN cDNA/NN contains/VBZ an/DT open/JJ reading/JJ frame/NN (/( ORF/NN )/SYM of/IN 477/CD bp/NN encoding/VBG a/DT polypeptide/NN of/IN 159/CD amino/JJ acids/NNS (/( aa/NNS )/SYM which/WDT differs/VBZ at/IN only/RB one/PRP position/NN (/( position/NN 65/CD )/SYM from/IN the/DT human/NEWGENE U1-C/NEWGENE protein/NEWGENE ./.
@@114943911375 Our/PRP results/NNS demonstrated/VBN that/IN 50%/NN of/IN the/DT hepatic/JJ artery-alone/NNP ALT/NNP graft/NN showed/VBD almost/RB normal/JJ structure/NN histologically/RB at/IN 1/CD month/NN after/IN grafting/NN ,/, with/IN bile/NN secretion/NN preserved/VBN ./.
@@82687183496 Human/NEWGENE bcl3/NEWGENE protein/NEWGENE specifically/RB displaces/VBZ (/NEWGENE p50/NEWGENE )/NEWGENE 2-DNA/NEWGENE complexes/NEWGENE ./.
@@48371835198 Observations/NNS on/IN saccules/NNS of/IN rats/NNS exposed/VBN to/IN long-term/JJ hypergravity/NN ./.
@@85284799119 Videonystagmoscopy/NN has/VBZ been/VBN used/VBN to/IN subjectively/RB observe/VB the/DT responses/NNS of/IN the/DT vestibular/JJ system/NN in/IN a/DT population/NN of/IN patients/NNS with/IN vestibular/JJ deficits/NNS ./.
@@63063427804 In/NN conclusion/NN ,/, these/DT studies/NNS indicate/VBP that/DT LiCl/NN (/( 1/CD )/SYM decreases/NNS histamine-stimulated/JJ gastric/JJ acid/NN secretion/NN ,/, and/CC (/( 2/CD )/SYM diminishes/VBZ bile-induced/JJ disruption/NN of/IN the/DT gastric/JJ mucosal/JJ barrier/NN in/IN the/DT canine/JJ Heidenhain/NNP pouch/NN ./.
@@83875193450 We/PRP have/VBP previously/RB reported/VBN that/IN high/JJ level/NN human/NEWGENE desmin/NEWGENE expression/NN depends/VBZ on/IN a/DT 280-base/JJ pair/NN muscle-specific/NN enhancer/NN which/WDT can/MD function/VB not/RB only/RB in/IN myotubes/NNS ,/, but/CC can/MD also/RB activate/VB gene/NN expression/NN in/IN myoblasts/NNS ./.
@@1694014745 Treatment/NNP of/IN human/JJ myeloid/JJ cell/NN lines/NNS HL-60/NN and/CC U937/CD with/IN phorbol/NN 12-myristate/JJ 13-acetate/JJ (/( PMA/NN )/SYM increased/VBN within/IN 2/CD h/NN cellular/JJ levels/NNS of/IN the/DT RNA/NN hybridizable/JJ to/IN LD78/NEWGENE cDNA/NEWGENE ./.
@@110077775213 Analysis/NNP of/IN intron/NN //NN exon/NN boundaries/NNS of/IN the/DT genomic/JJ BAC/NN clones/NNS demonstrate/VBP that/DT junctin/NEWGENE ,/, junctate/NEWGENE ,/, and/CC aspartyl/NEWGENE beta-hydroxylase/NEWGENE result/NN from/IN alternative/JJ splicing/JJ of/IN the/DT same/JJ gene/NN ./.
@@105242589494 We/PRP have/VBP examined/VBN the/DT regulation/NN of/IN the/DT FGFR-1/NEWGENE gene/NEWGENE (/( cek-1/NEWGENE )/SYM in/IN avian/JJ myogenic/JJ cultures/NNS by/IN immunocytochemistry/NN and/CC Northern/NNP blot/NN analysis/NN ./.
@@34431441878 A/DT low/NN aspirin/NEWGENE esterase/NEWGENE activity/NN may/MD be/VB a/DT contributory/JJ factor/NN in/IN precipitating/JJ these/DT aspirin/NN sensitive/JJ reactions/NNS ./.
@@58330225765 On/IN the/DT character/NN of/IN changes/NNS in/IN the/DT enzyme/NN activity/NN in/IN the/DT brain/NN tissue/NN during/IN reflex/NN epilepsy/NN ./.
@@94957716637 Localized/JJ fluorescence/NN was/VBD detectable/JJ only/RB in/IN cells/NNS containing/JJ a/DT visible/JJ midcell/NN constriction/NN ,/, suggesting/VBG that/IN FtsK/NEWGENE targeting/JJ normally/RB occurs/VBZ only/RB at/IN a/DT late/JJ stage/NN of/IN septation/NN ./.
@@77302735347 The/DT NarX/NEWGENE and/CC NarQ/NEWGENE proteins/NEWGENE with/IN amino/JJ acid/NN substitutions/NNS at/IN the/DT first/RB conserved/VBN histidine/NN position/NN were/VBD also/RB unable/JJ to/IN dephosphorylate/VB NarL-phosphate/JJ in/IN vitro/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@92234751161 Chloramphenicol/NEWGENE acetyltransferase/NEWGENE assays/NNS examining/VBG the/DT ability/NN of/IN IE86/NEWGENE to/IN repress/VB activity/NN from/IN the/DT HCMV/NN major/JJ IE/NEWGENE promoter/NEWGENE or/CC activate/VB the/DT HCMV/NEWGENE early/NEWGENE promoter/NEWGENE for/IN the/DT 2/CD ./CD 2-kb/CD class/NN of/IN RNAs/NNS demonstrated/VBD the/DT functional/JJ integrity/NN of/IN the/DT IE86/NEWGENE protein/NEWGENE ./.
@@76815131402 Piroximone/NN is/VBZ a/DT new/JJ phosphodiesterase/NEWGENE III/NEWGENE inhibitor/NN that/WDT combines/VBP inotropic/JJ and/CC vasodilator/JJ properties/NNS ./.
@@89145327162 This/DT enzyme/NN is/VBZ designated/VBN (/NEWGENE 1--/NEWGENE >/NEWGENE 4/NEWGENE )/NEWGENE -beta-xylan/NEWGENE endohydrolase/NEWGENE isoenzyme/NEWGENE X-I/NEWGENE ./.
@@111321959044 Because/IN the/DT number/NN of/IN parameters/NNS required/VBN by/IN a/DT Volterra/NN series/NN grows/VBZ rapidly/RB with/IN both/PDT the/DT length/NN of/IN its/PRP memory/NN and/CC the/DT order/NN of/IN its/PRP nonlinearity/NN ,/, methods/NNS for/IN identifying/JJ these/DT models/NNS from/IN measurements/NNS of/IN input/NN //NN output/NN data/NN are/VBP limited/VBN to/IN low-order/JJ systems/NNS with/IN relatively/JJ short/JJ memories/NNS ./.
@@96472332327 In/JJ macrophages/NNS ,/, LPS-inducible/NNP HIV-1/NN gene/NN expression/NN is/VBZ mediated/JJ in/IN part/NN by/IN binding/NN of/IN NF-kappa/NEWGENE B/NEWGENE to/IN identical/JJ tandem/NN binding/JJ sites/NNS located/VBN within/IN the/DT long/NEWGENE terminal/NEWGENE repeat/NEWGENE (/( LTR/NEWGENE )/SYM ./.
@@107491457080 Both/DT normal/JJ and/CC transforming/NN PCPH/NEWGENE proteins/NEWGENE have/VBP guanosine/NEWGENE diphosphatase/NEWGENE activity/NN but/CC only/RB the/DT oncoprotein/NN cooperates/VBZ with/IN Ras/NEWGENE in/IN activating/JJ extracellular/NEWGENE signal-regulated/NEWGENE kinase/NEWGENE ERK1/NEWGENE1 ./.
@@1003185424 New/NNP Langevin/NNP equations/NNS for/IN a/DT translating/JJ and/CC simultaneously/RB rotating/JJ asymmetric/JJ top/NN ./.
@@107437197116 The/DT early/NN dg/NN ./NN of/IN rejection/NN and/CC especially/RB acute/JJ rejection/NN ,/, it's/NNS adequate/JJ management/NN ,/, decreased/VBN risk/NN for/IN the/DT future/JJ chronic/JJ rejection/NN nephropathy/NN ./.
@@41032484798 Improvement/NNP of/IN the/DT CRT/NN display/NN of/IN an/DT averager/NN ./.
@@84289652445 The/DT half-life/NN of/IN the/DT serum-induced/NN CBP/NEWGENE //NEWGENE tk/NEWGENE binding/JJ activity/NN was/VBD estimated/VBN to/IN be/VB less/PRP than/IN 1/CD h/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@21733992782 Seventy-two/NNS of/IN 73/CD negative/JJ controls/NNS and/CC all/DT positive/JJ blocks/NNS as/IN seen/VBP on/IN soft/JJ tissue/NN radiographs/NNS (/( STRs/NNS )/SYM were/VBD correctly/RB coded/VBN (/( specificity/NN 98/CD ./CD 6%/CD ,/, sensitivity/NN 100%/CD )/SYM ./.
@@13800761998 The/DT method/NN requires/VBZ a/DT reversed-phase/JJ column/NN and/CC a/DT paired-ion/JJ technique/NN to/IN separate/JJ docusate/NN sodium/NN from/IN other/DT components/NNS ./.
@@17670604601 This/DT study/NN was/VBD aimed/VBN at/IN assessing/JJ whether/IN c-DDP/NN administration/NN immediately/RB before/IN radiotherapy/NN could/MD increase/VB frequency/NN and/CC duration/NN of/IN objective/JJ responses/NNS ,/, as/RB well/VB as/IN survival/NN ,/, in/IN patients/NNS affected/VBN with/IN locally/RB advanced/JJ stages/NNS of/IN squamous/JJ carcinomas/NNS of/IN the/DT head/NN and/CC neck/NN ./.
@@1710985136 Chem/NNP ./.
@@62275706030 In/NN contrast/NN ,/, in/IN LL/NN patients/NNS during/IN ENL/PDT the/DT ConA-induced/NN suppressor/NN response/NN was/VBD markedly/RB reduced/VBN ./.
@@88876616991 In/NN contrast/NN ,/, cotransfection/NN of/IN TFIIB/NEWGENE and/CC IRF-1/NEWGENE into/IN NIH/NN 3T3/CD cells/NNS resulted/VBN in/IN a/DT dose-dependent/NN repression/NN of/IN promoter/NN activation/NN which/WDT occurred/VBD in/IN a/DT TATA-dependent/NNP manner/NN ./.
@@112745631104 Fetal/JJ lung/NN volume/NN :/: estimation/NN at/IN MR/NN imaging-initial/JJ results/NNS ./.
@@84015706919 It/PRP contains/VBZ three/CD putative/JJ binding/JJ sites/NNS for/IN transcription/NEWGENE factor/NEWGENE Sp1/NEWGENE as/RB well/VB as/IN several/DT short/JJ sequences/NNS that/WDT are/VBP similar/JJ to/IN known/VBP cis-acting/JJ enhancers/NNS or/CC binding/JJ sites/NNS for/IN transcription/NN factors/NNS ./.
@@83149228297 Thus/RB ,/, the/DT system/NN can/MD be/VB used/VBN to/IN detect/VB and/CC study/NN dynamic/JJ perfusion/NN changes/NNS from/IN the/DT brain/NN surface/NN with/IN minimal/JJ tissue/NN damage/NN ./.
@@111670191975 No/DT 'TATA'/NN motif/NN was/VBD identified/VBN near/IN either/DT the/DT GABPalpha/NEWGENE or/CC ATPsynCF6/NEWGENE transcription/NN start/NN sites/NNS ./.
@@75305029634 Addition/NN of/IN soluble/JJ recombinant/NEWGENE human/NEWGENE SLF/NEWGENE to/IN SI4-h220/NN cultures/NNS enhanced/VBD reduction/NN of/IN cell-surface/NN c-kit/NEWGENE expression/NN and/CC its/PRP protein/NN degradation/NN ./.
@@76651725034 Transcription/NNS factors/NNS containing/JJ a/DT basic/NEWGENE helix-loop-helix/NEWGENE (/NEWGENE bHLH/NEWGENE )/NEWGENE motif/NEWGENE regulate/VB the/DT expression/NN of/IN tissue-specific/NN genes/NN in/IN a/DT number/NN of/IN mammalian/JJ and/CC insect/NN systems/NNS ./.
@@91860566773 Also/RB ,/, transient/JJ overexpression/NN of/IN this/DT protein/NN in/IN C2C12/NNP cells/NNS reduced/VBD the/DT transcription/NN of/IN a/DT CAT-reporter/NEWGENE regulated/VBD by/IN an/DT E12/NEWGENE //NEWGENE MyoD/NEWGENE driven/NEWGENE enhancer/NEWGENE ./.
@@1097100803 Two/CD patients/NNS were/VBD treated/VBN with/IN both/DT regimens/NNS ./.
@@94188726708 271/CD :/: 31290-31295/CD ,/, 1996/NN )/NN ./.
@@88124908452 A/DT 1/CD ./CD 8-kb/CD cDNA/NN clone/NN (/( designed/VBN hKID/NN ,/, gene/NEWGENE symbol/NEWGENE AQP2L/NEWGENE )/SYM with/IN homology/NN to/IN the/DT aquaporins/NEWGENE was/VBD isolated/VBN from/IN a/DT human/NN kidney/NN cDNA/NN library/NN ./.
@@2399053905 The/DT Lm/NNS increased/VBN and/CC the/DT alveoli/NN //NN mm2/NN and/CC elastic/JJ recoil/NN pressure/NN decreased/VBN ./.
@@729287148 Serum-ferritin/NNP in/IN diagnosis/NN of/IN haemochromatosis/NN ./.
@@76364087559 Comparison/NNS of/IN 1/CD ./CD 5/CD Tesla/NN and/CC 0/CD ./CD 35/CD Tesla/NN field/NN strength/NN magnetic/JJ resonance/NN imaging/JJ scans/NNS in/IN the/DT morphometric/JJ evaluation/NN of/IN the/DT lumbar/JJ intervertebral/JJ foramina/NNS ./.
@@88421433362 Plasmid/NN pAL618/NN contains/VBZ the/DT genetic/JJ determinants/NNS for/IN H2/NN uptake/NN (/( hup/NEWGENE )/SYM from/IN Rhizobium/NN leguminosarum/NN bv/NN ./NN viciae/NNS ,/, including/JJ a/DT cluster/NN of/IN 17/CD genes/NNS named/VBD hupSLCDEFGHIJK-hypABFCDE/NEWGENE ./.
@@3292076617 Chronic/NN endotoxemia/NN appears/VBZ to/IN be/VB associated/VBN with/IN an/DT elevated/VBN pulmonary/JJ microvascular/JJ permeability/NN and/CC a/DT tendency/NN toward/IN a/DT hyperdynamic/JJ circulation/NN but/CC with/IN an/DT appreciable/JJ degree/NN of/IN refractoriness/NN associated/VBN with/IN regional/JJ hemodynamics/NN and/CC eicosanoid/NN biosynthesis/NN ./.
@@81870853823 These/DT rearrangements/NNS result/NN in/IN the/DT formation/NN of/IN chimeric/JJ genes/NNS showing/VBG the/DT tyrosine/NEWGENE kinase/NEWGENE domain/NEWGENE of/IN ret/NEWGENE fused/VBN with/IN the/DT 5'/CD end/NN sequences/NNS of/IN different/JJ genes/NNS ./.
@@9488486480 The/DT TATA/NEWGENE box-binding/NEWGENE protein/NEWGENE (/( TBP/NEWGENE )/SYM plays/VBP an/DT essential/JJ role/NN in/IN transcription/NN by/IN all/DT three/CD eukaryotic/NN nuclear/NEWGENE RNA/NEWGENE polymerases/NEWGENE ,/, polymerases/NEWGENE (/NEWGENE Pol/NEWGENE )/NEWGENE I/NEWGENE ,/NEWGENE II/NEWGENE ,/NEWGENE and/NEWGENE III/NEWGENE ./.
@@91688928444 Mutation/NN of/IN nucleotides/NNS adjacent/JJ to/IN the/DT AP-1/NEWGENE cis-response/NEWGENE elements/NEWGENE had/VBP no/DT effect/NN on/IN trans-activation/NN ./.
@@36845176670 Endurance/NNS training/NN resulted/VBN in/IN an/DT increase/NN of/IN stiffness/NN associated/VBN with/IN a/DT decrease/NN of/IN type/NN II/NN fibers/NNS ./.
@@100984195 Dual/JJ innervation/NN of/IN fast/JJ fibers/NNS in/IN trunk/NN muscles/NNS of/IN lamprey/NN larvae/NNS ./.
@@2438637424 Mucolipidosis/NNP type/NN IV/NN :/: clinical/JJ spectrum/NN and/CC natural/JJ history/NN ./.
@@69785663495 At/NN necropsy/NN 28/CD days/NNS post-inoculation/NN ,/, F344/NN rats/NNS had/VBP no/DT gross/JJ lung/NN lesions/NNS ,/, even/VB those/DT given/NN the/DT maximum/JJ dose/NN of/IN 1/CD ./CD 4/CD X/NN 10/NN (/NN 9/NN )/NN colony-forming/JJ units/NNS of/IN M/NNP ./NNP pulmonis/NNS ./.
@@97653944552 The/DT Epstein-Barr/NEWGENE virus/NEWGENE transactivator/NEWGENE Zta/NEWGENE triggers/VBP lytic/JJ gene/NN expression/NN and/CC is/VBZ essential/JJ for/IN replication/NN of/IN the/DT lytic/JJ origin/NN ,/, oriLyt/NEWGENE ./.
@@81735328679 Simple/JJ reaction/NN time/NN (/( RT/JJ )/SYM to/IN a/DT peripheral/NN visual/NN target/NN (/( S2/NN )/SYM is/VBZ shortened/VBN when/CC a/DT non-informative/JJ cue/NN (/( S1/NN )/SYM is/VBZ flashed/VBN at/IN the/DT S2/NN location/NN 100-150/JJ ms/NN before/IN target/NN onset/NN (/( early/JJ facilitation/NN )/SYM ./.
@@97551997548 We/PRP have/VBP determined/VBN the/DT molecular/JJ lesions/NNS of/IN nine/JJ Scm/NEWGENE mutant/NEWGENE alleles/NEWGENE ,/, which/WDT identify/VBP functional/JJ requirements/NNS for/IN specific/JJ domains/NNS ./.
@@77767115576 MATERIAL/NNP AND/CC METHODS/IN :/: Of/IN the/DT 17/CD men/NNS and/CC 17/CD women/NNS ,/, who/WP were/VBD 21/CD to/IN 80/CD years/NNS of/IN age/NN ,/, 27/CD had/VBP hereditary/JJ motor/JJ and/CC sensory/JJ neuropathy/NN type/NN I/NN and/CC 7/CD had/VBP acquired/VBN demyelinating/JJ polyneuropathy/NN ./.
@@81071674135 Anti-B/NEWGENE ./NEWGENE burgdorferi/NEWGENE ,/, anti-B/NEWGENE ./NEWGENE turicatae/NEWGENE and/CC anti-B/NEWGENE ./NEWGENE parkeri/NEWGENE antibodies/NEWGENE ,/, tested/VBN by/IN the/DT indirect/JJ immunofluorescent/JJ assay/NN (/( IFA/NN )/SYM ,/, were/VBD detected/VBN in/IN 10/CD ./CD 8/CD ,/, 16/CD ./CD 1/CD and/CC 8/CD ./CD 2%/CD of/IN the/DT serum/JJ samples/NNS tested/VBN ,/, and/CC confirmed/VBD by/IN IFA-ABS/NNP in/IN 1/CD ./CD 3/CD ,/, 1/CD ./CD 3/CD and/CC 1/CD ./CD 0%/CD ,/, respectively/RB ./.
@@12096181855 Tobramycin/NNP 60/CD mg/NN did/VBD not/RB show/VB any/DT remarkable/JJ effect/NN ,/, but/CC dibecacin/NN 100/NN mg/NN produced/VBD a/DT slight/JJ potentiating/JJ effect/NN on/IN the/DT action/NN of/IN d-tubocurarine/NN ./.
@@62385406034 Ventricular/JJ volume/NN stiffness/NN vs/IN ./IN the/DT mean/JJ wall/NN stress/NN relationship/NN of/IN LVH/NN shifted/VBD upward/JJ ,/, whereas/IN the/DT normalized/VBN wall/NN muscle/NN stiffness/NN vs/IN ./IN the/DT mean/JJ wall/NN stress/NN relationship/NN of/IN LVH/NN showed/VBD a/DT smaller/JJR slope/NN ./.
@@104794929432 OBJECTIVE/IN :/: 1998/CD Surveillance/NN ,/, Epidemiology/NNS ,/, and/CC End/NN Results/NNS (/( SEER/NN )/SYM data/NN estimate/NN an/DT 83/CD ./CD 1%/CD 5-year/JJ survival/NN rate/NN for/IN corpus/NN uteri/NNS adenocarcinoma/NN FIGO/NN stage/NN II/NNS ./NNS
@@16574153125 Intron/NN K1/NEWGENE cox1/NEWGENE ./NEWGENE 2/NEWGENE is/VBZ not/RB found/VB in/IN S/NNP ./NNP cerevisiae/NN and/CC appears/VBZ at/IN an/DT unique/JJ location/NN in/IN K/NNP ./NNP lactis/NN ./.
@@104551895740 In/NNP B/NNP cells/NNS ,/, HEF1/NEWGENE is/VBZ phosphorylated/VBN by/IN a/DT cytoskeleton-dependent/JJ mechanism/NN that/WDT is/VBZ triggered/VBN by/IN integrin/NEWGENE ligation/NN ./.
@@93283412866 Attenuation/NNS from/IN the/DT vit/NEWGENE A2/NEWGENE consensus/NN ERE/NEWGENE is/VBZ not/RB necessarily/RB dependent/JJ on/IN DNA/NN binding/JJ as/IN the/DT TR/NEWGENE alpha/NEWGENE DNA/NN binding/NN mutant/NN was/VBD still/RB able/JJ to/IN inhibit/VB E-dependent/NN transactivation/NN ./.
@@75938967491 We/PRP conclude/VBP that/IN this/DT new/JJ measurement/NN technique/NN provides/VBZ an/DT easy/RB and/CC accurate/JJ P0/CD ./CD 1/CD measurement/NN using/VBG standard/JJ respiratory/JJ equipment/NN when/CC tested/VBN in/IN a/DT lung/NN model/NN ./.
@@14297249724 The/DT data/NN indicate/VB that/IN the/DT minimal/JJ catalytic/JJ domain/NN of/IN Nmt1p/NEWGENE is/VBZ located/VBN between/IN Ile59--/CD >/CD Phe96/CD and/CC Gly451--/NNP >/NNP Leu455/NNP ./.
@@93145702736 This/DT family/NN of/IN proteins/NNS binds/VBZ GC-rich/NN motifs/NNS widely/RB distributed/VBN in/IN gene/NN promoters/NNS ,/, resulting/VBG in/IN distinct/JJ activation/NN or/CC repression/NN of/IN transcriptional/JJ activities/NNS ./.
@@25604158470 Rare/JJ neurogenic/JJ tumor/NN with/IN metastasis/NN to/IN mouth/NN ,/, jaw/NN and/CC face/NN regions/NNS ./.
@@77456934206 Studies/NNS using/VBG an/DT inhibitor/NN or/CC a/DT mutant/NEWGENE Lb/NEWGENE proteinase/NEWGENE indicated/VBD that/DT stimulation/NN of/IN IRES-driven/NN translation/NN is/VBZ mediated/JJ via/NN proteolysis/NN of/IN some/DT cellular/JJ component/NN (/NN s/NN )/NN ./.
@@11041308884 The/DT subjects/NNS were/VBD diagnosed/VBN on/IN the/DT basis/NN of/IN DSM-IV/DT pathological/JJ gambling/JJ criteria/NNS and/CC completed/VBD the/DT Turkish/NNP Version/NNP of/IN South/NNP Oaks/NNP Gambling/NN Screen/NN (/( SOGS/NNP )/SYM ./.
@@107237275984 The/DT newly/RB defined/VBN region/NN contains/VBZ an/DT intron/NN that/WDT may/MD be/VB alternatively/RB spliced/VBN and/CC seven/JJ polyadenylation/NN signal/NN sequences/NN ./.
@@82785485942 The/DT psaD/NEWGENE ,/, psaF/NEWGENE ,/, psaH/NEWGENE ,/, and/CC psaL/NEWGENE products/NEWGENE have/VBP two/JJ isoforms/NNS each/DT that/WDT are/VBP distinguished/VBN by/IN different/JJ mobilities/NNS in/IN polyacrylamide/NN gel/NN electrophoresis/NN ,/, and/CC the/DT psaE/NEWGENE product/NEWGENE has/VBZ four/CD isoforms/NNS ./.
@@113988991256 Fans/NNS in/IN tunnels/NNS and/CC open/JJ windows/NNS at/IN aboveground/JJ locations/NNS appeared/VBN to/IN greatly/RB reduce/VB the/DT likelihood/NN of/IN high/JJ PH3/NN concentrations/NNS in/IN enclosed/VBN areas/NNS ./.
@@102242934503 These/DT well-characterized/JJ brain/NN regions/NNS may/MD provide/VB a/DT basis/NN for/IN future/JJ studies/NNS of/IN RPTP-kappa/NEWGENE function/NN ./.
@@103986823935 The/DT crystal/NN structure/NN of/IN the/DT VP16/NEWGENE core/NEWGENE has/VBZ been/VBN determined/VBN at/IN 2/CD ./CD 1/CD A/DT resolution/NN ./.
@@80000745399 A/DT sequence/NN representing/VBG about/RB 50%/CD of/IN the/DT expected/VBN complete/JJ sequence/NN was/VBD obtained/VBN by/IN translation/NN of/IN the/DT two/JJ open/JJ reading/JJ frames/NNS present/VBP on/IN a/DT 1/CD ./CD 6/CD kb/NN DNA/NN genomic/JJ fragment/NN ./.
@@13109357635 Drosophila/NEWGENE UbcD1/NEWGENE encodes/VBZ a/DT highly/RB conserved/VBN ubiquitin-conjugating/NN enzyme/NN involved/VBN in/IN selective/JJ protein/NN degradation/NN ./.
@@106772976491 In/NN vitro/FW expression/NN of/IN four/CD different/JJ naturally/RB occurring/VBG nonsense/NN and/CC missense/JJ mutations/NNS revealed/VBD a/DT dramatically/RB altered/VBN subcellular/JJ location/NN of/IN the/DT protein/NN in/IN cultured/JJ cells/NNS ./.
@@8873159204 Five/CD of/IN these/DT eight/CD patients/NNS in/IN group/NN II/NNP also/RB received/VBD 8-in-1/NN chemotherapy/NN ./.
@@84110248374 What/WP young/JJ people/NN think/NN and/CC do/VB when/CC the/DT option/NN for/IN cystic/JJ fibrosis/NN carrier/NN testing/NN is/VBZ available/JJ ./.
@@10467465309 The/DT controversy/NN of/IN significance/NN testing/NN :/: misconceptions/NNS and/CC alternatives/NNS ./.
@@10085088211 These/DT results/NNS indicate/VBP that/IN the/DT p33/NEWGENE subunit/NEWGENE of/IN eIF3/NEWGENE plays/VBP an/DT important/JJ role/NN in/IN the/DT initiation/NN phase/NN of/IN protein/NN synthesis/NN and/CC that/IN its/PRP RNA-binding/NN domain/NN is/VBZ required/VBN for/IN optimal/JJ activity/NN ./.
@@72744287125 It/PRP has/VBZ been/VBN shown/VBP in/IN experiments/NNS in/IN vitro/FW that/IN the/DT hepatotrophic/JJ organic/JJ anions/NNS ,/, the/DT radiographic/JJ contrast/NN agent/NN (/( RCA/NN )/SYM bilignost/NN used/VBN in/IN cholecystography/NN and/CC Bengal/NN pink/JJ ,/, have/VB an/DT affinity/NN ,/, unlike/IN the/DT urographic/JJ RCA/NN triombrin/NN and/CC renotrophic/JJ dye/NN indigo-carmine/JJ ,/, for/IN the/DT plasmatic/JJ membranes/NNS (/( PM/NN )/SYM of/IN liver/NN cells/NNS ./.
@@81260967785 The/DT alpha/NEWGENE 7A/NEWGENE form/NEWGENE RNA/NEWGENE contains/VBZ an/DT additional/JJ 113/CD nucleotides/NNS compared/VBN to/IN the/DT B/NNP form/NN ,/, and/CC a/DT common/JJ coding/JJ region/NN in/IN the/PDT A/DT and/CC B/NNP form/NN RNAs/NNS is/VBZ used/VBN in/IN alternate/JJ reading/JJ frames/NNS ./.
@@18699072472 The/DT across-fiber/JJ pattern/NN of/IN the/DT responses/NNS to/IN hypotonic/JJ NaCl/NN solutions/NNS correlated/VBN strongly/RB to/IN that/DT elicited/VBD by/IN distilled/JJ H2O/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@102281576655 A/DT Bub2p-dependent/NNP spindle/NN checkpoint/NN pathway/NN regulates/VBZ the/DT Dbf2p/NEWGENE kinase/NEWGENE in/NEWGENE budding/NEWGENE yeast/NEWGENE ./.
@@19936565947 All/DT six/CD ARF/NEWGENE cDNAs/NEWGENE are/VBP more/RB similar/JJ to/IN each/DT other/DT than/IN to/IN other/DT approximately/RB 20-kDa/NEWGENE guanine/NEWGENE nucleotide-binding/NEWGENE proteins/NEWGENE ./.
@@9279379726 We/PRP have/VBP subcloned/JJ into/IN pBR322/NN deoxyribonucleic/JJ acid/NN (/( DNA/NN )/SYM sequences/NNS mapping/VBG either/DT in/NN the/DT coding/JJ region/NN ,/, the/DT 5'/CD spacer/NN ,/, or/CC the/DT 3'/CD spacer/NN of/IN the/DT H2B/NEWGENE histone/NEWGENE gene/NEWGENE ./.
@@106600693927 The/DT rrd1/NEWGENE ,/NEWGENE 2delta/NEWGENE mutant/NEWGENE was/VBD partially/RB rescued/VBN by/IN inactivation/NN of/IN HOG1/NEWGENE or/CC PBS2/NEWGENE ,/, suggesting/VBG an/DT interaction/NN between/IN the/DT RRD/NEWGENE genes/NEWGENE and/CC the/DT Hog1p/NEWGENE signal/NEWGENE transduction/NEWGENE pathway/NEWGENE ./.
@@50758575357 Oscilloscope/NNP triggering/JJ circuit/NN for/IN recording/JJ long/JJ transients/NNS at/IN fast/JJ sweep/NN speeds/NNS ./.
@@78082107783 The/DT negative/JJ predictive/JJ value/NN is/VBZ 92%/CD ,/, vs/NNP 80%/CD for/IN the/DT NCEP/NNP I/NNP ./NNP
@@1721992299 The/DT matrix/NN surrounding/JJ the/DT clusters/VBZ either/DT showed/VBN a/DT normal/JJ morphology/NN or/CC a/DT homogeneous/JJ appearance/NN ,/, within/IN which/WDT faint/JJ cross/NN striations/NNS but/CC no/DT distinctly/RB fibrillar/JJ outlines/VBP could/MD be/VB identified/VBN ./.
@@10982143816 The/DT muskox/NN is/VBZ a/DT new/JJ host/NN record/NN for/IN T/NNP ./NNP gondii/NN ./.
@@89870098941 The/DT patient's/VBZ role/NN ,/, organized/VBN by/IN the/DT prerequisites/NNS of/IN expressive/JJ freedom/NN ,/, is/VBZ counter/RB posed/VBN with/IN the/DT psychoanalyst's/NN ,/, which/WDT is/VBZ structured/JJ to/IN empower/VB listening/NN and/CC understanding/NN ./.
@@98805447929 Fas-resistant/NNP DT-40/NNP lymphoma/NN B-cells/NNS rendered/VBD BTK-deficient/NNP through/RB targeted/VBD disruption/NN of/IN the/DT btk/NEWGENE gene/NEWGENE by/IN homologous/JJ recombination/NN knockout/NN underwent/VBD apoptosis/NN after/IN Fas/NEWGENE ligation/NN ,/, but/CC wild-type/NNP DT-40/NNP cells/NNS or/CC BTK-deficient/NNP DT-40/NNP cells/NNS reconstituted/VBN with/IN wild-type/NEWGENE human/NEWGENE btk/NEWGENE gene/NEWGENE did/VBD not/RB ./.
@@79250974111 Immunoreactive/NNP AR/NEWGENE content/NN in/IN transfected/VBN COS-1/NNP cells/NNS was/VBD not/RB influenced/VBN by/IN exposure/NN to/IN 8-Br-cAMP/NN ./.
@@23076132748 Erythrocyte/NN protoporphyrin/NN concentration/NN increased/VBN significantly/RB (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM by/IN 14/CD days/NNS in/IN dogs/NNS fed/VBD the/DT basal/JJ diet/NN ,/, and/CC remained/VBD significantly/RB high/JJ relative/NN to/IN that/IN in/NN dogs/NNS of/IN the/PDT other/DT dietary/JJ groups/NNS for/IN the/DT remainder/NN of/IN the/DT study/NN ./.
@@21726722779 A/DT case/NN of/IN Goodpasture's/NNP syndrome/NN ./.
@@97161794368 RXR-gamma/NEWGENE expression/NN produced/VBD significant/JJ reduction/NN in/IN levels/NNS of/IN RA-responsive/JJ genes/NNS including/JJ the/DT cyclin-dependent/NEWGENE kinase/NEWGENE inhibitors/NEWGENE p21Cip1/NEWGENE1 //NEWGENE1 WAF1/NEWGENE1 and/CC p27Kip1/NEWGENE ,/, resulting/VBG in/IN increased/VBN cdc2/NEWGENE and/CC cdk2/NEWGENE kinase/NEWGENE activity/NN and/CC RB/NEWGENE phosphorylation/NN ./.
@@28082321357 Lower/JJR limits/NNS (/( to/IN 10/CD micrograms/NN //NN kg/NN )/SYM were/VBD detectable/JJ ,/, but/CC with/IN lower/JJR reliability/NN (/( 60%/CD )/SYM ./.
@@31670607101 Insulin-like/NEWGENE growth/NEWGENE factor/NEWGENE II/NEWGENE (/( IGFII/NEWGENE )/SYM is/VBZ a/DT mitogenic/JJ polypeptide/NN ,/, the/DT mRNAs/NNS of/IN which/WDT are/VBP present/VB in/IN multiple/JJ forms/NNS ,/, despite/IN derivation/NN from/IN a/DT single/JJ gene/NN ./.
@@105549462778 The/DT more/RB traditional/JJ SERMS/NN ,/, clomiphene/NN citrate/NN and/CC tamoxifen/NN ,/, will/MD be/VB reviewed/VBN along/IN with/IN such/JJ modern/JJ drugs/NNS as/IN raloxifene/NN and/CC faslodex/NN ,/, with/IN emphasis/NN upon/IN their/PRP actions/NNS on/IN breast/NN ,/, uterus/NN ,/, bone/NN and/CC lipids/NNS ./.
@@105344027144 We/PRP have/VBP cloned/VBN cDNA/NN and/CC genomic/JJ DNA/NN for/IN a/DT mouse/NN gene/NN encoding/VBG a/DT protein/NN with/IN significant/JJ sequence/NN similarity/NN to/IN conserved/VBN domains/NNS found/VBP in/IN proteins/NNS of/IN the/DT Spo11p/NEWGENE family/NEWGENE ./.
@@92261139179 If/IN E/NNP ./NNP coli/NN is/VBZ present/VB in/IN any/DT source/NN water/NN sample/NN ,/, the/DT borehole/NN and/CC any/DT directly/RB connected/VBN borehole/NN should/MD be/VB embargoed/VBN ./.
@@75932669949 One/CD of/IN these/DT is/VBZ surrounded/VBN by/IN an/DT adenine-uridine/NN rich/NN region/NN that/WDT can/MD form/VB an/DT 11-base/JJ pair/NN stem/NN structure/NN ./.
@@107498491739 An/DT important/JJ mechanism/NN by/IN which/WDT the/DT tumor/NN suppressor/NN p53/NEWGENE maintains/VBZ genomic/JJ stability/NN is/VBZ to/IN induce/VB cell/NN cycle/NN arrest/NN through/JJ activation/NN of/IN the/DT cyclin-dependent/NEWGENE kinase/NEWGENE inhibitor/NEWGENE p21/NEWGENE (/NEWGENE WAF1/NEWGENE //NEWGENE Cip1/NEWGENE )/NEWGENE gene/NEWGENE ./.
@@77380261776 However/RB ,/, the/DT mouse/NN has/VBZ previously/RB been/VBN shown/VBP to/IN possess/VB only/RB three/CD forms/NNS of/IN ADH/NEWGENE ./.
@@46155255053 The/DT effect/NN of/IN antilymphocyte/JJ sera/NNS on/IN formation/NN of/IN transplantation/NN and/CC anti-infection/NN immunity/NN in/IN mice/NNS ./.
@@117775751622 The/DT quantity/NN of/IN each/DT population/NN (/( L/NNP ./NNP bulgaricus/JJ ,/, S/NNP ./NNP thermophilus/JJ )/SYM was/VBD then/RB estimated/VBN in/IN the/DT pellet/NN by/IN PyMS/NNP ,/, and/CC the/DT data/NN were/VBD analysed/VBN by/IN artificial/JJ neural/JJ networks/NNS (/( ANNs/NNP )/SYM ./.
@@95242764516 LysR/NEWGENE proteins/NEWGENE have/VBP been/VBN shown/VBP to/IN regulate/VB urease/NEWGENE in/NEWGENE Klebsiella/NEWGENE aerogenes/NEWGENE (/( NAC/NEWGENE )/SYM ,/, and/CC catalase/NEWGENE in/NEWGENE Escherichia/NEWGENE coli/NEWGENE (/( OxyR/NEWGENE )/SYM ,/, which/WDT offers/VBP the/DT intracellular/JJ bacterium/NN protection/NN from/IN phagolysosome/NN damage/NN ./.
@@99298116671 Experiments/NNS on/IN narcotized/JJ cats/NNS demonstrated/VBN that/IN the/DT derivatives/NNS of/IN 2-mercaptobenzimidazole/JJ possessing/VBG the/DT properties/NNS of/IN specific/JJ bradycardic/JJ agents/NNS and/CC coded/VBN as/IN CM-251/NN ,/, CM-266/NN ,/, and/CC CM-345/NN ,/, reduce/VB the/DT mean/JJ rise/NN of/IN segment/NN ST/NN on/IN numerous/JJ leads/VBP of/IN the/DT epicardial/JJ electrogram/NN during/IN 5-min/JJ occlusion/NN of/IN the/DT anterior/JJ descending/JJ branch/NN of/IN the/DT left/JJ coronary/JJ artery/NN ./.
@@87311558716 Ten/CD weeks/NNS after/IN reconstruction/NN ,/, the/DT regenerating/JJ nerves/NNS already/RB resembled/VBN normal/JJ nerves/NNS ./.
@@10863352672 Franz/NNP Schubert--his/NN life/NN ,/, music/NN and/CC diseases/NNS ./.
@@106790158537 The/DT emerging/JJ view/NN based/VBN on/IN studies/NNS in/IN yeast/NN is/VBZ that/IN each/DT class/NN of/IN snoRNPs/NEWGENE is/VBZ composed/VBN of/IN a/DT unique/JJ set/NN of/IN proteins/NNS ./.
@@20382933605 Conclusion/NNS :/: inlet/NN type/NN VSD/NN and/CC perimembranous/JJ type/NN TOF/NN have/VB anatomic/JJ features/NNS in/IN which/WDT the/DT proximal/JJ His/NN bundle/NN tends/VBZ to/IN be/VB jeopardized/VBN by/IN suturing/VBG for/IN VSD/NN closure/NN ./.
@@24586995044 Svensson/NNP et/FW al/NNS ./NNS
@@19778564685 This/DT study/NN suggests/VBZ that/IN BSPMs/NN are/VBP useful/JJ in/IN the/DT assessment/NN of/IN AMI/NN in/IN terms/NNS of/IN diagnosis/NN ,/, location/NN and/CC extent/NN of/IN myocardial/JJ infarct/NN ./.
@@99766269968 Erratum/NNP :/: Absence/NNS of/IN precursor/NN effects/NNS above/RB the/DT martensitic/JJ transformation/NN in/IN a/DT virgin/JJ crystal/NN of/IN Li/NN metal/NN [/NN Phys/NN ./.
@@112641765779 B-myb/NEWGENE is/VBZ essential/JJ for/IN G1/NN //NN S/NN transition/NN and/CC has/VBZ been/VBN shown/VBP to/IN be/VB phosphorylated/VBN by/IN the/DT cyclin/NEWGENE A2/NEWGENE //NEWGENE cdk2/NEWGENE complex/NEWGENE ./.
@@64192516223 Movement/NNP programming/NN depends/VBZ on/IN understanding/NN of/IN behavioral/JJ requirements/NNS ./.
@@16641923719 Its/PRP neuromuscular/JJ effects/NNS are/VBP similar/JJ to/IN a/DT single/NN ED90/NN dose/NN of/IN vecuronium/NN ./.
@@95242593126 The/DT hp55/NEWGENE gamma/NEWGENE protein/NEWGENE interacts/VBZ strongly/RB with/IN the/DT activated/VBN IGFIR/NEWGENE but/CC not/RB with/IN the/DT kinase-negative/JJ mutant/JJ receptor/NN ./. hp55/NEWGENE gamma/NEWGENE also/RB interacts/VBZ with/IN the/DT insulin/NEWGENE receptor/NEWGENE (/( IR/NEWGENE )/SYM in/IN the/DT yeast/NN two-hybrid/JJ system/NN ./.
@@14004019034 In/JJ humans/NNS ,/, four/CD AMP/NEWGENE deaminase/NEWGENE variants/NEWGENE ,/, termed/JJ M/NN (/( muscle/NN )/SYM ,/, L/JJ (/( liver/NN )/SYM ,/, E1/NEWGENE ,/, and/CC E2/NEWGENE (/( erythrocyte/NN )/SYM can/MD be/VB distinguished/VBN by/IN a/DT variety/NN of/IN biochemical/JJ and/CC immunological/JJ criteria/NNS ./.
@@70948566873 In/NN a/DT longitudinal/JJ study/NN ,/, 14/CD low-risk/JJ fetuses/NNS were/VBD studied/VBN at/IN 2-week/JJ intervals/NNS from/IN 32/CD weeks/NNS of/IN gestation/NN onward/RB ./.
@@97926306704 However/RB the/DT sequence/NN surrounding/JJ the/DT transcription/NN start/NN site/NN CTCA/NN (/NN +1/NN )/NN TTCC/NN was/VBD similar/JJ to/IN the/DT consensus/NN CTCA/NN (/NN +1/NN )/NN NTCT/NN (/( N/NN is/VBZ any/DT nucleoside/NN )/SYM for/IN an/DT initiator/NN element/NN found/VB in/IN terminal/NEWGENE deoxynucleotidyltransferase/NEWGENE and/CC a/DT number/NN of/IN other/DT highly/RB regulated/VBN genes/NNS ./.
@@108193272015 C/NEWGENE ./NEWGENE elegans/NEWGENE KLP-11/NEWGENE //NEWGENE OSM-3/NEWGENE //NEWGENE KAP-1/NEWGENE :/: orthologs/NNS of/IN the/DT sea/NEWGENE urchin/NEWGENE kinesin-II/NEWGENE ,/, and/CC mouse/NEWGENE KIF3A/NEWGENE //NEWGENE KIFB/NEWGENE //NEWGENE KAP3/NEWGENE kinesin/NEWGENE complexes/NEWGENE ./.
@@78147177793 Increase/VB in/IN blood/NN NEFA/NN was/VBD further/RB augmented/VBN by/IN fat/JJ plus/IN AA/NN supplementation/NN ,/, but/CC no/DT changes/NNS in/IN concentrations/NNS of/IN Lys/NN or/CC Met/NNP in/IN blood/NN were/VBD found/VBN ./.
@@91855862316 Most/JJS eukaryotic/NN mRNAs/NN are/VBP translated/VBN by/IN a/DT "scanning/VBG ribosome"/NN mechanism/NN ./.
@@64951952517 According/VBG to/IN the/DT biochemical/JJ tests/NNS ,/, high/JJ activity/NN (/( over/RB 200/CD U/NNS //NNS l/NNS )/SYM of/IN alkaline/NEWGENE phosphatase/NEWGENE was/VBD recorded/VBN exclusively/RB in/IN patients/NNS with/IN the/DT lymphogranulomatosis-induced/JJ liver/NN damage/NN ./.
@@28213408730 During/IN sub-maximal/CD exercise/NN ,/, DCR/IN in/IN the/DT UT/NN dogs/NNS decreased/VBN from/IN a/DT resting/JJ value/NN of/IN 4/CD ./CD 08/CD +/NN //NN -/NN 0/CD ./CD 18/CD mm/NN Hg/NN X/NN ml-1/NN X/NN min-1/NN to/IN 1/CD ./CD 91/CD +/NN //NN -/NN 0/CD ./CD 17/CD mm/NN Hg/NN X/NN ml-1/NN X/NN min-1/NN at/IN a/DT workload/NN of/IN 6/CD ./CD 4/CD kph/NN (/( speed/NN )/NN //NN 16%/NN (/( grade/NN )/SYM ./.
@@80344868034 The/DT incidence/NN of/IN HSV-2/NN positive/JJ subjects/NNS (/( HSV-2/NEWGENE //NEWGENE HSV-1/NEWGENE antibody/NEWGENE ratio/NN >/SYM or/CC =/SYM 1/CD )/SYM was/VBD low/JJ in/IN the/DT Jewish/JJ Israeli/JJ population/NN ,/, compared/VBN to/IN other/DT demographic/JJ areas/NNS ./.
@@117692291609 The/DT sorption/NN mechanisms/NNS changed/VBN from/IN adsorption/NN to/IN partition/NN in/IN the/DT process/NN of/IN repetitious/JJ sorption/NN ./.
@@26305433301 According/VBG to/IN their/PRP staining/NN affinity/NN for/IN anti-T/NEWGENE antibodies/NEWGENE ,/, the/DT glandular/JJ tissue/NN cells/NNS were/VBD classified/VBN as/IN T-/DT ,/, T+/NNP ,/, T++/NNP ,/, and/CC T/NN and/CC the/DT annual/JJ changes/NNS in/IN the/DT numbers/NNS of/IN these/DT cell/NN populations/NNS ,/, as/RB well/VB as/IN in/IN the/DT volume/NN occupied/VBN by/IN the/DT glandular/JJ tissue/NN ,/, were/VBD calculated/VBN ./.
@@49217625240 Cardiac/NNP preservation/NN ./.
@@20921319420 A/DT new/JJ method/NN for/IN the/DT in/NN vitro/FW transfer/NN of/IN delayed/JJ hypersensitivity/NN by/IN dialysed/VBN transfer/NEWGENE factor/NEWGENE ./.
@@10853059661 Karger/NNP AG/NN ,/, Basel/NNP
@@9473040108 The/DT cloned/VBN alcR/NEWGENE gene/NEWGENE provided/VBN in/IN trans/RB restored/VBN these/DT siderophore/NN system/NN activities/NNS to/IN the/DT mutants/NNS ./.
@@64436396247 Study/NNP of/IN bacterial/JJ motility/NN and/CC rate/NN of/IN movement/NN using/VBG a/DT closed/JJ circuit/NN television/NN ./.
@@101980035529 Analysis/NNP of/IN lacZ/NEWGENE transcriptional/NEWGENE fusions/NEWGENE shows/VBZ that/IN the/DT KdgR-binding/NEWGENE sites/NEWGENE negatively/RB affect/VBP the/DT expression/NN of/IN rsmB/NEWGENE ./.
@@9647589618 Extramedullary/NNP plasmacytoma/NN of/IN the/DT parotid/JJ gland/NN ./.
@@13641006568 In/NN addition/NN ,/, a/DT 21-mer/NN subrepeat/NN structure/NN is/VBZ also/RB present/VB in/IN each/DT unit/NN ./.
@@30903723812 Intravenous/JJ glucose/NN tolerance/NN tests/NNS were/VBD performed/VBN before/IN operation/NN ,/, before/IN starting/VBG CyA/NN and/CC after/IN 3/CD weeks/NNS ./.
@@93533438931 Modulation/NNS of/IN AUUUA/NEWGENE response/NEWGENE element/NEWGENE binding/JJ by/IN heterogeneous/NEWGENE nuclear/NEWGENE ribonucleoprotein/NEWGENE A1/NEWGENE in/IN human/JJ T/NN lymphocytes/NNS ./.
@@110759298683 The/DT data/NN provide/VB strong/JJ evidence/NN that/DT ThlA/NEWGENE is/VBZ involved/VBN in/IN the/DT metabolism/NN of/IN both/DT acid/NN and/CC solvent/JJ formation/NN ,/, whereas/IN the/DT physiological/JJ function/NN of/IN ThlB/NEWGENE has/VBZ yet/RB to/IN be/VB elucidated/VBN ./.
@@25741935221 Selection/NN of/IN the/DT 22/CD items/NNS of/IN the/DT Clinical/NNP Institute/NNP Withdrawal/NN Assessment-Benzodiazepines/NN (/( CIWA-B/NN )/SYM was/VBD based/VBN on/IN statistically/RB significant/JJ differences/NNS between/IN baseline/NN and/CC critical/JJ withdrawal/NN periods/NNS in/IN high-dose/JJ subjects/NNS and/CC between/IN symptoms/NNS associated/VBN with/IN placebo/NN and/CC diazepam/NN in/IN low-dose/JJ subjects/NNS ,/, using/VBG contingency/NN tables/NNS and/CC logistic/JJ regression/NN analysis/NN ./.
@@103296256360 We/PRP also/RB observed/VBD that/DT cell/NEWGENE surface/NEWGENE CD4/NEWGENE (/NEWGENE -/NEWGENE )/NEWGENE CD8/NEWGENE (/NEWGENE -/NEWGENE )/NEWGENE CD3/NEWGENE (/NEWGENE -/NEWGENE )/NEWGENE cells/NNS with/IN rearranged/NEWGENE TCR/NEWGENE genes/NEWGENE developed/VBN from/IN Id3-transduced/JJ but/CC not/RB from/IN control-transduced/JJ pre-T/JJ cells/NNS in/IN an/DT FTOC/NNS ./.
@@79165771812 In/NN order/NN to/IN define/VB potential/JJ candidate/NN genes/NNS for/IN inherited/JJ disorders/NNS characterized/VBN by/IN aberrant/JJ gene/NN expression/NN ,/, we/PRP utilized/VBD Kruppel-related/NEWGENE sequences/NEWGENE to/IN isolate/NN zinc/NN finger-containing/NN cDNAs/NN ./.
@@83004638111 Praziquantel/NN and/CC Albendazole/CHEM were/VBD found/VBN effective/JJ in/IN the/DT treatment/NN of/IN neurocysticercosis/NN ,/, but/CC because/IN of/IN serious/JJ side/JJ effects/NNS encountered/VBN in/IN some/DT cases/NNS ,/, the/DT drugs/NNS should/MD be/VB used/VBN cautiously/RB in/IN selected/VBN cases/NNS only/RB ./.
@@98377146368 The/DT results/NNS raise/NN the/DT possibility/NN that/DT pH/NN induced/VBD post-translational/JJ modifications/NNS of/IN DdRPA/NEWGENE are/VBP involved/VBN in/IN events/NNS that/WDT halt/VBP cell/NN proliferation/NN and/CC induce/VB differentiation/NN in/IN Dictyostelium/DT ./.
@@106287481992 However/RB ,/, activation/NN of/IN the/DT cAMP/NN pathway/NN ,/, which/WDT is/NNS known/VBP to/IN regulate/VB inhibin/NEWGENE alpha/NEWGENE expression/NN ,/, greatly/RB enhanced/VBN the/DT actions/NNS of/IN SF-1/NEWGENE ./.
@@7824325988 At/NN different/JJ times/NNS of/IN the/DT surgical/JJ procedures/NNS (/( thorax/NN opening/NN and/CC closure/NN ,/, period/NN of/IN cardiopulmonary/JJ bypass/NN )/SYM 67/CD to/IN 100%/CD of/IN the/DT patients/NNS in/IN group/NN 1/CD had/VBP vancomycin/NN concentrations/NNS in/IN the/DT studied/VBN tissues/NNS above/RB the/DT MIC/NN 90/NN for/IN Staphylococcus/NN aureus/NN (/( 1/CD microgram/NN //NN g/NN )/SYM and/CC Staphylococcus/NN epidermidis/NN (/( 2/CD micrograms/NN //NN g/NN )/SYM ./.
@@92682986813 Ent-kaurene/NEWGENE synthase/NEWGENE from/NEWGENE the/NEWGENE fungus/NEWGENE Phaeosphaeria/NEWGENE sp/NN ./NN
@@118980181808 Data/NNP Management/NN in/IN Practice-based/JJ Research/NN ./.
@@86696765414 The/DT incidence/NN of/IN cardiac/JJ death/NN (/( one/PRP per/IN group/NN )/SYM ,/, Q/JJ wave/NN MI/NN (/( propofol/NN ,/, n/NN =/SYM 7/CD ;/: midazolam/NN ,/, n/NN =/SYM 3/CD ;/: P/NN =/SYM 0/CD ./CD 27/CD )/SYM ,/, or/CC non/NN Q/NN wave/NN MI/NN (/( propofol/NN ,/, n/NN =/SYM 16/CD ;/: midazolam/NN ,/, n/NN =/SYM 18/CD ;/: P/NN =/SYM 0/CD ./CD 81/CD )/SYM did/VBD not/RB differ/VB between/IN treatment/NN groups/NNS ./.
@@1080374615 Evidence/NN is/VBZ presented/VBN that/IN Leber's/NNP military/JJ aneurysm/NN retinitis/NN is/VBZ not/RB a/DT separate/JJ entity/NN but/CC a/DT special/JJ form/NN of/IN Coats'/NN disease/NN ./.
@@25050879766 Here/RB ,/, we/PRP alter/VBP the/DT dimerization/NN specificity/NN of/IN Fos/NEWGENE by/IN precisely/RB replacing/VBG its/PRP leucine/NN zipper/NN with/IN that/DT from/IN GCN4/NEWGENE ./.
@@112788556132 We/PRP confirmed/VBD the/DT interaction/NN between/IN TLS/NEWGENE and/CC p65/NEWGENE by/IN the/DT pull-down/JJ assay/NN in/IN vitro/FW and/CC by/IN a/DT coimmunoprecipitation/NN experiment/NN followed/VBN by/IN Western/JJ blot/NN of/IN the/DT cultured/JJ cell/NN in/IN vivo/NN ./.
@@9290571937 The/DT cycle/NN length/NN of/IN induced/VBN VT/NN (/( n/NN =/SYM 10/CD VTs/NNS )/SYM was/VBD 380/CD +/NN //NN -/NN 41/CD msec/NN ./.
@@111251517616 Nucleotide/NN sequence/NN ,/, genome/NN organization/NN and/CC phylogenetic/JJ analysis/NN of/IN pineapple/NN mealybug/NN wilt-associated/NN virus-2/NN ./.
@@47877165163 Observations/NNS on/IN the/DT flight/NN activities/NNS of/IN Chrysops/JJ caecutiens/NNP L/NNP ./NNP
@@82238752742 Stimulation/NNS of/IN [/NN 3H/NN ]/NN PA/NN production/NN upon/IN CD3/NEWGENE cross-linking/VBG was/VBD 77%/RB lower/JJR in/IN permeabilized/JJ CD45-/NEWGENE cells/NNS than/IN in/IN CD45+/NEWGENE cells/NNS ,/, consistent/JJ with/IN the/DT reduced/VBN activity/NN of/IN p59fyn/NEWGENE in/IN CD45-/NEWGENE cells/NNS ./.
@@37436834407 In/NN a/DT series/NN of/IN 402/CD consecutive/JJ autopsies/NNS ,/, parietal/JJ pleural/JJ plaques/NNS (/( PP/NN )/SYM were/VBD found/VBN in/IN 68/CD individuals/NNS above/RB 40/CD years/NNS of/IN age/NN ./.
@@11117523717 In/NN contrast/NN ,/, high/JJ COUP-TFI/NEWGENE expression/NN impeded/VBD the/DT neuronal/JJ differentiation/NN of/IN P19/CD cells/NNS induced/VBN with/IN RA/NN ,/, resulting/JJ in/IN cell/NN cultures/NNS lacking/JJ neurons/NNS ./.
@@112384024440 We/PRP show/VBP that/IN several/DT heme-responsive/JJ mechanisms/NNS combine/VBP to/IN regulate/VB DAN/NEWGENE //NEWGENE TIR/NEWGENE gene/NEWGENE expression/NN ./.
@@111503158347 NGF/NEWGENE ,/, but/CC not/RB EGF/NEWGENE ,/, enhances/VBZ the/DT upper/JJ bands/NNS ,/, corresponding/JJ to/IN phosphorylated/NEWGENE Fra-2/NEWGENE ./.
@@37220164395 The/DT FFA/NN levels/NNS were/VBD not/RB affected/VBN (/( P/NN greater/JJR than/IN ./CD 1/CD )/SYM by/IN meal/NN interval/NN ./.
@@85355378512 A/DT survey/NN is/NNS given/VBP of/IN the/DT pharmacological/JJ backgrounds/NNS that/WDT are/VBP relevant/JJ for/IN the/DT drug/NN treatment/NN of/IN essential/JJ hypertension/NN in/IN the/DT elderly/NN ./.
@@81820414080 Our/PRP results/NNS indicate/VBP that/IN the/DT minimal/JJ requirements/NNS for/IN induction/NN of/IN PEPCK/NEWGENE by/IN PKA/NEWGENE and/CC inhibition/NN by/IN insulin/NEWGENE include/VB :/: 1/NN )/NN the/DT CREB/NEWGENE activation/NEWGENE domain/NEWGENE ,/, 2/NN )/NN the/DT PEPCK/NEWGENE TATA/NEWGENE sequence/NEWGENE ,/, and/CC 3/NN )/NN insulin-responsive/JJ hepatoma/NN cells/NNS ./.
@@31233108656 The/DT Drosophila/NEWGENE melanogaster/NEWGENE Gart/NEWGENE gene/NEWGENE encodes/VBZ three/CD enzymatic/JJ activities/NNS in/IN the/DT pathway/NN for/IN purine/NN de/FW novo/FW synthesis/NN ./.
@@111729446714 In/NN contrast/NN ,/, we/PRP did/VBD not/RB detect/VB a/DT significant/JJ correlation/NN between/IN plasma/NEWGENE TNFalpha/NEWGENE and/CC radiation/NN pneumonitis/NN ./.
@@110952485801 Unlike/IN the/DT mammalian/JJ proteins/NNS ,/, XFGF3/NEWGENE is/VBZ efficiently/RB secreted/VBN as/IN a/DT Mr/NNP 31/CD ,/CD 000/CD glycoprotein/NN ,/, gp31/NEWGENE ,/, which/WDT undergoes/VBZ proteolytic/JJ cleavage/NN to/IN produce/NN an/DT NH2-terminally/RB truncated/JJ product/NN ,/, gp27/NEWGENE ./.
@@63626026158 Enhancement/NNP of/IN the/DT immune/JJ response/NN by/IN aspecific/JJ action/NN of/IN vaccine/NN additives/NNS in/IN the/DT aerogenic/JJ immunization/NN of/IN swine/NN against/IN swine/NN plague/NN ./.
@@89731857117 The/DT effect/NN of/IN six/CD arginine/NN mutations/NN of/IN oxidative/JJ phosphorylation/NN and/CC AAC/NEWGENE expression/NN ./.
@@105314463351 Neuregulin/NEWGENE stimulates/VBZ ErbB2/NEWGENE ,/, ErbB3/NEWGENE ,/, and/CC ErbB4/NEWGENE ,/, members/NNS of/IN the/DT ErbB/NEWGENE family/NEWGENE of/IN receptor/NEWGENE tyrosine/NEWGENE kinases/NEWGENE ./.
@@79331015025 Previous/JJ studies/NNS have/VBP demonstrated/VBN that/IN the/DT TATA/NN element/NN is/VBZ critical/JJ for/IN basal/JJ and/CC Tat-induced/NN HIV-1/NN gene/NN expression/NN ./.
@@87480332729 Furthermore/RB ,/, cpxA*/NEWGENE mutations/NN suppress/VBP the/DT toxicity/NN conferred/VBN by/IN the/DT LamB-LacZ/NEWGENE hybrid/NEWGENE protein/NEWGENE ,/, which/WDT exerts/VBZ its/PRP effects/NNS in/IN the/DT cytoplasm/NN ,/, sequestered/VBN from/IN DegP/NEWGENE ./.
@@7616569258 They/PRP include/VBP genes/NNS encoding/VBG three/CD subunits/NNS of/IN the/DT cytochrome/NEWGENE oxidase/NEWGENE (/( cox1/NEWGENE to/NEWGENE 3/NEWGENE )/SYM ,/, apocytochrome/NEWGENE b/NEWGENE (/( cob/NEWGENE )/SYM ,/, seven/JJ subunits/NNS of/IN the/DT NADH/NEWGENE dehydrogenase/NEWGENE complex/NEWGENE (/( nad1/NEWGENE to/NEWGENE 6/NEWGENE ,/, nad4L/NEWGENE )/SYM ,/, two/JJ ATPase/NEWGENE subunits/NN (/( atp6/NEWGENE and/CC atp9/NEWGENE )/SYM ,/, three/CD ribosomal/JJ RNAs/NNS (/( rrn5/NEWGENE ,/, srn/NEWGENE and/CC lrn/NEWGENE )/SYM ,/, 23/CD tRNAs/NNS and/CC four/CD ribosomal/NEWGENE proteins/NEWGENE (/( rps3/NEWGENE ,/, rps11/NEWGENE ,/, rps12/NEWGENE and/CC rpl16/NEWGENE )/SYM ./.
@@106907024486 OUTCOME/NNP :/: Acetylcholine/NEWGENE receptor/NEWGENE antibodies/NEWGENE and/CC single-fibre/JJ electromyogram/NN were/VBD useful/JJ in/IN the/DT diagnosis/NN of/IN myasthenia/NN gravis/MD ./.
@@110075099020 In/NN the/DT PMR/NN target/NN area/NN but/CC not/RB in/IN the/DT nontreated/JJ area/NN an/DT improvement/NN in/IN regional/JJ myocardial/JJ flow/NN reserve/NN occurs/VBZ in/IN wall/NN segments/NNS with/IN initially/RB severely/RB or/CC moderately/RB reduced/VBN stress/NN perfusion/NN ./.
@@14600543230 Therefore/RB ,/, ICSBP/NEWGENE may/MD be/VB involved/VBN in/IN maintaining/VBG submaximal/JJ transcriptional/JJ activity/NN of/IN IFN-inducible/NN genes/NNS in/IN hematopoietic/JJ cells/NNS ./.
@@40825924769 Blood/NNP eosinophils/NNS in/IN patients/NNS with/IN Taenia/NN saginata/NN taeniasis/NN ./.
@@112830144701 Our/PRP results/NNS suggest/VBP that/DT WASP/NEWGENE activates/VBZ transcription/NN following/IN TCR/NEWGENE stimulation/NN in/IN a/DT manner/NN that/WDT is/VBZ independent/NN of/IN its/PRP role/NN in/IN Arp2/NEWGENE //NN 3-directed/NN actin/NEWGENE polymerization/NN ./.
@@2496090833 O2/NN and/CC CO2/NN in/IN the/DT tracheostomy/NN tube/NN were/VBD continuously/RB monitored/VBN by/IN mass/JJ spectrometry/NN using/VBG a/DT special/JJ sample-hold/JJ phase-locked/JJ sampling/JJ technique/NN ./.
@@96758967731 Removal/NNP of/IN the/DT carboxyl/NN region/NN severely/RB reduced/VBD transcriptional/JJ activation/NN ./.
@@40114664670 Aortic/JJ diameters/NNS in/IN infants/NNS and/CC young/JJ children/NNS :/: normative/JJ angiographic/JJ data/NN ./.
@@82613989652 Using/VBG a/DT 3'-rapid/JJ amplification/NN of/IN cDNA/NN ends/NNS strategy/NN ,/, we/PRP have/VBP cloned/VBN cDNAs/NNS representing/VBG the/DT 3'-termini/NN of/IN both/PDT the/DT native/JJ and/CC mutant/JJ transcripts/NNS from/IN both/DT P388/NN //NN ADR/NN //NN 3/NN and/CC P388/NN //NN ADR/NN //NN 7/NN cells/NNS ./.
@@84744393987 Mutations/NNS at/IN three/CD sites/NNS have/VBP larger/JJR effects/NNS in/IN muscle/NN than/IN nonmuscle/JJ cells/NNS ;/: an/DT A/NN //NN T-rich/NN site/NN mutation/NN has/VBZ a/DT pronounced/VBN effect/NN in/IN both/DT striated/JJ muscle/NN types/NNS ,/, mutations/NNS at/IN the/DT MEF1/NEWGENE (/NEWGENE Right/NEWGENE E-box/NEWGENE )/NEWGENE site/NEWGENE are/VBP relatively/JJ specific/NN to/IN expression/NN in/IN skeletal/JJ muscle/NN ,/, and/CC mutations/NNS at/IN the/DT CArG/NN site/NN are/VBP relatively/JJ specific/NN to/IN expression/NN in/IN cardiac/JJ muscle/NN ./.
@@111180626738 Therefore/RB ,/, in/IN our/PRP in/IN vitro/FW model/NN ,/, the/DT localization/NN of/IN the/DT mutation/NN in/IN the/DT K-ras/NEWGENE gene/NEWGENE predisposes/VBZ to/IN a/DT different/JJ level/NN of/IN aggressiveness/NN in/IN the/DT transforming/NN phenotype/NN ./.
@@9893913552 Induction/NNS of/IN anaesthesia/NN was/VBD standardised/JJ :/: fentanyl/NN (/( 3/CD micrograms/NN //NN kg/NN )/SYM ,/, thiopentone/NN (/( 5/CD mg/CD //CD kg/CD )/SYM ,/, atracurium/NN (/( 0/CD ./CD 4/CD mg/CD //CD kg/CD )/SYM ./.
@@77898096476 Moreover/RB ,/, Western/JJ blots/NNS demonstrated/VBN at/IN least/RB six/CD types/NNS of/IN Ypt/NEWGENE in/IN both/DT Cr/NN and/CC Vc/NN ,/, suggesting/VBG that/IN these/DT Ypt/NEWGENE are/VBP used/VBN for/IN household/NN functions/NNS responsible/JJ for/IN vesicle/NN transport/NN rather/RB than/IN for/IN cellular/JJ differentiation/NN ./.
@@75472202670 In/NN on-going/JJ screening/JJ programmes/NNS ,/, the/DT Haemoccult/NN test/NN consists/VBZ of/IN six/CD slides/NNS and/CC a/DT test/NN is/VBZ considered/VBN positive/JJ if/IN at/IN least/RB one/PRP slide/NN is/VBZ coloured/JJ ./.
@@65204181214 The/DT results/NNS obtained/VBN were/VBD as/IN follows/VBZ :/: The/DT mitral/JJ valve/NN orifice/NN area/NN (/( MVA/NN )/SYM was/VBD significantly/RB smaller/JJR in/IN patients/NNS with/IN type/NN III/NN of/IN the/DT LVIT/NNP flow/NN velocity/NN pattern/NN than/IN in/IN patients/NNS with/IN type/NN I/NN (/( p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@112636643358 Our/PRP data/NN indicate/VB that/IN SIP1/NEWGENE is/VBZ required/VBN to/IN confine/VB XBra/NEWGENE gene/NEWGENE expression/NN to/IN the/DT mesoderm/NN ./.
@@86437598607 Menstrual-cycle/NNP phase/NN did/VBD not/RB significantly/RB affect/VB personality/NN variables/NNS in/IN either/DT group/NN ./.
@@1973384538 Here/RB we/PRP show/VBP that/IN these/DT synthetic/JJ binding/JJ sites/NNS have/VBP a/DT more/RB restricted/VBN and/CC specific/JJ ability/NN to/IN enhance/VB transcription/NN when/CC assayed/VBN in/IN transformed/VBN embryos/NNS ./.
@@30591716915 Administration/NNP of/IN anticoagulants/NNS ,/, i/FW ./FW e/FW ./FW ,/, heparin/NN ,/, prostaglandin/NN E1/NN and/CC ticlopidine/NN seems/VBZ to/IN be/VB effective/JJ in/IN alleviating/JJ symptoms/NNS and/CC might/MD prevent/VB further/JJ deterioration/NN ./.
@@20449752655 Both/DT tear/NN volume/NN and/CC tear/NN flow/NN were/VBD found/VBN to/IN be/VB significantly/RB (/( P/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM decreased/VBN up/JJ to/IN 6/CD h/NN after/IN instillation/NN ,/, reaching/VBG a/DT minimum/JJ 90/CD min/NN after/IN application/NN (/( tear/NN volume/NN :/: -63%/CD ;/: tear/NN flow/NN :/: -71%/CD )/SYM ./.
@@71260676934 Experimental/JJ reproduction/NN of/IN malignant/JJ catarrhal/JJ fever/NN in/IN Bali/NN cattle/NNS ./.
@@24238509601 Deletion/NNS analysis/NN was/VBD carried/VBN out/RB within/IN a/DT part/NN of/IN the/DT 5'-flanking/JJ region/NN showing/VBG homology/NN to/IN the/DT upstream/JJ region/NN of/IN the/DT yeast/NEWGENE CYC1/NEWGENE gene/NEWGENE ./.
@@75425771355 The/DT fusion/NN proteins/NNS were/VBD tested/VBN by/IN ELISA/NN for/IN reactivity/NN with/IN a/DT panel/NN of/IN human/NEWGENE anti-La/NEWGENE sera/NEWGENE in/IN order/NN to/IN define/VB the/DT nature/NN of/IN the/DT epitopes/NNS ./.
@@95921254469 Class/NEWGENE I/NEWGENE alpha1/NEWGENE ,/NEWGENE 2-mannosidases/NEWGENE play/VBP an/DT essential/JJ role/NN in/IN the/DT elaboration/NN of/IN complex/NN and/CC hybrid/JJ N/JJ -glycans/CD in/IN mammalian/JJ cells/NNS ./.
@@33737553778 Recent/JJ developments/NNS in/IN drugs/NNS antagonistic/JJ to/IN factors/NNS causing/JJ peptic/JJ ulcer--clinical/JJ efficacy/NN and/CC problems/NNS ;/: gastrin/NEWGENE receptor/NEWGENE blockaders/NNS ./.
@@104993578404 SCOB/NN testing/NN of/IN food-restricted/JJ animals/NNS ,/, using/VBG a/DT multiple/JJ fixed/JJ ratio/NN (/( FR/NN )/NN //NN fixed/NN interval/NN (/( FI/NN )/SYM schedule/NN (/( FR20/NNP :/: FI120/NNP )/SYM ,/, was/VBD conducted/VBN prior/NN to/IN each/DT exposure/NN to/IN maintain/VB the/DT operant/JJ behavior/NN ;/: the/DT data/NN from/IN Weeks/NN -1/CD ,/, 4/CD ,/, 8/CD ,/, and/CC 13/CD were/VBD evaluated/VBN for/IN evidence/NN of/IN neurotoxicity/NN ./.
@@86470915404 Two/CD overlapping/JJ clones/NNS contained/VBD the/DT complete/JJ Adh-2/NEWGENE gene/NEWGENE composed/VBN of/IN nine/JJ exons/NNS in/IN a/DT 12-kb/JJ region/NN ,/, with/IN the/DT placement/NN of/IN introns/NNS matching/JJ that/WDT observed/VBD in/IN other/DT mammalian/NEWGENE ADH/NEWGENE genes/NEWGENE ./.
@@89722111711 The/DT imprinted/JJ expression/NN of/IN the/DT endogenous/JJ gene/NN can/MD be/VB recapitulated/VBN in/IN mice/NNS by/IN using/VBG a/DT 14-kb/JJ transgene/NN encompassing/VBG 4/CD kb/NN of/IN 5'-flanking/JJ sequence/NN ,/, 8/CD kb/NN of/IN 3'-flanking/JJ sequence/NN ,/, which/WDT includes/VBZ the/DT two/JJ endoderm-specific/NN enhancers/NN ,/, and/CC an/DT internally/RB deleted/VBN structural/JJ gene/NN ./.
@@62987204928 The/DT strong/JJ conservation/NN of/IN the/DT inverted/JJ terminal/JJ repeat/NN sequence/NN may/MD reflect/VB a/DT common/JJ integration/NN mechanism/NN for/IN VL30/NEWGENE elements/NEWGENE and/CC MuLV/NN proviruses/NNS ./.
@@113762791214 A/DT method/NN of/IN three-station/JJ three-dimensional/JJ magnetic/JJ resonance/NN (/( MR/NN )/SYM angiography/NN of/IN the/DT lower/JJR extremities/NNS with/IN segmented/JJ volume/NN acquisition/NN is/VBZ presented/VBN ./.
@@88038458784 The/DT presence/NN of/IN unidentified/JJ macroscopic/JJ or/CC microscopic/JJ clusters/NNS of/IN neoplastic/JJ cells/NNS ,/, lying/NN around/IN ,/, more/RB or/CC less/PRP close/JJ to/IN ,/, the/DT line/NN of/IN insertion/NN of/IN lesion/NN ,/, could/MD render/VB any/DT attempt/NN to/IN gain/NN a/DT "radical"/NN excision/NN useless/JJ ./.
@@47827885157 Psychological/JJ examinations/NNS in/IN patients/NNS with/IN chronic/JJ kidney/NN insufficiency/NN ./.
@@46450785076 Pathological/JJ processes/NNS in/IN the/DT cervix/NN uteri/NNS ./.
@@96313669603 After/IN the/DT first/JJ cycle/NN ,/, 18/CD cases/NNS were/VBD treated/VBN at/IN dose/NN level/NN 1/CD ,/, after/IN a/DT second/JJ cycle/NN ,/, 13/CD cases/NNS were/VBD treated/VBN at/IN dose/NN level/NN 2/CD ./CD
@@24739422051 Their/PRP hydropathic/JJ plots/NNS are/VBP very/RB similar/JJ and/CC both/DT possess/VB three/CD hydrophobic/JJ segments/NNS that/WDT are/VBP likely/RB alpha-helical/NN transmembrane/NN segments/NN ./.
@@90000494678 We/PRP propose/VBP that/IN Mnt/NEWGENE :/: Max/NEWGENE :/: Sin3/NEWGENE complexes/NNS normally/RB function/VBP to/IN restrict/VB Myc/NEWGENE :/: Max/NEWGENE activities/NNS associated/VBN with/IN cell/NN proliferation/NN ./.
@@95456388301 We/PRP recently/RB characterized/VBD a/DT single/NN yeast/NEWGENE hnRNP/NEWGENE methyltransferase/NEWGENE (/( HMT1/NEWGENE )/SYM ./.
@@1662807389 The/DT factor/NN which/WDT binds/VBZ to/IN the/DT TR/NEWGENE promoter/NEWGENE co-sedimented/JJ with/IN SV40/NN chromosomes/NNS extracted/VBN late/RB in/IN infection/NN ./.
@@90201723340 Complexes/NNS of/IN qTBP42/NEWGENE with/IN each/DT complementary/JJ strand/NN of/IN telomeric/NN DNA/NN and/CC with/IN quadruplex/JJ forms/NNS of/IN the/DT guanine-rich/JJ strand/NN had/VBP 3/CD ./CD 7-14/CD ./CD 6/CD nM/NN dissociation/NN constants/NNS ,/, Kd/NN ,/, whereas/IN complexes/NNS with/IN double-stranded/JJ telomeric/NN DNA/NN had/VBP up/JJ to/IN 100-fold/JJ higher/JJ Kd/NN values/NNS ./.
@@78258887800 Between/IN the/DT subgroups/NNS of/IN dementia/NN disorders/NNS there/RB were/VBD no/DT significant/JJ differences/NNS in/IN basal/JJ cortisol/NN levels/NNS ./.
@@1012640112 Certain/JJ characteristics/NNS of/IN eye/NN changes/NNS in/IN patients/NNS with/IN pheochromocytoma/NN including/JJ Sipple's/NNP syndrome/NN ./.
@@117908974083 Proteomic/NN patterns/NNS of/IN nipple/NN aspirate/NN fluids/NNS obtained/VBN by/IN SELDI-TOF/NN :/: potential/JJ for/IN new/JJ biomarkers/NNS to/IN aid/NN in/IN the/DT diagnosis/NN of/IN breast/NN cancer/NN ./.
@@97048574582 Correlation/NNS of/IN skin/NN disorders/NNS with/IN CD4/NEWGENE lymphocyte/NN counts/NNS in/IN patients/NNS with/IN HIV/DT //DT AIDS/DT ./.
@@60970273130 An/DT intact/JJ 5/CD ./CD 7-kb/CD provirus/NN of/IN the/DT avian/JJ erythroblastosis/NN virus/NN E26/NN has/VBZ been/VBN molecularly/RB cloned/VBN for/IN comparisons/NNS with/IN avian/JJ myeloblastosis/NN virus/NN (/( AMV/NNS )/SYM and/CC other/DT avian/JJ tumor/NN viruses/NNS ./.
@@92569739216 RESULTS/NNS :/: For/IN E1/NN ,/, itraconazole/NN plasma/NN drug/NN concentration/NN extrapolated/VBN to/IN time/NN zero/NN (/( IV/NN dose/NN )/SYM was/VBD 5/CD ./CD 2/CD +/NN //NN -/NN 1/CD ./CD 4/CD micrograms/NN //NN ml/NN ,/, and/CC mean/JJ residence/NN time/NN (/( MRT/NN )/SYM was/VBD 37/CD +/NN //NN -/NN 16/CD hours/NNS ./.
@@86776781699 It/PRP was/VBD shown/VBP that/DT administration/NN of/IN immunomodulator/NN neurotropin/NEWGENE (/( NSP/NEWGENE )/SYM results/NNS in/IN more/RB steady/JJ consolidation/NN and/CC retention/NN of/IN feeding/NN and/CC avoidance/NN behavior/NN ,/, and/CC some/DT neurophysiological/JJ mechanisms/NNS of/IN that/DT phenomena/NNS were/VBD revealed/VBN ./.
@@97551991516 Intriguingly/RB ,/, three/CD hypomorphic/JJ Scm/NEWGENE mutations/NN ,/, which/WDT map/VBP within/IN an/DT mbt/NEWGENE repeat/NEWGENE ,/, interact/VB with/IN PcG/NEWGENE mutations/NEWGENE more/RB strongly/RB than/IN do/NN Scm/NEWGENE null/JJ alleles/NNS ./.
@@464387458 Serial/JJ measurements/NNS of/IN total/JJ serum/JJ IgE/NEWGENE appears/VBZ to/IN be/VB a/DT useful/JJ index/NN of/IN disease/NN activity/NN in/IN ABPA/DT ./.
@@14627862075 Dynamic/NNP decision/NN making/VBG :/: human/JJ control/NN of/IN complex/NN systems/NNS ./.
@@1407286220 Autopsy/NNS demonstrated/VBD good/JJ survival/NN of/IN the/DT transplanted/VBN cells/NNS with/IN good/JJ integration/NN with/IN the/DT brain/NN of/IN the/DT recipient/NN and/CC traces/NNS of/IN positive/JJ immunocytochemical/JJ reaction/NN for/IN tyrosine/NEWGENE hydroxylase/NEWGENE ./.
@@96387936092 After/IN profound/JJ normovolemic/JJ hemodilution/NN (/( Hct/NN 9%/CD )/SYM superiority/NN of/IN LV/NN MC/NN and/CC LV/JJ diastolic/JJ properties/NNS was/VBD found/VBN ,/, when/CC myocardial/JJ oxygenation/NN was/VBD supported/VBN by/IN i/CD ./CD v/CD ./. perflubron/NN emulsion/NN ,/, a/DT temporary/JJ O2/NN carrier/NN ./.
@@1675442273 The/DT inner/JJ ears/NNS were/VBD exposed/VBN by/IN microdissection/NN ,/, and/CC the/DT vestibular/JJ sensory/JJ regions/NNS were/VBD either/DT sectioned/VBN and/CC studied/VBN with/IN light/NN or/CC electron/NN microscopy/NN ,/, or/CC prepared/VBD and/CC studied/VBN with/IN the/DT surface/NN specimen/NN technique/NN ./.
@@98011567073 One/CD of/IN these/DT fragments/NNS shows/VBZ the/DT highest/JJS amino/JJ acid/NN sequence/NN homology/NN to/IN the/DT insect/NN ecdysone/NN inducible/NN gene/NEWGENE E75/NEWGENE ./.
@@85242604410 The/DT domain/NN structure/NN of/IN bovine/NEWGENE LTBP-2/NEWGENE is/VBZ very/RB similar/JJ to/IN that/DT of/IN the/DT human/NEWGENE LTBP-2/NEWGENE ,/, containing/JJ 20/CD examples/NNS of/IN 6-cysteine/NN epidermal/NEWGENE growth/NEWGENE factor-like/NEWGENE repeats/NEWGENE ,/, 16/CD of/IN which/WDT have/VBP the/DT consensus/NN sequence/NN for/IN calcium/NN binding/JJ ,/, together/RB with/IN 4/CD examples/NNS of/IN 8-cysteine/NEWGENE motifs/NEWGENE characteristic/NN of/IN fibrillins/NEWGENE and/CC LTBP-1/NEWGENE ./.
@@108102946965 Stat/NEWGENE activation/NN in/IN response/NN to/IN GH/NEWGENE and/CC IL-6/NEWGENE was/VBD determined/VBN by/IN reporter/NN gene/NN induction/NN ./.
@@98325111507 During/IN early/JJ neurogenesis/NN ,/, Vnd/NEWGENE protein/NEWGENE is/VBZ restricted/VBN to/IN ventral/JJ column/NN neuroectoderm/NN and/CC neuroblasts/NNS ;/: later/JJR it/PRP is/VBZ detected/VBN in/IN a/DT complex/NN pattern/NN of/IN neurons/NNS ./.
@@75301285554 The/DT median/JJ post-treatment/JJ ,/, pre-operative/NN serum/NEWGENE PSA/NEWGENE was/VBD 0/CD ./CD 4/CD ng/NN //NN ml/NN ./.
@@110079548729 The/DT growth/NEWGENE factor/NEWGENE receptor-bound/NEWGENE protein/NEWGENE 2/NEWGENE (/( Grb2/NEWGENE )/SYM adaptor/NN when/CC complexed/VBN with/IN Sos/NEWGENE (/( Son/NEWGENE of/NEWGENE sevenless/NEWGENE )/SYM ,/, the/DT exchange/NN factor/NN of/IN Ras/NEWGENE ,/, conveys/VBZ the/DT signal/RB induced/VBN by/IN tyrosine/NEWGENE kinase-activated/NEWGENE receptor/NEWGENE to/IN Ras/NEWGENE by/IN recruiting/JJ Sos/NEWGENE to/IN the/DT membrane/NN ,/, allowing/VBG activation/NN of/IN Ras/NEWGENE ./.
@@88715424035 Thus/RB ,/, despite/IN the/DT potential/NN for/IN common/JJ regulatory/JJ mechanisms/NNS ,/, the/DT available/JJ evidence/NN indicates/VBZ that/IN the/DT Mtx/NEWGENE minimal/NEWGENE promoter/NEWGENE does/VBP not/RB significantly/RB affect/VB Thbs3/NEWGENE gene/NEWGENE expression/NN ./.
@@115096153431 Phosphatidylinositol/NEWGENE 3-kinase/NEWGENE potentiates/VBZ ,/, but/CC does/VBP not/RB trigger/VB ,/, T/NN cell/NN proliferation/NN mediated/JJ by/IN the/DT IL-2/NEWGENE receptor/NEWGENE ./.
@@41766254841 Value/NNP of/IN the/DT EMG/NN in/IN the/DT diagnosis/NN of/IN a/DT cardiomyopathy/NN associated/VBN with/IN a/DT myotonic/JJ myopathy/NN ./.
@@84965998907 As/IN a/DT result/NN of/IN alternative/JJ splicing/JJ ,/, the/DT BGP/NEWGENE gene/NEWGENE is/VBZ transcribed/VBN into/IN at/IN least/RB seven/JJ distinct/JJ mRNA/NN species/NN ./.
@@17177183368 Finally/RB ,/, some/DT point/NN mutations/NNS in/IN the/DT Gag-Pol/NEWGENE PR/NEWGENE1 domain/NEWGENE1 inhibited/VBD activation/NN of/IN RT/NEWGENE in/IN trans/JJ by/IN a/DT wild-type/NEWGENE PR/NEWGENE ,/, suggesting/VBG that/IN the/DT correct/JJ conformation/NN of/IN the/DT PR/NEWGENE domain/NEWGENE in/IN Gag-Pol/NEWGENE is/VBZ prerequisite/JJ for/IN activation/NN of/IN RT/NN ./NN
@@101977636289 Three/CD different/JJ site-directed/NN mutations/NN of/IN the/DT cyclic/NEWGENE AMP/NEWGENE response/NEWGENE element/NEWGENE each/DT reduced/VBN the/DT nerve/NEWGENE growth/NEWGENE factor/NEWGENE effect/NN by/IN >/SYM 90%/CD ./.
@@68426298873 Significant/JJ GMBF/NN reductions/NNS occurred/VBN in/IN early/JJ shock/NN in/IN both/DT treatment/NN groups/NNS ./.
@@67157925415 HBB/NN concentration/NN in/IN the/DT fetuses/NNS indicated/VBD little/JJ ,/, if/IN any/DT accumulation/NN ./.
@@91827073408 SPP/NEWGENE also/RB induced/VBD transient/JJ tyrosine/NN phosphorylation/NN of/IN focal/NEWGENE adhesion/NEWGENE kinase/NEWGENE (/( p125/NEWGENE (/NEWGENE FAK/NEWGENE )/NEWGENE )/NN ,/, a/DT cytosolic/NEWGENE tyrosine/NEWGENE kinase/NEWGENE that/WDT localizes/VBZ in/IN focal/JJ adhesions/NNS ,/, and/CC of/IN the/DT cytoskeleton-associated/NEWGENE protein/NEWGENE paxillin/NEWGENE ./.
@@14270347162 Unlike/IN the/DT introns/NNS of/IN other/DT duplicated/VBN ribosomal/JJ protein/NN genes/NNS which/WDT are/VBP highly/RB diverged/VBN ,/, the/DT duplicated/VBN S13/NEWGENE genes/NEWGENE have/VBP two/JJ nearly/RB identical/JJ DNA/NN sequences/NNS of/IN 25/CD and/CC 31/CD bp/NN in/IN length/NN within/IN their/PRP introns/NNS ./.
@@75393142721 Changes/NNS induced/VBN in/IN the/DT gills/NNS of/IN milkfish/NN (/( Chanos/NNP chanos/NNS Forsskal/JJ )/SYM fingerlings/NNS after/IN acute/JJ exposure/NN to/IN nifurpirinol/NN (/( Furanace/NNP ;/: P-7138/NN )/SYM ./.
@@86208561400 In/NN agreement/NN with/IN these/DT data/NN ,/, western/JJ blot/NN experiments/NNS using/VBG an/DT antibody/NN directed/VBN against/IN the/DT carboxy-terminal/JJ portion/NN of/IN the/DT mouse/NN c-kit/NEWGENE protein/NEWGENE showed/VBN that/IN a/DT polypeptide/NN ,/, of/IN the/DT size/NN predicted/VBN by/IN the/DT open/JJ reading/JJ frame/NN of/IN the/DT spermatid-specific/NEWGENE c-kit/NEWGENE cDNA/NEWGENE ,/, accumulates/VBZ in/IN the/DT latest/JJS stages/NNS of/IN spermatogenesis/NN and/CC in/IN epididymal/JJ spermatozoa/NNS ./.
@@98519884291 Both/PDT the/DT presence/NN of/IN arginine/NN and/CC anaerobiosis/NN are/VBP needed/VBN to/IN trigger/NN induction/NN of/IN the/DT pathway/NN ./.
@@103597924355 The/DT relatively/JJ mild/JJ defects/NNS observed/VBN in/IN Rpd3/NEWGENE mutants/NEWGENE suggest/VBP that/IN the/DT recently/RB identified/VBN Groucho/NEWGENE and/CC dCtBP/NEWGENE corepressor/NEWGENE proteins/NEWGENE do/VBP not/RB function/VB solely/RB through/RB the/DT recruitment/NN of/IN histone/NEWGENE deacetylases/NEWGENE ./.
@@40408584716 Since/IN September/NN 1980/CD to/IN June/NN 1983/CD we/PRP have/VBP treated/VBN 32/CD patients/NNS with/IN ovarian/JJ cancer/NN ./.
@@86757698652 Nonreturn/NN rates/NNS can/MD be/VB used/VBN to/IN derive/VB more/RB elementary/JJ biological/JJ measures/NNS for/IN reproductive/JJ efficiency/NN ,/, such/JJ as/IN conception/NN rate/NN and/CC calving/JJ rate/NN ,/, which/WDT separately/RB might/MD be/VB more/RB reliable/JJ than/IN nonreturn/JJ rate/NN itself/PRP to/IN evaluate/VB the/DT fertility/NN of/IN a/DT bull/NN or/CC the/DT performance/NN of/IN an/DT AI/NN technician/NN ./.
@@89501445960 Waves/NNS N1/NN ,/, P3/NN and/CC CNV/NN were/VBD recorded/VBN during/IN a/DT CNV/NN paradigm/NN in/IN a/DT simple/JJ reaction/NN time/NN task/NN with/IN a/DT constant/JJ interstimulus/JJ interval/NN (/( ISI/NN )/SYM of/IN 1/CD sec/NN ./.
@@75200985531 In/NN the/DT B6-derived/NN Db/NEWGENE mutant/NEWGENE B6/NEWGENE ./NEWGENE CH-2bm13/NEWGENE (/NEWGENE bm13/NEWGENE )/NEWGENE strain/NN ,/, part/NN of/IN the/DT class/NEWGENE I/NEWGENE Db/NEWGENE antigen-presenting/NEWGENE groove/NEWGENE is/VBZ shaped/JJ by/IN a/DT class/NEWGENE I/NEWGENE Kb-encoded/NEWGENE sequence/NEWGENE ./.
@@68085296583 The/DT stability/NN of/IN isoniazid/NN solutions/NNS increases/NNS markedly/RB with/IN increasing/JJ NTA/NNS or/CC EDTA/NN concentration/NN up/JJ to/IN 1/CD mmol/NN //NN l/NN ./.
@@34034804101 Prolonged/VBN suspension/NN induced/VBD a/DT significant/JJ change/NN in/IN the/DT geometric/JJ configuration/NN of/IN the/DT femur/NN middiaphysis/NN by/IN increasing/JJ the/DT minimum/JJ diameter/NN (/( 12%/JJ )/SYM without/IN any/DT significant/JJ alterations/NNS in/IN cortical/JJ area/NN ,/, density/NN ,/, mineral/JJ ,/, and/CC collagen/NEWGENE concentrations/NNS ./.
@@86395212906 The/DT dynamic/JJ properties/NNS of/IN this/DT protein/NN fragment/NN were/VBD measured/VBN and/CC analyzed/VBN using/VBG both/DT isotropic/JJ and/CC anisotropic/JJ models/NNS of/IN molecular/JJ motion/NN ./.
@@19454302544 The/DT original/JJ technique/NN was/VBD developed/VBN in/IN the/DT 1960's/NN to/IN analyze/VB the/DT inner/JJ ear/NN fluid/NN as/IN a/DT diagnostic/JJ procedure/NN (/( i/FW ./FW e/FW ./FW ,/, diagnostic/JJ labyrinthotomy/NN )/SYM in/IN acoustic/JJ neuroma/NN suspects/NNS ./.
@@98499657954 This/DT study/NN utilizes/VBZ the/DT mammalian/JJ two-hybrid/JJ system/NN to/IN examine/VB the/DT role/NN of/IN ligand/NN in/IN the/DT dimerization/NN of/IN human/NEWGENE progesterone/NEWGENE receptor/NEWGENE (/( hPR/NEWGENE )/SYM ./.
@@115285005155 No/DT mutation/NN of/IN the/DT NRL/NEWGENE gene/NEWGENE was/VBD found/VBN in/IN any/DT of/IN the/DT two/JJ families/NNS ./.
@@100229254836 The/DT Nmd3/NEWGENE protein/NEWGENE sequence/NEWGENE does/VBP not/RB contain/VB readily/RB recognizable/JJ motifs/NNS of/IN known/VBP function/NN ./.
@@115836214247 Several/JJ distinct/JJ apoptotic/JJ stimuli/NNS induce/VBP the/DT expression/NN and/CC caspase-dependent/JJ cleavage/NN of/IN hTAF/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE 80/NEWGENE delta/NEWGENE ./. hTAF/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE 80/NEWGENE delta/NEWGENE ,/, unlike/IN hTAF/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE 80/NEWGENE ,/, forms/VBZ a/DT TFIID-like/NEWGENE complex/NEWGENE lacking/JJ hTAF/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE 31/NEWGENE ./.
@@63235561130 A/DT computed/JJ tomographic/JJ scan/NN obtained/VBN after/IN EOE-13/NN infusion/NN accurately/RB showed/VBD the/DT perfusion/NN pattern/NN of/IN the/DT implanted/VBN catheter/NN ./.
@@24204321697 Therefore/RB ,/, in/IN conjunction/NN with/IN a/DT positive/JJ pregnancy/NN test/NN and/CC the/DT patient's/NNS clinical/JJ history/NN ,/, a/DT severely/RB depressed/VBN or/CC absent/VB serum/JJ PAPP-A/NEWGENE level/NN may/MD aid/VB in/IN the/DT diagnosis/NN of/IN extrauterine/JJ pregnancy/NN ./.
@@81697092433 Aneurysmal/JJ bone/NN cyst/NN of/IN the/DT jaws/NNS :/: analysis/NN of/IN 11/CD cases/NNS ./.
@@80907467029 An/DT 8-bp/JJ sequence/NN (/( ATTTCAAA/NEWGENE )/SYM within/IN the/DT protected/VBN region/NN shares/VBP significant/JJ homology/NN with/IN promoter/NN sequences/NNS required/VBN for/IN ethylene/NN responsiveness/NN from/IN the/DT tomato/NN fruit-ripening/JJ E4/NEWGENE gene/NEWGENE ./.
@@107022417672 However/RB ,/, the/DT a1/NEWGENE isoform/NEWGENE is/VBZ expressed/VBN most/RB heavily/RB in/IN brain/NN and/CC heart/NN ,/, a2/NEWGENE in/IN liver/NN and/CC kidney/NN ,/, and/CC a3/NEWGENE in/IN liver/NN ,/, lung/NN ,/, heart/NN ,/, brain/NN ,/, spleen/NN ,/, and/CC kidney/NN ./.
@@80360047909 The/DT R2/NEWGENE region/NEWGENE within/IN the/DT class/NEWGENE I/NEWGENE enhancer/NEWGENE acts/NNS as/IN a/DT negative/JJ element/NN in/IN Ad12-transformed/JJ cells/NNS and/CC exhibits/VBP a/DT stronger/RBR binding/JJ activity/NN than/IN is/VBZ observed/VBN in/IN nontumorigenic/JJ Ad5-transformed/JJ cells/NNS ,/, which/WDT are/VBP not/RB reduced/VBN in/IN class/NEWGENE I/NEWGENE expression/NN ./.
@@106635588633 Diverse/JJ endogenous/JJ light/NN chains/NNS contribute/VBP to/IN basement/NN membrane/NN reactivity/NN in/IN nonautoimmune/JJ mice/NNS transgenic/JJ for/IN an/DT anti-laminin/NEWGENE Ig/NEWGENE heavy/NEWGENE chain/NEWGENE ./.
@@16215843466 UF-021/NN ophthalmic/JJ solution/NN (/( 0/CD ./CD 03/CD to/IN 0/CD ./CD 24%/CD )/SYM ,/, when/CC topically/RB applied/VBN to/IN the/DT eyes/NNS of/IN rabbits/NNS ,/, caused/VBN dose-dependent/NN IOP/NN reduction/NN (/( 2/CD ./CD 8/CD to/IN 5/CD ./CD 2/CD mmHg/NN )/SYM ,/, without/IN transient/JJ IOP/NN rise/NN ./.
@@11125411964 All/DT 9/CD untreated/JJ patients/NNS underwent/VBD laparoscopy/NN ,/, which/WDT identified/VBD 3/CD intra-abdominal/JJ ,/, 3/CD vanished/VBN and/CC 2/CD peeping/NN testes/NNS ,/, and/CC 1/CD atrophic/JJ testis/NN in/IN the/DT inguinal/JJ canal/NN ./.
@@4056218370 This/DT slope/NN tended/VBN to/IN be/VB higher/JJ (/( approximately/RB 1/CD ./CD 6/CD dB/NN //NN dB/NN )/SYM for/IN L1/NN =/SYM L2/NN greater/JJR than/IN 80/CD dB/CD ./CD
@@95656063784 Another/DT stem-loop/NN called/VBN structure/NN III/NN near/IN the/DT 3'-end/CD of/IN repY/NEWGENE sequesters/VBP both/PDT the/DT 5'-rCGCC-3'/NEWGENE sequence/NEWGENE and/CC the/DT repZ/NEWGENE ribosome-binding/NEWGENE site/NEWGENE ./.
@@108663237799 We/PRP further/RB studied/VBD the/DT effects/NNS of/IN SIE-1/NEWGENE hypermethylation/NN on/IN p21WAF1/NEWGENE induction/NN by/IN STAT/NEWGENE activation/NN ./.
@@76283899533 Tumor/NEWGENE necrosis/NEWGENE factor-alpha/NEWGENE (/( TNF/NEWGENE alpha/NEWGENE )/SYM ,/, a/DT proinflammatory/JJ cytokine/NN ,/, inhibits/VBZ cAMP-stimulated/JJ testosterone/NN production/NN in/IN mouse/NN Leydig/NN cells/NNS ./.
@@56272515616 Positive/JJ shifts/NNS of/IN basal/JJ skin/NN potentials/NNS during/IN human/JJ sleep/NN ./.
@@29035008793 To/TO explore/VB the/DT functional/JJ properties/NNS of/IN the/DT protein/NN encoded/VBN by/IN neu/NEWGENE ,/, we/PRP created/VBD a/DT fusion/NN gene/NN that/WDT joins/VBP the/DT cytoplasmic/JJ domain/NN of/IN neu/NEWGENE to/IN the/DT extracellular/JJ portion/NN of/IN an/DT immunoglobulin/NEWGENE heavy/NEWGENE chain/NEWGENE ./.
@@23615751647 Dermal/JJ toxicity/NN and/CC carcinogenicity/NN of/IN 4-vinyl-1-cyclohexene/JJ diepoxide/NN in/IN Fischer/NN rats/NNS and/CC B6C3F1/NN mice/NNS ./.
@@62347866562 Radiogallium/NN imaging/VBG is/VBZ thus/RB of/IN limited/VBN use/NN in/IN evaluation/NN of/IN suspected/VBN giant/NN cell/NN tumors/NNS of/IN bone/NN ./.
@@36680034332 In/NN vivo/NN epiluminescence/NN microscopy/NN of/IN pigmented/JJ skin/NN lesions/NNS ./.
@@109598381116 In/JJ invertebrates/NNS ,/, Fhit/NEWGENE is/VBZ encoded/VBN as/IN a/DT fusion/NN protein/NN with/IN Nit/NEWGENE ,/, a/DT member/NN of/IN the/DT nitrilase/NEWGENE superfamily/NEWGENE ./.
@@88434124590 Here/RB we/PRP localize/VBP a/DT transferable/JJ 40-amino/JJ acid/NN region/NN within/IN the/DT LBDs/NEWGENE of/IN RXR/NEWGENE ,/, RAR/NEWGENE ,/, TR/NEWGENE ,/, and/CC chicken/NEWGENE ovalbumin/NEWGENE upstream/NEWGENE promoter/NEWGENE transcription/NEWGENE factor/NEWGENE that/WDT is/VBZ critical/JJ for/IN determining/VBG identity/NN in/IN the/DT heterodimeric/JJ interaction/NN and/CC for/IN high-affinity/JJ DNA/NN binding/JJ ./.
@@16461577101 Recently/RB ,/, the/DT 3/NEWGENE ./NEWGENE 6-kb/NEWGENE full-length/NEWGENE alpha-GalNAc/NEWGENE cDNA/NEWGENE sequence/NEWGENE was/VBD isolated/VBN and/CC found/VB to/IN have/NN remarkable/JJ nucleotide/NN and/CC predicted/VBN amino/JJ acid/NN homology/NN (/( 55/CD ./CD 8/CD and/CC 46/CD ./CD 9%/CD ,/, respectively/RB )/SYM with/IN the/DT human/NEWGENE alpha-galactosidase/NEWGENE A/NEWGENE (/( alpha-Gal/NEWGENE A/NEWGENE )/SYM cDNA/NN ./.
@@71847747011 Re-examination/NNS of/IN the/DT ED01/NN study/NN ./.
@@117558945780 In/NN the/DT treatment/NN of/IN opioid/JJ naive/JJ patients/NNS who/WP underwent/VBD surgery/NN and/CC received/VBN opioids/NNS for/IN acute/JJ pain/NN ,/, oral/JJ ADL/NN 8-2698/CD (/( 6/CD ./CD 0/CD mg/NN )/SYM improved/VBN the/DT management/NN of/IN postoperative/JJ ileus/NN (/( POI/NN )/SYM by/IN shortening/VBG the/DT time/NN to/IN achieve/VB normal/JJ bowel/NN function/NN and/CC ,/, ultimately/RB ,/, hospital/NN stay/NN ./.
@@92201775666 The/DT CPK-MB/NEWGENE isoenzyme/NEWGENE showed/VBD no/DT percentage/NN increase/NN of/IN total/JJ CPK/NEWGENE higher/JJ than/IN 5%/JJ ,/, measured/VBN at/IN 6/CD ,/, 12/CD ,/, and/CC 24/CD h/NN after/IN the/DT shock/NN ,/, independent/NN of/IN the/DT number/NN of/IN attempts/NNS of/IN cardioversion/NN ./.
@@91542839202 Latanoprost/NN produces/VBZ an/DT additional/JJ reduction/NN of/IN intraocular/JJ pressure/NN (/( IOP/NN )/SYM when/CC used/VBN in/IN combination/NN with/IN timolol/NN ,/, pilocarpine/NN ,/, acetazolamide/NN and/CC dipivefrin/NN ./.
@@82298268211 The/DT inhibitory/JJ response/NN to/IN taps/NN is/VBZ essentially/RB a/DT protective/JJ reflex/NN which/WDT probably/RB serves/VBP to/IN reduce/VB the/DT activity/NN of/IN the/DT jaw-closing/JJ muscles/NNS when/CC one/PRP bites/NNS unexpectedly/RB on/IN hard/JJ objects/NNS ./.
@@39814214642 A/DT flow/NN rate/NN of/IN at/IN least/RB 5/CD mL/NN //NN h/NN is/VBZ required/VBN through/RB the/DT receptor/NN (/( volume/NN ,/, 0/CD ./CD 4/CD mL/NN )/SYM for/IN accurate/JJ results/NNS ./.
@@24313149421 We/PRP conclude/VBP that/IN Hansel's/NN stain/NN substantially/RB improves/VBZ the/DT recognition/NN of/RB eosinophiluria/NN as/IN compared/VBN with/IN Wright's/NNP stain/NN ./.
@@94233104179 Histopathologically/RB ,/, a/DT cystic/JJ lymphangioma/NN was/VBD diagnosed/VBN because/IN of/IN the/DT morphological/JJ features/NNS and/CC the/DT immunohistochemical/JJ stainings/NNS of/IN CD34/NEWGENE and/CC Factor/NEWGENE VIII/NEWGENE related/NEWGENE antigen/NEWGENE which/WDT were/VBD observed/VBN positive/JJ reactions/NNS in/IN endothelial/JJ cells/NNS of/IN the/DT cysts/NNS ./.
@@90606766831 These/DT changes/NNS in/IN virus/NN entry/NN features/NNS may/MD result/VB in/IN coronaviruses/NNS with/IN novel/JJ pathogenic/JJ properties/NNS ./.
@@27148523576 Allelic/NNP variation/NN in/IN HLA-B/NEWGENE and/CC HLA-C/NEWGENE sequences/NEWGENE and/CC the/DT evolution/NN of/IN the/DT HLA-B/NEWGENE alleles/NEWGENE ./.
@@56927595651 Nephrectomy/NNS applied/VBN to/IN cattle/NNS ./.
@@94070909063 Structure/NNS and/CC localization/NN of/IN the/DT human/NEWGENE gene/NEWGENE encoding/NEWGENE SR-BI/NEWGENE //NEWGENE CLA-1/NEWGENE ./.
@@95615608599 Rhesus/NNP macaques/NNS and/CC BALB/NN //NN c/NN mice/NNS inoculated/VBN with/IN the/DT Mengo/NNP virus/NN SIV/NN recombinants/NNS failed/VBN to/IN develop/VB CTL/NN responses/NNS against/IN the/DT SIV/NN gene/NN products/NN ,/, while/CC one/PRP of/IN the/DT HIV-Nef/NEWGENE recombinants/NEWGENE induced/VBD a/DT weak/JJ CTL/NN response/NN in/IN mice/NNS directed/VBN to/IN an/DT HIV1/NEWGENE Nef/NEWGENE peptide/NEWGENE spanning/VBG positions/NNS 182-198/CD ./.
@@21621031671 We/PRP cloned/VBN and/CC sequenced/VBN the/DT cDNAs/NNS against/IN genomic/JJ RNA/NN and/CC mRNA/NN for/IN phosphoprotein/NN (/( P/NN )/SYM of/IN human/JJ parainfluenza/NN type/NN 2/CD virus/NN (/( PIV-2/NN )/SYM ./. cDNA/NN clone/NN from/IN genomic/JJ RNA/NN was/VBD 1439/CD nucleotides/NNS in/IN length/NN excluding/JJ poly/NN (/NN A/NN )/NN and/CC was/VBD found/VBN to/IN have/NN two/JJ small/JJ open/JJ reading/JJ frames/NNS encoding/VBG proteins/NNS of/IN 233/CD and/CC 249/CD amino/JJ acids/NNS ./.
@@9565545518 Also/RB ,/, samples/VBZ of/IN serum/NN were/VBD absorbed/VBN with/IN the/DT various/JJ solid-phase/JJ allergens/NNS and/CC the/DT reactivity/NN of/IN the/DT remaining/JJ IgE/NEWGENE antibodies/NEWGENE was/VBD determined/VBN ./.
@@98155785299 This/DT study/NN demonstrates/VBZ that/DT alteration/NN of/IN CDKN2/NEWGENE is/VBZ one/PRP of/IN the/DT most/RB frequent/VB genetic/JJ abnormalities/NNS in/IN prostate/NN cancer/NN and/CC may/MD contribute/VB to/IN prostate/NN carcinogenesis/NN ./.
@@1377696224 The/DT chick/NN axon-associated/JJ surface/NN glycoprotein/NN neurofascin/NEWGENE is/VBZ implicated/VBN in/IN axonal/JJ growth/NN and/CC fasciculation/NN as/IN revealed/VBN by/IN antibody/NN perturbation/NN experiments/NNS ./.
@@94370011164 In/NN contrast/NN ,/, overproduction/NN of/IN Der3p/NEWGENE is/VBZ lethal/JJ in/IN a/DT sec61-2/NEWGENE strain/NN at/IN the/DT permissive/JJ temperature/NN of/IN 25/CD degrees/NNS C/NNP ./NNP
@@3847444524 The/DT unilateral/JJ vestibular/JJ hypofunction/NN ./.
@@93680146973 The/DT lysozyme/NEWGENE FEF/NEWGENE site/NEWGENE is/VBZ immediately/RB 5'/CD to/IN a/DT PU/NEWGENE ./.
@@66750476438 The/DT authors/NNS have/NN tested/VBD the/DT interference/NN of/IN the/DT hemoglobin/NEWGENE by/IN two/JJ routine/JJ methods/NNS (/( Berthelot/NNP classic/JJ and/CC Berthelot/NNP modified/JJ )/SYM for/IN the/DT determination/NN of/IN plasmatic/JJ urea/NN ./.
@@82266167686 The/DT nit-3/NEWGENE gene/NEWGENE of/NEWGENE the/NEWGENE filamentous/NEWGENE fungus/NEWGENE Neurospora/NEWGENE crassa/NEWGENE encodes/VBZ nitrate/NEWGENE reductase/NEWGENE ,/, the/DT enzyme/NN which/WDT catalyzes/VBZ the/DT first/JJ step/NN in/IN nitrate/NN assimilation/NN ./.
@@22003154555 IgG/NEWGENE and/CC IgM/NEWGENE antibody/NN activity/NN was/VBD determined/VBN by/IN adding/JJ a/DT 1/CD :/: 100/CD dilution/NN of/IN serum/JJ to/IN plates/NNS coated/JJ with/IN A60/NEWGENE antigen/NEWGENE ./.
@@14594514373 GAL4-VP16-mediated/JJ antirepression/NN required/VBD an/DT auxiliary/NN factor/NN ,/, denoted/VBN as/IN a/DT co-antirepressor/NN ,/, which/WDT was/VBD partially/RB purified/VBN from/IN Drosophila/NN embryos/NNS ./.
@@23559203134 A/DT consensus/NN binding/JJ site/NN for/IN the/DT transcription/NN factor/NN SP1/NEWGENE was/VBD identified/VBN in/IN intron/NN As/IN downstream/RB of/IN the/DT proenkephalin/NEWGENE germ/NEWGENE cell/NEWGENE cap/NEWGENE site/NEWGENE region/NEWGENE ./.
@@12845955555 The/DT isolation/NN of/IN this/DT gene/NN was/VBD based/VBN on/IN the/DT identification/NN of/IN the/DT Y-231/NN cosmid/NN that/WDT contains/VBZ CpG/NN rich/NN sequences/NN (/( HTF/NEWGENE islands/NEWGENE )/SYM in/IN its/PRP human/JJ insert/NN ./.
@@46798075092 Sulfuric/NNP acid/NN concentration/NN in/IN the/DT catalyzed/VBN breathalyzer/NN ampules/NNS ./.
@@11525486262 Additionally/RB ,/, a/DT CaCO3-CO2/NN //NN N2/NN buffered/JJ solution/NN was/VBD necessary/JJ to/IN maintain/VB a/DT pH/NN of/IN 8/CD ./CD
@@14568881997 For/IN this/DT reason/NN ,/, the/DT particle/NN forming/JJ capacity/NN of/IN derivatives/NNS of/IN the/DT HIV-1/NEWGENE group/NEWGENE specific/NEWGENE core/NEWGENE antigen/NEWGENE p55/NEWGENE gag/NEWGENE was/VBD assayed/VBN and/CC compared/VBN dependent/JJ on/IN various/JJ expression/NN systems/NNS :/: recombinant/JJ bacteria/NNS ,/, vaccinia-/JJ and/CC baculoviruses/NNS were/VBD established/VBN encoding/VBG the/DT entire/JJ core/NEWGENE protein/NEWGENE p55/NEWGENE either/DT in/NN its/PRP authentic/JJ sequence/NN or/CC lacking/JJ the/DT myristylation/NN consensus/NN signal/JJ ./.
@@111100405567 Ketanserin/IN ,/, a/DT hypotensive/JJ drug/NN with/IN 5-HT2/NEWGENE receptor/NEWGENE antagonism/NN ,/, when/CC administered/VBD by/IN topical/JJ infusion/NN of/IN a/DT 0/CD ./CD 25%/CD w/NN //NN v/NN solution/NN by/IN corneal/JJ and/CC scleral/JJ applications/NNS ,/, was/VBD found/VBN to/IN lower/JJR intraocular/JJ pressure/NN with/IN four/CD times/NNS more/JJ activity/NN than/IN its/PRP metabolite/NN ,/, ketanserinol/NN ./.
@@99246758453 The/DT starting/VBG point/NN is/VBZ the/DT consideration/NN that/IN the/DT conceptions/NNS underlying/JJ the/DT ICIDH/NN are/VBP not/RB suitable/JJ to/RB serve/NN as/IN a/DT mainstay/NN of/IN a/DT model/NN for/IN diagnostics/NNS in/IN rehabilitation/NN because/IN they/PRP do/VBP not/RB reflect/VB essential/JJ characteristics/NNS of/IN the/DT diagnostic/JJ process/NN which/WDT is/VBZ the/DT basis/NN for/IN intervention/NN ./.
@@13120054384 Analysis/NNP of/IN the/DT entire/JJ 16/CD ./CD 7-kb/CD mt/NN genome/NN determined/VBN that/IN a/DT MDP1/NEWGENE mediates/VBZ cleavage/NN of/IN chick/NN mtDNA/NN in/IN vitro/FW at/IN three/CD H-/NNP and/CC two/JJ L-strand/NNS sequence-specific/NN target/NN sites/NN located/VBN within/IN a/DT 90-bp/NN A/DT +/SYM T-rich/NNP genomic/JJ tract/NN ,/, theoretically/RB capable/JJ of/IN forming/JJ stable/JJ secondary/JJ structures/NNS ,/, approximately/RB 200/CD bases/NNS upstream/RB from/IN the/DT H-strand/NNS origin/NN (/( OH/NN )/SYM of/IN replication/NN ./.
@@115248237956 Utility/NNP of/IN OAE/NN screener/NN (/( GSI/NN 70/NN )/SYM for/IN the/DT evaluation/NN of/IN distortion/NN product/NN otoacoustic/JJ emissions/NNS The/DT purpose/NN of/IN this/DT study/NN was/VBD to/IN investigate/VB the/DT ability/NN of/IN the/DT OAE/NN screener/NN GSI/NN 70/NN to/IN evaluate/VB of/IN cochlea/NN function/NN in/IN neonates/NNS ,/, infants/NNS and/CC adults/NNS ./.
@@81390041015 The/DT 3'/NN UTR/NNS has/VBZ several/DT stable/JJ hairpins/NNS that/WDT are/VBP flanked/VBN by/IN single-stranded/NEWGENE (/NEWGENE A/NEWGENE //NEWGENE U/NEWGENE )/NEWGENE UGC/NEWGENE sequences/NEWGENE ./.
@@28848603152 Terazosin/NNP ,/, a/DT structural/JJ analog/NN of/IN prazosin/NN ,/, also/RB inhibits/VBZ alpha/NEWGENE 1/NEWGENE adrenoceptors/NEWGENE and/CC is/VBZ recommended/VBN as/IN once/CC or/CC twice-daily/JJ therapy/NN ./.
@@69926006766 The/DT extraction/NN measurements/NNS were/VBD used/VBN to/IN test/NN for/IN extracerebral/JJ contamination/NN of/IN venous/JJ outflow/NN ./.
@@87767938766 The/DT patients/NNS are/VBP two/JJ healthy/JJ adult/JJ males/NNS ./.
@@93143064032 Supplementation/NNS was/VBD stopped/VBN when/CC pl-ALB/NEWGENE reached/VBN 2/CD ./CD 0/CD g/NN //NN dL/NN ./.
@@78659177849 Treatment/NNP of/IN recurrent/JJ FSGS/NN has/VBZ included/VBN high-dose/JJ steroids/NNS ,/, high-dose/JJ cyclosporine/NN (/( CSA/NN )/SYM ,/, plasmapheresis/NN ,/, and/CC ACE/NEWGENE inhibitors/NN with/IN mixed/JJ results/NNS ./.
@@63914966191 Effect/NN of/IN proteolytic/JJ enzymes/NNS and/CC polypeptides/NNS on/IN the/DT antacid/JJ activity/NN of/IN almagate/NN and/CC other/DT antacids/NNS ./.
@@65429188239 We/PRP propose/VBP that/IN the/DT ambiguous/JJ discrimination/NN required/VBD a/DT greater/JJR time/NN for/IN simulus/NN evaluation/NN and/CC that/IN this/DT was/VBD reflected/VBN in/IN the/DT delayed/NN P3/NN latencies/NNS ./.
@@114504901327 The/DT median/JJ preoperative/JJ best-corrected/JJ visual/JJ acuity/NN of/IN 0/CD ./CD 08/CD (/( range/NN hand/NN motions/CD //CD 0/CD ./CD 003/CD to/IN 0/CD ./CD 4/CD )/SYM ,/, improved/VBN by/IN 5/CD lines/NNS to/IN a/DT median/JJ final/JJ postoperative/JJ best-corrected/JJ visual/JJ acuity/NN of/IN 0/CD ./CD 25/CD (/( range/NN 0/CD ./CD 025-0/CD ./CD 5/CD )/SYM (/( P/NN =/SYM 0/CD ./CD 001/CD )/SYM ./.
@@99180969998 In/NN the/DT second/JJ case/NN ,/, an/DT epidermal/NN cyst/NN was/VBD diagnosed/VBN ./.
@@81484634688 The/DT colony-stimulating/NEWGENE factors/NEWGENE (/( CSFs/NEWGENE )/SYM principally/RB involved/VBN in/IN the/DT production/NN of/IN neutrophils/NNS and/CC monocytes/NNS are/VBP granulocyte/NEWGENE CSF/NEWGENE ,/, granulocyte-macrophage/NEWGENE CSF/NEWGENE ,/, macrophage/NEWGENE CSF/NEWGENE ,/, and/CC interleukin/NEWGENE 3/NEWGENE (/( sometimes/RB called/VBN multi-CSF/NEWGENE )/SYM ./.
@@78621655742 By/IN treating/JJ monkey/NN COS/NN cells/NNS with/IN oligonucleotides/NNS linked/JJ to/IN psoralen/NN ,/, we/PRP have/VBP generated/VBN targeted/VBN mutations/NNS in/IN a/DT simian/JJ virus/NN 40/CD (/( SV40/NN )/SYM vector/NN contained/VBN within/IN the/DT cells/NNS via/NN intracellular/JJ triple/JJ helix/NN formation/NN ./.
@@95616169513 Deltamethrin/NNP was/VBD most/RB effective/JJ on/IN the/DT thatched/JJ surface/NN and/CC produced/VBN 100%/CD mortality/NN of/IN An/NNP ./NNP culicifacies/NNS adults/NNS up/JJ to/IN 12/CD weeks/NNS ,/, even/VB when/CC exposed/VBN at/IN the/DT lowest/JJS dose/NN //CD 12/CD ./CD 5/CD mg/NN //NN m2/NN ./.
@@79267891796 The/DT DNA/NN sequence/NN adjacent/JJ to/IN the/DT lacZ/NEWGENE gene/NEWGENE has/VBZ been/VBN determined/VBN for/IN 91/CD vegetative/JJ fusion/NN genes/NNS whose/WP products/NNS have/VBP been/VBN localized/VBN and/CC for/IN 43/CD meiotically/RB induced/VBN fusions/NNS ./.
@@85951848570 This/DT study/NN proposes/VBZ an/DT estimator/NN for/IN such/JJ global/JJ synchronizing/JJ effects/NNS upon/IN unit-pair/JJ correlations/NNS based/VBN on/IN local/JJ field/NN potentials/NNS (/( LFPs/NNP )/SYM ./.
@@109764139770 RESULTS/NNS :/: Neither/CC basal/NN FSH/NEWGENE level/NN nor/CC stimulated/VBN FSH/NEWGENE level/NN alone/RB were/VBD statistically/RB significant/JJ predictors/NNS of/IN IVF/NN success/NN ;/: however/RB ,/, no/DT patient/NN with/IN a/DT day/NN 3/CD FSH/NEWGENE level/NN >/SYM 11/CD ./CD 1/CD mIU/NN //NN ml/NN or/CC a/DT stimulated/VBN day/NN 10/CD FSH/NEWGENE level/NN >/SYM 13/CD ./CD 5/CD mIU/NN //NN ml/NN conceived/VBN and/CC carried/VBD a/DT pregnancy/NN ./.
@@35459554218 The/DT serum/NEWGENE insulin/NEWGENE response/NN cannot/MD ./.
@@21686402778 Significant/JJ correlations/NNS were/VBD obtained/VBN between/IN changes/NNS in/IN SSEP/NNS in/IN response/NN to/IN AS/NNP and/CC the/DT presence/NN of/IN not/RB deep/JJ residual-organic/JJ disturbances/NNS ,/, so-called/JJ "ground"/NN in/IN psychogenic/JJ disorders/NNS ./.
@@13841652000 In/JJ rats/NNS ,/, we/PRP examined/VBD the/DT effect/NN of/IN an/DT omentum/NN wrapping/NN on/IN the/DT vascularization/NN of/IN the/DT trachea/NN and/CC on/IN regeneration/NN of/IN the/DT mucosal/JJ epithelium/NN in/IN the/DT very/RB early/JJ stage/NN after/IN free/JJ tracheal/JJ grafting/NN ./.
@@89862144756 To/TO evaluate/VB the/DT hepatic/JJ regenerative/JJ response/NN in/IN patients/NNS with/IN alcoholic/JJ liver/NN disease/NN ,/, sera/NNS from/IN 263/CD patients/NNS with/IN severe/JJ alcoholic/JJ hepatitis/NN and/DT //DT or/DT cirrhosis/NN were/VBD analyzed/VBN for/IN hepatocyte/NEWGENE growth/NEWGENE factor/NEWGENE (/( HGF/NEWGENE )/SYM and/CC alpha-fetoprotein/NEWGENE (/( AFP/NEWGENE )/SYM ./.
@@45111395006 Composites/NNS as/IN restoration/NN materials/NNS ./.
@@110240269820 The/DT high/JJ selectivity/NN of/IN arrestins/NEWGENE for/IN this/DT particular/JJ functional/JJ form/NN of/IN receptor/NN ensures/VBZ their/PRP timely/JJ binding/NN and/CC dissociation/NN ./.
@@37121535607 Primary/JJ invasive/JJ Haemophilus/NN influenzae/NNS type/NN b/NN disease/NN :/: a/DT population-based/JJ assessment/NN of/IN risk/NN factors/NNS ./.
@@86173117321 However/RB ,/, while/CC the/DT sequence/NN similarity/NN between/IN the/DT membrane/NN exons/NNS of/IN avian/NEWGENE mIgY/NEWGENE and/CC mammalian/NEWGENE mIgG/NEWGENE and/NEWGENE IgE/NEWGENE is/VBZ striking/JJ ,/, the/DT overall/JJ similarity/NN with/IN Xenopus/NEWGENE mIgY/NEWGENE is/VBZ very/RB low/JJ ./.
@@63280121068 The/DT same-sized/JJ EBNA/NEWGENE protein/NEWGENE (/NEWGENE approximately/NEWGENE 78/NEWGENE ,/NEWGENE 000/NEWGENE )/NEWGENE was/VBD made/VBP after/IN transfection/NN with/IN BamHI-K/NEWGENE (/NEWGENE 5/NEWGENE ./NEWGENE 2/NEWGENE kilobase/NEWGENE pairs/NEWGENE [/NEWGENE kbp/NEWGENE ]/NEWGENE )/NEWGENE or/CC the/DT I1f/NEWGENE subfragment/NEWGENE (/NEWGENE 2/NEWGENE ./NEWGENE 9/NEWGENE kbp/NEWGENE )/NEWGENE ./.
@@25521432680 VP5/NEWGENE ,/, which/WDT encodes/VBZ the/DT major/NEWGENE capsid/NEWGENE protein/NEWGENE ,/, each/DT fused/VBN to/IN the/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE gene/NEWGENE ./.
@@81839158350 Alternative/JJ splicing/JJ of/IN RNA/NN transcripts/NNS encoded/VBN by/IN the/DT murine/NEWGENE p105/NEWGENE NF-kappa/NEWGENE B/NEWGENE gene/NEWGENE generates/VBZ I/NEWGENE kappa/NEWGENE B/NEWGENE gamma/NEWGENE isoforms/NEWGENE with/IN different/JJ inhibitory/JJ activities/NNS ./.
@@7771745852 Elevation/NNS of/IN the/DT tissues/NNS of/IN the/DT face/NN is/VBZ essentially/RB vertical/JJ and/CC acts/NNS on/IN the/DT forehead/NN ,/, temporal/NN region/NN ,/, gaze/NN and/CC cheekbones/NNS ./.
@@64116599237 If/IN facilities/NNS for/IN measurements/NNS of/IN O2/NN consumption/NN and/CC hence/RB metabolic/JJ rate/NN are/VBP available/JJ ,/, these/DT should/MD be/VB utilized/VBN ./.
@@61896983551 The/DT P165/NN component/NN ,/, however/RB ,/, could/MD be/VB differentiated/VBN from/IN the/DT two/RB later/JJR components/NNS since/IN it/PRP increased/VBD in/IN amplitude/NN with/IN increased/VBN task/NN demands/NNS while/CC the/DT N2/NN and/CC P3/NN amplitudes/NNS remained/VBD constant/JJ ./.
@@17384707247 Patients/NNS with/IN moderate/JJ PDDAT/NN were/VBD impaired/VBN on/IN all/DT serial/JJ positions/NNS for/IN both/DT spatial/JJ order/NN and/CC spatial/JJ recognition/NN memory/NN ./.
@@75005972043 At/NN the/DT time/NN of/IN the/DT 13/CD latest/JJS BPVs/NNP ,/, age/NN ranged/VBD from/IN three/CD days/NNS to/IN 13/CD ./CD 1/CD years/NNS (/( mean/JJ 5/CD ./CD 7/CD +/NN //NN -/NN SD/NN 4/NN ./NN 8/NN years/NNS )/SYM ./.
@@87767352964 Stably/RB transfected/VBN human/JJ kidney/NN 293/CD cells/NNS expressing/JJ the/DT wild/NEWGENE type/NEWGENE rat/NEWGENE LH/NEWGENE //NEWGENE CG/NEWGENE receptor/NEWGENE (/( rLHR/NEWGENE )/SYM or/CC receptors/NNS with/IN C-terminal/NN tails/NNS truncated/JJ at/IN residues/NNS 653/CD ,/, 631/CD ,/, or/CC 628/CD (/( designated/VBN rLHR-t653/NEWGENE ,/, rLHR-t631/NEWGENE ,/, and/CC rLHR-t628/NEWGENE )/SYM were/VBD used/VBN to/IN probe/NN the/DT importance/NN of/IN this/DT region/NN on/IN the/DT regulation/NN of/IN hormonal/JJ responsiveness/NN ./.
@@80675466205 We/PRP examined/VBD the/DT hypothesis/NN that/IN the/DT coronary/JJ vasomotor/JJ responses/NNS to/IN etomidate/NN (/( ETO/NN )/SYM ,/, propofol/NN (/( PRO/FW )/SYM ,/, and/CC sodium/NN thiopental/NN (/( STP/NNS )/SYM are/VBP mediated/JJ through/RB contrasting/JJ effects/NNS on/IN the/DT resting/JJ nitric/JJ oxide/NN (/( NO/DT )/NN -dependent/NN vasodilator/JJ tone/NN that/WDT opposes/VBZ adrenergic/JJ vasoconstrictor/JJ activity/NN in/IN the/DT intact/JJ dog/NN ./.
@@9472608430 Here/RB we/PRP have/VBP examined/VBN the/DT ability/NN of/IN the/DT cellular/JJ protein/NN YB-1/NEWGENE to/IN modulate/VB transcription/NN of/IN the/DT HIV-1/NEWGENE promoter/NEWGENE in/IN a/DT human/JJ astrocytic/JJ cell/NN line/NN (/( U-87MG/NNP )/SYM ,/, a/DT neuronal/JJ cell/NN line/NN (/( SK-N-MC/NNP )/SYM and/CC lymphoid/JJ cells/NNS (/( Jurkat/NN )/SYM by/IN transfection/NN assay/NN ./.
@@96326379502 In/NN this/DT study/NN we/PRP examined/VBD hepatic/JJ stellate/JJ cell/NN regulation/NN of/IN M6P/NEWGENE //NEWGENE IGFIIR/NEWGENE expression/NN and/CC found/VB that/IN M6P/NEWGENE //NEWGENE IGFIIR/NEWGENE mRNA/NEWGENE transcript/NEWGENE levels/NNS increased/VBN in/IN stellate/JJ cells/NNS from/IN rats/NNS exposed/VBN to/IN carbon/NN tetrachloride/NN (/( CCl4/NN )/SYM ,/, a/DT potent/JJ fibrogenic/JJ stimulant/NN ./.
@@15561119304 However/RB ,/, other/DT regions/NNS of/IN the/DT plasmid/NN are/VBP also/RB efficiently/RB repaired/VBN ./.
@@48526354862 Lack/NN of/IN effect/NN of/IN the/DT appetite/NN stimulant/JJ pizotifen/NN (/( BC/NN 105/NN )/SYM on/IN the/DT absorption/NN of/IN isonicotinylhydrazine/NN ./.
@@33616534049 We/PRP have/VBP improved/VBN our/PRP system/NN for/IN nuclear/JJ contour/NN digitization/NN and/CC determined/VBN its/PRP theoretical/JJ limitations/NNS by/IN digitizing/JJ standardized/JJ objects/NNS ./.
@@65822855008 To/TO evaluate/VB the/DT comparative/JJ safety/NN of/IN U-P/NNP and/CC D&E/NNP ,/, we/PRP analyzed/VBD 2/CD ,/CD 805/CD U-P/NN and/CC 9/NN ,/NN 572/NN D&E/NNP abortions/NNS at/IN 13/CD to/IN 24/CD menstrual/JJ weeks'/NN gestation/NN ./.
@@80110098004 2/CD ./CD
@@113761341714 These/DT corrections/NNS do/NN not/RB involve/VB sequences/NNS predicted/VBN to/RB function/NN as/IN transcription/NN factor/NN binding/JJ sites/NNS ./.
@@94349799388 Our/PRP results/NNS showed/VBD that/WDT compared/VBD to/IN the/DT primary/JJ photon/NN fluence/NN ,/, the/DT extra-focal/JJ photon/NN fluence/NN from/IN the/DT primary/NN collimator/NN and/CC the/DT flattening/NN filter/NN was/VBD 11%-16%/JJ at/IN the/DT isocenter/NN ,/, among/IN which/WDT 70%/CD was/VBD contributed/VBN by/IN the/DT flattening/NN filter/NN ./.
@@75835627483 In/NN men/NNS with/IN BMI/NN </SYM 30/CD ,/, the/DT OR/NN was/VBD 1/CD ./CD 83/CD for/IN postprandial/JJ TG/NN (/( P/NN =/SYM ./CD 041/CD )/SYM and/CC 2/CD ./CD 77/CD for/IN postprandial/JJ RP/NN (/( P/NN =/SYM ./CD 032/CD )/SYM in/IN models/NNS that/WDT included/VBD fasting/JJ TG/NN ,/, LDL-C/NNS ,/, and/CC hypertension/NN ./.
@@82768656062 The/DT kinase/NEWGENE inhibitor/NN staurosporine/NN (/( 1/CD microM/NN )/SYM blocks/NNS LPA-induced/JJ ,/, but/CC not/RB epidermal/JJ growth/NN factor-induced/NN ,/, activation/NN of/IN p21ras/NEWGENE and/CC MAP/NEWGENE kinase/NEWGENE ,/, consistent/JJ with/IN an/DT intermediate/NEWGENE protein/NEWGENE kinase/NEWGENE linking/JJ the/DT LPA/NEWGENE receptor/NEWGENE to/IN p21ras/NEWGENE activation/NN ./.
@@7404097249 The/DT histochemistry/NN and/CC ultrastructure/NN of/IN calcified/JJ cerebellar/JJ deposits/NNS described/VBN by/IN Tonge/NNP et/FW al/NNS ./NNS
@@85504255044 Three/CD of/IN these/DT subunits/NNS are/VBP also/RB homologous/JJ to/IN the/DT dimeric/JJ POR/NEWGENE from/IN a/DT mesophilic/JJ archaeon/NN ,/, Halobacterium/NN halobium/NN (/( 21%/JJ identity/NN )/SYM ./.
@@105440898 The/DT RNA/NN transcripts/NNS structurally/RB equivalent/JJ to/IN I/NEWGENE (/NEWGENE 2/NEWGENE )/NEWGENE sgRNAs/NEWGENE of/IN TMV/NN U1/NN and/CC crTMV/NEWGENE ,/, but/CC containing/NN a/NN hairpin/NN structure/NN (/( H/NN )/SYM immediately/RB upstream/RB of/IN IRES/NEWGENE (/NEWGENE MP/NEWGENE ,/NEWGENE 75/NEWGENE )/NEWGENE (/NEWGENE HIRES/NEWGENE (/NEWGENE MP/NEWGENE )/NEWGENE ,/NEWGENE (/NEWGENE 75/NEWGENE )/NEWGENE (/NEWGENE CR/NEWGENE )/NEWGENE -MP-CP-3'UTR/NEWGENE ;/: HIRES/NEWGENE (/NEWGENE MP/NEWGENE ,/NEWGENE 75/NEWGENE )/NEWGENE (/NEWGENE U1/NEWGENE )/NEWGENE -MP-CP-3'UTR/NEWGENE )/) ,/, were/VBD able/JJ to/IN express/NN the/DT MP/NEWGENE gene/NEWGENE in/IN vitro/FW ./.
@@16377584534 In/NN addition/NN a/DT greater/JJR proportion/NN of/IN women/NNS in/IN the/DT sweeping/NN group/NN had/VBP a/DT cervical/JJ dilatation/NN of/IN 4/CD cm/NN or/CC more/RB at/IN the/DT first/JJ vaginal/JJ examination/NN in/IN the/DT labour/NN ward/NN (/( 16/CD //CD 33/CD (/( 49%/CD )/SYM vs/NNP 5/CD //CD 32/CD (/( 16%/JJ )/SYM ;/: OR/NN 4/CD ./CD 39/CD ;/: 95%/CD CI/NN 1/NN ./NN 56/NN to/IN 12/CD ./CD 32/CD ;/: P/NN =/SYM 0/NN ./NN 005/NN )/NN ./.
@@64668045951 Exposure/NN of/IN endothelium/NN to/IN pulsatile/JJ shear/NN stresses/NNS that/WDT followed/VBD a/DT tape/NN recording/NN of/IN physiological/JJ flow/NN waveforms/NNS (/( electromagnetic/JJ flowmeter/NN )/SYM did/VBD not/RB cause/VB gross/JJ injury/NN or/CC denudation/NN even/VB when/CC peak/NN shear/NN exceeded/VBN 1500/CD dyne/NN //NN cm2/NN ./.
@@93118356844 We/PRP report/VBP the/DT preliminary/JJ biochemical/JJ characterization/NN of/IN the/DT T/NEWGENE antigens/NEWGENE encoded/VBN by/IN three/CD SV40/NN mutants/NN ,/, 5030/CD ,/, 5031/CD ,/, and/CC 5061/CD ,/, each/DT of/IN which/WDT have/VBP altered/VBN residues/NNS within/IN or/CC near/IN the/DT ATP/NN binding/JJ pocket/NN ./.
@@102315819704 Site-directed/JJ mutagenesis/NN showed/VBN that/IN two/JJ adjacent/JJ SP1/NEWGENE sites/NEWGENE proximal/JJ to/IN exon/NN 1/CD were/VBD equally/RB important/JJ in/IN sustaining/JJ basal/JJ promoter/NN activity/NN ./.
@@100749037862 Taken/VBN together/RB ,/, these/DT results/NNS are/VBP consistent/JJ with/IN the/DT possibility/NN that/IN p202/NEWGENE protein/NEWGENE contributes/VBZ to/IN the/DT cell/NN growth/NN retardation/NN activity/NN of/IN the/DT IFNs/NEWGENE ,/, at/IN least/RB in/IN part/NN ,/, by/IN modulating/JJ p21/NEWGENE protein/NEWGENE levels/NNS ./.
@@11121118706 Genomic/NN organization/NN of/IN the/DT human/NN phosphodiesterase/NEWGENE PDE11A/NEWGENE gene/NEWGENE ./.
@@98194401740 To/TO modulate/VB transcription/NN ,/, regulatory/JJ factors/NNS communicate/VBP with/IN basal/JJ transcription/NN factors/VBZ and/DT //DT or/DT RNA/NEWGENE polymerases/NEWGENE in/IN a/DT variety/NN of/IN ways/NNS ./.
@@81966243640 In/NNP Mv1Lu/NNP lung/NN epithelial/JJ cells/NNS ,/, ActR-IB/NEWGENE and/CC T/NEWGENE beta/NEWGENE R-I/NEWGENE signal/NN a/DT common/JJ set/NN of/IN growth-inhibitory/JJ and/CC transcriptional/JJ responses/NNS in/IN association/NN with/IN their/PRP corresponding/JJ ligands/NNS and/CC type/NEWGENE II/NEWGENE receptors/NEWGENE ./.
@@111583242741 The/DT observed/VBN phenotypes/NNS may/MD be/VB explained/VBN by/IN (/( i/NN )/SYM a/DT selective/JJ disruption/NN of/IN very-low-density/NEWGENE lipoprotein/NEWGENE secretion/NN due/NN to/IN decreased/VBN expression/NN of/IN genes/NNS encoding/VBG apolipoprotein/NEWGENE B/NEWGENE and/CC microsomal/NEWGENE triglyceride/NEWGENE transfer/NEWGENE protein/NEWGENE ,/, (/( ii/NN )/SYM an/DT increase/NN in/IN hepatic/JJ cholesterol/NN uptake/NN due/NN to/IN increased/VBN expression/NN of/IN the/DT major/JJ high-density/NEWGENE lipoprotein/NEWGENE receptor/NEWGENE ,/, scavenger/NEWGENE receptor/NEWGENE BI/NEWGENE ,/, and/CC (/( iii/NN )/SYM a/DT decrease/NN in/IN bile/NN acid/NN uptake/NN to/IN the/DT liver/NN due/NN to/IN down-regulation/NN of/IN the/DT major/JJ basolateral/NEWGENE bile/NEWGENE acid/NEWGENE transporters/NEWGENE sodium/NEWGENE1 taurocholate/NEWGENE1 cotransporter/NEWGENE1 protein/NEWGENE1 and/CC organic/NEWGENE anion/NEWGENE transporter/NEWGENE protein/NEWGENE 1/CD ./CD
@@106509384208 Two/CD estrogen/NEWGENE receptor/NEWGENE (/( ER/NEWGENE )/SYM isoforms/NNS with/IN different/JJ estrogen/NN dependencies/NNS are/VBP generated/VBN from/IN the/DT trout/NEWGENE ER/NEWGENE gene/NEWGENE ./.
@@77608416613 In/NN the/DT context/NN of/IN the/DT ADH2/NEWGENE upstream/NEWGENE regulatory/NEWGENE region/NEWGENE ,/, including/JJ UAS1/NEWGENE ,/, working/JJ in/IN concert/NN with/IN the/DT ADH2/NEWGENE basal/NEWGENE promoter/NEWGENE elements/NEWGENE ,/, UAS2-dependent/NN gene/NN activation/NN was/VBD dependent/JJ on/IN orientation/NN ,/, copy/NN number/NN ,/, and/CC helix/NN phase/NN ./.
@@18235202331 Measurements/NNS were/VBD done/VBP with/IN a/DT commercial/JJ haematofluorometer/NN Buchler/NNP ZF/NN which/WDT was/VBD calibrated/VBN to/IN the/DT average/JJ haematocrit/NN value/NN of/IN 0/CD ./CD 42/CD ./.
@@89189185454 Paracrine/NNP activation/NN of/IN the/DT HIV-1/NEWGENE LTR/NEWGENE promoter/NEWGENE by/IN the/DT viral/NEWGENE Tat/NEWGENE protein/NEWGENE is/VBZ mechanistically/RB similar/JJ to/IN trans-activation/NN within/IN a/DT cell/NN ./.
@@94906765111 Furthermore/RB ,/, binding/NN of/IN recombinant/NEWGENE Myb/NEWGENE and/CC Ets-2/NEWGENE protein/NEWGENE to/IN these/DT fragments/NNS could/MD be/VB competed/VBN with/IN an/DT excess/NN of/IN double/JJ stranded/JJ oligodeoxynucleotides/NNS containing/JJ canonical/JJ ,/, but/CC not/RB mutated/JJ ,/, Myb-/NNP or/CC Ets-binding/NEWGENE sites/NEWGENE ./.
@@34850642358 A/DT total/NN of/IN 117/CD EVS/NN treatments/NNS were/VBD performed/VBN on/IN 34/CD patients/NNS ./.
@@103295742900 O/NEWGENE ./NEWGENE novo-ulmi/NEWGENE RNA-7/NEWGENE ,/, previously/RB believed/VBN to/IN be/VB a/DT satellite-like/NN RNA/NN ,/, is/NNS shown/VBP to/IN be/VB a/DT defective/JJ RNA/NN ,/, derived/VBN from/IN OnuMV4-Ld/NEWGENE RNA/NEWGENE by/IN multiple/JJ internal/JJ deletions/NNS ./.
@@11522584174 Diffuse/JJ myalgias/NNS were/VBD more/RB frequent/VB in/IN patients/NNS with/IN than/IN without/IN an/DT MMF/NN lesion/NN at/IN deltoid/JJ muscle/NN biopsy/NN (/( P/NN </SYM 0/CD ./CD 0001/CD )/SYM ./.
@@95505912639 Successful/JJ treatment/NN with/IN nasal/JJ continuous/JJ positive/JJ airway/NN pressure/NN (/( 8/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 5/CD cmH2O/NN )/SYM for/IN 3/CD days/NNS caused/VBD a/DT significant/JJ decrease/NN in/IN mean/JJ blood/NN pressure/NN in/IN OSAS/DT ./.
@@115598217805 DNA/NN binding/JJ assays/NNS confirmed/VBD the/DT interference/NN of/IN p30/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE with/IN the/DT assembly/NN of/IN CREB-Tax-p300/NEWGENE //NEWGENE CBP/NEWGENE multiprotein/NEWGENE complexes/NEWGENE on/IN 21-bp/JJ repeat/NN oligonucleotides/NNS in/IN vitro/FW ./.
@@90033126017 Full-length/NEWGENE AT-PHH1/NEWGENE ,/, and/CC both/DT AT-PHH1/NEWGENE and/CC AT-PHH1/NEWGENE delta/NEWGENE C-513/NEWGENE (/( truncated/JJ to/IN be/VB approximately/RB the/DT size/NN of/IN microbial/NEWGENE photolyase/NEWGENE genes/NEWGENE )/SYM cDNAs/NNS ,/, were/VBD overexpressed/VBN ,/, respectively/RB ,/, in/IN yeast/NN and/CC Escherichia/NN coli/JJ mutants/NNS hypersensitive/JJ to/IN ultraviolet/JJ light/NN ./.
@@83442489818 GAP-N/NEWGENE bound/JJ constitutively/RB to/IN p190/NEWGENE in/IN both/DT serum-deprived/NN and/CC growth/NN factor-stimulated/NN cells/NNS ./.
@@77447636251 Binding/NN activity/NN in/IN rat/NN liver/NN nuclear/JJ extracts/NNS includes/VBZ these/DT orphan/NEWGENE receptors/NEWGENE as/IN judged/VBN from/IN electromobility/NN supershift/NN experiments/NNS and/CC from/IN results/NNS obtained/VBN with/IN expressed/VBN receptors/NNS ,/, although/IN the/DT element/NN in/IN CYP2C11/NEWGENE did/VBD not/RB bind/VB HNF-4/NEWGENE ./.
@@12362241871 Muscular/NNP pathology/NN ./.
@@77827757244 Further/RB ,/, the/DT ORFs/NNS of/IN components/NNS 3/CD and/CC 5/CD potentially/RB encoded/VBN proteins/NNS of/IN about/RB 20/CD kDa/NN ,/, the/DT size/NN of/IN the/DT BBTV/NEWGENE coat/NEWGENE protein/NEWGENE ./.
@@13595882160 This/DT computation/NN is/VBZ performed/VBN by/IN a/DT parallel/JJ network/NN of/IN locally/RB connected/VBN neuron-like/NN elements/NN ./.
@@65031326295 SFP/NN was/VBD significantly/RB elevated/VBN in/IN Hn/VB (/( s/NN )/SYM ./.
@@99311186653 Neither/CC the/DT p42/NEWGENE //NEWGENE 44/NEWGENE nor/CC the/DT JNK/NEWGENE pathway/NN was/VBD involved/VBN in/IN the/DT action/NN of/IN IL-1beta/NEWGENE ./.
@@88248818539 Linkage/NNS studies/NNS have/VBP shown/VBP locus/NN heterogeneity/NN with/IN one/PRP TSC/NEWGENE gene/NEWGENE mapped/VBN to/IN chromosome/NN 9q34/CD and/CC a/DT second/NN to/IN 16p13/CD ./CD 3/CD ./.
@@101878644200 These/DT results/NNS suggest/VBP KCC3/NEWGENE is/VBZ a/DT new/JJ member/NN of/IN the/DT KCC/NEWGENE family/NEWGENE that/WDT is/VBZ under/IN distinct/JJ regulation/NN from/IN KCC1/NEWGENE ./.
@@90045042484 The/DT primary/JJ structure/NN of/IN a/DT 2671/CD bp/NN DNA/NN fragment/NN between/IN the/DT pla/NEWGENE gene/NEWGENE (/( encoding/VBG plasminogen/NEWGENE activator/NEWGENE )/SYM and/CC the/DT origin/NN of/IN replication/NN of/IN the/DT wild-type/VBG Yersinia/DT pestis/NN plasmid/NN pYP358/NN was/VBD determined/VBN ./.
@@16756376359 A/DT single/JJ amino/JJ acid/NN difference/NN in/IN the/DT C-terminal/NN region/NN influences/NNS dominant/JJ negative/JJ activity/NN and/CC receptor/NN dimer/NN formation/NN ./.
@@11513121650 Progressive/NNP study/NN and/CC robustness/NN test/NN of/IN QSAR/NN model/NN based/VBN on/IN quantum/JJ chemical/JJ parameters/NNS for/IN predicting/JJ BCF/NN of/IN selected/VBN polychlorinated/JJ organic/JJ compounds/NNS (/( PCOCs/NNP )/SYM ./.
@@77689531044 EEA1/NEWGENE is/VBZ a/DT conserved/VBN alpha-helical/NN peripheral/NN membrane/NN protein/NN flanked/VBN by/IN cysteine/NN "fingers"/NN and/CC contains/VBZ a/DT calmodulin-binding/NEWGENE IQ/NEWGENE motif/NEWGENE ./.
@@10243927177 In/NN a/DT series/NN of/IN 16/CD full-scale/JJ fire/NN tests/NNS ,/, investigators/NNS at/IN the/DT IIT/NNP Research/NNP Institute/NNP have/VB concluded/VBN that/IN automatic/JJ door/NN control/NN in/IN the/DT room/NN of/IN fire/NN origin/NN can/MD significantly/RB reduce/VB the/DT spread/NN of/IN toxic/JJ smoke/NN and/CC gases/NNS ./.
@@39590455332 Two/CD studies/NNS on/IN the/DT relationship/NN between/IN taking/VBG a/DT commercial/JJ coaching/NN course/NN and/CC performance/NN on/IN the/DT Medical/NNP College/NNP Admission/NNP Test/NNP (/( MCAT/NN )/SYM are/VBP reported/VBN ./.
@@91125899065 However/RB ,/, in/IN some/DT of/IN them/PRP either/DT pattern/NN may/MD predominate/VB or/CC be/VB exclusively/RB present/VB ./.
@@80887772773 The/DT consensus/NN gene/NN order/NN deduced/VBN by/IN combining/JJ data/NN from/IN both/DT crosses/NNS is/VBZ D2Mit1-/NEWGENE (/( Dbh/NEWGENE ,/, Notch1/NEWGENE )/) -/SYM (/( Col5a1/NEWGENE ,/, Rxra/NEWGENE )/) -Spna2-Ab/NEWGENE l-/NEWGENE (/( Ak1/NEWGENE ,/, Fpgs/NEWGENE )/) -/SYM (/( Grp78/NEWGENE ,/, Pbx3/NEWGENE )/) -/SYM (/( Epb7/NEWGENE ./NEWGENE 2/NEWGENE ,/NEWGENE Hc/NEWGENE ,/NEWGENE Gsn/NEWGENE )/) -Acra/NEWGENE ./.
@@105274268430 One/CD form/NN of/IN the/DT SBEI/NEWGENE gene/NEWGENE transcript/NEWGENE in/IN 12-day/JJ old/JJ kernels/NNS contained/VBD the/DT exon/NN I+II+III/NN combination/NN at/IN the/DT 5'/CD end/NN ,/, whereas/IN other/DT forms/NNS differed/VBN by/IN inclusion/NN of/IN intron/NN 1/CD or/CC exclusion/NN of/IN exon/NN II/NN sequences/NN ./.
@@112208576534 CHAP/NN and/CC the/DT Department/NNP of/IN Veterans/NNP Affairs/NNP ./.
@@20462022656 The/DT remainder/NN (/( 18/CD ./CD 4%/CD )/SYM was/VBD with/IN IgA/NEWGENE nephropathy/NN ,/, which/WDT was/VBD histologically/RB mild/JJ ./.
@@17512554390 Cardiac/NNP output/NN (/( CO/NN )/SYM was/VBD significantly/RB higher/JJ (/( p/NN less/PRP than/IN 0/CD ./CD 0005/CD )/SYM in/IN the/DT MBBF/NN group/NN ./.
@@114662276823 The/DT presence/NN of/IN AS-oligo/NN had/VBP no/DT further/JJ effect/NN on/IN the/DT FSH-mediated/JJ activation/NN of/IN the/DT EB*-mTf-CAT/NEWGENE construct/NEWGENE but/CC reduced/VBN cAMP-mediated/JJ activation/NN ./.
@@111172633912 Among/IN eight/CD graminaceous/JJ species/NN tested/VBN ,/, Ids3/NEWGENE expression/NN was/VBD observed/VBN only/RB in/IN Fe-deficient/NNP roots/NNS of/IN H/NNP ./NNP vulgare/JJ and/CC Secale/NNP cereale/NN ./. which/WDT not/RB only/RB secrete/VB 2'-deoxymugineic/JJ acid/NN (/( DMA/NN )/SYM ,/, but/CC also/RB mugineic/JJ acid/NN (/( MA/NN )/SYM and/CC 3-epihydroxymugineic/JJ acid/NN (/( epiHMA/NN ,/, H/NNP ./NNP vulgare/JJ )/SYM ,/, and/CC 3-hydroxymugineic/JJ acid/NN (/( HMA/NNP ,/, S/NNP ./NNP cereale/NN )/SYM ./.
@@108619067416 We/PRP also/RB found/VBP that/IN environmental/JJ conditions/NNS for/IN meiosis/NN finely/RB regulate/VB the/DT transcript/NN levels/NNS of/IN KIN28/NEWGENE and/CC CCL1/NEWGENE ,/, such/JJ that/DT nitrogen/NN starvation/NN first/NN elevates/VBZ them/PRP but/CC subsequent/JJ alkalization/NN of/IN medium/NN decreases/NNS them/PRP ./.
@@98173734367 PURPOSE/NNS :/: To/TO determine/VB the/DT effects/NNS of/IN hypercholesterolemia/NN and/CC atherosclerosis-induced/JJ chronic/JJ cavernosal/JJ arterial/JJ insufficiency/NN on/IN cavernosal/JJ smooth/JJ muscle/NN tone/NN ,/, nitric/NEWGENE oxide/NEWGENE synthase/NEWGENE (/( NOS/NEWGENE )/SYM activity/NN and/CC cavernosal/JJ tissue/NN synthesis/NN of/IN constrictor/NN eicosanoids/NNS ./.
@@637637772 The/DT multiple/JJ factors/NNS affecting/VBG plasma/NN renin/NEWGENE activity/NN in/IN essential/JJ hypertension/NN ./.
@@82085405140 Transient/JJ co-transfection/NN assays/NNS involving/VBG NFKB2/NEWGENE expression/NN vectors/NNS and/CC kappa/NN B-driven/NNP reporter/NN plasmids/NNS indicate/VBP that/IN NFKB2/NEWGENE p85/NEWGENE1 has/VBZ lost/VBP the/DT transcriptional/JJ repressor/NN functions/NNS typical/JJ of/IN normal/JJ NFKB2/NEWGENE p52/NEWGENE1 ./.
@@11156303995 We/PRP suggest/VBP that/IN ventriculopleural/JJ shunting/NN should/MD be/VB considered/VBN as/IN the/DT preferred/VBN alternative/JJ to/IN peritoneal/JJ drainage/NN in/IN children/NNS with/IN intra-abdominal/JJ adhesions/NNS or/CC with/IN a/DT history/NN of/IN recent/JJ peritoneal/JJ infection/NN ./.
@@86611199128 We/PRP have/VBP obtained/VBN the/DT human/NEWGENE EP4/NEWGENE receptor/NEWGENE gene/NEWGENE sequence/NEWGENE and/CC determined/VBN its/PRP structure/NN relative/JJ to/IN EP4R/NEWGENE cDNA/NEWGENE synthesized/VBN from/IN peripheral/JJ blood/NN lymphocytes/NNS ./.
@@26895443363 Model/NN IV/NN :/: primary/JJ abutments/NNS with/IN the/DT lateral/JJ incisor/JJ and/CC the/DT second/JJ molar/NN as/IN secondary/JJ abutments/NNS ./.
@@19343789856 Skeletal/NN muscle/NN metaboreceptor/NN exercise/NN responses/NNS are/VBP attenuated/VBN in/IN heart/NN failure/NN ./.
@@27782371301 We/PRP use/NN the/DT term/NN corticosteroid-dependent/NN IA/NN to/IN refer/VB to/IN the/DT serious/JJ problem/NN of/IN chronic/JJ IA/NN requiring/JJ maintenance/NN prednisone/NN therapy/NN ./.
@@3690262377 The/DT maximum/JJ amplitude/NN of/IN evoked/VBN responses/NNS in/IN the/DT cervical/JJ sympathetic/JJ trunk/NN was/VBD obtained/VBN when/CC the/DT T2/NN white/NN ramus/NN was/VBD stimulated/VBN and/CC decreased/VBN gradually/RB when/CC followed/VBN by/IN the/DT stimulation/NN of/IN T1/NN ,/, T3/NN ,/, T4/NN and/CC T5/NN white/NN rami/NNS ./.
@@98065165695 CONCLUSION/IN :/: Local/JJ control/NN was/VBD highest/JJS with/IN Preop/NN in/IN patients/NNS presenting/VBG primarily/RB with/IN gross/JJ disease/NN ,/, and/CC with/IN Postop/NN in/IN patients/NNS presenting/VBG primarily/RB following/IN gross/JJ total/JJ excision/NN ./.
@@47572177208 Studies/NNS of/IN lipoprotein-X/NEWGENE (/( LP-X/NEWGENE )/SYM and/CC bile/NN acids/NNS in/IN familial/JJ LCAT/NEWGENE deficiency/NN ./.
@@29757534379 Oligonucleotide/NN mutagenesis/NN of/IN these/DT binding/JJ domains/NNS indicated/VBD their/PRP importance/NN in/IN the/DT transcriptional/JJ regulation/NN of/IN the/DT E3/NEWGENE promoter/NEWGENE in/IN yeast/NN cells/NNS ./.
@@11072265254 Residual/JJ amphotericin/NN B/NN was/VBD detected/VBN in/IN the/DT feces/NNS of/IN the/DT mice/NNS only/RB while/CC they/PRP were/VBD receiving/JJ the/DT 0/CD ./CD 3/CD mg/NN //NN ml/NN dose/NN level/NN ./.
@@98409341546 Neither/CC Ha-Ras/NEWGENE (/( G12V/NN ,/, T35S/NN )/SYM (/( Ha-RasV12S35/NEWGENE )/SYM ,/, which/WDT activates/VBZ the/DT Rafl/NEWGENE signaling/JJ pathway/NN ,/, nor/CC Ha-Ras/NEWGENE (/NEWGENE G12V/NEWGENE ,/NEWGENE E37G/NEWGENE )/NEWGENE (/( Ha-RasV12G37/NEWGENE )/SYM ,/, which/WDT stimulates/VBZ the/DT RalGDS/NEWGENE pathway/NN ,/, did/VBD not/RB have/VB significant/JJ effects/NNS on/IN factor-withdrawal/JJ apoptosis/NN of/IN myeloid/JJ cells/NNS ./.
@@48786805220 Effects/NNPS of/IN ionizing/JJ radiation/NN in/IN the/DT human/JJ oral/JJ cavity/NN and/CC oropharynx/NN :/: results/NNS of/IN a/DT survey/NN ./.
@@84300958886 This/DT report/NN describes/VBZ the/DT identification/NN of/IN a/DT gene/NN of/IN related/VBN function/NN ,/, SMD1/NEWGENE ,/, located/VBD immediately/RB 3'/CD to/IN PRP38/NEWGENE ./.
@@29590893665 Preventive/JJ effect/NN of/IN ONO-3708/NN on/IN thrombosis/NN and/CC vasospasms/NNS in/IN vitro/FW and/CC in/IN vivo/NN ./.
@@108972339220 CONCLUSION/IN :/: Rheumatic/JJ fever/NN in/IN the/DT Nazareth/NN area/NN is/VBZ still/RB manifest/VB ./.
@@34043344102 Water/NNP content/NN and/CC equilibrium/NN water/NN partition/NN in/IN immature/JJ cartilage/NN ./.
@@18424982266 A/DT novel/JJ cDNA/NN clone/NN termed/JJ R2/NN was/VBD isolated/VBN by/IN subtractive/JJ hybridization/NN of/IN a/DT cDNA/NN library/NN of/IN phytohemagglutinin/NEWGENE (/( PHA/NEWGENE )/NN //NN phorbol/NN myristate/NN acetate-stimulated/JJ Jurkat/NN cells/NNS and/CC by/IN rescreening/VBG a/DT cDNA/NN library/NN of/IN PHA-stimulated/JJ peripheral/JJ blood/NN lymphocytes/NNS ./.
@@17617366536 Diltiazem/NN decreased/VBN the/DT total/JJ body/NN clearance/NN from/IN 34/CD ./CD 0/CD +/NN //NN -/NN 8/CD ./CD 0/CD to/IN 28/CD ./CD 6/CD +/NN //NN -/NN 6/CD ./CD 1/CD mL/NN //NN min/NN (/( P/NN less/PRP than/IN ./CD 01/CD )/SYM ,/, and/CC prolonged/VBD the/DT elimination/NN half-life/NN from/IN 12/CD ./CD 6/CD +/NN //NN -/NN 3/CD ./CD 0/CD to/IN 14/CD ./CD 3/CD +/NN //NN -/NN 2/CD ./CD 5/CD hours/NNS (/( P/NN less/PRP than/IN ./CD 01/CD )/SYM of/IN antipyrine/NN without/IN any/DT changes/NNS in/IN volume/NN of/IN distribution/NN ./.
@@98585716527 The/DT yeast/NEWGENE RER2/NEWGENE gene/NEWGENE ,/, identified/VBN by/IN endoplasmic/JJ reticulum/NN protein/NN localization/NN mutations/NNS ,/, encodes/VBZ cis-prenyltransferase/NEWGENE ,/, a/DT key/NN enzyme/NN in/IN dolichol/NN synthesis/NN ./.
@@86043384565 In/NN electromobility/NN shift/NN assays/NNS ,/, EWS-FLI-1/NEWGENE binding/JJ to/IN the/DT SRE/NEWGENE is/VBZ detectable/JJ in/IN the/DT absence/NN of/IN SRF/NEWGENE whereas/IN the/DT binding/NN of/IN FLI-1/NEWGENE is/VBZ not/RB ,/, suggesting/VBG that/IN the/DT interaction/NN with/IN DNA/NN is/VBZ the/DT step/NN which/WDT limits/NNS ternary/JJ complex/NN formation/NN by/IN FLI-1/NEWGENE ./.
@@78166195713 We/PRP characterized/VBD three/CD Arabidopsis/NN thaliana/NN cDNA/NN clones/NNS that/WDT could/MD rescue/VB the/DT sterile/JJ phenotype/NN of/IN the/DT Schizosaccharomyces/NEWGENE pombe/NEWGENE pde1/NEWGENE mutant/NEWGENE ,/, which/WDT is/VBZ defective/JJ in/IN cAMP/NEWGENE phosphodiesterase/NEWGENE ./.
@@46224305056 Cortical/JJ afferents/NNS to/IN the/DT entorhinal/JJ cortex/NN of/IN the/DT Rhesus/NNP monkey/NN ./.
@@102156086193 In/NN this/DT study/NN ,/, we/PRP report/VBP the/DT isolation/NN and/CC characterization/NN of/IN the/DT entire/JJ rat/NEWGENE GSTA3/NEWGENE (/( rGST/NEWGENE Yc1/NEWGENE )/SYM subunit/NN gene/NN ./.
@@102331473839 Ras2p/NEWGENE activates/VBZ invasive/JJ growth/NN using/VBG either/DT of/IN two/JJ downstream/RB signaling/JJ pathways/NNS ,/, the/DT filamentation/NN MAPK/NEWGENE (/( Cdc42p/NEWGENE //NEWGENE Ste20p/NEWGENE //NEWGENE MAPK/NEWGENE )/SYM cascade/NN or/CC the/DT cAMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE (/( Cyr1p/NEWGENE //NEWGENE cAMP/NEWGENE //NEWGENE PKA/NEWGENE )/SYM pathway/NN ./.
@@234264715 Gamma/NEWGENE glutamyl/NEWGENE transpeptidase/NEWGENE activity/NN was/VBD increased/VBN up/JJ to/IN 15/CD times/NNS above/RB the/DT upper/JJ normal/JJ limit/NN in/IN children/NNS ,/, who/WP received/VBD aminopyrine/NN for/IN two/JJ weeks/NNS or/CC longer/JJR ./.
@@95092269473 CONCLUSIONS/WDT :/: Use/VB of/IN the/DT first/JJ method/NN was/VBD associated/VBN with/IN a/DT reduction/NN in/IN the/DT time/NN patients/NNS remained/VBN in/IN the/DT ICU/NN before/IN transfer/NN to/IN another/DT unit/NN and/CC savings/NNS in/IN nursing/JJ time/NN ,/, but/CC the/DT two/JJ methods/NNS did/VBD not/RB differ/VB according/VBG to/IN clinical/JJ outcomes/NNS ./.
@@10589562816 In/NN part/NN as/IN a/DT result/NN of/IN its/PRP inability/NN to/IN sustain/VB radiative/JJ loses/NNS ,/, the/DT BB/NN resonator/NN has/VBZ extremely/RB low/JJ RF/NN power/NN requirements/NNS ./.
@@2064119437 Hypoxic/NNP ventilatory/JJ responses/NNS were/VBD -1/CD ./CD 99/CD +/NN //NN -/NN 0/CD ./CD 37/CD L/NNP //NNP min/NNP //NNP %/NNP SaO2/NN in/IN the/DT relatives/NNS and/CC -1/CD ./CD 54/CD +/NN //NN -/NN 0/CD ./CD 25/CD L/NNP //NNP min/NNP //NNP %/NNP SaO2/NN in/IN the/DT control/NN subjects/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@41435284816 They/PRP also/RB discuss/VBP the/DT existing/JJ nomenclature/NN ./.
@@106112253589 These/DT data/NN indicate/VB that/IN the/DT interaction/NN of/IN eIF4A/NEWGENE with/IN the/DT middle/JJ region/NN of/IN eIF4GI/NEWGENE is/VBZ necessary/JJ for/IN translation/NN ,/, whereas/IN the/DT interaction/NN of/IN eIF4A/NEWGENE with/IN the/DT C-terminal/NN region/NN plays/VBP a/DT modulatory/JJ role/NN ./.
@@89722324184 In/NN this/DT report/NN ,/, we/PRP demonstrate/VBP that/IN hGCN5/NEWGENE is/VBZ also/RB an/DT HAT/NEWGENE and/CC has/VBZ the/DT same/JJ substrate/NN specificity/NN as/IN yGCN5/NEWGENE ./.
@@28091163505 Instead/RB ,/, some/DT small/JJ negative/JJ effects/NNS are/VBP observed/VBN ,/, particularly/RB involving/VBG effects/NNS of/IN husbands'/NN retirement/NN on/IN the/DT marital/JJ satisfaction/NN of/IN employed/VBN wives/NNS ./.
@@93716572571 We/PRP previously/RB described/VBD two/JJ alanine/NN cluster/NN mutations/NN ,/, R77/NNP to/IN A/DT (/( R77A/NNP )/NN -K79A/NN and/CC E192A-E194A/CD ,/, which/WDT selectively/RB inactivated/VBN the/DT triphosphatase/NEWGENE component/NEWGENE ./.
@@97887394039 CKII/NEWGENE as/IN a/DT CD44-associated/NEWGENE serine/NEWGENE kinase/NEWGENE therefore/RB may/MD serve/VB as/IN an/DT important/JJ molecule/NN in/IN a/DT signaling/JJ cascade/NN that/WDT produces/VBZ a/DT variety/NN of/IN cellular/JJ responses/NNS in/IN MDA231/NNP breast/NN cancer/NN cells/NNS ./.
@@108991287993 This/DT is/VBZ the/DT first/JJ example/NN of/IN a/DT eukaryotic/NN transcription/NN factor/NN complex/NN containing/JJ both/PDT a/DT MADS-box/NEWGENE and/CC a/DT forkhead/NEWGENE protein/NEWGENE ,/, and/CC it/PRP has/VBZ important/JJ implications/NNS for/IN the/DT regulation/NN of/IN mammalian/JJ gene/NN expression/NN ./.
@@94202753415 To/TO investigate/VB the/DT requirements/NNS for/IN CBF2/NEWGENE binding/JJ ,/, we/PRP synthesized/VBN a/DT series/NN of/IN oligonucleotides/NNS carrying/JJ double/JJ transversion/NN mutations/NNS spanning/VBG both/PDT the/DT conserved/VBN core/NN sequence/NN and/CC outside/RB flanking/JJ sequences/NNS ./.
@@85053126769 Biol/NNP ./.
@@83877433723 Replacement/NN of/IN the/DT wild-type/NN 5'-regulatory/NN region/NN with/IN either/DT of/IN the/DT mutants'/JJ cis-acting/JJ regulatory/JJ element/NN resulted/VBN in/IN the/DT anaerobic/JJ expression/NN of/IN active/NEWGENE Mn-superoxide/NEWGENE dismutase/NEWGENE ./.
@@83956813416 To/TO study/VB the/DT functional/JJ differences/NNS between/IN cutaneous/JJ HPV5/NN and/CC HPV8/NN E7s/NEWGENE and/CC genital/NEWGENE HPV16/NEWGENE E7/NEWGENE ,/, we/PRP cloned/VBN each/DT of/IN the/DT E7/NEWGENE open/JJ reading/JJ frames/NNS and/CC tested/VBN their/PRP immortalizing/JJ and/CC transforming/JJ activities/NNS ,/, the/DT binding/JJ ability/NN of/IN their/PRP products/NNS with/IN retinoblastoma/NEWGENE protein/NEWGENE (/( RB/NEWGENE )/SYM and/CC their/PRP complementation/NN activity/NN of/IN a/DT RB-nonbinding/NEWGENE adenovirus/NEWGENE E1A/NEWGENE mutant/NEWGENE ./.
@@105847041610 Immunohistochemical/JJ staining/NN was/VBD positive/JJ for/IN S-100/NEWGENE in/IN all/DT 9/CD cases/NNS stained/VBN ,/, positive/JJ for/IN HMB-45/NEWGENE in/IN 9/CD (/( 90%/CD )/SYM of/IN 10/CD ,/, and/CC negative/JJ for/IN cytokeratin/NEWGENE in/IN all/DT 9/CD cases/NNS in/IN which/WDT myxoid/JJ melanoma/NN remained/VBN in/IN the/DT block/NN after/IN previous/JJ sections/NNS ./.
@@47587995543 Pneumothorax/NN complicated/VBN by/IN chronic/JJ steroid/JJ treatment/NN ./.
@@9899734826 The/DT response/NN of/IN the/DT plasma/NEWGENE fibrinogen/NEWGENE level/NN to/IN the/DT subucutaneous/JJ injection/NN of/IN turpentine/NN and/CC to/IN the/DT intravenous/JJ injection/NN of/IN endotoxin/NN was/VBD measured/VBN in/IN normal/JJ rabbits/NNS and/CC in/IN rabbits/NNS made/VBP granulocytopenic/JJ and/CC thrombocytopenic/JJ with/IN busulfan/NN ./.
@@35636043879 The/DT spleen/NN rate/NN of/IN about/RB 600/CD villagers/NNS of/IN RK/NN I/NN examined/VBD was/VBD 54/CD ./CD 3%/CD and/CC the/DT parasite/NN rate/NN 13/CD ./CD 2%/CD before/IN the/DT drug/NN intervention/NN ./.
@@110886355976 A/DT thermal/JJ Kubo-Martin-Schwinger/NN condition/NN arises/VBZ due/NN to/IN the/DT coupling/NN of/IN a/DT computer/NN to/IN a/DT strong/JJ periodic/JJ source/NN ,/, namely/RB ,/, the/DT daily/JJ and/CC weekly/JJ usage/NN patterns/NNS of/IN the/DT system/NN ./.
@@77720369989 This/DT region/NN binds/VBZ two/JJ ubiquitous/JJ nuclear/JJ factors/NNS ,/, USF/NEWGENE //NEWGENE MLTF/NEWGENE and/CC the/DT CAAT-binding/NEWGENE transcription/NEWGENE factor/NEWGENE //NEWGENE nuclear/NEWGENE factor/NEWGENE 1/NEWGENE (/( CTF/NEWGENE //NEWGENE NF1/NEWGENE )/SYM ./.
@@86486653433 Among/IN the/DT LE6/NEWGENE deletions/NNS ,/, only/RB one/PRP had/VBP a/DT reduced/VBN transformation/NN efficiency/NN ,/, while/CC seven/RB transformed/VBN cells/NNS at/RB least/RB as/RB efficiently/RB as/IN wild-type/NEWGENE LE6/NEWGENE ./.
@@64976716293 Changes/NNS of/IN plasma/NN cortisol/NN level/NN in/IN late/JJ asthmatic/JJ responses/NNS ./.
@@81600542646 All/DT patients/NNS with/IN deterioriation/NN in/IN mental/JJ status/NN showed/VBD a/DT marked/JJ increase/NN in/IN liver/NN enzymes/NNS (/( aspartate/NEWGENE and/NEWGENE alanine/NEWGENE aminotransaminases/NEWGENE )/SYM and/CC severe/JJ coagulopathy/NN ./.
@@2388685695 The/DT results/NNS also/RB showed/VBD that/IN although/IN oyster/NN shell/NN supplementation/NN generally/RB increased/VBD alkaline/NEWGENE phosphatase/NEWGENE activity/NN ,/, bone/NN mineralization/NN was/VBD relatively/JJ uninfluenced/JJ as/IN judged/VBN by/IN the/DT low/JJ coefficients/NNS of/IN variation/NN (/( CV/NN )/SYM of/IN 3/CD ./CD 14-3/CD ./CD 51%/CD and/CC 3/CD ./CD 39-4/CD ./CD 82%/CD for/IN calcium/NN and/CC phosphorus/NN content/NN in/IN the/DT femur/NN and/CC tibia/NN respectively/RB ./.
@@71264136936 1/CD A/DT colonic/JJ delivery/NN system/NN is/VBZ described/VBN to/IN deliver/VB orally/RB ingested/VBN drugs/NNS to/IN the/DT colon/NN and/CC release/NN them/PRP at/IN that/DT site/NN by/IN coating/NN with/IN an/DT acrylic/RB based/VBN resin/NN (/( Eudragit/NNP S/NNP )/SYM ./SYM
@@23445291935 Treating/VBG renal/JJ anaemia/NN with/IN recombinant/JJ human/NN erythropoietin/NEWGENE ./.
@@16716756220 The/DT resulting/VBG clone/NN pKB11/NEWGENE ,/, which/WDT has/VBZ a/DT 1369-base/CD pair/NN (/( bp/NN )/SYM cDNA/NN insert/NN ,/, overlapping/JJ pCAD142/NEWGENE by/IN 781/CD bp/NN ,/, was/VBD identified/VBN by/IN hybridization/NN methods/NNS and/CC sequence/NN analysis/NN and/CC found/VB to/IN contain/VB the/DT entire/JJ cDNA/NN sequence/NN for/IN the/DT amino/JJ end/NN of/IN the/DT CAD/NEWGENE polypeptide/NEWGENE ./.
@@10490065323 Treatment/NNP of/IN unstable/JJ angina/NN :/: role/NN of/IN antithrombotic/JJ therapy/NN ./.
@@82190722829 Acad/NN ./.
@@16791248154 Biochemical/NNP studies/NNS revealed/VBD the/DT expected/VBN loss/NN of/IN ChAT/NEWGENE activity/NN in/IN the/DT dorsal/JJ and/CC ventral/JJ hippocampi/NNS of/IN lesioned/JJ animals/NNS along/IN with/IN elevated/VBN levels/NNS of/IN norepinephrine/NN (/( NE/NN )/SYM in/IN the/DT dorsal/JJ hippocampus/NN of/IN MS/NNP //NNP HSI/NNP animals/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@4155434826 Recognition/NNP of/IN emphysema/NN was/VBD poor/JJ when/CC radiographs/NNS of/IN inadequate/JJ quality/NN were/VBD included/VBN (/( anteroposterior/JJ films/NNS or/CC films/NNS from/IN patients/NNS with/IN acute/JJ or/CC chronic/JJ lung/NN disease/NN )/SYM ./.
@@81063693191 Vasopressin/NEWGENE (/( AVP/NEWGENE )/SYM ,/, the/DT antidiuretic/JJ hormone/NN ,/, is/VBZ a/DT cyclic/JJ nonapeptide/NN that/IN acts/NNS through/RB binding/JJ to/IN G/NEWGENE protein-coupled/NEWGENE specific/NEWGENE membrane/NEWGENE receptors/NEWGENE pharmacologically/RB divided/VBN into/IN three/CD subtypes/NNS (/( V1a/NEWGENE ,/, V1b/NEWGENE ,/, and/CC V2/NEWGENE )/SYM linked/JJ to/IN distinct/JJ second/JJ messengers/NNS ./.
@@111608961145 Immunofluorescence/NNS studies/NNS in/IN C2C12/NNP myotubes/NNS show/VBP that/IN Smad2/NEWGENE and/CC MEF2A/NEWGENE co-localise/NN in/IN the/DT nucleus/NN of/IN multinuclear/JJ myotubes/NNS during/IN differentiation/NN ./.
@@10326221189 Homozygous/JJ mutation/NN in/IN two/JJ children/NNS led/VBN to/IN amputation/NN of/IN legs/NNS due/NN to/IN purpura/NN fulminans/NNS ./.
@@19336142553 The/DT effect/NN of/IN salmon/NEWGENE calcitonin/NEWGENE nasal/JJ spray/NN in/IN women/NNS with/IN established/VBN osteoporosis/NN has/VBZ also/RB been/VBN studied/VBN ./.
@@90343376463 Studies/NNS in/IN mammalian/JJ cells/NNS have/VBP correlated/VBN induction/NN of/IN inhibitory/JJ tyrosine/NN 15/CD (/( Y15/NN )/SYM phosphorylation/NN on/IN p34cdc2/NEWGENE with/IN the/DT response/NN to/IN DNA/NN damage/NN ./.
@@94406169394 Altogether/RB 46/CD phase/NN III/NNP activities/NNS were/VBD recorded/VBN ./.
@@78239532763 Using/VBG a/DT battery/NN of/IN I/NEWGENE kappa/NEWGENE B/NEWGENE alpha/NEWGENE mutants/NEWGENE ,/, we/PRP show/VBP that/IN (/( i/NN )/SYM a/DT dimer/NN binds/VBZ a/DT single/NN I/NEWGENE kappa/NEWGENE B/NEWGENE alpha/NEWGENE molecule/NEWGENE ,/, (/( ii/NN )/SYM the/DT acidic/NN C-terminal/NN region/NN of/IN I/NEWGENE kappa/NEWGENE B/NEWGENE alpha/NEWGENE is/VBZ not/RB required/VBN for/IN protein-protein/JJ binding/JJ and/CC does/VBP not/RB mask/VB the/DT nuclear/JJ localization/NN signal/NN of/IN the/DT dimer/NN ,/, (/( iii/NN )/SYM the/DT same/JJ C-terminal/NN region/NN is/VBZ required/VBN for/IN inhibition/NN of/IN DNA/NN binding/JJ ,/, and/CC (/( iv/NN )/SYM this/DT inhibition/NN may/MD be/VB accomplished/VBN by/IN direct/JJ interaction/NN between/IN the/DT PEST-like/NEWGENE region/NEWGENE and/CC the/DT DNA-binding/NN region/NN of/IN one/PRP of/IN the/DT subunits/NNS of/IN the/DT dimer/NN ./.
@@87105047639 Activation/NNS mediated/JJ by/IN Cat8p/NEWGENE was/VBD no/RB longer/RB detectable/JJ in/IN a/DT cat1/NEWGENE mutant/NEWGENE ./.
@@91787529401 EGF/NEWGENE acts/NNS primarily/RB by/IN means/NN of/IN transactivation/NN domain/NN AF-1/NEWGENE ,/, whereas/IN cAMP/NN acts/NNS via/NN transactivation/NN domain/NN AF-2/NEWGENE of/IN the/DT ER/NNP ./NNP
@@103726279345 Of/IN those/DT injuries/NNS ,/, 143/CD cases/NNS were/VBD snowboard/NN related/VBN and/CC 158/CD cases/NNS were/VBD ski/NN related/VBN ./.
@@90996836388 Diacylglycerol/NEWGENE kinase/NEWGENE (/( DGK/NEWGENE )/SYM attenuates/VBZ levels/NNS of/IN second/JJ messenger/NN diacylglycerol/NN in/IN cells/NNS and/CC produces/VBZ another/DT (/( putative/JJ )/SYM messenger/NN ,/, phosphatidic/JJ acid/NN ./.
@@61842766006 Unusual/JJ course/NN of/IN plasmocytosis/NN ./.
@@93882014456 4/NN )/NN PU/NEWGENE and/CC PD/NEWGENE lacked/VBD the/DT canonical/JJ TATA/NN or/CC CAAT/NN motifs/NN ,/, and/CC are/VBP AT-rich/NNP ./.
@@88377464923 Their/PRP use/NN established/VBN that/IN the/DT BrAAP/NN activity/NN catalyzed/VBN both/PDT a/DT postproline/NN and/CC a/DT postglutamate/NN cleavage/NN and/CC therefore/RB has/VBZ a/DT broader/JJR specificity/NN than/IN previously/RB recognized/VBN ./.
@@89095466078 We/PRP have/VBP found/VBN that/IN PEA2/NEWGENE is/VBZ also/RB required/VBN for/IN the/DT bipolar/JJ budding/JJ pattern/NN and/CC that/IN it/PRP encodes/VBZ a/DT novel/JJ protein/NN with/IN a/DT predicted/VBN coiled-coil/NN domain/NN ./.
@@116773631525 The/DT most/RB important/JJ finding/NN ,/, however/RB ,/, was/VBD that/IN IMT/NNS values/NNS were/VBD related/VBN with/IN 24/CD h/NN SBP/NN or/CC PP/NN standard/JJ deviation/NN (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, a/DT measure/NN of/IN overall/JJ SBP/NN or/CC PP/NN variability/NN ./.
@@75185615784 We/PRP recently/RB found/VBP that/IN the/DT p72syk/NEWGENE protein/NEWGENE tyrosine/NEWGENE kinase/NEWGENE is/VBZ physically/RB associated/VBN with/IN the/DT TCR/NEWGENE //NEWGENE CD3/NEWGENE complex/NEWGENE and/CC is/VBZ rapidly/RB tyrosine/NN phosphorylated/VBN and/CC activated/VBN by/IN receptor/NN triggering/JJ also/RB in/IN T/NN cells/NNS lacking/JJ p56lck/NEWGENE ./.
@@82342763932 Similar/JJ synergistic/JJ activation/NN was/VBD observed/VBN in/IN the/DT IL-8/NEWGENE promoter/NEWGENE ,/, which/WDT also/RB contains/VBZ both/DT NF-IL6/NEWGENE and/CC NF-kappa/NEWGENE B/NEWGENE binding/NEWGENE sites/NEWGENE ./.
@@20195722382 To/TO identify/VB the/DT DNA/NN sequences/NNS that/WDT cis-regulate/VBD the/DT expression/NN of/IN the/DT rat/NEWGENE liver/NEWGENE pyruvate/NEWGENE kinase/NEWGENE (/( L-PK/NEWGENE )/SYM genes/NNS ,/, a/DT series/NN of/IN constructs/NNS in/IN which/WDT the/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE reporter/NEWGENE genes/NEWGENE is/NNS driven/VBP by/IN various/RB deleted/VBN fragments/NNS of/IN the/DT 3200/CD base/NN pairs/NNS (/( bp/NN )/SYM upstream/RB of/IN the/DT L-PK/NEWGENE gene/NEWGENE cap/NEWGENE site/NEWGENE have/NN been/VBN assayed/VBN for/IN transient/JJ expression/NN after/IN introduction/NN into/IN hepatoma/NN HepG2/NNP cells/NNS ,/, rat/NN hepatocytes/NNS in/IN primary/JJ culture/NN ,/, fibroblast/NN LTK-/NNP cells/NNS ,/, myogenic/JJ C2C12/NNP cells/NNS ,/, and/CC CHO/NN cells/NNS ./.
@@106518053962 Stable/NN transfection/NN of/IN the/DT truncated/JJ reduced/NEWGENE folate/NEWGENE carrier/NEWGENE cDNA/NEWGENE into/IN mouse/NN L1210/JJ leukemia/NN cells/NNS :/: increased/VBN folate/NN accumulation/NN ,/, decreased/VBD their/PRP leucovorin/NN and/CC folic/JJ acid/NN growth/JJ requirements/NNS ,/, and/CC increased/VBD their/PRP sensitivity/NN to/IN methotrexate/NN ./.
@@112852358109 Instead/RB ,/, TRPS1/NEWGENE potently/RB and/CC specifically/RB represses/VBZ transcriptional/JJ activation/NN mediated/JJ by/IN other/DT GATA/NEWGENE factors/NEWGENE ./.
@@106535506472 Hyaluronan/NN treatment/NN stimulated/VBD collagen/NEWGENE remodeling/NN in/IN the/DT peripheral/JJ region/NN and/CC inhibited/VBN swelling/NN of/IN the/DT meniscus/NN repaired/VBN in/IN the/DT inner/JJ region/NN ./.
@@19391996051 Recombinant/NEWGENE human/NEWGENE TFIID/NEWGENE supported/VBD weak/JJ basal/JJ transcription/NN in/IN heat-treated/JJ nuclear/JJ extracts/NNS whereas/IN a/DT partially/RB purified/VBN TFIID/NEWGENE fraction/NN from/IN HeLa/DT cells/NNS reconstituted/VBN a/DT maximal/JJ level/NN of/IN transcription/NN ./.
@@11234223751 We/PRP can/MD classify/VB antibiotics/NNS into/IN two/JJ groups/NNS based/VBN on/IN initial/JJ bactericidal/JJ activity/NN against/IN P/NNP ./NNP aeruginosa/NN ;/: one/PRP class/NN is/VBZ antibiotics/NNS having/VBG rapid/JJ initial/JJ killing/NN such/JJ as/IN AMK/NN ,/, IPM/NN and/CC PAPM/NNP ,/, the/PDT other/DT is/VBZ CAZ/IN ,/, MEPM/NNP showing/VBG slow/JJ initial/JJ killing/NN ./.
@@109381309784 X-ray/NN crystallographic/JJ data/NN show/NN that/IN the/DT PLZF/NEWGENE BTB/NEWGENE1 //NEWGENE1 POZ/NEWGENE1 domain/NEWGENE1 forms/VBZ an/DT obligate/JJ homodimer/NN via/NN an/DT extensive/JJ interface/NN ./.
@@105570728462 We/PRP have/VBP previously/RB identified/VBN mouse/NEWGENE and/NEWGENE human/NEWGENE cDNAs/NEWGENE encoding/NEWGENE UNC-51-like/NEWGENE kinase/NEWGENE (/( ULK1/NEWGENE )/SYM ./.
@@10453006488 Sequencing/NN of/IN zebrafish/NN (/( Danio/NNP rerio/NN )/SYM bacterial/JJ artificial/JJ chromosome/NN and/CC P1/NN artificial/JJ chromosome/NN genomic/JJ clone/NN fragments/NNS and/CC of/IN cDNA/NN clones/NNS has/VBZ led/VBN to/IN the/DT identification/NN of/IN five/CD new/JJ loci/NNS coding/JJ for/IN beta/NEWGENE subunits/NEWGENE of/NEWGENE proteasomes/NEWGENE (/( PSMB/NEWGENE )/SYM ./.
@@108728278233 Penicillin/NEWGENE acylase/NEWGENE (/( PA/NEWGENE )/SYM from/IN Escherichia/NN coli/JJ ATCC11105/NN is/VBZ a/DT periplasmic/JJ heterodimer/NN consisting/VBG of/IN a/DT 24/NN kDa/NN small/NN subunit/NN and/CC a/DT 65/NN kDa/NN large/NN subunit/NN ./.
@@91230552899 Hepatocellular/JJ injury/NN during/IN preservation/NN of/IN human/JJ livers/NNS with/IN UW/NN and/CC HTK/NN solution/NN ./.
@@40613422369 There/EX was/VBD a/DT significant/JJ but/CC similar/JJ elevation/NN of/IN mean/JJ O2/NN uptake/NN during/IN 40/CD min/NN postexercise/JJ by/IN 13/CD ./CD 6%/CD in/IN both/PDT the/DT fasted/VBN (/( p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM and/CC fed/VBN state/NN (/( p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@110178766382 Intracellular/JJ localization/NN studies/NNS using/VBG the/DT mDAP-3/NEWGENE //NEWGENE EGFP/NEWGENE fusion/NEWGENE protein/NEWGENE ,/, cell/NN fractionation/NN and/CC protease/NN protection/NN experiments/NNS localized/VBN mDAP-3/NEWGENE to/IN the/DT mitochondrial/JJ matrix/NN ./.
@@82242608196 CONCLUSION/IN :/: The/DT study/NN demonstrates/VBZ that/IN transvaginal/JJ ultrasonography/NN has/VBZ an/DT efficiency/NN of/IN 88%/JJ in/IN differentiating/JJ endometriomas/NNS from/IN other/DT ovarian/JJ masses/NNS with/IN a/DT specificity/NN of/IN 90%/CD ./.
@@28833277654 Two/CD polyadenylation/NN sites/NN were/VBD used/VBN ,/, one/PRP at/IN the/DT end/NN of/IN the/DT early/NEWGENE (/NEWGENE E/NEWGENE )/NEWGENE region/NEWGENE of/IN the/DT viral/JJ DNA/NN ,/, the/PDT other/DT at/IN the/DT end/NN of/IN the/DT late/NEWGENE (/NEWGENE L/NEWGENE )/NEWGENE region/NEWGENE ./.
@@32677321861 We/PRP concluded/VBD that/IN Ga-fbg/NN scintigraphy/NN is/VBZ a/DT very/RB simple/JJ method/NN and/CC sufficiently/RB useful/JJ for/IN detecting/JJ active/JJ left/NN ventricular/JJ thrombi/NNS and/CC for/IN monitoring/VBG the/DT effect/NN of/IN anticoagulant/JJ therapy/NN ./.
@@1633842227 The/DT carcass/NN of/IN a/DT great/JJ horned/JJ owl/NN (/( Bubo/NNP virginianus/NN )/SYM ,/, which/WDT had/VBP been/VBN found/VB moribund/JJ in/IN southern/JJ Ontario/NN ,/, was/VBD presented/VBN for/IN necropsy/NN ./.
@@111503157489 NGF/NEWGENE elicits/VBZ a/DT more/RB delayed/JJ and/CC sustained/JJ ERK/NEWGENE phosphorylation/NN than/IN EGF/NEWGENE ,/, consistent/JJ with/IN previous/JJ reports/NNS ./.
@@37831604468 Compound/JJ 1/CD is/VBZ either/DT 21-O-angeloyl/NN ,/, 22-O-tigloyl/NNP R1-barrigenol/NNP ,/, or/CC 21-O-tigloyl/JJ ,/, 22-O-angeloyl/NNP R1-barrigenol/NNP ./.
@@13213365195 The/DT enhancer/NN region/NN of/IN Akv/DT murine/JJ leukemia/NN virus/NN contains/VBZ the/DT sequence/NEWGENE motif/NEWGENE ACAGATGG/NEWGENE ./.
@@111131792417 We/PRP show/VBP that/IN in/IN contrast/NN to/IN SRC1/NEWGENE ,/, direct/JJ binding/NN of/IN CBP/NEWGENE to/IN the/DT estrogen/NEWGENE receptor/NEWGENE is/VBZ weak/JJ ,/, suggesting/VBG that/IN SRC1/NEWGENE functions/NNS primarily/RB as/IN an/DT adaptor/NN to/IN recruit/NN CBP/NEWGENE and/CC p300/NEWGENE ./.
@@20996223353 Immuno-cytochemistry/NNP ,/, using/VBG antisera/NNS against/IN Campylobacter/NN jejuni/JJ ,/, showed/VBD that/IN the/DT positive/JJ staining/NN in/IN altered/VBN epithelial/JJ cells/NNS were/VBD restricted/VBN to/IN intracellular/JJ organisms/NNS having/VBG a/DT structure/NN resembling/VBG Campylobacter/NN spp/NNS ./.
@@74870675668 The/DT translation/NN products/NNS of/IN both/DT clones/NNS are/VBP highly/RB homologous/JJ to/IN APS1/NEWGENE (/( 66/CD and/CC 86%/CD identity/NN ,/, respectively/RB )/SYM over/RB their/PRP entire/JJ lengths/NNS ,/, including/JJ amino/JJ terminal/JJ sequences/NNS resembling/VBG transit/NN peptides/NNS for/IN plastid/NN localization/NN ./.
@@91927865487 Organization/NNP of/IN the/DT human/NEWGENE LU/NEWGENE gene/NEWGENE and/CC molecular/JJ basis/NN of/IN the/DT Lu/NEWGENE (/NEWGENE a/NEWGENE )/NEWGENE //NEWGENE Lu/NEWGENE (/NEWGENE b/NEWGENE )/NEWGENE blood/NEWGENE group/NEWGENE polymorphism/NEWGENE ./.
@@8528796814 The/DT MCA/NN and/CC UA/NN PI/NN values/NNS showed/VBD the/DT greatest/JJS deviation/NN for/IN any/DT single-vessel/JJ parameter/NN ./.
@@88627438828 A/DT decrease/NN of/IN erythrocyte/NN Mn/NN with/IN age/NN ,/, expressed/VBN in/IN nmol/NN //NN L/NN ,/, was/VBD noted/VBN (/( p/NN </SYM 0/CD ./CD 02/CD )/SYM ./.
@@72829432903 Progressive/NNP 100-mmHg/JJ stepwise/JJ decreases/NNS in/IN superfusate/NN oxygen/NN partial/JJ pressure/NN (/( PO2/NN )/SYM from/IN control/NN (/( 95%/CD O2/NN aeration/NN ,/, PO2/NN ,/, 620-650/JJ mmHg/NN )/SYM were/VBD produced/VBN ,/, and/CC subsequent/JJ changes/NNS in/IN isometric/JJ active/JJ and/CC resting/JJ tension/NN were/VBD measured/VBN ./.
@@23964153057 Results/NNS of/IN the/DT long-term/JJ observation/NN and/CC treatment/NN of/IN patients/NNS with/IN arterial/JJ hypertension/NN ./.
@@95296495692 Jean/NNP Klig/NN reviews/VBP recent/JJ literature/NN about/RB lower/JJR respiratory/JJ tract/NN infection/NN in/IN children/NNS ./.
@@85334734614 In/NN particular/JJ ,/, the/DT highly/RB expressed/VBN ADH1/NEWGENE gene/NEWGENE is/VBZ represented/VBN in/IN this/DT database/NN by/IN no/DT less/PRP than/IN 20/NN EST/NN sequences/NN ./.
@@23736867821 Transient/JJ expression/NN of/IN human/NEWGENE and/NEWGENE chicken/NEWGENE progesterone/NEWGENE receptors/NEWGENE does/VBP not/RB support/VB alternative/JJ translational/JJ initiation/NN from/IN a/DT single/JJ mRNA/NN as/IN the/DT mechanism/NN generating/JJ two/JJ receptor/NN isoforms/NNS ./.
@@89736303806 In/NN some/DT cases/NNS ,/, factor-induced/NN Rac/NEWGENE activation/NN results/NNS in/IN Rho/NEWGENE activation/NN ,/, and/CC factor-induced/NN Cdc42/NEWGENE activation/NN leads/VBP to/IN Rac/NEWGENE activation/NN ,/, as/IN determined/VBN by/IN specific/JJ morphological/JJ changes/NNS ./.
@@83853377665 A/DT sequence/NN comparison/NN reveals/VBZ two/JJ CCAAT/NEWGENE //NEWGENE enhancer/NEWGENE binding/NEWGENE protein/NEWGENE (/( C/NEWGENE //NEWGENE EBP/NEWGENE )/SYM consensus/NN sequences/NNS ,/, basic/JJ DNA/NN binding/JJ region/NN and/CC leucine/NN zippers/NNS 1/CD and/CC 2/CD (/( bZIP1/NN and/CC bZIP2/NN )/SYM ,/, within/IN this/DT region/NN ./.
@@109913832130 In/NN the/DT lattice/NN ,/, 23%/NN of/IN the/DT sites/NNS are/VBP occupied/VBN ,/, 95%/CD of/IN the/DT atoms/NNS are/VBP in/IN the/DT lowest/JJS energy/NN magnetic/JJ sublevel/NN ,/, and/CC 37%/JJ are/VBP in/IN the/DT lowest/JJS 3D/NN vibrational/NN state/NN ./.
@@1786094425 Arsenic/NN contents/NNS in/IN native/JJ copper/NN ./.
@@13980682205 Complexes/NN containing/NN wild-type/NN and/CC either/DT his175/NEWGENE or/NEWGENE his273/NEWGENE mutant/NEWGENE p53/NEWGENE proteins/NEWGENE are/VBP completely/RB unable/JJ to/IN bind/NN to/IN the/DT RGC/NEWGENE DNA/NEWGENE sequence/NEWGENE ./.
@@88256335440 Analysis/NNP of/IN human/JJ genomic/JJ DNA/NN reveals/VBZ an/DT intronless/JJ sequence/NN with/IN strong/JJ homology/NN to/IN human/NEWGENE G/NEWGENE alpha/NEWGENE q/NEWGENE cDNA/NEWGENE ./.
@@29167643621 The/DT risk/NN factors/NNS studied/VBN were/VBD male/JJ sex/NN ,/, hypertension/NN ,/, diabetes/NN mellitus/MD ,/, hypercholesterolemia/NN ,/, cigarette/NN smoking/NN ,/, sedentary/JJ life-style/NN ,/, and/CC family/NN history/NN ./.
@@98660689853 CONCLUSIONS/IN :/: Pretreatment/NNS with/IN OCs/NNS prior/NN to/IN pituitary/JJ suppression/NN in/IN the/DT early/JJ follicular/JJ phase/NN decreases/NNS ovarian/JJ cyst/NN formation/NN ,/, without/IN an/DT apparent/JJ effect/NN on/IN subsequent/JJ follicular/JJ recruitment/NN or/CC pregnancy/NN rates/NNS ./.
@@112784409417 SV1/NEWGENE has/VBZ a/DT 33-amino/JJ acid/NN insert/NN in/IN the/DT S1/NEWGENE transmembrane/NEWGENE domain/NEWGENE that/WDT does/VBP not/RB alter/VB S1/NEWGENE overall/JJ hydrophobicity/NN ,/, but/CC makes/VBP the/DT S0-S1/NEWGENE linker/NEWGENE longer/JJR ./.
@@111372964290 Four/CD transcription/NN initiation/NN sites/NNS have/VBP been/VBN identified/VBN by/IN full-length/JJ RNA/NN ligase-mediated/JJ rapid/JJ amplification/NN of/IN cDNA/NN ends/NNS (/( RLM-RACE/NNP )/SYM between/IN -61/CD and/CC -32/CD bp/NN from/IN the/DT translation/NN initiation/NN codon/CD ./CD Reverse/CD transcription-PCR/NN analysis/NN revealed/VBN that/IN PFK-A/NEWGENE ,/, PFK-B/NEWGENE and/CC PFK-C/NEWGENE genes/NEWGENE were/VBD expressed/VBN ,/, in/IN all/DT mouse/NN tissues/NNS tested/VBN ,/, at/IN varying/JJ levels/NNS ./.
@@35376864145 The/DT small/JJ size/NN and/CC placement/NN of/IN the/DT mutagenesis/NN marker/NN (/( the/DT supF/NEWGENE suppressor/NEWGENE tRNA/NEWGENE gene/NEWGENE from/NEWGENE Escherichia/NEWGENE coli/NEWGENE )/SYM within/IN the/DT vector/NN substantially/RB reduced/VBD the/DT frequency/NN of/IN spontaneous/JJ mutations/NNS normally/RB observed/VBN after/IN transfection/NN of/IN mammalian/JJ cells/NNS with/IN plasmid/NN DNA/NN ;/: hence/RB ,/, UV-induced/NN mutations/NN were/VBD easily/RB identified/VBN above/RB the/DT spontaneous/JJ background/NN ./.
@@32285183915 Although/IN not/RB consistently/RB identified/VBN in/IN all/DT samples/NNS ,/, secondary/JJ Academic/NNP ,/, Personal/NNP Responsibility/NNP ,/, and/CC Community/JJ //JJ Vocational/JJ dimensions/NNS were/VBD also/RB identified/VBN ./.
@@89223443385 It/PRP can/MD be/VB concluded/VBN that/IN in/IN normotensive/JJ subjects/NNS ,/, uric/JJ acid/NN and/CC xanthine/NEWGENE oxidase/NEWGENE have/NN significant/JJ association/NN with/IN blood/NN pressure/NN and/CC thus/RB are/VBP one/PRP of/IN the/DT many/JJ factors/NNS which/WDT are/VBP involved/VBN in/IN the/DT cause/NN or/CC effect/NN of/IN hypertension/NN ./.
@@26841595789 Hybridization/NNS analysis/NN showed/VBN that/IN the/DT size/NN of/IN the/DT mRNA/NN is/VBZ about/RB 1/CD ./CD 4/CD kilobases/NNS ./.
@@96948971358 The/DT heterogeneous/JJ nuclear/NEWGENE ribonucleoprotein/NEWGENE C/NEWGENE protein/NEWGENE tetramer/NEWGENE binds/VBZ U1/NEWGENE ,/, U2/NEWGENE ,/, and/CC U6/NEWGENE snRNAs/NEWGENE through/RB its/PRP high/JJ affinity/NN RNA/NN binding/JJ domain/NN (/( the/DT bZIP-like/NEWGENE motif/NEWGENE )/SYM ./.
@@10240361176 Canadian/JJ survey/NN reveals/VBZ widespread/JJ dissatisfaction/NN among/IN physicians/NNS ./.
@@100943964331 Topoisomerase/NEWGENE II/NEWGENE is/VBZ a/DT major/JJ target/NN of/IN the/DT protein/NEWGENE kinase/NEWGENE casein/NEWGENE kinase/NEWGENE 2/NEWGENE (/( PK/NEWGENE CK2/NEWGENE )/SYM in/IN vivo/NN ./.
@@90001088966 Its/PRP transcription/NN product/NN ,/, a/DT 1/CD ./CD 3/CD kb/NN mRNA/NN ,/, is/VBZ polyadenylated/JJ at/IN a/DT site/NN containing/JJ consensus/NN eukaryotic/JJ polyadenylation/NN signals/NNS and/CC mapping/NN 87/CD bp/NN downstream/RB of/IN the/DT translation/NN termination/NN codon/NN for/IN CG30/NEWGENE ./.
@@105271583428 The/DT AL-R8/NN SI/NN :/: the/DT next/JJ generation/NN staging/JJ container/NN for/IN plutonium/NN pits/NNS at/IN the/DT USDOE/NNP Pantex/NNP Plant/NNP ./.
@@18526038842 The/DT rad9/NEWGENE ./NEWGENE 192/NEWGENE DNA/NEWGENE repair/NEWGENE mutant/NEWGENE from/NEWGENE the/NEWGENE fission/NEWGENE yeast/NEWGENE ,/NEWGENE Schizosaccharomyces/NEWGENE pombe/NEWGENE ,/, is/VBZ sensitive/JJ to/IN both/DT UV/NN and/CC ionising/JJ radiation/NN ./.
@@34214254123 Seven/CD patients/NNS (/( 8/CD ./CD 3/CD percent/NN )/SYM had/VBP latent/JJ hypothyroidism/NN only/RB discovered/VBD by/IN hormonal/JJ determinations/NNS ./.
@@96015109561 In/NN contrast/NN to/IN other/DT known/VBP retroviruses/NNS ,/, the/DT FV/NEWGENE pol/NEWGENE genes/NEWGENE are/VBP expressed/VBN via/NN spliced/VBN transcripts/NNS ./.
@@82916208270 Two/CD basic/JJ patterns/NNS of/IN locomotor/JJ behavior/NN and/CC corresponding/JJ torso/NN morphology/NN exist/VB among/IN extant/JJ anthropoids/NNS ./.
@@98456628786 Collagen/NEWGENE was/VBD extracted/VBN from/IN the/DT skin/NN ,/, and/CC the/DT lack/NN of/IN type/NEWGENE III/NEWGENE collagen/NEWGENE was/VBD determined/VBN by/IN means/NN of/IN sodium/NN dodecyl/NN sulfate-polyacrylamide/NN gel/NN electrophoresis/NN (/( SDS-PAGE/NN )/SYM ./.
@@85644889231 High/NNP fibrinogen/NEWGENE levels/NNS could/MD thus/RB be/VB a/DT risk/NN for/IN perioperative/JJ thrombosis/NN ./.
@@107048538259 Cooperative/JJ roles/NNS of/IN Bozozok/NEWGENE //NEWGENE Dharma/NEWGENE and/CC Nodal-related/NEWGENE proteins/NEWGENE in/IN the/DT formation/NN of/IN the/DT dorsal/JJ organizer/NN in/IN zebrafish/NN ./.
@@7253367091 Newcastle/NN disease/NN virus/NN surveillance/NN in/IN Hong/NNP Kong/NNP on/IN local/JJ and/CC imported/VBN poultry/NN ./.
@@10750524564 RESULTS/NNS :/: Auditory/JJ thresholds/NNS collected/VBN during/IN audiometric/JJ tests/NNS increased/VBN gradually/RB in/IN proportion/NN with/IN age/NN ,/, especially/RB in/IN the/DT hypertensive/JJ group/NN (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@85520426643 In/NN this/DT case/NN the/DT degree/NN of/IN promoter/NN methylation/NN ,/, which/WDT could/MD extend/VB beyond/RB the/DT T-DNA/NN borders/NN ,/, was/VBD not/RB correlated/VBN with/IN the/DT reduction/NN in/IN steady-state/JJ poly/NN (/NN A/NN )/NN +/NN mRNA/NN levels/NNS ,/, the/DT silenced/VBN state/NN was/VBD transmitted/VBN through/JJ meiosis/NN and/CC reactivation/NN lasted/VBD several/DT generations/NNS ./.
@@100856056176 Specimens/NNS were/VBD assayed/VBN for/IN alpha-fetoprotein/NEWGENE ,/, unconjugated/JJ estriol/NN ,/, free/JJ alpha/NEWGENE hCG/NEWGENE ,/, and/CC total/JJ hCG/NEWGENE ./.
@@32762469160 We/PRP report/VBP the/DT use/NN of/IN a/DT new/JJ technetium-99m-albumin/NN colloid/NN white/NN blood/NN cell/NN (/( TAC-WBC/NNP )/SYM scan/NN in/IN the/DT evaluation/NN of/IN appendicitis/NN ./.
@@106625508381 Thus/RB ,/, SOX8/NEWGENE is/VBZ a/DT good/JJ candidate/NN gene/NN contributing/JJ to/IN the/DT mental/JJ retardation/NN phenotype/NN seen/VBP in/IN ATR-16/NNP patients/NNS ./.
@@66856434820 The/DT concentrations/NNS of/IN C4/NEWGENE and/CC C1-INH/NEWGENE increased/VBD with/IN advancing/JJ stage/NN of/IN disease/NN and/CC were/VBD above/RB normal/JJ mean/JJ values/NNS in/IN all/DT stages/NNS ./.
@@86198662965 We/PRP measured/VBD serum/NEWGENE hepatocyte/NEWGENE growth/NEWGENE factor/NEWGENE (/( HGF/NEWGENE )/SYM in/IN patients/NNS with/IN acute/JJ myocardial/JJ infarction/NN ,/, angina/NN pectoris/JJ ,/, and/CC other/DT heart/NN diseases/NNS ./.
@@92195266486 The/DT Man9-mannosidase/NEWGENE specificity/NN of/IN the/DT cDNA/NN construct/NN was/VBD verified/VBN by/IN the/DT observation/NN that/IN all/DT peptide/NN sequences/NNS derived/VBN from/IN a/DT previously/RB purified/VBN ,/, catalytically/RB active/JJ 49-kDa/NN fragment/NN were/VBD found/VBN within/IN the/DT coding/JJ region/NN ./.
@@10231513173 Cranio-caudal/JJ differences/NNS in/IN granulation/NN tissue/NN formation/NN :/: an/DT experimental/JJ study/NN in/IN the/DT rat/NN ./.
@@80653244701 Here/RB we/PRP show/VBP that/IN for/IN expression/NN of/IN snRNA/NN genes/NN in/IN maize/NN ,/, a/DT monocotyledonous/JJ plant/NN ,/, the/DT USE/NNS and/CC TATA/NN elements/NN are/VBP essential/JJ ,/, but/CC not/RB sufficient/JJ ,/, for/IN transcription/NN ./.
@@25120109302 The/DT PETCO2/NN measurement/NN during/IN precordial/JJ compression/NN predicted/VBD the/DT success/NN of/IN defibrillation/NN with/IN return/NN of/IN spontaneous/JJ circulation/NN ./.
@@97762939762 RESULTS/NNS :/: The/DT binding/NN of/IN 99mTc/NN d/NN ,/, 1-HMPAO/JJ to/IN human/JJ placenta/NN ranged/VBN from/IN 2/CD ./CD 95%/CD +/NN //NN -/NN 1/CD ./CD 5%/CD to/IN 5/CD ./CD 82%/CD +/NN //NN -/NN 0/CD ./CD 3%/CD per/IN 1/CD ml/NN standard/JJ solution/NN ./.
@@66713856673 Low/NNP NA/NN and/CC A/DT may/MD participate/VB in/IN lowering/JJ the/DT plasma/NEWGENE renin/NEWGENE activity/NN which/WDT in/IN PA/JJ in/IN suppressed/VBN ,/, sometimes/RB disproportionately/RB to/IN the/DT actual/JJ body/NN sodium/NN content/NN ./.
@@38859834702 These/DT results/NNS suggest/VBP that/DT indoramin/NN may/MD have/NN Class/NN III/NN antiarrhythmic/JJ activity/NN ./.
@@24625234941 A/DT 9/NEWGENE ./NEWGENE 5-kb/NEWGENE KpnI-SalI/NEWGENE fragment/NEWGENE ,/, where/CC all/PDT the/DT DNA/NN changes/NNS associated/VBN with/IN su/NEWGENE (/NEWGENE Hw/NEWGENE )/NEWGENE mutations/NEWGENE were/VBD mapped/VBN ,/, was/VBD able/JJ to/IN rescue/NN the/DT su/NEWGENE (/NEWGENE Hw/NEWGENE )/NEWGENE mutant/NEWGENE phenotype/NN after/IN P-element-mediated/JJ germ-line/JJ transformation/NN ./.
@@105024026494 A/DT panel/NN of/IN pharmacologic/JJ inhibitors/NNS was/VBD used/VBN to/IN investigate/VB the/DT signal/JJ transduction/NN pathways/NNS involved/VBN in/IN TRAIL/NEWGENE gene/NEWGENE induction/NN following/IN T/NN lymphocyte/NN activation/NN ./.
@@9276339234 Scanning/NN electron/NN microscopic/JJ investigations/NNS on/IN the/DT formation/NN of/IN Reissner's/NNP fiber/NN in/IN Rattus/NNP rattus/NN ./.
@@28626567601 Changes/NNS in/IN dopamine/NEWGENE receptor/NEWGENE sensitivity/NN in/IN humans/NNS after/IN heavy/JJ alcohol/NN intake/NN ./.
@@39305494586 The/DT sample/NN is/VBZ deproteinized/JJ and/CC after/IN centrifugation/NN valproic/JJ acid/NN in/IN the/DT supernatant/NN is/VBZ measured/VBN in/IN the/DT free/JJ form/NN by/IN direct/JJ injection/NN into/IN the/DT gas/NN chromatograph/NN ./.
@@70949056672 Further/RB ,/, intracerebroventricular/JJ injections/NNS of/IN KA/NN resulted/VBN in/IN the/DT substantial/JJ loss/NN of/IN pyramidal/JJ cells/NNS in/IN the/DT whole/JJ CA3/NN field/NN of/IN the/DT hippocampus/NN ./.
@@114011057169 Gabapentin/NN for/IN opiod-related/JJ myoclonus/NN in/IN cancer/NN patients/NNS ./.
@@19634382734 Heterogeneous/JJ electron/NN transfer/NN of/IN cytochrome/NEWGENE c/NEWGENE facilitated/VBN by/IN polypyrrole/NN and/CC methylene/NN blue/JJ polypyrrole/NN film/NN modified/JJ electrodes/NNS ./.
@@79830117364 Sequence/NN analysis/NN revealed/VBN :/: 1/NN )/NN a/DT kinase/NEWGENE catalytic/NEWGENE domain/NEWGENE most/JJ characteristic/NN of/IN serine/NEWGENE //NEWGENE threonine/NEWGENE kinases/NEWGENE but/CC hybrid/JJ between/IN members/NNS of/IN the/DT family/NN of/IN microtubule-associated/NEWGENE protein/NEWGENE kinase/NEWGENE kinase/NEWGENE kinases/NEWGENE and/CC the/DT fibroblast/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE family/NEWGENE ;/: 2/NN )/NN two/JJ putative/JJ alpha-helical/NN leucine/NN zipper/NN motifs/NN separated/VBN by/IN a/DT 25-amino/JJ acid/NN charged/VBD intermediate/JJ segment/NN but/CC lacking/JJ an/DT NH2-terminal/NN basic/JJ domain/NN ;/: and/CC 3/NN )/NN COOH-terminal/NN and/CC NH2-terminal/NN proline-rich/JJ domains/NNS suggestive/JJ of/IN src/NEWGENE homology/NEWGENE 3/NEWGENE (/( SH3/NEWGENE )/SYM domain/NN binding/JJ regions/NNS ./.
@@27408747030 Epithelial/JJ damage/NN was/VBD not/RB observed/VBN in/IN any/DT controls/NNS but/CC was/VBD in/IN all/DT tissues/NNS exposed/VBN to/IN SO2/NN ./.
@@2195332815 Distribution/NNP and/CC correlations/NNS of/IN serum/JJ uric-acid/NN in/IN two/JJ French/JJ adult/JJ populations/NNS :/: 13/CD ,/CD 885/CD men/NNS and/CC 6/NN ,/NN 861/NN women/NNS ./.
@@47304675125 Effects/NNPS of/IN cortisone/NN ,/, starvation/NN ,/, and/CC rickets/NN on/IN oxidative/JJ enzyme/NN activities/NNS of/IN epiphyseal/JJ cartilage/NN from/IN rats/NNS ./.
@@94306612817 Transient/JJ overexpression/NN of/IN mutant/NEWGENE EphB1/NEWGENE receptors/NEWGENE (/( Y594F/NEWGENE )/SYM blocked/VBN Nck/NEWGENE recruitment/NN to/IN EphB1/NEWGENE ,/, attenuated/VBN downstream/NN JNK/NEWGENE activation/NN ,/, and/CC blocked/VBD cell/NN attachment/NN responses/NNS ./.
@@83162404230 Analysis/NNP of/IN the/DT upstream/RB untranslated/JJ region/NN of/IN CHL15/NEWGENE revealed/VBN the/DT presence/NN of/IN the/DT hexamer/NN element/NN ,/, ACGCGT/NEWGENE (/( an/DT MluI/NEWGENE restriction/NEWGENE site/NEWGENE )/SYM controlling/JJ both/PDT the/DT periodic/JJ expression/NN and/CC coordinate/JJ regulation/NN of/IN the/DT DNA/NN synthesis/NN genes/NNS in/IN budding/JJ yeast/NN ./.
@@109651354203 Our/PRP results/NNS indicate/VBP that/IN the/DT expression/NN of/IN Cktsf1b1/NEWGENE ,/, a/DT gene/NN associated/VBN with/IN early/JJ development/NN and/CC cell/NN transformation/NN ,/, is/VBZ sensitive/JJ to/IN MKK/NEWGENE levels/NNS and/CC may/MD be/VB regulated/VBN via/NN multiple/JJ transcription/NN factor/NN complexes/NNS ./.
@@83917482648 Drugs/NNS suppressed/VBN >/SYM or/CC =/SYM 75%/NN of/IN the/DT total/JJ premature/JJ ventricular/JJ contractions/NNS in/IN all/DT patients/NNS who/WP had/VBP both/DT use-dependent/NN QRS/NN prolongation/NN and/CC reverse/NN use-dependent/NN QT/NN prolongation/NN ,/, in/IN 79%/CD of/IN patients/NNS with/IN use-dependent/NN QRS/NN prolongation/NN alone/RB ,/, in/IN 70%/CD with/IN reverse/NN use-dependent/NN QT/NN prolongation/NN alone/RB ,/, and/CC in/IN 11%/JJ with/IN neither/DT use-dependent/NN QRS/NN prolongation/NN nor/CC reverse/NN use-dependent/NN QT/NN prolongation/NN ./.
@@103746323923 CONCLUSION/IN :/: NBP/NN pre-treatment/NN or/CC post-treatment/JJ markedly/RB enhanced/VBN the/DT rCBF/NN to/IN striatum/NN in/IN RMCAO/NNP rats/NNS ./.
@@81440373698 Thioredoxin/NEWGENE (/( TR/NEWGENE )/SYM is/VBZ a/DT small/JJ ubiquitous/JJ dithiol-reductase/NEWGENE enzyme/NEWGENE first/RB identified/VBD in/IN bacteria/NNS and/CC plants/NNS ./.
@@67539026517 4/CD Five/CD patients/NNS died/VBN within/IN one/PRP month/NN of/IN captopril/NN and/CC five/CD between/IN four/CD and/CC seven/CD months/NNS ,/, three/CD of/IN whom/WP had/VBP improved/VBN to/IN class/NN IIM/NN and/CC one/PRP to/IN IIS/NNP before/IN death/NN ./.
@@1734283730 We/PRP have/VBP partially/RB sequenced/VBN the/PDT RAP74/NEWGENE protein/NEWGENE from/IN purified/VBN HeLa/IN cells/NNS ,/, cloned/VBN its/PRP complementary/JJ DNA/NN and/CC shown/VBP that/IN its/PRP translation/NN product/NN can/MD interact/VB with/IN RAP30/NEWGENE in/RB vitro/FW as/RB well/VB as/IN in/IN vivo/NN ./.
@@96184814387 Regulation/NN of/IN the/DT human/NEWGENE p21/NEWGENE //NEWGENE WAF1/NEWGENE //NEWGENE Cip1/NEWGENE promoter/NEWGENE in/IN hepatic/JJ cells/NNS by/IN functional/JJ interactions/NNS between/IN Sp1/NEWGENE and/CC Smad/NEWGENE family/NEWGENE members/NEWGENE ./.
@@87412068727 Nonetheless/RB ,/, that/IN ventricular/JJ afferents/NNS ,/, in/IN certain/JJ special/JJ settings/NNS ,/, are/VBP able/JJ to/IN induce/VB e/NN ./NN g/NN ./. generalised/JJ vasodilation/NN and/CC hypotension/NN cannot/MD be/VB excluded/VBN ./.
@@103808009617 A/DT comparison/NN of/IN the/DT nucleotide/NN and/CC deduced/VBN amino/JJ acid/NN sequences/NNS of/IN the/DT core/NN regions/NNS of/IN the/DT RNA-dependent/NEWGENE RNA/NEWGENE polymerase/NEWGENE domains/NEWGENE found/VBP in/IN these/DT three/CD dsRNAs/NEWGENE suggested/VBN that/IN these/DT dsRNAs/NEWGENE probably/RB evolved/VBN independently/RB within/IN each/DT host/NN plant/NN from/IN a/DT common/JJ ancestor/NN ./.
@@97399139719 CASE/NNP REPORT/NNP :/: We/PRP observed/VBD a/DT congenital/JJ skin/NN defect/NN located/VBN exclusively/RB on/IN the/DT trunk/NN ./.
@@87027561635 The/DT small/NEWGENE GTPase/NEWGENE Rho/NEWGENE1 is/VBZ implicated/VBN in/IN physiological/JJ functions/NNS associated/VBN with/IN actin-myosin/NN filaments/NN such/JJ as/IN cytokinesis/NN ,/, cell/NN motility/NN ,/, and/CC smooth/JJ muscle/NN contraction/NN ./.
@@47969975169 Canine/NN reproduction/NN :/: effects/NNS of/IN a/DT single/JJ injection/NN of/IN medroxyprogesterone/NN acetate/NN on/IN the/DT reproductive/JJ organs/NNS of/IN the/DT bitch/NN ./.
@@112793241107 The/DT size/NN of/IN the/DT infarct/NN was/VBD determined/VBN using/VBG the/DT creatine/NEWGENE kinase/NEWGENE integral/JJ method/NN ./.
@@96118779584 The/DT identified/VBN isolates/NNS of/IN CSF/NN (/( 20/CD of/IN 29/CD )/SYM were/VBD :/: ECHO/NN 30/NN (/( 9/CD )/SYM ,/, ECHO/NN 11/NN (/( 7/CD )/SYM ,/, ECHO/NN 9/NN (/( 3/CD )/SYM and/CC ECHO/NN 7/NN (/( 1/CD )/SYM ./.
@@87608893734 The/DT cDNA/NN clone/NN was/VBD used/VBN as/IN a/DT homologous/JJ probe/NN to/IN isolate/NN a/DT truncated/JJ genomic/JJ clone/NN encoding/VBG H2A1/NEWGENE ./.
@@17428798978 RESULTS/NNS :/: Plasma/NEWGENE AVP/NEWGENE responses/NNS to/IN osmotic/JJ stimulation/NN ,/, and/CC non-osmotic/JJ inhibition/NN by/IN drinking/JJ ,/, were/VBD normal/JJ in/IN patients/NNS with/IN compulsive/JJ water/NN drinking/JJ ./.
@@28735933554 Moreover/RB ,/, in/IN rats/NNS allowed/VBN to/IN choose/VB in/IN a/DT T-maze/NN between/IN immediate-but-small/JJ vs/IN ./IN delayed-but-large/JJ reward/NN ,/, BZP/NN significantly/RB decreased/VBD the/DT frequency/NN with/IN which/WDT the/DT delayed/JJ reward/NN was/VBD chosen/VBP ,/, with/IN 5-HT/JJ uptake/NN blockers/NNS producing/JJ opposite/NN effects/NNS ./.
@@28302825146 Both/PDT the/DT intact/NEWGENE A1/NEWGENE protein/NEWGENE and/CC its/PRP proteolytic/JJ fragment/NN ,/, the/DT UP1/NEWGENE protein/NEWGENE ,/, can/MD be/VB cleaved/VBN by/IN Staphylococcus/NEWGENE aureus/NEWGENE V-8/NEWGENE protease/NEWGENE to/IN produce/NN two/JJ polypeptides/NNS of/IN 92/CD amino/JJ acids/NNS ./.
@@90034103006 The/DT human/NEWGENE p100/NEWGENE protein/NEWGENE was/VBD recently/RB identified/VBN as/IN a/DT coactivator/NN of/IN the/DT Epstein-Barr/NEWGENE virus/NEWGENE nuclear/NEWGENE antigen/NEWGENE 2/NEWGENE ./CD
@@95829538678 OBJECTIVES/NNS :/: To/TO measure/VB coagulation/NEWGENE factor/NEWGENE VIII/NEWGENE :/: coagulant/JJ (/( F/NEWGENE ./NEWGENE VIII/NEWGENE :/: C/NN )/SYM and/CC C1-esterase/NEWGENE inhibitor/NEWGENE (/( C1-INH/NEWGENE )/SYM ,/, hemostasis-associated/NN acute-phase/NN reactant/NN proteins/NNS and/CC coagulation/NEWGENE factors/NEWGENE VII/NEWGENE (/NEWGENE F/NEWGENE ./NEWGENE VII/NEWGENE )/NEWGENE ,/NEWGENE IX/NEWGENE (/NEWGENE F/NEWGENE ./NEWGENE IX/NEWGENE )/NEWGENE ,/NEWGENE and/NEWGENE X/NEWGENE (/NEWGENE F/NEWGENE ./NEWGENE X/NEWGENE )/NEWGENE ,/, hemostasis/NN proteins/NNS not/RB associated/VBN with/IN an/DT acute-phase/NN response/NN ,/, in/IN a/DT select/JJ population/NN of/IN horses/NNS with/IN colic/NN and/CC hemostasis/NN abnormalities/NNS ,/, and/CC presumed/VBD to/IN have/NN acute-phase/NN changes/NNS ./.
@@53037006934 SAM-TR-68-54/NN ./.
@@84145028959 Consistent/JJ with/IN the/DT hypothesis/NN that/IN it/PRP acts/NNS as/IN transcriptional/NN regulator/NN ,/, wild-type/NEWGENE p53/NEWGENE protein/NEWGENE binds/VBZ DNA/NN and/CC activates/VBZ transcription/NN of/IN several/DT promoters/NNS ./.
@@10480207676 Critique/NNS of/IN "Interactive/JJ Effects/NNPS of/IN Test/NNP Anxiety/NNP and/CC Credit/NNP //NNP No/NNP Credit/NNP or/CC A-F/NN Grade/NNP Condition/NN upon/IN Short-term/JJ and/CC Long-term/JJ Recall/VB of/IN Course/NNP Information/NNP ./.
@@111941471034 The/DT distribution/NN of/IN red/JJ rice/NN cultivation/NN in/IN Sri/NNP Lanka/NNP is/VBZ coincident/JJ with/IN the/DT HIDD/NN villages/NN ./.
@@82981291696 It/PRP was/VBD not/RB possible/JJ to/IN study/NN the/DT basis/NN for/IN tissue-specific/JJ expression/NN of/IN this/DT gene/NN ,/, because/IN the/DT beta/NEWGENE 3/NEWGENE gene/NEWGENE promoter/NEWGENE had/VBP not/RB been/VBN isolated/VBN previously/RB ./.
@@83823034462 The/DT E1/NEWGENE replication/NEWGENE protein/NEWGENE of/IN bovine/JJ papillomavirus/NN type/NN 1/CD contains/VBZ an/DT extended/VBN nuclear/JJ localization/NN signal/JJ that/WDT includes/VBZ a/DT p34cdc2/NEWGENE phosphorylation/NN site/NN ./.
@@110787265191 Stoichiometric/NNP phosphorylation/NN of/IN human/NEWGENE p53/NEWGENE at/IN Ser315/NN stimulates/VBZ p53-dependent/JJ transcription/NN ./. p53/NEWGENE protein/NEWGENE activity/NN as/IN a/DT transcription/NN factor/NN can/MD be/VB activated/VBN in/IN vivo/NN by/IN antibodies/NNS that/WDT target/VBP its/PRP C-terminal/NN negative/JJ regulatory/JJ domain/NN suggesting/VBG that/IN cellular/JJ enzymes/NNS that/WDT target/VBP this/DT domain/NN may/MD play/NN a/DT role/NN in/IN stimulating/NN p53-dependent/NN gene/NN expression/NN ./.
@@96361199613 Commutative/NNP saccadic/JJ generator/NN is/VBZ sufficient/JJ to/IN control/NN a/DT 3-D/JJ ocular/JJ plant/NN with/IN pulleys/NNS ./.
@@105919764204 Measurements/NNS in/IN the/DT LWS/NNP p/CD ./CD a/CD ./. ,/, LWS/NN lat/NN ./. and/CC at/IN Ward's/NNP triangle/NN were/VBD made/VBP in/IN a/DT total/NN of/IN 100/CD patients/NNS ./.
@@100771884191 This/DT suggests/VBZ that/IN helicase-like/NEWGENE genes/NEWGENE may/MD be/VB involved/VBN in/IN the/DT biosynthesis/NN of/IN nucleic/JJ acids/NNS and/CC proteins/NNS ,/, and/CC that/IN the/DT genes/NNS can/MD be/VB transcriptionally/RB activated/VBN by/IN heat/NN shock/NN to/IN compensate/VB for/IN the/DT repressed/VBN synthesis/NN of/IN mRNA/NN and/CC protein/NN ./.
@@8391534225 Elledge/NNP ,/, P/NNP ./NNP
@@2141425546 With/IN the/DT modified/JJ fingertip-to-floor/JJ (/( MFTF/NN )/SYM method/NN ,/, patients/NNS stand/NN on/IN a/DT stool/NN and/CC forward/JJ bend/NN so/RB that/IN measurements/NNS can/MD be/VB taken/VBP on/IN patients/NNS who/WP are/VBP able/JJ to/IN touch/NN the/DT floor/NN or/CC reach/NN beyond/RB the/DT level/NN of/IN the/DT floor/NN ./.
@@118164582087 Clicking/VBG on/IN "Examples/NNS and/CC Explanations/NNS of/IN APA/NN Form"/NN provides/VBZ a/DT help/NN system/NN with/IN examples/NNS of/IN the/DT various/JJ sections/NNS of/IN a/DT review/NN article/NN ,/, journal/NN article/NN that/WDT has/VBZ one/PRP experiment/NN ,/, or/CC journal/NN article/NN that/WDT has/VBZ two/JJ or/CC more/JJ experiments/NNS ./.
@@23568233014 This/DT proposed/VBN method/NN is/VBZ similar/JJ in/IN principle/NN to/IN the/DT sets/NNS technique/NN but/CC is/NNS shown/VBP to/IN have/NN much/RB better/RBR expected/VBN time/NN to/IN alarm/NN properties/NNS ./.
@@107623482422 After/IN phosphorylation/NN ,/, STAT/NEWGENE proteins/NEWGENE are/VBP transported/VBN into/IN the/DT nucleus/NN and/CC exhibit/NN transcriptional/JJ activity/NN ./.
@@30400233750 Morphine/IN produced/VBN a/DT dose-dependent/NN bradycardia/NN followed/VBN by/IN tachycardia/NN ./.
@@63823746180 For/IN the/DT first/JJ 30/CD min/NN following/IN insulin/NEWGENE administration/NN ,/, the/DT rate/NN of/IN change/NN in/IN glucose/NN levels/NNS was/VBD significantly/RB less/PRP among/IN the/DT patients/NNS with/IN major/JJ depressive/JJ disorder/NN than/IN among/IN either/DT the/DT patients/NNS with/IN dysthymic/JJ disorder/NN or/CC the/DT normal/JJ control/NN subjects/NNS ./.
@@63217704609 The/DT expression/NN of/IN chloramphenicol/NEWGENE acetyltransferase/NEWGENE was/VBD detected/VBN within/IN 1/CD h/NN after/IN infection/NN of/IN cells/NNS with/IN recombinant/JJ virus/NN ,/, reflecting/JJ the/DT early/JJ nature/NN of/IN the/DT promoters/NNS used/VBN ./.
@@98887116273 Bioplastique/NNP granuloma/NN presents/VBP with/IN irregularly/RB shaped/JJ cystic/JJ spaces/NNS of/IN varying/JJ size/NN containing/JJ jagged/JJ ,/, translucent/JJ ,/, nonbirefringent/JJ foreign/JJ bodies/NNS whereas/IN Artecoll/NN granuloma/NN shows/VBZ numerous/JJ round/JJ vacuoles/NNS nearly/RB identical/JJ in/IN size/NN and/CC shape/NN enclosing/VBG round/JJ and/CC sharply/RB circumscribed/JJ ,/, translucent/JJ ,/, nonbirefringent/JJ foreign/JJ bodies/NNS ./.
@@5555835595 Pharmacokinetics/NNS of/IN Carbamazepine/DT in/NN man/NN :/: a/DT review/NN ./.
@@75978047018 Two/CD transcripts/NNS of/IN 1/CD ./CD 6/CD kb/NN and/CC 5/CD ./CD 8/CD kb/NN are/VBP 5'/CD coterminal/JJ and/CC may/MD both/DT encode/VB the/DT novel/JJ glycoprotein/NEWGENE gene/NEWGENE EUS4/NEWGENE ./.
@@80208068018 A/DT randomised/JJ ,/, controlled/VBN trial/NN was/VBD undertaken/VBP in/IN 40/CD patients/NNS with/IN active/JJ Crohn's/NNP disease/NN to/IN evaluate/VB clinical/JJ and/CC nutritional/JJ outcomes/NNS after/IN an/DT amino/JJ acid/NN based/VBD diet/NN containing/JJ 3%/JJ fat/NN was/VBD given/VBP by/IN a/DT feeding/JJ tube/NN compared/VBN with/IN a/DT peptide/NN based/VBD diet/NN containing/JJ 33%/JJ fat/NN ./.
@@83522683322 Recombinant/NEWGENE human/NEWGENE erythropoietin/NEWGENE (/( epoetin/NEWGENE )/SYM is/VBZ approved/VBN to/IN be/VB administered/VBN by/IN the/DT intravenous/JJ (/( i/CD ./CD v/CD ./CD )/SYM or/CC subcutaneous/JJ (/( SC/NN )/SYM route/NN ./.
@@80404684426 We/PRP speculate/VBP that/DT mast/NN cell/NN degranulation/NN may/MD be/VB involved/VBN in/IN the/DT pathogenesis/NN of/IN necrobiosis/NN by/IN altering/VBG fibroblast/NN enzyme/NN activity/NN and/IN //IN or/IN producing/JJ prolonged/JJ inflammatory/JJ reactions/NNS ./.
@@111577745225 Hypomorphic/NNP dSLBP/NEWGENE alleles/NEWGENE support/NN zygotic/JJ development/NN but/CC cause/NN female/JJ sterility/NN ./.
@@91927699322 Molecular/NNP cloning/NN and/CC characterization/NN of/IN a/DT cDNA/NN ,/, CHEMR1/NEWGENE ,/, encoding/VBG a/DT chemokine/NEWGENE receptor/NEWGENE with/IN a/DT homology/NN to/IN the/DT human/NEWGENE C-C/NEWGENE chemokine/NEWGENE receptor/NEWGENE ,/, CCR-4/NEWGENE ./.
@@81428753101 To/TO achieve/VB complete/JJ dissection/NN of/IN the/DT anterior/NN vitreous/NN ,/, we/PRP remove/VBP even/VB a/DT clear/JJ lens/NN during/IN the/DT first/JJ surgical/JJ intervention/NN in/IN selected/VBN cases/NNS ./.
@@18483009895 Suggestive/JJ evidence/NN was/VBD obtained/VBN that/DT cstA/NEWGENE is/VBZ involved/VBN in/IN peptide/NN utilization/NN ./.
@@85971089939 QBMDs/NNP for/IN a/DT 5%/JJ change/NN in/IN response/NN (/( QBMD05/NN )/SYM were/VBD 6-fold/CD lower/JJR ,/, on/IN average/JJ ,/, than/IN the/DT corresponding/JJ NOAEL/NN ./.
@@98190385966 Recombinant/NEWGENE FVIIa/NEWGENE was/VBD stable/JJ in/IN the/DT infusion/NN pump/NN for/IN several/DT days/NNS at/IN room/NN temperature/NN and/CC for/IN 24/CD h/NN at/IN body/NN temperature/NN ./.
@@76852632650 Using/VBG the/DT polymerase/NEWGENE chain/NN reaction/NN ,/, Whipple-specific/NEWGENE DNA/NEWGENE fragments/NEWGENE of/IN 284/CD base/NN pairs/NNS from/IN the/DT genome/NN of/IN the/DT Whipple/NN bacterium/NN (/( Tropheryma/NNP whippelii/NN )/SYM were/VBD demonstrated/VBN ./.
@@94178708151 We/PRP have/VBP previously/RB reported/VBN that/DT depletion/NN of/IN protein/NEWGENE kinase/NEWGENE C/NEWGENE by/IN long-term/JJ treatment/NN of/IN B16/NN mouse/NN melanoma/NN cells/NNS with/IN phorbol/NN dibutyrate/NN (/( PDBu/NN )/SYM prevented/VBN cell/NN density-dependent/JJ melanogenesis/NN ./.
@@11127250967 PM/NN 12/NN or/CC 18/CD mg/CD //CD kg/CD daily/JJ plus/IN a/DT standard/JJ dose/NN of/IN SB/NN for/IN 21/CD days/NNS was/VBD statistically/RB more/RB effective/JJ than/IN SB/NN in/IN producing/JJ a/DT final/JJ cure/NN for/IN patients/NNS with/IN VL/JJ in/IN Bihar/JJ ,/, India/NNP ./.
@@40434891701 Visidex/NN I/NN is/VBZ unsuitable/JJ for/IN storage/NN and/CC re-reading/NN ./.
@@107480548291 A/DT pathway/NN for/IN regulation/NN of/IN B/NEWGENE lymphocyte/NEWGENE antigen/NEWGENE receptor-induced/JJ calcium/NN flux/NN ./.
@@6827626614 Silicosis/NNP mortality/NN ./.
@@22362769610 Rats/NNP with/IN one/PRP olfactory/NN bulb/NN removed/VBN and/CC the/DT contralateral/JJ naris/NN closed/NN can/MD detect/VB odors/NNS ./.
@@112957601863 Specimen/NNS mass/JJ reduction/NN increased/VBN with/IN irradiance/NN from/IN 19/CD to/IN 72%/NN of/IN the/DT initial/JJ mass/NN for/IN 9--31/NN W/NN //NN cm/NN (/NN 2/NN )/NN ,/, respectively/RB ./.
@@109186128526 The/DT transcription/NN factor/NN Jun/NEWGENE (/( c-Jun/NEWGENE )/SYM functions/NNS as/IN a/DT recipient/NN of/IN extracellular/JJ growth/NN signals/NNS and/CC converts/VBP them/PRP into/IN patterns/NNS of/IN gene/NN expression/NN ./.
@@85387024813 The/DT encoded/VBN polypeptide/NN is/VBZ similar/JJ in/IN sequence/NN to/IN the/DT ABA-1/NEWGENE allergen/NEWGENE of/NEWGENE Ascaris/NEWGENE ,/, the/DT gp15/NEWGENE //NEWGENE 400/NEWGENE 'ladder'/NEWGENE protein/NEWGENE of/NEWGENE Brugia/NEWGENE malayi/NEWGENE ,/NEWGENE Brugia/NEWGENE pahangi/NEWGENE and/NEWGENE Wuchereria/NEWGENE bancrofti/NEWGENE ,/, and/CC a/DT 15-kDa/NEWGENE antigen/NEWGENE of/NEWGENE Dirofilaria/NEWGENE immitis/NEWGENE ./.
@@90508618757 We/PRP now/RB describe/VBP the/DT identification/NN of/RB DEK/NEWGENE as/IN this/DT 43-kDa/NEWGENE pets/NEWGENE factor/NEWGENE ./.
@@76576683396 TH-SH3/NEWGENE binding/JJ in/IN vitro/FW is/VBZ abolished/VBN by/IN specific/JJ ,/, single/JJ amino/JJ acid/NN substitutions/NNS within/IN the/DT Btk/NEWGENE TH/NEWGENE1 domain/NEWGENE1 or/CC the/DT Fyn/NEWGENE SH3/NEWGENE1 domain/NEWGENE1 ./.
@@12793526490 Nuclear/NNP extracts/NNS prepared/VBN from/IN both/DT neural/JJ and/CC non-neural/JJ cell/NN lines/NNS ,/, mouse/NN brain/NN ,/, and/CC mouse/NN liver/NN contain/VB proteins/NNS that/WDT recognize/VBP and/CC bind/VB to/IN the/DT PROX/NEWGENE and/CC PAL/NEWGENE sequences/NEWGENE indicating/VBG that/IN proteins/NNS which/WDT bind/VBP to/IN these/DT target/NN sequences/NNS are/VBP widespread/JJ ./.
@@86611007569 The/DT exon-intron/JJ distribution/NN of/IN Cdebp/NEWGENE appears/VBZ strikingly/RB similar/JJ to/IN that/DT of/IN the/DT App/NEWGENE gene/NEWGENE in/IN the/DT regions/NNS encoding/VBG the/DT conserved/VBN domains/NNS ,/, with/IN a/DT divergent/JJ structure/NN in/IN the/PDT other/DT parts/NNS ./.
@@84402387232 A/DT region/NN in/IN the/DT C-terminus/NN of/IN adenovirus/NEWGENE 2/NEWGENE //NEWGENE 5/NEWGENE E1a/NEWGENE protein/NEWGENE is/VBZ required/VBN for/IN association/NN with/IN a/DT cellular/JJ phosphoprotein/NN and/CC important/JJ for/IN the/DT negative/JJ modulation/NN of/IN T24-ras/NEWGENE mediated/JJ transformation/NN ,/, tumorigenesis/NN and/CC metastasis/NN ./.
@@91505669102 We/PRP also/RB review/VBP the/DT role/NN of/IN grains/NNS in/IN the/DT formation/NN of/IN complex/NN molecules/NNS in/IN interstellar/JJ molecular/JJ clouds/NNS ./.
@@110002666828 Identification/NNP of/IN an/DT enhancer/NN and/CC an/DT alternative/JJ promoter/NN in/IN the/DT first/JJ intron/NN of/IN the/DT alpha-fetoprotein/NEWGENE gene/NEWGENE ./.
@@84921648457 Spontaneous/JJ burst/NN firing/JJ in/IN cat/NN primary/JJ auditory/JJ cortex/NN :/: age/NN and/CC depth/NN dependence/NN and/CC its/PRP effect/NN on/IN neural/JJ interaction/NN measures/NNS ./.
@@92338099059 Second/JJ ,/, plasmid-derived/NN transgenes/NN and/CC gene/NN targeting/NN of/IN the/DT endogenous/NEWGENE Hnf3g/NEWGENE gene/NEWGENE locus/NEWGENE were/VBD used/VBN to/IN demonstrate/VB that/IN the/DT 3'-flanking/JJ region/NN of/IN the/DT gene/NN is/VBZ necessary/JJ and/CC sufficient/JJ to/IN direct/JJ reporter/NN gene/NN expression/NN in/IN liver/NN ,/, pancreas/NN ,/, stomach/NN and/CC small/JJ intestine/NN ./.
@@93729607629 Polysome/NN analyses/NNS in/IN a/DT temperature-sensitive/JJ fal1-1/NEWGENE mutant/NEWGENE and/CC a/DT Fal1p-depleted/NN strain/NN reveal/VB a/DT decrease/NN in/IN the/DT number/NN of/IN 40S/NEWGENE ribosomal/NEWGENE subunits/NEWGENE ./.
@@85520959387 Consistent/JJ with/IN a/DT possible/JJ role/NN in/IN transcription/NN ,/, Paf1p/NEWGENE is/VBZ localized/VBN to/IN the/DT nucleus/NN ./.
@@10999205833 However/RB ,/, if/IN the/DT spatial/JJ resolution/NN is/VBZ not/RB critical/JJ and/CC interest/NN is/VBZ to/IN compare/NN a/DT pathologic/JJ area/NN with/IN a/DT contralateral/JJ VOI/NN ,/, then/RB the/DT acquisition/NN of/IN two/JJ single-voxel/JJ spectra/NNS may/MD be/VB preferred/VBN ./.
@@73758367215 Angiographic/NNP work-up/NN in/IN a/DT patient/NN with/IN late/JJ vaginal/JJ metastasis/NN from/IN a/DT renal/JJ carcinoma/NN ./.
@@8631848600 Adaptation/NN of/IN taurocholate/NN transport/NN maximum/JJ to/IN increased/VBN secretory/JJ load/NN in/IN the/DT rat/NN ./.
@@104355955247 The/DT molecular/JJ mechanism/NN of/IN Tax-mediated/JJ trans-activation/NN has/VBZ been/VBN well/VB investigated/VBN ./.
@@31384499798 This/DT suggested/VBN that/IN delta/NN 6/NN and/CC delta/NN 5/NN desaturation/NN activities/NNS are/VBP normal/JJ in/IN these/DT conditions/NNS with/IN this/DT C18/NN :/: 2w6/CD supply/NN ./.
@@94168989371 The/DT mean/JJ values/NNS of/IN the/DT first/JJ three/CD components/NNS were/VBD not/RB significantly/RB different/JJ in/IN ARVD/NNP patients/NNS and/CC control/NN subjects/NNS ./.
@@91331225618 Additional/JJ information/NN including/JJ echocardiographic/JJ sequences/NNS ,/, perioperative/JJ video/NN sequences/NN ,/, x-ray/NN analysis/NN ,/, angiograms/NNS ,/, etc/NN ./. is/VBZ represented/VBN in/IN the/DT program/NN ./.
@@117642267482 Classification/NNS according/VBG to/IN the/DT ILAR/NN criteria/NNS was/VBD possible/JJ in/IN 321/CD patients/NNS ;/: 290/CD patients/NNS had/VBP a/DT disease/NN duration/NN >/SYM or/CC =/SYM 3/CD months/NNS and/CC were/VBD classified/VBN according/VBG to/IN the/DT EULAR/NN criteria/NNS ./.
@@10437043286 METHODS/IN :/: 109/CD suspected/VBN cases/NNS with/IN SS/NN underwent/VBD the/DT biopsies/NNS ./.
@@87028454211 In/NN order/NN to/IN delineate/VB structural/JJ motifs/NNS regulating/JJ substrate/NN affinity/NN and/CC recognition/NN for/IN the/DT human/NEWGENE dopamine/NEWGENE transporter/NEWGENE (/( DAT/NEWGENE )/SYM ,/, we/PRP assessed/VBD [/NN 3H/NN ]/NN dopamine/NN uptake/NN kinetics/NN and/CC [/NN 3H/NN ]/NN CFT/NN binding/JJ characteristics/NNS of/IN COS-7/NNP cells/NNS transiently/RB expressing/NN mutant/NEWGENE DATs/NEWGENE in/IN which/WDT the/DT COOH/NNP terminus/NN was/VBD truncated/JJ or/CC substituted/JJ ./.
@@11038366949 Thus/RB ,/, methylation/NN of/IN Pph21p/NEWGENE is/VBZ important/JJ for/IN formation/NN of/IN PP2A/NEWGENE trimeric/NEWGENE and/NEWGENE dimeric/NEWGENE complexes/NEWGENE ,/, and/CC consequently/RB ,/, for/IN PP2A/NEWGENE function/NN ./.
@@16953142292 157/CD +/NN //NN -/NN 16/CD mg/NN //NN dl/NN ;/: NS/NN )/NN ,/, glucose/NN levels/NNS ,/, and/CC basal/JJ (/( 17/CD +/NN //NN -/NN 4/CD vs/IN ./IN
@@106832445532 Collectively/RB ,/, these/DT experiments/NNS demonstrate/VBP that/IN CFTR's/NEWGENE NBF1+R/NEWGENE region/NEWGENE and/CC its/PRP NBF2/NEWGENE domain/NEWGENE ,/, after/IN folding/NN separately/RB as/IN distinct/JJ units/NNS ,/, have/VB a/DT strong/JJ propensity/NN to/IN interact/VB and/CC that/IN this/DT interaction/NN is/VBZ stable/JJ in/IN the/DT absence/NN of/IN added/VBN nucleotides/NNS or/CC exogenously/RB induced/VBN phosphorylation/NN ./.
@@39858493908 Recurrent/JJ acute/JJ rhinosinusitis/NN was/VBD common/JJ in/IN both/DT groups/NNS of/IN patients/NNS ,/, but/CC the/DT development/NN of/IN chronic/JJ rhinosinusitis/NN was/VBD only/RB found/VB in/IN patients/NNS with/IN CVID/NN ,/, indicating/VBG the/DT more/RB severe/JJ nature/NN of/IN this/DT condition/NN compared/VBN with/IN selective/JJ IgA/NEWGENE deficiency/NN ./.
@@3137665503 In/NN patients/NNS who/WP were/VBD not/RB vented/VBN ,/, there/RB was/VBD overall/JJ significant/JJ depression/NN of/IN function/NN (/( 67/CD +/NN //NN -/NN 5%/NN of/IN control/NN ;/: range/NN ,/, 91--45%/NN ,/, p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@59609997025 Value/NNP of/IN the/DT method/NN of/IN passive/JJ hemagglutination/NN with/IN polysaccharide/NN C/NN in/IN detecting/JJ C-reactive/NEWGENE protein/NEWGENE as/IN compared/VBN to/IN precipitation/NN in/IN capillaries/NNS and/CC slide/NN latex/NN test/NN with/IN anti-CRP/NEWGENE serum/JJ ./.
@@3978064638 2/CD new/JJ Algerian/JJ cases/NNS ./.
@@111529638578 Expression/NNS of/IN the/DT src/NEWGENE homology/NEWGENE 3/NEWGENE (/( SH3/NEWGENE )/NN -encoding/NN ,/, expressed/VBN in/IN tumorigenic/JJ astrocytes/NNS (/( SETA/ORG )/SYM gene/NN is/VBZ associated/VBN with/IN astrocyte/NN transformation/NN in/IN culture/NN and/CC tumors/NNS in/IN the/DT adult/JJ brain/NN ./.
@@118193261686 AIM/NNP :/: To/TO understand/VB the/DT role/NN of/IN nutritional/JJ status/NN in/IN cirrhotic/JJ patients/NNS without/IN clinical/JJ porto-systemic/JJ encephalopathy/NN (/( PSE/NN )/NN ./NN METHODS/NN :/: Fifty-one/VBZ non-alcoholic/JJ patients/NNS with/IN cirrhosis/NN without/IN PSE/NN were/VBD studied/VBN prospectively/RB and/CC compared/VBN with/IN 20/CD healthy/JJ volunteers/NNS ./.
@@79691817982 We/PRP have/VBP recently/RB detected/VBN high/JJ levels/NNS of/IN CKB/NEWGENE mRNA/NEWGENE in/IN HeLa/DT cells/NNS and/CC ,/, in/IN this/DT study/NN ,/, have/NN tested/VBD whether/IN this/DT may/MD be/VB due/NN to/IN the/DT extremely/RB low/JJ amounts/NNS of/IN p53/NEWGENE protein/NEWGENE present/NN in/IN HeLa/DT cells/NNS ./.
@@111085238299 Video/NNP images/NNS of/IN the/DT nostrils/NNS were/VBD captured/VBN and/CC then/RB analyzed/VBN for/IN area/NN ,/, perimeter/NN ,/, centroid/NN ,/, principal/JJ axis/NN ,/, moments/NNS about/RB the/DT major/JJ and/CC minor/JJ axes/NNS (/( I11/NN ,/, I22/NN )/SYM ,/, anisometry/NN ,/, bulkiness/NN ,/, lateral/JJ offset/NN ,/, internostril/NN angle/NN ,/, and/CC rotational/JJ angle/NN ./.
@@115556691430 A/DT randomized/JJ mix/NN of/IN 180/CD sections/NNS (/( 10/CD samples/NNS x/NN 3/CD tissues/NNS x/NN 3/CD stains/NNS x/NN 2/CD )/SYM gave/VBD 90/CD matched/JJ pairs/NNS ./.
@@26754923348 Four/CD out/RB of/IN 10/CD patients/NNS showed/VBD clinical/JJ improvement/NN according/VBG to/IN Ritchie-Index/NN ,/, pain/NN score/NN ,/, ESR/NN and/CC CRP/NN ./.
@@104007604196 The/DT results/NNS of/IN these/DT analyses/NNS indicate/VBP that/IN the/DT proteinase/NEWGENE cleaves/VBZ at/IN amino/JJ acid/NN residues/NNS E960-A961/NN ,/, E1071-S1072/NN ,/, E1345-T1346/NN ,/, and/CC E1419-G1420/NN ;/: however/RB ,/, the/DT cleavage/NN efficiency/NN is/VBZ varied/VBN ./.
@@75378515038 Experiments/NNS with/IN recombinant/JJ proteins/NNS showed/VBN that/IN p50/NEWGENE //NEWGENE p65/NEWGENE and/CC high-mobility-group/NEWGENE I/NEWGENE (/NEWGENE Y/NEWGENE )/NEWGENE protein/NEWGENE cooperatively/RB facilitated/VBN the/DT binding/NN of/IN IRF-1/NEWGENE to/IN the/DT VCAM1/NEWGENE IRF/NEWGENE1 binding/NEWGENE1 site/NEWGENE1 and/CC that/IN IRF-1/NEWGENE physically/RB interacted/VBN with/IN p50/NEWGENE and/CC with/IN high-mobility-group/NEWGENE I/NEWGENE (/NEWGENE Y/NEWGENE )/NEWGENE protein/NEWGENE ./.
@@87930298775 Control/NNP intact/JJ rats/NNS were/VBD age-matched/JJ to/IN the/DT different/JJ treated/VBN groups/NNS ./.
@@29361632902 Platelet/NN function/NN and/CC platelet-polymorphonuclear-neutrophil/JJ interaction/NN in/IN patients/NNS with/IN deficient/NN platelet/NEWGENE lipoxygenase/NEWGENE activity/NN ./.
@@65038859100 This/DT machine/NN drift/NN ,/, which/WDT was/VBD not/RB associated/VBN with/IN a/DT rise/NN in/IN water/NN phantom/NN temperature/NN and/CC did/VBD not/RB consistently/RB correlate/VB with/IN estimated/VBN x-ray/NN tube/NN heat/NN ,/, could/MD result/VB in/IN a/DT significant/JJ overestimation/NN of/IN regional/JJ cerebral/JJ blood/NN flow/NN (/( rCBF/NN )/SYM for/IN a/DT xenon/NN //NN CT/NN rCBF/NN protocol/NN involving/VBG 5-7/CD sequential/JJ scans/NNS obtained/VBN at/IN 1-min/JJ interscan/NN intervals/NNS ./.
@@94468151756 In/NN addition/NN ,/, negatively/RB regulatory/JJ region/NN may/MD exist/VB from/IN -1782/CD to/IN -1295/CD bp/CD ./CD
@@81395621281 In/NN this/DT report/NN ,/, we/PRP present/VBP two/JJ lines/NNS of/IN evidence/NN that/IN all/DT ribosomes/NNS which/WDT synthesize/VBP GCN4/NEWGENE have/VBP previously/RB translated/VBN uORF1/NEWGENE ,/, resumed/VBN scanning/JJ ,/, and/CC reinitiated/VBN at/IN the/PDT GCN4/NEWGENE start/NN site/NN ./.
@@7414761591 A/DT 36/CD year-old/JJ woman/NN was/VBD given/VBP Ergotamine/NN Tartrate/NN 4/NN ./NN 5/NN mg/NN p/CD ./CD d/CD ./. during/IN seven/JJ days/NNS ,/, after/IN an/DT abortion/NN (/( a/DT still/JJ birth/NN )/SYM ./.
@@112923976276 An/DT economic/JJ analysis/NN using/VBG West/NN of/IN Scotland/NNP Coronary/NNP Prevention/NNP Study/NNP (/( WOSCOPS/NNP )/SYM findings/NNS indicates/VBZ that/DT statin/NN treatment/NN would/MD have/VB prevented/VBN 318/CD events/NNS per/IN 10/CD ,/CD 000/CD patients/NNS in/IN a/DT population/NN similar/JJ to/IN that/DT in/NNP WOSCOPS/NNP (/( average/JJ 1/CD ./CD 5%/CD annual/JJ risk/NN of/IN a/DT cardiovascular/JJ event/NN )/SYM at/IN a/DT discounted/VBN cost/NN per/IN life-year/NN gained/VBN of/IN pound20/NN ,/NN 375/NN (/( $31/CD ,/CD 818/CD )/SYM ./.
@@114562591330 The/DT titer/NN of/IN TSH/NEWGENE binding/NEWGENE inhibitor/NEWGENE immunoglobulin/NEWGENE (/( TBII/NEWGENE )/SYM ,/, which/WDT had/VBP been/VBN 8/CD ./CD 6%/CD at/IN initial/JJ presentation/NN ,/, rose/VBD to/IN 14/CD ./CD 9%/CD in/IN 2/CD weeks/NNS ./.
@@104007747860 Y/NNP ./NNP
@@95331099492 A/DT possible/JJ decrease/NN in/IN theophylline's/NNS volume/NN of/IN distribution/NN at/IN 4/CD days/NNS ,/, but/CC not/RB immediately/RB ,/, after/IN administration/NN of/IN chloroquine/NN was/VBD suggested/VBN ,/, although/IN this/DT just/RB failed/VBN to/IN achieve/VB statistical/JJ significance/NN (/( p/NN =/SYM 0/CD ./CD 055/CD )/SYM ./.
@@40855894772 There/EX was/VBD no/DT correlation/NN between/IN secretor/NN status/NN and/CC clinical/JJ status/NN ,/, spirometry/NN measurements/NNS ,/, salivary/NEWGENE and/NEWGENE serum/NEWGENE lysozyme/NEWGENE levels/NNS or/CC rates/NNS of/IN respiratory/JJ tract/NN colonization/NN with/IN P/NNP ./NNP aeruginosa/NN and/CC S/NNP ./NNP aureus/NN ./.
@@60988288685 The/DT results/NNS presented/VBN in/IN this/DT report/NN suggest/VB that/IN the/DT SV40/NN G-C-rich/NN sequences/NNS can/MD function/VB as/IN independent/NN RNA/NEWGENE polymerase/NEWGENE II/NEWGENE transcriptional-control/NN elements/NN ./.
@@91571001361 To/TO determine/VB if/IN signing/NN ,/, when/CC established/VBD ,/, would/MD compete/VB with/IN SIB/NN when/CC both/DT were/VBD reinforced/VBN ,/, extinction/NN was/VBD then/RB withdrawn/VBP ./.
@@13310603522 The/DT structure/NN of/IN the/DT calcineurin/NEWGENE A/NEWGENE gene/NEWGENE was/VBD determined/VBN by/IN comparison/NN of/IN the/DT genomic/JJ and/CC cDNA/NN sequences/NNS ./.
@@13173764558 Fructokinase/NEWGENE activity/NN is/VBZ elevated/VBN up/JJ to/IN twofold/RB when/CC Z/NNP ./NNP mobilis/NN was/VBD grown/VBP on/IN fructose/NN instead/RB of/IN glucose/NN ,/, and/CC there/RB was/VBD a/DT parallel/JJ increase/NN in/IN frk/NEWGENE mRNA/NEWGENE levels/NNS ./.
@@17974592409 Mycoplasma/NN pneumoniae/NNS was/VBD isolated/VBN from/IN the/DT pleural/JJ fluid/NN of/IN this/DT patient/NN ./.
@@82885963619 We/PRP found/VBP that/DT T3/NEWGENE (/( 10/NN (/NN -8/NN )/SYM M/NN )/NN selectively/RB stimulates/VBZ transcription/NN from/IN rGH-TRE-/JJ and/CC TREpal-/NNP ,/, but/CC not/RB ME-TRE-/NNP and/CC F2-TRE-/NNP ,/, containing/JJ templates/NNS in/IN which/WDT these/DT TREs/NNS are/VBP linked/JJ in/IN front/NN of/IN the/DT rGH/NEWGENE minimal/NEWGENE promoter/NEWGENE containing/JJ only/RB the/DT TATA/NEWGENE box/NEWGENE binding/NEWGENE protein/NEWGENE ,/, but/CC not/RB any/DT other/DT proximal/JJ binding/JJ protein/NN ,/, sequence/NN ./.
@@4505597795 On/IN the/DT basis/NN of/IN a/DT patient's/VBZ report/NN of/IN one/PRP inaccurate/JJ Clinitemp/NN ,/, we/PRP undertook/VBD to/IN investigate/VB the/DT accuracy/NN of/IN this/DT thermometer/NN ./.
@@30368176011 Oligonucleotide-directed/JJ mutagenesis/NN was/VBD used/VBN to/IN create/VB an/DT NdeI/NEWGENE restriction/NEWGENE site/NEWGENE at/IN the/DT natural/JJ ATG/NN of/IN the/DT yeast/NN R/NNP ./NNP
@@81200192897 However/RB ,/, three/CD Hm1/NEWGENE mutants/NEWGENE that/WDT were/VBD moderately/RB deficient/JJ in/IN stimulating/NN PI/NN turnover/NN displayed/VBD normal/JJ sequestration/NN ,/, suggesting/VBG distinct/JJ mechanisms/NNS ./.
@@14285132053 Therefore/RB ,/, it/PRP would/MD be/VB advantageous/JJ to/IN identify/VB such/JJ persons/NNS and/CC treat/NN them/PRP preferentially/RB ./.
@@1004684944 Large/JJ scale/NN electronic/JJ structure/NN calculations/NNS ./.
@@78160496930 Southern/NNP blot/NN hybridization/NN experiments/NNS suggest/VBP the/DT presence/NN of/IN one/PRP copy/NN of/IN Atcys1/NEWGENE ,/, Athyp1/NEWGENE and/CC AKin10/NEWGENE per/IN haploid/JJ genome/NN ,/, and/CC Northern/NNP blot/NN analysis/NN demonstrates/VBZ that/IN the/DT three/CD genes/NNS are/VBP differentially/RB expressed/VBN in/IN roots/NNS ,/, shoots/NNS and/CC leaves/NNS ./.
@@38772984233 The/DT results/NNS obtained/VBN are/VBP similar/JJ to/IN those/DT described/VBN with/IN the/DT previous/JJ Cremophor/NN formulation/NN although/IN greater/JJR variability/NN in/IN induction/NN and/CC recovery/NN times/NNS was/VBD noted/VBN with/IN the/DT emulsion/NN formulation/NN ./.
@@91784942120 Indeed/RB the/DT predicted/VBN folding/NN of/IN the/DT 5'/CD and/CC 3'-untranslated/CD regions/NNS revealed/VBD patterns/NNS of/IN stem/NN and/CC loop/NN structures/NNS conserved/VBN for/IN all/DT tick-borne/JJ flaviviruses/NNS suggesting/VBG a/DT purifying/JJ selection/NN for/IN preservation/NN of/IN essential/JJ RNA/NN secondary/JJ structures/NNS which/WDT could/MD be/VB involved/VBN in/IN translational/JJ control/NN and/CC replication/NN ./.
@@91876379135 Taurine/DT deficiency/NN significantly/RB depressed/VBD the/DT amplitude/NN of/IN OP1/NN and/CC OP4/NN ./.
@@92942626927 The/DT promoter/NN region/NN showed/VBD no/DT consensus/NN TATA/NN box/NN but/CC it/PRP contains/VBZ CCAAT/NN and/CC CreA/NEWGENE boxes/NEWGENE known/VBP to/IN be/VB involved/VBN in/IN both/DT stress/NN and/CC carbon-catabolite/JJ regulation/NN of/IN fungal/JJ promoters/NNS ./.
@@7928475854 We/PRP remain/VBP convinced/VBN that/IN antilymphocyte/NEWGENE globulin/NEWGENE (/( ALG/NEWGENE )/SYM is/VBZ a/DT potent/JJ immunosuppressive/JJ agent/NN in/IN humans/NNS ./.
@@14313805561 According/VBG to/IN out/JJ field/NN research/NN ,/, the/DT tick/NN fauna/NN was/VBD very/RB rich/JJ throughout/IN that/DT area/NN ,/, and/CC it/PRP was/VBD permissible/JJ enough/RB to/IN determine/VB ticks/NNS as/IN the/DT vectors/NNS ,/, based/VBN on/IN arising/VBG of/IN anti-SF/NEWGENE group/NEWGENE rickettsiae/NEWGENE (/( SFGR/NEWGENE )/SYM antibody/NN in/IN mice/NNS inoculated/VBN with/IN some/DT tick/NN emulsions/NNS ,/, findings/NNS of/IN rickettsiae/NNS reactive/NN to/IN patient/NN sera/NNS or/CC a/DT species-specific/JJ monoclonal/JJ antibody/NN to/IN JSFR/NEWGENE in/IN the/DT hemolymph/NN cells/NNS of/IN some/DT ticks/NNS ,/, and/CC electron/NN microscopical/JJ observations/NNS of/IN SFGR/NEWGENE in/IN various/JJ internal/JJ organs/NNS including/JJ the/DT salivary/JJ gland/NN of/IN ticks/NNS ./.
@@110369382561 An/DT increase/NN in/IN hypothalamic/JJ expression/NN of/IN at/IN least/JJ two/NN of/IN the/DT erbB/NEWGENE receptors/NEWGENE is/VBZ initiated/VBN before/IN the/DT pubertal/JJ augmentation/NN of/IN gonadal/JJ steroid/JJ secretion/NN and/CC is/VBZ completed/VBN on/IN the/DT day/NN of/IN the/DT first/JJ preovulatory/JJ surge/NN of/IN gonadotropins/NEWGENE ./.
@@78561026750 These/DT data/NN indicate/VB that/DT phosphorylation/NN of/IN M/NEWGENE protein/NEWGENE at/IN the/DT major/NN in/IN vivo/NN sites/NN is/VBZ not/RB essential/JJ for/IN virus/NN assembly/NN ./.
@@31786263865 Aviators/NNS from/IN the/DT Light/NNP Attack/NNP Wing/NNP ,/, Pacific/JJ were/VBD surveyed/VBN and/CC the/DT results/NNS were/VBD categorized/VBN by/IN aircraft/NN type/NN ./.
@@76918853476 Identification/NNP of/IN mutations/NNS in/IN the/DT coding/JJ sequence/NN of/IN the/DT proto-oncogene/NEWGENE c-kit/NEWGENE in/IN a/DT human/JJ mast/NN cell/NN leukemia/NN cell/NN line/NN causing/JJ ligand-independent/JJ activation/NN of/IN c-kit/NEWGENE product/NEWGENE ./.
@@21982594060 Deletion/NNS from/IN either/DT the/PDT N-/DT or/CC C-terminal/NN ends/NNS of/IN repA/NEWGENE (/( 28/CD and/CC 69/CD codons/NNS ,/, respectively/RB ,/, out/RB of/IN the/DT 286-codon/JJ open/JJ reading/JJ frame/NN )/SYM affected/VBN the/DT initiator/NN but/CC not/RB the/DT inhibitory/JJ activity/NN ./.
@@10684286562 73/CD :/: 658-666/JJ ,/, 1999/NN )/NN ./.
@@113803701219 A/DT patient/NN is/VBZ described/VBN with/IN skin/NN lesions/NNS resembling/VBG Kaposi's/NNP sarcoma/NN (/( KS/NN )/SYM ./.
@@94479794116 Such/JJ mutations/NNS are/VBP thought/VBP to/IN exert/VB their/PRP dominant/JJ phenotype/NN by/IN sequestration/NN of/IN the/DT guanine/NEWGENE nucleotide/NEWGENE exchange/NEWGENE factor/NEWGENE (/( GNEF/NEWGENE )/SYM ./.
@@93512427692 Induction/NNS of/IN AtP5CS1/NEWGENE mRNA/NEWGENE accumulation/NN in/IN salt-treated/JJ seedlings/NNS involves/VBZ an/DT immediate/JJ early/JJ transcriptional/JJ response/NN regulated/VBN by/IN ABA/NEWGENE signalling/JJ that/WDT is/VBZ not/RB inhibited/VBN by/IN cycloheximide/NN ,/, but/CC abolished/VBD by/IN the/DT deficiency/NN of/IN ABA/NEWGENE biosynthesis/NN in/IN the/DT aba1/NEWGENE Arabidopsis/NEWGENE mutant/NEWGENE ./.
@@113121201082 NF-kappaB/NEWGENE pathway/NN activation/NN occurs/VBZ during/IN transformation/NN induced/VBN by/IN a/DT number/NN of/IN classical/JJ oncogenes/NNS ,/, including/JJ Bcr/NEWGENE //NEWGENE Abl/NEWGENE ,/, Ras/NEWGENE and/CC Rac/NEWGENE ,/, and/CC is/VBZ necessary/JJ for/IN full/JJ transforming/JJ potential/NN ./.
@@91186643059 L-canavanine/NNP ,/, a/DT selective/JJ inhibitor/NN of/IN the/DT inducible/JJ nitric/NEWGENE oxide/NEWGENE synthase/NEWGENE ,/, increases/VBZ the/DT mean/JJ systemic/JJ filling/JJ pressure/NN ,/, thereby/RB improving/JJ venous/JJ return/NN ,/, under/IN these/DT conditions/NNS ./.
@@10438607519 One/CD of/IN these/DT SEBPs/NEWGENE ,/, SEBP2/NEWGENE ,/, was/VBD shown/VBP to/IN be/VB the/DT product/NN of/IN the/DT homeotic/NEWGENE gene/NEWGENE fork/NEWGENE1 head/NEWGENE1 ./.
@@86228874073 Electrophoretic/JJ mobility/NN shift/NN assays/NNS (/( EMSAs/NNS )/SYM using/VBG purified/VBN glucocorticoid/NEWGENE receptor/NEWGENE DNA/NEWGENE binding/NEWGENE domain/NEWGENE (/( DBD/NN )/SYM demonstrated/VBN that/IN both/DT GRE-2/NEWGENE and/NEWGENE -3/NEWGENE motifs/NEWGENE interact/VBP with/IN DBD/NN and/CC oligonucleotide/NN competition/NN experiments/NNS established/VBN that/IN these/DT have/JJ different/JJ affinities/NNS for/IN DBD/NN ./.
@@112641826330 Human/NEWGENE T-cell/NEWGENE leukemia/NEWGENE virus/NEWGENE type/NEWGENE I/NEWGENE (/NEWGENE HTLV-I/NEWGENE )/NEWGENE Tax/NEWGENE is/VBZ a/DT potent/JJ transcriptional/NN regulator/NN that/WDT can/MD activate/VB or/CC repress/VB specific/JJ cellular/JJ genes/NNS and/CC that/DT has/VBZ been/VBN proposed/VBN to/IN contribute/VB to/IN leukemogenesis/NN in/IN adult/JJ T-cell/NN leukemia/NN ./.
@@28251395560 The/DT major/RB inserted/VBN DNA/NN has/VBZ no/DT significant/JJ homology/NN to/IN published/VBN human/JJ nucleic/JJ acid/NN sequences/NNS ./.
@@10668701479 CONCLUSION/IN :/: Presence/NNP of/IN APOE/NEWGENE epsilon4/NEWGENE //NEWGENE */NEWGENE seems/VBZ to/IN increase/NN the/DT risk/NN for/IN dementia/NN and/CC AD/NN independently/RB of/IN its/PRP effect/NN on/IN dyslipidemia/NN and/CC atherogenesis/NN ./.
@@51201975377 Experimental/JJ pancreatitis/NN in/IN pigs/NNS ./.
@@29910604567 These/DT IgG/NEWGENE antibodies/NEWGENE in/IN the/DT babies/NNS diminished/VBN rapidly/RB after/IN delivery/NN ,/, and/CC were/VBD detectable/JJ only/RB in/IN 3/CD cases/NNS at/IN 2/CD ,/, 3/CD ,/, and/CC 5/CD months/NNS of/IN ages/NNS out/RB of/IN 38/CD babies/NNS up/JJ to/IN 21/CD months/NNS ./.
@@79314902162 PATIENTS/IN AND/CC METHODS/IN :/: One/CD hundred/JJ eighty-four/CD chemotherapy-naive/JJ patients/NNS receiving/JJ high-dose/JJ cisplatin/NN (/( 81/CD to/IN 120/CD mg/NN //NN m2/NN )/SYM were/VBD randomized/JJ to/IN receive/VB one/PRP of/IN four/CD granisetron/NN doses/NNS (/( 5/CD ,/, 10/CD ,/, 20/CD ,/, or/CC 40/CD micrograms/NN //NN kg/NN )/SYM administered/VBN before/IN chemotherapy/NN ./.
@@83257209211 The/DT O2/NN deficit/NN was/VBD not/RB related/VBN to/IN blood/NN lactate/NN during/IN submaximal/JJ exercise/NN ,/, muscle/NN enzyme/NN activity/NN (/( citrate/NEWGENE synthase/NEWGENE ,/, 3-hydroxyacyl-CoA-dehydrogenase/NEWGENE ,/, lactate/NEWGENE dehydrogenase/NEWGENE )/SYM ,/, number/NN of/IN muscle/NN capillaries/NNS ,/, %ST/NN fibres/NNS or/CC muscle/NN buffer/NN capacity/NN ./.
@@117048298085 Subtraction/NNS hybridization/NN identified/VBD melanoma/NEWGENE differentiation/NEWGENE associated/NEWGENE gene-7/NEWGENE (/( mda-7/NEWGENE )/SYM ,/, as/IN a/DT gene/NN induced/VBN during/IN these/DT physiological/JJ changes/NNS in/IN human/JJ melanoma/NN cells/NNS ./.
@@86821558662 The/DT euglobulin/NN clot/NN lysis/NN time/NN was/VBD slightly/RB longer/JJR in/IN the/DT smokers/NNS than/IN in/IN the/DT non-smokers/NNS in/IN all/DT three/CD experimental/JJ situations/NNS ,/, but/CC the/DT differences/NNS were/VBD not/RB significant/JJ ./.
@@27892175492 The/DT two/JJ IL6/NEWGENE mRNA/NEWGENE species/NN are/VBP generated/VBN by/IN alternative/JJ polyadenylation/NN at/IN sites/NNS separated/VBN by/IN a/DT distance/NN of/IN 1/CD ./CD 2/CD kilobases/NNS ./.
@@113601909752 We/PRP previously/RB reported/VBD that/IN Tax/NEWGENE induced/VBD cell/NN cycle/NN progression/NN from/IN G0/NN //NN G1/NN phase/NN to/IN S/NNP and/CC G2/NN //NN M/NN phases/NNS in/IN human/JJ T-cell/NN line/NN Kit/NNS 225/CD cells/NNS ./.
@@10690866504 The/DT variations/NNS were/VBD caused/VBN by/IN opposite/NN shifts/NNS in/IN TSH/NEWGENE frequency/NN distribution/NN in/IN mothers/NNS and/CC neonates/NNS ./.
@@15795379796 In/NN the/DT last/NN 20/CD years/NNS ,/, the/DT therapeutic/JJ uses/NNS of/IN botulinum/NEWGENE toxin/NEWGENE ,/, a/DT potent/JJ neurotoxin/NN ,/, have/VB been/VBN investigated/VBN ./.
@@7588608152 Obstruction/NNS of/IN the/DT ERF/NEWGENE repressor/NEWGENE function/NN by/IN the/DT transactivating/JJ members/NNS of/IN the/DT ets/NEWGENE family/NEWGENE of/IN genes/NNS (/( i/NNS ./NNS e/NNS ./NNS gag-myb-ets/NNS )/SYM may/MD be/VB essential/JJ for/IN the/DT control/NN of/IN genes/NNS involved/VBN in/IN cell/NN proliferation/NN and/CC may/MD also/RB underlie/VB their/PRP tumorigenic/JJ effects/NNS ./.
@@79576321380 Intraventricular/JJ injection/NN of/IN (/( 2S/CD ,/CD 1'R/CD ,/CD 2'R/CD ,/CD 3'R/CD )/NN -2-/NN (/NN 2/NN ,/NN 3-dicarboxycyclopropyl/NN )/NN glycine/NN (/( DCG-IV/NNP )/SYM ,/, a/DT potent/JJ agonist/NN for/IN metabotropic/JJ glutamate/NEWGENE receptors/NEWGENE ,/, to/IN rats/NNS retarded/VBN dose-dependently/VBD the/DT recovery/NN from/IN halothane/NN anesthesia/NN at/IN a/DT dose/NN range/NN from/IN 30/CD to/IN 300/CD pmol/NN //NN rat/NN ./.
@@16562354325 The/DT single/JJ most/RB important/JJ element/NN ,/, by/IN linker-scanning/JJ analysis/NN ,/, is/VBZ a/DT 10-bp/JJ region/NN that/WDT contains/VBZ a/DT CCAAT/NN motif/NN ./.
@@26447355634 An/DT FP/NEWGENE mutant/NEWGENE ,/, AcFP875-2/NEWGENE ,/, had/VBP a/DT 1/CD ./CD 6-kbp/CD insertion/NN of/IN S/NNP ./NNP frugiperda/NN DNA/NN near/IN the/DT 5'/CD end/NN of/IN these/DT transcripts/NNS which/WDT by/IN S1/NN analysis/NN were/VBD shown/VBP to/IN initiate/NN within/IN the/DT host/NN cell/NN sequence/NN ./.
@@79011259279 We/PRP took/VBD advantage/NN of/IN the/DT high/JJ degree/NN of/IN aa/NNS sequence/NN homology/NN between/IN DAHPSs/NEWGENE from/IN several/DT species/NN to/IN isolate/NN ARO3/NEWGENE homologues/NEWGENE from/IN the/DT pathogenic/JJ yeast/NN Candida/NN albicans/JJ ./.
@@92028593603 The/DT serum/JJ levels/NNS of/IN beta-human/NEWGENE chorionic/NEWGENE gonadotropin/NEWGENE (/( HCG/NEWGENE )/SYM and/CC placental/NEWGENE alkaline/NEWGENE phosphatase/NEWGENE (/( PLAP/NEWGENE )/SYM were/VBD not/RB elevated/VBN ./.
@@29109896715 Effects/NNPS of/IN aging/NN and/CC beta-adrenergic-blockade/JJ on/IN standing-induced/NN QT/NN //NN QS2/NN changes/NNS ./.
@@78859996801 Several/JJ nuclear/JJ factors/NNS that/WDT interact/VBP with/IN sequences/NNS in/IN the/DT 5'/CD flanking/JJ region/NN of/IN the/DT mouse/NEWGENE tyrosinase/NEWGENE gene/NEWGENE were/VBD identified/VBN using/VBG band/NN shift/NN and/CC methylation/NN interference/NN assays/NNS ./.
@@86214208306 Only/RB one/PRP of/IN these/DT bands/NNS was/VBD supershifted/VBN by/IN antibody/NN to/IN p50/NEWGENE ,/, whereas/IN antibodies/NNS to/IN p65/NEWGENE or/CC other/DT NF-kappaB/NEWGENE proteins/NEWGENE had/VBP no/DT effect/NN ./.
@@92295959184 All/DT corneal/JJ buttons/NNS were/VBD processed/VBN for/IN histopathologic/JJ and/CC electron/NN microscopic/JJ studies/NNS ./.
@@105363697293 In/NN gel/NN mobility/NN shift/NN assays/NNS ,/, we/PRP found/VBP no/DT evidence/NN for/IN VDR-TR/NEWGENE heterodimer/NEWGENE interaction/NN with/IN any/DT tested/VBN element/NN ./.
@@66556346398 A/DT combined/JJ series/NN of/IN patients/NNS experienced/VBD a/DT TOL/NN after/IN two/JJ or/CC more/RB previous/JJ cesarean/JJ deliveries/NNS ;/: the/DT rate/NN of/IN vaginal/JJ delivery/NN was/VBD 66%/JJ ,/, and/CC there/RB was/VBD virtually/RB no/DT morbidity/NN ./.
@@12922301932 The/DT two/JJ drugs/NNS increase/NN the/DT rate/NN of/IN early/JJ diastolic/JJ filling/NN ./.
@@91993184844 Furthermore/RB ,/, p150/NEWGENE suppresses/VBZ actin/NEWGENE gelation/NN ,/, which/WDT is/VBZ induced/VBN by/IN smooth/NEWGENE muscle/NEWGENE alpha-actinin/NEWGENE ./.
@@96408028247 3--It/NN is/VBZ necessary/JJ to/IN think/NN about/RB cosmetic/JJ consequences/NNS of/IN the/DT chinese/NN flap/NN and/CC consider/VB other/DT possibilities/NNS of/IN the/DT flap/NN choice/JJ ./.
@@10722063546 The/DT HPLC/NN method/NN involves/VBZ an/DT octadecylsilane/NN column/NN at/IN 55/CD degrees/NNS C/NN ,/, a/DT mixture/NN of/IN water-acetonitrile-orthophosphoric/JJ acid/NN (/( 779/CD :/: 220/CD :/: 1/CD ,/, v/NN //NN v/NN )/SYM as/IN mobile/JJ phase/NN and/CC detection/NN at/IN 226/CD nm/NN ./NN
@@81063138190 The/DT results/NNS indicate/VBP that/IN hrpRS/NEWGENE and/CC hrpL/NEWGENE are/VBP part/NN of/IN a/DT regulatory/JJ cascade/NN in/IN which/WDT HrpR/NEWGENE and/CC HrpS/NEWGENE activate/VB expression/NN of/IN hrpL/NEWGENE and/CC HrpL/NEWGENE ,/, a/DT putative/JJ sigma/NEWGENE factor/NEWGENE ,/, induces/VBZ expression/NN of/IN HrpL-responsive/NEWGENE genes/NEWGENE ./.
@@94276273445 In/NN Xenopus/JJ embryos/NNS ,/, the/DT engineered/NEWGENE PDGF/NEWGENE receptor/NEWGENE protein/NEWGENE induced/VBD the/DT formation/NN of/IN mesoderm/NN from/IN animal-pole/JJ explants/NNS in/IN an/DT FK1012-dependent/NNP manner/NN ./.
@@103756384177 Mutations/NNS within/IN human/NN UTR1/NN modulate/NN NRF-1/NEWGENE expression/NN by/IN interfering/JJ with/IN mRNA/NN translational/JJ efficiency/NN in/IN transfected/VBN cells/NNS and/CC in/IN an/DT in/NN vitro/FW translation/NN system/NN ./.
@@91152421373 In/NN particular/JJ ,/, Western/JJ ,/, supershift/NN ,/, and/CC promoter/NN deletion/NN analyses/NNS suggested/VBD a/DT role/NN for/IN CCAAT/NEWGENE //NEWGENE enhancer-binding/NEWGENE protein-beta/NEWGENE (/( C/NEWGENE //NEWGENE EBP-beta/NEWGENE )/SYM binding/JJ site/NN between/IN -2010/JJ and/CC -1954/CD in/IN regulating/JJ transcription/NN of/IN collagenase-1/NEWGENE in/IN monocytic/JJ cells/NNS ./.
@@10905349687 Mus81p/NEWGENE also/RB shares/VBP homology/NN with/IN motifs/NNS found/VBP in/IN the/DT XPF/NEWGENE endonuclease/NEWGENE superfamily/NEWGENE ./.
@@16266312218 In/NN the/DT Rett/NNP syndrome/NN we/PRP ,/, therefore/RB ,/, suspect/VB there/RB are/VBP disturbances/NNS in/IN the/DT brain/NN stem/NN functions/NNS especially/RB in/IN the/DT ascending/JJ reticular/JJ activating/JJ system/NN which/WDT is/VBZ related/VBN to/IN elevation/NN of/IN the/DT conscious/JJ level/NN ./.
@@30017053192 Multistep/NN transformation/NN by/IN defined/JJ fragments/NNS of/IN herpes/NEWGENE simplex/NEWGENE virus/NEWGENE type/NEWGENE 2/NEWGENE DNA/NEWGENE :/NEWGENE oncogenic/NEWGENE region/NEWGENE and/CC its/PRP gene/NN product/NN ./.
@@20383264814 The/DT gcd2-503/NEWGENE mutation/NN also/RB results/VBZ in/IN polysome/NN runoff/NN ,/, accumulation/NN of/IN inactive/JJ 80S/NEWGENE ribosomal/NEWGENE couples/NEWGENE ,/, and/CC accumulation/NN of/IN at/IN least/RB one/PRP of/IN the/DT subunits/NNS of/IN the/DT general/NEWGENE translation/NEWGENE initiation/NEWGENE factor/NEWGENE 2/NEWGENE (/( eIF-2/NEWGENE alpha/NEWGENE )/SYM in/IN 43S-48S/NEWGENE particles/NEWGENE following/IN a/DT shift/NN to/IN the/DT restrictive/JJ temperature/NN ./.
@@910802991 Similarly/RB ,/, the/DT DNA-binding/NN activity/NN of/IN activator/NEWGENE protein/NEWGENE 1/NEWGENE (/( AP-1/NEWGENE )/SYM is/VBZ modified/JJ by/IN a/DT DNA/NEWGENE repair/NEWGENE enzyme/NEWGENE ,/, redox/NEWGENE factor/NEWGENE 1/NEWGENE (/( Ref-1/NEWGENE )/SYM ,/, which/WDT is/VBZ identical/JJ to/IN a/DT DNA/NEWGENE repair/NEWGENE enzyme/NEWGENE ,/, AP/NEWGENE endonuclease/NEWGENE ./.
@@92256869178 Stereotactic/JJ radiofrequency/NN lesioning/VBG of/IN the/DT hamartoma/NN resulted/VBN in/IN seizure/NN remission/NN without/IN complications/NNS 20/CD months/NNS after/IN surgery/NN ./.
@@25144988422 Gastric/NNP CO2/NN //NN HCO3/NN was/VBD determined/VBN in/IN absence/NN of/IN simultaneous/JJ inhibition/NN of/IN acid/NN secretion/NN by/IN intra-/JJ and/CC extragastric/JJ pCO2/NN //NN pH/NN measurements/NNS in/IN 23/CD persons/NNS and/CC calculated/VBN using/VBG the/DT equation/NN of/IN Henderson-Hasselbalch/NNP ./. pCO2/NN was/VBD measured/VBN with/IN use/NN of/IN a/DT new/JJ electrode/NN ./.
@@89697779710 The/DT microdensitometric/JJ scores/NNS and/CC their/PRP side-to-side/JJ differences/NNS in/IN patients/NNS correlated/VBN negatively/RB with/IN the/DT serum/JJ 25-OHD/JJ concentration/NN and/CC positively/RB with/IN the/DT degree/NN of/IN paralysis/NN ./.
@@24694511012 The/DT investigation/NN was/VBD thereafter/RB continued/VBN in/IN an/DT open/JJ fashion/NN by/IN administering/JJ a/DT single/NN 10/NN mg/NN dose/NN of/IN the/DT MAO-B/NEWGENE inhibitor/NN deprenyl/NN to/IN the/DT same/JJ subjects/NNS ./.
@@105043324208 Immunofluoresence/NNP data/NN indicated/VBN that/IN once/CC bound/JJ to/IN the/DT mutant/JJ receptor/NN ,/, fluorescent-labeled/JJ RAP/NEWGENE co-localized/JJ with/IN markers/NNS of/IN the/DT endosomal/JJ pathway/NN ,/, whereas/IN ,/, in/IN cells/NNS expressing/JJ the/DT wild-type/NN receptor/NN ,/, RAP/NEWGENE fluorescence/NN co-localized/JJ with/IN lysosomal/NN markers/NN ./.
@@31324988677 In/NN 14/CD patients/NNS whose/WP PaCO2/NN was/VBD greater/JJR than/IN or/CC equal/NN to/IN 39/CD torr/NN (/( range/NN 39/CD to/IN 58/CD torr/NN )/SYM and/CC clinical/JJ asthma/NN score/NN was/VBD 6/CD or/CC greater/JJR ,/, PaCO2/NN decreased/VBN a/DT mean/NN of/IN 11/CD ./CD 7/CD torr/NN during/IN a/DT mean/NN of/IN 8/CD ./CD 1/CD hours/NNS ./.
@@97840633006 Deletion/NNS analysis/NN revealed/VBN that/IN the/DT essential/JJ domain/NN of/IN this/DT promoter/NN ,/, termed/VBD the/DT ORF5/NEWGENE //NEWGENE deltaX/NEWGENE transcript/NEWGENE promoter/NEWGENE ,/, mapped/VBN to/IN nucleotides/NNS 1525-1625/JJ ./.
@@53638165504 The/DT need/NN for/IN including/JJ forensic/JJ medical/JJ expertise/NN in/IN the/DT list/NN of/IN urgent/JJ criminal/JJ investigative/JJ actions/NNS ./.
@@8864061775 Expression/NNS of/IN thymidine/NEWGENE kinase/NEWGENE gene/NEWGENE in/IN normal/JJ human/JJ diploid/JJ cells/NNS is/VBZ both/DT cell/NN cycle-/NN and/CC age-dependent/NN and/CC appears/VBZ to/IN be/VB transcriptionally/RB regulated/VBN ./.
@@86658537517 By/IN using/VBG interleukin-3-dependent/JJ cells/NNS that/WDT ectopically/RB express/VB the/DT three/CD ErbB/NEWGENE proteins/NEWGENE or/CC their/PRP combinations/NNS ,/, we/PRP found/VBP that/IN ErbB-3/NEWGENE is/VBZ devoid/JJ of/IN any/DT biological/JJ activity/NN but/CC both/DT ErbB-1/NEWGENE and/CC ErbB-2/NEWGENE can/MD reconstitute/VB its/PRP extremely/RB potent/JJ mitogenic/JJ activity/NN ./.
@@97457979726 This/DT suggests/VBZ that/IN while/CC underpredictions/NNS of/IN pain/NN do/NN not/RB hurt/VB more/RB ,/, disruption/NN on/IN primary/JJ tasks/NNS and/CC physiological/JJ impact/NN are/VBP higher/JJ ./.
@@80660948049 Marine/NNP oils/NNS and/CC cardiovascular/JJ reactivity/NN ./.
@@26887723357 Psychiatry/NNP and/CC the/DT skin/NN ./.
@@110545717448 The/DT entire/JJ human/NEWGENE teneurin-1/NEWGENE (/( TEN1/NEWGENE )/SYM gene/NN is/VBZ contained/VBN in/IN eight/CD PAC/NN clones/NNS representing/VBG part/NN of/IN the/DT chromosomal/NN locus/NN Xq25/NN ./.
@@18119488907 In/NN the/DT present/NN study/NN ,/, we/PRP identified/VBD a/DT strong/JJ positive/JJ cis-regulatory/NN element/NN at/IN -70/NN bp/NN to/IN -75/CD bp/NN in/IN the/DT LpS1/NEWGENE beta/NEWGENE promoter/NEWGENE with/IN the/DT sequence/NN (/( G/NN )/NN 6/NN and/CC a/DT similar/JJ ,/, more/RB distal/JJ cis-element/NN at/IN -721/NN bp/NN to/IN -726/JJ bp/CD ./CD
@@89897638945 Several/JJ artifacts/NNS occurred/VBN that/WDT interfered/VBD with/IN visualization/NN of/IN the/DT diaphragm/NN ./.
@@10355910219 Developmental/NN follow-up/JJ at/IN age/NN 2/CD years/NNS was/VBD performed/VBN ./.
@@89334878890 On/IN the/DT third/JJ occasion/NN water/NN (/( W/NN )/SYM was/VBD ingested/VBN throughout/IN the/DT run/NN ./.
@@13101785680 The/DT JS78/NN mutation/NN changes/NNS Gln243/NNP in/IN gp0/CD ./CD 7/CD to/IN an/DT amber/JJ codon/NN ,/, which/WDT explains/VBZ the/DT production/NN of/IN the/DT truncated/JJ ,/, 30-kDa/NEWGENE gp0/NEWGENE ./NEWGENE 7-related/NEWGENE polypeptide/NEWGENE ,/, and/CC implicates/VBZ the/DT 11-kDa/JJ C-terminal/NN domain/NN in/IN host/NN transcription/NN shut-off/JJ ./.
@@112784003493 Both/DT pancreatic/JJ and/CC intestinal/JJ cell/NN lines/NNS were/VBD found/VBN to/IN express/NN a/DT number/NN of/IN POU/NEWGENE (/( OCT/NN binding/JJ )/SYM homeodomain/NEWGENE proteins/NEWGENE examined/VBN by/IN electrophoretic/JJ mobility/NN shift/NN assay/NN ./.
@@88173242632 Sequencing/NN of/IN the/DT 16p/CD 11/NN ./NN 1/NN //NN Xq28/NN duplication/NN breakpoints/NNS has/VBZ revealed/VBN the/DT presence/NN of/IN repetitive/JJ immunoglobulin-like/NEWGENE CAGGG/NEWGENE pentamer/NEWGENE sequences/NEWGENE at/IN or/CC near/IN the/DT paralogy/JJ boundaries/NNS ./.
@@93694505431 Thus/RB ,/, the/DT synergistic/JJ effects/NNS of/IN HNF-1beta/NEWGENE and/CC the/DT GR/NEWGENE on/IN dexamethasone-stimulated/JJ promoter/NN activity/NN require/VB that/IN they/PRP are/VBP bound/JJ to/IN the/DT HNF-1/NEWGENE site/NEWGENE and/CC the/DT GRE/NEWGENE ,/, respectively/RB ,/, and/CC may/MD involve/VB protein-protein/JJ interactions/NNS between/IN the/DT transcription/NN factors/NNS ,/, or/CC between/IN them/PRP and/CC the/DT basal/JJ transcription/NN machinery/NN or/CC a/DT steroid/NEWGENE receptor/NEWGENE coactivator/NEWGENE ./.
@@8793295133 In/NN the/DT control/NN preparation/NN before/IN weight/NN was/VBD allowed/VBN to/IN increase/NN ,/, isogravimetric/JJ capillary/JJ pressure/NN (/( Pci/NNS )/SYM averaged/VBN 8/CD mmHg/NN lower/JJR than/IN colloid/NN osmotic/JJ pressure/NN of/IN the/DT plasma/NN (/( IIp/NN )/SYM ./.
@@6099656152 Construction/NN of/IN human/JJ cell/NN lines/NNS which/WDT contain/VBP and/CC express/VB the/DT adenovirus/NEWGENE DNA/NEWGENE binding/NEWGENE protein/NEWGENE gene/NEWGENE by/IN cotransformation/NN with/IN the/DT HSV-1/NEWGENE tk/NEWGENE gene/NEWGENE ./.
@@22692811344 The/DT occurrence/NN ,/, maintenance/NN and/CC possible/JJ involvement/NN of/IN these/DT repeated/JJ sequences/NNS ,/, capable/JJ of/IN forming/JJ stable/JJ secondary/JJ structures/NNS ,/, are/VBP discussed/VBN in/IN relation/NN to/IN their/PRP location/NN in/IN the/DT region/NN of/IN control/NN signals/NNS ./.
@@114356882612 This/DT subfamily/NN of/IN genes/NNS all/DT have/NN a/DT single/JJ ATP-binding/JJ domain/NN at/IN the/DT N-terminus/NN and/CC a/DT single/JJ C-terminal/NN set/NN of/IN transmembrane/JJ segments/NNS ./.
@@23241049446 Approximately/RB 65%/VBP of/IN the/DT total/JJ cAMP-dependent/NEWGENE phosphotransferase/NEWGENE activity/NN is/VBZ recovered/VBN in/IN particulate/JJ fractions/NNS of/IN homogenates/NNS prepared/VBN from/IN asynchronous/JJ populations/NNS of/IN C/NNP ./NNP elegans/NNS ./.
@@98059779776 The/DT various/JJ available/JJ data/NN strongly/RB suggesting/VBG an/DT environmental/JJ toxic/JJ origin/NN for/IN the/DT "sperm/NN fall"/NN will/MD be/VB presented/VBN as/RB well/VB as/IN the/DT most/RB frequently/RB suspected/VBN class/NN of/IN substances/NNS ,/, the/DT xenoestrogens/NNS ./.
@@82768517928 The/DT predicted/VBN Pay4p/NEWGENE sequence/NEWGENE contains/VBZ two/JJ putative/JJ ATP-binding/NN domains/NN and/CC shows/VBZ structural/JJ relationships/NNS to/IN other/DT potential/JJ ATP-binding/NN proteins/NN involved/VBN in/IN biological/JJ processes/NNS as/RB diverse/JJ as/IN peroxisome/NN biogenesis/NN ,/, vesicle-mediated/JJ protein/NN transport/NN ,/, cell/NN cycle/NN control/NN ,/, and/CC transcriptional/JJ regulation/NN ./.
@@115605091053 DNA/NN recognition/NN by/IN F/NEWGENE factor/NEWGENE TraI36/NEWGENE1 :/: highly/RB sequence-specific/JJ binding/NN of/IN single-stranded/JJ DNA/NN ./.
@@61812164957 We/PRP have/VBP followed/VBN 37/CD phenytoin-treated/JJ patients/NNS with/IN reduced/VBN serum/NEWGENE IgA/NEWGENE concentrations/NNS for/IN 2-7/JJ years/NNS ./.
@@10918440739 Erythema/NNS exsudativum/NN multiforme/NN induced/VBN by/IN granulocyte/NEWGENE colony-stimulating/NEWGENE factor/NEWGENE in/IN an/DT allogeneic/JJ peripheral/JJ blood/NN stem/NN cell/NN donor/NN ./.
@@87639254158 The/DT expression/NN of/IN the/DT first/JJ two/JJ genes/NNS located/VBN in/IN this/DT unit/NN (/( c-gvpD/NEWGENE and/CC c-gvpE/NEWGENE )/SYM was/VBD also/RB monitored/VBN by/IN Western/JJ blot/NN (/( immunoblot/VB )/SYM analyses/NNS using/VBG antisera/NNS raised/VBN against/IN these/DT proteins/NNS synthesized/VBN in/IN Escherichia/NN coli/JJ ./.
@@85853247683 This/DT region/NN also/RB contains/VBZ a/DT gene/NN specifying/VBG a/DT Leu-tRNA/NEWGENE precursor/NEWGENE and/CC a/DT remnant/NN of/IN a/DT tau/NEWGENE element/NEWGENE ./.
@@20010332615 In/NN summary/NN ,/, at/IN equianesthetic/JJ concentrations/NNS ,/, desflurane/NN and/CC isoflurane/NN produced/VBD similar/JJ hemodynamic/JJ effects/NNS ;/: however/RB ,/, in/IN the/DT absence/NN of/IN drugs/NNS that/WDT inhibit/VBP autonomic/JJ reflexes/NNS ,/, desflurane/NN had/VBP less/PRP negative/JJ inotropic/JJ activity/NN and/CC produced/VBN less/PRP decrease/NN in/IN arterial/JJ pressure/NN ./.
@@108583554420 Sparfloxacin/NNP and/CC clinafloxacin/NN were/VBD evaluated/VBN against/IN Enterococcus/DT faecium/NN SF2149/NN and/CC Enterococcus/DT faecalis/NN WH245/NN ,/, respectively/RB ./.
@@17740625770 A/DT 330-kb/JJ YAC/NN ,/, A148A7/NNP ,/, spanned/VBN from/IN the/DT HLA-DQA1/NEWGENE locus/NEWGENE through/RB the/DT Y3/NEWGENE //NEWGENE Ring/NEWGENE 4/NEWGENE locus/NEWGENE and/CC extended/VBN at/IN least/RB 130/CD kb/NN centromeric/JJ of/IN YAC/NN B1D12/NN ./.
@@105168782423 Modification/NNS of/IN dopamine/NEWGENE D2/NEWGENE receptor/NEWGENE activity/NN by/IN pergolide/NN in/IN Parkinson's/NNP disease/NN :/: an/DT in/NN vivo/NN study/NN by/IN PET/NN ./.
@@71072876906 The/DT highest/JJS doses/NNS were/VBD found/VBN for/IN drivers/NNS who/WP transported/VBD large/JJ numbers/NNS of/IN 99Mo/CD generators/NNS ./.
@@95188084360 National/NNP certification/NN :/: a/DT vital/NN component/NN of/IN quality/NN assurance/NN ./.
@@67726121758 Effects/NNPS of/IN dopamine/NN and/CC of/IN a/DT dopaminergic/JJ blocker/NN ,/, haloperidol/NN ,/, on/IN the/DT responses/NNS of/IN carotid/JJ body/NN chemoreceptors/NN to/IN hypoxia/NN and/CC hypercapnia/NN were/VBD investigated/VBN in/IN 16/CD anesthetized/JJ cats/NNS ./.
@@12973329609 Mutational/JJ analysis/NN of/IN a/DT DNA/NN sequence/NN involved/VBN in/IN linking/NN gene/NN expression/NN to/IN the/DT cell/NN cycle/NN ./.
@@88124907436 PCR/NNP //NNP Southern/NNP blot/NN analysis/NN of/IN human/NN kidney/NN cDNA/NN using/VBG primers/NNS flanking/JJ the/DT hKID/NEWGENE coding/NEWGENE sequence/NEWGENE revealed/VBD expression/NN of/IN a/DT full-length/JJ mRNA/NN and/CC short/JJ transcripts/NNS with/IN partial/JJ exon/NN 1/CD and/CC partial/JJ exon/NN 4/CD deletions/NNS ./.
@@17189832786 E/NNP ./NNP ,/, Hession/NNP ,/, C/NNP ./NNP ,/, Goff/NNP ,/, D/NN ./NN ,/, Griffiths/NN ,/, B/NNP ./NNP ,/, Tizard/NNP ,/, R/NNP ./NNP ,/, Newman/NNP ,/, B/NNP ./NNP ,/, Chi-Rosso/NNP ,/, G/NNP ./NNP ,/, and/CC Lobb/NNP ,/, R/NNP ./NNP ,/, (/( 1990/CD )/SYM Cell/NNP 63/CD ,/, 1349-1356/NN )/NN ./.
@@105440889315 The/DT NF-kappaB/NEWGENE responsive/JJ reporter/NN construct/NN ,/, (/NEWGENE PRDII/NEWGENE )/NEWGENE (/NEWGENE 4/NEWGENE )/NEWGENE -CAT/NEWGENE ,/, was/VBD used/VBN to/IN explore/VB transcription/NN resulting/JJ from/IN NF-kappaB/NEWGENE activated/VBN by/IN Tat/NEWGENE ./.
@@109381207652 Transcriptional/JJ regulation/NN of/IN fbp1/NEWGENE promoter/NEWGENE constructs/NEWGENE containing/JJ only/RB UAS1/NEWGENE or/CC UAS2/NEWGENE confirms/VBZ that/IN the/DT PKA/NEWGENE and/CC MAPK/NEWGENE regulation/NN is/VBZ targeted/VBN to/IN both/DT sites/NNS ./.
@@26483967931 Furthermore/RB ,/, formation/NN of/IN foci/NNS of/IN transformed/VBN RECs/NN by/IN the/DT c-jun/NEWGENE //NEWGENE ras/NEWGENE combination/NEWGENE was/VBD augmented/VBN 3-fold/CD by/IN the/DT tumor/NN promoter/NN phorbol/NN 12-tetradecanoate/JJ 13-acetate/NN ./.
@@102245134167 Commonly/RB used/VBN stressors/NNS are/VBP mental/JJ arithmetics/NNS ,/, speech/NN tasks/NNS ,/, the/DT Stroop/NN test/NN ,/, videogame/NN playing/JJ ,/, films/NNS or/CC videotapes/NNS and/CC interviews/NNS ./.
@@22529537878 The/DT highly/RB restrained/VBN girls/NNS had/VBP a/DT significantly/RB higher/JJ EAT/NN score/NN than/IN the/DT low-restrained/JJ girls/NNS ,/, and/CC shared/VBD with/IN their/PRP mothers/NNS a/DT susceptibility/NN to/IN the/DT disinhibitory/JJ effects/NNS of/IN negative/JJ mood/NN states/NNS on/IN their/PRP eating/JJ behaviour/NN ./.
@@76238404266 It/PRP was/VBD proposed/VBN that/IN the/DT synthetase-related/NN sequences/NN of/IN GCN2/NEWGENE stimulate/VB the/DT activity/NN of/IN the/DT kinase/NN by/IN interacting/VBG directly/RB with/IN uncharged/JJ tRNA/NN that/WDT accumulates/VBZ during/IN amino/JJ acid/NN limitation/NN ./.
@@703350402 99mTc/NN phytate/NN ,/, 198Au/NN colloid/NN ,/, and/CC 99mTc/NN antimony/NN sulfide/NN have/NN been/VBN used/VBN ;/: the/DT last/NN appears/VBZ to/IN have/NN been/VBN the/DT most/RB satisfactory/JJ ./.
@@92169369511 Invited/JJ editorial/NN on/IN "Acute/NN and/CC chronic/JJ effects/NNS of/IN exercise/NN on/IN leptin/NEWGENE levels/NNS in/IN humans"/NN ./.
@@34932404181 Pharmacologic/NNP properties/NNS of/IN serotonergic/JJ agents/NNS and/CC antidepressant/JJ drugs/NNS ./.
@@68071929727 LCBF/NN in/IN normal/JJ and/CC hypoxic/JJ puppies/NNS was/VBD correlated/VBN with/IN local/JJ cerebral/JJ glucose/NN utilization/NN (/( LCGU/NNS )/SYM obtained/VBN under/IN the/DT same/JJ experimental/JJ conditions/NNS (/( Duffy/NNP et/FW al/NNS ,/, 1982/CD )/SYM ./.
@@112231645632 Retinoids/VBZ participate/VB in/IN the/DT onset/NN of/IN differentiation/NN ,/, apoptosis/NN and/CC the/DT inhibition/NN of/IN growth/NN in/IN a/DT wide/JJ variety/NN of/IN normal/JJ and/CC cancerous/JJ cells/NNS ./.
@@75255486615 The/DT results/NNS revealed/VBD a/DT hierarchy/NN of/IN ligand/NN affinities/NNS that/WDT mirrored/VBD their/PRP adhesive/JJ activity/NN (/( rsVCAM-1/NEWGENE >/SYM fibronectin/NEWGENE variants/NEWGENE containing/NN CS1/NEWGENE >/SYM >/SYM other/DT fibronectin/NEWGENE variants/NEWGENE )/SYM ./.
@@21664162775 The/DT diagnosis/NN of/IN miliary/JJ tuberculosis/NN should/MD be/VB systematically/RB considered/VBN in/IN ARDS/NNS of/IN unknown/JJ origin/NN ./.
@@9473279702 After/IN giving/JJ a/DT survey/NN on/IN the/DT situation/NN of/IN antibiotic/JJ resistance/NN in/IN the/DT region/NN of/IN Northern/NNP Bavaria/NN during/IN 1973/CD //CD 74/CD and/CC comparing/VBG the/DT activity/NN of/IN a/DT sulfamethoxazole/NN (/( SMZ/NNS )/SYM trimethoprim/NN (/( TMP/NN )/SYM combination/NN to/IN other/DT commonly/RB used/VBN antibiotics/NNS and/CC chemotherapeutic/JJ agents/NNS ,/, the/DT results/NNS of/IN tests/NNS with/IN the/DT new/JJ combination/NN of/IN N1-/NN (/NN 4/NN ,/NN 5-dimethyl-2-oxazolyl/NN )/NN -sulfanilamide/NN )/NN (/( sulfamoxole/NN )/SYM and/CC 2/NN ,/NN 4-diamino-5-/NN (/NN 3/NN ,/NN 4/NN ,/NN 5-trimethoxy-benzyl/NN )/NN -pyrimidine/NN (/( trimethoprim/NN )/SYM at/IN a/DT ratio/NN of/IN 5/CD :/: 1/CD (/( CN/NN 3123/CD ;/: Nevin/NN ,/, Supristol/NNP )/SYM are/VBP compared/VBN to/IN those/DT of/IN tests/NNS with/IN TMP/NNP //NNP SMZ/NNP ./.
@@8424061518 The/DT psychological/JJ tests/NNS consisted/VBP of/IN a/DT free-recall/NN task/NN ,/, a/DT test/NN for/IN visuomotor/JJ coordination/NN and/CC a/DT recognition/NN task/NN ./.
@@78158117795 Coronary/NNP vasoconstriction/NN caused/VBN by/IN endothelin-1/NEWGENE is/VBZ enhanced/VBN by/IN ischemia-reperfusion/NN and/CC by/IN norepinephrine/NN present/NN in/IN concentrations/NNS typically/RB observed/VBN after/IN neonatal/JJ cardiopulmonary/JJ bypass/NN ./.
@@19038414703 The/DT plasmid/NN shuffle/NN technique/NN was/VBD used/VBN to/IN replace/VB the/DT wild-type/NN gene/NN with/IN the/DT mutant/JJ form/NN ,/, resulting/JJ in/IN failure/NN of/IN the/DT yeast/NN cells/NNS to/IN grow/VB ./.
@@6184487299 Late/JJ mRNA/NN selected/VBN by/IN a/DT cDNA/NN homologous/JJ to/IN the/DT HindIII-P/NEWGENE //NEWGENE EcoRI-B/NEWGENE region/NEWGENE of/IN the/DT AcNPV/NN map/NN directed/VBD the/DT synthesis/NN of/IN 31K/CD and/CC 30K/NN proteins/NN which/WDT comigrated/VBN with/IN the/DT 31K/CD and/CC 30K/NN proteins/NN translated/VBN from/IN RNA/NN selected/VBN by/IN the/DT HindIII-A/NEWGENE //NEWGENE EcoRI-C/NEWGENE //NEWGENE SstI-G/NEWGENE cDNA/NEWGENE ./.
@@109131725110 To/TO determine/VB whether/IN the/DT NTP-binding/NN motif/NN is/VBZ important/JJ for/IN Rad24/NEWGENE function/NN ,/, we/PRP mutated/JJ the/DT conserved/VBN lysine/NN (/NN 115/NN )/NN residue/NN in/IN this/DT motif/NN ./.
@@44233474963 Copper/NN and/CC ceruloplasmin/NEWGENE content/NN in/IN pregnant/JJ women/NNS and/CC in/IN women/NNS with/IN certain/JJ gynecological/JJ diseases/NNS ./.
@@90322597516 Constitutive/JJ activation/NN of/IN Rac1/NEWGENE and/CC RhoA/NEWGENE causes/NNS tumorigenic/JJ transformation/NN of/IN NIH/NN 3T3/CD cells/NNS ,/, and/CC their/PRP functions/NNS may/MD be/VB required/VBN for/IN full/JJ Ras/NEWGENE transformation/NN ./.
@@51779355421 Proposals/NNS on/IN authorization/NN ;/: by/IN a/DT group/NN of/IN nurses/NNS from/IN psychiatric/JJ hospitals/NNS ./.
@@97779996941 RESULTS/NNS :/: The/DT cardiac/JJ index/NN significantly/RB changed/VBD with/IN varying/JJ PaCO2/NN levels/NNS (/( hypocapnia/NN ,/, -/: 9%/CD ;/: hypercapnia/NN ,/, 13%/JJ )/SYM ./.
@@1316900569 The/DT DNA/NN sequence/NN of/IN the/DT sulfate/NEWGENE activation/NEWGENE locus/NEWGENE from/IN Escherichia/NN coli/JJ K-12/NN has/VBZ been/VBN determined/VBN ./.
@@11593394235 Transforming/NEWGENE growth/NEWGENE factor-beta/NEWGENE (/( TGF-beta/NEWGENE )/SYM induced/VBN growth/NN arrest/NN of/IN cells/NNS involves/VBZ regulation/NN of/IN the/DT activities/NNS of/IN both/DT D-/NEWGENE and/NEWGENE E-type/NEWGENE cyclin/NEWGENE kinase/NEWGENE complexes/NEWGENE thought/VBP to/IN be/VB mediated/JJ primarily/RB by/IN the/DT regulation/NN of/IN p15/NEWGENE (/NEWGENE Ink4b/NEWGENE )/NEWGENE and/CC p27/NEWGENE (/NEWGENE Kip1/NEWGENE )/NEWGENE cyclin/NEWGENE kinase/NEWGENE inhibitors/NEWGENE ./.
@@98823033265 Epstein-Barr/NEWGENE virus-encoded/NEWGENE latent/NEWGENE membrane/NEWGENE protein/NEWGENE 1/NEWGENE activates/VBZ the/DT JNK/NEWGENE pathway/NN through/RB its/PRP extreme/JJ C/NN terminus/NN via/NN a/DT mechanism/NN involving/VBG TRADD/NEWGENE and/CC TRAF2/NEWGENE ./.
@@105560291534 WA/NN constructs/NN afforded/VBN relaxed/VBN and/CC positive/JJ topoisomers/NNS ,/, and/CC cyclization/NN kinetics/NN indicated/VBD slow/JJ interconversion/NN of/IN precursors/NNS to/IN the/DT two/JJ topoisomers/NNS ./.
@@86644628641 These/DT changes/NNS may/MD be/VB the/DT result/NN of/IN ,/, on/IN the/DT one/PRP hand/NN ,/, an/DT increased/VBN sensitivity/NN of/IN the/DT neuromuscular/JJ transmission/NN and/IN //IN or/IN decreased/VBN muscle/NN contractility/NN and/CC ,/, on/IN the/PDT other/DT hand/NN ,/, the/DT result/NN of/IN a/DT reduced/VBN plasma/NN clearance/NN during/IN hypothermia/NN ./.
@@1039490050 G-box-directed/JJ expression/NN in/IN leaves/NNS required/VBD the/DT presence/NN of/IN an/DT enhancer/NN region/NN from/IN the/DT cauliflower/NN mosaic/NN virus/NN (/( CaMV/NN )/SYM 35S/NEWGENE promoter/NEWGENE ./.
@@86265395180 Binding/NN specificity/NN and/CC modulation/NN of/IN the/DT ApoA-I/NEWGENE promoter/NEWGENE activity/NN by/IN homo-/JJ and/CC heterodimers/NNS of/IN nuclear/JJ receptors/NNS ./.
@@115427802699 Different/JJ thermoluminescent/JJ detectors/NNS (/( TLD/NN )/SYM have/VB been/VBN used/VBN to/IN measure/NN the/DT contribution/NN of/IN the/DT low/JJ linear/JJ energy/NN transfer/NN component/NN (/( LET/NN </SYM 10/CD keV/NN //NN micrometer/NN )/SYM and/CC plastic/JJ nuclear/JJ track/NN detectors/NNS (/( PNTD/NNP )/SYM for/IN the/DT high/JJ linear/JJ energy/NN tranfer/NN (/( LET/NN )/SYM component/NN ./.
@@92593283005 Deletion/NNS mapping/NN experiments/NNS determined/VBN that/IN the/DT sequences/NNS required/VBN for/IN full/JJ activity/NN in/IN MSC-1/NN cells/NNS were/VBD included/VBN within/IN 619/CD bp/NN of/IN the/DT start/NN site/NN and/CC identified/VBD several/DT regions/NNS that/WDT demonstrated/VBD increased/VBN luciferase/NEWGENE activity/NN :/: the/DT -583/JJ bp/NN to/IN -564/JJ bp/NN ,/, -503/NN bp/NN to/IN -484/CD bp/NN ,/, and/CC -114/NN bp/NN to/IN -65/CD regions/NNS ./.
@@110545651379 Like/IN the/DT p190-B/NEWGENE exon/NN ,/, the/DT first/JJ exon/NN of/IN p190-A/NEWGENE is/VBZ extremely/RB large/JJ (/( 3/CD ./CD 7/CD kb/NN in/IN length/NN )/SYM ,/, encoding/VBG both/PDT the/DT GTPase/NEWGENE and/CC middle/JJ domains/NNS (/( residues/NNS 1-1228/CD )/SYM ,/, but/CC not/RB the/DT remaining/JJ GAP/NEWGENE domain/NEWGENE ,/, suggesting/VBG a/DT high/JJ conservation/NN of/IN genomic/JJ structure/NN between/IN two/JJ p190/NEWGENE genes/NEWGENE ./.
@@114386669657 We/PRP have/VBP cloned/VBN a/DT novel/JJ mouse/NN protein/NN ,/, TAF/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE 140/NEWGENE ,/, containing/JJ an/DT HFD/NEWGENE and/CC a/DT plant/NEWGENE homeodomain/NEWGENE (/( PHD/NEWGENE )/SYM finger/NN ,/, which/WDT we/PRP demonstrated/VBD by/IN immunoprecipitation/NN to/IN be/VB a/DT mammalian/NEWGENE TFIID/NEWGENE component/NEWGENE ./.
@@102070417341 The/DT eukaryotic/JJ cell/NN cycle/NN is/VBZ governed/VBN in/IN part/NN by/IN the/DT periodic/JJ transcription/NN of/IN cyclin/NEWGENE genes/NEWGENE ,/, whose/WP protein/NN products/NNS associate/VBP with/IN and/CC positively/RB regulate/VB the/DT cyclin-dependent/NEWGENE kinases/NEWGENE ./.
@@97634707423 Dopamine/NEWGENE beta-hydroxylase/NEWGENE (/( DBH/NEWGENE )/SYM catalyzes/VBZ the/DT conversion/NN of/IN dopamine/NN to/IN noradrenaline/NN and/CC is/VBZ selectively/RB expressed/VBN in/IN noradrenergic/JJ and/CC adrenergic/JJ neurons/NNS and/CC neuroendocrine/JJ cells/NNS ./.
@@79011213600 Cooperative/JJ dimerization/NN of/IN paired/JJ class/NN homeo/NN domains/NN on/IN DNA/NN ./.
@@108716151160 G/NNP ./NNP ,/, and/CC Hyde/NNP ,/, C/NNP ./NNP
@@108438106028 The/DT cellular/JJ part/NN of/IN the/DT third/RB chimeric/JJ clone/NN shows/VBZ significant/JJ homology/NN to/IN an/DT exon/NN of/IN the/DT human/NEWGENE tyrosine/NEWGENE phosphatase/NEWGENE 1/NEWGENE gene/NEWGENE ,/, although/IN oriented/VBN in/IN the/DT antisense/NN direction/NN compared/VBN to/IN the/DT adjacent/JJ LTR/NN ./.
@@109518488178 Mobilization/NNP with/IN cyclophosphamide/NN and/CC granulocyte-colony/NEWGENE stimulating/NEWGENE factor/NEWGENE was/VBD effective/JJ in/IN terms/NNS of/IN CD34+/NEWGENE cell/NN shift/NN to/IN peripheral/JJ blood/NN and/CC the/DT good/JJ quality/NN autograft/NN reliaebly/RB led/VBD to/IN haematopoetic/JJ recovery/NN after/IN megachemotherapy/NN ./.
@@16196422204 Both/DT parents/NNS are/VBP clinically/RB normal/JJ and/CC unrelated/JJ ./.
@@82768546087 The/DT results/NNS show/NN that/IN the/DT structure/NN of/IN the/DT decorin/NEWGENE gene/NEWGENE promoter/NEWGENE is/VBZ different/JJ from/IN that/DT of/IN any/DT other/DT proteoglycan/NN promoter/NN characterized/VBN so/RB far/RB and/CC indicate/VB that/IN the/DT pur/NN //NN pyr/NN segment/NN plays/VBP a/DT role/NN in/IN the/DT regulation/NN of/IN gene/NN transcription/NN ./.
@@65456516335 Ammonia/ORG concentration/NN dropped/VBN significantly/RB in/IN all/DT treatments/NNS ,/, a/DT finding/NN which/WDT suggests/VBZ a/DT protective/JJ effect/NN on/IN protein/NN nitrogen/NN degradation/NN to/IN non-protein/JJ nitrogen/NN (/( NH3/NN )/SYM ./.
@@97869325203 Thus/RB ,/, IRF-7/NEWGENE exhibits/VBP functional/JJ similarity/NN to/IN IRF-3/NEWGENE ;/: however/RB ,/, the/DT preferential/JJ expression/NN of/IN IRF-7/NEWGENE in/IN lymphoid/JJ cells/NNS (/( the/DT cell/NN type/NN that/WDT expresses/VBP IFNA/NEWGENE )/SYM suggests/VBZ that/IN IRF-7/NEWGENE may/MD play/VB a/DT critical/JJ role/NN in/IN regulating/JJ the/DT IFNA/NEWGENE gene/NEWGENE expression/NN ./.
@@81446681139 Rather/RB ,/, complete/JJ skipping/NN of/IN exon/NN V/NN and/CC subsequent/JJ joining/NN of/IN exon/NN IV/NN to/IN exon/NN VI/NN caused/VBD a/DT shift/NN in/IN the/DT open/JJ reading/JJ frame/NN ,/, which/WDT remodeled/VBD GPHe/NEWGENE (/NEWGENE P2/NEWGENE )/NEWGENE with/IN an/DT elongated/JJ new/JJ hydrophobic/JJ sequence/NN for/IN membrane/NN anchoring/JJ ./.
@@99205392586 All/DT stimulations/NNS were/VBD down-regulated/IN with/IN GnRH-a/NEWGENE commenced/VBN on/IN day/NN 21/CD in/IN a/DT long/JJ protocol/NN before/IN gonadotropin/NEWGENE stimulation/NN ./.
@@107314116391 The/DT consensus/NN highlights/VBP the/DT importance/NN of/IN residues/NNS other/DT than/IN the/DT eight/CD motifs/NNS that/WDT are/VBP often/RB associated/VBN with/IN DEAD-box/NEWGENE RNA/NEWGENE helicases/NEWGENE ,/, as/RB well/VB as/IN de-emphasising/VBD the/DT importance/NN of/IN the/DT "A"/NN residue/NN within/IN the/DT "DEAD"/NEWGENE motif/NEWGENE ./.
@@19612133153 Fortunately/RB DDT-/NN ,/, HCH-/NN and/CC HCB-levels/NN decreased/VBD in/IN breast/NN milk/NN during/IN the/DT last/NN years/NNS ./.
@@2146495527 Two/CD other/DT peptides/NNS ,/, either/DT partially/RB or/CC totally/RB lacking/JJ the/DT basic/JJ region/NN ,/, but/CC containing/JJ the/DT intact/JJ leucine/NN zipper/NN domain/NN ,/, readily/RB form/VBP dimers/NNS but/CC do/VB not/RB bind/VB to/IN the/DT CRE/NEWGENE ./.
@@82493908236 The/DT duration/NN of/IN diabetes/NN mellitus/MD in/IN these/DT patients/NNS was/VBD from/IN 5/CD months/NNS to/IN 6/CD years/NNS ,/, and/CC in/IN all/DT patients/NNS this/DT was/VBD the/DT first/JJ myocardial/JJ infarction/NN ./.
@@28327444903 We/PRP detected/VBD mos/NEWGENE transcripts/NEWGENE by/IN Northern/NNP (/( RNA/NN )/SYM analyses/NNS in/IN RNA/NN prepared/VBN from/IN chicken/NN and/CC quail/NN ovaries/NNS and/CC testes/NNS ./.
@@66562496400 Nursing/NNP home/JJ discharges/NNS in/IN clinical/JJ practice/NN ./.
@@19863607038 Seven/CD clones/NNS encoding/VBG interferon/NEWGENE response/NEWGENE element/NEWGENE binding/NEWGENE factors/NEWGENE have/VBP been/VBN isolated/VBN from/IN a/DT mouse/NN fibroblast/NN lambda/NN gt11/NN cDNA/NN library/NN by/IN using/VBG a/DT 32P/JJ end-labeled/JJ tandem/NN trimer/NN of/IN the/DT mouse/NEWGENE (/NEWGENE 2'-5'/NEWGENE )/NEWGENE oligoadenylate/NEWGENE synthetase/NEWGENE gene/NEWGENE interferon/NEWGENE1 response/NEWGENE1 element/NEWGENE1 as/IN a/DT probe/NN ./.
@@16951161364 The/DT patient/NN initially/RB attained/VBD complete/JJ remission/NN (/( CR1/NN )/SYM with/IN conventional/JJ chemotherapy/NN and/CC then/RB relapsed/VBN 14/CD months/NNS later/JJR ./.
@@1328884914 Truncation/NNS variants/NNS of/IN peptides/NNS isolated/VBN from/IN MHC/NEWGENE class/NEWGENE II/NEWGENE molecules/NEWGENE suggest/VBP sequence/NN motifs/NNS ./.
@@79635409132 Recombinant/NEWGENE I-kappa/NEWGENE B/NEWGENE alpha/NEWGENE inhibited/VBD kappa/NEWGENE B/NEWGENE motif/NEWGENE binding/JJ by/IN nuclear/NEWGENE factor-kappa/NEWGENE B1/NEWGENE ,/, RelA/NEWGENE ,/, and/CC c-Rel/NEWGENE as/IN indicated/VBN by/IN studies/NNS using/VBG UV/NN radiation-induced/JJ covalent/JJ cross-linking/VBG to/IN a/DT bromodeoxyuridine-substituted/JJ kappa/NEWGENE B/NEWGENE oligonucleotide/NEWGENE ./.
@@114258778636 Cells/NNS lacking/JJ p116/NEWGENE exhibit/VB a/DT striking/JJ defect/NN in/IN the/DT formation/NN of/IN these/DT macropinocytic/JJ structures/NNS ,/, a/DT concomitant/JJ reduction/NN in/IN the/DT rate/NN of/IN fluid/NN phase/NN pinocytosis/NN ,/, a/DT significant/JJ decrease/NN in/IN the/DT efficiency/NN of/IN chemotactic/JJ aggregation/NN ,/, and/CC a/DT decrease/NN in/IN cellular/JJ F-actin/NEWGENE content/NN ./.
@@78676222467 Promoter/NNS region/NN of/IN the/DT transcriptional/JJ unit/NN for/IN human/NEWGENE alpha/NEWGENE 1-chimaerin/NEWGENE ,/, a/DT neuron-specific/NEWGENE GTPase-activating/NEWGENE protein/NEWGENE for/IN p21rac/NEWGENE ./. alpha/NEWGENE 1-chimaerin/NEWGENE is/VBZ a/DT neuron-specific/NEWGENE GTPase-activating/NEWGENE protein/NEWGENE for/IN p21rac/NEWGENE ,/, a/DT protein/NN involved/VBN in/IN morphological/JJ events/NNS ./.
@@94563126422 Surprisingly/RB ,/, the/DT COOH-terminal/NN domain/NN of/IN RanGAP1/NEWGENE was/VBD also/RB found/VB to/IN harbor/NN a/DT nuclear/JJ localization/NN signal/JJ ./.
@@111607386821 Thus/RB ,/, the/DT anti-interferon/JJ functions/NNS of/IN vIRF-2/NEWGENE may/MD contribute/VB to/IN the/DT establishment/NN of/IN a/DT chronic/JJ or/CC latent/JJ infection/NN ./.
@@105137565450 For/IN EPV/NN 3/NN ,/, 10/CD ,/, or/CC 40/CD ,/, the/DT bias/NN exceeded/VBD 25%/JJ for/IN 7/CD ,/, 3/CD ,/, and/CC 1/CD in/IN the/DT 8-predictor/NN model/NN respectively/RB ,/, when/CC a/DT conventional/JJ selection/NN criterion/NN was/VBD used/VBN (/( alpha/NN =/SYM 0/CD ./CD 05/CD )/SYM ./.
@@19238031856 Position/NN 22/CD is/VBZ an/DT isoleucine/NN in/IN the/DT complete/NEWGENE SsoL12/NEWGENE protein/NEWGENE sequence/NEWGENE ,/, coded/VBN by/IN an/DT AUA/NN codon/NN ./.
@@25320326614 Plasma/NN concentrations/NNS of/IN ANF/NEWGENE (/( pANF/NEWGENE )/SYM ,/, aldosterone/NN (/( PAC/NN )/SYM and/CC renin/NEWGENE (/( PRC/NEWGENE )/SYM were/VBD measured/VBN daily/JJ ,/, as/IN were/VBD hemodynamic/JJ parameters/NNS ./.
@@49735235282 Immunochemical/JJ studies/NNS with/IN filarial/JJ antigens/NNS ./.
@@113139466348 RPM/NEWGENE //NEWGENE RGL3/NEWGENE resembled/VBN AF-6/NEWGENE and/CC Nore1/NEWGENE in/IN interacting/VBG strongly/RB with/IN constitutively/RB active/JJ M-Ras/NEWGENE and/CC p21/NEWGENE Ras/NEWGENE1 ./.
@@82416568230 To/TO our/PRP knowledge/NN this/DT is/VBZ the/DT first/JJ case/NN in/IN which/WDT a/DT probable/JJ association/NN between/IN cholelithiasis/NN and/CC Wildervanck's/NN syndrome/NN has/VBZ been/VBN recorded/VBN ./.
@@117858275402 The/DT results/NNS are/VBP discussed/VBN in/IN relation/NN to/IN acoustical/JJ models/NNS of/IN sound/NN propagation/NN and/CC physiology/NN ,/, and/CC it/PRP is/VBZ suggested/VBN that/IN height-dependent/JJ degradation/NN within/IN a/DT forest/NN is/VBZ an/DT important/JJ selection/NN pressure/NN for/IN transmissibility/NN in/IN avian/JJ communication/NN ./.
@@111815489470 To/TO identify/VB the/DT important/JJ cis-DNA/JJ regulatory/JJ element/NN (/NN s/NN )/NN involved/VBN in/IN the/DT tissue-/NN ,/, region-/JJ ,/, and/CC cell-specific/JJ expression/NN of/IN the/DT mE-RABP/NEWGENE gene/NEWGENE ,/, the/DT 5-kb/JJ DNA/NN fragment/NN was/VBD sequenced/VBN ./.
@@2198289410 The/DT two/RB larger/JJR peptides/NNS ,/, one/PRP containing/JJ amino/JJ acids/NNS 1-228/CD and/CC the/PDT other/DT containing/JJ amino/JJ acids/NNS 85-228/CD ,/, formed/VBN dimers/NNS in/IN solution/NN and/CC bound/JJ DNA/NN specifically/RB as/IN a/DT dimer/NN ./.
@@76931327524 Here/RB the/DT cloning/NN and/CC molecular/JJ analysis/NN of/IN the/DT Zm-ERabp1/NEWGENE ,/, Zm-ERabp4/NEWGENE ,/, and/CC Zm-ERabp5/NEWGENE genes/NEWGENE is/VBZ presented/VBN ./.
@@75071875152 Mechanism/NNS of/IN enhancement/NN of/IN DNA/NN expression/NN consequent/JJ to/IN cointernalization/NN of/IN a/DT replication-deficient/JJ adenovirus/NN and/CC unmodified/JJ plasmid/NN DNA/NN ./.
@@78717557974 Using/VBG this/DT method/NN ,/, VLPs/NNS were/VBD obtained/VBN in/IN quantities/NNS sufficient/JJ for/IN further/JJ characterization/NN ./.
@@117262629035 Lactate/NN accumulation/NN peak/NN was/VBD unaffected/JJ by/IN supplementation/NN (/( HMB/NN ,/, 8/NN ./NN 1/NN +/NN //NN -/NN 1/CD ./CD 1/CD mM/NN ;/: LEU/NNP ,/, 6/CD ./CD 2/CD +/NN //NN -/NN 0/CD ./CD 8/CD mM/NN ;/: CON/IN ,/, 7/CD ./CD 5/CD +/NN //NN -/NN 1/CD ./CD 3/CD mM/NN )/SYM ./.
@@36299738260 W/NN ./NN
@@39442123811 Tissue/NN pressure/NN ,/, rCBF/NN ,/, and/CC water/NN content/NN were/VBD measured/VBN from/IN gray/JJ matter/NN in/IN the/DT central/JJ core/NN and/CC the/DT peripheral/JJ margin/NN of/IN the/DT MCA/NN territory/NN over/RB 6/CD h/NN after/IN MCAO/NNS ./.
@@89242116098 Exons/NNP III/NNP to/IN VIII/NNP ,/, which/WDT cover/VBP the/DT coding/JJ region/NN and/CC the/DT 3'/CD untranslated/JJ region/NN ,/, are/VBP almost/RB identical/JJ in/IN all/DT types/NNS of/IN PST/NEWGENE or/CC AST/NEWGENE cDNAs/NEWGENE ./.
@@14924639700 Alena/NN is/VBZ a/DT nurse/NN in/IN Prague--she/NNP dreams/NNS of/IN higher/JJ wages/NNS and/CC a/DT trip/NN across/IN the/DT ocean/NN ./.
@@15850149480 An/DT experiment/NN examined/VBD the/DT effects/NNS of/IN treatment/NN with/IN gonadotrophin/NN releasing/JJ hormone/NN (/( 100/CD micrograms/NNS GnRH/NEWGENE injected/VBN 24/CD h/NN after/IN progestagen/NN sponge/NN removal/NN )/SYM ,/, season/NN of/IN treatment/NN (/( autumn/NN v/NN ./NN spring/NN )/SYM ,/, the/DT effect/NN of/IN supplementary/JJ feeding/NN with/IN lupin/NN grain/NN (/( in/IN autumn/NN only/RB ,/, from/IN 12/CD days/NNS before/IN until/IN 8/CD days/NNS after/IN sponge/NN removal/NN )/SYM on/IN the/DT time/NN of/IN ovulation/NN in/IN 182/CD mature/JJ Merino/NN ewes/NNS superovulated/JJ with/IN a/DT combination/NN of/IN 400/CD I/NNP ./NNP U/NNP ./. pregnant/NEWGENE mare/NEWGENE serum/NEWGENE gonadotrophin/NEWGENE (/( PMSG/NEWGENE )/SYM and/CC 12/CD mg/NN follicle/NEWGENE stimulating/NEWGENE hormone/NEWGENE (/( FSH-P/NEWGENE )/SYM ./.
@@75053495078 The/DT early/JJ lethality/NN of/IN the/DT left-sided/JJ resectio/NN was/VBD 0%/CD and/CC the/DT postoperative/JJ survival--5-10/NN months/NNS ./.
@@105441139597 EIAV/NEWGENE LTR/NEWGENE sequence/NEWGENE variability/NN is/VBZ confined/VBN mostly/RB to/IN a/DT small/JJ portion/NN of/IN the/DT enhancer/NN within/IN the/DT U3/NEWGENE segment/NEWGENE of/IN the/DT LTR/NEWGENE ./.
@@93466218779 In/NN the/DT context/NN of/IN liver/NN allograft/NN shortage/NN ,/, our/PRP results/NNS suggest/VBP that/IN an/DT ELT/NN should/MD not/RB be/VB performed/VBN in/IN patients/NNS with/IN cardiac/JJ failure/NN ,/, more/RB than/IN two/JJ OSF/NN ,/, or/CC an/DT APACHE/NN II/NN score/NN higher/JJ than/IN 30/CD ./CD
@@99338489929 If/IN no/DT alloantibodies/NNS are/VBP detected/VBN ,/, further/JJ analysis/NN to/IN define/VB a/DT role/NN of/IN drug-/RB related/VBN or/CC autoantibodies/NNS is/VBZ required/VBN ./.
@@31540723858 The/DT protein/NN mixtures/NNS of/IN sesame/NN flour/NN and/CC soybean/NN flour/NN were/VBD well/VB accepted/VBN ./.
@@85303693453 The/DT site/NN of/IN autophosphorylation/NN is/VBZ Tyr397/NN which/WDT corresponds/VBZ to/IN the/DT consensus/NN autophosphorylation/NN site/NN of/IN other/DT Src/NEWGENE family/NEWGENE tyrosine/NEWGENE1 kinases/NEWGENE1 ./.
@@93343316448 Our/PRP results/NNS favor/NN the/DT possibility/NN that/IN the/DT Drosophila/NEWGENE EGF/NEWGENE receptor/NEWGENE DER/NEWGENE1 //NEWGENE1 Egfr/NEWGENE1 expressed/VBD by/IN the/DT EMA/NN cells/NNS functions/NNS as/IN a/DT receptor/NN for/IN Vein/NEWGENE ./.
@@1044338288 Infrared/JJ measurements/NNS of/IN temperature/NN changes/NNS and/CC estimates/NNS of/IN the/DT heating/NN produced/VBN at/IN the/DT mical/NN ./.
@@106113538582 Northern/NNP blot/NN and/CC reverse/JJ transcription-PCR/NN analyses/NNS of/IN human/JJ mRNA/NN samples/NNS demonstrate/VBP that/DT RNR/NEWGENE is/VBZ expressed/VBN exclusively/RB in/IN the/DT retina/NN ,/, with/IN transcripts/NNS of/IN approximately/RB 7/CD ./CD 5/CD kb/NN ,/, approximately/RB 3/CD ./CD 0/CD kb/NN ,/, and/CC approximately/RB 2/CD ./CD 3/CD kb/NN by/IN Northern/NNP blot/NN analysis/NN ./.
@@30391778640 One/CD group/NN of/IN six/CD cDNA/NN clones/NNS was/VBD derived/VBN from/IN a/DT 2/NN ./NN 9-kilobase/NN early/NN transcript/NN encoded/VBN by/IN the/DT IR2/NEWGENE repeat/NEWGENE element/NEWGENE and/CC showed/VBD restriction/NN site/NN polymorphism/NN for/IN the/DT enzyme/NEWGENE SmaI/NEWGENE ./.
@@10094518254 Compared/VBN to/IN controls/NNS ,/, both/DT UB/NN and/CC OCS/NN rats/NNS showed/VBD a/DT small/JJ but/CC significant/JJ post-operative/JJ reduction/NN in/IN the/DT nocturnality/NN of/IN drinking/NN ./.
@@78597772694 Recombinant/NEWGENE human/NEWGENE serum/NEWGENE albumin/NEWGENE (/( rHSA/NEWGENE )/SYM produced/VBN by/IN cultured/JJ fermentation/NN has/VBZ been/VBN prepared/VBN in/IN the/DT form/NN of/IN microcapsules/NNS nominally/RB 3-5/CD microns/NNS in/IN diameter/NN and/CC radiolabelled/JJ with/IN technetium-99m/NN following/IN reduction/NN with/IN stannous/JJ chloride/NN ./.
@@114330182674 These/DT data/NN suggest/VB that/IN proper/JJ direct/JJ binding/NN of/IN Nhp2p/NEWGENE to/IN H/NEWGENE //NEWGENE ACA/NEWGENE snoRNAs/NEWGENE is/VBZ required/VBN for/IN the/DT assembly/NN of/IN H/NEWGENE //NEWGENE ACA/NEWGENE snoRNPs/NEWGENE and/CC hence/RB for/IN the/DT stability/NN of/IN some/DT of/IN their/PRP components/NNS ./.
@@80832207304 This/DT mode/NN of/IN ternary/JJ complex/NN formation/NN is/VBZ in/IN contrast/NN to/IN the/DT one/PRP seen/VBP in/IN the/DT promoter/NN of/IN the/DT c-fos/NEWGENE protooncogene/NEWGENE ,/, where/CC formation/NN of/IN the/DT ternary/JJ complex/NN is/VBZ dependent/JJ on/IN the/DT prior/NN assembly/NN of/IN the/DT serum/NEWGENE response/NEWGENE factor-DNA/NEWGENE binary/NEWGENE complex/NEWGENE ./.
@@68094747184 Bile/NN bilirubin/NN did/VBD not/RB rise/VB within/IN 12/CD h/NN after/IN haem/NN infusion/NN a/DT finding/NN which/WDT warrants/VBP further/JJ investigation/NN ./.
@@11162547197 Following/VBG intravenous/JJ administration/NN ,/, the/DT myocardial/JJ concentration/NN of/IN tracer/NN thallium-201/NN ,/, potassium-43/NN ,/, and/CC rubidium-81/NN were/VBD determined/VBN in/IN mice/NNS ;/: thallium/NN was/VBD present/VB in/IN the/DT greatest/JJS concentration/NN in/IN the/DT myocardium/NN (/( 2/CD ./CD 08%/CD compared/VBN 1/CD ./CD 25%/CD for/IN potassium/NN and/CC 1/CD ./CD 15%/CD for/IN rubidium/NN at/IN 10/CD minutes/NNS )/SYM ./.
@@77807389902 It/PRP acts/NNS on/IN Cdks/NEWGENE in/IN the/DT G1/NN and/CC S/NNP phases/NNS of/IN the/DT cell/NN cycle/NN ,/, and/CC also/RB binds/VBZ to/IN proliferating/NEWGENE cell/NEWGENE nuclear/NEWGENE antigen/NEWGENE (/( PCNA/NEWGENE )/SYM ,/, blocking/JJ DNA/NN replication/NN in/IN vitro/FW ./.
@@81444703900 The/DT mutation/NN within/IN the/DT asgB480/NEWGENE allele/NEWGENE was/VBD identified/VBN as/IN an/DT A-to-G/NNP transition/NN that/IN results/NNS in/IN a/DT threonine-to-alanine/JJ substitution/NN in/IN the/DT predicted/VBN protein/NN product/NN ./.
@@14318092233 Nucleotide/NN sequence/NN and/CC transcriptional/JJ analysis/NN of/IN the/DT polyhedrin/NEWGENE gene/NEWGENE of/IN Spodoptera/NN exigua/NN nuclear/JJ polyhedrosis/NN virus/NN ./.
@@91996269151 In/NN 12/CD cases/NNS (/( 3/CD ./CD 1%/CD )/SYM ,/, a/DT change/NN in/IN stage/NN resulted/VBN ./.
@@4065854741 Inherent/JJ hematology/NN of/IN old/JJ age/NN ./.
@@1413984724 We/PRP couldn't/MD detect/VB any/DT effect/NN of/IN n-3/NN FA/NN supplementation/NN on/IN total/JJ cholesterol/NN ,/, HDL/NN cholesterol/NN ,/, LDL/NEWGENE cholesterol/NN ,/, apo/NEWGENE A1/NEWGENE ,/, Lp/NEWGENE (/NEWGENE a/NEWGENE )/NEWGENE ,/, HbA1C/NEWGENE ,/, glucose/NN ,/, fibrinogen/NEWGENE ,/, factor/NEWGENE VIII/NEWGENE ,/, antithrombin/NEWGENE III/NEWGENE ,/, plasminogen/NEWGENE activator/NEWGENE inhibitor/NEWGENE ,/, tissue/NEWGENE plasminogen/NEWGENE activator/NEWGENE and/CC von/NEWGENE Willebrand/NEWGENE factor/NEWGENE concentration/NN ,/, on/IN bleeding/NN time/NN or/CC on/IN systolic/JJ or/CC diastolic/JJ blood/NN pressure/NN ./.
@@10396343263 A/DT multi-centre/JJ evaluation/NN of/IN the/DT card/NN indirect/JJ agglutination/NN test/NN for/IN trypanosomiasis/NN (/( TrypTect/NNP CIATT/NNP )/SYM ./.
@@30410465132 Indeed/RB ,/, A-MuLV/IN pseudotyped/VBN with/IN some/DT viruses/NNS ,/, such/JJ as/IN the/DT Moloney/NN MuLV/NN ,/, has/VBZ been/VBN shown/VBP to/IN be/VB highly/RB lymphogenic/JJ ,/, whereas/IN A-MuLV/DT pseudotyped/NN with/IN other/DT viruses/NNS ,/, such/JJ as/IN the/DT BALB/JJ //JJ c/JJ endogenous/JJ N-tropic/NNP MuLV/NN ,/, has/VBZ been/VBN shown/VBP to/IN be/VB devoid/JJ of/IN lymphogenic/JJ potential/JJ (/( N/NNP ./NNP
@@95397799062 Whole-mount/NN in/IN situ/NN hybridization/NN to/IN early/JJ mouse/NN embryos/NNS of/IN 9/CD ./CD 5-10/CD ./CD 5/CD days/NNS indicated/VBD a/DT complex/NN pattern/NN of/IN Arp1/NEWGENE expression/NN spatially/RB overlapping/JJ with/IN the/DT expression/NN of/IN All1/NEWGENE ./.
@@77404907688 Conjugated/JJ estrogens/NNS shorten/VBP bleeding/VBG time/NN in/IN uraemia/NN :/: a/DT possible/JJ role/NN of/IN serotonin/NN ?/.
@@29028442559 The/DT subunit-a/NEWGENE gene/NEWGENE is/VBZ preceded/VBN by/IN a/DT gene/NN coding/JJ for/IN a/DT small/JJ hydrophobic/JJ protein/NN ,/, as/IN has/VBZ been/VBN observed/VBN previously/RB in/IN the/DT atp/NEWGENE operons/NEWGENE in/IN E/NNP ./NNP coli/JJ ,/, bacterium/NN PS3/NN and/CC cyanobacteria/NNS ./.
@@26578835613 US-Doppler/NN has/VBZ recently/RB gained/VBN attention/NN as/IN a/DT noninvasive/JJ method/NN for/IN the/DT functional/JJ evaluation/NN of/IN arteriovenous/JJ fistulas/NNS (/( FAV/NN )/SYM ./.
@@79637827951 The/DT physical/JJ and/CC chemical/JJ stability/NN of/IN a/DT combination/NN of/IN drugs/NNS commonly/RB administered/VBN into/IN the/DT epidural/JJ or/CC intrathecal/JJ space/NN for/IN the/DT treatment/NN of/IN chronic/JJ pain/NN was/VBD investigated/VBN ./.
@@87767484921 Are/VBP low/JJ P300/NN amplitudes/NNS a/DT marker/NN for/IN schizophrenia/NN ./.
@@98748034751 The/DT human/JJ pathogenic/JJ bacterium/NN group/NN A/DT Streptococcus/NN produces/VBZ an/DT extracellular/NEWGENE cysteine/NEWGENE protease/NEWGENE [/NEWGENE1 streptococcal/NEWGENE1 pyrogenic/NEWGENE1 exotoxin/NEWGENE1 B/NEWGENE1 (/( SpeB/NEWGENE )/NN ]/NN that/WDT is/VBZ a/DT critical/JJ virulence/NN factor/NN for/IN invasive/JJ disease/NN episodes/NNS ./.
@@81886068414 Restriction/NNS analysis/NN and/CC Southern/NNP hybridization/NN revealed/VBD the/DT presence/NN of/IN Tn5422/NEWGENE in/IN all/PDT the/DT plasmid-mediated/NNP cadmium-resistant/NNP L/NNP ./NNP monocytogenes/NNS strains/NNS tested/VBN but/CC not/RB in/IN strains/NNS encoding/VBG cadmium/NN resistance/NN on/IN the/DT chromosome/NN ./.
@@78124505416 Another/DT full/JJ ORF/NN was/VBD found/VBN on/IN the/DT opposite/NN strand/NN downstream/RB from/IN the/DT nspC/NEWGENE gene/NEWGENE ./.
@@110679284964 These/DT two/JJ mAbs/NNS used/VBD the/DT same/JJ V/NEWGENE (/NEWGENE H/NEWGENE )/NEWGENE and/CC J/NEWGENE (/NEWGENE H/NEWGENE )/NEWGENE gene/NEWGENE segments/NEWGENE ,/, but/CC different/JJ D/NEWGENE ,/, Vkappa/NEWGENE ,/, and/CC Jkappa/NEWGENE genes/NEWGENE ./.
@@89950546630 Similarity/NN is/VBZ most/RB striking/JJ in/IN the/DT zinc/NEWGENE knuckle/NEWGENE region/NEWGENE ,/, a/DT region/NN characteristic/NN of/IN gag/NEWGENE genes/NEWGENE of/IN most/RB replication-competent/JJ retroelements/NNS ./.
@@89002962513 The/DT up-regulation/NN of/IN E-selectin/NEWGENE ,/, one/PRP of/IN the/DT adhesion/NN molecules/NNS on/IN the/DT endothelium/NN ,/, is/VBZ an/DT important/JJ event/NN in/IN the/DT mediation/NN of/IN the/DT inflammatory/JJ response/NN ./.
@@80489166512 IGF/NEWGENE I/NEWGENE and/CC insulin/NEWGENE receptors/NEWGENE are/VBP homologous/JJ proteins/NNS that/WDT function/VBP in/IN distinct/JJ physiological/JJ pathways/NNS ./.
@@63613185975 Side/NNP effect/NN including/JJ subjective/JJ and/CC objective/JJ symptoms/NNS were/VBD strictly/RB evaluated/VBN in/IN 163/CD cases/NNS (/( KS-R1/NN group/NN in/IN 83/CD cases/NNS ,/, oral/JJ group/NN in/IN 80/CD cases/NNS )/SYM ,/, but/CC the/DT incidence/NN rate/NN which/WDT was/VBD 22/CD ./CD 9%/CD for/IN the/DT KS-R1/NN group/NN and/CC 23/CD ./CD 8%/CD for/IN the/DT oral/JJ group/NN showed/VBD no/DT significant/JJ difference/NN ./.
@@954128071 Increased/VBN plasma/NN IgE/NEWGENE was/VBD also/RB confirmed/VBN in/IN the/DT NC/NN mice/NNS ,/, and/CC treatment/NN with/IN FK506/NNS ointment/NN reduced/VBD the/DT plasma/NN IgE/NEWGENE level/NN ./.
@@109993692315 We/PRP found/VBP that/IN the/DT amplitude/NN of/IN the/DT cortical/RB evoked/VBN potentials/NNS (/( amplitude/NN of/IN the/DT N2/NN //NN P2/NN peak/NN )/SYM increased/VBN from/IN 5/CD ./CD 1/CD +/NN //NN -/NN 0/CD ./CD 7/CD microV/NN at/IN 5/CD mA/NN to/IN 16/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 1/CD microV/NN at/IN 20/CD mA/CD ./CD
@@85706153376 Disruption/NNS of/IN RB/NEWGENE //NEWGENE E2F-1/NEWGENE interaction/NN by/IN single/JJ point/NN mutations/NNS in/IN E2F-1/NEWGENE enhances/VBZ S-phase/NN entry/NN and/CC apoptosis/NN ./.
@@19198312541 Ventilatory/JJ management/NN casebook/NN ./.
@@29717103687 Plots/NNS of/IN RV/NN ,/, LV/JJ +/SYM S/NNP and/CC 2A/NN weight/NN vs/NNP real/JJ hematocrit/NN showed/VBD sharp/JJ upward/JJ inflections/NNS at/IN real/JJ hematocrit/NN 65%/JJ ,/, suggesting/VBG a/DT possible/JJ role/NN of/IN increased/VBN viscosity/NN in/IN CO/NN cardiomegaly/NN at/IN the/DT higher/JJ hematocrit/NN ./.
@@23487283003 We/PRP conclude/VBP that/DT DNA/NN ploidy/NN is/VBZ a/DT major/JJ objective/JJ prognostic/JJ factor/NN and/CC therapeutic/JJ determinant/NN for/IN endometrial/JJ carcinoma/NN ./.
@@30011103278 When/WRB phosphorylation/NN of/IN exogenous/JJ peptide/NN substrates/NNS was/VBD measured/VBN as/IN a/DT function/NN of/IN receptor/NN self-phosphorylation/NN ,/, tyrosine/NEWGENE kinase/NEWGENE activity/NN was/VBD found/VBN to/IN be/VB enhanced/VBN two/JJ to/IN threefold/RB at/IN 1-2/CD mol/NN of/IN phosphate/NN per/IN mol/NN of/IN receptor/NN ./.
@@87078255335 It/PRP is/VBZ exclusively/RB observed/VBN in/IN smooth/JJ muscle/NN cells/NNS by/IN Northern/NNP blotting/NN and/CC immunohistochemical/JJ analysis/NN and/CC therefore/RB designated/VBN "smoothelin/NEWGENE ./NEWGENE "/NEWGENE A/DT human/JJ smooth/JJ muscle/NN cDNA/NN library/NN was/VBD screened/VBN with/IN the/DT monoclonal/NEWGENE antibody/NEWGENE R4A/NEWGENE ,/, and/CC a/DT full-size/JJ cDNA/NN of/IN the/DT protein/NN was/VBD selected/VBN ./.
@@19775852026 The/DT native/JJ enzyme/NN purified/VBN from/IN protease-B-deficient/JJ URA2-transformed/JJ cells/NNS ,/, was/VBD phosphorylated/VBN in/IN vitro/FW using/VBG catalytic/JJ subunits/NNS of/IN pure/JJ cAMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE ./.
@@88815428838 Sodium/NN polystyrene/NN sulfonate/NN treatment/NN for/IN lithium/NN toxicity/NN :/: effects/NNS on/IN serum/JJ potassium/NN concentrations/NNS ./.
@@79181281042 BACKGROUND/IN :/: We/PRP conducted/VBD a/DT phase/NN I/PRP study/NN with/IN MDL/NN 73/NN ,/NN 147EF/NN ,/, a/DT new/JJ 5/NEWGENE hydroxytryptamine/NEWGENE 3/NEWGENE (/NEWGENE 5-HT3/NEWGENE )/NEWGENE receptor/NEWGENE antagonist/NN ,/, in/IN 25/CD patients/NNS requiring/JJ emetogenic/JJ chemotherapy/NN ./.
@@105214508226 We/PRP examined/VBD Akt/NEWGENE activation/NN in/IN Lyn-/NNP ,/, Syk-/NNP and/CC Btk-deficient/NNP DT40/NNP cells/NNS and/CC B/NNP cells/NNS from/IN Lyn/NEWGENE (/NEWGENE -/NEWGENE //NEWGENE -/NEWGENE )/NEWGENE mice/NNS ./.
@@87621725691 Large/JJ strain/NN differences/NNS were/VBD found/VBN for/IN all/DT variables/NNS recorded/VBN ,/, i/FW ./FW e/FW ./FW ,/, the/DT proportion/NN of/IN attacking/JJ males/NNS ,/, the/DT time/NN spent/VBP in/IN the/DT brightly/RB lit/NN box/NN ,/, and/CC the/DT number/NN of/IN transitions/NNS between/IN the/DT lit/NN and/CC the/DT dark/JJ boxes/NNS ./.
@@78699137868 During/IN ISO+AT/NN infusion/NN ,/, abdominal/JJ fat/JJ blood/NN flow/NN was/VBD still/RB significantly/RB increased/VBN as/IN compared/VBN with/IN control/NN values/NNS in/IN lean/JJ and/CC obese/JJ subjects/NNS ./.
@@60842791287 Twenty-two/CD of/IN the/DT 24/CD patients/NNS had/VBP a/DT rise/NN in/IN the/DT total/JJ serum/JJ amylase/NEWGENE following/IN ERCP/NN ./.
@@22624394969 MCh/NNS infusion/NN caused/VBD a/DT concentration-dependent/NN increase/NN in/IN airway/NN resistance/NN at/IN constant/NN QBA/NN ./.
@@84700216940 We/PRP obtained/VBD the/DT prevalence/NN of/IN IgG/NEWGENE antibodies/NEWGENE against/IN Trypanosoma/JJ cruzi/NN among/IN 1076/CD blood/NN donors/NNS at/IN the/DT Instituto/NNP Nacional/NNP de/FW Cardiologia/NNS "Ignacio/NNP Chavez"/NNP in/IN Mexico/NNP City/NNP ./.
@@96797504787 In/NN particular/JJ ,/, the/DT potential/NN for/IN prostate/NN cancer/NN chemoprevention/NN using/VBG nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS (/( cyclo-oxygenase/NEWGENE inhibitors/NN ;/: NSAIDs/NNS )/SYM has/VBZ received/VBN little/JJ attention/NN ./.
@@95242505029 Both/DT TRE-like/NEWGENE elements/NEWGENE were/VBD capable/JJ of/IN binding/NN AP1/NEWGENE ./.
@@72979787163 Anamnestic/JJ data/NN were/VBD obtained/VBN from/IN case/NN history/NN ,/, smoking/NN habits/NNS were/VBD not/RB known/VBP in/IN collective/JJ A/DT and/CC C/NNP ./NNP
@@91829901904 Using/VBG a/DT conditional-lethal/JJ mutant/NN allele/NN of/IN SUP45/NEWGENE (/( sup45-2/NEWGENE )/SYM and/CC a/DT combination/NN of/IN in/IN vivo/NN and/CC in/IN vitro/FW approaches/NNS ,/, we/PRP demonstrate/VBP that/IN the/DT product/NN of/IN the/DT SUP45/NEWGENE gene/NEWGENE (/( Sup45p/NEWGENE or/CC eRF1/NEWGENE )/SYM is/VBZ a/DT factor/NN required/VBN for/IN translation/NN termination/NN in/IN yeast/NN ./.
@@84275018384 Large/JJ differences/NNS between/IN the/DT groups/NNS were/VBD not/RB observed/VBN in/IN HA-synthesizing/JJ enzyme/NN activity/NN ,/, but/CC degradative/JJ enzyme/NN activity/NN was/VBD much/JJ higher/JJ in/IN aspirin-induced/JJ asthma-related/JJ polyps/NNS than/IN in/IN other/DT types/NNS of/IN nasal/JJ polyps/NNS tested/VBN ./.
@@28537991442 The/DT progression/NN of/IN non-A/NN ,/, non-B/NN hepatitis/NN to/IN chronic/JJ diseases/NNS ,/, and/CC the/DT transformation/NN to/IN hepatocellular/JJ carcinoma/NN ./.
@@78066511859 This/DT study/NN investigated/VBD the/DT degree/NN to/IN which/WDT racial/JJ identity/NN influences/NNS Mexican-Americans'/NNP performance/NN on/IN the/DT L/NN ,/, K/NN ,/, and/CC MF/NN scales/NNS of/IN the/DT MMPI-2/NN ./.
@@81390019297 The/DT results/NNS show/NN that/IN both/PDT the/DT amino/JJ and/CC carboxy/JJ termini/NNS of/IN the/DT NS1/NEWGENE protein/NEWGENE molecule/NEWGENE and/CC the/DT cysteines/NNS at/IN residues/NNS 337/CD and/CC 340/CD are/VBP essential/JJ for/IN tubule/NN formation/NN ./.
@@86305489478 Several/JJ cytokines/NNS exhibit/VBP a/DT high/JJ degree/NN of/IN temporal/JJ regulation/NN as/RB well/VB as/IN somnogenic/JJ potency/NN (/( e/FW ./FW g/FW ./FW ,/, interleukin-1/NEWGENE [/NEWGENE1 IL-1/NEWGENE1 ]/NEWGENE1 ,/, tumor/NEWGENE necrosis/NEWGENE factor-alpha/NEWGENE [/NEWGENE1 TNF-alpha/NEWGENE1 ]/NEWGENE1 )/SYM ./.
@@29798343700 Effects/NNPS of/IN single/JJ and/CC combined/JJ maltose/NN tetrapalmitate/NN immunotherapy/NN ,/, cyclophosphamide/NN chemotherapy/NN and/CC radiotherapy/NN on/IN ethyl/NN carbamate/NN accelerated/JJ primary/JJ lung/NN cancer/NN in/IN A/NNP //NNP J/NNP mice/NNS ./.
@@20798112688 The/DT authors/NNS evaluate/VBP the/DT clinical/JJ efficacy/NN of/IN EMB/NN AZS/NN in/IN recurrent/JJ ulcer/NN after/IN operation/NN on/IN the/DT stomach/NN caused/VBN by/IN a/DT high/JJ level/NN of/IN acid/NN production/NN and/CC ulcerative/JJ gastroduodenal/JJ bleeding/NN ./.
@@1004172837 Vacuum/NNP Rabi/NN splitting/NN as/IN a/DT feature/NN of/IN linear-dispersion/JJ theory/NN :/: Analysis/NNP and/CC experimental/JJ observations/NNS ./.
@@52034998819 Successive/JJ abdominal/JJ scintillation/NN with/IN 131-I-tagged/NNP BSP--description/NNP of/IN the/DT thyroid/JJ gland/NN ,/, kidney/NN and/CC spleen/NN (/( comparison/NN with/IN 131-I-RB/NN )/SYM ./.
@@74492217324 The/DT operation/NN recommended/VBN is/VBZ excision/NN of/IN 3/CD mm/NN of/IN central/NN slip/NN followed/VBN by/IN end-to-end/JJ repair/NN of/IN the/DT tendon/NN ./.
@@99888507848 The/DT Scales/NNS of/IN Cognitive/JJ Impairment/NNS Rated/VBN From/IN Institutional/JJ Records/NNPS (/( SCIRFIR/NN )/SYM ,/, a/DT battery/NN based/VBN on/IN commonly/RB used/VBN dementia/NN rating/JJ instruments/NNS ,/, was/VBD tested/VBN on/IN the/DT records/NNS of/IN 26/CD chronically/RB institutionalized/JJ ,/, elderly/JJ schizophrenia/NN patients/NNS ,/, for/IN the/DT purpose/NN of/IN retrospectively/RB evaluating/VBG the/DT long-term/JJ course/NN of/IN cognitive/JJ change/NN in/IN schizophrenia/NN and/CC relating/VBG it/PRP to/IN available/JJ autopsy/NN materials/NNS ./.
@@82371718221 We/PRP report/VBP an/DT odd/JJ case/NN of/IN marked/JJ enlargement/NN of/IN suprapineal/JJ recess/NN in/IN a/DT patient/NN with/IN triventricular/JJ hydrocephalus/NN ./.
@@111984245915 Molecular/NNP cloning/NN and/CC characterization/NN of/IN OsPSK/NEWGENE ,/, a/DT gene/NN encoding/VBG a/DT precursor/NN for/IN phytosulfokine-alpha/NEWGENE ,/, required/VBN for/IN rice/NN cell/NN proliferation/NN ./.
@@94669319657 Cross-talking/VBG among/IN Drosophila/NEWGENE nuclear/NEWGENE receptors/NEWGENE at/IN the/DT promiscuous/NEWGENE response/NEWGENE element/NEWGENE of/IN the/DT ng-1/NEWGENE and/CC ng-2/NEWGENE intermolt/NEWGENE genes/NEWGENE ./.
@@100808752225 The/DT results/NNS of/IN supershift/NN analysis/NN using/VBG specific/JJ antibodies/NNS against/IN transcription/NN factors/NNS suggested/VBN that/IN both/DT binding/JJ complexes/NNS contained/VBD the/DT NF-kappaB/NEWGENE components/NN p50/NEWGENE and/CC p65/NEWGENE ,/, and/CC did/VBD not/RB contain/VB other/DT NF-kappaB/NEWGENE proteins/NEWGENE (/( p52/NEWGENE ,/, c-Rel/NEWGENE ,/, Rel/NEWGENE B/NEWGENE )/SYM ,/, AP-1/NEWGENE proteins/NEWGENE (/( c-Fos/NEWGENE ,/, C-Jun/NEWGENE )/SYM ,/, CREB/NEWGENE or/CC C/NEWGENE //NEWGENE EBPbeta/NEWGENE (/( NF-IL6/NEWGENE )/SYM ./.
@@83006259903 The/DT COOH-terminal/NN 46/NN codons/NNS of/IN slyD/NEWGENE encode/VB a/DT remarkable/JJ histidine-rich/JJ peptide/NN sequence/NN which/WDT is/VBZ at/IN least/RB partly/RB dispensable/JJ for/IN slyD/NEWGENE function/NN in/IN E-mediated/JJ lysis/NN ./.
@@81063987292 These/DT results/NNS confirmed/VBD that/DT cleavage/NN of/IN the/DT leader/NN peptide/NN is/VBZ the/DT last/NN step/NN in/IN nisin/NEWGENE maturation/NN and/CC is/VBZ necessary/JJ to/IN generate/VB a/DT biologically/RB active/JJ peptide/NN ./.
@@64460486254 It/PRP is/VBZ concluded/VBN that/IN axillo-axillary/JJ by-pass/NN is/VBZ a/DT simple/JJ solution/NN for/IN a/DT complex/JJ haemodynamic/JJ ,/, clinical/JJ and/CC therapeutic/JJ problem/NN ./.
@@83617558112 Under/IN these/DT conditions/NNS ,/, transfections/NNS with/IN cDNAs/NNS of/IN the/DT NF-kappa/NEWGENE B/NEWGENE p50/NEWGENE and/NN serum/NEWGENE response/NEWGENE factor/NEWGENE (/( SRF/NEWGENE )/SYM produced/VBN a/DT factor/NN (/NN s/NN )/NN that/IN mediated/JJ Tax/NEWGENE binding/JJ to/IN the/DT NF-kappa/NEWGENE B/NEWGENE site/NEWGENE and/CC the/DT CArG/NEWGENE box/NEWGENE respectively/RB ./.
@@105233196252 Here/RB we/PRP report/VBP that/IN Dbp5p/NEWGENE and/CC Rat7p/NEWGENE interact/VB through/RB their/PRP Nterminal/JJ domains/NNS ./.
@@14489176971 Comparisons/NNS with/IN the/DT available/JJ amino/JJ acid/NN residue/NN (/( aa/NNS )/SYM sequence/NN information/NN from/IN the/DT complete/JJ CPMV/NEWGENE RNA/NEWGENE 1/NEWGENE sequence/NEWGENE and/CC the/DT partial/JJ sequence/NN of/IN red/NEWGENE clover/NEWGENE mottle/NEWGENE virus/NEWGENE RNA/NEWGENE 1/NEWGENE suggest/VB that/IN CPSMV/NEWGENE RNA/NEWGENE 1/NEWGENE specifies/VBZ the/DT expected/VBN set/NN of/IN five/CD mature/JJ proteins/NNS :/: 32K/NEWGENE proteinase/NEWGENE cofactor/NEWGENE ,/, 58K/NEWGENE presumed/NEWGENE helicase/NEWGENE ,/, VPg/NEWGENE 5'-linked/NEWGENE protein/NEWGENE of/IN the/DT genomic/JJ RNAs/NNS ,/, 24K/NEWGENE proteinase/NEWGENE ,/, and/CC 87K/NEWGENE presumed/NEWGENE polymerase/NEWGENE ,/, separated/VBN by/IN four/CD cleavage/NN sites/NNS ./.
@@112783904876 Reverse/VB transcriptase-polymerase/JJ chain/NN reaction/NN assays/NNS showed/VBN that/IN PKRDeltaE7/NEWGENE is/VBZ expressed/VBN in/IN a/DT broad/JJ range/NN of/IN human/JJ tissues/NNS at/IN variable/JJ levels/NNS ./.
@@77423633052 Two/CD mammalian/JJ enzymes/NNS ,/, the/DT haem-controlled/NEWGENE repressor/NEWGENE (/( HCR/NEWGENE )/SYM and/CC the/DT double-stranded/NEWGENE RNA-activated/NEWGENE inhibitor/NEWGENE (/( dsI/NEWGENE )/SYM ,/, phosphorylate/VB Ser-51/NN of/IN the/DT alpha/NN subunit/NN ,/, thereby/RB inhibiting/JJ the/DT exchange/NN of/IN bound/JJ nucleotides/NNS on/IN ,/, and/CC thus/RB the/DT recycling/NN of/IN ,/, eIF-2/NEWGENE ./.
@@15131148314 The/DT mean/JJ serum/JJ creatinine/NN levels/NNS were/VBD similar/JJ at/IN one/PRP year/NN (/( SPK/NN 1/NN ./NN 8/NN ,/, KTA/NN 1/NN ./NN 9/NN mg/NN //NN d/NN )/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@5217321154 Urinary/NNP excretion/NN of/IN oestrone/NN ,/, oestradiol-17/NN beta/NN and/CC oestriol/NN in/IN pregnancies/NNS complicated/VBN by/IN steroid/NEWGENE sulphatase/NEWGENE deficiency/NN ./.
@@85618938292 Although/IN a/DT great/JJ deal/NN is/NNS understood/VBP about/RB how/RB bHLH/NEWGENE factors/NEWGENE activate/NN gene/NN transcription/NN via/NN E-box/NN DNA/NN consensus/NN sequences/NNS ,/, studies/VBZ of/IN bHLH/NEWGENE factor/NEWGENE function/NN in/IN higher/JJ eukaryotes/NNS often/RB have/VBP been/VBN hindered/VBN by/IN the/DT presence/NN of/IN multiple/JJ family/NN members/NNS ./.
@@115341321409 However/RB these/DT search/NN engines/NNS respond/VBP with/IN such/JJ cumbersome/JJ results/NNS that/WDT domain/NN specific/JJ experts/NNS can/MD not/RB tolerate/VB ./.
@@97692092474 Previous/JJ genetic/JJ studies/NNS led/VBN to/IN the/DT conclusion/NN that/DT nitrate/NN and/CC nitrite/NN induction/NN of/IN nasF/NEWGENE operon/NEWGENE expression/NN is/VBZ determined/VBN by/IN a/DT transcriptional/JJ antitermination/NN mechanism/NN ./.
@@77420247694 According/VBG to/IN symptoms/NNS ,/, signs/NNS ,/, imaging/VBG features/NNS ,/, operation/NN findings/NNS ,/, the/DT original/JJ places/NNS and/CC the/DT expansive/JJ directions/NNS of/IN the/DT tumor/NN ,/, they/PRP were/VBD divided/VBN into/IN four/CD clinical/JJ types/NNS :/: sellar/JJ ,/, clival/JJ ,/, occipito-temporal/JJ and/CC extent/NN ./.
@@108789446869 ID-PaGIA/NN diphtheria/NEWGENE toxin/NEWGENE polymer/NN particle/NN diagnostic/JJ agent/NN manufactured/VBN by/IN DiaMed/NN AG/NN ,/, Switzerland/NN ,/, was/VBD tried/VBN at/IN bacteriological/JJ laboratory/NN of/IN Institute/NNP of/IN Childhood/NNP Infections/NNS in/IN St/NN ./NN
@@95751435244 The/DT localization/NN of/IN ZAP-70/NEWGENE to/IN the/DT cell/NN cortex/NN is/VBZ ,/, therefore/RB ,/, regulated/VBN by/IN the/DT activity/NN of/IN SRC-family/NEWGENE kinases/NEWGENE ,/, independently/RB of/IN their/PRP ability/NN to/IN phosphorylate/VB immunoreceptor/NN tyrosine-based/JJ activation/NN motifs/NN of/IN the/DT TCR/NEWGENE ./.
@@33048663993 Revascularization/NNS after/IN anterior/JJ maxillary/JJ and/CC mandibular/JJ osteotomy/NN ./.
@@77612164762 Short-course/NNP amphotericin/NN B/NN therapy/NN for/IN candidemia/NN in/IN pediatric/JJ patients/NNS ./.
@@108488484064 RESULTS/NNS :/: Fournier's/NN gangrene/NN occurs/VBZ worldwide/RB ./.
@@25078151298 Kindling/NN of/IN the/DT primary/NN visual/NN cortex/NN (/( VC/NN )/SYM was/VBD compared/VBN with/IN that/DT of/IN the/DT amygdala/NN in/IN cats/NNS ./.
@@104862103339 To/TO study/VB the/DT regulation/NN of/IN its/PRP expression/NN ,/, the/DT human/NEWGENE aldehyde/NEWGENE reductase/NEWGENE gene/NEWGENE and/CC promoter/NN were/VBD cloned/VBN and/CC characterized/VBN ./.
@@65083937734 Serodiagnosis/NNS of/IN trypanosomiasis/NN in/IN dromedary/NN camels/NNS using/VBG a/DT card/NN agglutination/NN test/NN set/NN (/( Testryp/NN CATT/NN )/SYM ./.
@@92100129164 The/DT impact/NN of/IN social/JJ support/NN on/IN the/DT relationships/NNS of/IN gay/JJ male/JJ couples/NNS is/VBZ examined/VBN ./.
@@86753958646 RESULTS/NNS :/: The/DT bilinear/JJ model/NN provided/VBD a/DT significantly/RB better/JJR fit/NN to/IN the/DT acuity/NN outcome/NN data/NN ./.
@@11786371636 Atherosclerosis/NNS ./.
@@81023649739 Tobacco/NNP mosaic/NN virus-infected/JJ tobacco/NN (/( Nicotiana/NNP tabacum/NN var/NN ./.
@@118539437019 The/DT long-term/JJ prediction/NN is/VBZ based/VBN on/IN an/DT algorithm/NN for/IN R-R/NNS interval/NN estimation/NN ./.
@@109340737465 Despite/IN these/DT limitations/NNS the/DT CHIME/NN monitor/NN provides/VBZ an/DT opportunity/NN to/IN record/NN physiological/JJ data/NN previously/RB unavailable/JJ in/IN the/DT home/NN ./.
@@76778367613 Diffuse/JJ white/JJ matter/NN injury/NN can/MD be/VB attributed/VBN to/IN radiation/NN and/CC associated/VBN with/IN neurological/JJ deficits/NNS ,/, but/CC leukoencephalopathy/NN is/VBZ rarely/RB observed/VBN in/IN the/DT absence/NN of/IN chemotherapy/NN ./.
@@54922855564 The/DT biology/NN of/IN Hyostrongylus/JJ ruidus/NN ./.
@@30501479144 This/DT observation/NN cannot/MD be/VB explained/VBN by/IN the/DT scanning/JJ model/NN for/IN ribosomal/JJ initiation/NN and/CC suggests/VBZ that/IN ribosomes/NNS may/MD be/VB binding/JJ directly/RB at/IN an/DT internal/JJ mRNA/NN site/NN at/IN or/CC near/IN the/DT initiator/NN AUG/NNS codon/NN for/IN the/DT C/NEWGENE protein/NEWGENE ./.
@@35412634209 Several/JJ new/JJ techniques/NNS are/VBP available/JJ for/IN monitoring/VBG control/NN of/IN diabetes/NN ./.
@@10694609853 Static/NN and/CC dynamic/JJ compliance/NN was/VBD measured/VBN after/IN induction/NN of/IN anesthesia/NN ,/, before/IN and/CC immediately/RB after/IN filtration/NN in/IN the/DT operating/JJ theater/NN ,/, 1/CD hour/NN after/IN return/NN to/IN the/DT pediatric/JJ intensive/JJ care/NN unit/NN ,/, and/CC 24/CD hours/NNS after/IN the/DT operation/NN ./.
@@87412808730 Large/JJ ones/NNS were/VBD similar/JJ in/IN size/NN to/IN the/DT main/JJ lobe/NN and/CC small/JJ ones/NNS were/VBD approximately/RB 1/CD //CD 4/CD of/IN the/DT length/NN of/IN the/DT main/JJ lobe/NN ./.
@@11247663366 Two/CD families/NNS with/IN concordant/JJ inheritance/NN of/IN DNAH9/NEWGENE alleles/NEWGENE in/IN affected/VBN individuals/NNS were/VBD observed/VBN ./.
@@38628986877 Serum/NEWGENE IgM/NEWGENE and/CC IgE/NEWGENE concentrations/NNS ,/, allergen-specific/NEWGENE IgE/NEWGENE scores/NNS ,/, and/CC the/DT tumor/NN E2R/NEWGENE status/NN were/VBD combined/JJ to/IN construct/NN a/DT three-level/JJ risk/NN classification/NN that/WDT was/VBD more/RB prognostic/JJ than/IN any/DT of/IN the/DT individual/JJ components/NNS ./.
@@32857645102 Hyperprolactinaemia/NN ,/, moderate/JJ hypogonadism/NN ,/, infraclinical/JJ neuropathies/NNS ,/, arterial/JJ stenoses/NNS and/CC moderate/JJ venous/JJ leakages/NNS seem/VBP to/IN play/NN a/DT partial/JJ role/NN of/IN organic/JJ starter/NN or/CC cofactor/NN ,/, the/DT sexual/JJ consequences/NNS of/IN which/WDT are/VBP amplified/VBN by/IN psychological/JJ factors/NNS ,/, partly/RB secondary/JJ to/IN the/DT initial/JJ sexual/JJ failures/NNS ./.
@@90005898954 The/DT resurgence/NN of/IN drug-resistant/NN malaria/NN makes/VBP urgent/JJ the/DT evaluation/NN of/IN new/JJ antimalarial/JJ agents/NNS ./.
@@7607537427 The/DT spectrum/NN of/IN phenotypes/NNS caused/VBN by/IN these/DT mutations/NNS was/VBD strikingly/RB different/JJ than/IN mutations/NNS in/IN the/DT adaptor/NN for/IN the/DT VP16/NEWGENE activation/NEWGENE domain/NEWGENE ./.
@@10511216340 CONCLUSIONS/IN :/: Congenital/JJ horizontal/JJ tarsal/JJ kink/NN is/VBZ rare/JJ and/CC its/PRP cause/NN is/VBZ unknown/JJ ./.
@@75094495244 The/DT transforming/NN gene/NN of/IN the/DT avian/NEWGENE sarcoma/NEWGENE virus/NEWGENE CT10/NEWGENE encodes/VBZ a/DT fusion/NN protein/NN (/( p47gag-crk/NEWGENE or/CC v-Crk/NEWGENE )/SYM containing/NN viral/NEWGENE Gag/NEWGENE sequences/NEWGENE fused/VBN to/IN cellular/JJ sequences/NNS consisting/VBG primarily/RB of/IN Src/NEWGENE homology/NEWGENE regions/NEWGENE 2/NEWGENE and/NEWGENE 3/NEWGENE (/( SH2/NEWGENE and/CC SH3/NEWGENE sequences/NEWGENE )/SYM ./.
@@88353931618 It/PRP is/VBZ likely/RB that/IN other/DT pathways/NNS involve/VBP alternate/JJ signal/JJ transduction/NN events/NNS (/( e/FW ./FW g/FW ./FW ,/, calcium/NN mobilization/NN )/SYM and/CC promoter/NN response/NN elements/NN (/( e/FW ./FW g/FW ./FW ,/, SRE/NNS )/SYM ./.
@@24709553127 Their/PRP studies/NNS have/VBP revealed/VBN a/DT considerable/JJ increase/NN of/IN CSF/NEWGENE AP/NEWGENE activity/NN in/IN purulent/JJ meningitides/NNS whereas/IN in/IN serous/JJ meningitides/NNS it/PRP grows/VBZ negligibly/RB ./.
@@75962876121 The/DT ORF3/NN probe/NN also/RB hybridized/VBN to/IN a/DT 540/CD bp/NN transcript/NN consistent/JJ with/IN the/DT size/NN of/IN ORF3/NN alone/RB and/CC supportive/JJ of/IN the/DT mutagenesis/NN data/NN of/IN non-linkage/NN ./.
@@85634837245 In/NN these/DT cases/NNS ,/, greatly/RB increased/VBN human/NEWGENE chorionic/NEWGENE gonadotropin/NEWGENE (/( hCG/NEWGENE )/SYM levels/NNS and/CC suppressed/VBN TSH/NEWGENE levels/NNS suggest/VBP that/DT hCG/NEWGENE has/VBZ thyrotropic/JJ activity/NN ./.
@@92069689160 Disturbance/NNS of/IN regeneration/NN in/IN the/DT above/RB pathological/JJ condition/NN results/NNS from/IN the/DT damage/NN to/IN tunica/NN propria/NN and/CC loss/NN of/IN its/PRP function/NN for/IN the/DT support/NN of/IN structural/JJ homeostasis/NN ./.
@@81249129255 However/RB ,/, a/DT correlation/NN was/VBD observed/VBN between/IN SF/NN levels/NNS of/IN IL-8/NEWGENE with/IN those/DT of/IN lactate/NN ,/, LDH/NEWGENE ,/, beta/NEWGENE 2-microglobulin/NEWGENE and/CC glucose/NN ./.
@@15543342162 The/DT recently/RB developed/VBN gamma-interferon/NEWGENE (/( IFN-gamma/NEWGENE )/SYM assay/NN system/NN for/IN the/DT diagnosis/NN of/IN bovine/JJ tuberculosis/NN in/IN cattle/NNS has/VBZ been/VBN accredited/VBN by/IN the/DT Standing/VBG Committee/NNP on/IN Agriculture/NNP for/IN use/NN in/IN Australia/NN ./.
@@94789212565 Substrates/NNS for/IN p210/NEWGENE (/NEWGENE bcr-abl/NEWGENE )/NEWGENE are/VBP likely/RB to/IN be/VB involved/VBN in/IN the/DT pathogenesis/NN of/IN CML/NN ./.
@@791450747 Comparison/NNS of/IN cDNA/NN sequences/NNS revealed/VBN that/IN the/DT two/JJ mRNA/NN species/NN arise/VB as/IN a/DT result/NN of/IN alternate/JJ use/NN of/IN poly/NN (/NN A/NN )/NN -addition/NN sites/NNS ./.
@@86426937578 Polyprotein/NN processing/VBG in/IN Southampton/NNP virus/NN :/: identification/NN of/IN 3C-like/NEWGENE protease/NEWGENE cleavage/NN sites/NNS by/IN in/IN vitro/FW mutagenesis/NN ./.
@@72762107131 Assay/NNS of/IN serum/NEWGENE immunoreactive/NEWGENE trypsin/NEWGENE in/IN dried/JJ blood/NN spots/NNS and/CC the/DT early/JJ detection/NN of/IN cystic/JJ fibrosis/NN ./.
@@109035835472 Reliability/NN of/IN cervical/JJ range/NN of/IN motion/NN using/VBG the/DT OSI/NN CA/NN 6000/CD spine/NN motion/NN analyser/NN on/IN asymptomatic/JJ and/CC symptomatic/JJ subjects/NNS ./.
@@74188297271 Implications/NNS of/IN this/DT observation/NN for/IN pediatrics/NN are/VBP discussed/VBN ./.
@@13723655984 At/NN some/DT sites/NNS ,/, %T/NN is/VBZ greatly/RB increased/VBN by/IN Cl-/NN concentrations/NNS up/JJ to/IN 1/CD M/NN ,/, while/CC at/IN other/DT sites/NNS %T/NN is/VBZ reduced/VBN or/CC unaffected/JJ by/IN these/DT conditions/NNS ./.
@@98930608081 Northern/NNP blot/NN analysis/NN demonstrated/VBD the/DT ubiquitous/JJ expression/NN of/IN 2/CD ./CD 9/CD kb/NN and/CC 3/CD ./CD
@@108821637408 Objective/JJ responses/NNS also/RB occurred/VBN in/IN studies/NNS that/WDT explored/VBD sequential/JJ use/NN of/IN exemestane/NN after/IN failure/NN of/IN aminoglutethimide/NN (/( 26%/JJ with/IN exemestane/NN 200/CD mg/NN //NN day/NN )/SYM or/CC other/DT nonsteroidal/JJ aromatase/NEWGENE inhibitors/NN (/( 6/CD ./CD 6%/CD with/IN exemestane/NN 25/CD mg/NN //NN day/NN )/SYM ./.
@@103768734643 Thus/RB ,/, sgRNA2/NEWGENE has/VBZ the/DT 3'TE/NEWGENE in/IN its/PRP 5'/CD UTR/NNS ./.
@@39103104563 Such/JJ a/DT concept/NN is/VBZ crucial/JJ to/IN our/PRP understanding/NN of/IN the/DT pathology/NN of/IN ageing/NN in/IN general/NN ./.
@@2680843930 After/IN the/DT application/NN of/IN RS/NN 86/NN ,/, REM/NN latency/NN was/VBD shortened/VBN in/IN all/DT groups/NNS under/IN investigation/NN ./.
@@107815412539 Two/CD additional/JJ cis-acting/JJ sequences/NNS ,/, conserved/VBN in/IN both/PDT the/DT region/NN 1/CD and/CC 3/CD promoters/NNS ,/, were/VBD identified/VBN ,/, suggesting/VBG a/DT role/NN for/IN these/DT sequences/NNS in/IN the/DT coordinate/JJ regulation/NN of/IN transcription/NN from/IN these/DT promoters/NNS ./.
@@92443506108 BRCA1/NEWGENE ,/, a/DT familial/JJ breast/NN and/CC ovarian/JJ cancer/NN susceptibility/NN gene/NN encodes/VBZ nuclear/NN phosphoproteins/NN that/WDT function/VBP as/IN tumor/NN suppressors/NNS in/IN human/JJ breast/NN cancer/NN cells/NNS ./.
@@38870852572 A/DT high/JJ efficacy/NN of/IN the/DT combined/JJ use/NN of/IN nontoxic/JJ doses/NNS of/IN two/JJ pharmaceuticals/NNS :/: cystamine/NN (/( 50/CD mg/CD //CD kg/CD )/SYM and/CC mexamine/NN (/( 25/CD mg/CD //CD kg/CD )/SYM under/IN the/DT conditions/NNS of/IN short-term/JJ exogenous/JJ hypoxia/NN (/( 7/CD ./CD 5%/CD O2/NN )/SYM was/VBD found/VBN in/IN (/( CBA/NN X/NNP C57Bl/NNP )/NN F1/NN mice/NNS ./.
@@92784944462 In/NN contrast/NN ,/, both/DT Sp1/NEWGENE and/CC ETS/NEWGENE proteins/NEWGENE are/VBP required/VBN to/IN bring/VB about/RB full/JJ promoter/NN activity/NN in/IN the/DT Surf-1/NEWGENE direction/NN ./.
@@81315458099 The/DT epidemic/RB occurred/VBN in/IN a/DT group/NN of/IN 26/CD community/NN members/NNS (/( 23/CD men/NNS and/CC 3/CD women/NNS ,/, mean/JJ age/NN ,/, 28/NN ./NN 9--3/NN years/NNS )/SYM living/VBG and/CC working/JJ together/RB ,/, who/WP underwent/VBD acute/JJ and/CC convalescent/JJ serologic/JJ tests/NNS for/IN Mycoplasma/NN pneumoniae/NNS ,/, Legionella/NN pneumophila/NN ,/, cytomegalovirus/NN ,/, adenovirus/NN ,/, Coxiella/NN burnetii/NN ,/, and/CC Chlamydia/NN pneumoniae/NNS ./.
@@8657183813 We/PRP found/VBP strand/NN selective/JJ repair/NN in/IN DNA/NN fragments/NNS within/IN two/JJ active/JJ genes/NNS ,/, DHFR/NEWGENE and/CC an/DT unknown/JJ gene/NN adjacent/JJ to/IN DHFR/NEWGENE ./.
@@29992673719 Six/CD (/( four/CD FAP/NN ;/: two/JJ primary/JJ amyloidosis/NN )/SYM also/RB had/VBP diffusely/RB positive/JJ myocardial/JJ uptakes/NNS ,/, but/CC the/DT intensity/NN was/VBD less/PRP than/IN that/DT of/IN the/DT sternum/NN ./.
@@88642197211 The/DT minimum/JJ inhibitory/JJ concentrations/NNS (/( MICs/NNS )/SYM of/IN ketoconazole/NN ,/, miconazole/NN ,/, itraconazole/NN ,/, fluconazole/NN ,/, and/CC amphotericin/NN B/NN were/VBD significantly/RB influenced/VBN by/IN the/DT inoculum/NN size/NN ,/, regardless/RB of/IN the/DT techniques/NNS used/VBN ./.
@@97634212030 The/DT major/JJ phenotypes/NNS resulting/VBG from/IN Fab1p/NEWGENE kinase/NEWGENE inactivation/NN include/VB temperature-sensitive/JJ growth/NN ,/, vacuolar/JJ acidification/NN defects/NNS ,/, and/CC dramatic/JJ increases/NNS in/IN vacuolar/JJ size/NN ./.
@@110058084808 These/DT results/NNS demonstrate/VBP Ras-/NNP and/CC Raf-independent/NN ERK/NEWGENE MAPK/NEWGENE activation/NN maintains/VBZ cell/NN viability/NN following/IN heat/NN shock/NN ./.
@@102158119867 Initial/JJ control/NN of/IN bleeding/NN is/VBZ similar/JJ ,/, but/CC eradication/NN is/VBZ achieved/VBN in/IN fewer/DT sessions/NNS with/IN EVL/NN ./.
@@63090204904 Naloxone/IN (/( 2/CD mg/CD //CD kg/CD bolus/NN +/SYM 2/CD mg/NN X/NN kg-1/NN X/NN h-1/NN )/SYM was/VBD given/VBP with/IN one/PRP of/IN the/DT two/JJ doses/NNS of/IN the/DT lipopolysaccharide/NN ./.
@@112389163559 Moreover/RB ,/, a/DT complex/NN containing/NN PTP/NEWGENE phi/NEWGENE ,/, paxillin/NEWGENE ,/, and/CC a/DT paxillin-associated/NEWGENE tyrosine/NEWGENE kinase/NEWGENE ,/, Pyk2/NEWGENE ,/, can/MD be/VB immunoprecipitated/VBN from/IN macrophage/NN lysates/NNS ,/, and/CC the/DT catalytic/JJ domain/NN of/IN PTP/NEWGENE phi/NEWGENE selectively/RB binds/VBZ paxillin/NEWGENE and/CC Pyk2/NEWGENE in/IN vitro/FW ./.
@@6351438697 Action/NNP of/IN strontium-90/NN and/CC metaphos/NN on/IN Cyprinus/NNP carpio/NN ./.
@@10866689819 In/NN the/DT pRb/NEWGENE (/NEWGENE -/NEWGENE )/NEWGENE SAOS-2/CELL cell/NN line/NN transiently/RB transfected/VBN with/IN a/DT reporter/NN plasmid/NN containing/JJ six/CD tal-1/NEWGENE binding/NEWGENE site/NEWGENE ,/, pRb/NEWGENE enhances/VBZ the/DT transcriptional/JJ activity/NN of/IN tal-1-E12-Lmo2/NEWGENE and/CC tal-1-E12-Lmo2-Ldb1/NEWGENE complexes/NEWGENE but/CC not/RB that/IN of/IN a/DT tal-1-E12/NEWGENE heterodimer/NEWGENE ./.
@@112662271100 The/DT flux/NN rates/NNS of/IN p-toluidine/RB decreased/VBN as/IN the/DT pH/NN value/NN in/IN the/DT donor/NN solution/NN increased/VBN ./.
@@111753336178 Using/VBG immunochemical/JJ co-precipitation/JJ methods/NNS ,/, we/PRP also/RB found/VBP that/IN the/DT two/JJ proteins/NNS are/VBP bound/JJ in/IN vivo/NN ./.
@@98132079075 Transcription/NNS start/NN site/NN mapping/NN identified/VBD the/DT presence/NN of/IN an/DT aphidicolin-sensitive/JJ late/JJ transcript/NN arising/VBG from/IN a/DT TAAG/NEWGENE motif/NEWGENE located/VBN at/IN -352/CD nucleotides/NNS and/CC an/DT aphidicolin-insensitive/JJ early/JJ transcript/NN originating/VBG from/IN a/DT TTGT/NEWGENE motif/NEWGENE located/VBN 35/CD nucleotides/NNS downstream/RB to/IN a/DT TATA/NN box/NN at/IN -312/CD nucleotides/NNS ,/, with/IN respect/NN to/IN the/DT +1/NN ATG/NN of/IN lef2/NEWGENE ./.
@@77152007666 Anesthesiologists/NNS often/RB use/VBP more/RB than/IN one/PRP drug/NN in/IN a/DT patient/NN to/IN achieve/VB a/DT target/NN response/NN ,/, such/JJ as/IN a/DT desired/JJ blood/NN pressure/NN ./.
@@69819916765 Aneurysmectomy/NNS and/CC the/DT performance/NN of/IN CABG/NN were/VBD not/RB significantly/RB associated/VBN with/IN postoperative/JJ ECG/NN changes/NNS ,/, but/CC more/JJ bypass/NN grafts/NNS per/IN patient/NN grafted/VBN appeared/VBN in/IN the/DT group/NN with/IN postoperative/JJ ECG/NN changes/NNS ,/, suggesting/VBG that/IN coronary/JJ artery/NN disease/NN may/MD be/VB more/RB severe/JJ in/IN that/DT group/NN ./.
@@75905257488 The/DT average/JJ values/NNS were/VBD 199/CD and/CC 424/CD revertants/NN //NN g/NN for/IN the/DT hamburgers/NNS and/CC hot/JJ dogs/NNS ,/, respectively/RB ./.
@@110697916412 Of/IN 208/CD eligible/JJ subjects/NNS ,/, 82/CD received/VBN supervised/JJ IPT/NNS at/IN a/DT dose/NN of/IN 900/CD mg/NN twice/RB weekly/JJ for/IN 6/CD mo/NN (/( Regimen/VBP A/DT )/SYM ,/, 73/CD received/VBN unsupervised/JJ IPT/NN 900/NN mg/NN twice/RB weekly/JJ for/IN 6/CD mo/NN (/( Regimen/VBP B/NNP )/SYM ,/, and/CC 53/CD received/VBN unsupervised/JJ IPT/NN 300/NN mg/NN daily/JJ for/IN 6/CD mo/NN (/( Regimen/VBP C/NN )/SYM ./SYM
@@75594027523 We/PRP demonstrate/VBP that/IN a/DT VT+/NNP peptide/NN was/VBD specifically/RB phosphorylated/VBN by/IN protein/NEWGENE kinase/NEWGENE C/NEWGENE (/( PKC/NEWGENE )/SYM in/IN vitro/FW ,/, but/CC not/RB by/IN protein/NEWGENE kinase/NEWGENE A/NEWGENE (/( PKA/NEWGENE )/SYM ./.
@@61310381813 Plasma/NN and/CC erthrocyte/NN lipid/NN profile/NN and/CC lipoprotein/NEWGENE lipase/NEWGENE activity/NN in/IN postheparin/NN plasma/NN on/IN vasectomized/JJ rabbits/NNS were/VBD studied/VBN and/CC also/RB the/DT incidence/NN of/IN atherosclerosis/NN in/IN different/JJ arterial/JJ beds/NNS ./.
@@71911838304 Treatment/NNP of/IN meat/NN muscle/NN 800/NN V/NN for/IN 45/CD s/NN reduced/VBD weeping/JJ but/CC increased/VBN slightly/RB the/DT rate/NN of/IN autoxidation/NN of/IN lipids/NNS ./.
@@75926474383 The/DT single-stranded/JJ DNA/NN Pur/NEWGENE alpha/NEWGENE recognition/NEWGENE element/NEWGENE disrupts/VBZ these/DT complexes/NNS ./.
@@108026698335 Our/PRP data/NN provide/VB a/DT biochemical/JJ explanation/NN for/IN the/DT similarity/NN in/IN phenotype/NN between/IN A-T/DT and/CC NBS/NNP ./.
@@96852261477 The/DT role/NN of/IN calcitonin/NEWGENE ,/, and/CC other/DT agonists/NNS which/WDT activate/VBP the/DT cAMP/NN pathway/NN ,/, in/IN regulating/JJ transcription/NN of/IN the/DT human/NEWGENE parathyroid/NEWGENE hormone-related/NEWGENE protein/NEWGENE (/( PTHrP/NEWGENE )/SYM gene/NN was/VBD investigated/VBN in/IN a/DT human/JJ lung/NN cancer/NN cell/NN line/NN (/( BEN/CELL )/SYM ./.
@@91886995874 The/DT extended/VBN rat/NEWGENE SP-A/NEWGENE isoforms/NEWGENE were/VBD enriched/VBN in/IN the/DT more/RB fully/RB glycosylated/JJ and/CC multimeric/JJ SP-A/NEWGENE species/NN separated/VBN on/IN SDS-PAGE/NN gels/NNS ./.
@@76964507631 PATIENTS/IN AND/CC METHODS/IN :/: We/PRP report/VBP our/PRP experience/NN with/IN seven/JJ children/NNS with/IN active/JJ small/JJ bowel/NN Crohn's/NNP disease/NN given/VBP a/DT casein-based/NN ,/, polymeric/JJ feed/JJ rich/NN in/IN TGF-beta/NEWGENE 2/NEWGENE (/( Specific/JJ Polymeric/NNP Diet/NNP ;/: Nestle-Clintec/NNP ;/: Vevey/NNP ,/, Switzerland/NN )/SYM as/IN complete/JJ nutrition/NN for/IN 8/CD weeks/NNS ./.
@@82304189780 The/DT action/NN of/IN nef/NN was/VBD specific/JJ to/IN the/DT LTR/NN ,/, as/IN expression/NN of/IN nef/NEWGENE had/VBP no/DT effect/NN on/IN the/DT activity/NN of/IN the/DT simian/JJ virus/NN 40/CD ,/, c-fms/NEWGENE ,/, urokinase/NEWGENE plasminogen/NEWGENE activator/NEWGENE ,/, or/CC type/NEWGENE 5/NEWGENE acid/NEWGENE phosphatase/NEWGENE promoter/NEWGENE ./. trans-activating/JJ activity/NN was/VBD also/RB manifested/VBN by/IN a/DT frameshift/JJ mutant/JJ expressing/JJ only/RB the/DT first/JJ 35/CD amino/JJ acids/NNS of/IN the/DT protein/NN ./.
@@34368774140 Kf/NNP ,/NNP c/NNP and/CC CT/NN (/( referenced/VBN to/IN the/DT initial/JJ lung/NN mass/JJ )/SYM decreased/VBN linearly/RB with/IN reductions/NNS in/IN lung/NN mass/JJ %/NN delta/NN Kf/NN ,/NN c/NN =/SYM 1/CD ./CD 26-0/CD ./CD 98%/CD mass/RB removed/VBN (/( r/JJ =/SYM 0/CD ./CD 90/CD ,/, P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM and/CC %/NN delta/NN CT/NN =/SYM -3/CD ./CD 99-0/CD ./CD 98%/CD mass/RB removed/VBN (/( r/JJ =/SYM 0/CD ./CD 82/CD ,/, P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM relationships/NNS that/WDT were/VBD not/RB altered/VBN by/IN blocker/NN pretreatment/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@103538801106 During/IN 1985/CD ,/, 1990/CD ,/, and/CC 1995/CD ,/, respectively/RB ,/, 11/CD ./CD 7/CD ,/, 11/CD ./CD 3/CD ,/, and/CC 11/CD ./CD 4/CD infants/NNS per/IN 100/NN ,/NN 000/NN live/VB births/NNS had/VBP a/DT diagnosis/NN of/IN HSV/NN (/( P/CD =/CD ./CD 98/CD )/SYM ./.
@@78625331431 The/DT Wilms'/NEWGENE tumour/NEWGENE suppressor/NEWGENE protein/NEWGENE (/( WT1/NEWGENE )/SYM is/VBZ a/DT putative/JJ transcriptional/JJ regulatory/JJ protein/NN with/IN four/CD zinc/NN fingers/NNS ,/, the/DT last/NN three/CD of/IN which/WDT have/VBP extensive/JJ sequence/NN homology/NN to/IN the/DT early/NEWGENE growth/NEWGENE response-1/NEWGENE (/( EGR-1/NEWGENE )/SYM protein/NN ./.
@@71404936955 This/DT study/NN demonstrates/VBZ secretion/NN of/IN bicarbonate/NN by/IN the/DT human/JJ stomach/NN in/IN vivo/NN at/IN a/DT rate/NN equivalent/JJ to/IN 10--20%/NN of/IN basal/JJ acid/NN secretion/NN ./.
@@70532516822 Commonly/RB observed/VBN systemic/JJ toxic/JJ effects/NNS (/( bone/NN marrow/NN ,/, gastrointestinal/JJ tract/NN ,/, and/CC heart/NN )/SYM were/VBD not/RB seen/VBP in/IN this/DT study/NN ./.
@@89105505664 Correlating/VBG with/IN the/DT previous/JJ observation/NN that/DT CBF/NEWGENE binding/JJ to/IN the/DT 78C1/NN site/NN is/VBZ enhanced/VBN by/IN EGTA/NNS and/CC EDTA/NN ,/, these/DT divalent/JJ cation/NN chelators/NNS specifically/RB stimulate/VBP 78C1-directed/NN transcription/NN ./.
@@74383467313 At/NN pH/NN 6/CD ./CD 9/CD ,/, the/DT same/JJ lidocaine/NN concentrations/NNS significantly/RB reduced/VBN resting/JJ potential/JJ (/( 3-10%/JJ )/SYM ,/, action/NN potential/JJ amplitude/NN (/( 3-8%/JJ )/SYM and/CC Vmax/NN (/( 14-22%/JJ )/SYM ./.
@@25422705900 The/DT methylation/NN of/IN nuclear/JJ and/CC chloroplast/NN DNAs/NNS has/VBZ been/VBN examined/VBN in/IN relation/NN to/IN the/DT known/VBP differential/JJ expression/NN of/IN C4/NEWGENE photosynthesis/NEWGENE genes/NEWGENE in/IN the/DT bundle/NN sheath/NN and/CC mesophyll/JJ cells/NNS of/IN etiolated/JJ ,/, greening/JJ ,/, and/CC fully/RB green/JJ maize/NN leaves/NNS ./.
@@90463843755 Marinol/NNP //NNP marijuana/NNP usage/NN was/VBD associated/VBN with/IN depressed/VBN CD4+/NEWGENE counts/NNS and/CC elevated/VBN amylase/NEWGENE levels/NNS within/IN the/DT DDI/NN subgroup/NN ./.
@@106407015176 Two/CD Pax2/NEWGENE //NEWGENE 5/NEWGENE //NEWGENE 8-binding/NEWGENE sites/NEWGENE in/IN Engrailed2/NEWGENE are/VBP required/VBN for/IN proper/JJ initiation/NN of/IN endogenous/JJ mid-hindbrain/NN expression/NN ./.
@@93469257317 The/DT SH3/NEWGENE domains/NEWGENE of/IN Grb2/NEWGENE bound/JJ in/IN vitro/FW to/IN specific/JJ proline-rich/JJ motifs/NNS in/IN the/DT HPK1/NEWGENE tail/NN and/CC functioned/VBN synergistically/RB to/IN direct/VB the/DT stable/JJ binding/NN of/IN Grb2/NEWGENE to/IN HPK1/NEWGENE in/IN transfected/VBN Cos1/NNP cells/NNS ./.
@@98048366978 An/DT approximately/RB 37-kDa/NN cytoplasmic/NN protein/NN is/VBZ rapidly/RB tyrosine-phosphorylated/JJ in/IN the/DT response/NN of/IN mouse/NN BAC1/NN ./NN 2F5/NN macrophages/NNS to/IN colony/NEWGENE stimulating/NEWGENE factor-1/NEWGENE (/( CSF-1/NEWGENE )/SYM ./. pp37/NEWGENE was/VBD purified/VBN from/IN the/DT cytosolic/JJ fraction/NN by/IN anti-Tyr/NEWGENE (/NEWGENE P/NEWGENE )/NEWGENE affinity/NN chromatography/NN ,/, size/NN exclusion/NN chromatography/NN ,/, and/CC C4/NN reverse/JJ phase/NN high/JJ pressure/NN liquid/JJ chromatography/NN ./.
@@91959237742 The/DT immunophilin/NEWGENE ,/, which/WDT can/MD be/VB of/IN the/DT FK506-/NNP or/CC cyclosporin/NN A-binding/JJ class/NN ,/, binds/VBZ to/IN hsp90/NEWGENE via/NN its/PRP tetratricopeptide/NN repeat/NN (/( TPR/NN )/SYM domain/NN ,/, and/CC different/JJ receptor/NN heterocomplexes/NNS exist/VBP depending/VBG upon/IN which/WDT immunophilin/NEWGENE occupies/VBZ the/DT TPR-binding/NEWGENE region/NEWGENE of/IN hsp90/NEWGENE ./.
@@30886433810 Cocaine-treated/JJ rats/NNS acquired/VBD a/DT preference/NN for/IN cocaine-associated/JJ contextual/JJ stimuli/NNS (/( CS/NN )/SYM relative/JJ to/IN saline-injected/JJ control/NN rats/NNS ./.
@@76651877787 Primer/NNS extension/NN and/CC S1/NEWGENE nuclease/NEWGENE mapping/NN experiments/NNS were/VBD used/VBN to/IN locate/VB the/DT transcription/NN initiation/NN site/NN of/IN Nramp1/NEWGENE and/CC revealed/VBD the/DT presence/NN of/IN one/PRP major/JJ and/CC several/DT minor/JJ initiation/NN sites/NNS ./.
@@9285299245 Feeding/NNP behavior/NN ,/, circannual/JJ body/NN weight/NN and/CC hibernation/NN rhythms/NNS in/IN European/JJ hamsters/NNS lesioned/JJ in/IN the/DT noradrenergic/JJ ascending/JJ bundles/NNS ./.
@@10827885632 Double-blind/NNP ,/, placebo-controlled/JJ trial/NN ./.
@@98379139871 We/PRP have/VBP identified/VBN two/JJ overlapping/JJ expressed/VBN sequence/NN tag/NN clones/NNS ,/, which/WDT contain/VBP the/DT missing/JJ 4/CD ./CD 4-kb/CD 3'-UTR/CD of/IN the/DT human/NEWGENE D2/NEWGENE (/( hD2/NEWGENE )/SYM cDNA/NN ./.
@@9268578670 Eight/CD induced/VBN cDNA/NN sequences/NNS were/VBD identified/VBN and/CC designated/VBN message/NEWGENE up-regulated/NEWGENE during/NEWGENE death/NEWGENE (/( mud/NEWGENE )/NN -1-8/NN ./.
@@81440354230 Several/JJ highly/RB conserved/VBN regions/NNS were/VBD identified/VBN at/IN the/DT near/IN N/JJ terminus/NN ,/, middle/NN and/CC C/NN terminus/NN ./.
@@82769009451 S/NNP ./NNP ,/, K/NNP ./NNP
@@92119138588 Aryl/NEWGENE hydrocarbon/NEWGENE receptor/NEWGENE nuclear/NEWGENE translocator/NEWGENE (/( ARNT/NEWGENE )/SYM is/VBZ a/DT component/NN of/IN the/DT transcription/NN factors/NNS ,/, aryl/NEWGENE hydrocarbon/NEWGENE receptor/NEWGENE (/( AhR/NEWGENE )/SYM and/CC hypoxia-inducible/NEWGENE factor/NEWGENE 1/NEWGENE ,/, which/WDT transactivate/VBP their/PRP target/NN genes/NNS ,/, such/JJ as/IN CYP1A1/NEWGENE and/CC erythropoietin/NEWGENE ,/, in/IN response/NN to/IN xenobiotic/NN aromatic/JJ hydrocarbons/NNS and/CC to/IN low/JJ O2/NN concentration/NN ,/, respectively/RB ./.
@@108608272606 Deletion/NNS and/CC mutational/JJ analyses/NNS revealed/VBD two/JJ positive/JJ cis-regulatory/NN elements/NN in/IN this/DT region/NN that/WDT are/VBP essential/JJ for/IN CSX1/NEWGENE expression/NN in/IN cardiomyocytes/NNS ./.
@@92347238288 This/DT mechanism/NN is/VBZ in/IN contrast/NN to/IN other/DT cases/NNS of/IN splicing/JJ regulation/NN by/IN PTB/NEWGENE ,/, in/IN which/WDT the/DT protein/NN represses/VBZ the/DT splice/NN site/NN to/IN which/WDT it/PRP binds/VBZ ./.
@@68226456606 Time/NNP shifts/NNS increase/NN growth/NEWGENE hormone/NEWGENE release/NN ./.
@@33951648735 The/DT pharmacological/JJ effects/NNS of/IN the/DT novel/JJ compound/NN WEB/NN 1881/NN FU/NN (/( 4-amino-methyl-1-benzyl-pyrrolidine-2-one-fumarate/JJ )/SYM were/VBD investigated/VBN ./.
@@10753553571 Phenazone/NN potentiates/VBZ the/DT local/JJ anaesthetic/JJ effect/NN of/IN lidocaine/NN in/IN mice/NNS ./.
@@36871489613 Salzburg/NN ,/, 9-12/CD September/NN 1987/CD ./.
@@97657549757 There/EX was/VBD a/DT trend/NN in/IN all/DT studies/NNS favouring/VBG PVI/NN ./.
@@8724421405 Estimation/NNS of/IN L-alanine/NNS in/IN serum/NN or/CC plasma/NN using/VBG the/DT LKB/NN reaction/NN rate/NN analyser/NN ./.
@@109586989005 We/PRP have/VBP carried/VBN out/RB a/DT comprehensive/JJ and/CC systematic/JJ mutagenesis/NN of/IN the/DT Cse4p/NEWGENE N/NEWGENE terminus/NEWGENE to/IN analyze/VB its/PRP function/NN ./.
@@58818335788 On/IN the/DT diagnosis/NN of/IN bovine/JJ leucosis/NN and/CC its/PRP control/NN in/IN southern/JJ Lower/JJR Saxony/NNP ./.
@@41390817986 HL-A/NEWGENE antibodies/NEWGENE in/IN polytransfused/JJ patients/NNS ./.
@@8449978143 Analysis/NNP of/IN cell/NN cycle/NN regulation/NN in/IN the/DT budding/JJ yeast/NN Saccharomyces/NN cerevisiae/NN has/VBZ shown/VBP that/IN a/DT central/NN regulatory/NN protein/NEWGENE kinase/NEWGENE ,/, Cdc28/NEWGENE ,/, undergoes/VBZ changes/NNS in/IN activity/NN through/RB the/DT cell/NN cycle/NN by/IN associating/JJ with/IN distinct/JJ groups/NNS of/IN cyclins/NEWGENE that/WDT accumulate/VBP at/IN different/JJ times/NNS ./.
@@93819509334 Ischaemia/NNS was/VBD induced/VBN by/IN a/DT low/JJ flow/NN rate/NN of/IN 0/CD ./CD 8/CD mL/NN min-1/NN for/IN 30/CD min/NN ,/, and/CC was/VBD followed/VBN by/IN a/DT 40-minute/JJ reperfusion/NN ./.
@@9649437568 They/PRP also/RB indicate/VBP that/IN direct/JJ interactions/NNS between/IN C/NEWGENE //NEWGENE EBPs/NEWGENE and/CC specific/JJ Ets/NEWGENE family/NN members/NNS ,/, together/RB with/IN GATA-1/NEWGENE ,/, are/VBP important/JJ for/IN eosinophil/JJ lineage/NN determination/NN ./.
@@111457434403 To/TO understand/VB the/DT molecular/JJ regulation/NN of/IN these/DT genes/NNS in/IN thyroid/JJ cells/NNS ,/, the/DT effect/NN of/IN thyroid/NEWGENE transcription/NEWGENE factor/NEWGENE 1/NEWGENE (/( TTF-1/NEWGENE )/SYM and/CC the/DT paired/NEWGENE domain-containing/NEWGENE protein/NEWGENE 8/NEWGENE (/( Pax-8/NEWGENE )/SYM on/IN the/DT transcriptional/JJ activity/NN of/IN the/DT deiodinase/NEWGENE promoters/NEWGENE were/VBD studied/VBN ./.
@@110627057446 To/TO begin/VB to/IN understand/VB this/DT role/NN ,/, we/PRP overexpressed/VBN ATF-2/NEWGENE in/IN a/DT human/JJ cancer/NN cell/NN line/NN ./.
@@118827472503 CD/NN was/VBD determined/VBN using/VBG the/DT Farnsworth/NNP D-15/NN method/NN ./.
@@30730913793 During/IN insulin/NEWGENE infusion/NN ,/, a/DT 20%/CD dextrose/NN solution/NN was/VBD infused/VBN by/IN a/DT Biostator/NN in/IN order/NN to/IN maintain/VB the/DT patient's/NNS glycemia/NN at/IN 90/CD mg/NN //NN dl/NN ./.
@@17205559199 An/DT approximately/RB 2-kilobase/NN B2/NN transcript/NN was/VBD expressed/VBN in/IN all/DT alfalfa/NN organs/NNS tested/VBN ./.
@@39955133363 Doxorubicin/NN ,/, dacarbazine/NN ,/, vincristine/NN ,/, and/CC cyclophosphamide/NN in/IN the/DT treatment/NN of/IN advanced/JJ gastrointestinal/JJ leiomyosarcoma/NN ./.
@@90036178967 A/DT cohort/NN of/IN Swedish/JJ children/NNS was/VBD monitored/VBN from/IN 6/CD months/NNS to/IN 11/CD years/NNS of/IN age/NN ./.
@@96010079303 We/PRP provide/VBP community/NN metabolic/JJ data/NN that/WDT indicate/VBP that/IN large/JJ changes/NNS in/IN CO2/NN concentration/NN can/MD occur/VB in/IN coral/JJ reef/NN waters/NNS via/NN biogeochemical/JJ processes/NNS not/RB directly/RB associated/VBN with/IN photosynthesis/NN ,/, respiration/NN ,/, calcification/NN ,/, and/CC CaCO3/NN dissolution/NN ./.
@@82225568192 Effect/NN of/IN aging/NN on/IN respiratory/JJ skeletal/JJ muscles/NNS ./.
@@79915824635 Mutational/JJ analysis/NN of/IN yeast/NEWGENE CEG1/NEWGENE demonstrated/VBN that/IN four/CD of/IN the/DT five/CD conserved/VBN motifs/NNS are/VBP essential/JJ for/IN capping/NN enzyme/NN function/NN in/IN vivo/NN ./.
@@2050742660 Chronic/NN hypophosphatemia/NN is/VBZ the/DT most/RB common/JJ type/NN of/IN "resistant"/JJ rickets/NN ./.
@@110697567176 Abbreviations/NNS :/: CAS/NEWGENE ,/, CRK-associated/NEWGENE substrate/NEWGENE ;/: CH/NEWGENE ,/, calponin-homology/NEWGENE domain/NEWGENE ;/: CSK/NEWGENE ,/, C-terminal/NEWGENE SRC/NEWGENE kinase/NEWGENE ;/: E6/NEWGENE ,/, Papillomavirus/NEWGENE E6/NEWGENE protein/NEWGENE ;/: FAK/NEWGENE ,/, focal/NEWGENE adhesion/NEWGENE kinase/NEWGENE ;/: GIT/NEWGENE ,/, GRK/NEWGENE interacter/NEWGENE ;/: GPCR/NEWGENE ,/, heterotrimeric-G-protein-coupled/NEWGENE receptor/NEWGENE ;/: GRK/NEWGENE ,/, G-protein-coupled-receptor/NEWGENE kinase/NEWGENE ;/: MAPK/NEWGENE ,/, mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( ERK/NEWGENE ,/, p38/NEWGENE ,/, JNK/NEWGENE )/SYM ;/: PAK/NEWGENE ,/, p21-activated/NEWGENE kinase/NEWGENE ;/: PBS/NEWGENE ,/, paxillin-binding/NEWGENE subdomain/NEWGENE ;/: PIX/NEWGENE ,/, PAK-interacting/NEWGENE exchange/NEWGENE factor/NEWGENE ;/: PKL/NEWGENE ,/, paxillin/NEWGENE kinase/NEWGENE linker/NEWGENE ;/: POR1/NEWGENE ,/, partner/NEWGENE of/NEWGENE Rac/NEWGENE ;/: PS/NN ,/, phosphoserine/NN ;/: PT/NN ,/, phosphothreonine/NN ;/: PY/NN ,/, phosphotyrosine/NN ;/: RTK/NEWGENE ,/, growth/NEWGENE factor/NEWGENE receptor/NEWGENE tyrosine/NEWGENE kinase/NEWGENE ;/: SH/NEWGENE ,/, SRC-homology/NEWGENE domain/NEWGENE ./.
@@16523725600 We/PRP have/VBP identified/VBN SWI5's/NNP nuclear/JJ localization/NN signal/JJ (/( NLS/NN )/SYM and/CC show/VB that/IN it/PRP can/MD confer/VB cell/NN cycle-dependent/JJ nuclear/JJ entry/NN to/IN a/DT heterologous/JJ protein/NN ./.
@@77801489838 We/PRP found/VBP that/DT PML/NEWGENE was/VBD expressed/VBN at/IN a/DT lower/JJR level/NN in/IN S/NNP ,/, G2/NN ,/, and/CC M/NN phases/NNS and/CC at/IN a/DT significantly/RB higher/JJ level/NN in/IN G1/NNP phase/NN ./.
@@33900743402 Electroglottography/NN is/VBZ a/DT useful/JJ ,/, non-invasive/JJ technique/NN that/WDT can/MD assist/VB in/IN the/DT assessment/NN of/IN vocal/JJ fold/NN dysfunction/NN ./.
@@75291246199 The/DT three-dimensional/JJ structure/NN of/IN RT/NEWGENE shows/NNS that/WDT it/PRP is/VBZ a/DT strikingly/RB asymmetric/JJ heterodimer/NN consisting/VBG of/IN two/JJ differently/RB folded/JJ subunits/NNS (/( molecular/JJ weights/NNS 66/CD kDa/NN and/CC 51/CD kDa/NN )/SYM with/IN identical/JJ amino-terminal/JJ amino/JJ acid/NN sequences/NNS (/( residues/NNS 1-428/CD )/SYM ./.
@@27028493373 Metformin/DT plasma/NN concentrations/NNS remained/VBD unchanged/JJ except/VB for/IN patients/NNS transferred/VBN from/IN 1/CD ./CD 5/CD to/IN 2/CD ./CD 0/CD g/NN daily/JJ to/IN 850/CD mg/NN twice/RB daily/JJ ;/: in/IN these/DT patients/NNS plasma/NN concentrations/NNS increased/VBN from/IN 1/CD ./CD 83/CD +/NN //NN -/NN 0/CD ./CD 87/CD to/IN 2/CD ./CD 50/CD +/NN //NN -/NN 0/CD ./CD 89/CD micrograms/NN //NN l/NN (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@27331163424 From/IN the/DT National/NNP Institutes/NNS of/IN Health/NNP ./.
@@88842736849 The/DT TYAC/NN //NN P1/NN resource/NN ,/, derivative/JJ STSs/NNS ,/, and/CC polymorphisms/NNS constitute/VB an/DT enabling/VBG resource/NN to/IN further/JJ studies/NNS of/IN telomere/NN structure/NN and/CC function/NN and/CC a/DT means/NN for/IN physical/JJ and/CC genetic/JJ map/NN integration/NN and/CC closure/NN ./.
@@82482463283 One/CD complex/NN most/RB likely/RB contained/VBN Sp1/NEWGENE ,/, and/CC another/DT complex/NN showed/VBD S-phase-specific/NNP binding/JJ ,/, suggesting/VBG a/DT direct/JJ role/NN in/IN the/DT cell-cycle-dependent/NN R1/NEWGENE gene/NEWGENE expression/NN ./.
@@21595596482 This/DT points/NNS to/IN a/DT specific/JJ interference/NN with/IN HSV-induced/NN DNA/NN amplification/NN ./.
@@93642114674 The/DT cell/NN cycle-regulated/NN transcription/NN factor/NN E2F/NEWGENE is/VBZ also/RB known/VBP to/IN bend/NN DNA/NN upon/IN binding/NN ./.
@@74539197074 In/NN 11/CD patients/NNS with/IN Horton's/NNP headache/NN morphological/JJ investigations/NNS (/( differential/JJ white/JJ blood/NN cell/NN count/NN )/SYM ,/, cytoenzymatic/JJ determinations/NNS (/( alkaline/NEWGENE and/NEWGENE acid/NEWGENE phosphatase/NEWGENE ,/, non-specific/NEWGENE esterase/NEWGENE )/SYM and/CC cytoimmunological/JJ tests/NNS (/( IgM/NEWGENE and/CC IgG/NEWGENE binding/JJ )/SYM were/VBD carried/VBN out/RB on/IN capillary/JJ blood/NN neutrophils/NNS obtained/VBN from/IN the/DT area/NN of/IN pain/NN ,/, non-painful/JJ area/NN of/IN the/DT skin/NN on/IN the/DT head/NN on/IN the/DT contralateral/JJ side/NN ,/, and/CC from/IN the/DT finger/NN ./.
@@27406271893 The/DT oxygen/NN uptake/NN (/( VO2/NN )/SYM ,/, carbon/NN dioxide/NN output/NN (/( VCO2/NN )/SYM ,/, respiratory/JJ rate/NN (/( fR/NN )/SYM ,/, minute/JJ ventilation/NN (/( VE/NN )/SYM ,/, alveolar/JJ ventilation/NN (/( VA/NN )/SYM ,/, alveolar/JJ oxygen/NN pressure/NN (/( PAO2/NN )/SYM ,/, and/CC VE/NN //NN VO2/NN ratio/NN were/VBD higher/JJ in/IN the/DT cows/NNS ,/, while/CC the/DT tidal/JJ volume/NN (/( VT/NN )/SYM and/CC physiological/JJ dead/JJ space/NN (/( VD/NN )/SYM were/VBD larger/JJR in/IN the/DT horses/NNS ./.
@@16278307749 Two/CD cDNAs/NNS encoding/VBG casein/NEWGENE kinase-1/NEWGENE have/VB been/VBN isolated/VBN from/IN a/DT yeast/NN cDNA/NN library/NN and/CC termed/JJ CKI1/NEWGENE and/CC CKI2/NEWGENE ./.
@@77974761902 The/DT RAP74/NEWGENE subunit/NEWGENE of/IN TFIIF/NEWGENE alone/RB contained/VBD the/DT stimulatory/JJ activity/NN and/CC the/DT minimal/JJ region/NN sufficient/JJ for/IN stimulation/NN corresponds/VBZ to/IN COOH-terminal/NN residues/NNS 358-517/JJ ./.
@@102113296667 These/DT observations/NNS of/IN elevated/VBN serum/NEWGENE lipase/NEWGENE and/CC serum/JJ CA/NEWGENE 19-9/NEWGENE in/IN Sjogren's/NNP syndrome/NN without/IN evidence/NN of/IN malignancy/NN may/MD reflect/VB pancreatic/JJ involvement/NN in/IN this/DT disorder/NN ./.
@@66710472845 These/DT results/NNS confirming/VBG the/DT high/JJ validity/NN of/IN NOM/NNP inhibiting/JJ test/NN in/IN the/DT diagnosis/NN of/IN tumoural/JJ hyperprolactinemic/JJ states/NNS ,/, reveal/VB contradictory/JJ responses/NNS to/IN CD/NNP //NNP LD/NNP ,/, LD/NN and/CC DOM/NN ,/, with/IN sustain/VB the/DT existence/NN of/IN 2/CD sub-group/NN of/IN Prolactinomas/NN :/: with/IN or/CC without/IN a/DT maintained/VBN DA/NN central/JJ tonus/NN supporting/JJ the/DT possibility/NN of/IN different/JJ etiopathogenetical/JJ factors/NNS in/IN inducing/JJ a/DT tumoural/JJ hyperprolactinemic/JJ states/NNS ./.
@@112486263599 Efficacy/NNS of/IN first-generation/JJ Cavermap/NN to/IN verify/VB location/NN and/CC function/NN of/IN cavernous/JJ nerves/NNS during/IN radical/JJ prostatectomy/NN :/: a/DT multi-institutional/JJ evaluation/NN by/IN experienced/JJ surgeons/NNS ./.
@@21668254131 In/NN order/NN to/IN characterize/VB the/DT functional/JJ elements/NNS of/IN the/DT promoter/NN that/IN in/IN some/DT way/NN must/MD respond/NN to/IN these/DT regulatory/JJ signals/NNS ,/, a/DT number/NN of/IN promoter/NN mutations/NNS were/VBD constructed/VBN ,/, including/JJ a/DT set/NN of/IN linker-scanning/JJ mutations/NNS across/IN the/DT entire/JJ promoter/NN region/NN ./.
@@104735985555 Skn-1a/NEWGENE lacking/VBG the/DT C-terminal/NN region/NN completely/RB lost/VBP transactivation/NN ability/NN ,/, irrespective/JJ of/IN the/DT promoter/NN tested/VBN ,/, and/CC was/VBD able/JJ to/IN block/NN transactivation/NN by/IN normal/JJ Skn-1a/NEWGENE in/IN competition/NN assays/NNS ./.
@@89454796925 Structural/NNP basis/NN for/IN activation/NN of/IN human/NEWGENE lymphocyte/NEWGENE kinase/NEWGENE Lck/NEWGENE1 upon/IN tyrosine/NN phosphorylation/NN ./.
@@37556734424 Among/IN them/PRP ,/, 26/CD cases/NNS were/VBD benign/JJ and/CC 34/CD malignant/JJ ./.
@@26021509703 Such/JJ transgenic/JJ plants/NNS should/MD enable/VB not/RB only/RB the/DT mutational/JJ analysis/NN of/IN sequence/NN elements/NNS within/IN the/DT replication/NN origin/NN region/NN ,/, but/CC also/RB the/DT construction/NN of/IN a/DT new/JJ generation/NN of/IN vectors/NNS for/IN gene/NN amplification/NN in/IN plants/NNS ,/, based/VBN on/IN a/DT minimal/JJ virus/NN replicon/NN ./.
@@15824139493 Site-directed/JJ mutagenesis/NN revealed/VBN that/IN two/JJ clusters/NNS of/IN basic/JJ amino/JJ acids/NNS within/IN a/DT conserved/VBN basic/JJ region/NN and/CC two/JJ amphipathic/JJ helices/NNS within/IN the/DT adjacent/JJ HLH/NEWGENE domain/NEWGENE are/VBP essential/JJ for/IN sequence-specific/NN DNA/NN binding/NN and/CC hetero-oligomerization/NN ,/, respectively/RB ./.
@@77559144879 OBJECTIVE/IN :/: To/TO determine/VB the/DT impact/NN of/IN the/DT introduction/NN of/IN clarithromycin/NN and/CC azithromycin/NN on/IN the/DT treatment/NN and/CC survival/NN of/IN patients/NNS with/IN AIDS/NN and/CC disseminated/JJ Mycobacterium/NN avium/NN complex/NN (/( DMAC/NN )/SYM ./.
@@7363767205 At/NN this/DT stage/NN ,/, the/DT eventual/JJ high/JJ mortality/NN of/IN acute/JJ ischemia/NN is/VBZ established/VBN whatever/WDT the/DT urgency/NN of/IN the/DT operation/NN or/CC the/DT skill/NN with/IN which/WDT it/PRP is/VBZ performed/VBN ./.
@@26329049530 The/DT relation/NN between/IN VE/NN //NN VO2/NN and/CC Q/NN //NN VO2/NN showed/VBD a/DT significant/JJ negative/JJ correlation/NN (/( r/JJ =/SYM -0/CD ./CD 93/CD ,/, p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@87773748767 Indoor/JJ concentrations/NNS were/VBD only/RB weakly/RB correlated/VBN with/IN outdoor/JJ concentrations/NNS ,/, however/RB ,/, and/CC personal/JJ exposures/NNS were/VBD even/VB more/RB poorly/RB correlated/VBN with/IN outdoor/JJ concentrations/NNS ./.
@@93681906370 However/RB ,/, when/CC a/DT second/NN ,/, upstream/NEWGENE IRE-like/NEWGENE sequence/NEWGENE was/VBD evaluated/VBN by/IN EMSA/NN ,/, a/DT DNA/NN binding/JJ pattern/NN distinct/JJ from/IN that/DT seen/VBP following/IN exposure/NN to/IN IFN-gamma/NEWGENE alone/RB was/VBD observed/VBN after/IN prolonged/JJ stimulation/NN with/IN both/DT IFN-alpha/NEWGENE and/CC IFN-gamma/NEWGENE ./.
@@89243815490 Growth/NEWGENE factor/NEWGENE allows/VBZ effective/JJ dose-intensive/JJ regimen/NN in/IN advanced/JJ breast/NN cancer/NN patients/NNS ./.
@@25476117493 Clone/NN 4c/NN (/( 2681/CD bp/NN )/SYM had/VBP a/DT coding/JJ region/NN identical/JJ to/IN that/DT of/IN clone/NN 22c/NN but/CC it/PRP included/VBD a/DT putative/JJ intron/NN of/IN 959/CD bp/CD ./CD
@@13202556855 These/DT results/NNS indicate/VBP that/IN an/DT internal/JJ short/JJ element/NN located/VBN at/IN the/DT very/RB 5'/CD terminal/NN of/IN L1/NEWGENE sequence/NEWGENE and/CC the/DT nuclear/JJ factor/NN binding/JJ to/IN the/DT element/NN play/NN a/DT crucial/JJ role/NN in/IN the/DT transcription/NN of/IN human/NEWGENE L1/NNP ./NNP
@@115609908282 E47/NEWGENE protein/NEWGENE levels/NNS remain/VBP high/JJ until/IN the/DT double/JJ positive/JJ developmental/JJ stage/NN ,/, at/IN which/WDT point/VBP they/PRP drop/NN to/IN relatively/JJ moderate/JJ levels/NNS ,/, and/CC are/VBP further/RB downregulated/VBN upon/IN transition/NN to/IN the/DT single/JJ positive/JJ stage/NN ./.
@@42917594908 Laboratory/NNP aspects/NNS with/IN particular/JJ reference/NN to/IN chemotherapy/NN and/CC control/NN ./.
@@23712737946 The/DT transcriptional/JJ unit/NN spans/VBZ a/DT chromosomal/JJ region/NN of/IN about/RB 55/CD kilobase/NN pairs/NNS (/( kbp/NN )/SYM ./.
@@95242673611 The/DT plant/NN protein/NN maintains/VBZ all/PDT the/DT functional/JJ domains/NNS found/VBP in/IN the/PDT other/DT proteins/NNS ,/, including/JJ nuclear/JJ localization/NN signal/JJ ,/, DNA-binding/NN domain/NN and/CC helicase/NEWGENE motifs/NEWGENE ,/, suggesting/VBG that/IN it/PRP might/MD also/RB act/VB as/IN part/NN of/IN the/DT RNA/NN transcription/NN apparatus/NN ,/, as/RB well/VB as/IN nucleotide/NN excision/NN repair/NN in/IN plant/NN cells/NNS ./.
@@109084787470 SELECTION/NN CRITERIA/NNP :/: All/DT controlled/VBN trials/NNS where/CC adults/NNS with/IN schizophrenia/NN or/CC similar/JJ illnesses/NNS were/VBD randomised/JJ to/IN quetiapine/NN ,/, placebo/NN or/CC other/DT neuroleptic/JJ drugs/NNS and/CC where/CC clinically/RB relevant/JJ outcomes/NNS were/VBD reported/VBN ./.
@@30256063845 Transcriptional/JJ control/NN signals/NNS of/IN a/DT herpes/NEWGENE simplex/NEWGENE virus/NEWGENE type/NEWGENE 1/NEWGENE late/NEWGENE (/NEWGENE gamma/NEWGENE 2/NEWGENE )/NEWGENE gene/NEWGENE lie/NN within/IN bases/NNS -34/CD to/IN +124/NN relative/JJ to/IN the/DT 5'/CD terminus/NN of/IN the/DT mRNA/NN ./.
@@5801515739 Although/IN it/PRP has/VBZ been/VBN shown/VBP that/IN it/PRP is/VBZ possible/JJ to/IN use/NN orally/RB administered/VBD testosterone/NN to/IN maintain/VB se-T/JJ levels/NNS in/IN the/DT normal/JJ male/JJ range/NN ,/, the/DT convenience/NN to/IN the/DT patient/NN must/MD be/VB balanced/JJ against/IN the/DT cost/NN and/CC possible/JJ side/JJ effects/NNS of/IN the/DT large/JJ doses/NNS required/VBN ./.
@@28113783511 The/DT congenital/JJ forms/NNS (/( 7/CD cases/NNS )/SYM all/DT occurred/VBN in/IN female/JJ infants/NNS and/CC involved/VBD the/DT mucosa/NN overlying/JJ either/DT the/DT anterior/JJ ridge/NN of/IN the/DT maxilla/NN or/CC the/DT mandible/NN ./.
@@79738257965 The/DT recovery/NN value/NN of/IN systolic/JJ pressure/NN was/VBD higher/JJ than/IN diastolic/JJ pressure/NN and/CC pulse/NN pressure/NN increased/VBN ./.
@@22430931370 Human/NNP T-cell/NN leukemia/NN virus/NN type/NN I/NN (/( HTLV-I/NN )/SYM encodes/VBZ a/DT 40-kDa/NN nuclear/NN protein/NN ,/, Tax/NEWGENE ,/, which/WDT stimulates/VBZ transcription/NN from/IN three/CD 21-base/JJ pair/NN (/( bp/NN )/SYM repeats/NNS in/IN its/PRP U3/NEWGENE region/NEWGENE ./.
@@87624728748 The/DT effect/NN of/IN ligustrazine/NN hydrochloride/NN (/( LTH/NNS )/SYM on/IN depressing/JJ pulmonary/JJ artery/NN hypertension/NN has/VBZ been/VBN proved/VBN in/IN recent/JJ studies/NNS ./.
@@96947253677 Band-shift/NNP assays/NNS were/VBD performed/VBN using/VBG the/DT LPS-and/NEWGENE IL-1-responsive/NEWGENE element/NEWGENE (/( LILRE/NEWGENE )/SYM oligonucleotide/NN ,/, a/DT gamma/NEWGENE interferon/NEWGENE activation/NEWGENE site-like/NEWGENE site/NEWGENE that/WDT is/VBZ present/VB in/IN the/DT human/NEWGENE IL-1beta/NEWGENE promoter/NEWGENE ./.
@@115669964984 Here/RB we/PRP suggest/VBP that/DT uvrA/NEWGENE and/CC the/DT nucleotide/NN excision/NN repair/NN pathway/NN are/VBP involved/VBN in/IN the/DT repair/NN of/IN acid-induced/NN DNA/NN damage/NN and/CC are/VBP associated/VBN with/IN successful/JJ adaptation/NN of/IN S/NNP ./NNP mutans/NNS to/IN low/JJ pH/CD ./CD
@@31664584005 A/DT protein/NN footprint/NN also/RB was/VBD identified/VBN for/IN a/DT GC/NN box/NN element/NN at/IN nucleotides/NNS -59/CD to/IN -45/CD ./.
@@82182302796 Thus/RB ,/, we/PRP have/VBP identified/VBN a/DT GRE/NEWGENE sufficient/JJ to/IN account/NN for/IN full/JJ glucocorticoid/NN inducibility/NN and/CC an/DT HNF-1/NEWGENE site/NEWGENE close/JJ to/IN the/DT promoter/NN that/WDT are/VBP major/JJ determinants/NNS of/IN transcriptional/JJ control/NN of/IN the/DT Xenopus/NEWGENE fibrinogen/NEWGENE B/NEWGENE beta/NEWGENE subunit/NEWGENE gene/NEWGENE in/IN cells/NNS from/IN normal/JJ liver/NN tissue/NN ./.
@@8595878975 Here/RB we/PRP present/VBP genetic/JJ evidence/NN suggesting/VBG that/IN PP2A/NEWGENE functions/NNS downstream/RB of/IN Ras1/NEWGENE in/IN the/DT Sevenless/NEWGENE receptor/NEWGENE1 tyrosine/NEWGENE1 kinase/NEWGENE1 (/( RTK/NEWGENE )/SYM signal/JJ transduction/NN pathway/NN that/WDT specifies/VBZ R7/NNS photoreceptor/NN cell/NN fate/NN in/IN the/DT developing/JJ Drosophila/NN eye/NN ./.
@@94196809373 CONCLUSION/IN :/: In/NN our/PRP animal/NN model/NN ,/, blood-brain/JJ barrier/NN disruption/NN was/VBD a/DT reproducible/JJ ,/, integral/JJ finding/NN of/IN single-fraction/JJ ,/, high-dose/JJ irradiation/NN injury/NN ./.
@@65844169474 Three/CD radiologists/NNS without/IN knowledge/NN of/IN patients'/NN data/NN and/CC treatment/NN analyzed/VBN 30/CD angiograms/NNS with/IN and/CC 30/CD examinations/NNS without/IN PGF/NN ./.
@@114439991321 Mean/VB Hg/NN concentrations/NNS in/IN the/DT livers/NNS of/IN mice/NNS at/IN some/DT sites/NNS in/IN Isle/NNP Royale/NNP are/VBP not/RB significantly/RB lower/JJR (/( P/NN =/SYM 0/CD ./CD 62/CD )/SYM than/IN Hg/NN concentrations/NNS considered/VBN by/IN some/DT government/NN agencies/NNS to/IN be/VB unhealthy/JJ for/IN human/JJ consumption/NN ./.
@@16562201725 axl/NN ,/, a/DT transforming/NN gene/NN isolated/VBN from/IN primary/JJ human/JJ myeloid/JJ leukemia/NN cells/NNS ,/, encodes/VBZ a/DT novel/JJ receptor/NEWGENE tyrosine/NEWGENE kinase/NEWGENE ./.
@@85504701781 In/NNP E/NNP ./NNP coli/JJ ,/, CheW/NEWGENE mediates/VBZ the/DT physical/JJ coupling/NN of/IN the/DT receptors/NNS to/IN the/DT kinase/NEWGENE CheA/NEWGENE1 ./.
@@118586351746 We/PRP argue/VBP that/IN this/DT is/VBZ the/DT general/JJ property/NN of/IN QSAR/NN models/NNS developed/VBN using/VBG LOO/NNP cross-validation/NN ./.
@@83884969250 Expression/NNS in/IN established/VBN LCLs/NNS ,/, occurring/VBG irrespective/JJ of/IN virus/NN producer/NN status/NN ,/, was/VBD not/RB a/DT consequence/NN of/IN continued/VBN in/IN vitro/FW passage/NN ;/: thus/RB ,/, appropriately/RB spliced/VBN BamHI-A/NEWGENE transcripts/NEWGENE could/MD be/VB amplified/VBN from/IN normal/JJ B/NNP cells/NNS within/IN 1/CD day/NN of/IN their/PRP experimental/JJ infection/NN in/IN vitro/FW ,/, along/IN with/IN BamHI-C/NEWGENE //NEWGENE W/NEWGENE promoter-initiated/JJ but/CC not/RB BamHI-F/NEWGENE promoter-initiated/NEWGENE mRNAs/NEWGENE ./.
@@83367383530 The/DT equivalent/NN of/IN the/DT third/JJ ligand/NN ,/, H-87/NEWGENE ,/, is/VBZ T-47/NN in/IN the/DT PSTAIRE/NEWGENE sequence/NEWGENE motif/NEWGENE ./.
@@89169603487 In/NN all/DT eight/CD cases/NNS ,/, neither/DT FL/NN nor/CC DLL/NNP cells/NNS showed/VBD alterations/NNS of/IN bcl-2/NEWGENE gene/NEWGENE sequences/NEWGENE in/IN the/DT breakpoint/NN region/NN ,/, suggesting/VBG high/JJ conservation/NN of/IN the/DT bcl-2/NEWGENE gene/NEWGENE during/IN both/DT t/NN (/NN 14/NN ;/: 18/NN )/NN translocation/NN and/CC morphologic/JJ transformation/NN of/IN the/DT FL/NN cells/NNS ./.
@@98868506143 The/DT transcriptional/JJ activity/NN of/IN PPARgamma/NEWGENE is/VBZ positively/RB modulated/VBN by/IN ligand/NN binding/JJ and/CC negatively/RB regulated/VBN by/IN phosphorylation/NN mediated/JJ by/IN the/DT MEK/NEWGENE //NEWGENE ERK/NEWGENE signaling/NEWGENE pathway/NEWGENE ./.
@@93352988637 Furthermore/RB ,/, the/DT insertion/NN of/IN the/DT ColE1/NEWGENE cer/NEWGENE site/NEWGENE into/IN the/DT RK2/NN plasmid/NN deleted/VBN for/IN the/DT par/NN region/NN failed/VBN to/IN stabilize/VB the/DT plasmid/NN in/IN the/DT MC1061K/NN strain/NN ,/, indicating/VBG that/IN the/DT multimer/NN resolution/NN activity/NN encoded/VBN by/IN parCBA/NEWGENE is/VBZ not/RB by/IN itself/PRP responsible/JJ for/IN the/DT stabilization/NN activity/NN observed/VBN for/IN this/DT operon/NN ./.
@@99949425765 19F/NN NMR/NN studies/NNS in/IN ABF4-type/NNP layered/JJ antiferromagnets/NNS ./.
@@76987277641 No/DT local/JJ destruction/NN by/IN tumor/NN or/CC infection/NN could/MD be/VB demonstrated/VBN apart/RB from/IN HIV/NN infection/NN ./.
@@111240248808 We/PRP have/VBP identified/VBN three/CD binding/JJ sites/NNS for/IN protein/NN complexes/NNS :/: a/DT palindrome/NN ,/, a/DT direct/JJ repeat/NN ,/, and/CC a/DT C+T/NN sequence/NN that/WDT corresponds/VBZ to/IN seven/JJ GAGA/NEWGENE motifs/NEWGENE on/IN the/DT transcribed/VBN strand/NN ./.
@@172084316 These/DT results/NNS indicate/VBP that/IN the/DT sulfhydryl/NN group/NN of/IN certain/JJ angiotensin/NEWGENE converting/NEWGENE enzyme/NEWGENE inhibitors/NN can/MD potentiate/VB their/PRP effect/NN on/IN the/DT endogenous/JJ nitrovasodilator/NN EDRF/NEWGENE ./.
@@68161232284 Selenium/NN ,/, as/IN a/DT constituent/NN of/IN glutathione/NEWGENE peroxidase/NEWGENE ,/, plays/VBP a/DT role/NN in/IN the/DT antioxidant/JJ defense/NN systems/NNS of/IN the/DT body/NN ,/, but/CC other/DT metabolic/JJ roles/NNS for/IN selenium/NN may/MD yet/RB be/VB discovered/VBN ./.
@@23424772310 Since/IN the/DT UfAP/NEWGENE and/CC UTMP/NEWGENE share/VB many/JJ biosynthetic/JJ and/CC structural/JJ features/NNS that/WDT include/VBP site/NN of/IN biosynthesis/NN in/IN the/DT endometrium/NN ,/, P4-responsiveness/NNP ,/, the/DT presence/NN of/IN the/DT mannose/NN 6-phosphate/NN lysosomal/NN recognition/NN marker/NN ,/, and/CC considerable/JJ sequence/NN similarity/NN ,/, the/DT UfAP/NEWGENE and/CC the/DT UTMP/NEWGENE may/MD have/NN homologous/JJ function/NN which/WDT for/IN both/DT still/RB remains/VBP obscure/VB ./.
@@75357682976 HVH2/NEWGENE mRNA/NEWGENE showed/VBD an/DT expression/NN pattern/NN distinct/JJ from/IN CL100/NEWGENE (/( human/NEWGENE homologue/NEWGENE of/NEWGENE mouse/NEWGENE MKP1/NEWGENE )/SYM and/CC PAC1/NEWGENE ,/, two/JJ previously/RB identified/VBN MAP/NEWGENE kinase/NEWGENE phosphatases/NEWGENE ./.
@@91713639734 In/JJ ciliates/NNS ,/, both/DT mechanisms/NNS are/VBP readily/RB observed/VBN ./.
@@90437681209 We/PRP have/VBP studied/VBN the/DT biokinetics/NN of/IN BLM/NN labeled/JJ with/IN indium-111/NN (/( In-111/NN )/SYM ./.
@@110632524849 Exon/VBP A/NNP is/VBZ located/VBN approximately/RB 7/CD kb/NN 5'/CD to/IN the/PDT HSL/NEWGENE translation/NEWGENE start/NEWGENE site/NEWGENE ./.
@@9882321531 In/NN contrast/NN ,/, transiently/RB transfected/VBN cells/NNS expressing/NN EBNA-3/NEWGENE revealed/VBN a/DT sixfold/JJ increase/NN in/IN EBNA-3/NEWGENE protein/NEWGENE expression/NN from/IN the/DT genomic/JJ EBNA-3/NEWGENE gene/NEWGENE compared/VBN to/IN EBNA-3/NEWGENE cDNA/NEWGENE ./.
@@94763995710 SETTING/VBG :/: A/DT division/NN of/IN a/DT large/NN tea/NN plantation/NN in/IN Kandy/NNP ./.
@@75807822156 Imaging/NNP features/NNS of/IN splenic/JJ epidermoid/NN cyst/NN with/IN pathologic/JJ correlation/NN ./.
@@838558170 One/CD of/IN these/DT genes/NNS ,/, REC114/NEWGENE ,/, is/VBZ described/VBN here/RB ,/, and/CC the/DT data/NN confirm/VB that/IN REC114/NEWGENE is/VBZ a/DT meiosis-specific/JJ recombination/NN gene/NN with/IN no/DT detectable/JJ function/NN in/IN mitosis/NN ./.
@@6405846204 2/NN )/NN The/DT time-sharing/JJ principle/NN was/VBD applied/VBN to/IN gain/NN high/JJ stability/NN ./.
@@111825207714 The/DT corresponding/JJ genotype/NN was/VBD determined/VBN with/IN a/DT restriction/NN enzyme-based/JJ assay/NN ./.
@@16481423967 In/NN patients/NNS with/IN limited/VBN disease/NN ,/, the/DT survival/NN in/IN the/DT alternating/JJ arm/NN was/VBD significantly/RB superior/JJ to/IN the/DT survival/NN in/IN the/DT CAV/NN arm/NN (/( P/NN =/SYM ./CD 014/CD )/SYM or/CC the/DT survival/NN in/IN the/DT PE/NN arm/NN (/( P/NN =/SYM ./CD 023/CD )/SYM ./.
@@79025836005 Analysis/NNP of/IN disassociation/NN rates/NNS indicates/VBZ that/IN the/DT Grf10-Swi5-DNA/NEWGENE complex/NEWGENE has/VBZ a/DT longer/JJR half-life/NN than/IN protein-DNA/JJ complexes/NNS that/WDT contain/VBP only/RB Swi5/NEWGENE or/CC Grf10/NEWGENE ./.
@@21609553558 Constructs/NNS were/VBD made/VBP in/IN which/WDT an/DT AATAAA/NNP and/CC the/DT GT-rich/NNP region/NN were/VBD separated/VBN by/IN various/JJ distances/NNS ranging/VBG from/IN 7/CD to/IN 43/CD bp/CD ./CD
@@9185569131 The/DT prevalence/NN of/IN hepatitis/NEWGENE B/NEWGENE surface/NEWGENE antigen/NEWGENE (/( HBsAg/NEWGENE )/SYM and/CC anti-HBs/NEWGENE was/VBD determined/VBN by/IN a/DT sensitive/JJ double-antibody/JJ radio-immunoassay/NN technique/NN in/IN a/DT series/NN of/IN patients/NNS with/IN chronic/JJ liver/NN diseases/NNS ./.
@@75426161477 GCD10/NEWGENE binds/VBZ RNA/NN in/IN vitro/FW and/CC we/PRP present/VBP strong/JJ biochemical/JJ evidence/NN that/IN it/PRP is/VBZ identical/JJ to/IN the/DT RNA-binding/NN subunit/NN of/IN yeast/NEWGENE initiation/NEWGENE factor-3/NEWGENE (/( eIF-3/NEWGENE )/SYM ./. eIF-3/NEWGENE is/VBZ a/DT multisubunit/JJ complex/NN that/WDT stimulates/VBZ translation/NN initiation/NN in/IN vitro/FW at/IN several/DT different/JJ steps/NNS ./.
@@75380682206 Based/VBN on/IN these/DT results/VBZ the/DT minimal/JJ control/NN element/NN (/( AX/NEWGENE 470/NEWGENE )/SYM specifying/VBG the/DT anterior/JJ boundary/NN of/IN Hox/NEWGENE expression/NN was/VBD designated/VBN as/IN Hoxa-7/NEWGENE enhancer/NEWGENE ./.
@@3746601335 There/EX have/VB been/VBN five/CD problems/NNS (/( extravasation/NN 2/CD ,/, suspected/VBN sepsis/NN 1/CD ,/, and/CC hematoma/NN 2/NN )/SYM during/IN a/DT total/NN of/IN 2/CD ,/CD 927/CD days/NNS of/IN exposure/NN ./.
@@17691895616 Plasma/NN lipid/NN and/CC lipoprotein/NN profiles/NNS were/VBD compared/VBN in/IN elderly/JJ female/JJ runners/NNS (/( RU/NNP :/: n/NN =/SYM 15/CD ,/, aged/VBN 66/CD +/NN //NN -/NN 5/CD years/NNS ,/, body/NN fat/JJ 20/CD +/NN //NN -/NN 4%/JJ ,/, training/NN distance/NN 35/CD +/NN //NN -/NN 15/CD km/NN week-1/NN ,/, VO2max/NN 36/NN +/NN //NN -/NN 4/CD ml/NN kg-1/NN min-1/NN ,/, mean/JJ +/NN //NN -/NN SD/NN )/SYM and/CC age-matched/JJ untrained/JJ women/NNS (/( UT/NN :/: n/NN =/SYM 28/CD ,/, 66/CD +/NN //NN -/NN 4/CD years/NNS ,/, body/NN fat/JJ 26/CD +/NN //NN -/NN 6%/JJ ,/, VO2max/NN 26/NN +/NN //NN -/NN 3/CD ml/NN kg-1/NN min-1/NN )/SYM ./.
@@118725701763 Dementia/NN is/NNS being/VBP avoided/VBN in/IN NHS/NN and/CC social/JJ care/NN ./.
@@1531086839 The/DT cDNA/NN has/VBZ an/DT open/JJ reading/JJ frame/NN of/IN 900/CD amino/JJ acids/NNS capable/JJ of/IN encoding/VBG a/DT 97-kDa/NN protein/NN ./.
@@112831684522 Two/CD independent/JJ transgenic/JJ lines/NNS were/VBD produced/VBN ,/, and/CC both/DT showed/VBN expression/NN of/IN the/DT Gus/NEWGENE gene/NEWGENE specifically/RB in/IN the/DT endosperm/NN during/IN mid-development/JJ (/( first/RB detected/VBN 10-12/CD d/NN after/IN anthesis/NN )/SYM ./.
@@77614677637 The/DT second/JJ complex/NN ,/, when/CC purified/VBN ,/, contained/VBN four/CD protein/NN components/NNS including/JJ the/DT 36-kDa/NN protein/NN ./.
@@74882911536 Histopathologic/NNP observations/NNS showed/VBN that/IN both/DT somatostatin/NEWGENE and/CC triamcinolone/NN acetonide/NN reduced/VBD the/DT inflammatory/JJ signs/NNS in/IN the/DT joint/JJ structures/NNS ,/, although/IN triamcinolone/NN acetonide/NN appeared/VBN to/IN be/VB more/RB effective/JJ ./.
@@77608442585 Induction/NNS in/IN AP-1/NEWGENE DNA/NN binding/JJ correlates/VBP with/IN a/DT concomitant/JJ GH/NEWGENE trans-activation/NN of/IN c-jun/NEWGENE and/CC c-fos/NEWGENE genes/NEWGENE described/VBN previously/RB ./.
@@31430489193 HDL-cholesterol/NN (/( +6%/NN ,/, P/NN less/PRP than/IN ./CD 01/CD )/SYM and/CC apolipoprotein/NEWGENE A-I/NEWGENE (/( +6%/NN ,/, P/NN less/PRP than/IN ./CD 01/CD )/SYM concentrations/NNS increased/VBN significantly/RB only/RB in/IN the/DT young/NN ./.
@@97996349433 We/PRP have/VBP generated/VBN a/DT computer/NN model/NN of/IN the/DT C-terminal/NN domain/NN of/IN the/DT 434/CD repressor/NN based/VBN on/IN the/DT crystal/NN structure/NN of/IN the/DT homologous/NEWGENE UmuD'/NEWGENE protein/NEWGENE ./.
@@106790658146 Activation/NNS of/IN a/DT CRE-dependent/NEWGENE junB/NEWGENE promoter/NEWGENE //NEWGENE chloramphenicol/NEWGENE acetyltransferase/NEWGENE (/( CAT/NEWGENE )/SYM reporter/NN gene/NN by/IN the/DT BCR/NEWGENE was/VBD also/RB blocked/VBN by/IN SB203580/NN ./.
@@36982518879 Oxygen/NN delivery/NN and/CC consumption/NN and/CC P50/NN in/IN patients/NNS with/IN acute/JJ myocardial/JJ infarction/NN ./.
@@81018439594 The/DT tyrosine/NEWGENE hydroxylase/NEWGENE gene/NEWGENE (/( TH/NEWGENE )/SYM contains/VBZ a/DT single/JJ copy/NN of/IN a/DT consensus/NN CRE/NEWGENE at/IN -45/CD to/IN -38/CD base/NN pair/NN (/( bp/NN )/SYM upstream/RB of/IN the/DT transcription/NN initiation/NN site/NN ./.
@@76639637589 Adrenergic/JJ system/NN activation/NN ,/, indicated/VBN by/IN metanephrine/NN //NN epinephrine/NN ratio/NN ,/, increased/VBN with/IN time/NN in/IN losing/JJ males/NNS ,/, except/VB that/IN after/IN one/PRP month/NN of/IN cohabitation/NN ,/, turnover/NN returned/VBD to/IN levels/NNS that/WDT equaled/VBD those/DT of/IN control/NN animals/NNS ./.
@@9489670626 In/NNP C/NNP ./NNP albicans/JJ ,/, HST6/NEWGENE is/VBZ expressed/VBN constitutively/RB at/IN high/JJ levels/NNS in/IN the/DT different/JJ cell/NN types/NNS analysed/VBN (/( yeast/NN ,/, hyphae/NNS ,/, white/JJ and/CC opaque/JJ )/SYM ,/, demonstrating/VBG that/IN HST6/NEWGENE transcription/NN is/VBZ not/RB repressed/VBN in/IN this/DT diploid/JJ yeast/NN ,/, unlike/IN in/IN diploid/JJ S/NNP ./NNP cerevisiae/NN ,/, and/CC suggesting/VBG a/DT basic/JJ biological/JJ function/NN for/IN the/DT Hst6p/NEWGENE transporter/NN in/IN C/NNP ./NNP albicans/JJ ./.
@@80314248026 Ketamine/IN in/IN the/DT treatment/NN of/IN bronchospasm/NN during/IN mechanical/JJ ventilation/NN ./.
@@31108018823 It/PRP is/VBZ concluded/VBN that/IN the/DT plasma/NEWGENE prolactin/NEWGENE response/NN to/IN 12/CD ./CD 5/CD micrograms/NNS i/CD ./CD v/CD ./.
@@21165379066 But/CC no/DT influence/NN was/VBD observed/VBN at/IN lower/JJR concentrations/NNS than/IN 1/CD //CD 4/CD MIC/NN of/IN AMK/NN ./.
@@6289906082 Three/CD patients/NNS with/IN four/CD renoureteral/JJ units/NNS have/VBP undergone/VBP single-stage/VBG reconstruction/NN involving/VBG ureteroureterostomy/NN and/CC ipsilateral/JJ ureteroneocystostomy/NN following/IN temporary/JJ loop/NN cutaneous/JJ ureterostomy/NN ./.
@@9885725577 Oxygen/NN tension/NN of/IN the/DT small/JJ lymph/NN vessels/NNS (/( PLO2/NN )/SYM of/IN the/DT rabbit/NN hind/JJ limb/NN was/VBD measured/VBN with/IN both/PDT a/DT flow-through/NN micro/NN chamber/NN and/CC a/DT polarographic/JJ catheter-tip/NN oxygen/NN electrode/NN to/IN obtain/VB experimental/JJ data/NN on/IN the/DT source/NN of/IN oxygen/NN in/IN the/DT lymph/NN ./.
@@18981131797 The/DT smaller/JJR uptake/NN rate/NN and/CC faster/JJR clearance/NN rate/NN resulted/VBN in/IN the/DT lower/JJR BCF/NN for/IN SWA/NNS killifish/NN ./.
@@107601696970 The/DT second/JJ functional/JJ pair/NN of/IN CreA/NEWGENE sites/NEWGENE is/VBZ located/VBN between/IN the/DT two/JJ transcription/NN initiation/NN sites/NNS ./.
@@10594130419 Six/CD out/RB of/IN ten/CD hearts/NNS from/IN macerated/JJ stillborn/JJ infants/NNS showed/VBD varying/JJ degrees/NNS of/IN positive/JJ staining/NN ./.
@@105675815891 The/DT proliferation-specific/JJ HNF-3/NEWGENE //NEWGENE fork/NEWGENE head/NEWGENE homolog-11B/NEWGENE protein/NEWGENE (/( HFH-11B/NEWGENE ;/: also/RB known/VBP as/IN Trident/NEWGENE and/CC Win/NEWGENE )/SYM is/VBZ a/DT family/NN member/NN of/IN the/DT winged/NEWGENE helix/NEWGENE //NEWGENE fork/NEWGENE head/NEWGENE transcription/NEWGENE factors/NEWGENE and/CC in/IN regenerating/JJ liver/NN its/PRP expression/NN is/VBZ reactivated/VBN prior/NN to/IN hepatocyte/NN entry/NN into/IN DNA/NN replication/NN (/( S/NNP phase/NN )/SYM ./.
@@104825168335 In/NN vitro/FW transcription/NN results/NNS indicate/VBP that/IN this/DT 5'/NN structure/NN functions/NNS in/IN the/DT attenuation/NN mechanism/NN ,/, since/IN deletion/NN of/IN the/DT stem-loop/NN caused/VBD an/DT increase/NN in/IN transcription/NN readthrough/NN ./.
@@88955798855 Northern/NNP blotting/NN showed/VBN that/IN MDMX/NEWGENE ,/, like/JJ MDM2/NEWGENE ,/, is/VBZ expressed/VBN in/IN all/DT tissues/NNS tested/VBN ,/, and/CC that/IN several/DT mRNAs/NNS for/IN MDMX/NEWGENE can/MD be/VB detected/VBN ./.
@@11370174506 The/DT mean/JJ serum/JJ creatinine/NN level/NN did/VBD not/RB change/VB during/IN the/DT first/JJ 6/CD months/NNS after/IN withdrawal/NN of/IN MMF/NN ./.
@@95912219544 Control/NNP subjects'/NN evoked/VBD potentials/NNS (/( EPs/NNS )/SYM were/VBD characterized/VBN by/IN an/DT initial/JJ positivity/NN in/IN the/DT 90-140/CD ms/NN range/NN (/( P1/NN )/SYM at/IN the/DT temporo-occipital/JJ site/NN ./.
@@24832108981 The/DT diagnostic/JJ value/NN of/IN blood/NN serum/JJ and/CC urinary/NEWGENE amylase/NEWGENE ,/, lipase/NEWGENE ,/, and/CC trypsin/NEWGENE in/IN exacerbations/NNS of/IN chronic/JJ relapsing/JJ pancreatitis/NN is/VBZ discussed/VBN ./.
@@100667908146 Gel/NNP filtration/NN ,/, sedimentation/NN velocity/NN ,/, and/CC immunoprecipitation/NN experiments/NNS revealed/VBN that/IN beta4/NEWGENE is/VBZ a/DT component/NN of/IN a/DT multisubunit/JJ complex/NN (/( AP-4/NEWGENE )/SYM that/WDT also/RB contains/VBZ the/DT sigma4/NEWGENE polypeptide/NEWGENE and/CC two/JJ additional/JJ adaptor/NN subunit/NN homologs/NNS named/VBN mu4/NEWGENE (/( mu-ARP2/NEWGENE )/SYM and/CC epsilon/NEWGENE ./.
@@35049713979 Hexsyn/NN is/VBZ the/DT Goodyear/NNP Tire/NNP and/CC Rubber/NNP Company/NNP tradename/NN for/IN a/DT polyolefin/NN rubber/NN synthesized/VBN from/IN 1-hexene/JJ with/IN 3-5%/JJ methylhexadiene/NN as/IN the/DT source/NN of/IN residual/JJ double/JJ bonds/NNS for/IN vulcanization/NN ./.
@@112975145718 The/DT recessive/JJ hos1/NEWGENE mutation/NN causes/NNS enhanced/VBD induction/NN of/IN the/DT CBF/NEWGENE transcription/NEWGENE factors/NEWGENE by/IN low/JJ temperature/NN as/RB well/VB as/IN of/IN their/PRP downstream/RB cold-responsive/JJ genes/NNS ./.
@@78621506207 This/DT mutant/NN was/VBD identified/VBN by/IN screening/JJ with/IN a/DT TGF-beta-inducible/NNP vector/NN a/DT series/NN of/IN mink/NN lung/NN epithelial/JJ cell/NN clones/NNS that/WDT have/VBP normal/JJ TGF-beta/NEWGENE binding/JJ activity/NN but/CC have/VB lost/VBP antiproliferative/JJ and/CC transcriptional/JJ responses/NNS to/IN TGF-beta/NEWGENE ./.
@@89518158132 Regulation/NN of/IN ASN1/NEWGENE and/CC ASN2/NEWGENE expression/NN was/VBD studied/VBN using/VBG lacZ/NEWGENE fusions/NEWGENE and/CC both/DT genes/NNS were/VBD found/VBN to/IN be/VB several/DT times/NNS less/PRP expressed/VBN in/IN the/DT absence/NN of/IN the/DT transcription/NN activator/NN Gcn4p/NEWGENE ./.
@@94510164840 GlcNAc-/NN and/CC GlcNAc2-PP-Dolichol/NEWGENE biosynthesis/NN could/MD be/VB shown/VBP with/IN isolated/VBN S/NNP ./NNP cerevisiae/NNP membranes/NNS from/IN cells/NNS harboring/VBG the/DT recombinant/JJ plasmid/NN and/CC grown/VBP on/IN glucose/NN thus/RB suppressing/JJ transcription/NN of/IN the/DT endogenous/JJ gene/NN ./.
@@97802282609 The/DT predicted/VBN domain/NN structures/NNS of/IN FkbB/NEWGENE and/CC FkbC/NEWGENE are/VBP analogous/JJ to/IN that/DT of/IN FkbA/NEWGENE and/CC comprise/VB 30/CD fatty-acid-synthase/NEWGENE (/NEWGENE FAS/NEWGENE )/NEWGENE -like/NEWGENE domains/NEWGENE arranged/VBN in/IN 6/CD modules/NNS ./.
@@94694151126 The/DT observation/NN that/DT beta/NEWGENE 2m/NEWGENE with/IN covalently/RB attached/VBN peptide/NN can/MD effectively/RB create/VB CTL/NN target/NN structures/NNS in/IN vitro/FW offers/VBP new/JJ possibilities/NNS for/IN the/DT in/NN vivo/NN induction/NN of/IN epitope-specific/NN CTL/NN responses/NNS by/IN either/DT DNA/NN immunization/NN or/CC injection/NN of/IN the/DT purified/VBN epitope-linked/NN beta/NEWGENE 2m/CD ./CD
@@95933022443 The/DT mechanistic/JJ implications/NNS of/IN aromatic/JJ non-responsiveness/NN of/IN autonomously/RB expressed/VBN A-domain/NNS ,/, despite/IN its/PRP demonstrated/VBN ability/NN to/IN bind/NN phenol/NN ,/, are/VBP discussed/VBN ./.
@@6178155999 No/DT systematic/JJ L-R/NN differences/NNS were/VBD observed/VBN ./.
@@78916387870 Computerized/JJ detection/NN of/IN abnormal/JJ asymmetry/NN in/IN digital/JJ chest/NN radiographs/NNS ./.
@@72709917123 When/WRB pollen/NN allergen/NN from/IN three/CD grass/NN species/NN were/VBD used/VBN ,/, The/DT RAST-test/NN results/NNS did/VBD not/RB differ/VB from/IN duplicate/JJ values/NNS either/RB ./.
@@92037315716 In/NN 1990/CD ,/, an/DT International/NNP Commission/NNP for/IN the/DT Certification/NNP of/IN Eradication/NNS of/IN Poliomyelitis/NN Eradication/NNS (/( ICCPE/NNP )/SYM was/VBD established/VBN by/IN the/DT Pan/NNP American/NNP Health/NNP Organization/NNP to/IN eventually/RB determine/VB if/IN transmission/NN was/VBD interrupted/VBN ./.
@@79889457976 New/NNP diagnostic/JJ strategies/NNS for/IN lupus/NN anticoagulants/NNS and/CC antiphospholipid/NEWGENE antibodies/NEWGENE ./.
@@85811747492 A/DT genetic/JJ and/CC molecular/JJ analysis/NN of/IN non-inducible/JJ qutA/NEWGENE mutants/NEWGENE showed/VBN that/IN all/DT 23/CD mutations/NNS analysed/VBN map/NN within/IN the/DT N-terminal/NN half/NN of/IN the/DT encoded/VBN QUTA/NEWGENE protein/NEWGENE ./.
@@111691495418 To/TO the/DT best/JJS of/IN our/PRP knowledge/NN ,/, SNTCS/NN is/VBZ highly/RB malignant/JJ ./.
@@49093555233 Motile/NNP nocardoid/NNP Actinomycetales/NNP ./.
@@76996327642 Our/PRP data/NN complement/NN other/DT studies/NNS of/IN circumpolar/JJ populations/NNS and/CC reinforce/VB the/DT reported/VBN high/JJ prevalences/NNS of/IN SPA/NN and/CC HLA-B27/NEWGENE among/IN those/DT populations/NNS ./.
@@93985987492 Here/RB ,/, we/PRP report/VBP that/IN a/DT transfected/VBN Chinese/JJ hamster/NN ovary/NN (/( CHO/NN )/SYM cell/NN line/NN expressing/NN a/NN murine/NEWGENE CD4/NEWGENE fragment/NEWGENE containing/JJ the/DT first/JJ two/JJ N-terminal/NN domains/NN secretes/VBZ both/DT monomeric/JJ molecules/NNS and/CC disulfide-linked/NN multimers/NN ./.
